[["index.html", "SCOPE &amp; STOP Hormones Analysis Overview", " SCOPE &amp; STOP Hormones Analysis 17 August 2023 Overview This page contains analysis results for SCOPE and STOP Hormones. Part I: Raw Data This section contains methods to estimate hormone concentrations used in analyses. Part II: Association with Factors This section contains results from all available data in SCOPE and STOP. Part III: Uncomplicated Pregnancies This section contains results for Uncomplicated pregnancies only in SCOPE and STOP. Part IV: GDM Cases This section contains results for GDM cases only in SCOPE and STOP. Part V: Non-GDM Cases This section contains results for non-GDM cases only in SCOPE and STOP. Part VI: GDM vs Uncomplicated This section contains results for GDM vs Uncomplicated pregnancies in SCOPE and STOP. Participants with other outcomes were excluded in this section. Part VII: GDM vs non-GDM This section contains results for GDM vs non-GDM cases in SCOPE and STOP. "],["part-raw-data.html", "(PART*) Raw Data", " (PART*) Raw Data "],["standard-curves.html", "1 Standard Curves", " 1 Standard Curves This section contains standard curves fitted for Prolactin, HPL, and GH2. GH2 Plate 22 (28-2-22) omitted due to invalid standard curve. Inter-assay CV for Prolactin and HPL higher than recommended 15%. According to the protocols, the following methods were used for curve fitting: - Prolactin: Quadratic - HPL: 4-parameter Logistic - GH2: non-linear splines "],["prolactin.html", "1.1 Prolactin", " 1.1 Prolactin 1.1.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;Prolactin_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL Combined Abs standards only&quot;) std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates # samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;Prolactin_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL SCOPE and STOP combined Abs &quot;) samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates 1.1.1.1 Standard concentration by plate Click for more details Concentration 0 5 15 50 100 200 Assay 1 1 1 1 1 1 1 Assay 2 1 1 1 1 1 1 Assay 3 1 1 1 1 1 1 Assay 4 1 1 1 1 1 1 Assay 5 1 1 1 1 1 1 Assay 6 1 1 1 1 1 1 Assay 7 1 1 1 1 1 1 Assay 8 1 1 1 1 1 1 Assay 9 1 1 1 1 1 1 Assay 10 1 1 1 1 1 1 Assay 11 1 1 1 1 1 1 Assay 12 1 1 1 1 1 1 Assay 13 1 1 1 1 1 1 Assay 14 1 1 1 1 1 1 Assay 15 1 1 1 1 1 1 Assay 16 1 1 1 1 1 1 Assay 17 1 1 1 1 1 1 Assay 18 1 1 1 1 1 1 Assay 19 1 1 1 1 1 1 Assay 20 1 1 1 1 1 1 Assay 21 1 1 1 1 1 1 Assay 22 1 1 1 1 1 1 Assay 23 1 1 1 1 1 1 Assay 24 1 1 1 1 1 1 Assay 25 1 1 1 1 1 1 Assay 26 1 1 1 1 1 1 Assay 27 1 1 1 1 1 1 Assay 28 1 1 1 1 1 1 Assay 29 1 1 1 1 1 1 Assay 30 1 1 1 1 1 1 Assay 31 1 1 1 1 1 1 Assay 32 1 1 1 1 1 1 Assay 33 1 1 1 1 1 1 Assay 34 1 1 1 1 1 1 Assay 35 1 1 1 1 1 1 Assay 36 1 1 1 1 1 1 Assay 37 1 1 1 1 1 1 Assay 38 1 1 1 1 1 1 Assay 39 1 1 1 1 1 1 Assay 40 1 1 1 1 1 1 Assay 41 1 1 1 1 1 1 Assay 42 1 1 1 1 1 1 Assay 43 1 1 1 1 1 1 Assay 44 1 1 1 1 1 1 Assay 45 1 1 1 1 1 1 Assay 46 1 1 1 1 1 1 Assay 47 1 1 1 1 1 1 Assay 48 1 1 1 1 1 1 Assay 49 1 1 1 1 1 1 Assay 50 1 1 1 1 1 1 Assay 51 1 1 1 1 1 1 Assay 52 1 1 1 1 1 1 Assay 53 1 1 1 1 1 1 Assay 54 1 1 1 1 1 1 Assay 55 1 1 1 1 1 1 Assay 56 1 1 1 1 1 1 Assay 57 1 1 1 1 1 1 1.1.1.2 Samples by plate Click for more details Study SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 22 18 40 Assay 19 15 1 16 Assay 20 12 29 41 Assay 21 5 35 40 Assay 22 22 18 40 Assay 23 15 25 40 Assay 24 15 25 40 Assay 25 26 14 40 Assay 26 23 17 40 Assay 27 23 17 40 Assay 28 18 22 40 Assay 29 21 19 40 Assay 30 20 20 40 Assay 31 17 23 40 Assay 32 30 10 40 Assay 33 18 22 40 Assay 34 25 15 40 Assay 35 25 15 40 Assay 36 23 17 40 Assay 37 24 16 40 Assay 38 22 18 40 Assay 39 20 20 40 Assay 40 25 15 40 Assay 41 21 19 40 Assay 42 20 20 40 Assay 43 14 26 40 Assay 44 24 16 40 Assay 45 17 23 40 Assay 46 21 19 40 Assay 47 18 22 40 Assay 48 23 17 40 Assay 49 22 18 40 Assay 50 21 19 40 Assay 51 20 20 40 Assay 52 21 19 40 Assay 53 28 12 40 Assay 54 26 14 40 Assay 55 23 17 40 Assay 56 18 22 40 Assay 57 19 14 33 1.1.2 CV ## Inter-assay CV cv_dat &lt;- std_raw #cv_dat &lt;- std_raw[with(std_raw,get(conc_name)&lt;=50),] #cv_dat &lt;- std_raw[!std_raw$Assay%in%c(2,6,7,11,18,19),] cv_dat$Group &lt;- as.factor(with(cv_dat,get(conc_name))) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$&quot;Abs Ave&quot;,x$Group,mean,na.tm=T))) cv_mean_dat[cv_mean_dat&lt;0.0000001] &lt;- 0 cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_gps[is.nan(cv_gps)] &lt;- 0 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) cv_intra &lt;- mean(samp_cv) Inter-assay CV = 25.25% from 57 assays. Intra-assay CV = 3.85% from 2247 sample measurements. 1.1.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ poly(Conc,2,raw=T),data=std_ls[[k]])}) #fit quadratic #std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ Conc + I(Conc^2),data=std_ls[[k]])}) #fit model std_fit2 &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit splines Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 57 1.1.4 Session info Results generated on: 2023-08-17 11:27:48.326579 Click for more details sessionInfo() ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] splines grid stats graphics grDevices utils datasets ## [8] methods base ## ## other attached packages: ## [1] widgetframe_0.3.1 fontawesome_0.5.1 doFuture_1.0.0 future_1.32.0 ## [5] foreach_1.5.2 plotly_4.10.2 investr_1.4.2 readxl_1.4.2 ## [9] htmlwidgets_1.6.2 kableExtra_1.3.4 knitr_1.42 rmarkdown_2.21 ## [13] ggplot2_3.4.2 devtools_2.4.3 usethis_2.1.5 pander_0.6.5 ## [17] magrittr_2.0.3 gridExtra_2.3 ## ## loaded via a namespace (and not attached): ## [1] gtable_0.3.3 xfun_0.39 bslib_0.4.2 remotes_2.4.2 ## [5] processx_3.8.1 callr_3.7.3 crosstalk_1.2.0 vctrs_0.6.3 ## [9] tools_4.3.1 ps_1.7.5 generics_0.1.3 parallel_4.3.1 ## [13] tibble_3.2.1 fansi_1.0.4 highr_0.10 pkgconfig_2.0.3 ## [17] data.table_1.14.8 webshot_0.5.4 lifecycle_1.0.3 compiler_4.3.1 ## [21] stringr_1.5.0 munsell_0.5.0 codetools_0.2-19 htmltools_0.5.5 ## [25] sass_0.4.6 yaml_2.3.7 lazyeval_0.2.2 tidyr_1.3.0 ## [29] pillar_1.9.0 crayon_1.5.2 jquerylib_0.1.4 ellipsis_0.3.2 ## [33] cachem_1.0.8 iterators_1.0.14 sessioninfo_1.2.2 parallelly_1.36.0 ## [37] tidyselect_1.2.0 rvest_1.0.3 digest_0.6.33 stringi_1.7.12 ## [41] listenv_0.8.0 dplyr_1.1.2 purrr_1.0.1 bookdown_0.34 ## [45] fastmap_1.1.1 colorspace_2.1-0 cli_3.6.1 pkgbuild_1.4.0 ## [49] utf8_1.2.3 future.apply_1.8.1 withr_2.5.0 prettyunits_1.1.1 ## [53] scales_1.2.1 httr_1.4.2 globals_0.16.2 cellranger_1.1.0 ## [57] memoise_2.0.1 evaluate_0.21 viridisLite_0.4.2 rlang_1.1.1 ## [61] Rcpp_1.0.11 glue_1.6.2 xml2_1.3.3 pkgload_1.3.2 ## [65] svglite_2.1.0 rstudioapi_0.14 jsonlite_1.8.4 R6_2.5.1 ## [69] systemfonts_1.0.4 fs_1.6.2 "],["hpl.html", "1.2 HPL", " 1.2 HPL 1.2.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;HPL_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs standards&quot;) std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates #std_raw$Abs.ave &lt;- std_raw$&quot;Abs Ave&quot; std_qc &lt;- read.csv(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;HPL_QC.csv&quot;),header=T) #standards QC std_qc$Abs.ave &lt;- apply(std_qc[,c(&quot;Abs.1&quot;,&quot;Abs.2&quot;)],1,mean,na.rm=T) #average replicates # samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;HPL_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs samples&quot;) #samples samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates samp_raw$Abs.ave[samp_raw$Abs.ave&lt;0] &lt;- 0 #restrict to &gt;=0 Standard concentration by plate Click for more details Concentration St 0 St 1.25 St 10 St 20 St 5 Assay 1 1 1 1 1 1 Assay 2 1 1 1 1 1 Assay 3 1 1 1 1 1 Assay 4 1 1 1 1 1 Assay 5 1 1 1 1 1 Assay 6 1 1 1 1 1 Assay 7 1 1 1 1 1 Assay 8 1 1 1 1 1 Assay 9 1 1 1 1 1 Assay 10 1 1 1 1 1 Assay 11 1 1 1 1 1 Assay 12 1 1 1 1 1 Assay 13 1 1 1 1 1 Assay 14 1 1 1 1 1 Assay 15 1 1 1 1 1 Assay 16 1 1 1 1 1 Assay 17 1 1 1 1 1 Assay 18 1 1 1 1 1 Assay 19 1 1 1 1 1 Assay 20 1 1 1 1 1 Assay 21 1 1 1 1 1 Assay 22 1 1 1 1 1 Assay 23 1 1 1 1 1 Assay 24 1 1 1 1 1 Assay 25 1 1 1 1 1 Assay 26 1 1 1 1 1 Assay 27 1 1 1 1 1 Assay 28 1 1 1 1 1 Assay 29 1 1 1 1 1 Assay 30 1 1 1 1 1 Assay 31 1 1 1 1 1 Assay 32 1 1 1 1 1 Assay 33 1 1 1 1 1 Assay 34 1 1 1 1 1 Assay 35 1 1 1 1 1 Assay 36 1 1 1 1 1 Assay 37 1 1 1 1 1 Assay 38 1 1 1 1 1 Assay 39 1 1 1 1 1 Assay 40 1 1 1 1 1 Assay 41 1 1 1 1 1 Assay 42 1 1 1 1 1 Assay 43 1 1 1 1 1 Assay 44 1 1 1 1 1 Assay 45 1 1 1 1 1 Assay 46 1 1 1 1 1 Assay 47 1 1 1 1 1 Assay 48 1 1 1 1 1 Assay 49 1 1 1 1 1 Assay 50 1 1 1 1 1 Assay 51 1 1 1 1 1 Assay 52 1 1 1 1 1 Assay 53 1 1 1 1 1 Assay 54 1 1 1 1 1 Assay 55 1 1 1 1 1 Assay 56 1 1 1 1 1 Assay 57 1 1 1 1 1 Samples by plate Click for more details Concentration SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 23 18 41 Assay 19 12 0 12 Assay 20 27 13 40 Assay 21 22 18 40 Assay 22 22 18 40 Assay 23 15 25 40 Assay 24 15 25 40 Assay 25 26 14 40 Assay 26 23 17 40 Assay 27 23 17 40 Assay 28 18 22 40 Assay 29 21 19 40 Assay 30 20 20 40 Assay 31 17 23 40 Assay 32 30 10 40 Assay 33 18 22 40 Assay 34 25 15 40 Assay 35 25 15 40 Assay 36 23 17 40 Assay 37 24 16 40 Assay 38 22 18 40 Assay 39 20 20 40 Assay 40 25 15 40 Assay 41 21 19 40 Assay 42 20 20 40 Assay 43 14 26 40 Assay 44 24 16 40 Assay 45 17 23 40 Assay 46 21 19 40 Assay 47 18 22 40 Assay 48 23 17 40 Assay 49 22 18 40 Assay 50 21 19 40 Assay 51 20 20 40 Assay 52 21 19 40 Assay 53 28 12 40 Assay 54 26 14 40 Assay 55 23 17 40 Assay 56 18 22 40 Assay 57 19 14 33 1.2.2 CV ## Inter-assay CV cv_dat &lt;- std_qc cv_dat$Group &lt;- as.factor(with(cv_dat,Standard.conc..pg.ml.)) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$Abs.Ave,x$Group,mean,na.tm=T))) cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) cv_intra &lt;- mean(samp_cv) Inter-assay CV = 20% from 57 assays. Intra-assay CV = 7.81% from 2243 sample measurements. 1.2.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate fit.4PL &lt;- function(x,a,b,g,d){return(d + ((a-d)/(1+((x/g)^b))))} #f1 &lt;- nls(Abs.ave ~ d + ((a-d)/(1+((Conc/g)^b))),data=std_ls[[1]],start=list(a=-1,b=1,g=5,d=2)) #std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit splines std_fit &lt;- lapply(1:length(std_ls),function(k){ #fit 4PL start_ls &lt;- list(a=floor(min(std_ls[[k]][,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)])), b=1,g=5, d=ceiling(max(std_ls[[k]][,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)]))) fit &lt;- NULL try(fit &lt;- nls(Abs.ave ~ fit.4PL(Conc,a,b,g,d),data=std_ls[[k]],start=start_ls),silent=T) if(is.null(fit)){fit &lt;- nlsLM(Abs.ave ~ fit.4PL(Conc,a,b,g,d),data=std_ls[[k]],start=start_ls)} return(fit)}) Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 57 1.2.4 Session info Results generated on: 2023-08-17 11:27:48.370312 Click for more details sessionInfo() ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] splines grid stats graphics grDevices utils datasets ## [8] methods base ## ## other attached packages: ## [1] minpack.lm_1.2-3 nlme_3.1-162 widgetframe_0.3.1 fontawesome_0.5.1 ## [5] doFuture_1.0.0 future_1.32.0 foreach_1.5.2 plotly_4.10.2 ## [9] investr_1.4.2 readxl_1.4.2 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [13] knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.3 ## [17] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## ## loaded via a namespace (and not attached): ## [1] gtable_0.3.3 xfun_0.39 bslib_0.4.2 remotes_2.4.2 ## [5] processx_3.8.1 lattice_0.21-8 callr_3.7.3 crosstalk_1.2.0 ## [9] vctrs_0.6.3 tools_4.3.1 ps_1.7.5 generics_0.1.3 ## [13] parallel_4.3.1 tibble_3.2.1 fansi_1.0.4 highr_0.10 ## [17] pkgconfig_2.0.3 data.table_1.14.8 webshot_0.5.4 lifecycle_1.0.3 ## [21] compiler_4.3.1 stringr_1.5.0 munsell_0.5.0 codetools_0.2-19 ## [25] htmltools_0.5.5 sass_0.4.6 yaml_2.3.7 lazyeval_0.2.2 ## [29] tidyr_1.3.0 pillar_1.9.0 crayon_1.5.2 jquerylib_0.1.4 ## [33] ellipsis_0.3.2 cachem_1.0.8 iterators_1.0.14 sessioninfo_1.2.2 ## [37] parallelly_1.36.0 tidyselect_1.2.0 rvest_1.0.3 digest_0.6.33 ## [41] stringi_1.7.12 listenv_0.8.0 dplyr_1.1.2 purrr_1.0.1 ## [45] bookdown_0.34 fastmap_1.1.1 colorspace_2.1-0 cli_3.6.1 ## [49] pkgbuild_1.4.0 utf8_1.2.3 future.apply_1.8.1 withr_2.5.0 ## [53] prettyunits_1.1.1 scales_1.2.1 httr_1.4.2 globals_0.16.2 ## [57] cellranger_1.1.0 memoise_2.0.1 evaluate_0.21 viridisLite_0.4.2 ## [61] rlang_1.1.1 Rcpp_1.0.11 glue_1.6.2 xml2_1.3.3 ## [65] pkgload_1.3.2 svglite_2.1.0 rstudioapi_0.14 jsonlite_1.8.4 ## [69] R6_2.5.1 systemfonts_1.0.4 fs_1.6.2 "],["gh2.html", "1.3 GH2", " 1.3 GH2 1.3.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;GH2_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs standards only&quot;) #standards std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates std_raw$Abs.ave[std_raw$Abs.ave&lt; 1e-10] &lt;- 0 ## samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;GH2_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs samples&quot;) #samples samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates Standard concentration by plate Click for more details Concentration 0 78.125 156.25 312.5 625 1250 2500 5000 Assay 1 1 1 1 1 1 1 1 1 Assay 2 1 1 1 1 1 1 1 1 Assay 3 1 1 1 1 1 1 1 1 Assay 4 1 1 1 1 1 1 1 1 Assay 5 1 1 1 1 1 1 1 1 Assay 6 1 1 1 1 1 1 1 1 Assay 7 1 1 1 1 1 1 1 1 Assay 8 1 1 1 1 1 1 1 1 Assay 9 1 1 1 1 1 1 1 1 Assay 10 1 1 1 1 1 1 1 1 Assay 11 1 1 1 1 1 1 1 1 Assay 12 1 1 1 1 1 1 1 1 Assay 13 1 1 1 1 1 1 1 1 Assay 14 1 1 1 1 1 1 1 1 Assay 15 1 1 1 1 1 1 1 1 Assay 16 1 1 1 1 1 1 1 1 Assay 17 1 1 1 1 1 1 1 1 Assay 18 1 1 1 1 1 1 1 1 Assay 19 1 1 1 1 1 1 1 1 Assay 20 1 1 1 1 1 1 1 1 Assay 21 1 1 1 1 1 1 1 1 Assay 22 1 1 1 1 1 1 1 1 Assay 23 1 1 1 1 1 1 1 1 Assay 24 1 1 1 1 1 1 1 1 Assay 25 1 1 1 1 1 1 1 1 Assay 26 1 1 1 1 1 1 1 1 Assay 27 1 1 1 1 1 1 1 1 Assay 28 1 1 1 1 1 1 1 1 Assay 29 1 1 1 1 1 1 1 1 Assay 30 1 1 1 1 1 1 1 1 Assay 31 1 1 1 1 1 1 1 1 Assay 32 1 1 1 1 1 1 1 1 Assay 33 1 1 1 1 1 1 1 1 Assay 34 1 1 1 1 1 1 1 1 Assay 35 1 1 1 1 1 1 1 1 Assay 36 1 1 1 1 1 1 1 1 Assay 37 1 1 1 1 1 1 1 1 Assay 38 1 1 1 1 1 1 1 1 Assay 39 1 1 1 1 1 1 1 1 Assay 40 1 1 1 1 1 1 1 1 Assay 41 1 1 1 1 1 1 1 1 Assay 42 1 1 1 1 1 1 1 1 Assay 43 1 1 1 1 1 1 1 1 Assay 44 1 1 1 1 1 1 1 1 Assay 45 1 1 1 1 1 1 1 1 Assay 46 1 1 1 1 1 1 1 1 Assay 47 1 1 1 1 1 1 1 1 Assay 48 1 1 1 1 1 1 1 1 Assay 49 1 1 1 1 1 1 1 1 Assay 50 1 1 1 1 1 1 1 1 Assay 51 1 1 1 1 1 1 1 1 Assay 52 1 1 1 1 1 1 1 1 Assay 53 1 1 1 1 1 1 1 1 Assay 54 1 1 1 1 1 1 1 1 Assay 55 1 1 1 1 1 1 1 1 Assay 56 1 1 1 1 1 1 1 1 Assay 57 1 1 1 1 1 1 1 1 Assay 58 1 1 1 1 1 1 1 1 Assay 59 1 1 1 1 1 1 1 1 Samples by plate Click for more details Concentration SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 0 16 16 Assay 19 38 2 40 Assay 20 22 18 40 Assay 21 20 20 40 Assay 22 27 13 40 Assay 23 22 18 40 Assay 24 22 18 40 Assay 25 15 25 40 Assay 26 15 25 40 Assay 27 26 14 40 Assay 28 23 17 40 Assay 29 23 17 40 Assay 30 18 22 40 Assay 31 21 19 40 Assay 32 20 20 40 Assay 33 17 23 40 Assay 34 30 10 40 Assay 35 18 22 40 Assay 36 25 15 40 Assay 37 25 15 40 Assay 38 23 17 40 Assay 39 24 16 40 Assay 40 22 18 40 Assay 41 20 20 40 Assay 42 25 15 40 Assay 43 21 19 40 Assay 44 20 20 40 Assay 45 14 26 40 Assay 46 24 16 40 Assay 47 17 23 40 Assay 48 21 19 40 Assay 49 18 22 40 Assay 50 23 17 40 Assay 51 22 18 40 Assay 52 21 19 40 Assay 53 20 20 40 Assay 54 21 19 40 Assay 55 28 12 40 Assay 56 26 14 40 Assay 57 23 17 40 Assay 58 18 22 40 Assay 59 19 14 33 1.3.2 CV ## Inter-assay CV cv_dat &lt;- std_raw[!std_raw$Assay%in%exc_plate,] cv_dat &lt;- std_raw cv_dat$Group &lt;- as.factor(with(cv_dat,get(conc_name))) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$&quot;Abs Ave&quot;,x$Group,mean,na.tm=T))) cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_gps[is.nan(cv_gps)] &lt;- 0 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) samp_cv[is.infinite(samp_cv)|samp_cv&lt;0] &lt;- NA cv_intra &lt;- mean(samp_cv,na.rm=T) Inter-assay CV = 15.24% from 59 assays. Intra-assay CV = 3.78% from 2326 sample measurements. Plate 22 (28-2-22) omitted due to invalid standard curve. 1.3.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit model Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 59 1.3.4 Session info Results generated on: 2023-08-17 11:27:48.413638 Click for more details sessionInfo() ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] splines grid stats graphics grDevices utils datasets ## [8] methods base ## ## other attached packages: ## [1] minpack.lm_1.2-3 nlme_3.1-162 widgetframe_0.3.1 fontawesome_0.5.1 ## [5] doFuture_1.0.0 future_1.32.0 foreach_1.5.2 plotly_4.10.2 ## [9] investr_1.4.2 readxl_1.4.2 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [13] knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.3 ## [17] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## ## loaded via a namespace (and not attached): ## [1] gtable_0.3.3 xfun_0.39 bslib_0.4.2 remotes_2.4.2 ## [5] processx_3.8.1 lattice_0.21-8 callr_3.7.3 crosstalk_1.2.0 ## [9] vctrs_0.6.3 tools_4.3.1 ps_1.7.5 generics_0.1.3 ## [13] parallel_4.3.1 tibble_3.2.1 fansi_1.0.4 highr_0.10 ## [17] pkgconfig_2.0.3 data.table_1.14.8 webshot_0.5.4 lifecycle_1.0.3 ## [21] compiler_4.3.1 stringr_1.5.0 munsell_0.5.0 codetools_0.2-19 ## [25] htmltools_0.5.5 sass_0.4.6 yaml_2.3.7 lazyeval_0.2.2 ## [29] tidyr_1.3.0 pillar_1.9.0 crayon_1.5.2 jquerylib_0.1.4 ## [33] ellipsis_0.3.2 cachem_1.0.8 iterators_1.0.14 sessioninfo_1.2.2 ## [37] parallelly_1.36.0 tidyselect_1.2.0 rvest_1.0.3 digest_0.6.33 ## [41] stringi_1.7.12 listenv_0.8.0 dplyr_1.1.2 purrr_1.0.1 ## [45] bookdown_0.34 fastmap_1.1.1 colorspace_2.1-0 cli_3.6.1 ## [49] pkgbuild_1.4.0 utf8_1.2.3 future.apply_1.8.1 withr_2.5.0 ## [53] prettyunits_1.1.1 scales_1.2.1 httr_1.4.2 globals_0.16.2 ## [57] cellranger_1.1.0 memoise_2.0.1 evaluate_0.21 viridisLite_0.4.2 ## [61] rlang_1.1.1 Rcpp_1.0.11 glue_1.6.2 xml2_1.3.3 ## [65] pkgload_1.3.2 svglite_2.1.0 rstudioapi_0.14 jsonlite_1.8.4 ## [69] R6_2.5.1 systemfonts_1.0.4 fs_1.6.2 "],["plate-effect.html", "2 Plate Effect", " 2 Plate Effect This section explores the Plate effect on hormone levels. Outcomes: Prolactin, hPL, GH2 (all outcomes log-transformed) Independent variables: Plate + Study, BMI, GA at sampling Model fitted: LME model       log(hormones) ~ Plate + Study + BMI + GA at sampling       Random intercepts for Study ID There is evidence of a Plate effect and it will be adjusted for (as a random effect) in the analyses. "],["prolactin-1.html", "2.1 Prolactin", " 2.1 Prolactin Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 199.66141 1 &lt;0.0001 *** Assay.Prolactin 3242.32129 56 &lt;0.0001 *** Study 0.39792 1 0.5 ns BMI 20.34960 1 &lt;0.0001 *** GA_samp 243.34574 1 &lt;0.0001 *** 2.1.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 2.7029744 0.1912911 2699.476 14.1301595 &lt;0.0001 *** Assay.Prolactin1 0.1212429 0.1059894 2432.003 1.1439154 0.3 ns Assay.Prolactin2 -0.1778566 0.1164062 2644.382 -1.5278971 0.1 ns Assay.Prolactin3 0.0276810 0.1298168 2712.887 0.2132314 0.8 ns Assay.Prolactin4 0.6684824 0.1336746 2711.326 5.0008192 &lt;0.0001 *** Assay.Prolactin5 -2.7409455 0.1179895 2243.227 -23.2304142 &lt;0.0001 *** Assay.Prolactin6 0.6409714 0.1270956 2623.257 5.0432216 &lt;0.0001 *** Assay.Prolactin7 -0.1247035 0.1242381 2559.986 -1.0037455 0.3 ns Assay.Prolactin8 -0.0314571 0.1266782 2528.487 -0.2483227 0.8 ns Assay.Prolactin9 -0.0105195 0.1232303 2503.349 -0.0853644 0.9 ns Assay.Prolactin10 0.1684885 0.1273688 2629.966 1.3228396 0.2 ns Assay.Prolactin11 -0.1515120 0.1276569 2639.532 -1.1868684 0.2 ns Assay.Prolactin12 0.0851213 0.1324984 2702.232 0.6424328 0.5 ns Assay.Prolactin13 0.1201180 0.1242124 2510.966 0.9670369 0.3 ns Assay.Prolactin14 0.3695932 0.1201204 2438.010 3.0768571 0.002 ** Assay.Prolactin15 0.0363681 0.1199989 2386.639 0.3030705 0.8 ns Assay.Prolactin16 -0.1975497 0.1205968 2441.830 -1.6381006 0.1 ns Assay.Prolactin17 0.2384564 0.1186976 2352.060 2.0089403 0.04 * Assay.Prolactin18 -0.0096860 0.1191918 2397.717 -0.0812641 0.9 ns Assay.Prolactin19 -0.2778632 0.1327844 1795.499 -2.0925896 0.04 * Assay.Prolactin20 1.3669180 0.1168697 2375.834 11.6960823 &lt;0.0001 *** Assay.Prolactin21 0.2718832 0.1032018 2404.313 2.6344795 0.008 ** Assay.Prolactin22 -0.0736811 0.1147746 2665.747 -0.6419630 0.5 ns Assay.Prolactin23 0.6455957 0.1278116 2602.500 5.0511524 &lt;0.0001 *** Assay.Prolactin24 0.4746078 0.1293510 2658.915 3.6691463 0.0002 *** Assay.Prolactin25 0.2473075 0.1337241 2702.103 1.8493859 0.06 ns Assay.Prolactin26 -0.4426617 0.1308254 2707.453 -3.3836078 0.0007 *** Assay.Prolactin27 0.0793262 0.1311297 2706.948 0.6049448 0.5 ns Assay.Prolactin28 -0.0203714 0.1311472 2707.661 -0.1553320 0.9 ns Assay.Prolactin29 0.5754633 0.1308084 2698.094 4.3992841 &lt;0.0001 *** Assay.Prolactin30 0.1374354 0.1336598 2708.164 1.0282479 0.3 ns Assay.Prolactin31 0.7510783 0.1292684 2677.630 5.8102225 &lt;0.0001 *** Assay.Prolactin32 0.2829795 0.1298106 2693.328 2.1799418 0.03 * Assay.Prolactin33 0.2428402 0.1314159 2709.509 1.8478750 0.06 ns Assay.Prolactin34 -0.0032740 0.1281654 2623.648 -0.0255454 1.0 ns Assay.Prolactin35 0.0472200 0.1252984 2583.389 0.3768603 0.7 ns Assay.Prolactin36 -0.0709905 0.1336269 2702.845 -0.5312586 0.6 ns Assay.Prolactin37 -0.0405481 0.1316884 2710.312 -0.3079096 0.8 ns Assay.Prolactin38 0.2676561 0.1297542 2680.044 2.0627940 0.04 * Assay.Prolactin39 -0.1316890 0.1319063 2703.547 -0.9983530 0.3 ns Assay.Prolactin40 0.0215482 0.1290479 2701.244 0.1669785 0.9 ns Assay.Prolactin41 0.1862089 0.1337114 2703.047 1.3926175 0.2 ns Assay.Prolactin42 0.2115212 0.1270103 2640.916 1.6653859 0.10 ns Assay.Prolactin43 0.3240612 0.1332052 2712.017 2.4327970 0.02 * Assay.Prolactin44 0.0393886 0.1289286 2653.485 0.3055073 0.8 ns Assay.Prolactin45 0.1143590 0.1313129 2704.973 0.8708894 0.4 ns Assay.Prolactin46 0.0123467 0.1283756 2631.277 0.0961764 0.9 ns Assay.Prolactin47 -0.2727913 0.1324885 2711.041 -2.0589807 0.04 * Assay.Prolactin48 0.0159011 0.1312939 2699.744 0.1211109 0.9 ns Assay.Prolactin49 0.2076152 0.1333566 2710.643 1.5568428 0.1 ns Assay.Prolactin50 0.1781638 0.1281007 2644.721 1.3908105 0.2 ns Assay.Prolactin51 0.2760667 0.1314998 2708.357 2.0993701 0.04 * Assay.Prolactin52 -0.0623079 0.1305366 2691.379 -0.4773213 0.6 ns Assay.Prolactin54 0.2941893 0.1280834 2674.690 2.2968568 0.02 * Assay.Prolactin55 0.2087797 0.1280497 2674.447 1.6304584 0.1 ns Assay.Prolactin56 0.2677806 0.1346602 2684.107 1.9885660 0.05 ns Assay.Prolactin57 1.2168334 0.1401107 2695.656 8.6848013 &lt;0.0001 *** StudySTOP 0.0301960 0.0478687 2710.543 0.6308090 0.5 ns BMI -0.0089192 0.0019772 2628.076 -4.5110530 &lt;0.0001 *** GA_samp 0.1511183 0.0096874 2707.712 15.5995430 &lt;0.0001 *** 2.1.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Male Female Plate 1 (n=206) 0 (0.0) 206 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 206 (100.0) 0 (0.0) 92 (44.7) 114 (55.3) Plate 2 (n=86) 0 (0.0) 8 (9.3) 78 (90.7) 0 (0.0) 0 (0.0) 86 (100.0) 0 (0.0) 63 (73.3) 23 (26.7) Plate 3 (n=49) 0 (0.0) 5 (10.2) 44 (89.8) 0 (0.0) 0 (0.0) 49 (100.0) 0 (0.0) 29 (59.2) 20 (40.8) Plate 4 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 23 (53.5) 20 (46.5) Plate 5 (n=45) 0 (0.0) 5 (11.1) 40 (88.9) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 25 (55.6) 20 (44.4) Plate 6 (n=45) 0 (0.0) 5 (11.1) 40 (88.9) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 16 (35.6) 29 (64.4) Plate 7 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 34 (70.8) 14 (29.2) Plate 8 (n=40) 0 (0.0) 5 (12.5) 35 (87.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 9 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 27 (56.2) 21 (43.8) Plate 10 (n=44) 0 (0.0) 6 (13.6) 38 (86.4) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 20 (45.5) 24 (54.5) Plate 11 (n=44) 0 (0.0) 4 (9.1) 40 (90.9) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 14 (31.8) 30 (68.2) Plate 12 (n=41) 0 (0.0) 4 (9.8) 37 (90.2) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 18 (43.9) 23 (56.1) Plate 13 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 23 (50.0) 23 (50.0) Plate 14 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 26 (52.0) 24 (48.0) Plate 15 (n=48) 0 (0.0) 4 (8.3) 44 (91.7) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 30 (62.5) 18 (37.5) Plate 16 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 1 (2.0) 26 (52.0) 23 (46.0) Plate 17 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 15 (30.0) 35 (70.0) Plate 18 (n=51) 0 (0.0) 27 (52.9) 24 (47.1) 0 (0.0) 17 (33.3) 34 (66.7) 0 (0.0) 24 (47.1) 27 (52.9) Plate 19 (n=24) 0 (0.0) 23 (95.8) 1 (4.2) 0 (0.0) 14 (58.3) 10 (41.7) 0 (0.0) 7 (29.2) 17 (70.8) Plate 20 (n=53) 0 (0.0) 15 (28.3) 38 (71.7) 0 (0.0) 0 (0.0) 53 (100.0) 0 (0.0) 34 (64.2) 19 (35.8) Plate 21 (n=130) 0 (0.0) 29 (22.3) 101 (77.7) 0 (0.0) 0 (0.0) 130 (100.0) 0 (0.0) 56 (43.1) 74 (56.9) Plate 22 (n=112) 0 (0.0) 44 (39.3) 68 (60.7) 0 (0.0) 0 (0.0) 112 (100.0) 0 (0.0) 72 (64.3) 40 (35.7) Plate 23 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 24 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 25 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 26 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 27 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 28 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 29 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 30 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 31 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 25 (62.5) 15 (37.5) Plate 32 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 33 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 34 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 35 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 36 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 37 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 38 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 39 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 40 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 41 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 42 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 43 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 44 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 45 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 46 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 23 (57.5) 16 (40.0) Plate 47 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 48 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 49 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 28 (60.9) 18 (39.1) Plate 50 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 51 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 53 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 54 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 22 (51.2) 21 (48.8) Plate 55 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 28 (65.1) 15 (34.9) Plate 56 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 57 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 17 (51.5) 13 (39.4) Plate Total (n=2776) 0 (0.0) 1201 (43.3) 1575 (56.7) 0 (0.0) 31 (1.1) 2745 (98.9) 5 (0.2) 1418 (51.1) 1353 (48.7) "],["hpl-1.html", "2.2 HPL", " 2.2 HPL Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 89.04744 1 &lt;0.0001 *** Assay.HPL 738.44227 56 &lt;0.0001 *** Study 12.65682 1 0.0004 *** BMI 281.91493 1 &lt;0.0001 *** GA_samp 3001.83025 1 &lt;0.0001 *** 2.2.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 0.9918178 0.1051045 2533.466 9.4364953 &lt;0.0001 *** Assay.HPL1 0.0921711 0.0606656 2625.550 1.5193305 0.1 ns Assay.HPL2 0.2305057 0.0664929 2693.257 3.4666206 0.0005 *** Assay.HPL3 0.0324389 0.0715481 2652.110 0.4533860 0.7 ns Assay.HPL4 0.0768561 0.0735279 2622.508 1.0452644 0.3 ns Assay.HPL5 0.1891226 0.0678734 2497.891 2.7864029 0.005 ** Assay.HPL6 0.2354691 0.0716632 2692.436 3.2857748 0.001 ** Assay.HPL7 -0.0648563 0.0703540 2693.768 -0.9218564 0.4 ns Assay.HPL8 0.2909962 0.0722893 2693.732 4.0254407 &lt;0.0001 *** Assay.HPL9 0.0574963 0.0703906 2690.741 0.8168175 0.4 ns Assay.HPL10 0.0977651 0.0719626 2689.477 1.3585548 0.2 ns Assay.HPL11 0.1245978 0.0718970 2684.512 1.7330032 0.08 ns Assay.HPL12 0.2577725 0.0734449 2646.439 3.5097395 0.0005 *** Assay.HPL13 0.3311287 0.0709268 2692.442 4.6685975 &lt;0.0001 *** Assay.HPL14 0.1470589 0.0691096 2677.509 2.1279094 0.03 * Assay.HPL15 0.1324150 0.0693577 2673.204 1.9091614 0.06 ns Assay.HPL16 0.2984871 0.0693148 2677.391 4.3062555 &lt;0.0001 *** Assay.HPL17 -0.0358695 0.0686740 2651.758 -0.5223152 0.6 ns Assay.HPL18 0.0544943 0.0644116 2626.621 0.8460317 0.4 ns Assay.HPL19 0.2686786 0.0990292 2143.426 2.7131257 0.007 ** Assay.HPL20 -0.2121390 0.0631995 2582.169 -3.3566574 0.0008 *** Assay.HPL21 -0.1312074 0.0586272 2671.829 -2.2379947 0.03 * Assay.HPL22 -0.0543114 0.0643441 2617.564 -0.8440767 0.4 ns Assay.HPL23 0.7437893 0.0723670 2692.466 10.2780225 &lt;0.0001 *** Assay.HPL24 0.0334058 0.0726732 2681.475 0.4596709 0.6 ns Assay.HPL25 0.6560953 0.0738694 2604.776 8.8818215 &lt;0.0001 *** Assay.HPL26 0.0799927 0.0740999 2660.203 1.0795247 0.3 ns Assay.HPL27 0.1095021 0.0728614 2653.404 1.5028829 0.1 ns Assay.HPL28 0.0196264 0.0728741 2653.324 0.2693193 0.8 ns Assay.HPL29 0.1805839 0.0728864 2659.331 2.4776074 0.01 * Assay.HPL30 -0.0553226 0.0734201 2586.721 -0.7535075 0.5 ns Assay.HPL31 0.1580722 0.0724168 2677.426 2.1828106 0.03 * Assay.HPL32 0.3118338 0.0724805 2669.127 4.3023152 &lt;0.0001 *** Assay.HPL33 0.1090237 0.0729327 2649.276 1.4948532 0.1 ns Assay.HPL34 0.1072198 0.0723386 2688.378 1.4821926 0.1 ns Assay.HPL35 -0.1816678 0.0711618 2693.932 -2.5528833 0.01 * Assay.HPL36 0.0570492 0.0733728 2604.436 0.7775243 0.4 ns Assay.HPL37 0.1132805 0.0730191 2643.142 1.5513835 0.1 ns Assay.HPL38 0.3106045 0.0726500 2674.769 4.2753557 &lt;0.0001 *** Assay.HPL39 0.1459116 0.0729377 2653.643 2.0004958 0.05 ns Assay.HPL40 0.0566781 0.0718851 2661.086 0.7884536 0.4 ns Assay.HPL41 0.1994536 0.0734263 2605.205 2.7163791 0.007 ** Assay.HPL42 -0.0677224 0.0715788 2687.222 -0.9461240 0.3 ns Assay.HPL43 0.2401154 0.0736095 2602.954 3.2620161 0.001 ** Assay.HPL44 0.1141842 0.0724814 2682.267 1.5753580 0.1 ns Assay.HPL45 0.1800752 0.0730007 2653.527 2.4667617 0.01 * Assay.HPL46 0.1009820 0.0725317 2681.930 1.3922466 0.2 ns Assay.HPL47 0.2556517 0.0734007 2635.412 3.4829610 0.0005 *** Assay.HPL48 0.1066926 0.0730994 2653.596 1.4595558 0.1 ns Assay.HPL49 -0.0254198 0.0733466 2592.945 -0.3465716 0.7 ns Assay.HPL50 0.1892451 0.0721640 2687.798 2.6224304 0.009 ** Assay.HPL51 0.1394344 0.0731642 2634.829 1.9057741 0.06 ns Assay.HPL52 0.1119099 0.0728747 2665.948 1.5356468 0.1 ns Assay.HPL54 0.3039624 0.0717702 2675.625 4.2352185 &lt;0.0001 *** Assay.HPL55 0.2546358 0.0717667 2676.413 3.5481031 0.0004 *** Assay.HPL56 0.0147899 0.0736068 2584.311 0.2009311 0.8 ns Assay.HPL57 0.0507690 0.0768536 2607.965 0.6605935 0.5 ns StudySTOP 0.0926816 0.0260514 2576.298 3.5576422 0.0004 *** BMI -0.0178690 0.0010642 2367.090 -16.7903227 &lt;0.0001 *** GA_samp 0.2925421 0.0053394 2549.329 54.7889611 &lt;0.0001 *** 2.2.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Male Female Plate 1 (n=106) 0 (0.0) 106 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 106 (100.0) 0 (0.0) 46 (43.4) 60 (56.6) Plate 2 (n=86) 0 (0.0) 8 (9.3) 78 (90.7) 0 (0.0) 0 (0.0) 86 (100.0) 0 (0.0) 63 (73.3) 23 (26.7) Plate 3 (n=48) 0 (0.0) 5 (10.4) 43 (89.6) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 28 (58.3) 20 (41.7) Plate 4 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 23 (53.5) 20 (46.5) Plate 5 (n=81) 0 (0.0) 8 (9.9) 73 (90.1) 0 (0.0) 0 (0.0) 81 (100.0) 0 (0.0) 47 (58.0) 34 (42.0) Plate 6 (n=44) 0 (0.0) 5 (11.4) 39 (88.6) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 15 (34.1) 29 (65.9) Plate 7 (n=47) 0 (0.0) 6 (12.8) 41 (87.2) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 32 (68.1) 15 (31.9) Plate 8 (n=41) 0 (0.0) 6 (14.6) 35 (85.4) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 19 (46.3) 22 (53.7) Plate 9 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 27 (56.2) 21 (43.8) Plate 10 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 20 (46.5) 23 (53.5) Plate 11 (n=44) 0 (0.0) 4 (9.1) 40 (90.9) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 14 (31.8) 30 (68.2) Plate 12 (n=42) 0 (0.0) 5 (11.9) 37 (88.1) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 19 (45.2) 23 (54.8) Plate 13 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 23 (50.0) 23 (50.0) Plate 14 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 26 (52.0) 24 (48.0) Plate 15 (n=49) 0 (0.0) 5 (10.2) 44 (89.8) 0 (0.0) 0 (0.0) 49 (100.0) 0 (0.0) 30 (61.2) 19 (38.8) Plate 16 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 1 (2.0) 26 (52.0) 23 (46.0) Plate 17 (n=51) 0 (0.0) 4 (7.8) 47 (92.2) 0 (0.0) 0 (0.0) 51 (100.0) 0 (0.0) 15 (29.4) 36 (70.6) Plate 18 (n=71) 0 (0.0) 46 (64.8) 25 (35.2) 0 (0.0) 14 (19.7) 57 (80.3) 0 (0.0) 25 (35.2) 46 (64.8) Plate 19 (n=13) 0 (0.0) 13 (100.0) 0 (0.0) 0 (0.0) 13 (100.0) 0 (0.0) 0 (0.0) 4 (30.8) 9 (69.2) Plate 20 (n=72) 0 (0.0) 50 (69.4) 22 (30.6) 0 (0.0) 0 (0.0) 72 (100.0) 0 (0.0) 42 (58.3) 30 (41.7) Plate 21 (n=162) 0 (0.0) 78 (48.1) 84 (51.9) 0 (0.0) 0 (0.0) 162 (100.0) 0 (0.0) 74 (45.7) 88 (54.3) Plate 22 (n=112) 0 (0.0) 44 (39.3) 68 (60.7) 0 (0.0) 0 (0.0) 112 (100.0) 0 (0.0) 72 (64.3) 40 (35.7) Plate 23 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 24 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 25 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 26 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 27 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 28 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 29 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 30 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 31 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 25 (62.5) 15 (37.5) Plate 32 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 33 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 34 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 35 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 36 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 37 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 38 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 39 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 40 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 41 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 42 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 43 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 44 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 45 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 46 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 23 (57.5) 16 (40.0) Plate 47 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 48 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 49 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 28 (60.9) 18 (39.1) Plate 50 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 51 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 53 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 54 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 22 (51.2) 21 (48.8) Plate 55 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 28 (65.1) 15 (34.9) Plate 56 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 57 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 17 (51.5) 13 (39.4) Plate Total (n=2772) 0 (0.0) 1197 (43.2) 1575 (56.8) 0 (0.0) 27 (1.0) 2745 (99.0) 5 (0.2) 1416 (51.1) 1351 (48.7) "],["gh2-1.html", "2.3 GH2", " 2.3 GH2 Plate 22 omitted due to invalid standard curve. Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 212.579351 1 &lt;0.0001 *** Assay.GH2 228.193477 57 &lt;0.0001 *** Study 4.354346 1 0.04 * BMI 109.759740 1 &lt;0.0001 *** GA_samp 1154.337251 1 &lt;0.0001 *** 2.3.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) -2.0852748 0.1430220 2582.496 -14.5801012 &lt;0.0001 *** Assay.GH21 -0.0791846 0.0837897 2525.783 -0.9450398 0.3 ns Assay.GH22 0.1754518 0.0903899 2634.047 1.9410538 0.05 ns Assay.GH23 0.2868065 0.0986797 2611.877 2.9064371 0.004 ** Assay.GH24 -0.0048460 0.1050752 2438.502 -0.0461189 1.0 ns Assay.GH25 0.1980649 0.0943090 2610.141 2.1001708 0.04 * Assay.GH26 0.2803362 0.0976512 2634.714 2.8707907 0.004 ** Assay.GH27 0.0989152 0.0950059 2602.154 1.0411480 0.3 ns Assay.GH28 -0.0810342 0.0973165 2610.799 -0.8326878 0.4 ns Assay.GH29 0.0634070 0.0945526 2587.036 0.6706003 0.5 ns Assay.GH210 -0.1162066 0.0994339 2636.863 -1.1686820 0.2 ns Assay.GH211 -0.1601729 0.0975028 2635.430 -1.6427510 0.1 ns Assay.GH212 -0.0603924 0.1011241 2609.689 -0.5972102 0.6 ns Assay.GH213 0.1146427 0.0958679 2610.351 1.1958399 0.2 ns Assay.GH214 0.2642879 0.0932988 2565.499 2.8327037 0.005 ** Assay.GH215 0.1451245 0.0937086 2575.083 1.5486792 0.1 ns Assay.GH216 0.1255673 0.0931174 2556.264 1.3484842 0.2 ns Assay.GH217 0.3126568 0.0924637 2539.728 3.3814022 0.0007 *** Assay.GH218 0.3073315 0.1247045 2637.952 2.4644781 0.01 * Assay.GH219 0.0798359 0.0908369 2308.265 0.8788927 0.4 ns Assay.GH220 -0.0715429 0.0892041 2582.031 -0.8020143 0.4 ns Assay.GH221 0.1159995 0.0818348 2553.780 1.4174827 0.2 ns Assay.GH223 0.1156668 0.0814530 2562.999 1.4200437 0.2 ns Assay.GH224 -0.0715429 0.0892041 2582.031 -0.8020143 0.4 ns Assay.GH225 0.3472763 0.0978500 2627.980 3.5490665 0.0004 *** Assay.GH226 0.0567823 0.0990734 2639.989 0.5731334 0.6 ns Assay.GH227 0.0386721 0.1019304 2567.883 0.3793975 0.7 ns Assay.GH228 0.0803651 0.1012572 2594.081 0.7936724 0.4 ns Assay.GH229 0.0381013 0.1005929 2630.209 0.3787673 0.7 ns Assay.GH230 -0.1241027 0.1001082 2626.523 -1.2396856 0.2 ns Assay.GH231 -0.0019059 0.0999963 2631.126 -0.0190602 1.0 ns Assay.GH232 0.2835346 0.1018710 2571.564 2.7832699 0.005 ** Assay.GH233 -0.0613889 0.1005350 2618.603 -0.6106217 0.5 ns Assay.GH234 0.0560195 0.1009235 2612.151 0.5550687 0.6 ns Assay.GH235 -0.0076636 0.0989012 2638.810 -0.0774879 0.9 ns Assay.GH236 0.2298988 0.0997097 2639.804 2.3056812 0.02 * Assay.GH237 0.1735538 0.0961543 2619.356 1.8049509 0.07 ns Assay.GH238 -0.0645211 0.1017993 2566.048 -0.6338064 0.5 ns Assay.GH239 -0.0706903 0.1007704 2613.399 -0.7014987 0.5 ns Assay.GH240 0.0480588 0.0993875 2638.649 0.4835499 0.6 ns Assay.GH241 -0.0688661 0.0987487 2639.995 -0.6973873 0.5 ns Assay.GH242 -0.0583906 0.0987406 2633.463 -0.5913532 0.6 ns Assay.GH243 -0.1163097 0.1017559 2568.225 -1.1430258 0.3 ns Assay.GH244 0.1624526 0.0972865 2637.584 1.6698366 0.10 ns Assay.GH245 0.2267436 0.1012045 2596.831 2.2404505 0.03 * Assay.GH246 -0.0126099 0.0989556 2639.895 -0.1274296 0.9 ns Assay.GH247 -0.0684904 0.1001997 2628.590 -0.6835389 0.5 ns Assay.GH248 0.0704647 0.0985888 2636.871 0.7147330 0.5 ns Assay.GH249 0.1156909 0.1011720 2614.499 1.1435066 0.3 ns Assay.GH250 0.0953516 0.1005831 2629.596 0.9479887 0.3 ns Assay.GH251 0.1946719 0.1015888 2587.762 1.9162727 0.06 ns Assay.GH252 -0.0969296 0.0997871 2634.971 -0.9713637 0.3 ns Assay.GH254 -0.0028326 0.0997500 2635.834 -0.0283965 1.0 ns Assay.GH255 -0.0164475 0.0987908 2638.169 -0.1664878 0.9 ns Assay.GH256 0.0426585 0.0980730 2639.719 0.4349666 0.7 ns Assay.GH257 0.2281709 0.0978808 2639.943 2.3311089 0.02 * Assay.GH258 0.0975326 0.1022645 2535.274 0.9537292 0.3 ns Assay.GH259 0.1453408 0.1081603 2495.146 1.3437527 0.2 ns StudySTOP -0.0754529 0.0361588 2632.840 -2.0867070 0.04 * BMI -0.0155536 0.0014846 2542.218 -10.4766283 &lt;0.0001 *** GA_samp 0.2526113 0.0074351 2610.748 33.9755390 &lt;0.0001 *** 2.3.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Male Female Plate 1 (n=91) 0 (0.0) 91 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 91 (100.0) 0 (0.0) 38 (41.8) 53 (58.2) Plate 2 (n=70) 0 (0.0) 8 (11.4) 62 (88.6) 0 (0.0) 0 (0.0) 70 (100.0) 0 (0.0) 49 (70.0) 21 (30.0) Plate 3 (n=47) 0 (0.0) 5 (10.6) 42 (89.4) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 29 (61.7) 18 (38.3) Plate 4 (n=42) 0 (0.0) 5 (11.9) 37 (88.1) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 23 (54.8) 19 (45.2) Plate 5 (n=79) 0 (0.0) 8 (10.1) 71 (89.9) 0 (0.0) 0 (0.0) 79 (100.0) 0 (0.0) 47 (59.5) 32 (40.5) Plate 6 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 16 (37.2) 27 (62.8) Plate 7 (n=45) 0 (0.0) 6 (13.3) 39 (86.7) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 30 (66.7) 15 (33.3) Plate 8 (n=41) 0 (0.0) 6 (14.6) 35 (85.4) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 19 (46.3) 22 (53.7) Plate 9 (n=46) 0 (0.0) 8 (17.4) 38 (82.6) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 25 (54.3) 21 (45.7) Plate 10 (n=44) 0 (0.0) 6 (13.6) 38 (86.4) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 20 (45.5) 24 (54.5) Plate 11 (n=43) 0 (0.0) 4 (9.3) 39 (90.7) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 14 (32.6) 29 (67.4) Plate 12 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 19 (44.2) 24 (55.8) Plate 13 (n=45) 0 (0.0) 4 (8.9) 41 (91.1) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 24 (53.3) 21 (46.7) Plate 14 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 15 (n=47) 0 (0.0) 5 (10.6) 42 (89.4) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 28 (59.6) 19 (40.4) Plate 16 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 1 (2.2) 24 (52.2) 21 (45.7) Plate 17 (n=47) 0 (0.0) 4 (8.5) 43 (91.5) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 15 (31.9) 32 (68.1) Plate 18 (n=20) 0 (0.0) 0 (0.0) 20 (100.0) 0 (0.0) 0 (0.0) 20 (100.0) 0 (0.0) 11 (55.0) 9 (45.0) Plate 19 (n=48) 0 (0.0) 43 (89.6) 5 (10.4) 0 (0.0) 35 (72.9) 13 (27.1) 0 (0.0) 21 (43.8) 27 (56.2) Plate 20 (n=64) 0 (0.0) 22 (34.4) 42 (65.6) 0 (0.0) 0 (0.0) 64 (100.0) 0 (0.0) 43 (67.2) 21 (32.8) Plate 21 (n=109) 0 (0.0) 55 (50.5) 54 (49.5) 0 (0.0) 0 (0.0) 109 (100.0) 0 (0.0) 44 (40.4) 65 (59.6) Plate 22 (n=72) 0 (0.0) 50 (69.4) 22 (30.6) 0 (0.0) 0 (0.0) 72 (100.0) 0 (0.0) 39 (54.2) 33 (45.8) Plate 23 (n=115) 0 (0.0) 61 (53.0) 54 (47.0) 0 (0.0) 0 (0.0) 115 (100.0) 0 (0.0) 50 (43.5) 65 (56.5) Plate 24 (n=64) 0 (0.0) 22 (34.4) 42 (65.6) 0 (0.0) 0 (0.0) 64 (100.0) 0 (0.0) 43 (67.2) 21 (32.8) Plate 25 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 26 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 27 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 28 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 29 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 30 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 31 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 32 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 33 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 25 (62.5) 15 (37.5) Plate 34 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 35 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 36 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 37 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 38 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 39 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 40 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 41 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 42 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 43 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 44 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 45 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 46 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 47 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 48 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 23 (57.5) 16 (40.0) Plate 49 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 50 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 51 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 28 (60.9) 18 (39.1) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 53 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 54 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 55 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 56 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 22 (51.2) 21 (48.8) Plate 57 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 28 (65.1) 15 (34.9) Plate 58 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 59 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 17 (51.5) 13 (39.4) Plate Total (n=2780) 0 (0.0) 1205 (43.3) 1575 (56.7) 0 (0.0) 35 (1.3) 2745 (98.7) 5 (0.2) 1419 (51.0) 1356 (48.8) "],["session-info-3.html", "2.4 Session info", " 2.4 Session info Results generated on: 2023-08-17 11:27:52.877558 Click for more details sessionInfo() ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.3 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] grid stats graphics grDevices utils datasets methods ## [8] base ## ## other attached packages: ## [1] xlsx_0.6.5 plotly_4.10.2 geepack_1.3.9 lmerTest_3.1-3 ## [5] lme4_1.1-33 Matrix_1.6-0 ggpubr_0.6.0 emmeans_1.8.5 ## [9] car_3.1-2 carData_3.0-5 readxl_1.4.2 Hmisc_5.1-0 ## [13] fontawesome_0.5.1 htmlwidgets_1.6.2 kableExtra_1.3.4 knitr_1.42 ## [17] rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.3 usethis_2.1.5 ## [21] pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## ## loaded via a namespace (and not attached): ## [1] remotes_2.4.2 sandwich_3.0-1 rlang_1.1.1 ## [4] multcomp_1.4-18 compiler_4.3.1 systemfonts_1.0.4 ## [7] callr_3.7.3 vctrs_0.6.3 rvest_1.0.3 ## [10] stringr_1.5.0 pkgconfig_2.0.3 crayon_1.5.2 ## [13] fastmap_1.1.1 backports_1.4.1 ellipsis_0.3.2 ## [16] labeling_0.4.2 utf8_1.2.3 sessioninfo_1.2.2 ## [19] nloptr_2.0.0 ps_1.7.5 purrr_1.0.1 ## [22] xfun_0.39 cachem_1.0.8 jsonlite_1.8.4 ## [25] highr_0.10 xlsxjars_0.6.1 broom_1.0.4 ## [28] prettyunits_1.1.1 cluster_2.1.4 R6_2.5.1 ## [31] bslib_0.4.2 stringi_1.7.12 boot_1.3-28 ## [34] pkgload_1.3.2 rpart_4.1.19 numDeriv_2016.8-1.1 ## [37] jquerylib_0.1.4 cellranger_1.1.0 estimability_1.4.1 ## [40] Rcpp_1.0.11 bookdown_0.34 zoo_1.8-9 ## [43] base64enc_0.1-3 splines_4.3.1 nnet_7.3-19 ## [46] tidyselect_1.2.0 rstudioapi_0.14 abind_1.4-5 ## [49] yaml_2.3.7 codetools_0.2-19 processx_3.8.1 ## [52] pkgbuild_1.4.0 lattice_0.21-8 tibble_3.2.1 ## [55] withr_2.5.0 coda_0.19-4 evaluate_0.21 ## [58] foreign_0.8-82 survival_3.5-5 rJava_1.0-6 ## [61] xml2_1.3.3 pillar_1.9.0 checkmate_2.0.0 ## [64] generics_0.1.3 munsell_0.5.0 scales_1.2.1 ## [67] minqa_1.2.4 xtable_1.8-4 glue_1.6.2 ## [70] lazyeval_0.2.2 tools_4.3.1 data.table_1.14.8 ## [73] webshot_0.5.4 ggsignif_0.6.4 fs_1.6.2 ## [76] mvtnorm_1.1-3 tidyr_1.3.0 colorspace_2.1-0 ## [79] nlme_3.1-162 htmlTable_2.4.0 Formula_1.2-4 ## [82] cli_3.6.1 fansi_1.0.4 viridisLite_0.4.2 ## [85] svglite_2.1.0 dplyr_1.1.2 gtable_0.3.3 ## [88] rstatix_0.7.2 sass_0.4.6 digest_0.6.33 ## [91] TH.data_1.1-0 farver_2.1.1 memoise_2.0.1 ## [94] htmltools_0.5.5 lifecycle_1.0.3 httr_1.4.2 ## [97] MASS_7.3-60 "],["part-association-with-factors.html", "(PART*) Association with Factors", " (PART*) Association with Factors "],["descriptives.html", "3 Descriptives", " 3 Descriptives Descriptives on raw data. Tables in this page are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value PRL (ng/ml): Mean (SD) 187.6 (190.2) 105.4 (113.5) 138.9 (154.9) &lt;0.0001 hPL (μg/ml): Mean (SD) 183.6 (55.5) 74.1 (49.8) 119.3 (75.1) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.7 (2.8) 1.9 (1.6) 3.1 (2.6) &lt;0.0001 Insulin (uU/ml): Mean (SD) 24.9 (28.9) 18.7 (26.3) 21.2 (27.6) &lt;0.0001 HOMA-IR: Mean (SD) 6.5 (8.4) 4.2 (7.2) 5.1 (7.8) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.5 (0.8) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 Number of available samples Var SCOPE: Available N(%) STOP: Available N(%) PRL (ng/ml) 836 (71.8%) 1214 (93.4%) hPL (μg/ml) 835 (71.7%) 1188 (91.4%) GH2 (ng/ml) 842 (72.3%) 1191 (91.6%) Insulin (uU/ml) 876 (75.3%) 1264 (97.2%) HOMA-IR 870 (74.7%) 1263 (97.2%) Glucose (mmol/L) 1147 (98.5%) 1254 (96.5%) "],["by-study.html", "3.1 By Study", " 3.1 By Study 3.1.1 Demographics Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 26.0 (22.0-29.0) 25.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.02 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1140 (97.9) 1252 (96.3) 2392 (97.1) &gt;=35 24 (2.1) 48 (3.7) 72 (2.9) Maternal BMI: Median (IQ range) 25.6 (22.2-30.8) 26.3 (22.7-31.8) 25.9 (22.5-31.3) 0.006 Maternal BMI (category): N(%) 0.02 Missing 0 (0.0) 1 (0.1) 1 (0.0) &lt;20 122 (10.5) 95 (7.3) 217 (8.8) &gt;=20 to &lt;25 398 (34.2) 442 (34.0) 840 (34.1) &gt;=25 to &lt;30 322 (27.7) 361 (27.8) 683 (27.7) &gt;=30 to &lt;40 267 (22.9) 315 (24.2) 582 (23.6) &gt;=40 55 (4.7) 86 (6.6) 141 (5.7) SEI: Median (IQ range) 25.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-34.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 1067 (91.7) 1073 (82.5) 2140 (86.9) Maori 5 (0.4) 2 (0.2) 7 (0.3) Pacific Islander 1 (0.1) 4 (0.3) 5 (0.2) South East and Far East 42 (3.6) 66 (5.1) 108 (4.4) Indian 4 (0.3) 60 (4.6) 64 (2.6) African 4 (0.3) 23 (1.8) 27 (1.1) Middle-eastern 6 (0.5) 25 (1.9) 31 (1.3) Hispanic 0 (0.0) 5 (0.4) 5 (0.2) Aboriginal 23 (2.0) 24 (1.8) 47 (1.9) China and Japan 0 (0.0) 16 (1.2) 16 (0.6) Other 12 (1.0) 2 (0.2) 14 (0.6) Smoking: N(%) &lt;0.0001 Missing 0 (0.0) 7 (0.5) 7 (0.3) No 886 (76.1) 1077 (82.8) 1963 (79.7) Yes 278 (23.9) 216 (16.6) 494 (20.0) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 152 (11.7) 152 (6.2) None 251 (21.6) 97 (7.5) 348 (14.1) &lt;800 611 (52.5) 271 (20.8) 882 (35.8) &gt;=800 302 (25.9) 780 (60.0) 1082 (43.9) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 152 (11.7) 152 (6.2) None 251 (21.6) 97 (7.5) 348 (14.1) &lt;=400 116 (10.0) 15 (1.2) 131 (5.3) &gt;400 to &lt;800 495 (42.5) 256 (19.7) 751 (30.5) &gt;=800 302 (25.9) 780 (60.0) 1082 (43.9) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 16 (1.2) 16 (0.6) &lt;1-3x/month 117 (10.1) 95 (7.3) 212 (8.6) 1-6x/week 454 (39.0) 388 (29.8) 842 (34.2) &gt;=1-&lt;3x/day 410 (35.2) 639 (49.2) 1049 (42.6) &gt;=3x/day 183 (15.7) 162 (12.5) 345 (14.0) Leafy vege (1st trim): N(%) 0.004 Missing 0 (0.0) 17 (1.3) 17 (0.7) &lt;1-3x/month 113 (9.7) 143 (11.0) 256 (10.4) 1-2x/week 265 (22.8) 291 (22.4) 556 (22.6) 3-6x/week 474 (40.7) 440 (33.8) 914 (37.1) &gt;=1x/day 312 (26.8) 409 (31.5) 721 (29.3) Fast food (1st trim): N(%) &lt;0.0001 Missing 233 (20.0) 176 (13.5) 409 (16.6) Never 16 (1.4) 58 (4.5) 74 (3.0) &gt;0-&lt;2x/week 109 (9.4) 216 (16.6) 325 (13.2) &gt;=2-&lt;4x/week 479 (41.2) 501 (38.5) 980 (39.8) &gt;=4x/week 327 (28.1) 349 (26.8) 676 (27.4) Vigorous exercise: N(%) 0.45 Missing 3 (0.3) 12 (0.9) 15 (0.6) Never 755 (64.9) 809 (62.2) 1564 (63.5) Once a week 290 (24.9) 318 (24.5) 608 (24.7) 2-3/wk 87 (7.5) 119 (9.2) 206 (8.4) 4-6/wk 14 (1.2) 22 (1.7) 36 (1.5) Daily 12 (1.0) 18 (1.4) 30 (1.2) More than once a day 3 (0.3) 2 (0.2) 5 (0.2) Moderate exercise: N(%) 0.46 Missing 3 (0.3) 14 (1.1) 17 (0.7) Never 500 (43.0) 516 (39.7) 1016 (41.2) Once a week 302 (25.9) 334 (25.7) 636 (25.8) 2-3/wk 231 (19.8) 286 (22.0) 517 (21.0) 4-6/wk 53 (4.6) 64 (4.9) 117 (4.7) Daily 67 (5.8) 71 (5.5) 138 (5.6) More than once a day 8 (0.7) 15 (1.2) 23 (0.9) Recreational walking: N(%) 0.08 Missing 3 (0.3) 14 (1.1) 17 (0.7) Never 266 (22.9) 272 (20.9) 538 (21.8) Once a week 363 (31.2) 464 (35.7) 827 (33.6) 2-3/wk 309 (26.5) 313 (24.1) 622 (25.2) 4-6/wk 84 (7.2) 95 (7.3) 179 (7.3) Daily 113 (9.7) 126 (9.7) 239 (9.7) More than once a day 26 (2.2) 16 (1.2) 42 (1.7) Serum folate concentration (nM): Median (IQ range) 36.0 (28.2-42.8) 40.5 (36.3-45.3) 39.1 (33.3-44.1) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.2) &lt;0.0001 B12 concentration (pM): Median (IQ range) 245.5 (195.0-309.0) 278.0 (218.0-356.0) 262.0 (206.0-337.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 143.1 (102.9-208.5) 152.6 (114.8-222.1) 148.8 (108.7-217.2) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.5 (24.1) 69.3 (25.5) 64.9 (25.2) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 603.3 (437.9-895.6) 628.1 (461.3-920.6) 620.6 (448.9-901.5) 0.05 Vitamin D: Median (IQ range) 57.6 (42.1-76.0) 61.0 (46.0-77.0) 59.6 (44.0-76.2) 0.009 UIC (ug/L): Median (IQ range) 107.2 (66.4-163.3) 202.5 (125.5-331.4) 159.3 (92.8-269.0) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.5) 0.14 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.7-1.4) 1.0 (0.7-1.4) 0.08 Haemoglobin (g/L): Mean (SD) 129.2 (9.3) 131.5 (9.6) 130.4 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 3.1.2 MetS Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value MetS: N(%) &lt;0.0001 Missing 11 (0.9) 92 (7.1) 103 (4.2) No 952 (81.8) 1100 (84.6) 2052 (83.3) Yes 201 (17.3) 108 (8.3) 309 (12.5) MetS: number of criteria met: Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-98.0) 82.0 (75.0-94.0) 85.0 (76.5-96.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.6 (0.8) 5.0 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.8) 1.1 (0.9-1.4) 1.2 (1.0-1.6) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.5 (0.8) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.1 (0.8) 2.5 (0.7) 2.7 (0.8) &lt;0.0001 Systolic BP (mmHg): Mean (SD) 109.3 (10.3) 115.9 (10.6) 112.7 (11.0) &lt;0.0001 Diastolic BP (mmHg): Mean (SD) 64.5 (8.0) 70.7 (8.7) 67.7 (9.0) &lt;0.0001 MAP (mmHg): Mean (SD) 79.4 (7.8) 85.8 (8.4) 82.7 (8.7) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 3 (0.3) 28 (2.2) 31 (1.3) &lt;80 cm 307 (26.4) 528 (40.6) 835 (33.9) &gt;=80 cm 854 (73.4) 744 (57.2) 1598 (64.9) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 15 (1.2) 15 (0.6) &lt;1.7 mmol/L 828 (71.1) 1108 (85.2) 1936 (78.6) &gt;=1.7 mmol/L 336 (28.9) 177 (13.6) 513 (20.8) MetS criteria: HDL: N(%) 0.001 Missing 0 (0.0) 15 (1.2) 15 (0.6) &gt;=1.3 mmol/L 1036 (89.0) 1085 (83.5) 2121 (86.1) &lt;1.3 mmol/L 128 (11.0) 200 (15.4) 328 (13.3) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 10 (0.9) 15 (1.2) 25 (1.0) &lt;5.6 mmol/L 661 (56.8) 1184 (91.1) 1845 (74.9) &gt;=5.6 mmol/L 493 (42.4) 101 (7.8) 594 (24.1) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 56 (4.3) 56 (2.3) &lt;130 mmHg 1127 (96.8) 1112 (85.5) 2239 (90.9) &gt;=130 mmHg 37 (3.2) 132 (10.2) 169 (6.9) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 56 (4.3) 56 (2.3) &lt;85 mmHg 1156 (99.3) 1169 (89.9) 2325 (94.4) &gt;=85 mmHg 8 (0.7) 75 (5.8) 83 (3.4) MetS criteria: BP: N(%) &lt;0.0001 Missing 0 (0.0) 56 (4.3) 56 (2.3) &lt;130/85 mmHg 1124 (96.6) 1079 (83.0) 2203 (89.4) &gt;=130/85 mmHg 40 (3.4) 165 (12.7) 205 (8.3) CRP (mg/L): Median (IQ range) 4.9 (2.5-9.1) 3.4 (1.4-6.6) 4.0 (1.9-7.6) &lt;0.0001 3.1.3 Outcomes Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value Gestational age at birth (weeks): Median (IQ range) 39.9 (38.7-40.9) 39.6 (38.6-40.5) 39.7 (38.7-40.7) 0.0004 Birthweight (g): Median (IQ range) 3390.0 (3050.0-3730.0) 3390.0 (3039.0-3704.5) 3390.0 (3045.0-3720.0) 0.78 Birthweight centile: Median (IQ range) 44.5 (20.8-71.0) 46.2 (23.3-73.6) 45.2 (22.0-72.4) 0.10 Baby sex: N(%) 0.18 Missing 6 (0.5) 17 (1.3) 23 (0.9) Male 567 (48.7) 664 (51.1) 1231 (50.0) Female 591 (50.8) 619 (47.6) 1210 (49.1) Mode of delivery: N(%) 0.02 Missing 6 (0.5) 16 (1.2) 22 (0.9) Unassisted vaginal 617 (53.0) 643 (49.5) 1260 (51.1) Operative vaginal 186 (16.0) 268 (20.6) 454 (18.4) Pre-labour LSCS 77 (6.6) 89 (6.8) 166 (6.7) LSCS in labour 278 (23.9) 284 (21.8) 562 (22.8) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) Induction of Labour: N(%) &lt;0.0001 Missing 7 (0.6) 0 (0.0) 7 (0.3) No 804 (69.1) 663 (51.0) 1467 (59.5) Yes 353 (30.3) 637 (49.0) 990 (40.2) PE vs Uncomplicated: N(%) 0.59 Missing 467 (40.1) 469 (36.1) 936 (38.0) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 93 (8.0) 120 (9.2) 213 (8.6) SPTB vs Uncomplicated: N(%) 0.14 Missing 491 (42.2) 528 (40.6) 1019 (41.4) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 69 (5.9) 61 (4.7) 130 (5.3) SGA vs Uncomplicted: N(%) 0.65 Missing 419 (36.0) 435 (33.5) 854 (34.7) No 604 (51.9) 710 (54.6) 1314 (53.3) Yes 141 (12.1) 155 (11.9) 296 (12.0) GDM vs Uncomplicated: N(%) &lt;0.0001 Missing 502 (43.1) 391 (30.1) 893 (36.2) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 58 (5.0) 198 (15.2) 256 (10.4) GHT vs Uncomplicated: N(%) 0.001 Missing 442 (38.0) 505 (38.8) 947 (38.4) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 118 (10.1) 84 (6.5) 202 (8.2) PE vs non-PE: N(%) 0.27 Missing 5 (0.4) 20 (1.5) 25 (1.0) No 1066 (91.6) 1160 (89.2) 2226 (90.3) Yes 93 (8.0) 120 (9.2) 213 (8.6) SPTB vs non-SPTB: N(%) 0.22 Missing 5 (0.4) 16 (1.2) 21 (0.9) No 1090 (93.6) 1223 (94.1) 2313 (93.9) Yes 69 (5.9) 61 (4.7) 130 (5.3) SGA vs non-SGA: N(%) 0.99 Missing 6 (0.5) 17 (1.3) 23 (0.9) No 1017 (87.4) 1128 (86.8) 2145 (87.1) Yes 141 (12.1) 155 (11.9) 296 (12.0) GDM vs non-GDM: N(%) &lt;0.0001 Missing 33 (2.8) 54 (4.2) 87 (3.5) No 1073 (92.2) 1048 (80.6) 2121 (86.1) Yes 58 (5.0) 198 (15.2) 256 (10.4) GHT vs non-GHT: N(%) 0.002 Missing 6 (0.5) 20 (1.5) 26 (1.1) No 1040 (89.3) 1196 (92.0) 2236 (90.7) Yes 118 (10.1) 84 (6.5) 202 (8.2) "],["folate-vs-fa-supplement.html", "3.2 Folate vs FA supplement", " 3.2 Folate vs FA supplement 3.2.1 FA supp (3 categories) Characteristic None (n=348) &lt;800 (n=882) &gt;=800 (n=1082) Total (n=2312) P-value Serum folate concentration (nM): Median (IQ range) 29.5 (20.4-36.4) 38.4 (32.2-43.8) 41.2 (36.9-56.8) 39.3 (33.3-44.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.7 (1.2) 4.7 (1.0) 4.7 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 246.0 (192.0-302.5) 254.0 (200.0-326.8) 275.0 (217.0-355.0) 262.0 (205.0-337.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.2 (24.2) 63.1 (25.7) 68.5 (24.8) 65.1 (25.3) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 117.0 (78.4-165.1) 150.8 (112.0-219.6) 158.8 (117.9-237.3) 149.8 (109.0-218.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 478.0 (331.8-675.2) 628.6 (471.7-924.4) 653.3 (481.0-1012.1) 619.3 (447.8-913.0) &lt;0.0001 Vitamin D: Median (IQ range) 52.6 (39.3-69.0) 58.0 (42.5-75.7) 63.5 (47.9-79.0) 60.0 (44.0-76.7) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=251) &lt;800 (n=611) &gt;=800 (n=302) Total (n=1164) P-value Serum folate concentration (nM): Median (IQ range) 25.6 (17.5-33.3) 37.3 (30.2-43.2) 40.0 (34.8-48.7) 36.0 (28.2-42.8) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (179.0-291.0) 250.0 (198.0-319.0) 249.5 (198.8-310.2) 245.5 (195.0-309.0) 0.002 Active B12 concentration (pM): Mean (SD) 55.9 (22.2) 60.0 (24.3) 65.4 (24.6) 60.5 (24.1) 0.002 Folate:B12 ratio: Median (IQ range) 108.4 (72.7-157.7) 143.2 (108.4-208.8) 167.7 (119.7-253.8) 143.1 (102.9-208.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (332.7-708.0) 632.8 (476.9-923.9) 650.8 (489.9-1074.3) 603.3 (437.9-895.6) &lt;0.0001 Vitamin D: Median (IQ range) 51.7 (38.9-68.5) 55.3 (40.2-74.2) 67.7 (50.9-83.4) 57.6 (42.1-76.0) &lt;0.0001 Click here for table within STOP Characteristic None (n=97) &lt;800 (n=271) &gt;=800 (n=780) Total (n=1148) P-value Serum folate concentration (nM): Median (IQ range) 36.6 (30.5-41.2) 40.4 (35.5-54.4) 41.5 (37.6-58.0) 40.9 (36.7-54.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.3 (1.4) 5.1 (1.3) 4.8 (1.0) 4.9 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 279.0 (217.0-339.0) 266.0 (205.0-345.0) 282.0 (226.0-370.0) 279.0 (220.0-361.5) 0.007 Active B12 concentration (pM): Mean (SD) 74.2 (25.3) 70.8 (27.8) 69.8 (24.8) 70.4 (25.6) 0.55 Folate:B12 ratio: Median (IQ range) 132.7 (101.4-193.7) 166.7 (121.1-234.6) 155.4 (116.7-227.8) 154.9 (116.2-227.9) 0.003 Folate:Active B12 ratio: Median (IQ range) 518.7 (336.7-647.2) 622.1 (460.9-916.9) 658.3 (472.2-979.9) 627.4 (460.1-939.8) 0.001 Vitamin D: Median (IQ range) 57.0 (43.0-69.5) 64.0 (48.0-80.0) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.04 3.2.2 FA supp (4 categories) Characteristic None (n=348) &lt;=400 (n=131) &gt;400 to &lt;800 (n=751) &gt;=800 (n=1082) Total (n=2312) P-value Serum folate concentration (nM): Median (IQ range) 29.5 (20.4-36.4) 36.3 (28.6-42.7) 38.8 (33.0-44.0) 41.2 (36.9-56.8) 39.3 (33.3-44.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.6 (1.0) 4.7 (1.2) 4.7 (1.0) 4.7 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 246.0 (192.0-302.5) 260.0 (200.8-347.5) 254.0 (200.0-322.0) 275.0 (217.0-355.0) 262.0 (205.0-337.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.2 (24.2) 62.3 (27.2) 63.2 (25.5) 68.5 (24.8) 65.1 (25.3) 0.0002 Folate:B12 ratio: Median (IQ range) 117.0 (78.4-165.1) 135.4 (106.9-185.3) 154.9 (113.5-225.5) 158.8 (117.9-237.3) 149.8 (109.0-218.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 478.0 (331.8-675.2) 540.9 (429.0-882.4) 638.0 (476.3-938.6) 653.3 (481.0-1012.1) 619.3 (447.8-913.0) &lt;0.0001 Vitamin D: Median (IQ range) 52.6 (39.3-69.0) 50.1 (37.1-69.1) 58.9 (43.7-77.0) 63.5 (47.9-79.0) 60.0 (44.0-76.7) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=251) &lt;=400 (n=116) &gt;400 to &lt;800 (n=495) &gt;=800 (n=302) Total (n=1164) P-value Serum folate concentration (nM): Median (IQ range) 25.6 (17.5-33.3) 35.5 (27.8-41.6) 37.5 (30.9-43.5) 40.0 (34.8-48.7) 36.0 (28.2-42.8) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (179.0-291.0) 251.0 (201.0-339.0) 248.5 (198.0-311.5) 249.5 (198.8-310.2) 245.5 (195.0-309.0) 0.002 Active B12 concentration (pM): Mean (SD) 55.9 (22.2) 62.1 (28.3) 59.6 (23.4) 65.4 (24.6) 60.5 (24.1) 0.005 Folate:B12 ratio: Median (IQ range) 108.4 (72.7-157.7) 132.4 (105.5-179.9) 146.7 (111.8-219.3) 167.7 (119.7-253.8) 143.1 (102.9-208.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (332.7-708.0) 537.9 (410.4-891.6) 641.2 (484.9-967.9) 650.8 (489.9-1074.3) 603.3 (437.9-895.6) &lt;0.0001 Vitamin D: Median (IQ range) 51.7 (38.9-68.5) 49.0 (35.5-65.2) 56.6 (41.6-75.6) 67.7 (50.9-83.4) 57.6 (42.1-76.0) &lt;0.0001 Click here for table within STOP Characteristic None (n=97) &lt;=400 (n=15) &gt;400 to &lt;800 (n=256) &gt;=800 (n=780) Total (n=1148) P-value Serum folate concentration (nM): Median (IQ range) 36.6 (30.5-41.2) 43.0 (39.8-57.2) 40.1 (35.5-49.5) 41.5 (37.6-58.0) 40.9 (36.7-54.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.3 (1.4) 5.0 (0.9) 5.1 (1.3) 4.8 (1.0) 4.9 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 279.0 (217.0-339.0) 276.0 (203.5-360.5) 265.0 (205.8-343.2) 282.0 (226.0-370.0) 279.0 (220.0-361.5) 0.02 Active B12 concentration (pM): Mean (SD) 74.2 (25.3) 63.7 (17.7) 71.2 (28.3) 69.8 (24.8) 70.4 (25.6) 0.62 Folate:B12 ratio: Median (IQ range) 132.7 (101.4-193.7) 180.2 (141.2-214.2) 166.1 (119.0-236.7) 155.4 (116.7-227.8) 154.9 (116.2-227.9) 0.007 Folate:Active B12 ratio: Median (IQ range) 518.7 (336.7-647.2) 794.6 (550.8-848.5) 620.0 (455.9-931.1) 658.3 (472.2-979.9) 627.4 (460.1-939.8) 0.003 Vitamin D: Median (IQ range) 57.0 (43.0-69.5) 68.0 (53.5-94.0) 63.0 (48.0-79.8) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.06 "],["fa-supp-3-categories-1.html", "4 FA supp: 3 categories", " 4 FA supp: 3 categories Characteristic None (n=341) &lt;800 (n=872) &gt;=800 (n=1067) Total (n=2280) P-value Prolactin: Median (IQ range) 132.0 (81.5-215.5) 117.9 (72.2-183.5) 82.1 (51.0-137.3) 100.4 (58.8-166.0) &lt;0.0001 HPL: Median (IQ range) 158.4 (106.8-201.2) 153.0 (78.1-195.9) 73.4 (43.9-137.4) 113.0 (55.1-179.2) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.3-5.2) 3.3 (1.8-4.7) 1.7 (1.0-3.3) 2.6 (1.3-4.2) &lt;0.0001 LME for duplicated or repeated measures shown on next page. "],["prolactin-2.html", "4.1 Prolactin", " 4.1 Prolactin Model summary Var Effect P (Intercept) 12.46 (8.09, 19.19) &lt;0.0001 folate_cat2&lt;800 1.02 (0.91, 1.16) 0.70 folate_cat2&gt;=800 1.08 (0.93, 1.25) 0.31 StudySTOP 1.29 (1.01, 1.65) 0.04 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.83 (0.65, 1.07) 0.15 folate_cat2&gt;=800:StudySTOP 0.70 (0.54, 0.90) 0.005 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 97.17 5.89 Inf 86.29 109.41 &lt;800 SCOPE 99.53 4.51 Inf 91.07 108.77 &gt;=800 SCOPE 104.78 6.47 Inf 92.83 118.27 None STOP 125.14 13.05 Inf 102.00 153.53 &lt;800 STOP 106.64 5.90 Inf 95.68 118.86 &gt;=800 STOP 93.80 3.68 Inf 86.87 101.29 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.02 (0.89, 1.18) 0.9 &gt;=800 / None Study: SCOPE 1.08 (0.91, 1.28) 0.6 &gt;=800 / &lt;800 Study: SCOPE 1.05 (0.91, 1.22) 0.7 &lt;800 / None Study: STOP 0.85 (0.65, 1.11) 0.3 &gt;=800 / None Study: STOP 0.75 (0.58, 0.96) 0.02 &gt;=800 / &lt;800 Study: STOP 0.88 (0.77, 1.00) 0.06 STOP / SCOPE Folic acid supplement (μg): None 1.29 (1.01, 1.65) 0.04 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.07 (0.91, 1.26) 0.4 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.90 (0.76, 1.05) 0.2 "],["hpl-2.html", "4.2 HPL", " 4.2 HPL Model summary Var Effect P (Intercept) 2.01 (1.60, 2.54) &lt;0.0001 folate_cat2&lt;800 1.00 (0.95, 1.05) 0.92 folate_cat2&gt;=800 0.99 (0.93, 1.05) 0.74 StudySTOP 1.12 (1.01, 1.24) 0.03 GA_samp 1.33 (1.31, 1.35) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.96 (0.86, 1.08) 0.52 folate_cat2&gt;=800:StudySTOP 0.96 (0.86, 1.07) 0.43 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 93.87 2.64 Inf 88.82 99.20 &lt;800 SCOPE 93.60 1.98 Inf 89.80 97.56 &gt;=800 SCOPE 92.88 2.45 Inf 88.19 97.81 None STOP 105.24 4.46 Inf 96.85 114.36 &lt;800 STOP 101.25 2.58 Inf 96.31 106.44 &gt;=800 STOP 99.63 1.74 Inf 96.28 103.10 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.00 (0.94, 1.06) 1.0 &gt;=800 / None Study: SCOPE 0.99 (0.92, 1.07) 0.9 &gt;=800 / &lt;800 Study: SCOPE 0.99 (0.93, 1.06) 1.0 &lt;800 / None Study: STOP 0.96 (0.86, 1.08) 0.7 &gt;=800 / None Study: STOP 0.95 (0.85, 1.05) 0.5 &gt;=800 / &lt;800 Study: STOP 0.98 (0.92, 1.05) 0.8 STOP / SCOPE Folic acid supplement (μg): None 1.12 (1.01, 1.24) 0.03 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.08 (1.00, 1.16) 0.04 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.07 (1.00, 1.15) 0.05 "],["gh2-2.html", "4.3 GH2", " 4.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 folate_cat2&lt;800 1.00 (0.94, 1.08) 0.90 folate_cat2&gt;=800 1.07 (0.98, 1.17) 0.12 StudySTOP 1.14 (1.00, 1.30) 0.04 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.84 (0.73, 0.97) 0.02 folate_cat2&gt;=800:StudySTOP 0.82 (0.71, 0.94) 0.006 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 2.37 0.08 Inf 2.21 2.54 &lt;800 SCOPE 2.38 0.07 Inf 2.25 2.51 &gt;=800 SCOPE 2.53 0.09 Inf 2.36 2.72 None STOP 2.70 0.15 Inf 2.43 3.00 &lt;800 STOP 2.29 0.07 Inf 2.15 2.43 &gt;=800 STOP 2.36 0.07 Inf 2.24 2.49 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.00 (0.92, 1.09) 1.0 &gt;=800 / None Study: SCOPE 1.07 (0.97, 1.19) 0.3 &gt;=800 / &lt;800 Study: SCOPE 1.07 (0.97, 1.17) 0.2 &lt;800 / None Study: STOP 0.85 (0.73, 0.98) 0.02 &gt;=800 / None Study: STOP 0.87 (0.76, 1.00) 0.06 &gt;=800 / &lt;800 Study: STOP 1.03 (0.95, 1.12) 0.7 STOP / SCOPE Folic acid supplement (μg): None 1.14 (1.00, 1.30) 0.04 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.96 (0.88, 1.06) 0.4 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.93 (0.84, 1.03) 0.2 "],["insulin.html", "4.4 Insulin", " 4.4 Insulin Model summary Var Effect P (Intercept) 11.61 (7.07, 19.05) &lt;0.0001 folate_cat2&lt;800 0.96 (0.82, 1.14) 0.67 folate_cat2&gt;=800 0.97 (0.81, 1.17) 0.75 StudySTOP 0.80 (0.62, 1.03) 0.08 GA_samp 1.02 (0.99, 1.05) 0.21 folate_cat2&lt;800:StudySTOP 1.09 (0.83, 1.44) 0.54 folate_cat2&gt;=800:StudySTOP 1.02 (0.77, 1.34) 0.90 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 15.09 1.13 Inf 13.03 17.49 &lt;800 SCOPE 14.56 0.88 Inf 12.93 16.39 &gt;=800 SCOPE 14.64 1.09 Inf 12.65 16.95 None STOP 12.04 1.21 Inf 9.89 14.66 &lt;800 STOP 12.66 0.81 Inf 11.17 14.35 &gt;=800 STOP 11.90 0.54 Inf 10.89 13.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.96 (0.79, 1.17) 0.9 &gt;=800 / None Study: SCOPE 0.97 (0.78, 1.21) 0.9 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.83, 1.22) 1.0 &lt;800 / None Study: STOP 1.05 (0.80, 1.37) 0.9 &gt;=800 / None Study: STOP 0.99 (0.77, 1.26) 1.0 &gt;=800 / &lt;800 Study: STOP 0.94 (0.81, 1.10) 0.6 STOP / SCOPE Folic acid supplement (μg): None 0.80 (0.62, 1.03) 0.08 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.87 (0.72, 1.06) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.81 (0.67, 0.99) 0.04 "],["homa-ir.html", "4.5 HOMA-IR", " 4.5 HOMA-IR Model summary Var Effect P (Intercept) 2.97 (1.76, 5.01) &lt;0.0001 folate_cat2&lt;800 0.97 (0.81, 1.15) 0.70 folate_cat2&gt;=800 0.97 (0.80, 1.19) 0.80 StudySTOP 0.69 (0.52, 0.90) 0.007 GA_samp 1.02 (0.98, 1.05) 0.34 folate_cat2&lt;800:StudySTOP 1.09 (0.81, 1.46) 0.58 folate_cat2&gt;=800:StudySTOP 1.01 (0.75, 1.36) 0.93 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 3.66 0.29 Inf 3.13 4.28 &lt;800 SCOPE 3.54 0.23 Inf 3.12 4.01 &gt;=800 SCOPE 3.57 0.29 Inf 3.05 4.18 None STOP 2.52 0.27 Inf 2.04 3.11 &lt;800 STOP 2.65 0.18 Inf 2.32 3.03 &gt;=800 STOP 2.49 0.12 Inf 2.27 2.74 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.97 (0.78, 1.19) 0.9 &gt;=800 / None Study: SCOPE 0.97 (0.77, 1.24) 1.0 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.82, 1.24) 1.0 &lt;800 / None Study: STOP 1.05 (0.79, 1.40) 0.9 &gt;=800 / None Study: STOP 0.99 (0.76, 1.28) 1.0 &gt;=800 / &lt;800 Study: STOP 0.94 (0.80, 1.11) 0.6 STOP / SCOPE Folic acid supplement (μg): None 0.69 (0.52, 0.90) 0.007 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.75 (0.61, 0.92) 0.006 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.70 (0.57, 0.86) 0.0007 "],["glucose.html", "4.6 Glucose", " 4.6 Glucose Model summary Var Effect P (Intercept) 5.50 (4.96, 6.11) &lt;0.0001 folate_cat2&lt;800 1.04 (1.00, 1.08) 0.03 folate_cat2&gt;=800 1.03 (1.00, 1.08) 0.09 StudySTOP 0.90 (0.85, 0.94) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.47 folate_cat2&lt;800:StudySTOP 0.95 (0.90, 1.01) 0.11 folate_cat2&gt;=800:StudySTOP 0.96 (0.91, 1.01) 0.08 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.33 0.08 Inf 5.17 5.49 &lt;800 SCOPE 5.55 0.07 Inf 5.42 5.69 &gt;=800 SCOPE 5.52 0.08 Inf 5.35 5.68 None STOP 4.78 0.08 Inf 4.62 4.95 &lt;800 STOP 4.76 0.08 Inf 4.61 4.91 &gt;=800 STOP 4.73 0.04 Inf 4.65 4.81 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.04 (1.00, 1.09) 0.08 &gt;=800 / None Study: SCOPE 1.03 (0.99, 1.08) 0.2 &gt;=800 / &lt;800 Study: SCOPE 0.99 (0.95, 1.04) 0.9 &lt;800 / None Study: STOP 0.99 (0.94, 1.05) 1.0 &gt;=800 / None Study: STOP 0.99 (0.95, 1.03) 0.8 &gt;=800 / &lt;800 Study: STOP 0.99 (0.96, 1.03) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.90 (0.85, 0.94) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.86 (0.82, 0.89) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.83, 0.89) &lt;0.0001 "],["fa-supp-4-categories-1.html", "5 FA supp: 4 categories", " 5 FA supp: 4 categories Characteristic None (n=341) &lt;=400 (n=131) &gt;400 to &lt;800 (n=741) &gt;=800 (n=1067) Total (n=2280) P-value Prolactin: Median (IQ range) 132.0 (81.5-215.5) 128.5 (84.7-209.4) 112.4 (70.9-178.5) 82.1 (51.0-137.3) 100.4 (58.8-166.0) &lt;0.0001 HPL: Median (IQ range) 158.4 (106.8-201.2) 171.8 (128.8-205.8) 145.8 (71.1-195.0) 73.4 (43.9-137.4) 113.0 (55.1-179.2) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.3-5.2) 4.0 (3.0-5.7) 3.2 (1.6-4.5) 1.7 (1.0-3.3) 2.6 (1.3-4.2) &lt;0.0001 Insulin: Mean (SD) 22.6 (28.9) 26.2 (31.7) 22.9 (29.0) 19.8 (25.7) 21.5 (27.6) 0.03 HOMA.IR: Mean (SD) 5.6 (8.5) 7.0 (10.0) 5.6 (7.8) 4.7 (7.6) 5.3 (8.0) 0.009 GLUC3_mmol.L: Mean (SD) 5.2 (0.8) 5.4 (0.9) 5.3 (0.8) 5.0 (0.8) 5.1 (0.8) &lt;0.0001 LME or GEE for duplicated or repeated measures. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. "],["prolactin-3.html", "5.1 Prolactin", " 5.1 Prolactin Model summary Var Effect P (Intercept) 12.38 (8.03, 19.08) &lt;0.0001 folate_cat3&lt;=400 1.03 (0.86, 1.23) 0.75 folate_cat3&gt;400 to &lt;800 1.02 (0.90, 1.16) 0.72 folate_cat3&gt;=800 1.08 (0.93, 1.25) 0.31 StudySTOP 1.29 (1.01, 1.65) 0.04 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.91 (0.55, 1.51) 0.72 folate_cat3&gt;400 to &lt;800:StudySTOP 0.83 (0.64, 1.07) 0.15 folate_cat3&gt;=800:StudySTOP 0.70 (0.54, 0.90) 0.005 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 97.07 5.88 Inf 86.20 109.32 &lt;=400 SCOPE 99.93 8.22 Inf 85.06 117.41 &gt;400 to &lt;800 SCOPE 99.30 4.76 Inf 90.39 109.08 &gt;=800 SCOPE 104.69 6.47 Inf 92.75 118.18 None STOP 125.21 13.06 Inf 102.06 153.61 &lt;=400 STOP 117.56 25.83 Inf 76.42 180.84 &gt;400 to &lt;800 STOP 106.07 5.94 Inf 95.04 118.39 &gt;=800 STOP 93.88 3.68 Inf 86.93 101.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.03 (0.81, 1.30) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 1.02 (0.87, 1.21) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.99 (0.80, 1.23) 1.0 &gt;=800 / None Study: SCOPE 1.08 (0.89, 1.30) 0.7 &gt;=800 / &lt;=400 Study: SCOPE 1.05 (0.83, 1.33) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.05 (0.89, 1.24) 0.8 &lt;=400 / None Study: STOP 0.94 (0.51, 1.74) 1.0 &gt;400 to &lt;800 / None Study: STOP 0.85 (0.63, 1.14) 0.5 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.90 (0.51, 1.60) 1.0 &gt;=800 / None Study: STOP 0.75 (0.57, 0.99) 0.04 &gt;=800 / &lt;=400 Study: STOP 0.80 (0.46, 1.40) 0.7 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.89 (0.76, 1.03) 0.1 STOP / SCOPE Folic acid supplement (μg): None 1.29 (1.01, 1.65) 0.04 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.18 (0.73, 1.88) 0.5 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.07 (0.91, 1.26) 0.4 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.90 (0.76, 1.06) 0.2 "],["hpl-3.html", "5.2 HPL", " 5.2 HPL Model summary Var Effect P (Intercept) 2.00 (1.59, 2.52) &lt;0.0001 folate_cat3&lt;=400 1.00 (0.92, 1.08) 0.98 folate_cat3&gt;400 to &lt;800 1.00 (0.94, 1.05) 0.90 folate_cat3&gt;=800 0.99 (0.93, 1.05) 0.74 StudySTOP 1.12 (1.01, 1.24) 0.03 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.06 (0.86, 1.31) 0.59 folate_cat3&gt;400 to &lt;800:StudySTOP 0.96 (0.86, 1.07) 0.46 folate_cat3&gt;=800:StudySTOP 0.96 (0.86, 1.07) 0.43 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 93.78 2.65 Inf 88.74 99.11 &lt;=400 SCOPE 93.69 3.49 Inf 87.08 100.79 &gt;400 to &lt;800 SCOPE 93.47 2.06 Inf 89.52 97.59 &gt;=800 SCOPE 92.80 2.45 Inf 88.11 97.73 None STOP 105.30 4.46 Inf 96.91 114.43 &lt;=400 STOP 111.36 10.06 Inf 93.30 132.92 &gt;400 to &lt;800 STOP 100.70 2.62 Inf 95.70 105.96 &gt;=800 STOP 99.71 1.74 Inf 96.35 103.18 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.00 (0.90, 1.11) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 1.00 (0.93, 1.07) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.00 (0.91, 1.10) 1.0 &gt;=800 / None Study: SCOPE 0.99 (0.91, 1.07) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.99 (0.89, 1.10) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 0.99 (0.93, 1.06) 1.0 &lt;=400 / None Study: STOP 1.06 (0.82, 1.36) 0.9 &gt;400 to &lt;800 / None Study: STOP 0.96 (0.84, 1.09) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.90 (0.71, 1.14) 0.7 &gt;=800 / None Study: STOP 0.95 (0.84, 1.07) 0.6 &gt;=800 / &lt;=400 Study: STOP 0.90 (0.71, 1.13) 0.6 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.99 (0.92, 1.07) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.12 (1.01, 1.24) 0.03 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.19 (0.98, 1.45) 0.09 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.08 (1.00, 1.16) 0.05 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.07 (1.00, 1.15) 0.04 "],["gh2-3.html", "5.3 GH2", " 5.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 folate_cat3&lt;=400 1.08 (0.97, 1.19) 0.16 folate_cat3&gt;400 to &lt;800 0.99 (0.92, 1.06) 0.70 folate_cat3&gt;=800 1.07 (0.98, 1.17) 0.12 StudySTOP 1.14 (1.00, 1.30) 0.05 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.69 (0.54, 0.88) 0.002 folate_cat3&gt;400 to &lt;800:StudySTOP 0.87 (0.75, 1.00) 0.05 folate_cat3&gt;=800:StudySTOP 0.82 (0.71, 0.94) 0.006 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 2.37 0.08 Inf 2.21 2.54 &lt;=400 SCOPE 2.55 0.12 Inf 2.32 2.80 &gt;400 to &lt;800 SCOPE 2.33 0.07 Inf 2.20 2.47 &gt;=800 SCOPE 2.54 0.09 Inf 2.36 2.73 None STOP 2.70 0.15 Inf 2.43 3.00 &lt;=400 STOP 2.00 0.20 Inf 1.65 2.43 &gt;400 to &lt;800 STOP 2.31 0.07 Inf 2.17 2.45 &gt;=800 STOP 2.36 0.07 Inf 2.23 2.49 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.08 (0.94, 1.23) 0.5 &gt;400 to &lt;800 / None Study: SCOPE 0.99 (0.89, 1.09) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.92 (0.81, 1.04) 0.3 &gt;=800 / None Study: SCOPE 1.07 (0.96, 1.20) 0.4 &gt;=800 / &lt;=400 Study: SCOPE 1.00 (0.87, 1.14) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.09 (0.98, 1.20) 0.2 &lt;=400 / None Study: STOP 0.74 (0.56, 0.99) 0.04 &gt;400 to &lt;800 / None Study: STOP 0.85 (0.73, 1.00) 0.05 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.15 (0.89, 1.49) 0.5 &gt;=800 / None Study: STOP 0.87 (0.75, 1.02) 0.1 &gt;=800 / &lt;=400 Study: STOP 1.18 (0.91, 1.52) 0.3 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.02 (0.93, 1.12) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.14 (1.00, 1.30) 0.05 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.78 (0.63, 0.98) 0.03 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.99 (0.90, 1.09) 0.8 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.93 (0.84, 1.03) 0.2 "],["insulin-1.html", "5.4 Insulin", " 5.4 Insulin Model summary Var Effect P (Intercept) 11.73 (7.14, 19.26) &lt;0.0001 folate_cat3&lt;=400 0.95 (0.73, 1.25) 0.73 folate_cat3&gt;400 to &lt;800 0.97 (0.82, 1.15) 0.70 folate_cat3&gt;=800 0.97 (0.81, 1.17) 0.75 StudySTOP 0.80 (0.62, 1.03) 0.08 GA_samp 1.02 (0.99, 1.05) 0.23 folate_cat3&lt;=400:StudySTOP 0.94 (0.52, 1.71) 0.85 folate_cat3&gt;400 to &lt;800:StudySTOP 1.10 (0.83, 1.45) 0.52 folate_cat3&gt;=800:StudySTOP 1.02 (0.77, 1.34) 0.90 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 15.12 1.13 Inf 13.05 17.51 &lt;=400 SCOPE 14.42 1.79 Inf 11.31 18.39 &gt;400 to &lt;800 SCOPE 14.62 0.94 Inf 12.89 16.58 &gt;=800 SCOPE 14.66 1.10 Inf 12.67 16.98 None STOP 12.03 1.21 Inf 9.88 14.65 &lt;=400 STOP 10.83 2.77 Inf 6.57 17.87 &gt;400 to &lt;800 STOP 12.77 0.83 Inf 11.24 14.50 &gt;=800 STOP 11.88 0.54 Inf 10.87 12.99 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.95 (0.67, 1.35) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.97 (0.78, 1.21) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.01 (0.73, 1.42) 1.0 &gt;=800 / None Study: SCOPE 0.97 (0.76, 1.24) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.02 (0.72, 1.44) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.80, 1.25) 1.0 &lt;=400 / None Study: STOP 0.90 (0.45, 1.81) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.06 (0.79, 1.43) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.18 (0.61, 2.29) 0.9 &gt;=800 / None Study: STOP 0.99 (0.75, 1.29) 1.0 &gt;=800 / &lt;=400 Study: STOP 1.10 (0.57, 2.11) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.93 (0.78, 1.10) 0.7 STOP / SCOPE Folic acid supplement (μg): None 0.80 (0.62, 1.03) 0.08 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.75 (0.43, 1.32) 0.3 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.87 (0.72, 1.07) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.81 (0.67, 0.98) 0.03 "],["homa-ir-1.html", "5.5 HOMA-IR", " 5.5 HOMA-IR Model summary Var Effect P (Intercept) 3.00 (1.78, 5.07) &lt;0.0001 folate_cat3&lt;=400 0.96 (0.72, 1.28) 0.78 folate_cat3&gt;400 to &lt;800 0.97 (0.81, 1.16) 0.72 folate_cat3&gt;=800 0.97 (0.80, 1.19) 0.80 StudySTOP 0.69 (0.52, 0.90) 0.007 GA_samp 1.02 (0.98, 1.05) 0.37 folate_cat3&lt;=400:StudySTOP 0.93 (0.50, 1.75) 0.83 folate_cat3&gt;400 to &lt;800:StudySTOP 1.10 (0.81, 1.48) 0.55 folate_cat3&gt;=800:StudySTOP 1.01 (0.75, 1.36) 0.93 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 3.67 0.29 Inf 3.13 4.29 &lt;=400 SCOPE 3.52 0.47 Inf 2.72 4.56 &gt;400 to &lt;800 SCOPE 3.55 0.24 Inf 3.10 4.05 &gt;=800 SCOPE 3.57 0.29 Inf 3.05 4.18 None STOP 2.52 0.27 Inf 2.04 3.11 &lt;=400 STOP 2.26 0.61 Inf 1.33 3.83 &gt;400 to &lt;800 STOP 2.67 0.18 Inf 2.34 3.06 &gt;=800 STOP 2.49 0.12 Inf 2.27 2.73 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.96 (0.66, 1.40) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.97 (0.76, 1.22) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.01 (0.71, 1.44) 1.0 &gt;=800 / None Study: SCOPE 0.97 (0.75, 1.27) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.02 (0.70, 1.48) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.79, 1.28) 1.0 &lt;=400 / None Study: STOP 0.90 (0.43, 1.87) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.06 (0.77, 1.45) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.18 (0.59, 2.38) 0.9 &gt;=800 / None Study: STOP 0.99 (0.74, 1.32) 1.0 &gt;=800 / &lt;=400 Study: STOP 1.10 (0.55, 2.19) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.93 (0.78, 1.12) 0.7 STOP / SCOPE Folic acid supplement (μg): None 0.69 (0.52, 0.90) 0.007 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.64 (0.35, 1.17) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.75 (0.61, 0.93) 0.009 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.70 (0.57, 0.86) 0.0006 "],["glucose-1.html", "5.6 Glucose", " 5.6 Glucose Model summary Var Effect P (Intercept) 5.44 (4.93, 6.01) &lt;0.0001 folate_cat3&lt;=400 1.09 (0.99, 1.20) 0.07 folate_cat3&gt;400 to &lt;800 1.03 (1.00, 1.06) 0.09 folate_cat3&gt;=800 1.04 (1.00, 1.08) 0.09 StudySTOP 0.90 (0.86, 0.94) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.59 folate_cat3&lt;=400:StudySTOP 1.07 (0.84, 1.35) 0.59 folate_cat3&gt;400 to &lt;800:StudySTOP 0.96 (0.91, 1.00) 0.06 folate_cat3&gt;=800:StudySTOP 0.96 (0.91, 1.01) 0.09 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.32 0.08 Inf 5.16 5.48 &lt;=400 SCOPE 5.81 0.26 Inf 5.32 6.34 &gt;400 to &lt;800 SCOPE 5.47 0.06 Inf 5.36 5.59 &gt;=800 SCOPE 5.51 0.08 Inf 5.35 5.67 None STOP 4.79 0.08 Inf 4.63 4.95 &lt;=400 STOP 5.57 0.61 Inf 4.50 6.91 &gt;400 to &lt;800 STOP 4.70 0.05 Inf 4.61 4.80 &gt;=800 STOP 4.73 0.04 Inf 4.66 4.81 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.09 (0.96, 1.24) 0.3 &gt;400 to &lt;800 / None Study: SCOPE 1.03 (0.99, 1.07) 0.3 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.94 (0.83, 1.06) 0.6 &gt;=800 / None Study: SCOPE 1.04 (0.98, 1.09) 0.3 &gt;=800 / &lt;=400 Study: SCOPE 0.95 (0.84, 1.08) 0.7 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.96, 1.05) 1.0 &lt;=400 / None Study: STOP 1.16 (0.88, 1.55) 0.5 &gt;400 to &lt;800 / None Study: STOP 0.98 (0.94, 1.03) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.84 (0.64, 1.12) 0.4 &gt;=800 / None Study: STOP 0.99 (0.95, 1.03) 0.9 &gt;=800 / &lt;=400 Study: STOP 0.85 (0.64, 1.12) 0.4 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.01 (0.98, 1.03) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.90 (0.86, 0.94) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.96 (0.76, 1.21) 0.7 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.86 (0.83, 0.89) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.83, 0.89) &lt;0.0001 "],["age-groups.html", "6 Age groups", " 6 Age groups Descriptives with univariate P-values. Characteristic &lt;35 yrs (n=2329) &gt;=35 yrs (n=96) Total (n=2425) P-value PRL (ng/ml): Median (IQ range) 99.2 (58.5-164.2) 79.2 (47.7-132.5) 98.4 (58.1-163.5) 0.03 hPL (μg/ml): Median (IQ range) 108.1 (54.5-177.0) 76.7 (37.2-143.4) 106.2 (54.1-176.4) 0.003 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.2) 1.9 (1.1-3.4) 2.5 (1.2-4.2) 0.07 Insulin (uU/L): Median (IQ range) 11.6 (6.4-24.8) 12.1 (8.0-20.9) 11.7 (6.5-24.6) 0.73 HOMA-IR: Median (IQ range) 2.6 (1.4-5.7) 2.7 (1.7-4.5) 2.6 (1.4-5.6) 0.74 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.6) 5.0 (4.6-5.4) 5.0 (4.6-5.5) 0.34 Within SCOPE Characteristic &lt;35 yrs (n=1126) &gt;=35 yrs (n=31) Total (n=1157) P-value PRL (ng/ml): Median (IQ range) 139.8 (92.0-222.0) 129.7 (79.3-223.8) 139.8 (91.8-222.1) 0.66 hPL (μg/ml): Median (IQ range) 179.8 (147.9-215.7) 160.1 (130.8-208.1) 179.6 (147.5-215.5) 0.13 GH2 (ng/ml): Median (IQ range) 4.2 (3.1-5.7) 3.8 (3.3-6.1) 4.2 (3.1-5.7) 0.77 Insulin (uU/L): Median (IQ range) 14.5 (6.7-31.8) 19.5 (10.2-37.2) 14.5 (6.8-31.8) 0.19 HOMA-IR: Median (IQ range) 3.4 (1.6-7.8) 4.8 (2.7-10.8) 3.4 (1.6-7.8) 0.10 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.2-5.9) 5.4 (5.0-5.8) 0.28 Serum folate concentration (nM): Median (IQ range) 36.0 (28.2-42.7) 41.1 (34.6-57.9) 36.1 (28.3-42.8) 0.01 B12 concentration (pM): Median (IQ range) 245.0 (194.0-309.0) 255.0 (212.0-364.0) 245.0 (195.0-310.0) 0.24 Folate:B12 ratio: Median (IQ range) 143.0 (102.3-208.9) 164.5 (121.3-204.5) 143.7 (103.3-208.9) 0.16 Active B12 concentration (pM): Median (IQ range) 57.0 (43.0-73.5) 52.0 (39.0-94.0) 57.0 (43.0-74.0) 0.65 Folate:Active B12 ratio: Median (IQ range) 603.3 (438.7-893.4) 685.4 (405.0-904.2) 606.9 (438.3-898.4) 0.67 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.6 (4.0-5.0) 4.4 (3.8-5.1) 0.41 Within STOP Characteristic &lt;35 yrs (n=1203) &gt;=35 yrs (n=65) Total (n=1268) P-value PRL (ng/ml): Median (IQ range) 75.4 (49.0-118.7) 64.9 (43.4-110.8) 74.6 (48.5-118.7) 0.29 hPL (μg/ml): Median (IQ range) 60.3 (40.3-92.2) 59.1 (31.5-90.1) 60.2 (40.1-92.1) 0.38 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.5 (1.0-2.5) 1.4 (0.9-2.4) 0.66 Insulin (uU/L): Median (IQ range) 10.4 (6.3-20.9) 11.7 (7.1-16.0) 10.4 (6.3-20.7) 0.93 HOMA-IR: Median (IQ range) 2.1 (1.2-4.5) 2.3 (1.4-3.2) 2.2 (1.3-4.4) 0.94 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.8 (4.4-5.0) 4.7 (4.4-5.1) 0.93 Serum folate concentration (nM): Median (IQ range) 40.3 (36.1-45.1) 43.7 (39.8-80.1) 40.5 (36.2-45.3) 0.0003 B12 concentration (pM): Median (IQ range) 279.0 (220.0-356.0) 273.0 (204.0-376.5) 278.5 (218.8-357.0) 0.83 Folate:B12 ratio: Median (IQ range) 151.5 (114.3-218.3) 194.2 (126.5-297.3) 152.4 (114.8-220.6) 0.009 Active B12 concentration (pM): Median (IQ range) 65.0 (50.0-86.0) 67.5 (54.0-96.0) 65.0 (50.0-87.0) 0.64 Folate:Active B12 ratio: Median (IQ range) 626.2 (460.9-883.7) 771.8 (493.6-1019.2) 627.0 (461.1-913.0) 0.21 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.9 (4.5-5.5) 4.8 (4.2-5.6) 0.48 Red cell folate (nmol/L): Median (IQ range) 1477.5 (1216.0-1785.2) 1592.0 (1327.0-1792.0) 1492.0 (1223.0-1788.0) 0.03 "],["prolactin-4.html", "6.1 Prolactin", " 6.1 Prolactin LME for repeated measures. Model summary Var Effect P (Intercept) 13.03 (8.72, 19.47) &lt;0.0001 Age_gp&gt;=35 yrs 0.89 (0.57, 1.39) 0.62 StudySTOP 0.99 (0.88, 1.12) 0.88 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.02 (0.63, 1.65) 0.93 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 99.12 3.88 Inf 91.79 107.03 &gt;=35 yrs SCOPE 88.61 20.28 Inf 56.58 138.79 &lt;35 yrs STOP 98.22 3.22 Inf 92.11 104.73 &gt;=35 yrs STOP 89.70 8.39 Inf 74.67 107.76 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.89 (0.57, 1.39) 0.6 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.91 (0.76, 1.10) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.99 (0.88, 1.12) 0.9 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.01 (0.62, 1.66) 1.0 "],["hpl-4.html", "6.2 HPL", " 6.2 HPL LME for repeated measures. Model summary Var Effect P (Intercept) 1.87 (1.51, 2.30) &lt;0.0001 Age_gp&gt;=35 yrs 0.90 (0.80, 1.02) 0.11 StudySTOP 1.11 (1.05, 1.17) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.95 (0.80, 1.13) 0.56 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 89.79 1.68 Inf 86.55 93.14 &gt;=35 yrs SCOPE 81.16 5.20 Inf 71.60 92.01 &lt;35 yrs STOP 99.31 1.34 Inf 96.73 101.96 &gt;=35 yrs STOP 85.38 4.89 Inf 76.31 95.52 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.90 (0.80, 1.02) 0.1 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.86 (0.77, 0.96) 0.010 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.11 (1.05, 1.17) 0.0002 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.05 (0.89, 1.25) 0.6 "],["gh2-4.html", "6.3 GH2", " 6.3 GH2 LME for repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 Age_gp&gt;=35 yrs 1.01 (0.82, 1.24) 0.95 StudySTOP 1.01 (0.94, 1.09) 0.80 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.99 (0.77, 1.28) 0.95 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 2.32 0.06 Inf 2.21 2.43 &gt;=35 yrs SCOPE 2.34 0.25 Inf 1.90 2.88 &lt;35 yrs STOP 2.34 0.05 Inf 2.25 2.44 &gt;=35 yrs STOP 2.34 0.17 Inf 2.03 2.69 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.01 (0.82, 1.24) 0.9 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.00 (0.87, 1.15) 1.0 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.01 (0.94, 1.09) 0.8 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.00 (0.78, 1.29) 1.0 "],["insulin-2.html", "6.4 Insulin", " 6.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 11.74 (7.47, 18.46) &lt;0.0001 Age_gp&gt;=35 yrs 1.35 (0.99, 1.84) 0.06 StudySTOP 0.82 (0.71, 0.95) 0.006 GA_samp 1.02 (0.99, 1.05) 0.26 Age_gp&gt;=35 yrs:StudySTOP 0.72 (0.50, 1.03) 0.08 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 14.64 0.71 Inf 13.31 16.10 &gt;=35 yrs SCOPE 19.75 3.11 Inf 14.50 26.90 &lt;35 yrs STOP 11.97 0.44 Inf 11.14 12.87 &gt;=35 yrs STOP 11.57 1.16 Inf 9.50 14.09 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.35 (0.99, 1.84) 0.06 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.97 (0.79, 1.18) 0.7 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.82 (0.71, 0.95) 0.006 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.59 (0.40, 0.85) 0.005 "],["homa-ir-2.html", "6.5 HOMA-IR", " 6.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.98 (1.85, 4.80) &lt;0.0001 Age_gp&gt;=35 yrs 1.45 (1.04, 2.01) 0.03 StudySTOP 0.71 (0.61, 0.82) &lt;0.0001 GA_samp 1.01 (0.98, 1.04) 0.39 Age_gp&gt;=35 yrs:StudySTOP 0.67 (0.45, 0.99) 0.04 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 3.55 0.18 Inf 3.21 3.93 &gt;=35 yrs SCOPE 5.14 0.86 Inf 3.70 7.14 &lt;35 yrs STOP 2.51 0.10 Inf 2.32 2.71 &gt;=35 yrs STOP 2.43 0.26 Inf 1.97 2.98 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.45 (1.04, 2.01) 0.03 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.97 (0.78, 1.19) 0.8 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.71 (0.61, 0.82) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.47 (0.32, 0.70) 0.0002 "],["glucose-2.html", "6.6 Glucose", " 6.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.63 (5.15, 6.14) &lt;0.0001 Age_gp&gt;=35 yrs 1.03 (0.97, 1.10) 0.27 StudySTOP 0.86 (0.84, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.53 Age_gp&gt;=35 yrs:StudySTOP 0.96 (0.90, 1.03) 0.25 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 5.48 0.05 Inf 5.39 5.58 &gt;=35 yrs SCOPE 5.67 0.17 Inf 5.35 6.02 &lt;35 yrs STOP 4.74 0.04 Inf 4.67 4.81 &gt;=35 yrs STOP 4.72 0.05 Inf 4.61 4.82 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.03 (0.97, 1.10) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.00 (0.97, 1.02) 0.7 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.86 (0.84, 0.89) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.83 (0.78, 0.89) &lt;0.0001 "],["bmi-groups.html", "7 BMI groups", " 7 BMI groups Descriptives with univariate P-values. Characteristic Underweight (n=63) Normal (n=975) Overweight (n=672) Obese (n=715) Total (n=2425) P-value PRL (ng/ml): Median (IQ range) 104.2 (52.4-216.8) 105.8 (62.8-172.4) 102.1 (59.4-172.6) 85.7 (50.7-145.5) 98.4 (58.1-163.5) &lt;0.0001 hPL (μg/ml): Median (IQ range) 155.5 (87.4-215.8) 125.8 (61.0-197.4) 108.7 (55.5-170.0) 74.1 (41.9-146.5) 106.2 (54.1-176.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.3 (2.3-6.2) 3.0 (1.3-4.8) 2.5 (1.2-4.0) 2.1 (1.0-3.3) 2.5 (1.2-4.2) &lt;0.0001 Insulin (uU/L): Median (IQ range) 6.2 (4.4-12.5) 7.9 (4.7-17.3) 11.8 (7.0-25.5) 17.6 (10.6-34.5) 11.7 (6.5-24.6) &lt;0.0001 HOMA-IR: Median (IQ range) 1.5 (0.9-3.1) 1.7 (1.0-3.9) 2.6 (1.5-5.7) 3.8 (2.3-8.2) 2.6 (1.4-5.6) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.9 (4.4-5.4) 5.0 (4.6-5.4) 5.0 (4.6-5.6) 5.1 (4.7-5.6) 5.0 (4.6-5.5) 0.0009 Within SCOPE Characteristic Underweight (n=36) Normal (n=479) Overweight (n=321) Obese (n=321) Total (n=1157) P-value PRL (ng/ml): Median (IQ range) 182.4 (98.9-303.2) 142.3 (96.6-221.9) 146.5 (97.3-234.1) 128.7 (79.0-199.9) 139.8 (91.8-222.1) 0.005 hPL (μg/ml): Median (IQ range) 198.4 (166.8-249.6) 198.9 (169.0-227.6) 171.0 (148.0-208.2) 155.3 (127.7-184.2) 179.6 (147.5-215.5) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 5.1 (4.3-6.6) 4.7 (3.5-6.5) 4.0 (3.1-5.4) 3.4 (2.6-4.3) 4.2 (3.1-5.7) &lt;0.0001 Insulin (uU/L): Median (IQ range) 8.8 (4.8-18.1) 9.6 (5.1-24.3) 17.9 (9.1-38.3) 20.4 (10.9-39.8) 14.5 (6.8-31.8) &lt;0.0001 HOMA-IR: Median (IQ range) 1.8 (1.2-4.2) 2.2 (1.2-5.9) 4.4 (2.0-8.6) 4.7 (2.5-9.8) 3.4 (1.6-7.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.8-5.8) 5.3 (5.0-5.7) 5.5 (5.0-5.9) 5.4 (5.0-6.0) 5.4 (5.0-5.8) 0.03 Serum folate concentration (nM): Median (IQ range) 29.3 (22.8-38.0) 36.3 (29.1-43.4) 36.2 (29.6-41.2) 36.1 (26.8-43.2) 36.1 (28.3-42.8) 0.08 B12 concentration (pM): Median (IQ range) 269.0 (208.0-329.0) 254.0 (196.0-323.5) 243.5 (199.8-309.0) 231.0 (185.0-291.0) 245.0 (195.0-310.0) 0.005 Folate:B12 ratio: Median (IQ range) 113.8 (74.6-181.7) 141.7 (102.3-206.1) 144.8 (107.0-200.9) 148.3 (103.5-217.0) 143.7 (103.3-208.9) 0.21 Active B12 concentration (pM): Median (IQ range) 52.0 (40.0-71.0) 54.0 (42.0-71.0) 57.0 (43.5-72.0) 62.0 (46.0-77.0) 57.0 (43.0-74.0) 0.05 Folate:Active B12 ratio: Median (IQ range) 609.3 (427.4-805.2) 651.8 (454.0-973.3) 618.9 (465.8-897.8) 539.1 (399.4-818.9) 606.9 (438.3-898.4) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.2-5.3) 4.5 (3.9-5.3) 4.3 (3.7-4.8) 4.4 (3.8-5.0) 4.4 (3.8-5.1) 0.008 Within STOP Characteristic Underweight (n=27) Normal (n=496) Overweight (n=351) Obese (n=394) Total (n=1268) P-value PRL (ng/ml): Median (IQ range) 80.1 (41.3-103.4) 78.8 (51.5-125.2) 76.5 (51.7-115.3) 68.2 (44.3-112.8) 74.6 (48.5-118.7) 0.03 hPL (μg/ml): Median (IQ range) 86.3 (51.8-125.0) 66.6 (45.7-105.4) 62.4 (42.1-97.9) 49.8 (33.4-71.7) 60.2 (40.1-92.1) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.9 (1.4-3.8) 1.5 (1.0-2.5) 1.4 (0.8-2.3) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.0001 Insulin (uU/L): Median (IQ range) 4.8 (4.4-11.7) 7.4 (4.3-13.6) 9.7 (6.6-17.7) 16.2 (10.4-30.9) 10.4 (6.3-20.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.0 (0.8-2.5) 1.5 (0.9-2.9) 2.0 (1.3-4.0) 3.5 (2.2-6.9) 2.2 (1.3-4.4) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.4 (4.2-4.9) 4.7 (4.3-5.0) 4.7 (4.4-5.1) 4.8 (4.5-5.2) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 35.4 (29.6-41.6) 40.9 (36.9-54.0) 40.5 (36.3-46.0) 39.9 (35.6-45.2) 40.5 (36.2-45.3) 0.0008 B12 concentration (pM): Median (IQ range) 345.0 (230.5-391.0) 293.0 (228.0-374.0) 282.0 (215.0-355.0) 264.0 (209.0-329.0) 278.5 (218.8-357.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 108.9 (70.3-158.9) 152.3 (110.0-222.4) 148.0 (115.8-218.3) 162.5 (118.1-230.1) 152.4 (114.8-220.6) 0.001 Active B12 concentration (pM): Median (IQ range) 50.0 (42.0-50.5) 65.5 (48.8-84.0) 62.0 (47.0-86.0) 70.0 (53.0-88.2) 65.0 (50.0-87.0) 0.05 Folate:Active B12 ratio: Median (IQ range) 752.6 (636.0-850.5) 637.7 (486.5-947.5) 670.2 (455.9-940.0) 575.0 (444.5-833.1) 627.0 (461.1-913.0) 0.12 Homocysteine concentration (μM): Median (IQ range) 5.3 (4.6-5.8) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.8 (4.2-5.6) 4.8 (4.2-5.6) 0.37 Red cell folate (nmol/L): Median (IQ range) 1276.0 (1054.5-1458.5) 1466.0 (1212.8-1764.2) 1503.0 (1216.0-1792.0) 1512.0 (1275.0-1792.0) 1492.0 (1223.0-1788.0) 0.02 "],["prolactin-5.html", "7.1 Prolactin", " 7.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 16.31 (9.52, 27.95) &lt;0.0001 BMI_gp3Normal 0.85 (0.60, 1.22) 0.39 BMI_gp3Overweight 0.90 (0.62, 1.29) 0.56 BMI_gp3Obese 0.69 (0.48, 0.99) 0.04 StudySTOP 0.79 (0.50, 1.25) 0.32 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.27 (0.81, 2.00) 0.30 BMI_gp3Overweight:StudySTOP 1.23 (0.78, 1.94) 0.38 BMI_gp3Obese:StudySTOP 1.26 (0.80, 1.99) 0.31 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 120.93 22.18 Inf 84.41 173.26 Normal SCOPE 103.17 4.89 Inf 94.02 113.21 Overweight SCOPE 108.57 6.27 Inf 96.95 121.57 Obese SCOPE 83.27 4.53 Inf 74.86 92.64 Underweight STOP 95.97 12.93 Inf 73.70 124.96 Normal STOP 104.05 4.69 Inf 95.26 113.65 Overweight STOP 105.93 5.20 Inf 96.21 116.63 Obese STOP 83.54 3.84 Inf 76.34 91.42 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.85 (0.53, 1.37) 0.8 Overweight / Underweight Study: SCOPE 0.90 (0.56, 1.45) 0.9 Overweight / Normal Study: SCOPE 1.05 (0.90, 1.23) 0.8 Obese / Underweight Study: SCOPE 0.69 (0.43, 1.11) 0.2 Obese / Normal Study: SCOPE 0.81 (0.70, 0.93) 0.0009 Obese / Overweight Study: SCOPE 0.77 (0.65, 0.91) 0.0003 Normal / Underweight Study: STOP 1.08 (0.76, 1.55) 0.9 Overweight / Underweight Study: STOP 1.10 (0.77, 1.58) 0.9 Overweight / Normal Study: STOP 1.02 (0.87, 1.19) 1.0 Obese / Underweight Study: STOP 0.87 (0.61, 1.25) 0.8 Obese / Normal Study: STOP 0.80 (0.69, 0.93) 0.0008 Obese / Overweight Study: STOP 0.79 (0.68, 0.92) 0.0005 STOP / SCOPE Maternal BMI: Underweight 0.79 (0.50, 1.25) 0.3 STOP / SCOPE Maternal BMI: Normal 1.01 (0.87, 1.17) 0.9 STOP / SCOPE Maternal BMI: Overweight 0.98 (0.83, 1.15) 0.8 STOP / SCOPE Maternal BMI: Obese 1.00 (0.86, 1.17) 1.0 "],["hpl-5.html", "7.2 HPL", " 7.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.13 (1.70, 2.66) &lt;0.0001 BMI_gp3Normal 1.00 (0.92, 1.09) 0.97 BMI_gp3Overweight 0.92 (0.84, 1.01) 0.08 BMI_gp3Obese 0.80 (0.73, 0.88) &lt;0.0001 StudySTOP 1.32 (1.10, 1.59) 0.003 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.84 (0.70, 1.01) 0.07 BMI_gp3Overweight:StudySTOP 0.85 (0.70, 1.03) 0.09 BMI_gp3Obese:StudySTOP 0.78 (0.65, 0.95) 0.01 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 98.14 4.40 Inf 89.89 107.16 Normal SCOPE 98.33 2.08 Inf 94.33 102.50 Overweight SCOPE 90.54 2.14 Inf 86.43 94.84 Obese SCOPE 78.51 2.08 Inf 74.54 82.69 Underweight STOP 129.73 10.72 Inf 110.33 152.53 Normal STOP 109.17 1.92 Inf 105.47 113.01 Overweight STOP 101.64 2.31 Inf 97.22 106.26 Obese STOP 81.07 1.84 Inf 77.53 84.77 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.00 (0.90, 1.12) 1.0 Overweight / Underweight Study: SCOPE 0.92 (0.82, 1.04) 0.3 Overweight / Normal Study: SCOPE 0.92 (0.87, 0.98) 0.002 Obese / Underweight Study: SCOPE 0.80 (0.71, 0.90) &lt;0.0001 Obese / Normal Study: SCOPE 0.80 (0.75, 0.85) &lt;0.0001 Obese / Overweight Study: SCOPE 0.87 (0.81, 0.93) &lt;0.0001 Normal / Underweight Study: STOP 0.84 (0.68, 1.05) 0.2 Overweight / Underweight Study: STOP 0.78 (0.63, 0.98) 0.02 Overweight / Normal Study: STOP 0.93 (0.87, 1.00) 0.05 Obese / Underweight Study: STOP 0.62 (0.50, 0.78) &lt;0.0001 Obese / Normal Study: STOP 0.74 (0.69, 0.80) &lt;0.0001 Obese / Overweight Study: STOP 0.80 (0.74, 0.86) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 1.32 (1.10, 1.59) 0.003 STOP / SCOPE Maternal BMI: Normal 1.11 (1.05, 1.18) 0.0006 STOP / SCOPE Maternal BMI: Overweight 1.12 (1.05, 1.20) 0.001 STOP / SCOPE Maternal BMI: Obese 1.03 (0.96, 1.11) 0.4 "],["gh2-5.html", "7.3 GH2", " 7.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.09 (0.06, 0.11) &lt;0.0001 BMI_gp3Normal 0.96 (0.83, 1.10) 0.56 BMI_gp3Overweight 0.85 (0.74, 0.99) 0.04 BMI_gp3Obese 0.68 (0.59, 0.79) &lt;0.0001 StudySTOP 1.45 (1.04, 2.02) 0.03 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.66 (0.47, 0.92) 0.01 BMI_gp3Overweight:StudySTOP 0.65 (0.46, 0.91) 0.01 BMI_gp3Obese:StudySTOP 0.79 (0.56, 1.10) 0.16 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 2.76 0.20 Inf 2.40 3.18 Normal SCOPE 2.64 0.08 Inf 2.50 2.80 Overweight SCOPE 2.36 0.08 Inf 2.20 2.52 Obese SCOPE 1.89 0.06 Inf 1.78 2.00 Underweight STOP 4.00 0.61 Inf 2.97 5.38 Normal STOP 2.52 0.07 Inf 2.38 2.66 Overweight STOP 2.22 0.07 Inf 2.08 2.37 Obese STOP 2.15 0.07 Inf 2.02 2.29 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.96 (0.80, 1.15) 0.9 Overweight / Underweight Study: SCOPE 0.85 (0.70, 1.04) 0.2 Overweight / Normal Study: SCOPE 0.89 (0.81, 0.98) 0.01 Obese / Underweight Study: SCOPE 0.68 (0.57, 0.83) &lt;0.0001 Obese / Normal Study: SCOPE 0.71 (0.66, 0.78) &lt;0.0001 Obese / Overweight Study: SCOPE 0.80 (0.72, 0.89) &lt;0.0001 Normal / Underweight Study: STOP 0.63 (0.43, 0.93) 0.01 Overweight / Underweight Study: STOP 0.56 (0.37, 0.83) 0.0008 Overweight / Normal Study: STOP 0.88 (0.79, 0.98) 0.009 Obese / Underweight Study: STOP 0.54 (0.36, 0.80) 0.0003 Obese / Normal Study: STOP 0.85 (0.77, 0.95) 0.0005 Obese / Overweight Study: STOP 0.97 (0.87, 1.08) 0.9 STOP / SCOPE Maternal BMI: Underweight 1.45 (1.04, 2.02) 0.03 STOP / SCOPE Maternal BMI: Normal 0.95 (0.87, 1.04) 0.3 STOP / SCOPE Maternal BMI: Overweight 0.94 (0.85, 1.04) 0.2 STOP / SCOPE Maternal BMI: Obese 1.14 (1.03, 1.25) 0.008 "],["insulin-3.html", "7.4 Insulin", " 7.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 6.74 (3.78, 12.01) &lt;0.0001 BMI_gp3Normal 1.20 (0.82, 1.75) 0.36 BMI_gp3Overweight 1.82 (1.24, 2.68) 0.002 BMI_gp3Obese 2.42 (1.65, 3.55) &lt;0.0001 StudySTOP 0.82 (0.50, 1.33) 0.41 GA_samp 1.02 (0.99, 1.05) 0.13 BMI_gp3Normal:StudySTOP 0.98 (0.61, 1.59) 0.94 BMI_gp3Overweight:StudySTOP 0.87 (0.54, 1.42) 0.58 BMI_gp3Obese:StudySTOP 1.10 (0.67, 1.79) 0.71 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 9.01 1.72 Inf 6.20 13.09 Normal SCOPE 10.77 0.67 Inf 9.53 12.17 Overweight SCOPE 16.44 1.11 Inf 14.39 18.77 Obese SCOPE 21.77 1.47 Inf 19.07 24.85 Underweight STOP 7.36 1.10 Inf 5.50 9.86 Normal STOP 8.65 0.41 Inf 7.88 9.49 Overweight STOP 11.72 0.60 Inf 10.61 12.94 Obese STOP 19.54 0.98 Inf 17.71 21.55 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.20 (0.73, 1.97) 0.8 Overweight / Underweight Study: SCOPE 1.82 (1.10, 3.03) 0.01 Overweight / Normal Study: SCOPE 1.53 (1.24, 1.88) &lt;0.0001 Obese / Underweight Study: SCOPE 2.42 (1.46, 4.00) &lt;0.0001 Obese / Normal Study: SCOPE 2.02 (1.65, 2.48) &lt;0.0001 Obese / Overweight Study: SCOPE 1.32 (1.07, 1.64) 0.005 Normal / Underweight Study: STOP 1.17 (0.80, 1.73) 0.7 Overweight / Underweight Study: STOP 1.59 (1.08, 2.35) 0.01 Overweight / Normal Study: STOP 1.36 (1.17, 1.57) &lt;0.0001 Obese / Underweight Study: STOP 2.65 (1.79, 3.92) &lt;0.0001 Obese / Normal Study: STOP 2.26 (1.95, 2.62) &lt;0.0001 Obese / Overweight Study: STOP 1.67 (1.43, 1.95) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.82 (0.50, 1.33) 0.4 STOP / SCOPE Maternal BMI: Normal 0.80 (0.67, 0.96) 0.01 STOP / SCOPE Maternal BMI: Overweight 0.71 (0.59, 0.86) 0.0003 STOP / SCOPE Maternal BMI: Obese 0.90 (0.75, 1.08) 0.3 "],["homa-ir-3.html", "7.5 HOMA-IR", " 7.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 1.66 (0.91, 3.00) 0.10 BMI_gp3Normal 1.23 (0.84, 1.79) 0.29 BMI_gp3Overweight 1.88 (1.28, 2.76) 0.001 BMI_gp3Obese 2.51 (1.71, 3.68) &lt;0.0001 StudySTOP 0.69 (0.43, 1.12) 0.14 GA_samp 1.02 (0.99, 1.05) 0.21 BMI_gp3Normal:StudySTOP 0.99 (0.61, 1.60) 0.96 BMI_gp3Overweight:StudySTOP 0.89 (0.54, 1.45) 0.63 BMI_gp3Obese:StudySTOP 1.14 (0.70, 1.86) 0.59 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 2.12 0.40 Inf 1.47 3.08 Normal SCOPE 2.60 0.17 Inf 2.29 2.96 Overweight SCOPE 3.99 0.29 Inf 3.45 4.60 Obese SCOPE 5.33 0.39 Inf 4.62 6.16 Underweight STOP 1.47 0.22 Inf 1.10 1.98 Normal STOP 1.78 0.09 Inf 1.61 1.96 Overweight STOP 2.45 0.13 Inf 2.20 2.72 Obese STOP 4.22 0.23 Inf 3.80 4.69 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.23 (0.74, 2.01) 0.7 Overweight / Underweight Study: SCOPE 1.88 (1.13, 3.11) 0.008 Overweight / Normal Study: SCOPE 1.53 (1.22, 1.91) &lt;0.0001 Obese / Underweight Study: SCOPE 2.51 (1.52, 4.15) &lt;0.0001 Obese / Normal Study: SCOPE 2.05 (1.64, 2.55) &lt;0.0001 Obese / Overweight Study: SCOPE 1.34 (1.06, 1.69) 0.008 Normal / Underweight Study: STOP 1.21 (0.82, 1.79) 0.6 Overweight / Underweight Study: STOP 1.66 (1.12, 2.47) 0.006 Overweight / Normal Study: STOP 1.37 (1.17, 1.61) &lt;0.0001 Obese / Underweight Study: STOP 2.87 (1.93, 4.27) &lt;0.0001 Obese / Normal Study: STOP 2.37 (2.03, 2.78) &lt;0.0001 Obese / Overweight Study: STOP 1.73 (1.46, 2.04) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.69 (0.43, 1.12) 0.1 STOP / SCOPE Maternal BMI: Normal 0.68 (0.57, 0.82) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.61 (0.50, 0.75) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.79 (0.65, 0.97) 0.02 "],["glucose-3.html", "7.6 Glucose", " 7.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.34 (4.83, 5.91) &lt;0.0001 BMI_gp3Normal 1.03 (0.99, 1.08) 0.17 BMI_gp3Overweight 1.07 (1.01, 1.14) 0.03 BMI_gp3Obese 1.05 (1.00, 1.10) 0.07 StudySTOP 0.86 (0.81, 0.91) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.61 BMI_gp3Normal:StudySTOP 1.00 (0.95, 1.07) 0.90 BMI_gp3Overweight:StudySTOP 0.98 (0.91, 1.06) 0.61 BMI_gp3Obese:StudySTOP 1.03 (0.96, 1.09) 0.41 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 5.24 0.12 Inf 5.01 5.48 Normal SCOPE 5.41 0.06 Inf 5.29 5.53 Overweight SCOPE 5.62 0.12 Inf 5.38 5.86 Obese SCOPE 5.48 0.07 Inf 5.34 5.62 Underweight STOP 4.51 0.08 Inf 4.34 4.68 Normal STOP 4.67 0.05 Inf 4.58 4.76 Overweight STOP 4.74 0.06 Inf 4.62 4.86 Obese STOP 4.84 0.05 Inf 4.74 4.94 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.03 (0.97, 1.10) 0.5 Overweight / Underweight Study: SCOPE 1.07 (0.99, 1.16) 0.1 Overweight / Normal Study: SCOPE 1.04 (0.97, 1.11) 0.5 Obese / Underweight Study: SCOPE 1.05 (0.98, 1.11) 0.3 Obese / Normal Study: SCOPE 1.01 (0.97, 1.05) 0.8 Obese / Overweight Study: SCOPE 0.98 (0.91, 1.04) 0.8 Normal / Underweight Study: STOP 1.04 (0.99, 1.09) 0.3 Overweight / Underweight Study: STOP 1.05 (0.99, 1.11) 0.10 Overweight / Normal Study: STOP 1.01 (0.98, 1.05) 0.8 Obese / Underweight Study: STOP 1.07 (1.02, 1.13) 0.003 Obese / Normal Study: STOP 1.04 (1.00, 1.07) 0.03 Obese / Overweight Study: STOP 1.02 (0.98, 1.06) 0.5 STOP / SCOPE Maternal BMI: Underweight 0.86 (0.81, 0.91) &lt;0.0001 STOP / SCOPE Maternal BMI: Normal 0.86 (0.83, 0.89) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.84 (0.80, 0.88) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.88 (0.85, 0.92) &lt;0.0001 "],["age-bmi-groups.html", "8 Age &amp; BMI groups", " 8 Age &amp; BMI groups Descriptives with univariate P-values. Characteristic &lt;35 yrs, non-obese (n=1657) &lt;35 yrs, obese (n=672) &gt;=35 yrs, non-obese (n=53) &gt;=35 yrs, obese (n=43) Total (n=2425) P-value PRL (ng/ml): Median (IQ range) 104.2 (61.8-174.8) 88.8 (52.2-146.2) 93.9 (67.3-178.7) 54.6 (40.6-110.3) 98.4 (58.1-163.5) &lt;0.0001 hPL (μg/ml): Median (IQ range) 122.7 (59.5-187.9) 76.2 (43.5-148.3) 90.4 (59.1-160.1) 41.7 (26.5-98.8) 106.2 (54.1-176.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.8 (1.3-4.5) 2.1 (1.1-3.3) 2.2 (1.1-4.5) 1.7 (1.0-2.8) 2.5 (1.2-4.2) &lt;0.0001 Insulin (uU/L): Median (IQ range) 9.4 (5.3-21.4) 18.1 (10.6-35.3) 9.2 (5.3-17.7) 12.9 (10.3-24.0) 11.7 (6.5-24.6) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.2-4.8) 3.9 (2.3-8.3) 2.0 (1.1-4.0) 2.8 (2.2-5.4) 2.6 (1.4-5.6) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.7-5.7) 5.1 (4.6-5.4) 4.8 (4.5-5.2) 5.0 (4.6-5.5) 0.0005 Within SCOPE Characteristic &lt;35 yrs, non-obese (n=815) &lt;35 yrs, obese (n=311) &gt;=35 yrs, non-obese (n=21) &gt;=35 yrs, obese (n=10) Total (n=1157) P-value PRL (ng/ml): Median (IQ range) 145.6 (97.1-225.0) 130.4 (79.7-205.3) 199.6 (98.1-334.1) 69.8 (36.8-121.3) 139.8 (91.8-222.1) 0.0007 hPL (μg/ml): Median (IQ range) 190.0 (157.0-222.9) 155.3 (127.9-183.8) 161.9 (136.3-202.0) 158.4 (78.6-204.8) 179.6 (147.5-215.5) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.5 (3.4-6.1) 3.4 (2.6-4.3) 4.1 (3.4-6.1) 3.8 (2.4-5.0) 4.2 (3.1-5.7) &lt;0.0001 Insulin (uU/L): Median (IQ range) 12.6 (5.9-29.5) 20.4 (10.6-39.1) 14.2 (8.6-25.3) 36.5 (16.0-53.5) 14.5 (6.8-31.8) &lt;0.0001 HOMA-IR: Median (IQ range) 3.0 (1.4-7.3) 4.7 (2.5-9.3) 3.9 (2.1-6.9) 8.8 (4.0-15.8) 3.4 (1.6-7.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.4 (4.9-5.8) 5.4 (5.0-6.0) 5.5 (5.2-5.8) 5.5 (5.1-5.9) 5.4 (5.0-5.8) 0.31 Serum folate concentration (nM): Median (IQ range) 36.0 (28.6-42.4) 36.0 (26.3-43.1) 42.1 (36.3-74.5) 37.1 (32.3-42.6) 36.1 (28.3-42.8) 0.06 B12 concentration (pM): Median (IQ range) 250.0 (198.0-317.0) 232.0 (185.0-292.0) 305.0 (239.8-367.0) 219.5 (197.0-249.0) 245.0 (195.0-310.0) 0.002 Folate:B12 ratio: Median (IQ range) 142.3 (102.0-204.3) 145.7 (102.8-218.6) 157.4 (117.5-207.7) 174.2 (140.7-200.8) 143.7 (103.3-208.9) 0.35 Active B12 concentration (pM): Median (IQ range) 55.0 (42.0-71.0) 61.5 (46.2-77.0) 48.0 (43.5-98.5) 67.0 (39.0-93.0) 57.0 (43.0-74.0) 0.07 Folate:Active B12 ratio: Median (IQ range) 630.8 (455.8-929.4) 539.3 (400.5-817.1) 804.5 (646.0-977.4) 420.3 (400.0-817.9) 606.9 (438.3-898.4) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.4 (3.8-5.0) 4.6 (4.1-5.1) 4.5 (3.9-4.9) 4.4 (3.8-5.1) 0.72 Within STOP Characteristic &lt;35 yrs, non-obese (n=842) &lt;35 yrs, obese (n=361) &gt;=35 yrs, non-obese (n=32) &gt;=35 yrs, obese (n=33) Total (n=1268) P-value PRL (ng/ml): Median (IQ range) 77.4 (50.7-120.2) 69.3 (45.6-113.1) 82.3 (50.7-110.8) 53.2 (40.6-107.8) 74.6 (48.5-118.7) 0.03 hPL (μg/ml): Median (IQ range) 65.4 (44.1-101.3) 50.4 (34.5-71.5) 67.2 (51.1-100.0) 37.9 (24.6-82.1) 60.2 (40.1-92.1) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.5 (1.0-2.4) 1.5 (1.0-2.4) 1.4 (0.9-2.4) 0.03 Insulin (uU/L): Median (IQ range) 8.2 (4.9-15.4) 16.8 (10.5-32.0) 8.0 (4.4-14.8) 12.4 (9.8-20.6) 10.4 (6.3-20.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.7 (1.0-3.2) 3.7 (2.2-7.4) 1.7 (0.9-2.9) 2.6 (2.1-4.3) 2.2 (1.3-4.4) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.8 (4.5-5.2) 4.8 (4.4-5.1) 4.7 (4.5-5.0) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.2) 39.6 (35.5-44.7) 44.2 (40.6-71.5) 42.9 (37.5-93.9) 40.5 (36.2-45.3) 0.0007 B12 concentration (pM): Median (IQ range) 288.0 (225.8-367.5) 262.0 (209.0-322.0) 263.0 (200.0-329.0) 300.5 (204.5-387.5) 278.5 (218.8-357.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 148.6 (109.9-217.3) 161.1 (118.1-221.7) 174.3 (128.3-354.5) 199.8 (114.5-286.9) 152.4 (114.8-220.6) 0.01 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-83.8) 70.0 (53.0-89.0) 63.5 (50.2-99.0) 72.0 (54.8-80.2) 65.0 (50.0-87.0) 0.20 Folate:Active B12 ratio: Median (IQ range) 654.8 (474.4-937.1) 569.5 (441.6-812.2) 779.9 (441.0-1019.2) 751.2 (586.3-1025.3) 627.0 (461.1-913.0) 0.04 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.5) 4.8 (4.2-5.6) 4.9 (4.2-6.0) 4.8 (4.5-5.2) 4.8 (4.2-5.6) 0.84 Red cell folate (nmol/L): Median (IQ range) 1464.0 (1209.0-1778.0) 1501.0 (1276.0-1792.0) 1572.0 (1344.0-1792.0) 1631.0 (1314.0-1792.0) 1492.0 (1223.0-1788.0) 0.10 "],["prolactin-6.html", "8.1 Prolactin", " 8.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 14.38 (9.73, 21.26) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.81 (0.74, 0.90) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.37 (0.94, 1.99) 0.10 Age_BMI_gp&gt;=35 yrs, obese 0.48 (0.25, 0.92) 0.03 StudySTOP 0.99 (0.87, 1.13) 0.92 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.98 (0.85, 1.13) 0.79 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.67 (0.42, 1.08) 0.10 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.62 (0.82, 3.19) 0.16 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 105.42 4.41 Inf 97.12 114.42 &lt;35 yrs, obese SCOPE 85.68 4.30 Inf 77.65 94.54 &gt;=35 yrs, non-obese SCOPE 144.21 27.38 Inf 99.41 209.22 &gt;=35 yrs, obese SCOPE 51.10 16.86 Inf 26.77 97.54 &lt;35 yrs, non-obese STOP 104.75 3.80 Inf 97.56 112.46 &lt;35 yrs, obese STOP 83.53 4.03 Inf 76.00 91.80 &gt;=35 yrs, non-obese STOP 96.42 14.35 Inf 72.03 129.08 &gt;=35 yrs, obese STOP 82.16 8.46 Inf 67.15 100.53 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.81 (0.71, 0.92) 0.0002 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.37 (0.84, 2.23) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.68 (1.03, 2.76) 0.03 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.48 (0.21, 1.13) 0.1 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.60 (0.25, 1.40) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.35 (0.13, 0.94) 0.03 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.80 (0.70, 0.91) 0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.92 (0.63, 1.35) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.15 (0.78, 1.71) 0.8 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.78 (0.60, 1.03) 0.09 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.98 (0.74, 1.30) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.85 (0.54, 1.35) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.99 (0.87, 1.13) 0.9 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.97 (0.84, 1.13) 0.7 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.67 (0.41, 1.08) 0.10 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.61 (0.81, 3.18) 0.2 "],["hpl-6.html", "8.2 HPL", " 8.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.05 (1.67, 2.51) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.83 (0.79, 0.87) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.93 (0.82, 1.06) 0.30 Age_BMI_gp&gt;=35 yrs, obese 0.78 (0.65, 0.94) 0.008 StudySTOP 1.12 (1.06, 1.18) &lt;0.0001 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.93 (0.87, 1.00) 0.06 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.05 (0.88, 1.25) 0.57 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.82 (0.64, 1.05) 0.11 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 95.19 1.80 Inf 91.72 98.79 &lt;35 yrs, obese SCOPE 78.64 2.11 Inf 74.61 82.89 &gt;=35 yrs, non-obese SCOPE 88.80 5.97 Inf 77.84 101.31 &gt;=35 yrs, obese SCOPE 73.94 7.04 Inf 61.35 89.12 &lt;35 yrs, non-obese STOP 106.81 1.55 Inf 103.82 109.88 &lt;35 yrs, obese STOP 82.47 1.91 Inf 78.81 86.31 &gt;=35 yrs, non-obese STOP 104.74 5.89 Inf 93.81 116.95 &gt;=35 yrs, obese STOP 67.74 5.80 Inf 57.28 80.11 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.83 (0.77, 0.88) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 0.93 (0.79, 1.11) 0.7 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.13 (0.94, 1.35) 0.3 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.78 (0.61, 0.99) 0.04 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.94 (0.73, 1.21) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.83 (0.62, 1.12) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.77 (0.72, 0.83) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.98 (0.85, 1.14) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.27 (1.09, 1.48) 0.0004 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.63 (0.51, 0.79) &lt;0.0001 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.82 (0.66, 1.03) 0.1 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.65 (0.50, 0.84) 0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 1.12 (1.06, 1.18) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.05 (0.97, 1.13) 0.2 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 1.18 (0.99, 1.40) 0.06 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.92 (0.71, 1.18) 0.5 "],["gh2-6.html", "8.3 GH2", " 8.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.74 (0.70, 0.79) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.06 (0.81, 1.38) 0.68 Age_BMI_gp&gt;=35 yrs, obese 0.78 (0.59, 1.04) 0.09 StudySTOP 0.96 (0.88, 1.04) 0.28 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.20 (1.09, 1.31) 0.0003 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.00 (0.73, 1.37) 0.99 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.11 (0.78, 1.59) 0.56 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 2.53 0.06 Inf 2.41 2.66 &lt;35 yrs, obese SCOPE 1.88 0.06 Inf 1.77 2.00 &gt;=35 yrs, non-obese SCOPE 2.68 0.37 Inf 2.05 3.50 &gt;=35 yrs, obese SCOPE 1.98 0.28 Inf 1.50 2.62 &lt;35 yrs, non-obese STOP 2.42 0.06 Inf 2.31 2.54 &lt;35 yrs, obese STOP 2.15 0.07 Inf 2.01 2.30 &gt;=35 yrs, non-obese STOP 2.57 0.21 Inf 2.18 3.02 &gt;=35 yrs, obese STOP 2.11 0.24 Inf 1.69 2.63 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.74 (0.69, 0.81) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.06 (0.75, 1.50) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.42 (1.00, 2.02) 0.05 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.78 (0.54, 1.13) 0.3 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.05 (0.73, 1.52) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.74 (0.45, 1.23) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.89 (0.81, 0.98) 0.01 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 1.06 (0.85, 1.32) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.19 (0.95, 1.49) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.87 (0.65, 1.17) 0.6 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.98 (0.72, 1.33) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.82 (0.57, 1.18) 0.5 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.96 (0.88, 1.04) 0.3 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.14 (1.03, 1.26) 0.009 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.96 (0.70, 1.31) 0.8 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.06 (0.75, 1.52) 0.7 "],["insulin-4.html", "8.4 Insulin", " 8.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 9.53 (6.12, 14.85) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 1.71 (1.49, 1.97) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.17 (0.82, 1.67) 0.40 Age_BMI_gp&gt;=35 yrs, obese 2.31 (1.55, 3.43) &lt;0.0001 StudySTOP 0.77 (0.66, 0.90) 0.0009 GA_samp 1.02 (0.99, 1.05) 0.15 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.20 (1.01, 1.44) 0.04 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.81 (0.50, 1.30) 0.38 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.66 (0.42, 1.03) 0.07 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 12.58 0.65 Inf 11.37 13.91 &lt;35 yrs, obese SCOPE 21.53 1.49 Inf 18.80 24.67 &gt;=35 yrs, non-obese SCOPE 14.67 2.66 Inf 10.29 20.92 &gt;=35 yrs, obese SCOPE 29.01 5.82 Inf 19.58 42.98 &lt;35 yrs, non-obese STOP 9.72 0.39 Inf 8.99 10.52 &lt;35 yrs, obese STOP 20.02 1.05 Inf 18.06 22.19 &gt;=35 yrs, non-obese STOP 9.15 1.44 Inf 6.72 12.47 &gt;=35 yrs, obese STOP 14.70 1.57 Inf 11.92 18.13 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.71 (1.42, 2.06) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.17 (0.73, 1.87) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 0.68 (0.42, 1.11) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 2.31 (1.37, 3.88) 0.0002 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.35 (0.79, 2.29) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 1.98 (1.00, 3.92) 0.05 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 2.06 (1.79, 2.37) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.94 (0.63, 1.41) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.46 (0.30, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.51 (1.14, 2.00) 0.0008 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.73 (0.55, 0.98) 0.03 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 1.61 (0.99, 2.60) 0.06 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.77 (0.66, 0.90) 0.0009 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.93 (0.77, 1.12) 0.5 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.62 (0.39, 1.01) 0.05 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.51 (0.32, 0.80) 0.003 "],["homa-ir-4.html", "8.5 HOMA-IR", " 8.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.40 (1.50, 3.83) 0.0002 Age_BMI_gp&lt;35 yrs, obese 1.73 (1.49, 2.02) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.26 (0.85, 1.86) 0.25 Age_BMI_gp&gt;=35 yrs, obese 2.41 (1.57, 3.72) &lt;0.0001 StudySTOP 0.66 (0.56, 0.78) &lt;0.0001 GA_samp 1.02 (0.99, 1.05) 0.24 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.25 (1.03, 1.51) 0.02 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.76 (0.46, 1.26) 0.29 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.63 (0.39, 1.03) 0.07 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 3.04 0.17 Inf 2.73 3.38 &lt;35 yrs, obese SCOPE 5.27 0.40 Inf 4.54 6.10 &gt;=35 yrs, non-obese SCOPE 3.82 0.75 Inf 2.60 5.62 &gt;=35 yrs, obese SCOPE 7.34 1.61 Inf 4.78 11.27 &lt;35 yrs, non-obese STOP 2.01 0.08 Inf 1.85 2.18 &lt;35 yrs, obese STOP 4.34 0.24 Inf 3.88 4.84 &gt;=35 yrs, non-obese STOP 1.92 0.32 Inf 1.38 2.67 &gt;=35 yrs, obese STOP 3.08 0.34 Inf 2.48 3.84 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.73 (1.42, 2.12) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.26 (0.76, 2.09) 0.7 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 0.73 (0.43, 1.23) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 2.41 (1.37, 4.26) 0.0004 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.39 (0.78, 2.49) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 1.92 (0.91, 4.05) 0.1 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 2.16 (1.86, 2.51) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.96 (0.62, 1.47) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.44 (0.28, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.53 (1.15, 2.05) 0.0010 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.71 (0.52, 0.97) 0.02 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 1.60 (0.96, 2.67) 0.08 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.66 (0.56, 0.78) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.82 (0.67, 1.01) 0.06 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.50 (0.30, 0.84) 0.009 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.42 (0.26, 0.68) 0.0005 "],["glucose-4.html", "8.6 Glucose", " 8.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.59 (5.13, 6.10) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 1.00 (0.96, 1.03) 0.77 Age_BMI_gp&gt;=35 yrs, non-obese 1.01 (0.96, 1.05) 0.73 Age_BMI_gp&gt;=35 yrs, obese 1.06 (0.95, 1.19) 0.28 StudySTOP 0.86 (0.83, 0.88) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.65 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.04 (1.00, 1.08) 0.08 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.00 (0.95, 1.05) 0.96 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.94 (0.84, 1.06) 0.33 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 5.49 0.06 Inf 5.37 5.61 &lt;35 yrs, obese SCOPE 5.46 0.07 Inf 5.32 5.60 &gt;=35 yrs, non-obese SCOPE 5.53 0.11 Inf 5.32 5.75 &gt;=35 yrs, obese SCOPE 5.84 0.33 Inf 5.23 6.52 &lt;35 yrs, non-obese STOP 4.69 0.04 Inf 4.61 4.77 &lt;35 yrs, obese STOP 4.85 0.06 Inf 4.74 4.96 &gt;=35 yrs, non-obese STOP 4.73 0.07 Inf 4.60 4.85 &gt;=35 yrs, obese STOP 4.71 0.08 Inf 4.57 4.86 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.00 (0.95, 1.04) 1.0 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.01 (0.95, 1.07) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.01 (0.96, 1.07) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.06 (0.92, 1.23) 0.7 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.07 (0.92, 1.24) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 1.06 (0.91, 1.23) 0.8 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.03 (1.00, 1.07) 0.06 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 1.01 (0.97, 1.05) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.97 (0.93, 1.02) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.00 (0.96, 1.05) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.97 (0.93, 1.02) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 1.00 (0.95, 1.05) 1.0 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.86 (0.83, 0.88) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.89 (0.86, 0.92) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.85 (0.81, 0.90) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.81 (0.72, 0.90) 0.0002 "],["mets-1.html", "9 MetS", " 9 MetS Descriptives with univariate P-values. Characteristic No MetS (n=2036) MetS (n=308) Total (n=2344) P-value PRL (ng/ml): Median (IQ range) 96.2 (57.8-158.3) 109.2 (58.5-183.4) 97.6 (57.8-161.6) 0.06 hPL (μg/ml): Median (IQ range) 102.1 (54.1-176.8) 124.7 (53.2-172.6) 105.2 (54.0-176.0) 0.64 GH2 (ng/ml): Median (IQ range) 2.4 (1.2-4.1) 2.7 (1.5-4.2) 2.5 (1.2-4.2) 0.11 Insulin (uU/L): Median (IQ range) 10.5 (6.1-21.3) 31.0 (15.4-53.5) 11.7 (6.5-24.6) &lt;0.0001 HOMA-IR: Median (IQ range) 2.3 (1.3-4.8) 7.6 (3.5-14.5) 2.6 (1.4-5.7) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.4) 5.8 (5.3-6.2) 5.0 (4.6-5.6) &lt;0.0001 Within SCOPE Characteristic No MetS (n=946) MetS (n=200) Total (n=1146) P-value PRL (ng/ml): Median (IQ range) 137.8 (90.4-223.7) 145.2 (93.5-214.1) 139.7 (91.4-222.3) 0.61 hPL (μg/ml): Median (IQ range) 181.6 (150.3-217.9) 165.5 (132.2-202.1) 179.7 (147.1-215.6) 0.0007 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.8) 3.7 (2.7-5.3) 4.2 (3.1-5.7) 0.005 Insulin (uU/L): Median (IQ range) 12.3 (6.2-25.8) 35.7 (17.9-60.1) 14.5 (6.8-31.8) &lt;0.0001 HOMA-IR: Median (IQ range) 2.9 (1.4-6.2) 8.9 (4.4-16.6) 3.4 (1.6-7.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.7) 5.9 (5.6-6.4) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.1 (28.3-42.9) 36.2 (28.4-42.5) 36.1 (28.4-42.8) 0.73 B12 concentration (pM): Median (IQ range) 250.0 (196.0-316.0) 230.0 (190.5-291.0) 245.0 (195.0-310.0) 0.002 Folate:B12 ratio: Median (IQ range) 142.5 (101.5-205.9) 152.3 (114.1-212.8) 144.1 (103.5-209.0) 0.20 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-72.5) 59.0 (46.0-78.0) 57.0 (43.0-74.0) 0.16 Folate:Active B12 ratio: Median (IQ range) 618.5 (450.9-923.7) 553.8 (406.5-771.1) 608.2 (438.8-900.5) 0.04 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.9) 4.4 (3.8-5.0) 0.01 Within STOP Characteristic No MetS (n=1090) MetS (n=108) Total (n=1198) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.5-115.2) 69.6 (44.4-111.5) 73.7 (48.3-114.4) 0.42 hPL (μg/ml): Median (IQ range) 60.3 (40.8-90.2) 49.9 (34.0-69.9) 59.2 (39.7-89.0) 0.0005 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.3 (0.9-2.1) 1.4 (0.9-2.3) 0.38 Insulin (uU/L): Median (IQ range) 9.6 (5.9-18.3) 24.4 (13.9-46.9) 10.5 (6.3-20.7) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.2-3.9) 5.9 (3.0-12.2) 2.2 (1.3-4.4) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 5.4 (4.8-5.8) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.6 (36.3-46.8) 39.3 (34.6-44.5) 40.4 (36.2-45.3) 0.02 B12 concentration (pM): Median (IQ range) 281.0 (220.0-363.0) 261.0 (200.5-324.5) 278.0 (218.0-357.0) 0.006 Folate:B12 ratio: Median (IQ range) 151.8 (114.3-222.5) 156.3 (119.4-206.1) 152.2 (114.8-221.9) 0.56 Active B12 concentration (pM): Median (IQ range) 65.0 (50.0-85.8) 66.0 (54.0-88.0) 66.0 (50.0-86.5) 0.66 Folate:Active B12 ratio: Median (IQ range) 630.6 (461.5-920.9) 550.7 (447.9-726.8) 626.0 (461.0-885.0) 0.05 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.8 (4.2-5.6) 0.88 Red cell folate (nmol/L): Median (IQ range) 1479.0 (1216.0-1778.0) 1496.0 (1273.8-1792.0) 1483.0 (1220.5-1782.8) 0.44 "],["prolactin-7.html", "9.1 Prolactin", " 9.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 15.83 (10.35, 24.21) &lt;0.0001 metab.C1MetS 0.96 (0.84, 1.11) 0.61 StudySTOP 0.93 (0.82, 1.06) 0.28 GA_samp 1.15 (1.12, 1.18) &lt;0.0001 metab.C1MetS:StudySTOP 0.99 (0.79, 1.23) 0.90 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 102.09 4.27 Inf 94.04 110.82 MetS SCOPE 98.43 7.49 Inf 84.79 114.26 No MetS STOP 94.94 3.33 Inf 88.64 101.69 MetS STOP 90.22 7.65 Inf 76.40 106.54 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.96 (0.84, 1.11) 0.6 MetS / No MetS Study: STOP 0.95 (0.80, 1.12) 0.6 STOP / SCOPE MetS: No MetS 0.93 (0.82, 1.06) 0.3 STOP / SCOPE MetS: MetS 0.92 (0.72, 1.16) 0.5 "],["hpl-7.html", "9.2 HPL", " 9.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.07 (1.69, 2.53) &lt;0.0001 metab.C1MetS 0.90 (0.85, 0.95) 0.0003 StudySTOP 1.08 (1.02, 1.14) 0.007 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.92 (0.82, 1.02) 0.10 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 92.30 1.73 Inf 88.97 95.75 MetS SCOPE 82.93 2.56 Inf 78.07 88.10 No MetS STOP 99.46 1.39 Inf 96.78 102.21 MetS STOP 81.79 3.61 Inf 75.02 89.18 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.90 (0.85, 0.95) 0.0003 MetS / No MetS Study: STOP 0.82 (0.75, 0.90) &lt;0.0001 STOP / SCOPE MetS: No MetS 1.08 (1.02, 1.14) 0.007 STOP / SCOPE MetS: MetS 0.99 (0.88, 1.10) 0.8 "],["gh2-7.html", "9.3 GH2", " 9.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 metab.C1MetS 0.86 (0.79, 0.93) 0.0003 StudySTOP 0.98 (0.91, 1.07) 0.69 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 metab.C1MetS:StudySTOP 1.12 (0.97, 1.29) 0.11 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.38 0.06 Inf 2.27 2.51 MetS SCOPE 2.05 0.09 Inf 1.88 2.23 No MetS STOP 2.34 0.05 Inf 2.24 2.45 MetS STOP 2.26 0.13 Inf 2.01 2.53 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.86 (0.79, 0.93) 0.0003 MetS / No MetS Study: STOP 0.96 (0.86, 1.08) 0.5 STOP / SCOPE MetS: No MetS 0.98 (0.91, 1.07) 0.7 STOP / SCOPE MetS: MetS 1.10 (0.95, 1.28) 0.2 "],["insulin-5.html", "9.4 Insulin", " 9.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 9.92 (6.27, 15.68) &lt;0.0001 metab.C1MetS 2.53 (2.18, 2.94) &lt;0.0001 StudySTOP 0.89 (0.76, 1.03) 0.11 GA_samp 1.02 (0.99, 1.05) 0.24 metab.C1MetS:StudySTOP 0.95 (0.75, 1.20) 0.65 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 12.50 0.62 Inf 11.33 13.78 MetS SCOPE 31.68 2.37 Inf 27.36 36.68 No MetS STOP 11.06 0.42 Inf 10.28 11.91 MetS STOP 26.54 2.48 Inf 22.10 31.88 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.53 (2.18, 2.94) &lt;0.0001 MetS / No MetS Study: STOP 2.40 (2.00, 2.88) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.89 (0.76, 1.03) 0.1 STOP / SCOPE MetS: MetS 0.84 (0.65, 1.07) 0.2 "],["homa-ir-5.html", "9.5 HOMA-IR", " 9.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.39 (1.48, 3.86) 0.0004 metab.C1MetS 2.84 (2.42, 3.35) &lt;0.0001 StudySTOP 0.78 (0.66, 0.91) 0.002 GA_samp 1.02 (0.99, 1.05) 0.30 metab.C1MetS:StudySTOP 0.97 (0.75, 1.26) 0.82 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.96 0.16 Inf 2.67 3.29 MetS SCOPE 8.43 0.68 Inf 7.19 9.88 No MetS STOP 2.30 0.09 Inf 2.13 2.49 MetS STOP 6.35 0.65 Inf 5.19 7.75 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.84 (2.42, 3.35) &lt;0.0001 MetS / No MetS Study: STOP 2.76 (2.26, 3.37) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.78 (0.66, 0.91) 0.002 STOP / SCOPE MetS: MetS 0.75 (0.58, 0.99) 0.04 "],["glucose-5.html", "9.6 Glucose", " 9.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.38 (4.92, 5.89) &lt;0.0001 metab.C1MetS 1.14 (1.08, 1.21) &lt;0.0001 StudySTOP 0.88 (0.85, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.85 metab.C1MetS:StudySTOP 1.00 (0.94, 1.07) 0.90 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 5.34 0.05 Inf 5.25 5.44 MetS SCOPE 6.10 0.15 Inf 5.81 6.41 No MetS STOP 4.69 0.03 Inf 4.63 4.76 MetS STOP 5.38 0.09 Inf 5.20 5.56 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.14 (1.08, 1.21) &lt;0.0001 MetS / No MetS Study: STOP 1.15 (1.11, 1.18) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.88 (0.85, 0.90) &lt;0.0001 STOP / SCOPE MetS: MetS 0.88 (0.83, 0.93) &lt;0.0001 "],["birthweight-centile.html", "10 Birthweight centile", " 10 Birthweight centile Descriptives with univariate P-values. Characteristic &lt;=90th centile (n=2165) &gt;90th centile (n=232) Total (n=2397) P-value PRL (ng/ml): Median (IQ range) 97.8 (57.7-160.3) 106.5 (64.1-191.5) 98.5 (58.1-163.6) 0.05 hPL (μg/ml): Median (IQ range) 108.0 (54.1-175.8) 95.2 (55.2-185.1) 106.5 (54.2-176.4) 0.61 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.2) 2.2 (1.1-4.1) 2.5 (1.2-4.2) 0.33 Insulin (uU/L): Median (IQ range) 11.6 (6.5-24.4) 12.8 (6.3-27.9) 11.7 (6.5-24.6) 0.65 HOMA-IR: Median (IQ range) 2.6 (1.4-5.5) 2.8 (1.3-6.3) 2.6 (1.4-5.6) 0.62 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.0 (4.6-5.6) 5.0 (4.6-5.5) 0.62 Within SCOPE Characteristic &lt;=90th centile (n=1048) &gt;90th centile (n=103) Total (n=1151) P-value PRL (ng/ml): Median (IQ range) 137.9 (89.3-221.6) 177.5 (118.9-229.5) 139.9 (91.7-222.2) 0.02 hPL (μg/ml): Median (IQ range) 177.2 (147.1-212.9) 203.1 (149.7-239.2) 179.4 (147.5-215.5) 0.01 GH2 (ng/ml): Median (IQ range) 4.1 (3.1-5.7) 4.5 (3.1-5.6) 4.2 (3.1-5.7) 0.74 Insulin (uU/L): Median (IQ range) 14.1 (6.8-30.1) 20.9 (7.0-39.8) 14.6 (6.8-31.9) 0.14 HOMA-IR: Median (IQ range) 3.3 (1.6-7.5) 5.0 (1.6-9.9) 3.5 (1.6-7.8) 0.13 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.0-5.9) 5.4 (5.0-5.8) 0.29 Serum folate concentration (nM): Median (IQ range) 36.0 (28.2-42.8) 38.0 (30.3-42.8) 36.1 (28.3-42.8) 0.36 B12 concentration (pM): Median (IQ range) 243.0 (193.0-305.0) 255.5 (203.8-330.2) 245.0 (195.0-309.0) 0.09 Folate:B12 ratio: Median (IQ range) 143.7 (104.4-208.7) 146.8 (99.1-211.0) 144.6 (103.5-208.8) 0.84 Active B12 concentration (pM): Median (IQ range) 56.0 (43.0-73.0) 66.0 (49.0-81.0) 57.0 (43.0-74.0) 0.11 Folate:Active B12 ratio: Median (IQ range) 608.8 (435.2-901.0) 556.2 (455.8-871.4) 606.9 (438.3-898.4) 0.95 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.7) 4.4 (3.8-5.1) 0.09 Within STOP Characteristic &lt;=90th centile (n=1117) &gt;90th centile (n=129) Total (n=1246) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.5-118.1) 83.1 (51.8-141.3) 74.6 (48.5-118.7) 0.19 hPL (μg/ml): Median (IQ range) 60.3 (39.3-93.2) 60.9 (46.0-88.0) 60.3 (40.1-92.3) 0.30 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-2.2) 1.4 (0.9-2.4) 0.85 Insulin (uU/L): Median (IQ range) 10.4 (6.3-20.8) 10.4 (5.6-19.7) 10.4 (6.3-20.8) 0.78 HOMA-IR: Median (IQ range) 2.2 (1.2-4.4) 2.0 (1.3-4.3) 2.2 (1.3-4.4) 0.92 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.7 (4.5-5.1) 4.7 (4.4-5.1) 0.49 Serum folate concentration (nM): Median (IQ range) 40.4 (36.1-45.7) 40.9 (36.8-45.0) 40.5 (36.2-45.3) 0.52 B12 concentration (pM): Median (IQ range) 278.5 (216.8-356.0) 276.0 (231.0-363.5) 278.0 (218.0-356.0) 0.71 Folate:B12 ratio: Median (IQ range) 152.7 (114.8-222.8) 153.2 (116.2-212.1) 152.7 (114.9-221.7) 0.62 Active B12 concentration (pM): Median (IQ range) 64.5 (49.8-86.2) 70.0 (51.5-87.5) 65.0 (50.0-87.0) 0.25 Folate:Active B12 ratio: Median (IQ range) 630.7 (464.9-921.5) 615.5 (446.0-843.8) 628.0 (461.0-914.4) 0.44 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.7 (4.2-5.3) 4.8 (4.2-5.6) 0.08 Red cell folate (nmol/L): Median (IQ range) 1483.0 (1215.0-1781.0) 1508.0 (1236.0-1792.0) 1490.0 (1221.5-1786.0) 0.33 "],["prolactin-8.html", "10.1 Prolactin", " 10.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 12.47 (8.29, 18.76) &lt;0.0001 BW_gp&gt;90th centile 1.29 (1.09, 1.51) 0.002 StudySTOP 1.00 (0.88, 1.14) 0.99 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.88 (0.69, 1.11) 0.28 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 96.51 4.00 Inf 88.99 104.67 &gt;90th centile SCOPE 124.20 10.23 Inf 105.69 145.95 &lt;=90th centile STOP 96.61 3.18 Inf 90.58 103.04 &gt;90th centile STOP 108.87 9.84 Inf 91.20 129.97 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.29 (1.09, 1.51) 0.002 &gt;90th centile / &lt;=90th centile Study: STOP 1.13 (0.94, 1.35) 0.2 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.00 (0.88, 1.14) 1.0 STOP / SCOPE Birthweight centile: &gt;90th centile 0.88 (0.68, 1.12) 0.3 "],["hpl-8.html", "10.2 HPL", " 10.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.84 (1.49, 2.27) &lt;0.0001 BW_gp&gt;90th centile 1.13 (1.03, 1.23) 0.008 StudySTOP 1.10 (1.04, 1.16) 0.0005 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.01 (0.90, 1.12) 0.92 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 88.76 1.69 Inf 85.51 92.13 &gt;90th centile SCOPE 99.96 4.51 Inf 91.49 109.21 &lt;=90th centile STOP 97.54 1.32 Inf 94.98 100.16 &gt;90th centile STOP 110.43 3.50 Inf 103.77 117.52 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.13 (1.03, 1.23) 0.008 &gt;90th centile / &lt;=90th centile Study: STOP 1.13 (1.06, 1.20) &lt;0.0001 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.10 (1.04, 1.16) 0.0005 STOP / SCOPE Birthweight centile: &gt;90th centile 1.10 (0.99, 1.24) 0.09 "],["gh2-8.html", "10.3 GH2", " 10.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.06, 0.09) &lt;0.0001 BW_gp&gt;90th centile 1.01 (0.90, 1.13) 0.91 StudySTOP 1.01 (0.93, 1.08) 0.89 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.01 (0.86, 1.18) 0.91 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 2.33 0.06 Inf 2.22 2.44 &gt;90th centile SCOPE 2.34 0.14 Inf 2.09 2.63 &lt;=90th centile STOP 2.34 0.05 Inf 2.24 2.44 &gt;90th centile STOP 2.38 0.13 Inf 2.14 2.64 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.01 (0.90, 1.13) 0.9 &gt;90th centile / &lt;=90th centile Study: STOP 1.02 (0.91, 1.13) 0.8 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.01 (0.93, 1.08) 0.9 STOP / SCOPE Birthweight centile: &gt;90th centile 1.01 (0.86, 1.19) 0.9 "],["insulin-6.html", "10.4 Insulin", " 10.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 12.01 (7.61, 18.94) &lt;0.0001 BW_gp&gt;90th centile 1.13 (0.88, 1.45) 0.34 StudySTOP 0.81 (0.70, 0.94) 0.005 GA_samp 1.02 (0.99, 1.05) 0.31 BW_gp&gt;90th centile:StudySTOP 0.89 (0.66, 1.20) 0.44 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 14.67 0.72 Inf 13.32 16.16 &gt;90th centile SCOPE 16.56 2.07 Inf 12.97 21.16 &lt;=90th centile STOP 11.90 0.44 Inf 11.07 12.80 &gt;90th centile STOP 11.94 1.04 Inf 10.07 14.16 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.13 (0.88, 1.45) 0.3 &gt;90th centile / &lt;=90th centile Study: STOP 1.00 (0.85, 1.19) 1.0 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.81 (0.70, 0.94) 0.005 STOP / SCOPE Birthweight centile: &gt;90th centile 0.72 (0.53, 0.98) 0.04 "],["homa-ir-6.html", "10.5 HOMA-IR", " 10.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.06 (1.89, 4.94) &lt;0.0001 BW_gp&gt;90th centile 1.15 (0.89, 1.49) 0.30 StudySTOP 0.70 (0.60, 0.82) &lt;0.0001 GA_samp 1.01 (0.98, 1.04) 0.46 BW_gp&gt;90th centile:StudySTOP 0.88 (0.64, 1.20) 0.42 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 3.56 0.19 Inf 3.21 3.94 &gt;90th centile SCOPE 4.09 0.53 Inf 3.16 5.28 &lt;=90th centile STOP 2.49 0.10 Inf 2.31 2.69 &gt;90th centile STOP 2.52 0.23 Inf 2.11 3.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.15 (0.89, 1.49) 0.3 &gt;90th centile / &lt;=90th centile Study: STOP 1.01 (0.85, 1.21) 0.9 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.70 (0.60, 0.82) &lt;0.0001 STOP / SCOPE Birthweight centile: &gt;90th centile 0.62 (0.45, 0.85) 0.003 "],["glucose-6.html", "10.6 Glucose", " 10.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.59 (5.12, 6.11) &lt;0.0001 BW_gp&gt;90th centile 1.05 (1.00, 1.10) 0.06 StudySTOP 0.86 (0.84, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.56 BW_gp&gt;90th centile:StudySTOP 0.99 (0.92, 1.06) 0.79 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 5.46 0.05 Inf 5.36 5.56 &gt;90th centile SCOPE 5.72 0.14 Inf 5.46 5.99 &lt;=90th centile STOP 4.72 0.03 Inf 4.65 4.79 &gt;90th centile STOP 4.90 0.13 Inf 4.66 5.15 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.05 (1.00, 1.10) 0.06 &gt;90th centile / &lt;=90th centile Study: STOP 1.04 (0.99, 1.09) 0.2 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.86 (0.84, 0.89) &lt;0.0001 STOP / SCOPE Birthweight centile: &gt;90th centile 0.86 (0.80, 0.92) &lt;0.0001 "],["hormone-models.html", "11 Hormone Models", " 11 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 33 0 15wks 891 1276 "],["raw-plots.html", "11.1 Raw plots", " 11.1 Raw plots "],["scope-vs-stop.html", "11.2 SCOPE vs STOP", " 11.2 SCOPE vs STOP Fit GEE models - Outcomes: Prolactin, hPL, GH2, Insulin, HOMA-IR, Glucose (all outcomes log-transformed) - Independent variables: Study, GA at sampling - Model fitted: GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       Clustering: Study ID, Correlation structure: independence 11.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 2.425 2.425 0.1 ns 3 GA_samp 1 Inf 93.744 93.744 &lt;0.0001 *** 2 Study:GA_samp 1 Inf 2.537 2.537 0.1 ns hPL (μg/ml) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 35.919 35.919 &lt;0.0001 *** 3 GA_samp 1 Inf 832.798 832.798 &lt;0.0001 *** 2 Study:GA_samp 1 Inf 40.845 40.845 &lt;0.0001 *** GH2 (ng/ml) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 20.067 20.067 &lt;0.0001 *** 3 GA_samp 1 Inf 499.472 499.472 &lt;0.0001 *** 2 Study:GA_samp 1 Inf 20.431 20.431 &lt;0.0001 *** Insulin (uU/L) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 3.706 3.706 0.05 ns 3 GA_samp 1 Inf 0.183 0.183 0.7 ns 2 Study:GA_samp 1 Inf 2.665 2.665 0.1 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 4.810 4.810 0.03 * 3 GA_samp 1 Inf 0.432 0.432 0.5 ns 2 Study:GA_samp 1 Inf 2.900 2.900 0.09 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 0.138 0.138 0.7 ns 3 GA_samp 1 Inf 0.001 0.001 1.0 ns 2 Study:GA_samp 1 Inf 0.190 0.190 0.7 ns 11.2.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 1.82 (0.82, 2.82) 0.0004 StudySTOP 0.84 (-0.22, 1.89) 0.12 GA_samp 0.20 (0.14, 0.27) &lt;0.0001 StudySTOP:GA_samp -0.06 (-0.13, 0.01) 0.11 hPL (μg/ml) Var Effect P (Intercept) 2.10 (1.62, 2.58) &lt;0.0001 StudySTOP -1.57 (-2.09, -1.06) &lt;0.0001 GA_samp 0.20 (0.17, 0.23) &lt;0.0001 StudySTOP:GA_samp 0.11 (0.08, 0.15) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) -1.43 (-2.00, -0.87) &lt;0.0001 StudySTOP -1.39 (-1.99, -0.78) &lt;0.0001 GA_samp 0.19 (0.15, 0.22) &lt;0.0001 StudySTOP:GA_samp 0.09 (0.05, 0.13) &lt;0.0001 Insulin (uU/L) Var Effect P (Intercept) 3.45 (2.16, 4.73) &lt;0.0001 StudySTOP -1.31 (-2.64, 0.02) 0.05 GA_samp -0.05 (-0.13, 0.04) 0.27 StudySTOP:GA_samp 0.07 (-0.01, 0.16) 0.10 HOMA-IR Var Effect P (Intercept) 2.16 (0.83, 3.50) 0.001 StudySTOP -1.55 (-2.94, -0.16) 0.03 GA_samp -0.06 (-0.14, 0.03) 0.21 StudySTOP:GA_samp 0.08 (-0.01, 0.17) 0.09 Glucose (mmol/L) Var Effect P (Intercept) 1.66 (1.30, 2.02) &lt;0.0001 StudySTOP -0.07 (-0.43, 0.29) 0.71 GA_samp 0.00 (-0.02, 0.03) 0.84 StudySTOP:GA_samp -0.01 (-0.03, 0.02) 0.66 11.2.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/L) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 11.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. PRL (ng/ml) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 46.77984 8.557414 Inf 32.68503 66.95279 STOP 10 60.98198 1.984145 Inf 57.21453 64.99751 SCOPE 16 157.65554 4.671804 Inf 148.75981 167.08324 STOP 16 145.80292 10.047989 Inf 127.38133 166.88860 hPL (μg/ml) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 58.66173 5.1415039 Inf 49.40261 69.65621 STOP 10 37.37513 0.7441673 Inf 35.94469 38.86251 SCOPE 16 191.79504 2.4328863 Inf 187.08546 196.62318 STOP 16 239.75276 7.7025414 Inf 225.12153 255.33490 GH2 (ng/ml) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 1.5266388 0.1577893 Inf 1.246690 1.869452 STOP 10 0.9794978 0.0222874 Inf 0.936775 1.024169 SCOPE 16 4.6508967 0.0835049 Inf 4.490076 4.817477 STOP 16 5.2495097 0.2270129 Inf 4.822907 5.713847 Insulin (uU/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 19.77659 4.6279509 Inf 12.50145 31.28545 STOP 10 11.15166 0.3842101 Inf 10.42348 11.93070 SCOPE 16 14.96218 0.6124863 Inf 13.80862 16.21210 STOP 16 13.12747 0.9877112 Inf 11.32756 15.21337 HOMA-IR Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 5.004074 1.2160703 Inf 3.107908 8.057111 STOP 10 2.360224 0.0858766 Inf 2.197770 2.534686 SCOPE 16 3.587401 0.1563751 Inf 3.293639 3.907364 STOP 16 2.735166 0.2179779 Inf 2.339631 3.197568 Glucose (mmol/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 5.395297 0.3344260 Inf 4.778085 6.092238 STOP 10 4.773670 0.0366162 Inf 4.702440 4.845979 SCOPE 16 5.475695 0.0719187 Inf 5.336536 5.618483 STOP 16 4.691147 0.0561450 Inf 4.582385 4.802490 11.2.5 Comparisons Hormone Contrast GA_samp Ratio of Geometric means (95% CI) P-value PRL (ng/ml) STOP / SCOPE 10 1.30 (0.91, 1.88) 0.2 PRL (ng/ml) STOP / SCOPE 16 0.92 (0.80, 1.07) 0.3 hPL (μg/ml) STOP / SCOPE 10 0.64 (0.53, 0.76) &lt;0.0001 hPL (μg/ml) STOP / SCOPE 16 1.25 (1.17, 1.34) &lt;0.0001 GH2 (ng/ml) STOP / SCOPE 10 0.64 (0.52, 0.79) &lt;0.0001 GH2 (ng/ml) STOP / SCOPE 16 1.13 (1.03, 1.24) 0.010 Insulin (uU/L) STOP / SCOPE 10 0.56 (0.35, 0.90) 0.02 Insulin (uU/L) STOP / SCOPE 16 0.88 (0.74, 1.04) 0.1 HOMA-IR STOP / SCOPE 10 0.47 (0.29, 0.76) 0.002 HOMA-IR STOP / SCOPE 16 0.76 (0.64, 0.91) 0.003 Glucose (mmol/L) STOP / SCOPE 10 0.88 (0.78, 1.00) 0.05 Glucose (mmol/L) STOP / SCOPE 16 0.86 (0.83, 0.89) &lt;0.0001 11.2.6 Plots for GA "],["session-info-4.html", "12 Session info", " 12 Session info Results generated on: 2023-08-17 11:28:18.825119 Click for more details ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] grid stats graphics grDevices utils datasets methods ## [8] base ## ## other attached packages: ## [1] ggpubr_0.6.0 car_3.1-2 carData_3.0-5 xlsx_0.6.5 ## [5] geepack_1.3.9 doFuture_1.0.0 future_1.32.0 foreach_1.5.2 ## [9] emmeans_1.8.5 lmerTest_3.1-3 lme4_1.1-33 Matrix_1.5-4.1 ## [13] readxl_1.4.2 Hmisc_5.1-0 fontawesome_0.5.1 htmlwidgets_1.6.2 ## [17] kableExtra_1.3.4 knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 ## [21] devtools_2.4.3 usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 ## [25] gridExtra_2.3 ## ## loaded via a namespace (and not attached): ## [1] remotes_2.4.2 sandwich_3.0-1 rlang_1.1.1 ## [4] multcomp_1.4-18 compiler_4.3.1 mgcv_1.8-42 ## [7] systemfonts_1.0.4 callr_3.7.3 vctrs_0.6.3 ## [10] rvest_1.0.3 stringr_1.5.0 pkgconfig_2.0.3 ## [13] crayon_1.5.2 fastmap_1.1.1 backports_1.4.1 ## [16] ellipsis_0.3.2 labeling_0.4.2 utf8_1.2.3 ## [19] sessioninfo_1.2.2 ps_1.7.5 nloptr_2.0.0 ## [22] purrr_1.0.1 xfun_0.39 cachem_1.0.8 ## [25] jsonlite_1.8.4 highr_0.10 xlsxjars_0.6.1 ## [28] broom_1.0.4 parallel_4.3.1 prettyunits_1.1.1 ## [31] cluster_2.1.4 R6_2.5.1 bslib_0.4.2 ## [34] stringi_1.7.12 parallelly_1.36.0 boot_1.3-28 ## [37] pkgload_1.3.2 rpart_4.1.19 jquerylib_0.1.4 ## [40] cellranger_1.1.0 numDeriv_2016.8-1.1 estimability_1.4.1 ## [43] Rcpp_1.0.11 bookdown_0.34 iterators_1.0.14 ## [46] future.apply_1.8.1 zoo_1.8-9 base64enc_0.1-3 ## [49] splines_4.3.1 nnet_7.3-19 tidyselect_1.2.0 ## [52] abind_1.4-5 rstudioapi_0.14 yaml_2.3.7 ## [55] codetools_0.2-19 processx_3.8.1 listenv_0.8.0 ## [58] pkgbuild_1.4.0 lattice_0.21-8 tibble_3.2.1 ## [61] withr_2.5.0 coda_0.19-4 evaluate_0.21 ## [64] foreign_0.8-82 survival_3.5-5 rJava_1.0-6 ## [67] xml2_1.3.3 pillar_1.9.0 checkmate_2.0.0 ## [70] generics_0.1.3 munsell_0.5.0 scales_1.2.1 ## [73] minqa_1.2.4 globals_0.16.2 xtable_1.8-4 ## [76] glue_1.6.2 tools_4.3.1 data.table_1.14.8 ## [79] ggsignif_0.6.4 webshot_0.5.4 fs_1.6.2 ## [82] mvtnorm_1.1-3 tidyr_1.3.0 colorspace_2.1-0 ## [85] nlme_3.1-162 htmlTable_2.4.0 Formula_1.2-4 ## [88] cli_3.6.1 fansi_1.0.4 viridisLite_0.4.2 ## [91] svglite_2.1.0 dplyr_1.1.2 gtable_0.3.3 ## [94] rstatix_0.7.2 sass_0.4.6 digest_0.6.33 ## [97] TH.data_1.1-0 farver_2.1.1 memoise_2.0.1 ## [100] htmltools_0.5.5 lifecycle_1.0.3 httr_1.4.2 ## [103] MASS_7.3-60 "],["part-uncomplicated-pregnancies.html", "(PART*) Uncomplicated Pregnancies", " (PART*) Uncomplicated Pregnancies "],["descriptives-1.html", "13 Descriptives", " 13 Descriptives Descriptives on raw data. Tables in this section are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value PRL (ng/ml): Mean (SD) 184.4 (193.4) 101.3 (112.3) 134.1 (155.0) &lt;0.0001 hPL (μg/ml): Mean (SD) 188.4 (57.8) 76.7 (50.5) 121.4 (76.6) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.6 (2.0) 1.9 (1.5) 3.0 (2.2) &lt;0.0001 Insulin (uU/ml): Mean (SD) 21.8 (23.0) 15.4 (18.2) 18.0 (20.5) &lt;0.0001 HOMA-IR: Mean (SD) 5.6 (6.8) 3.4 (4.3) 4.3 (5.5) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 Number of available samples Var SCOPE: Available N(%) STOP: Available N(%) PRL (ng/ml) 435 (72.0%) 666 (93.7%) hPL (μg/ml) 435 (72.0%) 652 (91.7%) GH2 (ng/ml) 443 (73.3%) 651 (91.6%) Insulin (uU/ml) 455 (75.3%) 677 (95.2%) HOMA-IR 454 (75.2%) 677 (95.2%) Glucose (mmol/L) 601 (99.5%) 701 (98.6%) "],["by-study-1.html", "13.1 By Study", " 13.1 By Study 13.1.1 Demographics Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-26.0) 25.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.92 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 591 (97.8) 694 (97.6) 1285 (97.7) &gt;=35 13 (2.2) 17 (2.4) 30 (2.3) Maternal BMI: Median (IQ range) 25.1 (22.0-29.1) 25.3 (22.4-29.5) 25.2 (22.2-29.4) 0.27 Maternal BMI (category): N(%) 0.41 Missing 0 (0.0) 1 (0.1) 1 (0.1) &lt;20 64 (10.6) 55 (7.7) 119 (9.0) &gt;=20 to &lt;25 228 (37.7) 278 (39.1) 506 (38.5) &gt;=25 to &lt;30 176 (29.1) 212 (29.8) 388 (29.5) &gt;=30 to &lt;40 117 (19.4) 136 (19.1) 253 (19.2) &gt;=40 19 (3.1) 29 (4.1) 48 (3.7) SEI: Median (IQ range) 24.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-36.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 555 (91.9) 595 (83.7) 1150 (87.5) Maori 3 (0.5) 0 (0.0) 3 (0.2) Pacific Islander 0 (0.0) 3 (0.4) 3 (0.2) South East and Far East 25 (4.1) 30 (4.2) 55 (4.2) Indian 2 (0.3) 27 (3.8) 29 (2.2) African 3 (0.5) 11 (1.5) 14 (1.1) Middle-eastern 4 (0.7) 18 (2.5) 22 (1.7) Hispanic 0 (0.0) 2 (0.3) 2 (0.2) Aboriginal 9 (1.5) 13 (1.8) 22 (1.7) China and Japan 0 (0.0) 10 (1.4) 10 (0.8) Other 3 (0.5) 2 (0.3) 5 (0.4) Smoking: N(%) 0.002 Missing 0 (0.0) 6 (0.8) 6 (0.5) No 476 (78.8) 602 (84.7) 1078 (82.0) Yes 128 (21.2) 103 (14.5) 231 (17.6) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;800 335 (55.5) 134 (18.8) 469 (35.7) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;=400 66 (10.9) 7 (1.0) 73 (5.6) &gt;400 to &lt;800 269 (44.5) 127 (17.9) 396 (30.1) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 58 (9.6) 47 (6.6) 105 (8.0) 1-6x/week 222 (36.8) 203 (28.6) 425 (32.3) &gt;=1-&lt;3x/day 221 (36.6) 349 (49.1) 570 (43.3) &gt;=3x/day 103 (17.1) 101 (14.2) 204 (15.5) Leafy vege (1st trim): N(%) 0.52 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 60 (9.9) 73 (10.3) 133 (10.1) 1-2x/week 144 (23.8) 159 (22.4) 303 (23.0) 3-6x/week 220 (36.4) 235 (33.1) 455 (34.6) &gt;=1x/day 180 (29.8) 233 (32.8) 413 (31.4) Fast food (1st trim): N(%) 0.001 Missing 114 (18.9) 93 (13.1) 207 (15.7) Never 12 (2.0) 30 (4.2) 42 (3.2) &gt;0-&lt;2x/week 62 (10.3) 118 (16.6) 180 (13.7) &gt;=2-&lt;4x/week 249 (41.2) 261 (36.7) 510 (38.8) &gt;=4x/week 167 (27.6) 209 (29.4) 376 (28.6) Vigorous exercise: N(%) 0.71 Missing 3 (0.5) 5 (0.7) 8 (0.6) Never 390 (64.6) 439 (61.7) 829 (63.0) Once a week 148 (24.5) 179 (25.2) 327 (24.9) 2-3/wk 50 (8.3) 63 (8.9) 113 (8.6) 4-6/wk 7 (1.2) 12 (1.7) 19 (1.4) Daily 6 (1.0) 12 (1.7) 18 (1.4) More than once a day 0 (0.0) 1 (0.1) 1 (0.1) Moderate exercise: N(%) 0.16 Missing 3 (0.5) 7 (1.0) 10 (0.8) Never 248 (41.1) 266 (37.4) 514 (39.1) Once a week 146 (24.2) 173 (24.3) 319 (24.3) 2-3/wk 134 (22.2) 156 (21.9) 290 (22.1) 4-6/wk 36 (6.0) 49 (6.9) 85 (6.5) Daily 35 (5.8) 48 (6.8) 83 (6.3) More than once a day 2 (0.3) 12 (1.7) 14 (1.1) Recreational walking: N(%) 0.24 Missing 3 (0.5) 8 (1.1) 11 (0.8) Never 147 (24.3) 158 (22.2) 305 (23.2) Once a week 187 (31.0) 233 (32.8) 420 (31.9) 2-3/wk 161 (26.7) 170 (23.9) 331 (25.2) 4-6/wk 44 (7.3) 53 (7.5) 97 (7.4) Daily 52 (8.6) 83 (11.7) 135 (10.3) More than once a day 10 (1.7) 6 (0.8) 16 (1.2) Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.0) 40.5 (36.4-45.2) 39.2 (33.8-44.2) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 248.0 (195.5-316.0) 277.5 (219.0-355.0) 262.0 (206.0-339.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.6 (104.0-207.4) 155.9 (115.7-222.4) 150.5 (109.3-217.2) 0.0006 Active B12 concentration (pM): Mean (SD) 58.8 (23.4) 66.7 (24.7) 62.9 (24.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 617.0 (458.5-931.9) 670.7 (493.5-950.5) 634.4 (480.9-941.9) 0.05 Vitamin D: Median (IQ range) 56.3 (40.2-76.1) 61.0 (45.0-76.0) 59.3 (43.0-76.0) 0.02 UIC (ug/L): Median (IQ range) 109.8 (66.5-164.3) 199.0 (127.1-320.1) 156.1 (93.2-257.5) &lt;0.0001 HCG (MoM): Median (IQ range) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.6) 0.26 PAPP-A (MoM): Median (IQ range) 1.1 (0.8-1.5) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.07 Haemoglobin (g/L): Mean (SD) 128.3 (9.1) 130.8 (9.7) 129.7 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 13.1.2 MetS Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value MetS: N(%) &lt;0.0001 Missing 3 (0.5) 51 (7.2) 54 (4.1) No 525 (86.9) 624 (87.8) 1149 (87.4) Yes 76 (12.6) 36 (5.1) 112 (8.5) MetS: number of criteria met: Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 86.0 (79.0-95.0) 81.0 (74.0-89.0) 83.0 (76.0-93.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.4 (0.9) 4.6 (0.8) 5.0 (0.9) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.3 (1.1-1.6) 1.1 (0.9-1.4) 1.2 (0.9-1.5) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.8 (0.4) 1.7 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.7) 2.4 (0.7) 2.7 (0.8) &lt;0.0001 Systolic BP (mmHg): Mean (SD) 107.8 (9.3) 113.9 (9.7) 111.0 (10.0) &lt;0.0001 Diastolic BP (mmHg): Mean (SD) 63.4 (7.5) 69.4 (8.2) 66.6 (8.4) &lt;0.0001 MAP (mmHg): Mean (SD) 78.2 (7.1) 84.2 (7.7) 81.4 (8.0) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;80 cm 168 (27.8) 329 (46.3) 497 (37.8) &gt;=80 cm 436 (72.2) 371 (52.2) 807 (61.4) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 10 (1.4) 10 (0.8) &lt;1.7 mmol/L 468 (77.5) 627 (88.2) 1095 (83.3) &gt;=1.7 mmol/L 136 (22.5) 74 (10.4) 210 (16.0) MetS criteria: HDL: N(%) 0.003 Missing 0 (0.0) 10 (1.4) 10 (0.8) &gt;=1.3 mmol/L 554 (91.7) 606 (85.2) 1160 (88.2) &lt;1.3 mmol/L 50 (8.3) 95 (13.4) 145 (11.0) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 3 (0.5) 10 (1.4) 13 (1.0) &lt;5.6 mmol/L 341 (56.5) 648 (91.1) 989 (75.2) &gt;=5.6 mmol/L 260 (43.0) 53 (7.5) 313 (23.8) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;130 mmHg 596 (98.7) 634 (89.2) 1230 (93.5) &gt;=130 mmHg 8 (1.3) 44 (6.2) 52 (4.0) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;85 mmHg 602 (99.7) 654 (92.0) 1256 (95.5) &gt;=85 mmHg 2 (0.3) 24 (3.4) 26 (2.0) MetS criteria: BP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;130/85 mmHg 595 (98.5) 622 (87.5) 1217 (92.5) &gt;=130/85 mmHg 9 (1.5) 56 (7.9) 65 (4.9) CRP (mg/L): Median (IQ range) 4.3 (2.3-7.7) 3.1 (1.3-6.0) 3.6 (1.7-6.9) &lt;0.0001 13.1.3 Outcomes Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Gestational age at birth (weeks): Median (IQ range) 40.3 (39.4-41.0) 40.0 (39.1-40.9) 40.1 (39.3-40.9) 0.010 Birthweight (g): Median (IQ range) 3542.5 (3290.0-3825.0) 3506.0 (3250.0-3786.0) 3526.0 (3270.0-3810.0) 0.03 Birthweight centile: Mean (SD) 54.2 (25.1) 53.3 (26.1) 53.7 (25.7) 0.52 Baby sex: N(%) 0.53 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 291 (48.2) 356 (50.1) 647 (49.2) Female 313 (51.8) 355 (49.9) 668 (50.8) Mode of delivery: N(%) 0.15 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 361 (59.8) 382 (53.7) 743 (56.5) Operative vaginal 103 (17.1) 147 (20.7) 250 (19.0) Pre-labour LSCS 24 (4.0) 35 (4.9) 59 (4.5) LSCS in labour 116 (19.2) 147 (20.7) 263 (20.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) Induction of Labour: N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 470 (77.8) 415 (58.4) 885 (67.3) Yes 134 (22.2) 296 (41.6) 430 (32.7) "],["folate-vs-fa-supplement-1.html", "14 Folate vs FA supplement", " 14 Folate vs FA supplement 14.0.1 FA supp (3 categories) Characteristic None (n=171) &lt;800 (n=469) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 38.7 (32.2-44.2) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.7 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 254.5 (199.2-336.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 59.8 (23.4) 66.9 (25.0) 62.9 (24.5) 0.0004 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 151.4 (111.3-225.3) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 637.9 (482.6-1013.6) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.0008 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 57.0 (40.8-76.0) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=122) &lt;800 (n=335) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 37.8 (30.1-43.9) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 252.0 (196.8-327.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.005 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 59.0 (22.8) 65.1 (26.7) 58.8 (23.4) 0.0007 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 143.7 (107.5-210.1) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 618.7 (486.6-988.8) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.03 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 53.6 (38.6-75.0) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Click here for table within STOP Characteristic None (n=49) &lt;800 (n=134) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 39.8 (35.5-44.6) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.002 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 260.5 (205.0-347.2) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.06 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 62.3 (25.0) 67.6 (24.4) 67.4 (25.0) 0.04 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 171.1 (119.0-245.9) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.50 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 758.2 (480.3-1110.3) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.07 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 63.5 (49.2-79.8) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 14.0.2 FA supp (4 categories) Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 36.5 (29.7-42.0) 39.0 (32.7-44.4) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.8 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 255.0 (193.8-338.5) 254.5 (200.0-332.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 56.7 (21.6) 60.4 (23.7) 66.9 (25.0) 62.9 (24.5) 0.0009 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 141.7 (108.7-186.1) 152.4 (111.9-234.0) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 563.0 (487.9-894.8) 649.1 (483.2-1041.9) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.001 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 49.0 (35.7-69.0) 58.8 (42.1-76.4) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=122) &lt;=400 (n=66) &gt;400 to &lt;800 (n=269) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 35.6 (28.9-41.6) 38.4 (30.4-44.2) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 251.0 (192.5-338.0) 252.0 (198.0-318.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.01 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 55.3 (21.3) 59.9 (23.2) 65.1 (26.7) 58.8 (23.4) 0.001 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 131.6 (107.4-184.5) 146.9 (107.8-228.4) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 563.0 (507.4-920.2) 629.2 (483.2-997.7) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.06 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 47.1 (35.5-62.8) 55.6 (40.0-75.8) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Click here for table within STOP Characteristic None (n=49) &lt;=400 (n=7) &gt;400 to &lt;800 (n=127) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 42.1 (36.6-56.3) 39.8 (35.4-44.5) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.006 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.1 (1.1) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 261.0 (203.5-315.5) 260.0 (205.0-346.5) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.12 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 68.0 (23.3) 61.8 (25.3) 67.6 (24.4) 67.4 (25.0) 0.09 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 180.2 (165.0-201.9) 168.0 (116.3-248.2) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.52 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 550.8 (476.6-682.4) 805.2 (504.9-1155.7) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.08 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 76.0 (63.5-104.0) 63.0 (49.0-78.5) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 "],["folate.html", "14.1 Folate", " 14.1 Folate 14.1.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0918622 0.0940957 32.858714 &lt;0.0001 *** folate_cat2&lt;800 0.4044411 0.0532352 7.597252 &lt;0.0001 *** folate_cat2&gt;=800 0.4779058 0.0612912 7.797297 &lt;0.0001 *** StudySTOP 0.4876934 0.0824564 5.914563 &lt;0.0001 *** f1_age 0.0132802 0.0029572 4.490775 &lt;0.0001 *** BMI -0.0056414 0.0023590 -2.391397 0.02 * folate_cat2&lt;800:StudySTOP -0.3899550 0.0960217 -4.061112 &lt;0.0001 *** folate_cat2&gt;=800:StudySTOP -0.3603296 0.0943408 -3.819446 0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.50 (1.29, 1.74) &lt;0.0001 SCOPE: &gt;=800/None 1.61 (1.36, 1.91) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.08 (0.94, 1.23) 1 STOP: &lt;800/None 1.01 (0.81, 1.27) 1 STOP: &gt;=800/None 1.12 (0.92, 1.37) 0.9 STOP: &gt;=800/&lt;800 1.11 (0.97, 1.26) 0.3 None: STOP/SCOPE 1.63 (1.30, 2.05) &lt;0.0001 &lt;800: STOP/SCOPE 1.10 (0.96, 1.27) 0.5 &gt;=800: STOP/SCOPE 1.14 (1.00, 1.29) 0.05 P-value adjustment: bonferroni method for 9 tests 14.1.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0905284 0.0940717 32.852890 &lt;0.0001 *** folate_cat3&lt;=400 0.3173159 0.0767843 4.132562 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4255637 0.0548854 7.753682 &lt;0.0001 *** folate_cat3&gt;=800 0.4775237 0.0612737 7.793285 &lt;0.0001 *** StudySTOP 0.4873285 0.0824325 5.911846 &lt;0.0001 *** f1_age 0.0134131 0.0029575 4.535215 &lt;0.0001 *** BMI -0.0057020 0.0023587 -2.417392 0.02 * folate_cat3&lt;=400:StudySTOP -0.2254040 0.2062415 -1.092913 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4155745 0.0974396 -4.264946 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3600711 0.0943133 -3.817818 0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.37 (1.09, 1.72) 0.0006 SCOPE: &gt;400 to &lt;800/None 1.53 (1.30, 1.80) &lt;0.0001 SCOPE: &gt;=800/None 1.61 (1.34, 1.93) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.17 (0.94, 1.46) 0.5 SCOPE: &gt;=800/&gt;400 to &lt;800 1.05 (0.91, 1.22) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.90 (0.73, 1.10) 1 STOP: &lt;=400/None 1.10 (0.62, 1.93) 1 STOP: &gt;400 to &lt;800/None 1.01 (0.80, 1.28) 1 STOP: &gt;=800/None 1.12 (0.91, 1.39) 1 STOP: &gt;=800/&lt;=400 1.03 (0.60, 1.75) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.96, 1.28) 0.4 STOP: &lt;=400/&gt;400 to &lt;800 1.09 (0.63, 1.87) 1 None: STOP/SCOPE 1.63 (1.28, 2.08) &lt;0.0001 &lt;=400: STOP/SCOPE 1.30 (0.74, 2.28) 1 &gt;400 to &lt;800: STOP/SCOPE 1.07 (0.92, 1.26) 1 &gt;=800: STOP/SCOPE 1.14 (0.99, 1.30) 0.10 P-value adjustment: bonferroni method for 16 tests "],["b12.html", "14.2 B12", " 14.2 B12 14.2.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4221270 0.0745587 72.7228994 &lt;0.0001 *** folate_cat2&lt;800 0.1122967 0.0421820 2.6621912 0.008 ** folate_cat2&gt;=800 0.1217016 0.0485654 2.5059308 0.01 * StudySTOP 0.1714030 0.0653361 2.6234043 0.009 ** f1_age 0.0106478 0.0023432 4.5440955 &lt;0.0001 *** BMI -0.0098606 0.0018692 -5.2752170 &lt;0.0001 *** folate_cat2&lt;800:StudySTOP -0.1600879 0.0760849 -2.1040696 0.04 * folate_cat2&gt;=800:StudySTOP -0.0702722 0.0747530 -0.9400586 0.35 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.12 (1.00, 1.26) 0.07 SCOPE: &gt;=800/None 1.13 (0.99, 1.29) 0.1 SCOPE: &gt;=800/&lt;800 1.01 (0.91, 1.12) 1 STOP: &lt;800/None 0.95 (0.80, 1.14) 1 STOP: &gt;=800/None 1.05 (0.90, 1.23) 1 STOP: &gt;=800/&lt;800 1.10 (1.00, 1.23) 0.07 None: STOP/SCOPE 1.19 (0.99, 1.42) 0.08 &lt;800: STOP/SCOPE 1.01 (0.91, 1.13) 1 &gt;=800: STOP/SCOPE 1.11 (1.00, 1.22) 0.05 P-value adjustment: bonferroni method for 9 tests 14.2.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4221799 0.0746248 72.6592525 &lt;0.0001 *** folate_cat3&lt;=400 0.1116077 0.0609111 1.8323054 0.07 ns folate_cat3&gt;400 to &lt;800 0.1124641 0.0435392 2.5830535 0.010 ** folate_cat3&gt;=800 0.1216999 0.0486069 2.5037563 0.01 * StudySTOP 0.1713993 0.0653917 2.6211177 0.009 ** f1_age 0.0106483 0.0023461 4.5386395 &lt;0.0001 *** BMI -0.0098630 0.0018711 -5.2711581 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.1894511 0.1636063 -1.1579699 0.25 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1585432 0.0772964 -2.0511079 0.04 * folate_cat3&gt;=800:StudySTOP -0.0702675 0.0748164 -0.9391987 0.35 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.12 (0.93, 1.34) 1 SCOPE: &gt;400 to &lt;800/None 1.12 (0.98, 1.27) 0.2 SCOPE: &gt;=800/None 1.13 (0.98, 1.30) 0.2 SCOPE: &gt;=800/&lt;=400 1.01 (0.85, 1.20) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.01 (0.90, 1.14) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 1.00 (0.85, 1.17) 1 STOP: &lt;=400/None 0.93 (0.59, 1.45) 1 STOP: &gt;400 to &lt;800/None 0.95 (0.79, 1.15) 1 STOP: &gt;=800/None 1.05 (0.89, 1.25) 1 STOP: &gt;=800/&lt;=400 1.14 (0.75, 1.74) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.10 (0.98, 1.24) 0.2 STOP: &lt;=400/&gt;400 to &lt;800 0.97 (0.63, 1.49) 1 None: STOP/SCOPE 1.19 (0.98, 1.44) 0.1 &lt;=400: STOP/SCOPE 0.98 (0.63, 1.53) 1 &gt;400 to &lt;800: STOP/SCOPE 1.01 (0.89, 1.15) 1 &gt;=800: STOP/SCOPE 1.11 (0.99, 1.23) 0.09 P-value adjustment: bonferroni method for 16 tests "],["homocysteine.html", "14.3 Homocysteine", " 14.3 Homocysteine 14.3.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5756808 0.0444031 35.4858518 &lt;0.0001 *** folate_cat2&lt;800 -0.1151020 0.0251167 -4.5826830 &lt;0.0001 *** folate_cat2&gt;=800 -0.1623759 0.0289179 -5.6150683 &lt;0.0001 *** StudySTOP 0.0302406 0.0389037 0.7773193 0.44 ns f1_age 0.0005980 0.0013961 0.4283576 0.67 ns BMI 0.0002349 0.0011148 0.2106636 0.83 ns folate_cat2&lt;800:StudySTOP 0.1285288 0.0453036 2.8370549 0.005 ** folate_cat2&gt;=800:StudySTOP 0.0856836 0.0445148 1.9248354 0.05 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 0.89 (0.83, 0.96) &lt;0.0001 SCOPE: &gt;=800/None 0.85 (0.78, 0.92) &lt;0.0001 SCOPE: &gt;=800/&lt;800 0.95 (0.89, 1.02) 0.4 STOP: &lt;800/None 1.01 (0.91, 1.13) 1 STOP: &gt;=800/None 0.93 (0.84, 1.02) 0.2 STOP: &gt;=800/&lt;800 0.91 (0.86, 0.97) 0.0005 None: STOP/SCOPE 1.03 (0.93, 1.15) 1 &lt;800: STOP/SCOPE 1.17 (1.10, 1.25) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.06, 1.19) &lt;0.0001 P-value adjustment: bonferroni method for 9 tests 14.3.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5755699 0.0444379 35.4555061 &lt;0.0001 *** folate_cat3&lt;=400 -0.1268829 0.0362651 -3.4987635 0.0005 *** folate_cat3&gt;400 to &lt;800 -0.1122455 0.0259222 -4.3300917 &lt;0.0001 *** folate_cat3&gt;=800 -0.1624262 0.0289397 -5.6125727 &lt;0.0001 *** StudySTOP 0.0301903 0.0389329 0.7754434 0.44 ns f1_age 0.0006154 0.0013977 0.4402927 0.66 ns BMI 0.0002245 0.0011159 0.2012125 0.84 ns folate_cat3&lt;=400:StudySTOP 0.1173646 0.0974071 1.2048878 0.23 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.1269687 0.0460204 2.7589678 0.006 ** folate_cat3&gt;=800:StudySTOP 0.0857212 0.0445481 1.9242383 0.05 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 0.88 (0.79, 0.98) 0.008 SCOPE: &gt;400 to &lt;800/None 0.89 (0.83, 0.97) 0.0003 SCOPE: &gt;=800/None 0.85 (0.78, 0.93) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 0.97 (0.87, 1.07) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.95 (0.89, 1.02) 0.6 SCOPE: &lt;=400/&gt;400 to &lt;800 0.99 (0.90, 1.08) 1 STOP: &lt;=400/None 0.99 (0.76, 1.29) 1 STOP: &gt;400 to &lt;800/None 1.01 (0.91, 1.14) 1 STOP: &gt;=800/None 0.93 (0.84, 1.02) 0.4 STOP: &gt;=800/&lt;=400 0.94 (0.73, 1.20) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.91 (0.85, 0.98) 0.001 STOP: &lt;=400/&gt;400 to &lt;800 0.98 (0.75, 1.26) 1 None: STOP/SCOPE 1.03 (0.92, 1.16) 1 &lt;=400: STOP/SCOPE 1.16 (0.89, 1.51) 1 &gt;400 to &lt;800: STOP/SCOPE 1.17 (1.09, 1.26) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.05, 1.20) &lt;0.0001 P-value adjustment: bonferroni method for 16 tests "],["active-b12.html", "14.4 Active B12", " 14.4 Active B12 14.4.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6122690 0.1028613 35.117846 &lt;0.0001 *** folate_cat2&lt;800 0.1367106 0.0555196 2.462387 0.01 * folate_cat2&gt;=800 0.2164003 0.0633348 3.416767 0.0007 *** StudySTOP 0.4286753 0.0919347 4.662825 &lt;0.0001 *** f1_age 0.0076438 0.0033803 2.261274 0.02 * BMI 0.0029555 0.0026004 1.136572 0.26 ns folate_cat2&lt;800:StudySTOP -0.4092640 0.1100691 -3.718247 0.0002 *** folate_cat2&gt;=800:StudySTOP -0.3901251 0.1049792 -3.716212 0.0002 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.15 (0.98, 1.34) 0.1 SCOPE: &gt;=800/None 1.24 (1.04, 1.48) 0.006 SCOPE: &gt;=800/&lt;800 1.08 (0.94, 1.25) 1 STOP: &lt;800/None 0.76 (0.58, 0.99) 0.04 STOP: &gt;=800/None 0.84 (0.67, 1.06) 0.4 STOP: &gt;=800/&lt;800 1.10 (0.94, 1.30) 0.8 None: STOP/SCOPE 1.54 (1.19, 1.98) &lt;0.0001 &lt;800: STOP/SCOPE 1.02 (0.86, 1.21) 1 &gt;=800: STOP/SCOPE 1.04 (0.90, 1.20) 1 P-value adjustment: bonferroni method for 9 tests 14.4.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6107066 0.1029489 35.0727978 &lt;0.0001 *** folate_cat3&lt;=400 0.0765721 0.0837526 0.9142653 0.36 ns folate_cat3&gt;400 to &lt;800 0.1509771 0.0574959 2.6258750 0.009 ** folate_cat3&gt;=800 0.2164867 0.0633662 3.4164408 0.0007 *** StudySTOP 0.4288045 0.0919802 4.6619199 &lt;0.0001 *** f1_age 0.0076339 0.0033820 2.2571861 0.02 * BMI 0.0030216 0.0026033 1.1606941 0.25 ns folate_cat3&lt;=400:StudySTOP -0.2189817 0.2258022 -0.9697942 0.33 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4336678 0.1120755 -3.8694268 0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3903496 0.1050317 -3.7164949 0.0002 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.08 (0.84, 1.38) 1 SCOPE: &gt;400 to &lt;800/None 1.16 (0.98, 1.38) 0.1 SCOPE: &gt;=800/None 1.24 (1.03, 1.50) 0.01 SCOPE: &gt;=800/&lt;=400 1.15 (0.90, 1.47) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.07 (0.91, 1.26) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.93 (0.74, 1.17) 1 STOP: &lt;=400/None 0.87 (0.47, 1.62) 1 STOP: &gt;400 to &lt;800/None 0.75 (0.57, 1.00) 0.06 STOP: &gt;=800/None 0.84 (0.65, 1.08) 0.6 STOP: &gt;=800/&lt;=400 0.97 (0.54, 1.73) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.93, 1.33) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.15 (0.63, 2.09) 1 None: STOP/SCOPE 1.54 (1.17, 2.02) &lt;0.0001 &lt;=400: STOP/SCOPE 1.23 (0.67, 2.28) 1 &gt;400 to &lt;800: STOP/SCOPE 1.00 (0.82, 1.20) 1 &gt;=800: STOP/SCOPE 1.04 (0.89, 1.21) 1 P-value adjustment: bonferroni method for 16 tests "],["folateb12.html", "14.5 Folate:B12", " 14.5 Folate:B12 14.5.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5774904 0.1135284 40.3202170 &lt;0.0001 *** folate_cat2&lt;800 0.2921444 0.0642294 4.5484542 &lt;0.0001 *** folate_cat2&gt;=800 0.3562042 0.0739492 4.8168797 &lt;0.0001 *** StudySTOP 0.3162904 0.0994854 3.1792654 0.002 ** f1_age 0.0026324 0.0035680 0.7377927 0.46 ns BMI 0.0042192 0.0028462 1.4823900 0.14 ns folate_cat2&lt;800:StudySTOP -0.2298671 0.1158523 -1.9841398 0.05 * folate_cat2&gt;=800:StudySTOP -0.2900574 0.1138242 -2.5482928 0.01 * Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.34 (1.12, 1.60) &lt;0.0001 SCOPE: &gt;=800/None 1.43 (1.16, 1.75) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.07 (0.91, 1.26) 1 STOP: &lt;800/None 1.06 (0.81, 1.39) 1 STOP: &gt;=800/None 1.07 (0.84, 1.36) 1 STOP: &gt;=800/&lt;800 1.00 (0.86, 1.18) 1 None: STOP/SCOPE 1.37 (1.04, 1.81) 0.01 &lt;800: STOP/SCOPE 1.09 (0.92, 1.29) 1 &gt;=800: STOP/SCOPE 1.03 (0.88, 1.20) 1 P-value adjustment: bonferroni method for 9 tests 14.5.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5761038 0.1135359 40.3053372 &lt;0.0001 *** folate_cat3&lt;=400 0.2057082 0.0926716 2.2197548 0.03 * folate_cat3&gt;400 to &lt;800 0.3130996 0.0662416 4.7266319 &lt;0.0001 *** folate_cat3&gt;=800 0.3558238 0.0739518 4.8115659 &lt;0.0001 *** StudySTOP 0.3159292 0.0994885 3.1755350 0.002 ** f1_age 0.0027648 0.0035695 0.7745620 0.44 ns BMI 0.0041610 0.0028468 1.4616578 0.14 ns folate_cat3&lt;=400:StudySTOP -0.0359529 0.2489145 -0.1444386 0.89 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2570313 0.1176006 -2.1856289 0.03 * folate_cat3&gt;=800:StudySTOP -0.2898036 0.1138275 -2.5459896 0.01 * Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.23 (0.93, 1.62) 0.4 SCOPE: &gt;400 to &lt;800/None 1.37 (1.12, 1.66) &lt;0.0001 SCOPE: &gt;=800/None 1.43 (1.15, 1.78) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.16 (0.89, 1.51) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.04 (0.87, 1.25) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.90 (0.70, 1.15) 1 STOP: &lt;=400/None 1.19 (0.60, 2.35) 1 STOP: &gt;400 to &lt;800/None 1.06 (0.79, 1.41) 1 STOP: &gt;=800/None 1.07 (0.83, 1.38) 1 STOP: &gt;=800/&lt;=400 0.90 (0.47, 1.72) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.01 (0.85, 1.20) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.12 (0.58, 2.16) 1 None: STOP/SCOPE 1.37 (1.02, 1.84) 0.02 &lt;=400: STOP/SCOPE 1.32 (0.67, 2.60) 1 &gt;400 to &lt;800: STOP/SCOPE 1.06 (0.88, 1.28) 1 &gt;=800: STOP/SCOPE 1.03 (0.87, 1.21) 1 P-value adjustment: bonferroni method for 16 tests "],["folateactive-b12.html", "14.6 Folate:Active B12", " 14.6 Folate:Active B12 14.6.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5761805 0.1554473 42.3048944 &lt;0.0001 *** folate_cat2&lt;800 0.2297706 0.0839029 2.7385302 0.006 ** folate_cat2&gt;=800 0.2003714 0.0957136 2.0934487 0.04 * StudySTOP 0.0302250 0.1389345 0.2175484 0.83 ns f1_age 0.0001884 0.0051084 0.0368818 0.97 ns BMI -0.0097795 0.0039298 -2.4885510 0.01 * folate_cat2&lt;800:StudySTOP 0.0872974 0.1663398 0.5248135 0.60 ns folate_cat2&gt;=800:StudySTOP 0.0707165 0.1586479 0.4457452 0.66 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.26 (1.00, 1.59) 0.06 SCOPE: &gt;=800/None 1.22 (0.94, 1.59) 0.3 SCOPE: &gt;=800/&lt;800 0.97 (0.78, 1.21) 1 STOP: &lt;800/None 1.37 (0.92, 2.05) 0.2 STOP: &gt;=800/None 1.31 (0.92, 1.87) 0.3 STOP: &gt;=800/&lt;800 0.96 (0.75, 1.22) 1 None: STOP/SCOPE 1.03 (0.70, 1.52) 1 &lt;800: STOP/SCOPE 1.12 (0.87, 1.45) 1 &gt;=800: STOP/SCOPE 1.11 (0.89, 1.37) 1 P-value adjustment: bonferroni method for 9 tests 14.6.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5810099 0.1555581 42.3058016 &lt;0.0001 *** folate_cat3&lt;=400 0.1714131 0.1265520 1.3544877 0.18 ns folate_cat3&gt;400 to &lt;800 0.2435284 0.0868776 2.8031201 0.005 ** folate_cat3&gt;=800 0.2002737 0.0957477 2.0916821 0.04 * StudySTOP 0.0299622 0.1389842 0.2155798 0.83 ns f1_age 0.0001536 0.0051103 0.0300603 0.98 ns BMI -0.0099293 0.0039336 -2.5241999 0.01 * folate_cat3&lt;=400:StudySTOP -0.1628045 0.3411921 -0.4771638 0.63 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0977125 0.1693485 0.5769909 0.56 ns folate_cat3&gt;=800:StudySTOP 0.0712919 0.1587051 0.4492099 0.65 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.19 (0.82, 1.73) 1 SCOPE: &gt;400 to &lt;800/None 1.28 (0.99, 1.65) 0.08 SCOPE: &gt;=800/None 1.22 (0.92, 1.62) 0.6 SCOPE: &gt;=800/&lt;=400 1.03 (0.71, 1.49) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.96 (0.75, 1.22) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.93 (0.66, 1.32) 1 STOP: &lt;=400/None 1.01 (0.39, 2.58) 1 STOP: &gt;400 to &lt;800/None 1.41 (0.91, 2.17) 0.3 STOP: &gt;=800/None 1.31 (0.90, 1.91) 0.5 STOP: &gt;=800/&lt;=400 1.30 (0.54, 3.13) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.93 (0.71, 1.22) 1 STOP: &lt;=400/&gt;400 to &lt;800 0.72 (0.29, 1.77) 1 None: STOP/SCOPE 1.03 (0.68, 1.56) 1 &lt;=400: STOP/SCOPE 0.88 (0.35, 2.21) 1 &gt;400 to &lt;800: STOP/SCOPE 1.14 (0.85, 1.52) 1 &gt;=800: STOP/SCOPE 1.11 (0.88, 1.39) 1 P-value adjustment: bonferroni method for 16 tests "],["fa-supp-3-categories-9.html", "15 FA supp: 3 categories", " 15 FA supp: 3 categories Characteristic None (n=171) &lt;800 (n=469) &gt;=800 (n=588) Total (n=1228) P-value Prolactin: Median (IQ range) 120.7 (74.1-194.3) 120.0 (79.1-184.2) 76.5 (49.8-130.4) 98.4 (59.2-160.6) &lt;0.0001 HPL: Median (IQ range) 155.9 (95.6-206.4) 157.2 (91.4-202.8) 71.3 (44.7-134.7) 114.2 (55.9-181.1) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.0-5.0) 3.5 (2.2-4.9) 1.7 (1.0-3.2) 2.6 (1.3-4.2) &lt;0.0001 LME for duplicated or repeated measures shown on next page. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat2&quot; mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(mod1)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) mod_sum &lt;- lapply(mod_ls,extract.ci.mod,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) names(mod_sum) &lt;- names(mod_em_sum) &lt;- names(mod_em_est) &lt;- names(mod_ls) "],["prolactin-9.html", "15.1 Prolactin", " 15.1 Prolactin cat(&quot;\\n&lt;b&gt;Model summary&lt;/b&gt;\\n&quot;) Model summary mod_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Var Effect P (Intercept) 12.47 (7.75, 20.06) &lt;0.0001 folate_cat2&lt;800 1.02 (0.88, 1.18) 0.83 folate_cat2&gt;=800 1.14 (0.96, 1.35) 0.13 StudySTOP 1.24 (0.97, 1.59) 0.09 GA_samp 1.17 (1.13, 1.20) &lt;0.0001 folate_cat2&lt;800:StudySTOP 1.00 (0.77, 1.29) 0.98 folate_cat2&gt;=800:StudySTOP 0.68 (0.53, 0.89) 0.004 cat(&quot;\\n&lt;b&gt;Estimated marginal means&lt;/b&gt;\\n&quot;) Estimated marginal means mod_em_est[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 94.59 9.53 203.66 77.55 115.38 &lt;800 SCOPE 96.14 8.39 119.20 80.89 114.27 &gt;=800 SCOPE 107.83 10.39 173.62 89.16 130.41 None STOP 117.45 13.94 354.82 93.00 148.33 &lt;800 STOP 119.07 11.01 148.52 99.19 142.93 &gt;=800 STOP 91.38 7.43 90.74 77.75 107.41 if(!any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=lower.CL,ymax=upper.CL,group=Study,color=Study))} if(any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=asymp.LCL,ymax=asymp.UCL,group=Study,color=Study))} p1 &lt;- p1 + geom_pointrange(size=0.7,position=position_dodge(width=0.2)) + geom_errorbar(width=0.08,size=1,position=position_dodge(width=0.2))+ scale_y_continuous(limits=c(0,NA),expand=expansion(mult=c(0,0.1))) + labs(title=&quot;Estimated marginal means (95% CI)&quot;,x=dat_labels[fvarc],y=dat_labels[varc]) + theme_bw() + theme(axis.title=element_text(size=16,face=&quot;bold&quot;),axis.text=element_text(color=&quot;black&quot;,size=14), plot.title=element_text(face=&quot;bold&quot;,color=&quot;black&quot;,size=14), panel.grid.major.x=element_blank(), legend.position=&quot;bottom&quot;,legend.title=element_text(size=15,face=&quot;bold&quot;),legend.text=element_text(size=14)) print(p1) cat(&quot;\\n\\n\\n&lt;br /&gt;&lt;b&gt;Post-hoc comparisons&lt;/b&gt;&lt;br /&gt;\\n&quot;) Post-hoc comparisons mod_em_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.02 (0.85, 1.21) 1.0 &gt;=800 / None Study: SCOPE 1.14 (0.93, 1.40) 0.3 &gt;=800 / &lt;800 Study: SCOPE 1.12 (0.95, 1.33) 0.2 &lt;800 / None Study: STOP 1.01 (0.79, 1.31) 1.0 &gt;=800 / None Study: STOP 0.78 (0.61, 0.99) 0.03 &gt;=800 / &lt;800 Study: STOP 0.77 (0.66, 0.89) 0.0001 STOP / SCOPE Folic acid supplement (μg): None 1.24 (0.97, 1.59) 0.09 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.24 (1.04, 1.48) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.85 (0.71, 1.01) 0.07 "],["hpl-9.html", "15.2 HPL", " 15.2 HPL Model summary Var Effect P (Intercept) 1.96 (1.53, 2.51) &lt;0.0001 folate_cat2&lt;800 0.99 (0.91, 1.07) 0.78 folate_cat2&gt;=800 0.98 (0.90, 1.07) 0.68 StudySTOP 1.16 (1.02, 1.32) 0.03 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.97 (0.85, 1.12) 0.71 folate_cat2&gt;=800:StudySTOP 0.99 (0.86, 1.14) 0.88 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 94.35 4.03 570.38 86.76 102.60 &lt;800 SCOPE 93.31 3.10 278.76 87.41 99.61 &gt;=800 SCOPE 92.57 3.68 474.46 85.61 100.10 None STOP 109.41 6.00 873.71 98.25 121.84 &lt;800 STOP 105.38 4.01 416.20 97.78 113.58 &gt;=800 STOP 106.22 3.14 178.20 100.21 112.60 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.99 (0.90, 1.09) 1.0 &gt;=800 / None Study: SCOPE 0.98 (0.88, 1.09) 0.9 &gt;=800 / &lt;800 Study: SCOPE 0.99 (0.91, 1.08) 1.0 &lt;800 / None Study: STOP 0.96 (0.84, 1.10) 0.8 &gt;=800 / None Study: STOP 0.97 (0.86, 1.10) 0.8 &gt;=800 / &lt;800 Study: STOP 1.01 (0.93, 1.09) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.16 (1.02, 1.32) 0.03 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.13 (1.03, 1.24) 0.01 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.15 (1.05, 1.26) 0.004 "],["gh2-9.html", "15.3 GH2", " 15.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 folate_cat2&lt;800 1.04 (0.94, 1.16) 0.41 folate_cat2&gt;=800 1.05 (0.93, 1.19) 0.39 StudySTOP 1.16 (0.97, 1.39) 0.09 GA_samp 1.30 (1.28, 1.33) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.83 (0.69, 1.01) 0.06 folate_cat2&gt;=800:StudySTOP 0.83 (0.69, 1.00) 0.05 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 2.32 0.12 923.22 2.09 2.57 &lt;800 SCOPE 2.42 0.09 554.23 2.24 2.61 &gt;=800 SCOPE 2.44 0.12 839.00 2.22 2.69 None STOP 2.69 0.19 1046.47 2.34 3.09 &lt;800 STOP 2.35 0.11 739.24 2.15 2.56 &gt;=800 STOP 2.35 0.08 318.25 2.21 2.50 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.04 (0.92, 1.18) 0.7 &gt;=800 / None Study: SCOPE 1.05 (0.91, 1.22) 0.7 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.90, 1.14) 1.0 &lt;800 / None Study: STOP 0.87 (0.72, 1.05) 0.2 &gt;=800 / None Study: STOP 0.87 (0.74, 1.03) 0.1 &gt;=800 / &lt;800 Study: STOP 1.00 (0.90, 1.11) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.16 (0.97, 1.39) 0.10 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.97 (0.86, 1.10) 0.6 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.96 (0.85, 1.09) 0.5 "],["insulin-7.html", "15.4 Insulin", " 15.4 Insulin Model summary Var Effect P (Intercept) 18.22 (9.81, 33.84) &lt;0.0001 folate_cat2&lt;800 0.76 (0.61, 0.93) 0.009 folate_cat2&gt;=800 0.76 (0.59, 0.98) 0.03 StudySTOP 0.48 (0.35, 0.66) &lt;0.0001 GA_samp 1.00 (0.96, 1.04) 0.90 folate_cat2&lt;800:StudySTOP 1.64 (1.17, 2.31) 0.004 folate_cat2&gt;=800:StudySTOP 1.58 (1.12, 2.23) 0.010 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 17.63 1.67 Inf 14.64 21.22 &lt;800 SCOPE 13.33 1.03 Inf 11.47 15.50 &gt;=800 SCOPE 13.41 1.39 Inf 10.94 16.44 None STOP 8.47 1.01 Inf 6.72 10.69 &lt;800 STOP 10.52 0.85 Inf 8.98 12.32 &gt;=800 STOP 10.17 0.57 Inf 9.11 11.36 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.76 (0.59, 0.97) 0.03 &gt;=800 / None Study: SCOPE 0.76 (0.57, 1.02) 0.08 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.77, 1.31) 1.0 &lt;800 / None Study: STOP 1.24 (0.90, 1.71) 0.3 &gt;=800 / None Study: STOP 1.20 (0.90, 1.60) 0.3 &gt;=800 / &lt;800 Study: STOP 0.97 (0.80, 1.18) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.48 (0.35, 0.66) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.79 (0.62, 1.01) 0.06 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.76 (0.58, 0.98) 0.04 "],["homa-ir-7.html", "15.5 HOMA-IR", " 15.5 HOMA-IR Model summary Var Effect P (Intercept) 4.69 (2.45, 8.95) &lt;0.0001 folate_cat2&lt;800 0.75 (0.60, 0.94) 0.01 folate_cat2&gt;=800 0.74 (0.57, 0.97) 0.03 StudySTOP 0.41 (0.29, 0.57) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.76 folate_cat2&lt;800:StudySTOP 1.64 (1.14, 2.36) 0.008 folate_cat2&gt;=800:StudySTOP 1.62 (1.11, 2.34) 0.01 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 4.31 0.44 Inf 3.53 5.27 &lt;800 SCOPE 3.23 0.26 Inf 2.75 3.78 &gt;=800 SCOPE 3.21 0.36 Inf 2.58 4.00 None STOP 1.77 0.22 Inf 1.38 2.26 &lt;800 STOP 2.16 0.19 Inf 1.83 2.56 &gt;=800 STOP 2.12 0.12 Inf 1.89 2.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.75 (0.57, 0.98) 0.03 &gt;=800 / None Study: SCOPE 0.74 (0.54, 1.03) 0.08 &gt;=800 / &lt;800 Study: SCOPE 1.00 (0.75, 1.32) 1.0 &lt;800 / None Study: STOP 1.23 (0.87, 1.72) 0.3 &gt;=800 / None Study: STOP 1.20 (0.89, 1.64) 0.3 &gt;=800 / &lt;800 Study: STOP 0.98 (0.80, 1.21) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.41 (0.29, 0.57) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.67 (0.52, 0.87) 0.002 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.66 (0.50, 0.87) 0.003 "],["glucose-7.html", "15.6 Glucose", " 15.6 Glucose Model summary Var Effect P (Intercept) 5.65 (4.98, 6.41) &lt;0.0001 folate_cat2&lt;800 1.00 (0.96, 1.05) 0.96 folate_cat2&gt;=800 1.01 (0.95, 1.08) 0.73 StudySTOP 0.89 (0.82, 0.95) 0.001 GA_samp 1.00 (0.99, 1.00) 0.40 folate_cat2&lt;800:StudySTOP 0.99 (0.91, 1.07) 0.75 folate_cat2&gt;=800:StudySTOP 0.97 (0.89, 1.05) 0.42 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.42 0.13 Inf 5.16 5.68 &lt;800 SCOPE 5.42 0.07 Inf 5.30 5.55 &gt;=800 SCOPE 5.48 0.12 Inf 5.24 5.72 None STOP 4.80 0.12 Inf 4.56 5.05 &lt;800 STOP 4.74 0.11 Inf 4.53 4.97 &gt;=800 STOP 4.69 0.05 Inf 4.60 4.79 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.00 (0.95, 1.06) 1.0 &gt;=800 / None Study: SCOPE 1.01 (0.94, 1.09) 0.9 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.95, 1.07) 0.9 &lt;800 / None Study: STOP 0.99 (0.91, 1.07) 0.9 &gt;=800 / None Study: STOP 0.98 (0.92, 1.04) 0.7 &gt;=800 / &lt;800 Study: STOP 0.99 (0.93, 1.05) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.89 (0.82, 0.95) 0.001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.87 (0.83, 0.92) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.82, 0.90) &lt;0.0001 "],["fa-supp-4-categories-9.html", "16 FA supp: 4 categories", " 16 FA supp: 4 categories Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Prolactin: Median (IQ range) 120.7 (74.1-194.3) 134.9 (95.6-200.4) 118.8 (76.3-178.8) 76.5 (49.8-130.4) 98.4 (59.2-160.6) &lt;0.0001 HPL: Median (IQ range) 155.9 (95.6-206.4) 175.7 (143.2-201.1) 154.3 (81.7-202.7) 71.3 (44.7-134.7) 114.2 (55.9-181.1) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.0-5.0) 4.0 (3.2-5.9) 3.3 (2.1-4.6) 1.7 (1.0-3.2) 2.6 (1.3-4.2) &lt;0.0001 Insulin: Mean (SD) 19.0 (18.2) 25.6 (34.9) 18.2 (18.3) 16.7 (20.1) 18.0 (20.5) 0.01 HOMA.IR: Mean (SD) 4.7 (5.0) 6.8 (10.4) 4.4 (5.1) 3.9 (5.2) 4.3 (5.6) 0.002 GLUC3_mmol.L: Mean (SD) 5.3 (0.8) 5.4 (0.8) 5.2 (0.7) 4.9 (0.7) 5.1 (0.8) &lt;0.0001 LME or GEE for duplicated or repeated measures. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat3&quot; "],["prolactin-10.html", "16.1 Prolactin", " 16.1 Prolactin Model summary Var Effect P (Intercept) 12.27 (7.62, 19.75) &lt;0.0001 folate_cat3&lt;=400 1.04 (0.84, 1.28) 0.74 folate_cat3&gt;400 to &lt;800 1.01 (0.87, 1.18) 0.87 folate_cat3&gt;=800 1.14 (0.96, 1.35) 0.13 StudySTOP 1.25 (0.97, 1.59) 0.08 GA_samp 1.17 (1.13, 1.20) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.35 (0.79, 2.33) 0.28 folate_cat3&gt;400 to &lt;800:StudySTOP 0.98 (0.76, 1.28) 0.91 folate_cat3&gt;=800:StudySTOP 0.68 (0.53, 0.88) 0.004 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 94.38 9.51 204.08 77.37 115.13 &lt;=400 SCOPE 97.84 11.45 334.03 77.72 123.16 &gt;400 to &lt;800 SCOPE 95.56 8.53 130.73 80.08 114.02 &gt;=800 SCOPE 107.66 10.37 173.73 89.02 130.20 None STOP 117.53 13.94 354.88 93.07 148.41 &lt;=400 STOP 164.98 41.65 998.33 100.52 270.77 &gt;400 to &lt;800 STOP 117.16 10.91 152.99 97.47 140.82 &gt;=800 STOP 91.46 7.44 90.76 77.82 107.49 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.04 (0.79, 1.37) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 1.01 (0.83, 1.24) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.98 (0.76, 1.25) 1.0 &gt;=800 / None Study: SCOPE 1.14 (0.91, 1.43) 0.4 &gt;=800 / &lt;=400 Study: SCOPE 1.10 (0.84, 1.44) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.13 (0.93, 1.36) 0.4 &lt;=400 / None Study: STOP 1.40 (0.72, 2.73) 0.6 &gt;400 to &lt;800 / None Study: STOP 1.00 (0.75, 1.32) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.71 (0.38, 1.34) 0.5 &gt;=800 / None Study: STOP 0.78 (0.60, 1.01) 0.06 &gt;=800 / &lt;=400 Study: STOP 0.55 (0.30, 1.04) 0.07 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.78 (0.66, 0.92) 0.0009 STOP / SCOPE Folic acid supplement (μg): None 1.25 (0.97, 1.59) 0.08 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.69 (1.00, 2.83) 0.05 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.23 (1.02, 1.47) 0.03 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.85 (0.71, 1.01) 0.07 "],["hpl-10.html", "16.2 HPL", " 16.2 HPL Model summary Var Effect P (Intercept) 1.94 (1.51, 2.49) &lt;0.0001 folate_cat3&lt;=400 1.00 (0.90, 1.12) 0.96 folate_cat3&gt;400 to &lt;800 0.99 (0.91, 1.07) 0.73 folate_cat3&gt;=800 0.98 (0.90, 1.07) 0.69 StudySTOP 1.16 (1.02, 1.32) 0.02 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.18 (0.88, 1.57) 0.27 folate_cat3&gt;400 to &lt;800:StudySTOP 0.97 (0.84, 1.11) 0.63 folate_cat3&gt;=800:StudySTOP 0.99 (0.86, 1.14) 0.88 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 94.18 4.02 565.40 86.60 102.42 &lt;=400 SCOPE 94.48 5.00 810.00 85.16 104.82 &gt;400 to &lt;800 SCOPE 92.86 3.24 325.60 86.70 99.45 &gt;=800 SCOPE 92.44 3.68 470.37 85.48 99.97 None STOP 109.48 6.00 868.96 98.31 121.92 &lt;=400 STOP 129.24 16.62 942.41 100.41 166.34 &gt;400 to &lt;800 STOP 104.29 4.03 430.60 96.65 112.52 &gt;=800 STOP 106.32 3.15 177.05 100.29 112.72 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.00 (0.87, 1.16) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.99 (0.89, 1.10) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.98 (0.86, 1.12) 1.0 &gt;=800 / None Study: SCOPE 0.98 (0.87, 1.11) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.85, 1.13) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.90, 1.10) 1.0 &lt;=400 / None Study: STOP 1.18 (0.83, 1.67) 0.6 &gt;400 to &lt;800 / None Study: STOP 0.95 (0.82, 1.11) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.81 (0.58, 1.13) 0.3 &gt;=800 / None Study: STOP 0.97 (0.85, 1.11) 0.9 &gt;=800 / &lt;=400 Study: STOP 0.82 (0.59, 1.14) 0.4 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.02 (0.93, 1.12) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.16 (1.02, 1.33) 0.02 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.37 (1.04, 1.80) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.12 (1.02, 1.24) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.15 (1.05, 1.26) 0.003 "],["gh2-10.html", "16.3 GH2", " 16.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 folate_cat3&lt;=400 1.10 (0.95, 1.28) 0.20 folate_cat3&gt;400 to &lt;800 1.03 (0.92, 1.15) 0.61 folate_cat3&gt;=800 1.05 (0.93, 1.19) 0.40 StudySTOP 1.16 (0.97, 1.38) 0.10 GA_samp 1.30 (1.28, 1.33) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.67 (0.46, 0.99) 0.05 folate_cat3&gt;400 to &lt;800:StudySTOP 0.86 (0.71, 1.03) 0.11 folate_cat3&gt;=800:StudySTOP 0.83 (0.69, 1.00) 0.05 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 2.32 0.12 921.92 2.09 2.57 &lt;=400 SCOPE 2.56 0.17 993.64 2.25 2.91 &gt;400 to &lt;800 SCOPE 2.39 0.10 654.15 2.20 2.58 &gt;=800 SCOPE 2.44 0.12 837.96 2.22 2.69 None STOP 2.69 0.19 1044.77 2.34 3.09 &lt;=400 STOP 2.00 0.35 963.93 1.42 2.81 &gt;400 to &lt;800 STOP 2.37 0.11 761.87 2.16 2.59 &gt;=800 STOP 2.35 0.08 319.11 2.21 2.50 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.10 (0.91, 1.34) 0.6 &gt;400 to &lt;800 / None Study: SCOPE 1.03 (0.89, 1.19) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.93 (0.78, 1.11) 0.7 &gt;=800 / None Study: SCOPE 1.05 (0.90, 1.24) 0.8 &gt;=800 / &lt;=400 Study: SCOPE 0.96 (0.79, 1.16) 0.9 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.02 (0.90, 1.17) 1.0 &lt;=400 / None Study: STOP 0.74 (0.46, 1.20) 0.4 &gt;400 to &lt;800 / None Study: STOP 0.88 (0.72, 1.08) 0.4 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.19 (0.75, 1.87) 0.8 &gt;=800 / None Study: STOP 0.87 (0.72, 1.05) 0.2 &gt;=800 / &lt;=400 Study: STOP 1.18 (0.75, 1.84) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.99 (0.88, 1.12) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.16 (0.97, 1.39) 0.1 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.78 (0.54, 1.13) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.99 (0.87, 1.13) 0.9 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.96 (0.85, 1.09) 0.5 "],["insulin-8.html", "16.4 Insulin", " 16.4 Insulin Model summary Var Effect P (Intercept) 18.35 (9.88, 34.06) &lt;0.0001 folate_cat3&lt;=400 0.77 (0.54, 1.11) 0.16 folate_cat3&gt;400 to &lt;800 0.75 (0.61, 0.93) 0.01 folate_cat3&gt;=800 0.76 (0.59, 0.98) 0.03 StudySTOP 0.48 (0.35, 0.66) &lt;0.0001 GA_samp 1.00 (0.96, 1.04) 0.88 folate_cat3&lt;=400:StudySTOP 1.39 (0.58, 3.35) 0.47 folate_cat3&gt;400 to &lt;800:StudySTOP 1.66 (1.18, 2.35) 0.004 folate_cat3&gt;=800:StudySTOP 1.58 (1.12, 2.23) 0.010 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 17.64 1.67 Inf 14.65 21.24 &lt;=400 SCOPE 13.63 2.30 Inf 9.79 18.98 &gt;400 to &lt;800 SCOPE 13.28 1.07 Inf 11.34 15.54 &gt;=800 SCOPE 13.42 1.40 Inf 10.95 16.46 None STOP 8.47 1.00 Inf 6.71 10.69 &lt;=400 STOP 9.08 3.60 Inf 4.18 19.74 &gt;400 to &lt;800 STOP 10.60 0.86 Inf 9.03 12.43 &gt;=800 STOP 10.16 0.57 Inf 9.10 11.35 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.77 (0.48, 1.24) 0.5 &gt;400 to &lt;800 / None Study: SCOPE 0.75 (0.57, 1.00) 0.05 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.97 (0.62, 1.53) 1.0 &gt;=800 / None Study: SCOPE 0.76 (0.55, 1.05) 0.1 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.61, 1.59) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.75, 1.36) 1.0 &lt;=400 / None Study: STOP 1.07 (0.37, 3.08) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.25 (0.88, 1.78) 0.4 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.17 (0.42, 3.26) 1.0 &gt;=800 / None Study: STOP 1.20 (0.88, 1.64) 0.4 &gt;=800 / &lt;=400 Study: STOP 1.12 (0.41, 3.09) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.96 (0.77, 1.19) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.48 (0.35, 0.66) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.67 (0.28, 1.57) 0.4 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.80 (0.62, 1.02) 0.07 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.76 (0.58, 0.98) 0.04 "],["homa-ir-8.html", "16.5 HOMA-IR", " 16.5 HOMA-IR Model summary Var Effect P (Intercept) 4.70 (2.46, 8.97) &lt;0.0001 folate_cat3&lt;=400 0.75 (0.51, 1.10) 0.14 folate_cat3&gt;400 to &lt;800 0.75 (0.59, 0.94) 0.01 folate_cat3&gt;=800 0.74 (0.57, 0.97) 0.03 StudySTOP 0.41 (0.29, 0.57) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.76 folate_cat3&lt;=400:StudySTOP 1.52 (0.57, 4.04) 0.40 folate_cat3&gt;400 to &lt;800:StudySTOP 1.65 (1.14, 2.38) 0.008 folate_cat3&gt;=800:StudySTOP 1.62 (1.11, 2.34) 0.01 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 4.32 0.44 Inf 3.53 5.27 &lt;=400 SCOPE 3.24 0.58 Inf 2.28 4.61 &gt;400 to &lt;800 SCOPE 3.23 0.27 Inf 2.73 3.81 &gt;=800 SCOPE 3.21 0.36 Inf 2.58 4.00 None STOP 1.76 0.22 Inf 1.38 2.26 &lt;=400 STOP 2.01 0.90 Inf 0.84 4.82 &gt;400 to &lt;800 STOP 2.17 0.19 Inf 1.83 2.57 &gt;=800 STOP 2.12 0.12 Inf 1.89 2.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.75 (0.46, 1.24) 0.5 &gt;400 to &lt;800 / None Study: SCOPE 0.75 (0.55, 1.01) 0.07 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.99 (0.62, 1.61) 1.0 &gt;=800 / None Study: SCOPE 0.74 (0.52, 1.06) 0.1 &gt;=800 / &lt;=400 Study: SCOPE 0.99 (0.59, 1.65) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.72, 1.37) 1.0 &lt;=400 / None Study: STOP 1.14 (0.35, 3.72) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.23 (0.85, 1.79) 0.5 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.08 (0.34, 3.43) 1.0 &gt;=800 / None Study: STOP 1.20 (0.86, 1.68) 0.5 &gt;=800 / &lt;=400 Study: STOP 1.06 (0.34, 3.31) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.98 (0.78, 1.23) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.41 (0.29, 0.57) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.62 (0.24, 1.61) 0.3 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.67 (0.52, 0.87) 0.003 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.66 (0.50, 0.87) 0.003 "],["glucose-8.html", "16.6 Glucose", " 16.6 Glucose Model summary Var Effect P (Intercept) 5.54 (4.91, 6.25) &lt;0.0001 folate_cat3&lt;=400 1.00 (0.94, 1.07) 0.95 folate_cat3&gt;400 to &lt;800 1.00 (0.96, 1.05) 0.97 folate_cat3&gt;=800 1.01 (0.95, 1.08) 0.73 StudySTOP 0.89 (0.83, 0.96) 0.002 GA_samp 1.00 (0.99, 1.01) 0.60 folate_cat3&lt;=400:StudySTOP 1.27 (1.04, 1.56) 0.02 folate_cat3&gt;400 to &lt;800:StudySTOP 0.96 (0.90, 1.03) 0.31 folate_cat3&gt;=800:StudySTOP 0.97 (0.89, 1.05) 0.42 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.40 0.13 Inf 5.15 5.66 &lt;=400 SCOPE 5.41 0.15 Inf 5.12 5.72 &gt;400 to &lt;800 SCOPE 5.41 0.06 Inf 5.29 5.53 &gt;=800 SCOPE 5.46 0.12 Inf 5.23 5.71 None STOP 4.81 0.12 Inf 4.57 5.05 &lt;=400 STOP 6.14 0.58 Inf 5.10 7.39 &gt;400 to &lt;800 STOP 4.64 0.06 Inf 4.53 4.76 &gt;=800 STOP 4.70 0.05 Inf 4.61 4.80 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.00 (0.92, 1.10) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 1.00 (0.94, 1.06) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.00 (0.93, 1.07) 1.0 &gt;=800 / None Study: SCOPE 1.01 (0.93, 1.10) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.01 (0.92, 1.10) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.95, 1.07) 1.0 &lt;=400 / None Study: STOP 1.28 (0.99, 1.64) 0.06 &gt;400 to &lt;800 / None Study: STOP 0.97 (0.90, 1.03) 0.6 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.76 (0.59, 0.96) 0.02 &gt;=800 / None Study: STOP 0.98 (0.91, 1.05) 0.8 &gt;=800 / &lt;=400 Study: STOP 0.77 (0.60, 0.98) 0.03 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.01 (0.98, 1.05) 0.8 STOP / SCOPE Folic acid supplement (μg): None 0.89 (0.83, 0.96) 0.002 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.13 (0.93, 1.38) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.86 (0.83, 0.89) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.82, 0.90) &lt;0.0001 "],["age-groups-1.html", "17 Age groups", " 17 Age groups Descriptives with univariate P-values. Characteristic &lt;35 yrs (n=1270) &gt;=35 yrs (n=45) Total (n=1315) P-value PRL (ng/ml): Median (IQ range) 97.6 (59.0-158.9) 74.6 (43.8-99.7) 96.8 (58.3-157.1) 0.01 hPL (μg/ml): Median (IQ range) 108.9 (54.6-179.9) 81.6 (43.8-136.1) 108.1 (54.6-179.4) 0.08 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.1) 2.1 (1.4-3.4) 2.5 (1.2-4.1) 0.54 Insulin (uU/ml): Median (IQ range) 10.8 (6.0-21.9) 10.3 (6.3-16.8) 10.8 (6.1-21.7) 0.69 HOMA-IR: Median (IQ range) 2.4 (1.3-5.1) 2.5 (1.3-3.7) 2.4 (1.3-5.0) 0.68 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 4.9 (4.5-5.3) 5.0 (4.6-5.5) 0.22 Within SCOPE Characteristic &lt;35 yrs (n=587) &gt;=35 yrs (n=17) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 140.1 (95.6-215.5) 101.2 (74.7-174.9) 139.9 (94.7-215.5) 0.20 hPL (μg/ml): Median (IQ range) 183.5 (151.1-220.8) 168.6 (123.6-206.2) 183.5 (149.9-220.6) 0.17 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.6) 3.8 (3.1-5.6) 4.2 (3.2-5.6) 0.70 Insulin (uU/ml): Median (IQ range) 14.4 (6.5-29.1) 19.5 (10.0-35.6) 14.4 (6.5-29.1) 0.37 HOMA-IR: Median (IQ range) 3.3 (1.5-7.2) 4.5 (2.5-9.7) 3.3 (1.5-7.2) 0.28 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.2-5.8) 5.4 (5.0-5.8) 0.66 Serum folate concentration (nM): Median (IQ range) 36.5 (28.3-43.0) 34.6 (32.1-42.2) 36.4 (28.5-43.0) 1.00 B12 concentration (pM): Median (IQ range) 248.0 (195.0-316.0) 255.0 (218.0-331.8) 248.0 (195.5-316.0) 0.69 Folate:B12 ratio: Median (IQ range) 143.0 (103.0-210.0) 133.8 (117.5-192.9) 142.6 (104.0-207.4) 0.93 Active B12 concentration (pM): Median (IQ range) 54.0 (42.5-72.0) 55.5 (48.0-78.8) 54.0 (43.0-72.0) 0.51 Folate:Active B12 ratio: Median (IQ range) 617.5 (462.2-951.7) 500.8 (390.1-718.5) 617.0 (458.5-931.9) 0.21 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.2 (3.9-4.6) 4.4 (3.8-5.0) 0.67 Within STOP Characteristic &lt;35 yrs (n=683) &gt;=35 yrs (n=28) Total (n=711) P-value PRL (ng/ml): Median (IQ range) 73.2 (49.2-114.9) 52.6 (38.2-90.3) 72.9 (48.6-113.6) 0.08 hPL (μg/ml): Median (IQ range) 62.2 (41.7-96.7) 68.1 (39.3-83.4) 62.4 (41.4-96.2) 0.91 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.6 (1.1-2.2) 1.4 (0.9-2.4) 0.53 Insulin (uU/ml): Median (IQ range) 9.3 (5.7-17.3) 8.5 (4.7-13.9) 9.3 (5.6-17.0) 0.34 HOMA-IR: Median (IQ range) 1.9 (1.1-3.8) 1.8 (1.0-2.8) 1.9 (1.1-3.7) 0.28 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.5 (4.4-4.9) 4.7 (4.4-5.1) 0.14 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-44.9) 44.0 (41.2-97.7) 40.5 (36.4-45.2) 0.001 B12 concentration (pM): Median (IQ range) 277.5 (218.8-354.2) 283.5 (228.5-363.0) 277.5 (219.0-355.0) 0.81 Folate:B12 ratio: Median (IQ range) 155.5 (114.9-219.5) 172.7 (132.5-316.0) 155.9 (115.7-222.4) 0.06 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.0) 57.0 (54.5-83.5) 63.0 (48.0-80.0) 0.82 Folate:Active B12 ratio: Median (IQ range) 670.5 (493.5-950.0) 747.4 (505.0-965.5) 670.7 (493.5-950.5) 0.86 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.8 (4.4-5.8) 4.8 (4.3-5.6) 0.40 Red cell folate (nmol/L): Median (IQ range) 1435.0 (1202.0-1760.0) 1592.0 (1443.5-1743.0) 1446.5 (1204.8-1755.5) 0.15 mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ # if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) #mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log # mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} # if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))#} return(mod1)}) #mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) #mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) mod_em &lt;- foreach(ind1=1:length(mod_ls)) %dofuture% { if(!any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)} return(em1)} mod_em2 &lt;- foreach(ind2=1:length(mod_ls)) %dofuture% { if(!any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)} return(em2)} names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls)) %dofuture% { extract.ci.mod(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- c(hormone_var,insulin_var) mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-11.html", "17.1 Prolactin", " 17.1 Prolactin LME for repeated measures. Model summary Var Effect P (Intercept) 11.88 (6.98, 20.22) &lt;0.0001 Age_gp&gt;=35 yrs 0.79 (0.45, 1.39) 0.41 StudySTOP 0.98 (0.83, 1.15) 0.78 GA_samp 1.17 (1.14, 1.22) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.98 (0.52, 1.82) 0.94 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 98.03 5.16 Inf 88.41 108.69 &gt;=35 yrs SCOPE 77.43 22.36 Inf 43.97 136.37 &lt;35 yrs STOP 95.83 4.17 Inf 88.00 104.37 &gt;=35 yrs STOP 74.00 9.83 Inf 57.04 96.00 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.79 (0.45, 1.39) 0.4 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.77 (0.59, 1.00) 0.05 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.98 (0.83, 1.15) 0.8 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.96 (0.51, 1.79) 0.9 "],["hpl-11.html", "17.2 HPL", " 17.2 HPL LME for repeated measures. Model summary Var Effect P (Intercept) 1.98 (1.50, 2.61) &lt;0.0001 Age_gp&gt;=35 yrs 0.86 (0.72, 1.04) 0.12 StudySTOP 1.10 (1.03, 1.18) 0.007 GA_samp 1.34 (1.31, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.09 (0.86, 1.40) 0.47 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 91.78 2.29 Inf 87.40 96.38 &gt;=35 yrs SCOPE 79.24 7.66 Inf 65.57 95.76 &lt;35 yrs STOP 100.87 1.64 Inf 97.70 104.15 &gt;=35 yrs STOP 95.31 7.76 Inf 81.25 111.81 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.86 (0.72, 1.04) 0.1 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.94 (0.80, 1.11) 0.5 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.10 (1.03, 1.18) 0.007 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.20 (0.93, 1.55) 0.2 "],["gh2-11.html", "17.3 GH2", " 17.3 GH2 LME for repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 Age_gp&gt;=35 yrs 0.98 (0.77, 1.24) 0.86 StudySTOP 1.06 (0.96, 1.16) 0.25 GA_samp 1.32 (1.30, 1.35) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.02 (0.76, 1.39) 0.88 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 2.26 0.07 Inf 2.13 2.40 &gt;=35 yrs SCOPE 2.21 0.27 Inf 1.74 2.82 &lt;35 yrs STOP 2.39 0.06 Inf 2.27 2.52 &gt;=35 yrs STOP 2.39 0.22 Inf 2.00 2.87 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.98 (0.77, 1.24) 0.9 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.00 (0.83, 1.20) 1.0 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.06 (0.96, 1.16) 0.3 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.08 (0.80, 1.47) 0.6 "],["insulin-9.html", "17.4 Insulin", " 17.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 15.26 (8.64, 26.97) &lt;0.0001 Age_gp&gt;=35 yrs 1.26 (0.82, 1.94) 0.29 StudySTOP 0.73 (0.61, 0.88) 0.0008 GA_samp 0.99 (0.96, 1.03) 0.76 Age_gp&gt;=35 yrs:StudySTOP 0.64 (0.38, 1.08) 0.09 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 14.17 0.89 Inf 12.52 16.04 &gt;=35 yrs SCOPE 17.86 3.90 Inf 11.64 27.40 &lt;35 yrs STOP 10.34 0.47 Inf 9.45 11.31 &gt;=35 yrs STOP 8.34 1.23 Inf 6.24 11.15 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.26 (0.82, 1.94) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.81 (0.60, 1.08) 0.2 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.73 (0.61, 0.88) 0.0008 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.47 (0.28, 0.79) 0.004 "],["homa-ir-9.html", "17.5 HOMA-IR", " 17.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.79 (2.09, 6.87) &lt;0.0001 Age_gp&gt;=35 yrs 1.34 (0.84, 2.13) 0.22 StudySTOP 0.63 (0.52, 0.77) &lt;0.0001 GA_samp 0.99 (0.96, 1.03) 0.68 Age_gp&gt;=35 yrs:StudySTOP 0.59 (0.34, 1.03) 0.06 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 3.42 0.23 Inf 3.00 3.89 &gt;=35 yrs SCOPE 4.57 1.08 Inf 2.88 7.26 &lt;35 yrs STOP 2.16 0.10 Inf 1.97 2.37 &gt;=35 yrs STOP 1.70 0.27 Inf 1.24 2.32 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.34 (0.84, 2.13) 0.2 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.79 (0.57, 1.08) 0.1 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.63 (0.52, 0.77) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.37 (0.21, 0.66) 0.0006 "],["glucose-9.html", "17.6 Glucose", " 17.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.54 (4.97, 6.17) &lt;0.0001 Age_gp&gt;=35 yrs 1.06 (0.95, 1.17) 0.30 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.62 Age_gp&gt;=35 yrs:StudySTOP 0.93 (0.83, 1.04) 0.19 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 5.41 0.07 Inf 5.29 5.54 &gt;=35 yrs SCOPE 5.71 0.29 Inf 5.16 6.32 &lt;35 yrs STOP 4.72 0.04 Inf 4.64 4.80 &gt;=35 yrs STOP 4.64 0.08 Inf 4.48 4.80 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.06 (0.95, 1.17) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.98 (0.95, 1.02) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.87 (0.84, 0.90) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.81 (0.73, 0.90) 0.0001 "],["bmi-groups-1.html", "18 BMI groups", " 18 BMI groups Descriptives with univariate P-values. Characteristic Underweight (n=32) Normal (n=593) Overweight (n=388) Obese (n=301) Total (n=1314) P-value PRL (ng/ml): Median (IQ range) 103.1 (78.8-182.4) 103.2 (64.2-160.3) 97.3 (56.9-164.2) 80.6 (48.1-131.6) 96.8 (58.3-157.1) 0.0003 hPL (μg/ml): Median (IQ range) 144.8 (88.1-242.9) 121.0 (61.1-195.3) 109.6 (54.2-172.4) 75.7 (41.7-145.4) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.1 (1.5-5.9) 2.9 (1.3-4.7) 2.5 (1.2-3.9) 2.2 (1.0-3.3) 2.5 (1.2-4.1) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 6.1 (4.4-12.4) 7.7 (4.6-16.6) 11.6 (6.8-23.3) 15.4 (9.6-31.6) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.4 (0.9-2.8) 1.7 (1.0-3.7) 2.6 (1.4-5.4) 3.6 (2.1-7.0) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.4-5.3) 5.0 (4.6-5.4) 5.0 (4.6-5.6) 5.1 (4.7-5.6) 5.0 (4.6-5.5) 0.02 Within SCOPE Characteristic Underweight (n=16) Normal (n=276) Overweight (n=176) Obese (n=136) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 187.3 (146.2-325.0) 142.3 (97.1-212.7) 139.1 (97.5-222.1) 130.4 (82.4-194.3) 139.9 (94.7-215.5) 0.10 hPL (μg/ml): Median (IQ range) 262.2 (219.0-278.0) 197.4 (170.3-230.2) 172.9 (150.5-210.5) 153.3 (130.2-181.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 6.2 (4.6-6.5) 4.7 (3.5-6.5) 4.0 (3.2-5.2) 3.4 (2.6-4.4) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 9.0 (6.0-11.4) 10.6 (5.2-22.4) 17.7 (9.0-29.6) 20.3 (9.7-36.3) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 1.9 (1.4-2.4) 2.5 (1.2-5.7) 4.0 (2.0-7.5) 4.7 (2.3-9.3) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.2 (4.8-5.8) 5.4 (5.0-5.7) 5.5 (5.0-6.0) 5.4 (5.1-5.9) 5.4 (5.0-5.8) 0.18 Serum folate concentration (nM): Median (IQ range) 29.2 (24.9-36.1) 37.0 (29.7-43.8) 37.0 (29.7-41.2) 35.2 (24.8-43.0) 36.4 (28.5-43.0) 0.07 B12 concentration (pM): Median (IQ range) 288.0 (252.0-355.0) 256.0 (198.5-324.0) 248.5 (198.2-311.2) 227.0 (181.0-285.0) 248.0 (195.5-316.0) 0.005 Folate:B12 ratio: Median (IQ range) 105.6 (74.6-117.3) 142.5 (104.6-204.3) 144.2 (106.8-208.7) 143.0 (103.5-210.0) 142.6 (104.0-207.4) 0.24 Active B12 concentration (pM): Median (IQ range) 63.5 (53.5-78.0) 53.0 (41.0-72.0) 54.0 (43.0-70.2) 60.5 (43.8-72.2) 54.0 (43.0-72.0) 0.36 Folate:Active B12 ratio: Median (IQ range) 491.8 (337.4-589.7) 641.2 (465.6-1042.9) 638.0 (491.8-953.1) 537.6 (404.5-693.9) 617.0 (458.5-931.9) 0.009 Homocysteine concentration (μM): Median (IQ range) 4.5 (4.2-5.3) 4.4 (3.9-5.0) 4.2 (3.8-4.9) 4.4 (3.8-5.0) 4.4 (3.8-5.0) 0.24 Within STOP Characteristic Underweight (n=16) Normal (n=317) Overweight (n=212) Obese (n=165) Total (n=710) P-value PRL (ng/ml): Median (IQ range) 91.6 (47.1-99.5) 78.8 (53.8-120.4) 72.9 (49.1-115.1) 62.1 (40.3-99.3) 72.9 (48.6-113.6) 0.003 hPL (μg/ml): Median (IQ range) 90.3 (64.3-140.4) 67.3 (45.7-101.5) 61.0 (42.3-97.2) 50.5 (34.5-73.3) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.6 (1.4-3.5) 1.5 (1.0-2.4) 1.5 (0.8-2.3) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.03 Insulin (uU/ml): Median (IQ range) 4.8 (4.3-14.1) 7.2 (4.2-12.8) 9.6 (6.5-16.1) 14.8 (9.5-26.4) 9.3 (5.6-17.0) &lt;0.0001 HOMA-IR: Median (IQ range) 1.0 (0.8-2.9) 1.5 (0.8-2.9) 1.9 (1.2-3.6) 3.3 (2.0-5.9) 1.9 (1.1-3.7) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.5 (4.3-4.9) 4.7 (4.4-5.0) 4.7 (4.4-5.0) 4.8 (4.5-5.3) 4.7 (4.4-5.1) 0.01 Serum folate concentration (nM): Median (IQ range) 35.0 (29.9-40.4) 40.8 (37.0-52.4) 40.4 (36.2-45.1) 40.5 (35.8-45.2) 40.5 (36.4-45.3) 0.008 B12 concentration (pM): Median (IQ range) 349.5 (240.0-494.2) 288.0 (227.0-369.0) 275.5 (213.2-338.8) 260.5 (217.2-333.0) 278.0 (219.0-355.0) 0.03 Folate:B12 ratio: Median (IQ range) 98.0 (68.5-159.2) 154.8 (114.8-227.6) 151.2 (120.5-215.2) 168.3 (118.0-233.7) 155.8 (115.6-222.5) 0.03 Active B12 concentration (pM): Median (IQ range) 50.0 (48.0-82.0) 63.0 (46.0-79.0) 63.0 (49.0-82.2) 62.0 (51.5-76.0) 63.0 (48.0-80.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 602.0 (490.9-735.8) 693.8 (534.1-990.9) 675.3 (461.4-944.2) 644.4 (517.4-898.6) 670.9 (493.7-951.1) 0.59 Homocysteine concentration (μM): Median (IQ range) 5.3 (4.7-5.7) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.9 (4.3-5.7) 4.8 (4.3-5.6) 0.15 Red cell folate (nmol/L): Median (IQ range) 1305.5 (1058.0-1585.0) 1445.0 (1212.0-1744.5) 1469.0 (1208.5-1785.5) 1433.0 (1189.0-1737.0) 1446.5 (1204.8-1755.5) 0.55 "],["prolactin-12.html", "18.1 Prolactin", " 18.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 15.53 (7.34, 32.85) &lt;0.0001 BMI_gp3Normal 0.81 (0.49, 1.34) 0.42 BMI_gp3Overweight 0.83 (0.50, 1.39) 0.48 BMI_gp3Obese 0.67 (0.40, 1.12) 0.13 StudySTOP 0.74 (0.41, 1.35) 0.33 GA_samp 1.17 (1.13, 1.21) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.36 (0.75, 2.46) 0.31 BMI_gp3Overweight:StudySTOP 1.37 (0.75, 2.50) 0.31 BMI_gp3Obese:StudySTOP 1.18 (0.65, 2.16) 0.59 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 124.08 32.11 Inf 74.71 206.06 Normal SCOPE 100.83 6.10 Inf 89.55 113.54 Overweight SCOPE 103.19 8.40 Inf 87.97 121.05 Obese SCOPE 83.26 6.15 Inf 72.04 96.24 Underweight STOP 92.19 13.99 Inf 68.47 124.13 Normal STOP 102.04 5.95 Inf 91.02 114.40 Overweight STOP 104.88 6.69 Inf 92.55 118.85 Obese STOP 73.04 5.38 Inf 63.22 84.39 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.81 (0.42, 1.57) 0.9 Overweight / Underweight Study: SCOPE 0.83 (0.42, 1.63) 0.9 Overweight / Normal Study: SCOPE 1.02 (0.82, 1.27) 1.0 Obese / Underweight Study: SCOPE 0.67 (0.34, 1.31) 0.4 Obese / Normal Study: SCOPE 0.83 (0.68, 1.01) 0.06 Obese / Overweight Study: SCOPE 0.81 (0.63, 1.03) 0.1 Normal / Underweight Study: STOP 1.11 (0.74, 1.67) 0.9 Overweight / Underweight Study: STOP 1.14 (0.75, 1.72) 0.9 Overweight / Normal Study: STOP 1.03 (0.84, 1.26) 1.0 Obese / Underweight Study: STOP 0.79 (0.52, 1.21) 0.5 Obese / Normal Study: STOP 0.72 (0.57, 0.90) 0.0008 Obese / Overweight Study: STOP 0.70 (0.55, 0.88) 0.0004 STOP / SCOPE Maternal BMI: Underweight 0.74 (0.41, 1.35) 0.3 STOP / SCOPE Maternal BMI: Normal 1.01 (0.84, 1.22) 0.9 STOP / SCOPE Maternal BMI: Overweight 1.02 (0.81, 1.27) 0.9 STOP / SCOPE Maternal BMI: Obese 0.88 (0.70, 1.09) 0.2 "],["hpl-12.html", "18.2 HPL", " 18.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.40 (1.78, 3.23) &lt;0.0001 BMI_gp3Normal 0.94 (0.85, 1.04) 0.25 BMI_gp3Overweight 0.88 (0.80, 0.98) 0.02 BMI_gp3Obese 0.75 (0.66, 0.84) &lt;0.0001 StudySTOP 1.31 (1.05, 1.62) 0.02 GA_samp 1.33 (1.31, 1.36) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.83 (0.67, 1.03) 0.09 BMI_gp3Overweight:StudySTOP 0.84 (0.68, 1.04) 0.11 BMI_gp3Obese:StudySTOP 0.80 (0.64, 1.00) 0.05 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 105.33 5.78 Inf 94.58 117.30 Normal SCOPE 99.29 2.74 Inf 94.07 104.81 Overweight SCOPE 92.98 2.64 Inf 87.95 98.31 Obese SCOPE 78.50 3.00 Inf 72.84 84.60 Underweight STOP 137.59 12.97 Inf 114.38 165.50 Normal STOP 107.76 2.32 Inf 103.30 112.42 Overweight STOP 101.84 2.71 Inf 96.67 107.28 Obese STOP 81.93 2.60 Inf 76.98 87.18 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.94 (0.83, 1.08) 0.7 Overweight / Underweight Study: SCOPE 0.88 (0.77, 1.01) 0.09 Overweight / Normal Study: SCOPE 0.94 (0.87, 1.00) 0.07 Obese / Underweight Study: SCOPE 0.75 (0.64, 0.87) &lt;0.0001 Obese / Normal Study: SCOPE 0.79 (0.72, 0.87) &lt;0.0001 Obese / Overweight Study: SCOPE 0.84 (0.76, 0.93) &lt;0.0001 Normal / Underweight Study: STOP 0.78 (0.61, 1.00) 0.05 Overweight / Underweight Study: STOP 0.74 (0.58, 0.95) 0.01 Overweight / Normal Study: STOP 0.95 (0.87, 1.03) 0.3 Obese / Underweight Study: STOP 0.60 (0.46, 0.77) &lt;0.0001 Obese / Normal Study: STOP 0.76 (0.69, 0.84) &lt;0.0001 Obese / Overweight Study: STOP 0.80 (0.73, 0.89) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 1.31 (1.05, 1.62) 0.02 STOP / SCOPE Maternal BMI: Normal 1.09 (1.01, 1.17) 0.03 STOP / SCOPE Maternal BMI: Overweight 1.10 (1.01, 1.19) 0.04 STOP / SCOPE Maternal BMI: Obese 1.04 (0.94, 1.16) 0.4 "],["gh2-12.html", "18.3 GH2", " 18.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.04, 0.09) &lt;0.0001 BMI_gp3Normal 1.02 (0.85, 1.22) 0.85 BMI_gp3Overweight 0.91 (0.76, 1.10) 0.34 BMI_gp3Obese 0.78 (0.64, 0.93) 0.007 StudySTOP 1.40 (1.00, 1.98) 0.05 GA_samp 1.32 (1.29, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.70 (0.50, 1.00) 0.05 BMI_gp3Overweight:StudySTOP 0.73 (0.52, 1.04) 0.08 BMI_gp3Obese:StudySTOP 0.82 (0.58, 1.18) 0.29 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 2.46 0.23 Inf 2.05 2.95 Normal SCOPE 2.51 0.09 Inf 2.33 2.69 Overweight SCOPE 2.25 0.09 Inf 2.08 2.43 Obese SCOPE 1.91 0.08 Inf 1.76 2.07 Underweight STOP 3.45 0.51 Inf 2.59 4.61 Normal STOP 2.48 0.09 Inf 2.31 2.66 Overweight STOP 2.32 0.10 Inf 2.13 2.52 Obese STOP 2.20 0.11 Inf 1.99 2.44 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.02 (0.80, 1.29) 1.0 Overweight / Underweight Study: SCOPE 0.91 (0.72, 1.16) 0.8 Overweight / Normal Study: SCOPE 0.90 (0.80, 1.00) 0.06 Obese / Underweight Study: SCOPE 0.78 (0.61, 0.99) 0.04 Obese / Normal Study: SCOPE 0.76 (0.68, 0.85) &lt;0.0001 Obese / Overweight Study: SCOPE 0.85 (0.75, 0.96) 0.003 Normal / Underweight Study: STOP 0.72 (0.49, 1.06) 0.1 Overweight / Underweight Study: STOP 0.67 (0.45, 0.99) 0.04 Overweight / Normal Study: STOP 0.94 (0.82, 1.07) 0.6 Obese / Underweight Study: STOP 0.64 (0.43, 0.95) 0.02 Obese / Normal Study: STOP 0.89 (0.76, 1.04) 0.2 Obese / Overweight Study: STOP 0.95 (0.81, 1.12) 0.9 STOP / SCOPE Maternal BMI: Underweight 1.40 (1.00, 1.98) 0.05 STOP / SCOPE Maternal BMI: Normal 0.99 (0.88, 1.11) 0.9 STOP / SCOPE Maternal BMI: Overweight 1.03 (0.91, 1.17) 0.6 STOP / SCOPE Maternal BMI: Obese 1.16 (1.00, 1.33) 0.04 "],["insulin-10.html", "18.4 Insulin", " 18.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 8.46 (4.06, 17.62) &lt;0.0001 BMI_gp3Normal 1.35 (0.83, 2.19) 0.22 BMI_gp3Overweight 1.77 (1.09, 2.87) 0.02 BMI_gp3Obese 2.35 (1.44, 3.83) 0.0007 StudySTOP 0.87 (0.47, 1.64) 0.68 GA_samp 1.00 (0.97, 1.04) 0.95 BMI_gp3Normal:StudySTOP 0.80 (0.43, 1.50) 0.48 BMI_gp3Overweight:StudySTOP 0.81 (0.43, 1.52) 0.51 BMI_gp3Obese:StudySTOP 0.95 (0.50, 1.79) 0.86 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 8.57 2.07 Inf 5.35 13.75 Normal SCOPE 11.58 0.96 Inf 9.84 13.64 Overweight SCOPE 15.14 1.29 Inf 12.81 17.90 Obese SCOPE 20.12 1.92 Inf 16.69 24.25 Underweight STOP 7.50 1.51 Inf 5.05 11.13 Normal STOP 8.09 0.48 Inf 7.20 9.08 Overweight STOP 10.72 0.64 Inf 9.54 12.06 Obese STOP 16.64 1.14 Inf 14.55 19.03 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.35 (0.72, 2.54) 0.6 Overweight / Underweight Study: SCOPE 1.77 (0.93, 3.34) 0.10 Overweight / Normal Study: SCOPE 1.31 (1.00, 1.71) 0.05 Obese / Underweight Study: SCOPE 2.35 (1.23, 4.46) 0.004 Obese / Normal Study: SCOPE 1.74 (1.30, 2.31) &lt;0.0001 Obese / Overweight Study: SCOPE 1.33 (0.99, 1.78) 0.06 Normal / Underweight Study: STOP 1.08 (0.64, 1.82) 1.0 Overweight / Underweight Study: STOP 1.43 (0.84, 2.42) 0.3 Overweight / Normal Study: STOP 1.33 (1.11, 1.59) 0.0003 Obese / Underweight Study: STOP 2.22 (1.30, 3.79) 0.0008 Obese / Normal Study: STOP 2.06 (1.68, 2.52) &lt;0.0001 Obese / Overweight Study: STOP 1.55 (1.26, 1.91) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.87 (0.47, 1.64) 0.7 STOP / SCOPE Maternal BMI: Normal 0.70 (0.56, 0.88) 0.002 STOP / SCOPE Maternal BMI: Overweight 0.71 (0.56, 0.89) 0.003 STOP / SCOPE Maternal BMI: Obese 0.83 (0.64, 1.06) 0.1 "],["homa-ir-10.html", "18.5 HOMA-IR", " 18.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 1.99 (0.94, 4.19) 0.07 BMI_gp3Normal 1.41 (0.88, 2.26) 0.15 BMI_gp3Overweight 1.86 (1.16, 3.00) 0.01 BMI_gp3Obese 2.50 (1.54, 4.05) 0.0002 StudySTOP 0.77 (0.42, 1.43) 0.41 GA_samp 1.00 (0.96, 1.04) 0.97 BMI_gp3Normal:StudySTOP 0.78 (0.42, 1.45) 0.43 BMI_gp3Overweight:StudySTOP 0.79 (0.42, 1.47) 0.45 BMI_gp3Obese:StudySTOP 0.95 (0.50, 1.79) 0.87 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 1.97 0.46 Inf 1.24 3.12 Normal SCOPE 2.78 0.24 Inf 2.34 3.30 Overweight SCOPE 3.67 0.34 Inf 3.06 4.40 Obese SCOPE 4.92 0.51 Inf 4.02 6.02 Underweight STOP 1.52 0.31 Inf 1.02 2.26 Normal STOP 1.67 0.10 Inf 1.48 1.88 Overweight STOP 2.23 0.14 Inf 1.97 2.52 Obese STOP 3.61 0.26 Inf 3.13 4.16 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.41 (0.76, 2.62) 0.5 Overweight / Underweight Study: SCOPE 1.86 (1.00, 3.49) 0.05 Overweight / Normal Study: SCOPE 1.32 (0.99, 1.77) 0.06 Obese / Underweight Study: SCOPE 2.50 (1.33, 4.71) 0.001 Obese / Normal Study: SCOPE 1.77 (1.30, 2.41) &lt;0.0001 Obese / Overweight Study: SCOPE 1.34 (0.97, 1.85) 0.09 Normal / Underweight Study: STOP 1.10 (0.65, 1.86) 1.0 Overweight / Underweight Study: STOP 1.46 (0.86, 2.49) 0.3 Overweight / Normal Study: STOP 1.34 (1.11, 1.61) 0.0005 Obese / Underweight Study: STOP 2.37 (1.38, 4.07) 0.0002 Obese / Normal Study: STOP 2.16 (1.75, 2.68) &lt;0.0001 Obese / Overweight Study: STOP 1.62 (1.30, 2.02) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.77 (0.42, 1.43) 0.4 STOP / SCOPE Maternal BMI: Normal 0.60 (0.47, 0.76) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.61 (0.48, 0.77) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.73 (0.56, 0.96) 0.02 "],["glucose-10.html", "18.6 Glucose", " 18.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.19 (4.58, 5.89) &lt;0.0001 BMI_gp3Normal 1.05 (0.98, 1.13) 0.17 BMI_gp3Overweight 1.06 (0.98, 1.15) 0.15 BMI_gp3Obese 1.07 (0.99, 1.15) 0.09 StudySTOP 0.89 (0.82, 0.98) 0.01 GA_samp 1.00 (0.99, 1.01) 0.73 BMI_gp3Normal:StudySTOP 0.97 (0.89, 1.06) 0.49 BMI_gp3Overweight:StudySTOP 0.97 (0.88, 1.08) 0.62 BMI_gp3Obese:StudySTOP 0.99 (0.90, 1.09) 0.79 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 5.11 0.19 Inf 4.76 5.49 Normal SCOPE 5.38 0.07 Inf 5.24 5.53 Overweight SCOPE 5.43 0.12 Inf 5.20 5.68 Obese SCOPE 5.47 0.10 Inf 5.28 5.66 Underweight STOP 4.57 0.11 Inf 4.35 4.80 Normal STOP 4.66 0.06 Inf 4.55 4.77 Overweight STOP 4.73 0.08 Inf 4.57 4.90 Obese STOP 4.82 0.08 Inf 4.66 4.99 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.05 (0.96, 1.16) 0.5 Overweight / Underweight Study: SCOPE 1.06 (0.95, 1.18) 0.5 Overweight / Normal Study: SCOPE 1.01 (0.95, 1.07) 1.0 Obese / Underweight Study: SCOPE 1.07 (0.97, 1.18) 0.3 Obese / Normal Study: SCOPE 1.02 (0.97, 1.07) 0.9 Obese / Overweight Study: SCOPE 1.01 (0.94, 1.08) 1.0 Normal / Underweight Study: STOP 1.02 (0.95, 1.09) 0.9 Overweight / Underweight Study: STOP 1.04 (0.96, 1.12) 0.7 Overweight / Normal Study: STOP 1.02 (0.96, 1.07) 0.9 Obese / Underweight Study: STOP 1.05 (0.98, 1.14) 0.3 Obese / Normal Study: STOP 1.03 (0.98, 1.09) 0.4 Obese / Overweight Study: STOP 1.02 (0.95, 1.09) 0.9 STOP / SCOPE Maternal BMI: Underweight 0.89 (0.82, 0.98) 0.01 STOP / SCOPE Maternal BMI: Normal 0.87 (0.83, 0.90) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.87 (0.82, 0.92) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.88 (0.84, 0.93) &lt;0.0001 "],["age-bmi-groups-1.html", "19 Age &amp; BMI groups", " 19 Age &amp; BMI groups Descriptives with univariate P-values. Characteristic &lt;35y, non-obese (n=984) &lt;35y, obese (n=285) &gt;=35y, non-obese (n=29) &gt;=35y, obese (n=16) Total (n=1314) P-value PRL (ng/ml): Median (IQ range) 102.6 (62.6-164.4) 81.7 (49.5-132.4) 79.2 (52.1-95.7) 45.1 (32.3-103.1) 96.8 (58.3-157.1) &lt;0.0001 hPL (μg/ml): Median (IQ range) 120.8 (58.4-189.2) 73.8 (43.5-145.4) 81.8 (58.5-136.1) 81.2 (33.9-129.1) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.4) 2.2 (1.0-3.3) 2.1 (1.2-3.7) 2.1 (1.6-3.0) 2.5 (1.2-4.1) 0.0004 Insulin (uU/ml): Median (IQ range) 9.3 (5.2-19.2) 16.1 (9.7-31.6) 8.5 (4.6-16.8) 11.6 (8.8-23.2) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.1-4.4) 3.6 (2.2-7.0) 2.1 (0.9-3.7) 2.6 (1.7-5.2) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.7-5.6) 4.9 (4.5-5.4) 4.7 (4.5-5.2) 5.0 (4.6-5.5) 0.02 Within SCOPE Characteristic &lt;35y, non-obese (n=457) &lt;35y, obese (n=130) &gt;=35y, non-obese (n=11) &gt;=35y, obese (n=6) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 142.7 (100.7-221.2) 131.3 (82.8-196.2) 134.9 (82.4-210.6) 85.0 (45.7-124.5) 139.9 (94.7-215.5) 0.12 hPL (μg/ml): Median (IQ range) 192.3 (157.8-226.8) 153.3 (130.7-180.3) 168.6 (136.6-202.0) 160.7 (98.5-202.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.4 (3.4-6.0) 3.4 (2.6-4.4) 3.8 (3.4-4.7) 4.5 (2.7-6.9) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 13.4 (5.8-25.7) 20.1 (9.7-34.8) 11.3 (8.1-20.2) 50.4 (39.0-53.5) 14.4 (6.5-29.1) 0.0007 HOMA-IR: Median (IQ range) 3.1 (1.3-6.4) 4.6 (2.3-9.0) 2.7 (2.1-4.8) 14.0 (10.0-15.8) 3.3 (1.5-7.2) 0.001 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.1-5.9) 5.4 (5.2-5.7) 5.5 (5.1-6.1) 5.4 (5.0-5.8) 0.91 Serum folate concentration (nM): Median (IQ range) 36.8 (29.2-43.0) 35.5 (24.8-43.2) 37.6 (33.9-43.0) 32.7 (31.3-36.9) 36.4 (28.5-43.0) 0.57 B12 concentration (pM): Median (IQ range) 252.5 (199.0-318.8) 227.0 (182.0-287.5) 289.0 (245.2-345.2) 227.5 (181.2-249.0) 248.0 (195.5-316.0) 0.02 Folate:B12 ratio: Median (IQ range) 142.8 (103.4-207.5) 143.0 (103.1-215.4) 124.3 (115.6-165.0) 153.9 (126.0-192.9) 142.6 (104.0-207.4) 0.97 Active B12 concentration (pM): Median (IQ range) 53.5 (42.0-72.0) 60.0 (43.5-71.0) 48.0 (48.0-53.5) 74.0 (52.0-93.0) 54.0 (43.0-72.0) 0.45 Folate:Active B12 ratio: Median (IQ range) 634.3 (471.2-1019.0) 546.7 (436.3-698.7) 685.4 (633.4-794.8) 400.0 (360.2-420.3) 617.0 (458.5-931.9) 0.01 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-5.0) 4.4 (3.8-5.0) 4.2 (3.9-4.5) 4.3 (3.9-4.6) 4.4 (3.8-5.0) 0.98 Within STOP Characteristic &lt;35y, non-obese (n=527) &lt;35y, obese (n=155) &gt;=35y, non-obese (n=18) &gt;=35y, obese (n=10) Total (n=710) P-value PRL (ng/ml): Median (IQ range) 76.3 (52.4-119.1) 62.9 (40.9-99.3) 72.9 (50.0-90.3) 41.2 (32.3-60.9) 72.9 (48.6-113.6) 0.001 hPL (μg/ml): Median (IQ range) 66.5 (44.4-101.1) 50.5 (34.5-71.7) 68.1 (49.4-83.4) 60.2 (33.9-90.7) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.6 (1.1-2.1) 1.6 (1.3-2.4) 1.4 (0.9-2.4) 0.10 Insulin (uU/ml): Median (IQ range) 8.1 (4.8-14.6) 15.2 (9.9-27.4) 6.7 (4.1-15.4) 9.2 (8.4-12.4) 9.3 (5.6-17.0) &lt;0.0001 HOMA-IR: Median (IQ range) 1.7 (1.0-3.1) 3.5 (2.1-6.0) 1.1 (0.8-2.9) 1.9 (1.7-2.6) 1.9 (1.1-3.7) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.8 (4.5-5.3) 4.6 (4.3-4.9) 4.5 (4.4-4.7) 4.7 (4.4-5.1) 0.002 Serum folate concentration (nM): Median (IQ range) 40.4 (36.5-45.0) 40.0 (35.4-44.9) 44.5 (40.3-78.6) 43.6 (42.1-99.6) 40.5 (36.4-45.3) 0.007 B12 concentration (pM): Median (IQ range) 284.5 (221.5-361.2) 260.0 (218.0-330.0) 272.0 (239.0-363.0) 295.0 (205.0-363.0) 278.0 (219.0-355.0) 0.20 Folate:B12 ratio: Median (IQ range) 152.6 (114.8-219.0) 166.7 (116.5-224.1) 168.2 (127.9-316.8) 241.6 (144.4-313.7) 155.8 (115.6-222.5) 0.22 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-80.5) 62.0 (51.5-76.0) 68.0 (55.0-100.0) 56.0 (53.2-59.5) 63.0 (48.0-80.0) 0.72 Folate:Active B12 ratio: Median (IQ range) 691.9 (487.2-959.9) 630.9 (513.8-898.6) 527.9 (444.1-965.5) 756.4 (713.9-1092.8) 670.9 (493.7-951.1) 0.71 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.5) 4.9 (4.3-5.7) 4.8 (4.4-6.1) 4.9 (4.7-5.3) 4.8 (4.3-5.6) 0.68 Red cell folate (nmol/L): Median (IQ range) 1445.0 (1205.8-1760.5) 1388.0 (1182.0-1744.0) 1592.0 (1361.0-1751.0) 1592.5 (1529.2-1667.0) 1446.5 (1204.8-1755.5) 0.50 "],["prolactin-13.html", "19.1 Prolactin", " 19.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 12.76 (7.55, 21.59) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.83 (0.73, 0.95) 0.007 Age_BMI_gp&gt;=35y, non-obese 0.98 (0.69, 1.39) 0.90 Age_BMI_gp&gt;=35y, obese 0.57 (0.19, 1.73) 0.32 StudySTOP 1.01 (0.86, 1.20) 0.88 GA_samp 1.17 (1.13, 1.21) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 0.85 (0.69, 1.06) 0.14 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.79 (0.50, 1.26) 0.33 Age_BMI_gp&gt;=35y, obese:StudySTOP 1.05 (0.31, 3.53) 0.94 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 102.33 5.77 Inf 91.62 114.29 &lt;35y, obese SCOPE 85.08 5.78 Inf 74.47 97.19 &gt;=35y, non-obese SCOPE 100.13 17.93 Inf 70.49 142.24 &gt;=35y, obese SCOPE 57.94 33.06 Inf 18.94 177.28 &lt;35y, non-obese STOP 103.70 4.83 Inf 94.65 113.61 &lt;35y, obese STOP 73.67 5.60 Inf 63.47 85.50 &gt;=35y, non-obese STOP 80.30 12.50 Inf 59.18 108.96 &gt;=35y, obese STOP 61.58 14.68 Inf 38.59 98.27 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.83 (0.70, 0.99) 0.04 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.98 (0.62, 1.55) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.18 (0.73, 1.89) 0.8 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.57 (0.13, 2.45) 0.8 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 0.68 (0.16, 2.96) 0.9 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.58 (0.13, 2.67) 0.8 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.71 (0.57, 0.88) 0.0002 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.77 (0.52, 1.16) 0.4 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.09 (0.71, 1.69) 1.0 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.59 (0.32, 1.10) 0.1 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.84 (0.44, 1.58) 0.9 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.77 (0.37, 1.58) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.01 (0.86, 1.20) 0.9 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.87 (0.70, 1.07) 0.2 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.80 (0.50, 1.29) 0.4 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 1.06 (0.32, 3.58) 0.9 "],["hpl-13.html", "19.2 HPL", " 19.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.15 (1.64, 2.81) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.82 (0.76, 0.88) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 0.95 (0.82, 1.10) 0.52 Age_BMI_gp&gt;=35y, obese 0.71 (0.55, 0.92) 0.01 StudySTOP 1.10 (1.03, 1.18) 0.004 GA_samp 1.33 (1.31, 1.36) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 0.95 (0.86, 1.05) 0.34 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 1.07 (0.85, 1.35) 0.58 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.95 (0.69, 1.31) 0.75 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 96.62 2.37 Inf 92.09 101.39 &lt;35y, obese SCOPE 78.83 3.02 Inf 73.12 84.99 &gt;=35y, non-obese SCOPE 92.04 6.99 Inf 79.31 106.82 &gt;=35y, obese SCOPE 68.90 9.16 Inf 53.10 89.40 &lt;35y, non-obese STOP 106.44 1.77 Inf 103.01 109.97 &lt;35y, obese STOP 82.73 2.71 Inf 77.60 88.21 &gt;=35y, non-obese STOP 108.22 9.87 Inf 90.50 129.40 &gt;=35y, obese STOP 71.96 7.05 Inf 59.39 87.20 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.82 (0.74, 0.89) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.95 (0.79, 1.15) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.17 (0.95, 1.44) 0.2 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.71 (0.51, 1.00) 0.05 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 0.87 (0.62, 1.24) 0.8 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.75 (0.51, 1.10) 0.2 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.78 (0.71, 0.85) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 1.02 (0.80, 1.29) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.31 (1.02, 1.67) 0.03 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.68 (0.52, 0.87) 0.0004 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.87 (0.67, 1.13) 0.5 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.66 (0.47, 0.94) 0.01 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.10 (1.03, 1.18) 0.004 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.05 (0.94, 1.17) 0.4 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 1.18 (0.93, 1.49) 0.2 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 1.04 (0.75, 1.45) 0.8 "],["gh2-13.html", "19.3 GH2", " 19.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.79 (0.73, 0.85) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 0.94 (0.77, 1.14) 0.52 Age_BMI_gp&gt;=35y, obese 0.91 (0.56, 1.49) 0.71 StudySTOP 1.02 (0.92, 1.12) 0.74 GA_samp 1.32 (1.30, 1.35) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 1.16 (1.01, 1.33) 0.04 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 1.13 (0.83, 1.54) 0.45 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.91 (0.54, 1.52) 0.71 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 2.40 0.08 Inf 2.25 2.55 &lt;35y, obese SCOPE 1.89 0.08 Inf 1.74 2.05 &gt;=35y, non-obese SCOPE 2.25 0.23 Inf 1.84 2.74 &gt;=35y, obese SCOPE 2.18 0.54 Inf 1.34 3.56 &lt;35y, non-obese STOP 2.44 0.07 Inf 2.30 2.58 &lt;35y, obese STOP 2.22 0.12 Inf 1.99 2.47 &gt;=35y, non-obese STOP 2.58 0.31 Inf 2.03 3.27 &gt;=35y, obese STOP 2.01 0.17 Inf 1.71 2.36 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.79 (0.71, 0.88) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.94 (0.72, 1.21) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.19 (0.91, 1.55) 0.3 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.91 (0.48, 1.73) 1.0 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.16 (0.61, 2.21) 0.9 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.97 (0.49, 1.94) 1.0 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.91 (0.78, 1.06) 0.4 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 1.06 (0.77, 1.45) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.16 (0.83, 1.63) 0.7 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.83 (0.66, 1.03) 0.1 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.91 (0.71, 1.16) 0.7 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.78 (0.54, 1.13) 0.3 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.02 (0.92, 1.12) 0.7 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.18 (1.02, 1.36) 0.03 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 1.15 (0.84, 1.57) 0.4 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.92 (0.55, 1.54) 0.8 "],["insulin-11.html", "19.4 Insulin", " 19.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 12.74 (7.23, 22.42) &lt;0.0001 Age_BMI_gp&lt;35y, obese 1.55 (1.27, 1.89) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 0.96 (0.65, 1.41) 0.82 Age_BMI_gp&gt;=35y, obese 2.30 (1.22, 4.34) 0.010 StudySTOP 0.71 (0.58, 0.86) 0.0005 GA_samp 1.00 (0.96, 1.04) 0.99 Age_BMI_gp&lt;35y, obese:StudySTOP 1.22 (0.95, 1.57) 0.11 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.90 (0.50, 1.59) 0.71 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.47 (0.24, 0.92) 0.03 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 12.78 0.86 Inf 11.21 14.58 &lt;35y, obese SCOPE 19.77 1.93 Inf 16.32 23.95 &gt;=35y, non-obese SCOPE 12.22 2.38 Inf 8.34 17.89 &gt;=35y, obese SCOPE 29.44 9.47 Inf 15.67 55.30 &lt;35y, non-obese STOP 9.04 0.45 Inf 8.20 9.96 &lt;35y, obese STOP 17.09 1.22 Inf 14.86 19.66 &gt;=35y, non-obese STOP 7.75 1.69 Inf 5.06 11.87 &gt;=35y, obese STOP 9.81 0.95 Inf 8.12 11.85 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.55 (1.19, 2.01) 0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.96 (0.58, 1.59) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 0.62 (0.36, 1.06) 0.10 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.30 (1.01, 5.28) 0.05 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.49 (0.64, 3.48) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 2.41 (0.93, 6.25) 0.08 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.89 (1.56, 2.29) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.86 (0.49, 1.50) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.45 (0.25, 0.81) 0.002 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 1.09 (0.83, 1.42) 0.9 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.57 (0.42, 0.78) &lt;0.0001 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 1.27 (0.69, 2.32) 0.7 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.71 (0.58, 0.86) 0.0005 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.86 (0.67, 1.12) 0.3 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.63 (0.35, 1.14) 0.1 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.33 (0.17, 0.65) 0.001 "],["homa-ir-11.html", "19.5 HOMA-IR", " 19.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.13 (1.74, 5.65) 0.0001 Age_BMI_gp&lt;35y, obese 1.57 (1.26, 1.95) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 1.00 (0.65, 1.52) 0.99 Age_BMI_gp&gt;=35y, obese 2.52 (1.26, 5.06) 0.009 StudySTOP 0.61 (0.50, 0.75) &lt;0.0001 GA_samp 1.00 (0.96, 1.04) 0.94 Age_BMI_gp&lt;35y, obese:StudySTOP 1.27 (0.97, 1.66) 0.08 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.85 (0.46, 1.59) 0.61 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.42 (0.20, 0.87) 0.02 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 3.07 0.22 Inf 2.67 3.53 &lt;35y, obese SCOPE 4.82 0.51 Inf 3.91 5.92 &gt;=35y, non-obese SCOPE 3.06 0.65 Inf 2.02 4.63 &gt;=35y, obese SCOPE 7.74 2.74 Inf 3.87 15.49 &lt;35y, non-obese STOP 1.87 0.10 Inf 1.69 2.07 &lt;35y, obese STOP 3.72 0.28 Inf 3.21 4.32 &gt;=35y, non-obese STOP 1.59 0.38 Inf 1.00 2.52 &gt;=35y, obese STOP 1.99 0.19 Inf 1.65 2.39 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.57 (1.18, 2.09) 0.0003 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.00 (0.57, 1.73) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 0.64 (0.35, 1.14) 0.2 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.52 (1.01, 6.28) 0.05 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.61 (0.63, 4.09) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 2.53 (0.89, 7.20) 0.1 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.99 (1.63, 2.44) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.85 (0.46, 1.56) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.43 (0.23, 0.80) 0.003 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 1.06 (0.82, 1.38) 0.9 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.53 (0.39, 0.72) &lt;0.0001 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 1.25 (0.65, 2.39) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.61 (0.50, 0.75) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.77 (0.59, 1.02) 0.07 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.52 (0.28, 0.98) 0.04 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.26 (0.12, 0.53) 0.0002 "],["glucose-11.html", "19.6 Glucose", " 19.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.48 (4.93, 6.10) &lt;0.0001 Age_BMI_gp&lt;35y, obese 1.01 (0.97, 1.05) 0.68 Age_BMI_gp&gt;=35y, non-obese 1.01 (0.95, 1.07) 0.82 Age_BMI_gp&gt;=35y, obese 1.12 (0.94, 1.34) 0.20 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.74 Age_BMI_gp&lt;35y, obese:StudySTOP 1.02 (0.97, 1.08) 0.45 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.99 (0.92, 1.07) 0.75 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.87 (0.72, 1.04) 0.12 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 5.40 0.07 Inf 5.26 5.54 &lt;35y, obese SCOPE 5.44 0.10 Inf 5.25 5.63 &gt;=35y, non-obese SCOPE 5.43 0.17 Inf 5.12 5.77 &gt;=35y, obese SCOPE 6.05 0.54 Inf 5.08 7.21 &lt;35y, non-obese STOP 4.69 0.05 Inf 4.59 4.79 &lt;35y, obese STOP 4.83 0.09 Inf 4.66 5.00 &gt;=35y, non-obese STOP 4.67 0.10 Inf 4.48 4.86 &gt;=35y, obese STOP 4.55 0.09 Inf 4.39 4.73 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.01 (0.96, 1.06) 1.0 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.01 (0.93, 1.09) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.00 (0.92, 1.09) 1.0 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.12 (0.89, 1.41) 0.6 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.11 (0.88, 1.40) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 1.11 (0.88, 1.42) 0.7 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.03 (0.98, 1.09) 0.5 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.99 (0.94, 1.05) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.97 (0.90, 1.03) 0.6 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.97 (0.92, 1.03) 0.5 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.94 (0.88, 1.01) 0.1 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.98 (0.91, 1.05) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.87 (0.84, 0.90) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.89 (0.84, 0.93) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.86 (0.80, 0.92) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.75 (0.63, 0.90) 0.002 "],["mets-3.html", "20 MetS", " 20 MetS Descriptives with univariate P-values. Characteristic No MetS (n=1149) MetS (n=112) Total (n=1261) P-value PRL (ng/ml): Median (IQ range) 95.2 (57.7-150.3) 107.5 (66.8-182.2) 96.3 (58.2-154.4) 0.11 hPL (μg/ml): Median (IQ range) 100.5 (54.0-179.2) 143.6 (59.4-179.6) 105.2 (54.1-179.5) 0.21 GH2 (ng/ml): Median (IQ range) 2.4 (1.2-4.1) 3.0 (1.6-4.6) 2.5 (1.2-4.1) 0.07 Insulin (uU/ml): Median (IQ range) 9.9 (5.7-19.6) 28.0 (14.4-51.6) 10.8 (6.1-21.9) &lt;0.0001 HOMA-IR: Median (IQ range) 2.1 (1.2-4.5) 7.4 (3.6-14.1) 2.4 (1.3-5.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.4) 5.8 (5.6-6.2) 5.0 (4.6-5.5) &lt;0.0001 Within SCOPE Characteristic No MetS (n=525) MetS (n=76) Total (n=601) P-value PRL (ng/ml): Median (IQ range) 138.1 (92.3-218.7) 154.1 (105.0-204.0) 139.7 (94.2-215.5) 0.50 hPL (μg/ml): Median (IQ range) 185.1 (151.8-222.3) 169.0 (146.8-201.1) 183.5 (149.7-220.6) 0.04 GH2 (ng/ml): Median (IQ range) 4.2 (3.3-5.7) 4.1 (2.8-5.4) 4.2 (3.2-5.6) 0.29 Insulin (uU/ml): Median (IQ range) 12.5 (6.1-24.7) 33.9 (20.3-60.0) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 2.8 (1.4-5.8) 8.9 (4.7-15.9) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.8) 5.9 (5.6-6.2) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.8 (28.2-43.2) 35.2 (30.3-42.5) 36.5 (28.6-43.0) 0.76 B12 concentration (pM): Median (IQ range) 252.0 (198.2-320.5) 223.0 (173.5-291.5) 249.5 (196.0-316.0) 0.006 Folate:B12 ratio: Median (IQ range) 141.0 (101.6-203.1) 154.1 (118.2-216.4) 142.6 (104.3-208.3) 0.18 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-72.0) 51.0 (43.5-68.0) 54.0 (42.8-72.0) 0.65 Folate:Active B12 ratio: Median (IQ range) 615.9 (456.2-973.2) 620.0 (505.1-746.5) 617.2 (461.4-935.8) 0.80 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.3 (3.8-4.7) 4.4 (3.8-4.9) 0.44 Within STOP Characteristic No MetS (n=624) MetS (n=36) Total (n=660) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.5-112.3) 65.1 (46.2-98.4) 72.6 (48.4-111.3) 0.28 hPL (μg/ml): Median (IQ range) 60.9 (41.3-91.0) 50.6 (34.5-71.3) 60.5 (41.1-90.6) 0.07 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.5 (0.8-2.0) 1.4 (0.9-2.3) 0.37 Insulin (uU/ml): Median (IQ range) 9.1 (5.5-16.2) 16.5 (10.9-37.2) 9.2 (5.7-17.1) &lt;0.0001 HOMA-IR: Median (IQ range) 1.9 (1.1-3.5) 4.5 (2.8-8.6) 1.9 (1.1-3.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 5.6 (4.9-5.8) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-45.1) 40.3 (37.2-45.0) 40.5 (36.3-45.1) 0.85 B12 concentration (pM): Median (IQ range) 279.5 (220.2-356.0) 247.0 (201.0-335.5) 278.0 (219.0-356.0) 0.13 Folate:B12 ratio: Median (IQ range) 153.6 (114.8-223.8) 172.4 (143.0-203.7) 155.4 (115.6-222.8) 0.27 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-81.0) 62.0 (56.0-74.0) 63.0 (49.0-81.0) 0.84 Folate:Active B12 ratio: Median (IQ range) 670.5 (487.1-941.9) 633.9 (493.7-726.8) 667.9 (488.1-936.8) 0.63 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.9 (4.5-5.5) 4.8 (4.3-5.6) 0.91 Red cell folate (nmol/L): Median (IQ range) 1446.0 (1206.0-1751.0) 1469.5 (1207.5-1784.8) 1446.5 (1206.0-1753.8) 0.66 "],["prolactin-14.html", "20.1 Prolactin", " 20.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 13.52 (7.76, 23.57) &lt;0.0001 metab.C1MetS 1.01 (0.82, 1.25) 0.90 StudySTOP 0.95 (0.80, 1.13) 0.55 GA_samp 1.16 (1.12, 1.21) &lt;0.0001 metab.C1MetS:StudySTOP 0.79 (0.57, 1.09) 0.15 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 99.07 5.51 Inf 88.84 110.49 MetS SCOPE 100.42 11.07 Inf 80.90 124.64 No MetS STOP 94.01 4.34 Inf 85.88 102.92 MetS STOP 75.23 8.98 Inf 59.54 95.06 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.01 (0.82, 1.25) 0.9 MetS / No MetS Study: STOP 0.80 (0.63, 1.02) 0.07 STOP / SCOPE MetS: No MetS 0.95 (0.80, 1.13) 0.5 STOP / SCOPE MetS: MetS 0.75 (0.54, 1.05) 0.09 "],["hpl-14.html", "20.2 HPL", " 20.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.17 (1.70, 2.77) &lt;0.0001 metab.C1MetS 0.90 (0.83, 0.98) 0.02 StudySTOP 1.08 (1.01, 1.15) 0.03 GA_samp 1.33 (1.31, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.96 (0.82, 1.12) 0.58 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 93.49 2.20 Inf 89.28 97.90 MetS SCOPE 84.35 3.87 Inf 77.10 92.28 No MetS STOP 100.55 1.70 Inf 97.28 103.93 MetS STOP 86.83 5.61 Inf 76.50 98.54 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.90 (0.83, 0.98) 0.02 MetS / No MetS Study: STOP 0.86 (0.76, 0.98) 0.03 STOP / SCOPE MetS: No MetS 1.08 (1.01, 1.15) 0.03 STOP / SCOPE MetS: MetS 1.03 (0.88, 1.21) 0.7 "],["gh2-14.html", "20.3 GH2", " 20.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 metab.C1MetS 0.91 (0.82, 1.02) 0.12 StudySTOP 1.06 (0.96, 1.17) 0.27 GA_samp 1.32 (1.30, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 1.03 (0.81, 1.30) 0.81 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.27 0.07 Inf 2.14 2.42 MetS SCOPE 2.08 0.13 Inf 1.84 2.34 No MetS STOP 2.41 0.07 Inf 2.28 2.55 MetS STOP 2.27 0.23 Inf 1.85 2.77 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.91 (0.82, 1.02) 0.1 MetS / No MetS Study: STOP 0.94 (0.77, 1.16) 0.6 STOP / SCOPE MetS: No MetS 1.06 (0.96, 1.17) 0.3 STOP / SCOPE MetS: MetS 1.09 (0.86, 1.39) 0.5 "],["insulin-12.html", "20.4 Insulin", " 20.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 12.83 (7.08, 23.24) &lt;0.0001 metab.C1MetS 2.51 (2.00, 3.14) &lt;0.0001 StudySTOP 0.79 (0.65, 0.96) 0.02 GA_samp 1.00 (0.96, 1.04) 0.96 metab.C1MetS:StudySTOP 0.78 (0.54, 1.13) 0.19 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 12.65 0.84 Inf 11.11 14.41 MetS SCOPE 31.73 3.51 Inf 25.54 39.43 No MetS STOP 9.99 0.48 Inf 9.09 10.98 MetS STOP 19.59 2.87 Inf 14.69 26.11 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.51 (2.00, 3.14) &lt;0.0001 MetS / No MetS Study: STOP 1.96 (1.46, 2.62) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.79 (0.65, 0.96) 0.02 STOP / SCOPE MetS: MetS 0.62 (0.43, 0.89) 0.01 "],["homa-ir-12.html", "20.5 HOMA-IR", " 20.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.09 (1.67, 5.71) 0.0003 metab.C1MetS 2.85 (2.24, 3.63) &lt;0.0001 StudySTOP 0.69 (0.56, 0.85) 0.0004 GA_samp 1.00 (0.96, 1.04) 0.91 metab.C1MetS:StudySTOP 0.80 (0.53, 1.20) 0.28 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 3.00 0.21 Inf 2.62 3.44 MetS SCOPE 8.54 1.02 Inf 6.76 10.79 No MetS STOP 2.08 0.10 Inf 1.88 2.29 MetS STOP 4.72 0.76 Inf 3.44 6.48 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.85 (2.24, 3.63) &lt;0.0001 MetS / No MetS Study: STOP 2.28 (1.65, 3.14) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.69 (0.56, 0.85) 0.0004 STOP / SCOPE MetS: MetS 0.55 (0.37, 0.83) 0.004 "],["glucose-12.html", "20.6 Glucose", " 20.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.35 (4.79, 5.98) &lt;0.0001 metab.C1MetS 1.12 (1.09, 1.16) &lt;0.0001 StudySTOP 0.88 (0.85, 0.91) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.95 metab.C1MetS:StudySTOP 1.04 (0.97, 1.11) 0.27 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 5.33 0.07 Inf 5.20 5.47 MetS SCOPE 6.00 0.10 Inf 5.81 6.19 No MetS STOP 4.68 0.04 Inf 4.60 4.76 MetS STOP 5.46 0.15 Inf 5.17 5.77 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.12 (1.09, 1.16) &lt;0.0001 MetS / No MetS Study: STOP 1.17 (1.10, 1.23) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.88 (0.85, 0.91) &lt;0.0001 STOP / SCOPE MetS: MetS 0.91 (0.85, 0.97) 0.006 "],["birthweight-centile-1.html", "21 Birthweight centile", " 21 Birthweight centile Descriptives with univariate P-values. Characteristic &lt;=90th centile (n=1175) &gt;90th centile (n=135) Total (n=1310) P-value PRL (ng/ml): Median (IQ range) 97.0 (57.9-155.7) 96.1 (62.2-159.9) 96.9 (58.2-157.3) 0.89 hPL (μg/ml): Median (IQ range) 111.1 (54.6-179.0) 93.2 (54.6-184.1) 108.1 (54.6-179.7) 0.90 GH2 (ng/ml): Median (IQ range) 2.6 (1.2-4.1) 2.0 (1.1-4.1) 2.5 (1.2-4.1) 0.31 Insulin (uU/ml): Median (IQ range) 10.7 (6.1-21.4) 11.1 (5.8-22.7) 10.8 (6.0-21.7) 0.67 HOMA-IR: Median (IQ range) 2.4 (1.3-5.0) 2.6 (1.3-5.2) 2.4 (1.3-5.0) 0.54 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.6-5.6) 5.0 (4.6-5.5) 0.31 Within SCOPE Characteristic &lt;=90th centile (n=549) &gt;90th centile (n=55) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 139.1 (92.8-215.5) 156.5 (106.3-223.3) 139.9 (94.7-215.5) 0.30 hPL (μg/ml): Median (IQ range) 181.5 (148.0-217.8) 206.6 (159.9-259.2) 183.5 (149.9-220.6) 0.02 GH2 (ng/ml): Median (IQ range) 4.1 (3.2-5.6) 4.6 (3.5-6.0) 4.2 (3.2-5.6) 0.36 Insulin (uU/ml): Median (IQ range) 14.1 (6.4-27.4) 19.8 (7.2-39.0) 14.4 (6.5-29.1) 0.14 HOMA-IR: Median (IQ range) 3.2 (1.5-6.8) 4.8 (1.8-9.4) 3.3 (1.5-7.2) 0.10 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.1-6.1) 5.4 (5.0-5.8) 0.07 Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.2) 37.7 (26.5-42.4) 36.4 (28.5-43.0) 0.72 B12 concentration (pM): Median (IQ range) 249.0 (195.0-313.0) 245.0 (202.0-325.0) 248.0 (195.5-316.0) 0.71 Folate:B12 ratio: Median (IQ range) 142.8 (105.2-207.8) 141.1 (96.2-202.9) 142.6 (104.0-207.4) 0.64 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-71.2) 56.0 (44.5-76.5) 54.0 (43.0-72.0) 0.41 Folate:Active B12 ratio: Median (IQ range) 617.2 (449.7-946.3) 575.0 (478.4-872.4) 617.0 (458.5-931.9) 0.88 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-5.0) 4.3 (3.7-4.9) 4.4 (3.8-5.0) 0.62 Within STOP Characteristic &lt;=90th centile (n=626) &gt;90th centile (n=80) Total (n=706) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.7-114.6) 68.7 (47.2-104.7) 72.9 (48.6-113.5) 0.68 hPL (μg/ml): Median (IQ range) 63.5 (41.0-98.8) 58.5 (48.5-86.7) 62.4 (41.4-96.7) 0.98 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-1.9) 1.4 (0.9-2.4) 0.33 Insulin (uU/ml): Median (IQ range) 9.3 (5.7-17.0) 8.3 (5.3-16.9) 9.2 (5.6-17.0) 0.74 HOMA-IR: Median (IQ range) 1.9 (1.1-3.7) 1.9 (1.1-3.9) 1.9 (1.1-3.7) 0.90 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.8 (4.5-5.1) 4.7 (4.4-5.1) 0.25 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-45.3) 41.3 (37.2-44.8) 40.5 (36.4-45.3) 0.52 B12 concentration (pM): Median (IQ range) 277.0 (217.0-353.8) 285.0 (231.0-366.0) 277.0 (219.0-355.0) 0.48 Folate:B12 ratio: Median (IQ range) 155.8 (116.3-225.5) 163.4 (114.6-216.1) 155.9 (115.6-222.8) 0.51 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.0) 68.0 (51.0-88.8) 63.0 (48.0-80.0) 0.25 Folate:Active B12 ratio: Median (IQ range) 670.9 (502.6-964.3) 646.1 (460.7-853.3) 670.5 (493.5-950.0) 0.38 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.4-5.5) 4.8 (4.3-5.6) 0.89 Red cell folate (nmol/L): Median (IQ range) 1454.0 (1206.5-1761.0) 1383.5 (1187.0-1704.0) 1447.0 (1205.0-1754.0) 0.42 "],["prolactin-15.html", "21.1 Prolactin", " 21.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 11.23 (6.54, 19.27) &lt;0.0001 BW_gp&gt;90th centile 1.27 (1.00, 1.61) 0.05 StudySTOP 1.00 (0.85, 1.17) 0.96 GA_samp 1.18 (1.14, 1.22) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.83 (0.60, 1.17) 0.29 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 95.00 5.20 Inf 85.34 105.77 &gt;90th centile SCOPE 120.45 14.48 Inf 95.16 152.45 &lt;=90th centile STOP 94.60 4.10 Inf 86.90 102.98 &gt;90th centile STOP 99.97 12.26 Inf 78.61 127.13 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.27 (1.00, 1.61) 0.05 &gt;90th centile / &lt;=90th centile Study: STOP 1.06 (0.83, 1.34) 0.7 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.00 (0.85, 1.17) 1.0 STOP / SCOPE Birthweight centile: &gt;90th centile 0.83 (0.58, 1.18) 0.3 "],["hpl-15.html", "21.2 HPL", " 21.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.88 (1.42, 2.49) &lt;0.0001 BW_gp&gt;90th centile 1.16 (1.05, 1.28) 0.002 StudySTOP 1.11 (1.03, 1.19) 0.004 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.99 (0.87, 1.11) 0.81 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 89.90 2.30 Inf 85.50 94.53 &gt;90th centile SCOPE 104.51 5.38 Inf 94.48 115.60 &lt;=90th centile STOP 99.70 1.67 Inf 96.48 103.03 &gt;90th centile STOP 114.22 4.15 Inf 106.38 122.64 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.16 (1.05, 1.28) 0.002 &gt;90th centile / &lt;=90th centile Study: STOP 1.15 (1.07, 1.23) 0.0002 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.11 (1.03, 1.19) 0.004 STOP / SCOPE Birthweight centile: &gt;90th centile 1.09 (0.96, 1.25) 0.2 "],["gh2-15.html", "21.3 GH2", " 21.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 BW_gp&gt;90th centile 1.03 (0.89, 1.19) 0.69 StudySTOP 1.06 (0.96, 1.16) 0.25 GA_samp 1.32 (1.30, 1.35) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.02 (0.84, 1.23) 0.85 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 2.26 0.07 Inf 2.12 2.40 &gt;90th centile SCOPE 2.32 0.17 Inf 2.01 2.68 &lt;=90th centile STOP 2.38 0.07 Inf 2.26 2.52 &gt;90th centile STOP 2.50 0.16 Inf 2.21 2.83 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.03 (0.89, 1.19) 0.7 &gt;90th centile / &lt;=90th centile Study: STOP 1.05 (0.92, 1.19) 0.5 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.06 (0.96, 1.16) 0.3 STOP / SCOPE Birthweight centile: &gt;90th centile 1.08 (0.88, 1.32) 0.5 "],["insulin-13.html", "21.4 Insulin", " 21.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 15.27 (8.60, 27.11) &lt;0.0001 BW_gp&gt;90th centile 1.16 (0.83, 1.62) 0.38 StudySTOP 0.73 (0.61, 0.88) 0.0009 GA_samp 0.99 (0.96, 1.03) 0.74 BW_gp&gt;90th centile:StudySTOP 0.82 (0.56, 1.21) 0.33 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 14.08 0.90 Inf 12.41 15.97 &gt;90th centile SCOPE 16.35 2.72 Inf 11.80 22.67 &lt;=90th centile STOP 10.30 0.47 Inf 9.41 11.27 &gt;90th centile STOP 9.87 1.00 Inf 8.09 12.04 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.16 (0.83, 1.62) 0.4 &gt;90th centile / &lt;=90th centile Study: STOP 0.96 (0.79, 1.17) 0.7 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.73 (0.61, 0.88) 0.0009 STOP / SCOPE Birthweight centile: &gt;90th centile 0.60 (0.41, 0.90) 0.01 "],["homa-ir-13.html", "21.5 HOMA-IR", " 21.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.78 (2.08, 6.88) &lt;0.0001 BW_gp&gt;90th centile 1.20 (0.85, 1.70) 0.30 StudySTOP 0.63 (0.52, 0.77) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.67 BW_gp&gt;90th centile:StudySTOP 0.81 (0.54, 1.21) 0.31 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 3.39 0.23 Inf 2.96 3.87 &gt;90th centile SCOPE 4.07 0.71 Inf 2.89 5.72 &lt;=90th centile STOP 2.15 0.10 Inf 1.96 2.36 &gt;90th centile STOP 2.09 0.22 Inf 1.70 2.58 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.20 (0.85, 1.70) 0.3 &gt;90th centile / &lt;=90th centile Study: STOP 0.97 (0.79, 1.20) 0.8 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.63 (0.52, 0.77) &lt;0.0001 STOP / SCOPE Birthweight centile: &gt;90th centile 0.51 (0.34, 0.78) 0.002 "],["glucose-13.html", "21.6 Glucose", " 21.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.44 (4.89, 6.06) &lt;0.0001 BW_gp&gt;90th centile 1.07 (1.00, 1.13) 0.04 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.80 BW_gp&gt;90th centile:StudySTOP 1.00 (0.91, 1.10) 0.99 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 5.38 0.06 Inf 5.26 5.51 &gt;90th centile SCOPE 5.73 0.17 Inf 5.40 6.08 &lt;=90th centile STOP 4.69 0.04 Inf 4.61 4.76 &gt;90th centile STOP 5.00 0.19 Inf 4.64 5.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.07 (1.00, 1.13) 0.04 &gt;90th centile / &lt;=90th centile Study: STOP 1.07 (0.99, 1.15) 0.10 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.87 (0.84, 0.90) &lt;0.0001 STOP / SCOPE Birthweight centile: &gt;90th centile 0.87 (0.79, 0.96) 0.006 "],["hormone-models-1.html", "22 Hormone Models", " 22 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 22 0 15wks 465 684 "],["raw-plots-1.html", "22.1 Raw plots", " 22.1 Raw plots "],["scope-vs-stop-1.html", "22.2 SCOPE vs STOP", " 22.2 SCOPE vs STOP Fit LME models for Prolactin, HPL and GH2. Fit GEE models for Insulin and HOMA-IR. Outcomes: Prolactin, hPL, GH2, Insulin, HOMA-IR, Glucose (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME or GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       LME only: Random intercepts for Study ID and Plate       GEE only: Independence correlation structure 22.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 8.706512 1 0.003 ** Study 2.244395 1 0.1 ns GA_samp 30.790407 1 &lt;0.0001 *** Study:GA_samp 2.221336 1 0.1 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 46.94900 1 &lt;0.0001 *** Study 21.66283 1 &lt;0.0001 *** GA_samp 94.21469 1 &lt;0.0001 *** Study:GA_samp 25.95307 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 12.13572 1 0.0005 *** Study 16.86104 1 &lt;0.0001 *** GA_samp 53.71079 1 &lt;0.0001 *** Study:GA_samp 17.66908 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 6.440 6.440 0.01 * 3 GA_samp 1 Inf 3.036 3.036 0.08 ns 2 Study:GA_samp 1 Inf 4.677 4.677 0.03 * HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 7.472 7.472 0.006 ** 3 GA_samp 1 Inf 3.420 3.420 0.06 ns 2 Study:GA_samp 1 Inf 4.874 4.874 0.03 * Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 0.232 0.232 0.6 ns 3 GA_samp 1 Inf 0.008 0.008 0.9 ns 2 Study:GA_samp 1 Inf 0.111 0.111 0.7 ns 22.2.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 1.72 (0.58, 2.87) 0.003 StudySTOP 0.91 (-0.28, 2.10) 0.13 GA_samp 0.21 (0.13, 0.28) &lt;0.0001 StudySTOP:GA_samp -0.06 (-0.14, 0.02) 0.14 hPL (μg/ml) Var Effect P (Intercept) 2.14 (1.52, 2.76) &lt;0.0001 StudySTOP -1.51 (-2.15, -0.87) &lt;0.0001 GA_samp 0.20 (0.16, 0.24) &lt;0.0001 StudySTOP:GA_samp 0.11 (0.07, 0.15) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) -1.33 (-2.10, -0.56) 0.0005 StudySTOP -1.64 (-2.45, -0.83) &lt;0.0001 GA_samp 0.18 (0.13, 0.23) &lt;0.0001 StudySTOP:GA_samp 0.11 (0.06, 0.17) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 4.31 (2.75, 5.87) &lt;0.0001 StudySTOP -2.10 (-3.73, -0.48) 0.01 GA_samp -0.11 (-0.21, -0.01) 0.04 StudySTOP:GA_samp 0.12 (0.01, 0.23) 0.03 HOMA-IR Var Effect P (Intercept) 3.01 (1.39, 4.64) 0.0003 StudySTOP -2.36 (-4.05, -0.67) 0.006 GA_samp -0.12 (-0.22, -0.01) 0.03 StudySTOP:GA_samp 0.13 (0.01, 0.24) 0.03 Glucose (mmol/L) Var Effect P (Intercept) 1.67 (1.34, 1.99) &lt;0.0001 StudySTOP -0.08 (-0.42, 0.26) 0.63 GA_samp 0.00 (-0.02, 0.02) 0.90 StudySTOP:GA_samp -0.00 (-0.03, 0.02) 0.74 22.2.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. PRL (ng/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 44.67877 9.765118 775.60673 29.09173 68.61720 STOP 10 60.90187 4.717695 79.27188 52.20009 71.05425 SCOPE 16 155.26985 12.165875 82.42309 132.86150 181.45757 STOP 16 147.84441 14.552006 197.53829 121.76053 179.51605 hPL (μg/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 60.06118 6.777997 1013.3294 48.13041 74.94940 STOP 10 39.61791 1.055110 108.7181 37.58090 41.76535 SCOPE 16 194.04839 5.259046 113.7242 183.90473 204.75155 STOP 16 247.31102 10.211412 486.6536 228.03943 268.21126 GH2 (ng/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 1.600762 0.2192977 433.4993 1.222895 2.095387 STOP 10 0.948957 0.0264086 216.5576 0.898308 1.002462 SCOPE 16 4.703807 0.1314798 197.9604 4.451542 4.970366 STOP 16 5.462550 0.2814179 922.9232 4.937259 6.043728 Insulin (uU/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 25.31505 7.1937998 Inf 14.504141 44.18404 STOP 10 10.17569 0.4433112 Inf 9.342878 11.08274 SCOPE 16 13.27781 0.7140309 Inf 11.949565 14.75370 STOP 16 10.90728 1.0191172 Inf 9.082069 13.09930 HOMA-IR Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 6.371755 1.8874508 Inf 3.565455 11.386841 STOP 10 2.137866 0.0979181 Inf 1.954312 2.338660 SCOPE 16 3.173325 0.1800916 Inf 2.839275 3.546678 STOP 16 2.273611 0.2215450 Inf 1.878337 2.752067 Glucose (mmol/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 5.361853 0.3217762 Inf 4.766861 6.031111 STOP 10 4.750210 0.0569715 Inf 4.639850 4.863194 SCOPE 16 5.406086 0.0560985 Inf 5.297246 5.517163 STOP 16 4.682279 0.0697641 Inf 4.547522 4.821030 22.2.5 Comparisons Hormone Contrast GA_samp Ratio of Geometric means (95% CI) P-value PRL (ng/ml) STOP / SCOPE 10 1.36 (0.90, 2.07) 0.1 PRL (ng/ml) STOP / SCOPE 16 0.95 (0.81, 1.11) 0.5 hPL (μg/ml) STOP / SCOPE 10 0.66 (0.53, 0.82) 0.0003 hPL (μg/ml) STOP / SCOPE 16 1.27 (1.18, 1.38) &lt;0.0001 GH2 (ng/ml) STOP / SCOPE 10 0.59 (0.45, 0.78) 0.0002 GH2 (ng/ml) STOP / SCOPE 16 1.16 (1.04, 1.29) 0.007 Insulin (uU/ml) STOP / SCOPE 10 0.40 (0.23, 0.71) 0.002 Insulin (uU/ml) STOP / SCOPE 16 0.82 (0.67, 1.01) 0.07 HOMA-IR STOP / SCOPE 10 0.34 (0.19, 0.60) 0.0003 HOMA-IR STOP / SCOPE 16 0.72 (0.57, 0.89) 0.003 Glucose (mmol/L) STOP / SCOPE 10 0.89 (0.79, 1.00) 0.05 Glucose (mmol/L) STOP / SCOPE 16 0.87 (0.84, 0.90) &lt;0.0001 22.2.6 Barplots by Study Barplots in this section may be misleading due to involvement of Study by GA interaction. 22.2.7 Plots for GA "],["folate-1.html", "22.3 Folate", " 22.3 Folate 22.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 129.2308225 1 &lt;0.0001 *** Folate 2.0006170 1 0.2 ns Study 0.5519894 1 0.5 ns GA_samp 130.9134873 1 &lt;0.0001 *** Folate:Study 2.1143312 1 0.1 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 32.2090781 1 &lt;0.0001 *** Folate 0.1917908 1 0.7 ns Study 8.1357120 1 0.004 ** GA_samp 1633.8508884 1 &lt;0.0001 *** Folate:Study 0.0205584 1 0.9 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 329.3390138 1 &lt;0.0001 *** Folate 0.4074204 1 0.5 ns Study 1.3523959 1 0.2 ns GA_samp 806.7098807 1 &lt;0.0001 *** Folate:Study 1.0842100 1 0.3 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 8.298 8.298 0.004 ** 3 Study 1 Inf 11.103 11.103 0.0009 *** 4 GA_samp 1 Inf 0.126 0.126 0.7 ns 2 Folate:Study 1 Inf 1.122 1.122 0.3 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 8.507 8.507 0.004 ** 3 Study 1 Inf 19.086 19.086 &lt;0.0001 *** 4 GA_samp 1 Inf 0.220 0.220 0.6 ns 2 Folate:Study 1 Inf 1.183 1.183 0.3 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 0.001 0.001 1.0 ns 3 Study 1 Inf 42.997 42.997 &lt;0.0001 *** 4 GA_samp 1 Inf 0.215 0.215 0.6 ns 2 Folate:Study 1 Inf 1.230 1.230 0.3 ns 22.3.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 12.75 (8.19, 19.85) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.69 StudySTOP 1.02 (0.89, 1.16) 0.83 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.94 (1.54, 2.43) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.59 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.72 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 17.06 (9.66, 30.13) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.006 StudySTOP 0.72 (0.60, 0.86) 0.0004 GA_samp 0.99 (0.96, 1.03) 0.72 HOMA-IR Var Effect P (Intercept) 4.28 (2.37, 7.76) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.006 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.64 Glucose (mmol/L) Var Effect P (Intercept) 5.56 (4.99, 6.19) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.96 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.60 22.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 96.09899 7.956285 102.42390 81.54608 113.2491 STOP 97.55176 7.571251 79.54175 83.58929 113.8465 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.84074 2.658071 185.6178 84.74693 95.24072 STOP 102.82324 2.703799 116.2500 97.60520 108.32023 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.275956 0.0759402 410.0751 2.131466 2.430241 STOP 2.346964 0.0644066 219.8201 2.223402 2.477393 Insulin (uU/L) Study response SE df asymp.LCL asymp.UCL SCOPE 14.58196 0.9172011 Inf 12.890676 16.49515 STOP 10.49963 0.4816931 Inf 9.596731 11.48748 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.525574 0.2354573 Inf 3.093014 4.018628 STOP 2.195501 0.1052510 Inf 1.998608 2.411792 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.423416 0.0681547 Inf 5.291467 5.558655 STOP 4.715630 0.0419170 Inf 4.634186 4.798506 22.3.4 Comparisons Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.7 PRL (ng/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.7 hPL (μg/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.6 hPL (μg/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.6 GH2 (ng/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.7 GH2 (ng/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.7 Insulin (uU/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.006 Insulin (uU/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.006 HOMA-IR Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.006 HOMA-IR Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.006 Glucose (mmol/L) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 1.0 Glucose (mmol/L) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 1.0 22.3.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.3.6 Plots "],["folate-categories.html", "22.4 Folate (categories)", " 22.4 Folate (categories) Folate range (&lt;45.3 vs &gt;=45.3) 22.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 130.8498286 1 &lt;0.0001 *** Folate_gp 1.5474194 1 0.2 ns Study 0.0028985 1 1.0 ns GA_samp 129.9037148 1 &lt;0.0001 *** Folate_gp:Study 0.1873616 1 0.7 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 31.8026411 1 &lt;0.0001 *** Folate_gp 0.5247425 1 0.5 ns Study 15.3487117 1 &lt;0.0001 *** GA_samp 1637.3958932 1 &lt;0.0001 *** Folate_gp:Study 1.3445950 1 0.2 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 340.5884144 1 &lt;0.0001 *** Folate_gp 0.8284085 1 0.4 ns Study 0.9187959 1 0.3 ns GA_samp 809.0684784 1 &lt;0.0001 *** Folate_gp:Study 1.6021790 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 4.454 4.454 0.03 * 3 Study 1 Inf 10.576 10.576 0.001 ** 4 GA_samp 1 Inf 0.113 0.113 0.7 ns 2 Folate_gp:Study 1 Inf 0.585 0.585 0.4 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 3.940 3.940 0.05 ns 3 Study 1 Inf 20.069 20.069 &lt;0.0001 *** 4 GA_samp 1 Inf 0.199 0.199 0.7 ns 2 Folate_gp:Study 1 Inf 0.723 0.723 0.4 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 0.361 0.361 0.5 ns 3 Study 1 Inf 53.217 53.217 &lt;0.0001 *** 4 GA_samp 1 Inf 0.198 0.198 0.7 ns 2 Folate_gp:Study 1 Inf 1.123 1.123 0.3 ns 22.4.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 12.92 (8.33, 20.02) &lt;0.0001 Folate_gp≥45.3 0.93 (0.86, 1.02) 0.14 StudySTOP 1.01 (0.88, 1.16) 0.86 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.92 (1.54, 2.41) &lt;0.0001 Folate_gp≥45.3 0.99 (0.95, 1.04) 0.75 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 Folate_gp≥45.3 0.99 (0.93, 1.06) 0.87 StudySTOP 1.03 (0.94, 1.13) 0.53 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 16.05 (9.08, 28.36) &lt;0.0001 Folate_gp≥45.3 0.88 (0.79, 0.99) 0.04 StudySTOP 0.71 (0.60, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.74 HOMA-IR Var Effect P (Intercept) 4.00 (2.21, 7.25) &lt;0.0001 Folate_gp≥45.3 0.89 (0.78, 1.00) 0.06 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.66 Glucose (mmol/L) Var Effect P (Intercept) 5.53 (4.97, 6.16) &lt;0.0001 Folate_gp≥45.3 1.01 (0.98, 1.04) 0.42 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.63 22.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 94.28120 7.881276 105.81912 79.88169 111.2764 STOP 95.46369 7.493420 82.64525 81.66396 111.5953 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.55766 2.703633 200.0909 84.38197 95.0508 STOP 102.42476 2.760721 126.5065 97.10473 108.0363 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.270358 0.0783020 457.2962 2.121580 2.429569 STOP 2.339495 0.0664836 239.7681 2.212127 2.474197 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 13.92731 0.8952145 Inf 12.278749 15.79722 STOP 9.94880 0.4661921 Inf 9.075784 10.90579 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.367075 0.2289763 Inf 2.946912 3.847143 STOP 2.078715 0.1024898 Inf 1.887239 2.289617 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.441858 0.0705402 Inf 5.305343 5.581886 STOP 4.733070 0.0429425 Inf 4.649648 4.817988 22.4.4 Comparisons (Overall) Hormone Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) ≥45.3 / &lt;45.3 0.93 (0.86, 1.02) 0.1 hPL (μg/ml) ≥45.3 / &lt;45.3 0.99 (0.95, 1.04) 0.8 GH2 (ng/ml) ≥45.3 / &lt;45.3 0.99 (0.93, 1.06) 0.9 Insulin (uU/ml) ≥45.3 / &lt;45.3 0.88 (0.79, 0.99) 0.04 HOMA-IR ≥45.3 / &lt;45.3 0.89 (0.78, 1.00) 0.06 Glucose (mmol/L) ≥45.3 / &lt;45.3 1.01 (0.98, 1.04) 0.4 22.4.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.4.6 Plots "],["b12-1.html", "22.5 B12", " 22.5 B12 22.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 113.7952111 1 &lt;0.0001 *** B12 0.0039381 1 0.9 ns Study 0.1835478 1 0.7 ns GA_samp 132.0512503 1 &lt;0.0001 *** B12:Study 0.4161577 1 0.5 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 24.428879 1 &lt;0.0001 *** B12 1.133261 1 0.3 ns Study 3.998083 1 0.05 ns GA_samp 1648.072726 1 &lt;0.0001 *** B12:Study 0.017806 1 0.9 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 336.340208 1 &lt;0.0001 *** B12 6.624419 1 0.01 * Study 1.872150 1 0.2 ns GA_samp 815.254269 1 &lt;0.0001 *** B12:Study 1.840691 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 4.297 4.297 0.04 * 3 Study 1 Inf 7.878 7.878 0.005 ** 4 GA_samp 1 Inf 0.122 0.122 0.7 ns 2 B12:Study 1 Inf 1.131 1.131 0.3 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 3.806 3.806 0.05 ns 3 Study 1 Inf 11.788 11.788 0.0006 *** 4 GA_samp 1 Inf 0.209 0.209 0.6 ns 2 B12:Study 1 Inf 1.079 1.079 0.3 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 2.841 2.841 0.09 ns 3 Study 1 Inf 30.734 30.734 &lt;0.0001 *** 4 GA_samp 1 Inf 0.333 0.333 0.6 ns 2 B12:Study 1 Inf 0.595 0.595 0.4 ns 22.5.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 12.05 (7.69, 18.87) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.41 StudySTOP 1.01 (0.88, 1.16) 0.87 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.81 (1.44, 2.28) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.04 StudySTOP 1.14 (1.06, 1.22) 0.0003 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.01 StudySTOP 1.02 (0.93, 1.12) 0.66 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 18.19 (9.98, 33.15) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.04 StudySTOP 0.72 (0.60, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.71 HOMA-IR Var Effect P (Intercept) 4.54 (2.43, 8.49) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.06 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.63 Glucose (mmol/L) Var Effect P (Intercept) 5.67 (5.09, 6.31) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.10 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.57 22.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 96.44883 7.991495 103.34357 81.83386 113.6739 STOP 97.57641 7.546418 78.86473 83.65432 113.8155 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 90.37671 2.675871 190.0294 85.24966 95.81211 STOP 102.98997 2.681540 114.0150 97.81254 108.44145 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.305636 0.0775524 424.6029 2.158132 2.463223 STOP 2.354790 0.0636642 207.0318 2.232563 2.483709 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.15732 0.8882227 Inf 12.519214 16.00976 STOP 10.17033 0.4597934 Inf 9.307926 11.11264 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.420104 0.2279209 Inf 3.001332 3.897308 STOP 2.123460 0.1003240 Inf 1.935658 2.329483 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.406117 0.0673630 Inf 5.275688 5.539772 STOP 4.711955 0.0397875 Inf 4.634615 4.790586 22.5.4 Comparisons Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) B12363.5 / B12263.5 SCOPE 1.01 (0.98, 1.05) 0.4 PRL (ng/ml) B12363.5 / B12263.5 STOP 1.01 (0.98, 1.05) 0.4 hPL (μg/ml) B12363.5 / B12263.5 SCOPE 1.02 (1.00, 1.04) 0.04 hPL (μg/ml) B12363.5 / B12263.5 STOP 1.02 (1.00, 1.04) 0.04 GH2 (ng/ml) B12363.5 / B12263.5 SCOPE 1.03 (1.01, 1.05) 0.01 GH2 (ng/ml) B12363.5 / B12263.5 STOP 1.03 (1.01, 1.05) 0.01 Insulin (uU/ml) B12363.5 / B12263.5 SCOPE 0.95 (0.91, 1.00) 0.04 Insulin (uU/ml) B12363.5 / B12263.5 STOP 0.95 (0.91, 1.00) 0.04 HOMA-IR B12363.5 / B12263.5 SCOPE 0.95 (0.90, 1.00) 0.06 HOMA-IR B12363.5 / B12263.5 STOP 0.95 (0.90, 1.00) 0.06 Glucose (mmol/L) B12363.5 / B12263.5 SCOPE 0.99 (0.99, 1.00) 0.10 Glucose (mmol/L) B12363.5 / B12263.5 STOP 0.99 (0.99, 1.00) 0.10 22.5.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 96.12350 7.943488 102.26730 81.59159 113.2436 STOP 97.24727 7.514380 78.60051 83.38271 113.4172 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.98138 2.648226 185.8123 84.90570 95.36048 STOP 102.53947 2.664550 113.1569 97.39417 107.95658 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.288290 0.0761590 410.6529 2.143372 2.443006 STOP 2.337074 0.0630674 206.3572 2.215985 2.464780 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.33738 0.8943328 Inf 12.687433 16.20189 STOP 10.29968 0.4592552 Inf 9.437771 11.24031 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.463888 0.2293611 Inf 3.042297 3.943901 STOP 2.150644 0.1002700 Inf 1.962830 2.356429 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.415384 0.0667619 Inf 5.286101 5.547829 STOP 4.720032 0.0401342 Inf 4.642022 4.799353 22.5.6 Comparisons (50 unit increase) Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) B12313.5 / B12263.5 SCOPE 1.01 (0.99, 1.02) 0.4 PRL (ng/ml) B12313.5 / B12263.5 STOP 1.01 (0.99, 1.02) 0.4 hPL (μg/ml) B12313.5 / B12263.5 SCOPE 1.01 (1.00, 1.02) 0.04 hPL (μg/ml) B12313.5 / B12263.5 STOP 1.01 (1.00, 1.02) 0.04 GH2 (ng/ml) B12313.5 / B12263.5 SCOPE 1.02 (1.00, 1.03) 0.01 GH2 (ng/ml) B12313.5 / B12263.5 STOP 1.02 (1.00, 1.03) 0.01 Insulin (uU/ml) B12313.5 / B12263.5 SCOPE 0.98 (0.95, 1.00) 0.04 Insulin (uU/ml) B12313.5 / B12263.5 STOP 0.98 (0.95, 1.00) 0.04 HOMA-IR B12313.5 / B12263.5 SCOPE 0.97 (0.95, 1.00) 0.06 HOMA-IR B12313.5 / B12263.5 STOP 0.97 (0.95, 1.00) 0.06 Glucose (mmol/L) B12313.5 / B12263.5 SCOPE 1.00 (0.99, 1.00) 0.10 Glucose (mmol/L) B12313.5 / B12263.5 STOP 1.00 (0.99, 1.00) 0.10 22.5.7 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.5.8 Plots "],["folateb12-1.html", "22.6 Folate:B12", " 22.6 Folate:B12 22.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 131.619724 1 &lt;0.0001 *** folate_B12 2.967510 1 0.08 ns Study 1.329267 1 0.2 ns GA_samp 131.577880 1 &lt;0.0001 *** folate_B12:Study 5.013235 1 0.03 * hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 32.3040552 1 &lt;0.0001 *** folate_B12 0.1638235 1 0.7 ns Study 9.3893442 1 0.002 ** GA_samp 1638.1363304 1 &lt;0.0001 *** folate_B12:Study 0.0023293 1 1.0 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 320.4006010 1 &lt;0.0001 *** folate_B12 1.3497714 1 0.2 ns Study 0.1266652 1 0.7 ns GA_samp 807.9421439 1 &lt;0.0001 *** folate_B12:Study 0.0677801 1 0.8 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.333 0.333 0.6 ns 3 Study 1 Inf 9.600 9.600 0.002 ** 4 GA_samp 1 Inf 0.076 0.076 0.8 ns 2 folate_B12:Study 1 Inf 0.120 0.120 0.7 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.406 0.406 0.5 ns 3 Study 1 Inf 17.721 17.721 &lt;0.0001 *** 4 GA_samp 1 Inf 0.153 0.153 0.7 ns 2 folate_B12:Study 1 Inf 0.217 0.217 0.6 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.412 0.412 0.5 ns 3 Study 1 Inf 44.737 44.737 &lt;0.0001 *** 4 GA_samp 1 Inf 0.213 0.213 0.6 ns 2 folate_B12:Study 1 Inf 1.231 1.231 0.3 ns 22.6.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 13.46 (8.64, 20.98) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.09 StudySTOP 0.91 (0.77, 1.07) 0.25 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 folate_B12:StudySTOP 1.00 (1.00, 1.00) 0.03 hPL (μg/ml) Var Effect P (Intercept) 1.94 (1.55, 2.43) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.49 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.13 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 15.64 (8.87, 27.58) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.60 StudySTOP 0.71 (0.59, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.79 HOMA-IR Var Effect P (Intercept) 3.91 (2.16, 7.07) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.58 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.96, 1.03) 0.70 Glucose (mmol/L) Var Effect P (Intercept) 5.53 (4.96, 6.16) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.57 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.61 22.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 95.45434 7.888834 102.11034 81.02226 112.4571 STOP 97.32665 7.521490 78.50036 83.44885 113.5124 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.70666 2.645779 184.2667 84.63571 95.08143 STOP 102.63004 2.675395 112.7167 97.46401 108.06989 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.271708 0.0755750 406.0961 2.127895 2.425241 STOP 2.342068 0.0633228 205.9442 2.220493 2.470299 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.41229 0.9070753 Inf 12.739738 16.30443 STOP 10.28088 0.4603074 Inf 9.417142 11.22383 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.481303 0.2322185 Inf 3.05466 3.967535 STOP 2.146647 0.1004986 Inf 1.95844 2.352940 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.423639 0.0673084 Inf 5.293309 5.557179 STOP 4.717079 0.0405035 Inf 4.638358 4.797136 22.6.4 Comparisons Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) folate_B12247.58 / folate_B12147.58 SCOPE 0.96 (0.93, 1.01) 0.09 PRL (ng/ml) folate_B12247.58 / folate_B12147.58 STOP 1.02 (0.99, 1.06) 0.2 hPL (μg/ml) folate_B12247.58 / folate_B12147.58 SCOPE 1.00 (0.98, 1.01) 0.5 hPL (μg/ml) folate_B12247.58 / folate_B12147.58 STOP 1.00 (0.98, 1.01) 0.5 GH2 (ng/ml) folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.97, 1.00) 0.1 GH2 (ng/ml) folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.97, 1.00) 0.1 Insulin (uU/ml) folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.96, 1.02) 0.6 Insulin (uU/ml) folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.96, 1.02) 0.6 HOMA-IR folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.96, 1.02) 0.6 HOMA-IR folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.96, 1.02) 0.6 Glucose (mmol/L) folate_B12247.58 / folate_B12147.58 SCOPE 1.00 (0.99, 1.01) 0.6 Glucose (mmol/L) folate_B12247.58 / folate_B12147.58 STOP 1.00 (0.99, 1.01) 0.6 22.6.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.6.6 Plots "],["active-b12-1.html", "22.7 Active B12", " 22.7 Active B12 22.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 67.4457733 1 &lt;0.0001 *** Active.B12 0.1176992 1 0.7 ns Study 0.1615703 1 0.7 ns GA_samp 58.6983233 1 &lt;0.0001 *** Active.B12:Study 0.0319285 1 0.9 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 6.1178575 1 0.01 * Active.B12 0.0010379 1 1.0 ns Study 3.0037869 1 0.08 ns GA_samp 832.2474984 1 &lt;0.0001 *** Active.B12:Study 0.0508695 1 0.8 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 193.194888 1 &lt;0.0001 *** Active.B12 1.660906 1 0.2 ns Study 2.898371 1 0.09 ns GA_samp 463.652179 1 &lt;0.0001 *** Active.B12:Study 2.181948 1 0.1 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 0.122 0.122 0.7 ns 3 Study 1 Inf 2.404 2.404 0.1 ns 4 GA_samp 1 Inf 0.098 0.098 0.8 ns 2 Active.B12:Study 1 Inf 0.008 0.008 0.9 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 0.136 0.136 0.7 ns 3 Study 1 Inf 4.369 4.369 0.04 * 4 GA_samp 1 Inf 0.177 0.177 0.7 ns 2 Active.B12:Study 1 Inf 0.023 0.023 0.9 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 1.951 1.951 0.2 ns 3 Study 1 Inf 11.796 11.796 0.0006 *** 4 GA_samp 1 Inf 0.769 0.769 0.4 ns 2 Active.B12:Study 1 Inf 0.057 0.057 0.8 ns 22.7.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 14.66 (7.87, 27.29) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.75 StudySTOP 0.91 (0.76, 1.10) 0.34 GA_samp 1.16 (1.11, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.53 (1.09, 2.15) 0.01 Active.B12 1.00 (1.00, 1.00) 0.75 StudySTOP 1.19 (1.08, 1.32) 0.0008 GA_samp 1.36 (1.33, 1.38) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.03, 0.07) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.81 StudySTOP 1.06 (0.93, 1.20) 0.39 GA_samp 1.33 (1.30, 1.37) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 16.87 (7.76, 36.71) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.74 StudySTOP 0.71 (0.57, 0.90) 0.004 GA_samp 0.99 (0.95, 1.04) 0.75 HOMA-IR Var Effect P (Intercept) 4.28 (1.88, 9.74) 0.0005 Active.B12 1.00 (1.00, 1.00) 0.73 StudySTOP 0.62 (0.48, 0.79) 0.0001 GA_samp 0.99 (0.94, 1.04) 0.67 Glucose (mmol/L) Var Effect P (Intercept) 5.66 (4.96, 6.46) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.16 StudySTOP 0.86 (0.83, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.38 22.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 104.01066 9.614865 132.9306 86.63012 124.8783 STOP 94.94685 8.201065 102.8474 79.99860 112.6883 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 90.59169 3.234625 260.1075 84.44106 97.19032 STOP 107.89007 3.433358 166.1723 101.32000 114.88617 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.293938 0.0976149 313.1236 2.109694 2.494272 STOP 2.425388 0.0890781 204.3571 2.255967 2.607534 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.72221 1.1449052 Inf 12.640885 17.14623 STOP 10.51991 0.6520471 Inf 9.316497 11.87877 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.563678 0.2995429 Inf 3.022395 4.201900 STOP 2.196609 0.1440558 Inf 1.931657 2.497902 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.538397 0.0830353 Inf 5.378018 5.703558 STOP 4.767779 0.0589751 Inf 4.653580 4.884780 22.7.4 Comparisons Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Active.B1270 / Active.B1260 SCOPE 1.00 (0.98, 1.03) 0.7 PRL (ng/ml) Active.B1270 / Active.B1260 STOP 1.00 (0.98, 1.03) 0.7 hPL (μg/ml) Active.B1270 / Active.B1260 SCOPE 1.00 (0.99, 1.01) 0.7 hPL (μg/ml) Active.B1270 / Active.B1260 STOP 1.00 (0.99, 1.01) 0.7 GH2 (ng/ml) Active.B1270 / Active.B1260 SCOPE 1.00 (0.99, 1.02) 0.8 GH2 (ng/ml) Active.B1270 / Active.B1260 STOP 1.00 (0.99, 1.02) 0.8 Insulin (uU/ml) Active.B1270 / Active.B1260 SCOPE 0.99 (0.96, 1.03) 0.7 Insulin (uU/ml) Active.B1270 / Active.B1260 STOP 0.99 (0.96, 1.03) 0.7 HOMA-IR Active.B1270 / Active.B1260 SCOPE 0.99 (0.96, 1.03) 0.7 HOMA-IR Active.B1270 / Active.B1260 STOP 0.99 (0.96, 1.03) 0.7 Glucose (mmol/L) Active.B1270 / Active.B1260 SCOPE 1.01 (1.00, 1.01) 0.2 Glucose (mmol/L) Active.B1270 / Active.B1260 STOP 1.01 (1.00, 1.01) 0.2 22.7.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.7.6 Plots "],["folateactive-b12-1.html", "22.8 Folate:Active B12", " 22.8 Folate:Active B12 22.8.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 81.653013 1 &lt;0.0001 *** folate_Active.B12 2.405026 1 0.1 ns Study 5.359313 1 0.02 * GA_samp 60.136224 1 &lt;0.0001 *** folate_Active.B12:Study 7.831834 1 0.005 ** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 6.7473777 1 0.009 ** folate_Active.B12 0.4492223 1 0.5 ns Study 16.2494864 1 &lt;0.0001 *** GA_samp 843.1941108 1 &lt;0.0001 *** folate_Active.B12:Study 4.5843424 1 0.03 * GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 198.6866206 1 &lt;0.0001 *** folate_Active.B12 1.0610568 1 0.3 ns Study 0.0121323 1 0.9 ns GA_samp 468.3134903 1 &lt;0.0001 *** folate_Active.B12:Study 2.2694976 1 0.1 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 1.589 1.589 0.2 ns 3 Study 1 Inf 8.527 8.527 0.003 ** 4 GA_samp 1 Inf 0.097 0.097 0.8 ns 2 folate_Active.B12:Study 1 Inf 1.432 1.432 0.2 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 1.851 1.851 0.2 ns 3 Study 1 Inf 14.060 14.060 0.0002 *** 4 GA_samp 1 Inf 0.177 0.177 0.7 ns 2 folate_Active.B12:Study 1 Inf 1.383 1.383 0.2 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 4.808 4.808 0.03 * 3 Study 1 Inf 41.897 41.897 &lt;0.0001 *** 4 GA_samp 1 Inf 1.163 1.163 0.3 ns 2 folate_Active.B12:Study 1 Inf 0.226 0.226 0.6 ns 22.8.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 15.95 (8.75, 29.04) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.12 StudySTOP 0.77 (0.62, 0.96) 0.02 GA_samp 1.16 (1.12, 1.20) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.005 hPL (μg/ml) Var Effect P (Intercept) 1.54 (1.11, 2.14) 0.010 folate_Active.B12 1.00 (1.00, 1.00) 0.50 StudySTOP 1.28 (1.13, 1.44) &lt;0.0001 GA_samp 1.36 (1.33, 1.38) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.03 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.03, 0.07) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 1.00 StudySTOP 1.06 (0.93, 1.20) 0.39 GA_samp 1.33 (1.30, 1.37) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 16.90 (8.16, 35.02) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.18 StudySTOP 0.71 (0.57, 0.90) 0.004 GA_samp 0.99 (0.95, 1.04) 0.78 HOMA-IR Var Effect P (Intercept) 4.29 (1.98, 9.31) 0.0002 folate_Active.B12 1.00 (1.00, 1.00) 0.15 StudySTOP 0.62 (0.48, 0.79) 0.0001 GA_samp 0.99 (0.94, 1.04) 0.69 Glucose (mmol/L) Var Effect P (Intercept) 6.04 (5.16, 7.06) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.004 StudySTOP 0.86 (0.83, 0.90) &lt;0.0001 GA_samp 0.99 (0.98, 1.00) 0.28 22.8.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 103.52216 9.538256 132.2925 86.27438 124.2181 STOP 95.26028 8.205226 102.5693 80.30054 113.0070 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 90.58383 3.238948 255.1716 84.42475 97.19225 STOP 107.75515 3.443906 164.9170 101.16542 114.77411 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.292618 0.0973988 309.6921 2.108763 2.492503 STOP 2.425090 0.0890729 203.7927 2.255676 2.607228 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.69993 1.1456949 Inf 12.617509 17.12604 STOP 10.50458 0.6474221 Inf 9.309302 11.85333 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.557729 0.2993955 Inf 3.016764 4.195701 STOP 2.192979 0.1431559 Inf 1.929606 2.492300 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.531632 0.0815836 Inf 5.374020 5.693867 STOP 4.765678 0.0585860 Inf 4.652224 4.881899 22.8.4 Comparisons Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.96 (0.92, 1.01) 0.1 PRL (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 1.06 (1.01, 1.12) 0.02 hPL (μg/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 1.01 (0.98, 1.04) 0.5 hPL (μg/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.94, 1.00) 0.02 GH2 (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 1.00 (0.98, 1.02) 1.0 GH2 (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 1.00 (0.98, 1.02) 1.0 Insulin (uU/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.97 (0.93, 1.01) 0.2 Insulin (uU/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.93, 1.01) 0.2 HOMA-IR folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.97 (0.93, 1.01) 0.1 HOMA-IR folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.93, 1.01) 0.1 Glucose (mmol/L) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.99 (0.99, 1.00) 0.004 Glucose (mmol/L) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.99 (0.99, 1.00) 0.004 22.8.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.8.6 Plots "],["homocysteine-1.html", "22.9 Homocysteine", " 22.9 Homocysteine 22.9.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 117.9823128 1 &lt;0.0001 *** Homocysteine 2.2161224 1 0.1 ns Study 0.0338807 1 0.9 ns GA_samp 122.0902307 1 &lt;0.0001 *** Homocysteine:Study 0.0959458 1 0.8 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 31.1427141 1 &lt;0.0001 *** Homocysteine 0.6346316 1 0.4 ns Study 3.0978882 1 0.08 ns GA_samp 1551.6084962 1 &lt;0.0001 *** Homocysteine:Study 0.0725759 1 0.8 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 239.2035022 1 &lt;0.0001 *** Homocysteine 1.5409841 1 0.2 ns Study 0.8917925 1 0.3 ns GA_samp 785.9602453 1 &lt;0.0001 *** Homocysteine:Study 1.7161585 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.759 0.759 0.4 ns 3 Study 1 Inf 1.868 1.868 0.2 ns 4 GA_samp 1 Inf 0.138 0.138 0.7 ns 2 Homocysteine:Study 1 Inf 0.001 0.001 1.0 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.548 0.548 0.5 ns 3 Study 1 Inf 3.470 3.470 0.06 ns 4 GA_samp 1 Inf 0.210 0.210 0.6 ns 2 Homocysteine:Study 1 Inf 0.000 0.000 1.0 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.136 0.136 0.7 ns 3 Study 1 Inf 4.358 4.358 0.04 * 4 GA_samp 1 Inf 0.348 0.348 0.6 ns 2 Homocysteine:Study 1 Inf 0.290 0.290 0.6 ns 22.9.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 15.39 (9.51, 24.91) &lt;0.0001 Homocysteine 0.97 (0.94, 1.00) 0.05 StudySTOP 1.02 (0.89, 1.16) 0.81 GA_samp 1.16 (1.13, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 2.09 (1.63, 2.68) &lt;0.0001 Homocysteine 0.99 (0.97, 1.00) 0.12 StudySTOP 1.14 (1.06, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.04, 0.09) &lt;0.0001 Homocysteine 1.00 (0.97, 1.02) 0.71 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 17.53 (9.25, 33.20) &lt;0.0001 Homocysteine 0.98 (0.93, 1.03) 0.36 StudySTOP 0.71 (0.60, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.71 HOMA-IR Var Effect P (Intercept) 4.31 (2.21, 8.39) &lt;0.0001 Homocysteine 0.98 (0.93, 1.03) 0.44 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.64 Glucose (mmol/L) Var Effect P (Intercept) 5.63 (4.88, 6.50) &lt;0.0001 Homocysteine 1.00 (0.99, 1.01) 0.67 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.59 22.9.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 95.14832 7.868709 102.32772 80.75415 112.1082 STOP 96.72139 7.491155 79.16093 82.90351 112.8424 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.48048 2.644842 186.9890 84.41212 94.85316 STOP 102.27292 2.678403 115.6379 97.10307 107.71801 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.271353 0.0759250 408.5979 2.126899 2.425619 STOP 2.342118 0.0640575 213.6254 2.219195 2.471849 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.32849 0.9049166 Inf 12.660262 16.21653 STOP 10.23459 0.4633987 Inf 9.365476 11.18435 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.462311 0.2324445 Inf 3.035429 3.949226 STOP 2.138542 0.1012539 Inf 1.949018 2.346496 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.418600 0.0647559 Inf 5.293156 5.547017 STOP 4.712809 0.0395282 Inf 4.635969 4.790924 22.9.4 Comparisons Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 0.97 (0.94, 1.00) 0.05 PRL (ng/ml) Homocysteine5.6 / Homocysteine4.6 STOP 0.97 (0.94, 1.00) 0.05 hPL (μg/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 0.99 (0.97, 1.00) 0.1 hPL (μg/ml) Homocysteine5.6 / Homocysteine4.6 STOP 0.99 (0.97, 1.00) 0.1 GH2 (ng/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 1.00 (0.97, 1.02) 0.7 GH2 (ng/ml) Homocysteine5.6 / Homocysteine4.6 STOP 1.00 (0.97, 1.02) 0.7 Insulin (uU/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 0.98 (0.93, 1.03) 0.4 Insulin (uU/ml) Homocysteine5.6 / Homocysteine4.6 STOP 0.98 (0.93, 1.03) 0.4 HOMA-IR Homocysteine5.6 / Homocysteine4.6 SCOPE 0.98 (0.93, 1.03) 0.4 HOMA-IR Homocysteine5.6 / Homocysteine4.6 STOP 0.98 (0.93, 1.03) 0.4 Glucose (mmol/L) Homocysteine5.6 / Homocysteine4.6 SCOPE 1.00 (0.99, 1.01) 0.7 Glucose (mmol/L) Homocysteine5.6 / Homocysteine4.6 STOP 1.00 (0.99, 1.01) 0.7 22.9.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.9.6 Plots "],["red-cell-folate.html", "22.10 Red cell folate", " 22.10 Red cell folate 22.10.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 43.64894 1 &lt;0.0001 *** ns(rcfolate, 3) 5.76169 3 0.1 ns GA_samp 70.48397 1 &lt;0.0001 *** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 10.1918551 1 0.001 ** ns(rcfolate, 3) 0.1840576 3 1.0 ns GA_samp 1109.0784596 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 94.062933 1 &lt;0.0001 *** ns(rcfolate, 3) 6.776213 3 0.08 ns GA_samp 558.762160 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.363 0.363 0.5 ns GA_samp 1 Inf 0.389 0.389 0.5 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.345 0.345 0.6 ns GA_samp 1 Inf 0.266 0.266 0.6 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.171 0.171 0.7 ns GA_samp 1 Inf 1.236 1.236 0.3 ns 22.10.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 17.37 (7.46, 40.43) &lt;0.0001 ns(rcfolate, 3)1 0.80 (0.49, 1.32) 0.39 ns(rcfolate, 3)2 0.89 (0.18, 4.41) 0.89 ns(rcfolate, 3)3 1.01 (0.80, 1.27) 0.92 GA_samp 1.15 (1.11, 1.18) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 2.13 (1.34, 3.40) 0.001 ns(rcfolate, 3)1 0.95 (0.72, 1.25) 0.72 ns(rcfolate, 3)2 0.87 (0.36, 2.10) 0.75 ns(rcfolate, 3)3 0.99 (0.87, 1.12) 0.86 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.04 (0.02, 0.08) &lt;0.0001 ns(rcfolate, 3)1 0.93 (0.64, 1.37) 0.73 ns(rcfolate, 3)2 1.52 (0.44, 5.27) 0.51 ns(rcfolate, 3)3 0.90 (0.75, 1.07) 0.24 GA_samp 1.35 (1.32, 1.38) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 11.14 (4.71, 26.36) &lt;0.0001 ns(rcfolate, 3)1 0.80 (0.48, 1.31) 0.37 ns(rcfolate, 3)2 0.65 (0.13, 3.15) 0.59 ns(rcfolate, 3)3 1.07 (0.85, 1.35) 0.57 GA_samp 1.01 (0.97, 1.06) 0.53 HOMA-IR Var Effect P (Intercept) 2.42 (0.93, 6.32) 0.07 ns(rcfolate, 3)1 0.79 (0.45, 1.38) 0.41 ns(rcfolate, 3)2 0.63 (0.10, 3.76) 0.61 ns(rcfolate, 3)3 1.09 (0.85, 1.40) 0.50 GA_samp 1.01 (0.97, 1.06) 0.61 Glucose (mmol/L) Var Effect P (Intercept) 5.04 (4.04, 6.30) &lt;0.0001 ns(rcfolate, 3)1 1.00 (0.88, 1.13) 1.00 ns(rcfolate, 3)2 0.96 (0.60, 1.52) 0.86 ns(rcfolate, 3)3 1.06 (1.00, 1.13) 0.05 GA_samp 1.00 (0.99, 1.00) 0.27 22.10.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.10.4 Plots "],["red-cell-folate-categories.html", "22.11 Red cell folate (categories)", " 22.11 Red cell folate (categories) Within reference ranges (360 to 1400 vs &gt;1400). 22.11.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 176.5298310 1 &lt;0.0001 *** rcfolate_gp 0.0020879 1 1.0 ns GA_samp 75.7290268 1 &lt;0.0001 *** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 41.4726214 1 &lt;0.0001 *** rcfolate_gp 0.2775494 1 0.6 ns GA_samp 1126.6013558 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 420.04231 1 &lt;0.0001 *** rcfolate_gp 6.18705 1 0.01 * GA_samp 572.93929 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 0.418 0.418 0.5 ns GA_samp 1 Inf 0.761 0.761 0.4 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 0.435 0.435 0.5 ns GA_samp 1 Inf 0.646 0.646 0.4 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 4.135 4.135 0.04 * GA_samp 1 Inf 0.457 0.457 0.5 ns 22.11.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 14.79 (9.94, 22.00) &lt;0.0001 rcfolate_gp&gt;1400 1.00 (0.90, 1.11) 0.96 GA_samp 1.15 (1.12, 1.19) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.98 (1.61, 2.44) &lt;0.0001 rcfolate_gp&gt;1400 1.02 (0.96, 1.08) 0.60 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.04, 0.06) &lt;0.0001 rcfolate_gp&gt;1400 0.90 (0.83, 0.98) 0.01 GA_samp 1.35 (1.32, 1.39) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 8.11 (5.00, 13.13) &lt;0.0001 rcfolate_gp&gt;1400 1.04 (0.92, 1.19) 0.52 GA_samp 1.02 (0.98, 1.06) 0.38 HOMA-IR Var Effect P (Intercept) 1.71 (1.04, 2.82) 0.03 rcfolate_gp&gt;1400 1.05 (0.91, 1.20) 0.51 GA_samp 1.02 (0.97, 1.06) 0.42 Glucose (mmol/L) Var Effect P (Intercept) 4.78 (4.35, 5.25) &lt;0.0001 rcfolate_gp&gt;1400 1.04 (1.00, 1.07) 0.04 GA_samp 1.00 (0.99, 1.00) 0.50 22.11.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.11.4 Estimated marginal means Outcome rcfolate_gp response SE df lower.CL upper.CL PRL (ng/ml) 360 to 1400 74.847 6.442 75.895 63.057 88.843 PRL (ng/ml) &gt;1400 74.659 6.331 71.843 63.048 88.409 hPL (μg/ml) 360 to 1400 61.851 2.053 74.734 57.894 66.078 hPL (μg/ml) &gt;1400 62.844 2.025 67.509 58.930 67.018 GH2 (ng/ml) 360 to 1400 1.529 0.063 96.552 1.410 1.658 GH2 (ng/ml) &gt;1400 1.378 0.054 85.205 1.274 1.490 Insulin (uU/ml) 360 to 1400 10.052 0.468 Inf 9.176 11.013 Insulin (uU/ml) &gt;1400 10.498 0.504 Inf 9.556 11.533 HOMA-IR 360 to 1400 2.104 0.102 Inf 1.913 2.314 HOMA-IR &gt;1400 2.204 0.112 Inf 1.996 2.434 Glucose (mmol/L) 360 to 1400 4.648 0.056 Inf 4.540 4.759 Glucose (mmol/L) &gt;1400 4.818 0.062 Inf 4.698 4.941 22.11.5 Plots 22.11.6 Post-hoc comparisons Outcome Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) &gt;1400 / 360 to 1400 1.00 (0.90, 1.11) 1.0 hPL (μg/ml) &gt;1400 / 360 to 1400 1.02 (0.96, 1.08) 0.6 GH2 (ng/ml) &gt;1400 / 360 to 1400 0.90 (0.83, 0.98) 0.01 Insulin (uU/ml) &gt;1400 / 360 to 1400 1.04 (0.92, 1.19) 0.5 HOMA-IR &gt;1400 / 360 to 1400 1.05 (0.91, 1.20) 0.5 Glucose (mmol/L) &gt;1400 / 360 to 1400 1.04 (1.00, 1.07) 0.04 "],["red-cell-folate-categories-2.html", "22.12 Red cell folate (categories 2)", " 22.12 Red cell folate (categories 2) Over detection limit (360 to 1789 vs &gt;=1790). 22.12.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 180.256937 1 &lt;0.0001 *** rcfolate_gp2 4.092289 1 0.04 * GA_samp 71.304099 1 &lt;0.0001 *** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 42.3880663 1 &lt;0.0001 *** rcfolate_gp2 0.2369317 1 0.6 ns GA_samp 1115.0372969 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 424.0485398 1 &lt;0.0001 *** rcfolate_gp2 0.0362665 1 0.8 ns GA_samp 553.8496342 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 5.039 5.039 0.02 * GA_samp 1 Inf 0.370 0.370 0.5 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 5.570 5.570 0.02 * GA_samp 1 Inf 0.271 0.271 0.6 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 4.972 4.972 0.03 * GA_samp 1 Inf 1.108 1.108 0.3 ns 22.12.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 15.04 (10.13, 22.34) &lt;0.0001 rcfolate_gp2≥1790 1.14 (1.00, 1.29) 0.04 GA_samp 1.15 (1.11, 1.18) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 2.00 (1.62, 2.46) &lt;0.0001 rcfolate_gp2≥1790 1.02 (0.95, 1.09) 0.63 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.03, 0.06) &lt;0.0001 rcfolate_gp2≥1790 0.99 (0.90, 1.09) 0.85 GA_samp 1.35 (1.32, 1.38) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 8.46 (5.22, 13.72) &lt;0.0001 rcfolate_gp2≥1790 1.23 (1.03, 1.47) 0.02 GA_samp 1.01 (0.97, 1.06) 0.54 HOMA-IR Var Effect P (Intercept) 1.80 (1.09, 2.96) 0.02 rcfolate_gp2≥1790 1.25 (1.04, 1.51) 0.02 GA_samp 1.01 (0.97, 1.06) 0.60 Glucose (mmol/L) Var Effect P (Intercept) 4.89 (4.46, 5.36) &lt;0.0001 rcfolate_gp2≥1790 1.06 (1.01, 1.12) 0.03 GA_samp 1.00 (0.99, 1.00) 0.29 22.12.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 22.12.4 Estimated marginal means Outcome rcfolate_gp2 response SE df lower.CL upper.CL PRL (ng/ml) 360 to 1789 72.674 5.958 63.383 61.693 85.609 PRL (ng/ml) ≥1790 82.714 7.863 110.212 68.511 99.861 hPL (μg/ml) 360 to 1789 62.143 1.865 51.975 58.510 66.001 hPL (μg/ml) ≥1790 63.218 2.526 144.272 58.417 68.414 GH2 (ng/ml) 360 to 1789 1.449 0.052 61.530 1.348 1.558 GH2 (ng/ml) ≥1790 1.435 0.075 206.783 1.295 1.590 Insulin (uU/ml) 360 to 1789 9.833 0.351 Inf 9.168 10.545 Insulin (uU/ml) ≥1790 12.070 1.012 Inf 10.241 14.226 HOMA-IR 360 to 1789 2.052 0.077 Inf 1.906 2.210 HOMA-IR ≥1790 2.570 0.224 Inf 2.166 3.050 Glucose (mmol/L) 360 to 1789 4.669 0.039 Inf 4.593 4.747 Glucose (mmol/L) ≥1790 4.954 0.125 Inf 4.715 5.204 22.12.5 Plots 22.12.6 Post-hoc comparisons Outcome Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) ≥1790 / 360 to 1789 1.14 (1.00, 1.29) 0.04 hPL (μg/ml) ≥1790 / 360 to 1789 1.02 (0.95, 1.09) 0.6 GH2 (ng/ml) ≥1790 / 360 to 1789 0.99 (0.90, 1.09) 0.8 Insulin (uU/ml) ≥1790 / 360 to 1789 1.23 (1.03, 1.47) 0.02 HOMA-IR ≥1790 / 360 to 1789 1.25 (1.04, 1.51) 0.02 Glucose (mmol/L) ≥1790 / 360 to 1789 1.06 (1.01, 1.12) 0.03 "],["session-info-5.html", "23 Session info", " 23 Session info Results generated on: 2023-08-17 11:29:55.295442 Click for more details sessionInfo() ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.3 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] splines grid stats graphics grDevices utils datasets ## [8] methods base ## ## other attached packages: ## [1] ggpubr_0.6.0 car_3.1-2 carData_3.0-5 xlsx_0.6.5 ## [5] geepack_1.3.9 doFuture_1.0.0 future_1.32.0 foreach_1.5.2 ## [9] emmeans_1.8.5 lmerTest_3.1-3 lme4_1.1-33 Matrix_1.6-0 ## [13] readxl_1.4.2 fontawesome_0.5.1 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [17] knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.3 ## [21] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [25] Hmisc_5.1-0 ## ## loaded via a namespace (and not attached): ## [1] remotes_2.4.2 sandwich_3.0-1 rlang_1.1.1 ## [4] multcomp_1.4-18 compiler_4.3.1 mgcv_1.9-0 ## [7] systemfonts_1.0.4 callr_3.7.3 vctrs_0.6.3 ## [10] rvest_1.0.3 stringr_1.5.0 pkgconfig_2.0.3 ## [13] crayon_1.5.2 fastmap_1.1.1 backports_1.4.1 ## [16] ellipsis_0.3.2 labeling_0.4.2 utf8_1.2.3 ## [19] sessioninfo_1.2.2 ps_1.7.5 nloptr_2.0.0 ## [22] purrr_1.0.1 xfun_0.39 cachem_1.0.8 ## [25] jsonlite_1.8.4 highr_0.10 xlsxjars_0.6.1 ## [28] broom_1.0.4 parallel_4.3.1 prettyunits_1.1.1 ## [31] cluster_2.1.4 R6_2.5.1 bslib_0.4.2 ## [34] stringi_1.7.12 parallelly_1.36.0 boot_1.3-28 ## [37] pkgload_1.3.2 rpart_4.1.19 jquerylib_0.1.4 ## [40] cellranger_1.1.0 numDeriv_2016.8-1.1 estimability_1.4.1 ## [43] Rcpp_1.0.11 bookdown_0.34 iterators_1.0.14 ## [46] future.apply_1.8.1 zoo_1.8-9 base64enc_0.1-3 ## [49] nnet_7.3-19 tidyselect_1.2.0 abind_1.4-5 ## [52] rstudioapi_0.14 yaml_2.3.7 codetools_0.2-19 ## [55] processx_3.8.1 listenv_0.8.0 pkgbuild_1.4.0 ## [58] lattice_0.21-8 tibble_3.2.1 withr_2.5.0 ## [61] coda_0.19-4 evaluate_0.21 foreign_0.8-82 ## [64] survival_3.5-5 rJava_1.0-6 xml2_1.3.3 ## [67] pillar_1.9.0 checkmate_2.0.0 generics_0.1.3 ## [70] munsell_0.5.0 scales_1.2.1 minqa_1.2.4 ## [73] globals_0.16.2 xtable_1.8-4 glue_1.6.2 ## [76] tools_4.3.1 data.table_1.14.8 ggsignif_0.6.4 ## [79] webshot_0.5.4 fs_1.6.2 mvtnorm_1.1-3 ## [82] tidyr_1.3.0 colorspace_2.1-0 nlme_3.1-162 ## [85] htmlTable_2.4.0 Formula_1.2-4 cli_3.6.1 ## [88] fansi_1.0.4 viridisLite_0.4.2 svglite_2.1.0 ## [91] dplyr_1.1.2 gtable_0.3.3 rstatix_0.7.2 ## [94] sass_0.4.6 digest_0.6.33 pbkrtest_0.5.2 ## [97] TH.data_1.1-0 farver_2.1.1 memoise_2.0.1 ## [100] htmltools_0.5.5 lifecycle_1.0.3 httr_1.4.2 ## [103] MASS_7.3-60 "],["part-gdm-cases.html", "(PART*) GDM Cases", " (PART*) GDM Cases "],["descriptives-2.html", "24 Descriptives", " 24 Descriptives Descriptives on raw data. Tables in this section are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value PRL (ng/ml): Mean (SD) 118.8 (86.5) 98.5 (95.8) 101.1 (94.7) 0.27 hPL (μg/ml): Mean (SD) 116.5 (49.3) 70.4 (50.6) 76.2 (52.6) &lt;0.0001 GH2 (ng/ml): Mean (SD) 3.1 (2.0) 1.7 (1.2) 1.9 (1.4) 0.003 Insulin (uU/ml): Mean (SD) 50.4 (55.0) 30.6 (41.0) 33.7 (43.9) 0.05 HOMA-IR: Mean (SD) 14.8 (18.7) 7.5 (13.0) 8.6 (14.2) 0.04 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 Number of available samples Var SCOPE: Available N(%) STOP: Available N(%) PRL (ng/ml) 27 (46.6%) 189 (95.5%) hPL (μg/ml) 26 (44.8%) 180 (90.9%) GH2 (ng/ml) 26 (44.8%) 179 (90.4%) Insulin (uU/ml) 35 (60.3%) 192 (97.0%) HOMA-IR 34 (58.6%) 192 (97.0%) Glucose (mmol/L) 57 (98.3%) 197 (99.5%) "],["by-study-2.html", "24.1 By Study", " 24.1 By Study 24.1.1 Demographics Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Maternal age (yrs): Median (IQ range) 28.0 (25.0-32.0) 28.0 (24.0-31.0) 28.0 (24.0-32.0) 0.95 Maternal age (yrs): N(%) 0.26 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 56 (96.6) 181 (91.4) 237 (92.6) &gt;=35 2 (3.4) 17 (8.6) 19 (7.4) Maternal BMI: Median (IQ range) 30.6 (25.4-36.3) 30.9 (24.6-37.6) 30.6 (24.6-37.3) 0.85 Maternal BMI (category): N(%) 0.74 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 1 (1.7) 8 (4.0) 9 (3.5) &gt;=20 to &lt;25 13 (22.4) 47 (23.7) 60 (23.4) &gt;=25 to &lt;30 13 (22.4) 40 (20.2) 53 (20.7) &gt;=30 to &lt;40 24 (41.4) 68 (34.3) 92 (35.9) &gt;=40 7 (12.1) 35 (17.7) 42 (16.4) SEI: Median (IQ range) 27.0 (20.2-34.0) 28.5 (20.0-45.0) 28.0 (20.0-45.0) 0.19 Ethnicity: N(%) 0.19 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 51 (87.9) 141 (71.2) 192 (75.0) Maori 0 (0.0) 1 (0.5) 1 (0.4) Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0) South East and Far East 4 (6.9) 24 (12.1) 28 (10.9) Indian 1 (1.7) 17 (8.6) 18 (7.0) African 0 (0.0) 5 (2.5) 5 (2.0) Middle-eastern 0 (0.0) 4 (2.0) 4 (1.6) Hispanic 0 (0.0) 1 (0.5) 1 (0.4) Aboriginal 1 (1.7) 3 (1.5) 4 (1.6) China and Japan 0 (0.0) 2 (1.0) 2 (0.8) Other 1 (1.7) 0 (0.0) 1 (0.4) Smoking: N(%) 0.62 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 50 (86.2) 163 (82.3) 213 (83.2) Yes 8 (13.8) 35 (17.7) 43 (16.8) Folic acid supplement (μg): N(%) 0.0003 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;800 27 (46.6) 44 (22.2) 71 (27.7) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Folic acid supplement (μg): N(%) 0.0001 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;=400 6 (10.3) 3 (1.5) 9 (3.5) &gt;400 to &lt;800 21 (36.2) 41 (20.7) 62 (24.2) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Fruit (1st trim): N(%) 0.86 Missing 0 (0.0) 3 (1.5) 3 (1.2) &lt;1-3x/month 3 (5.2) 16 (8.1) 19 (7.4) 1-6x/week 19 (32.8) 66 (33.3) 85 (33.2) &gt;=1-&lt;3x/day 32 (55.2) 96 (48.5) 128 (50.0) &gt;=3x/day 4 (6.9) 17 (8.6) 21 (8.2) Leafy vege (1st trim): N(%) 0.10 Missing 0 (0.0) 4 (2.0) 4 (1.6) &lt;1-3x/month 3 (5.2) 21 (10.6) 24 (9.4) 1-2x/week 13 (22.4) 42 (21.2) 55 (21.5) 3-6x/week 31 (53.4) 72 (36.4) 103 (40.2) &gt;=1x/day 11 (19.0) 59 (29.8) 70 (27.3) Fast food (1st trim): N(%) 0.36 Missing 9 (15.5) 24 (12.1) 33 (12.9) Never 1 (1.7) 11 (5.6) 12 (4.7) &gt;0-&lt;2x/week 6 (10.3) 34 (17.2) 40 (15.6) &gt;=2-&lt;4x/week 25 (43.1) 84 (42.4) 109 (42.6) &gt;=4x/week 17 (29.3) 45 (22.7) 62 (24.2) Vigorous exercise: N(%) 0.25 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 38 (65.5) 124 (62.6) 162 (63.3) Once a week 19 (32.8) 48 (24.2) 67 (26.2) 2-3/wk 1 (1.7) 16 (8.1) 17 (6.6) 4-6/wk 0 (0.0) 4 (2.0) 4 (1.6) Daily 0 (0.0) 3 (1.5) 3 (1.2) More than once a day 0 (0.0) 0 (0.0) 0 (0.0) Moderate exercise: N(%) 0.68 Missing 0 (0.0) 4 (2.0) 4 (1.6) Never 30 (51.7) 87 (43.9) 117 (45.7) Once a week 16 (27.6) 54 (27.3) 70 (27.3) 2-3/wk 8 (13.8) 42 (21.2) 50 (19.5) 4-6/wk 1 (1.7) 3 (1.5) 4 (1.6) Daily 3 (5.2) 6 (3.0) 9 (3.5) More than once a day 0 (0.0) 2 (1.0) 2 (0.8) Recreational walking: N(%) 0.88 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 9 (15.5) 33 (16.7) 42 (16.4) Once a week 21 (36.2) 81 (40.9) 102 (39.8) 2-3/wk 17 (29.3) 49 (24.7) 66 (25.8) 4-6/wk 5 (8.6) 12 (6.1) 17 (6.6) Daily 6 (10.3) 17 (8.6) 23 (9.0) More than once a day 0 (0.0) 3 (1.5) 3 (1.2) Serum folate concentration (nM): Median (IQ range) 40.1 (32.0-43.8) 40.1 (35.5-45.2) 40.1 (35.0-44.8) 0.26 Homocysteine concentration (μM): Mean (SD) 4.1 (0.9) 4.8 (1.0) 4.7 (1.0) &lt;0.0001 B12 concentration (pM): Median (IQ range) 253.5 (194.2-333.0) 273.0 (217.5-348.5) 270.0 (215.0-345.5) 0.16 Folate:B12 ratio: Median (IQ range) 158.9 (116.5-210.2) 148.0 (112.4-225.9) 149.3 (113.3-220.0) 0.79 Active B12 concentration (pM): Mean (SD) 72.7 (26.4) 76.6 (26.1) 75.7 (26.1) 0.48 Folate:Active B12 ratio: Median (IQ range) 553.8 (424.7-660.3) 531.9 (417.3-788.4) 536.7 (418.1-784.2) 0.97 Vitamin D: Median (IQ range) 55.8 (44.6-72.0) 60.0 (44.5-77.5) 59.0 (44.3-75.1) 0.52 UIC (ug/L): Median (IQ range) 132.7 (68.3-167.0) 220.6 (139.0-344.1) 206.4 (124.8-323.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.1 (0.7-1.6) 1.0 (0.7-1.6) 0.92 PAPP-A (MoM): Median (IQ range) 0.9 (0.5-1.4) 0.9 (0.7-1.3) 0.9 (0.7-1.4) 0.53 Haemoglobin (g/L): Mean (SD) 130.9 (9.4) 132.2 (10.0) 131.9 (9.8) 0.38 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.07 24.1.2 MetS Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value MetS: N(%) 0.0001 Missing 1 (1.7) 14 (7.1) 15 (5.9) No 29 (50.0) 144 (72.7) 173 (67.6) Yes 28 (48.3) 40 (20.2) 68 (26.6) MetS: number of criteria met: Median (IQ range) 2.0 (1.0-2.0) 0.0 (0.0-1.5) 1.0 (0.0-2.0) &lt;0.0001 Waist (cm): Median (IQ range) 97.0 (87.0-109.0) 91.0 (78.0-107.5) 93.0 (80.0-108.0) 0.03 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.7 (0.9) 4.9 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.8 (1.6-2.4) 1.2 (0.9-1.6) 1.3 (1.0-1.8) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.6 (0.3) 1.5 (0.3) 1.6 (0.3) 0.09 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.8) 2.6 (0.7) 2.7 (0.7) 0.004 Systolic BP (mmHg): Mean (SD) 112.9 (12.0) 118.8 (11.6) 117.4 (11.9) 0.001 Diastolic BP (mmHg): Mean (SD) 68.6 (8.9) 73.5 (9.9) 72.3 (9.9) 0.0005 MAP (mmHg): Mean (SD) 83.4 (8.9) 88.6 (9.6) 87.4 (9.7) 0.0002 MetS criteria: Waist circumference: N(%) 0.05 Missing 1 (1.7) 3 (1.5) 4 (1.6) &lt;80 cm 8 (13.8) 54 (27.3) 62 (24.2) &gt;=80 cm 49 (84.5) 141 (71.2) 190 (74.2) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 1 (0.5) 1 (0.4) &lt;1.7 mmol/L 23 (39.7) 156 (78.8) 179 (69.9) &gt;=1.7 mmol/L 35 (60.3) 41 (20.7) 76 (29.7) MetS criteria: HDL: N(%) 0.68 Missing 0 (0.0) 1 (0.5) 1 (0.4) &gt;=1.3 mmol/L 48 (82.8) 156 (78.8) 204 (79.7) &lt;1.3 mmol/L 10 (17.2) 41 (20.7) 51 (19.9) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 1 (1.7) 1 (0.5) 2 (0.8) &lt;5.6 mmol/L 18 (31.0) 174 (87.9) 192 (75.0) &gt;=5.6 mmol/L 39 (67.2) 23 (11.6) 62 (24.2) MetS criteria: sBP: N(%) 0.06 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130 mmHg 54 (93.1) 155 (78.3) 209 (81.6) &gt;=130 mmHg 4 (6.9) 32 (16.2) 36 (14.1) MetS criteria: dBP: N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;85 mmHg 56 (96.6) 162 (81.8) 218 (85.2) &gt;=85 mmHg 2 (3.4) 25 (12.6) 27 (10.5) MetS criteria: BP: N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130/85 mmHg 53 (91.4) 145 (73.2) 198 (77.3) &gt;=130/85 mmHg 5 (8.6) 42 (21.2) 47 (18.4) CRP (mg/L): Median (IQ range) 7.8 (4.4-12.5) 3.9 (2.1-8.1) 4.5 (2.4-9.1) &lt;0.0001 24.1.3 Outcomes Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Gestational age at birth (weeks): Median (IQ range) 38.9 (38.1-40.0) 38.9 (38.1-39.7) 38.9 (38.1-39.9) 0.91 Birthweight (g): Median (IQ range) 3260.0 (2825.0-3728.8) 3350.0 (3020.0-3645.0) 3330.0 (2990.5-3650.0) 0.61 Birthweight centile: Mean (SD) 47.6 (31.9) 52.5 (30.3) 51.4 (30.7) 0.30 Baby sex: N(%) 0.78 Missing 0 (0.0) 1 (0.5) 1 (0.4) Male 27 (46.6) 98 (49.5) 125 (48.8) Female 31 (53.4) 99 (50.0) 130 (50.8) Mode of delivery: N(%) 0.08 Missing 0 (0.0) 1 (0.5) 1 (0.4) Unassisted vaginal 19 (32.8) 91 (46.0) 110 (43.0) Operative vaginal 7 (12.1) 34 (17.2) 41 (16.0) Pre-labour LSCS 10 (17.2) 19 (9.6) 29 (11.3) LSCS in labour 22 (37.9) 53 (26.8) 75 (29.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) Induction of Labour: N(%) 0.65 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 26 (44.8) 80 (40.4) 106 (41.4) Yes 32 (55.2) 118 (59.6) 150 (58.6) "],["folate-vs-fa-supplement-2.html", "25 Folate vs FA supplement", " 25 Folate vs FA supplement 25.0.1 FA supp (3 categories) Characteristic None (n=22) &lt;800 (n=71) &gt;=800 (n=142) Total (n=235) P-value Serum folate concentration (nM): Median (IQ range) 30.4 (26.5-40.2) 39.8 (34.0-44.5) 41.2 (37.9-58.0) 40.7 (35.9-45.2) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.0) 4.6 (1.0) 4.6 (0.9) 4.6 (1.0) 0.88 B12 concentration (pM): Median (IQ range) 260.5 (175.2-314.0) 268.0 (219.0-301.0) 278.0 (220.0-353.0) 271.5 (216.8-345.8) 0.35 Active B12 concentration (pM): Mean (SD) 65.2 (22.4) 83.8 (27.1) 74.1 (24.1) 76.4 (25.5) 0.04 Folate:B12 ratio: Median (IQ range) 123.5 (80.3-170.6) 155.4 (117.5-220.6) 160.1 (117.5-256.9) 150.7 (116.1-227.3) 0.04 Folate:Active B12 ratio: Median (IQ range) 510.1 (409.2-591.5) 534.1 (423.4-660.1) 565.1 (429.3-895.6) 539.5 (424.7-784.2) 0.19 Vitamin D: Median (IQ range) 45.4 (29.4-69.3) 58.0 (44.7-73.0) 61.0 (46.8-76.5) 59.0 (44.5-75.2) 0.14 Click here for table within SCOPE Characteristic None (n=9) &lt;800 (n=27) &gt;=800 (n=22) Total (n=58) P-value Serum folate concentration (nM): Median (IQ range) 26.7 (21.7-29.6) 39.5 (32.3-43.5) 42.5 (38.4-65.4) 40.1 (32.0-43.8) 0.0009 Homocysteine concentration (μM): Mean (SD) 4.3 (1.1) 4.1 (0.8) 4.1 (0.8) 4.1 (0.9) 0.73 B12 concentration (pM): Median (IQ range) 200.5 (171.8-265.5) 278.5 (237.0-335.0) 237.5 (192.0-342.8) 253.5 (194.2-333.0) 0.15 Active B12 concentration (pM): Mean (SD) 66.6 (22.5) 77.0 (29.1) 71.7 (27.1) 72.7 (26.4) 0.72 Folate:B12 ratio: Median (IQ range) 125.3 (68.1-178.3) 140.3 (114.5-167.0) 210.6 (147.3-391.7) 158.9 (116.5-210.2) 0.01 Folate:Active B12 ratio: Median (IQ range) 447.5 (321.0-553.6) 549.0 (418.2-642.7) 674.9 (540.9-1118.7) 553.8 (424.7-660.3) 0.12 Vitamin D: Median (IQ range) 45.4 (29.8-79.0) 51.7 (44.1-68.7) 65.5 (51.4-75.2) 55.8 (44.6-72.0) 0.14 Click here for table within STOP Characteristic None (n=13) &lt;800 (n=44) &gt;=800 (n=120) Total (n=177) P-value Serum folate concentration (nM): Median (IQ range) 35.6 (30.1-42.0) 39.8 (35.0-49.8) 41.1 (37.5-56.3) 40.7 (36.1-53.6) 0.03 Homocysteine concentration (μM): Mean (SD) 4.7 (0.9) 4.8 (1.0) 4.7 (0.9) 4.7 (1.0) 0.86 B12 concentration (pM): Median (IQ range) 279.0 (243.8-381.5) 268.0 (212.0-284.0) 285.0 (224.0-358.5) 275.5 (221.2-348.8) 0.17 Active B12 concentration (pM): Mean (SD) 63.4 (24.8) 86.8 (26.2) 74.5 (23.8) 77.6 (25.2) 0.04 Folate:B12 ratio: Median (IQ range) 123.5 (102.6-144.2) 164.4 (120.3-258.0) 150.2 (116.3-228.4) 150.6 (116.1-231.2) 0.13 Folate:Active B12 ratio: Median (IQ range) 633.8 (487.5-645.7) 524.9 (430.5-693.7) 542.1 (424.7-838.0) 534.2 (427.0-788.4) 0.68 Vitamin D: Median (IQ range) 45.0 (29.0-54.8) 64.0 (45.8-80.5) 60.5 (46.0-77.5) 60.0 (44.8-78.0) 0.15 25.0.2 FA supp (4 categories) Characteristic None (n=22) &lt;=400 (n=9) &gt;400 to &lt;800 (n=62) &gt;=800 (n=142) Total (n=235) P-value Serum folate concentration (nM): Median (IQ range) 30.4 (26.5-40.2) 41.3 (36.3-54.4) 39.8 (33.8-44.0) 41.2 (37.9-58.0) 40.7 (35.9-45.2) 0.0002 Homocysteine concentration (μM): Mean (SD) 4.6 (1.0) 4.1 (0.9) 4.6 (1.0) 4.6 (0.9) 4.6 (1.0) 0.43 B12 concentration (pM): Median (IQ range) 260.5 (175.2-314.0) 268.0 (222.0-292.0) 268.5 (218.0-303.5) 278.0 (220.0-353.0) 271.5 (216.8-345.8) 0.55 Active B12 concentration (pM): Mean (SD) 65.2 (22.4) 80.3 (35.3) 84.4 (26.1) 74.1 (24.1) 76.4 (25.5) 0.09 Folate:B12 ratio: Median (IQ range) 123.5 (80.3-170.6) 162.4 (135.4-220.6) 153.1 (112.8-215.4) 160.1 (117.5-256.9) 150.7 (116.1-227.3) 0.10 Folate:Active B12 ratio: Median (IQ range) 510.1 (409.2-591.5) 715.7 (399.3-826.4) 524.9 (427.0-593.3) 565.1 (429.3-895.6) 539.5 (424.7-784.2) 0.30 Vitamin D: Median (IQ range) 45.4 (29.4-69.3) 68.6 (44.3-74.0) 57.6 (45.2-72.7) 61.0 (46.8-76.5) 59.0 (44.5-75.2) 0.23 Click here for table within SCOPE Characteristic None (n=9) &lt;=400 (n=6) &gt;400 to &lt;800 (n=21) &gt;=800 (n=22) Total (n=58) P-value Serum folate concentration (nM): Median (IQ range) 26.7 (21.7-29.6) 36.8 (32.7-40.3) 41.5 (32.6-43.7) 42.5 (38.4-65.4) 40.1 (32.0-43.8) 0.002 Homocysteine concentration (μM): Mean (SD) 4.3 (1.1) 3.7 (0.7) 4.2 (0.9) 4.1 (0.8) 4.1 (0.9) 0.52 B12 concentration (pM): Median (IQ range) 200.5 (171.8-265.5) 280.0 (259.8-348.2) 271.5 (228.5-333.0) 237.5 (192.0-342.8) 253.5 (194.2-333.0) 0.25 Active B12 concentration (pM): Mean (SD) 66.6 (22.5) 102.7 (39.7) 68.4 (21.1) 71.7 (27.1) 72.7 (26.4) 0.22 Folate:B12 ratio: Median (IQ range) 125.3 (68.1-178.3) 138.4 (125.8-157.2) 144.0 (111.7-170.7) 210.6 (147.3-391.7) 158.9 (116.5-210.2) 0.03 Folate:Active B12 ratio: Median (IQ range) 447.5 (321.0-553.6) 320.2 (289.2-478.5) 558.4 (516.5-660.3) 674.9 (540.9-1118.7) 553.8 (424.7-660.3) 0.12 Vitamin D: Median (IQ range) 45.4 (29.8-79.0) 56.5 (33.3-70.7) 51.7 (45.9-68.3) 65.5 (51.4-75.2) 55.8 (44.6-72.0) 0.27 Click here for table within STOP Characteristic None (n=13) &lt;=400 (n=3) &gt;400 to &lt;800 (n=41) &gt;=800 (n=120) Total (n=177) P-value Serum folate concentration (nM): Median (IQ range) 35.6 (30.1-42.0) 54.4 (49.5-57.2) 39.4 (34.6-44.5) 41.1 (37.5-56.3) 40.7 (36.1-53.6) 0.02 Homocysteine concentration (μM): Mean (SD) 4.7 (0.9) 4.9 (0.8) 4.8 (1.1) 4.7 (0.9) 4.7 (1.0) 0.96 B12 concentration (pM): Median (IQ range) 279.0 (243.8-381.5) 182.0 (181.0-227.0) 268.5 (218.0-284.2) 285.0 (224.0-358.5) 275.5 (221.2-348.8) 0.20 Active B12 concentration (pM): Mean (SD) 63.4 (24.8) 58.0 (6.2) 90.2 (25.6) 74.5 (23.8) 77.6 (25.2) 0.01 Folate:B12 ratio: Median (IQ range) 123.5 (102.6-144.2) 244.5 (232.5-273.4) 162.0 (116.1-254.6) 150.2 (116.3-228.4) 150.6 (116.1-231.2) 0.09 Folate:Active B12 ratio: Median (IQ range) 633.8 (487.5-645.7) 836.9 (815.8-984.5) 512.7 (419.6-590.5) 542.1 (424.7-838.0) 534.2 (427.0-788.4) 0.13 Vitamin D: Median (IQ range) 45.0 (29.0-54.8) 89.0 (77.0-107.5) 59.0 (45.0-79.0) 60.5 (46.0-77.5) 60.0 (44.8-78.0) 0.07 "],["folate-2.html", "25.1 Folate", " 25.1 Folate 25.1.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.3407424 0.2307184 14.4797384 &lt;0.0001 *** folate_cat2&lt;800 0.5056130 0.1849208 2.7342145 0.007 ** folate_cat2&gt;=800 0.7593460 0.1934207 3.9258772 0.0001 *** StudySTOP 0.3654362 0.2041072 1.7904132 0.07 ns f1_age 0.0010667 0.0059696 0.1786897 0.86 ns BMI -0.0058475 0.0037545 -1.5574781 0.12 ns folate_cat2&lt;800:StudySTOP -0.2817845 0.2351237 -1.1984522 0.23 ns folate_cat2&gt;=800:StudySTOP -0.4202476 0.2345038 -1.7920715 0.07 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.66 (0.99, 2.78) 0.06 SCOPE: &gt;=800/None 2.14 (1.24, 3.67) 0.001 SCOPE: &gt;=800/&lt;800 1.29 (0.86, 1.92) 0.7 STOP: &lt;800/None 1.25 (0.83, 1.88) 1 STOP: &gt;=800/None 1.40 (0.96, 2.05) 0.1 STOP: &gt;=800/&lt;800 1.12 (0.90, 1.40) 1 None: STOP/SCOPE 1.44 (0.81, 2.55) 0.7 &lt;800: STOP/SCOPE 1.09 (0.78, 1.51) 1 &gt;=800: STOP/SCOPE 0.95 (0.69, 1.30) 1 P-value adjustment: bonferroni method for 9 tests 25.1.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.3471914 0.2321327 14.4193043 &lt;0.0001 *** folate_cat3&lt;=400 0.4432260 0.2444391 1.8132368 0.07 ns folate_cat3&gt;400 to &lt;800 0.5299461 0.1937447 2.7352803 0.007 ** folate_cat3&gt;=800 0.7606836 0.1940713 3.9196082 0.0001 *** StudySTOP 0.3660788 0.2047024 1.7883461 0.08 ns f1_age 0.0008740 0.0060636 0.1441340 0.89 ns BMI -0.0059110 0.0037684 -1.5685392 0.12 ns folate_cat3&lt;=400:StudySTOP -0.0180752 0.3762056 -0.0480462 0.96 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.3207961 0.2432012 -1.3190560 0.19 ns folate_cat3&gt;=800:StudySTOP -0.4212786 0.2352169 -1.7910216 0.07 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.56 (0.75, 3.23) 1 SCOPE: &gt;400 to &lt;800/None 1.70 (0.95, 3.03) 0.1 SCOPE: &gt;=800/None 2.14 (1.20, 3.82) 0.002 SCOPE: &gt;=800/&lt;=400 1.37 (0.73, 2.58) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.26 (0.79, 2.01) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.92 (0.48, 1.75) 1 STOP: &lt;=400/None 1.53 (0.64, 3.64) 1 STOP: &gt;400 to &lt;800/None 1.23 (0.79, 1.91) 1 STOP: &gt;=800/None 1.40 (0.94, 2.11) 0.2 STOP: &gt;=800/&lt;=400 0.92 (0.42, 2.01) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.14 (0.89, 1.46) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.24 (0.56, 2.77) 1 None: STOP/SCOPE 1.44 (0.78, 2.66) 1 &lt;=400: STOP/SCOPE 1.42 (0.55, 3.65) 1 &gt;400 to &lt;800: STOP/SCOPE 1.05 (0.70, 1.56) 1 &gt;=800: STOP/SCOPE 0.95 (0.67, 1.33) 1 P-value adjustment: bonferroni method for 16 tests "],["b12-2.html", "25.2 B12", " 25.2 B12 25.2.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.3919012 0.2171520 24.8300740 &lt;0.0001 *** folate_cat2&lt;800 0.2215223 0.1742693 1.2711491 0.21 ns folate_cat2&gt;=800 -0.0728874 0.1822761 -0.3998734 0.69 ns StudySTOP 0.2123474 0.1923511 1.1039574 0.27 ns f1_age 0.0097913 0.0056227 1.7413930 0.08 ns BMI -0.0080118 0.0035316 -2.2685932 0.02 * folate_cat2&lt;800:StudySTOP -0.3272987 0.2215821 -1.4770988 0.14 ns folate_cat2&gt;=800:StudySTOP 0.0871648 0.2209832 0.3944407 0.69 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.25 (0.77, 2.03) 1 SCOPE: &gt;=800/None 0.93 (0.56, 1.55) 1 SCOPE: &gt;=800/&lt;800 0.74 (0.51, 1.09) 0.3 STOP: &lt;800/None 0.90 (0.61, 1.32) 1 STOP: &gt;=800/None 1.01 (0.71, 1.45) 1 STOP: &gt;=800/&lt;800 1.13 (0.91, 1.39) 1 None: STOP/SCOPE 1.24 (0.72, 2.12) 1 &lt;800: STOP/SCOPE 0.89 (0.65, 1.21) 1 &gt;=800: STOP/SCOPE 1.35 (1.00, 1.82) 0.05 P-value adjustment: bonferroni method for 9 tests 25.2.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.3807508 0.2185164 24.6240112 &lt;0.0001 *** folate_cat3&lt;=400 0.2238783 0.2303965 0.9717089 0.33 ns folate_cat3&gt;400 to &lt;800 0.2183292 0.1826154 1.1955682 0.23 ns folate_cat3&gt;=800 -0.0761421 0.1829189 -0.4162615 0.68 ns StudySTOP 0.2107435 0.1929436 1.0922546 0.28 ns f1_age 0.0102666 0.0057121 1.7973547 0.07 ns BMI -0.0080105 0.0035454 -2.2594080 0.02 * folate_cat3&lt;=400:StudySTOP -0.5327520 0.3545958 -1.5024205 0.13 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.3093740 0.2292319 -1.3496111 0.18 ns folate_cat3&gt;=800:StudySTOP 0.0897609 0.2216917 0.4048905 0.69 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.25 (0.63, 2.49) 1 SCOPE: &gt;400 to &lt;800/None 1.24 (0.72, 2.15) 1 SCOPE: &gt;=800/None 0.93 (0.54, 1.60) 1 SCOPE: &gt;=800/&lt;=400 0.74 (0.41, 1.34) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.74 (0.48, 1.16) 0.7 SCOPE: &lt;=400/&gt;400 to &lt;800 1.01 (0.55, 1.84) 1 STOP: &lt;=400/None 0.73 (0.32, 1.66) 1 STOP: &gt;400 to &lt;800/None 0.91 (0.60, 1.38) 1 STOP: &gt;=800/None 1.01 (0.69, 1.48) 1 STOP: &gt;=800/&lt;=400 1.38 (0.66, 2.89) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.88, 1.40) 1 STOP: &lt;=400/&gt;400 to &lt;800 0.80 (0.38, 1.71) 1 None: STOP/SCOPE 1.23 (0.69, 2.20) 1 &lt;=400: STOP/SCOPE 0.72 (0.30, 1.77) 1 &gt;400 to &lt;800: STOP/SCOPE 0.91 (0.62, 1.32) 1 &gt;=800: STOP/SCOPE 1.35 (0.98, 1.86) 0.09 P-value adjustment: bonferroni method for 16 tests "],["homocysteine-2.html", "25.3 Homocysteine", " 25.3 Homocysteine 25.3.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5012780 0.1039194 14.4465634 &lt;0.0001 *** folate_cat2&lt;800 -0.0481093 0.0833976 -0.5768665 0.56 ns folate_cat2&gt;=800 -0.0452825 0.0872293 -0.5191205 0.60 ns StudySTOP 0.0968574 0.0920508 1.0522169 0.29 ns f1_age -0.0011702 0.0026908 -0.4348877 0.66 ns BMI -0.0011260 0.0016901 -0.6662333 0.51 ns folate_cat2&lt;800:StudySTOP 0.0675621 0.1060394 0.6371408 0.52 ns folate_cat2&gt;=800:StudySTOP 0.0454692 0.1057528 0.4299571 0.67 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 0.95 (0.75, 1.20) 1 SCOPE: &gt;=800/None 0.96 (0.75, 1.22) 1 SCOPE: &gt;=800/&lt;800 1.00 (0.84, 1.20) 1 STOP: &lt;800/None 1.02 (0.85, 1.23) 1 STOP: &gt;=800/None 1.00 (0.84, 1.19) 1 STOP: &gt;=800/&lt;800 0.98 (0.89, 1.09) 1 None: STOP/SCOPE 1.10 (0.85, 1.43) 1 &lt;800: STOP/SCOPE 1.18 (1.02, 1.37) 0.02 &gt;=800: STOP/SCOPE 1.15 (1.00, 1.33) 0.05 P-value adjustment: bonferroni method for 9 tests 25.3.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.4953941 0.1042649 14.3422579 &lt;0.0001 *** folate_cat3&lt;=400 -0.1468555 0.1099335 -1.3358576 0.18 ns folate_cat3&gt;400 to &lt;800 -0.0129441 0.0871348 -0.1485521 0.88 ns folate_cat3&gt;=800 -0.0478846 0.0872796 -0.5486346 0.58 ns StudySTOP 0.0955482 0.0920628 1.0378582 0.30 ns f1_age -0.0007860 0.0027255 -0.2883946 0.77 ns BMI -0.0012271 0.0016917 -0.7253598 0.47 ns folate_cat3&lt;=400:StudySTOP 0.1973845 0.1691950 1.1666095 0.24 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0300149 0.1093778 0.2744149 0.78 ns folate_cat3&gt;=800:StudySTOP 0.0475878 0.1057800 0.4498755 0.65 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 0.86 (0.62, 1.20) 1 SCOPE: &gt;400 to &lt;800/None 0.99 (0.76, 1.28) 1 SCOPE: &gt;=800/None 0.95 (0.73, 1.24) 1 SCOPE: &gt;=800/&lt;=400 1.10 (0.83, 1.47) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.97 (0.78, 1.19) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.87 (0.65, 1.17) 1 STOP: &lt;=400/None 1.05 (0.71, 1.55) 1 STOP: &gt;400 to &lt;800/None 1.02 (0.83, 1.24) 1 STOP: &gt;=800/None 1.00 (0.83, 1.20) 1 STOP: &gt;=800/&lt;=400 0.95 (0.67, 1.35) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.98 (0.88, 1.10) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.03 (0.72, 1.48) 1 None: STOP/SCOPE 1.10 (0.84, 1.45) 1 &lt;=400: STOP/SCOPE 1.34 (0.88, 2.05) 0.7 &gt;400 to &lt;800: STOP/SCOPE 1.13 (0.95, 1.36) 0.6 &gt;=800: STOP/SCOPE 1.15 (0.99, 1.34) 0.09 P-value adjustment: bonferroni method for 16 tests "],["active-b12-2.html", "25.4 Active B12", " 25.4 Active B12 25.4.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.0254936 0.2390657 16.8384375 &lt;0.0001 *** folate_cat2&lt;800 0.0934074 0.1734305 0.5385867 0.59 ns folate_cat2&gt;=800 0.0138517 0.1905709 0.0726854 0.94 ns StudySTOP -0.0872134 0.2157742 -0.4041883 0.69 ns f1_age 0.0028531 0.0072355 0.3943127 0.69 ns BMI 0.0020973 0.0040796 0.5140848 0.61 ns folate_cat2&lt;800:StudySTOP 0.2382425 0.2481408 0.9601103 0.34 ns folate_cat2&gt;=800:StudySTOP 0.1553473 0.2564123 0.6058495 0.55 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.10 (0.67, 1.79) 1 SCOPE: &gt;=800/None 1.01 (0.59, 1.74) 1 SCOPE: &gt;=800/&lt;800 0.92 (0.58, 1.46) 1 STOP: &lt;800/None 1.39 (0.85, 2.29) 0.6 STOP: &gt;=800/None 1.18 (0.74, 1.91) 1 STOP: &gt;=800/&lt;800 0.85 (0.67, 1.07) 0.5 None: STOP/SCOPE 0.92 (0.50, 1.69) 1 &lt;800: STOP/SCOPE 1.16 (0.82, 1.66) 1 &gt;=800: STOP/SCOPE 1.07 (0.74, 1.54) 1 P-value adjustment: bonferroni method for 9 tests 25.4.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.9713767 0.2361728 16.8155524 &lt;0.0001 *** folate_cat3&lt;=400 0.3962406 0.2469376 1.6046184 0.11 ns folate_cat3&gt;400 to &lt;800 -0.0147737 0.1796329 -0.0822437 0.93 ns folate_cat3&gt;=800 -0.0025415 0.1870321 -0.0135886 0.99 ns StudySTOP -0.0974162 0.2113993 -0.4608163 0.65 ns f1_age 0.0043798 0.0072257 0.6061329 0.55 ns BMI 0.0027146 0.0040065 0.6775427 0.50 ns folate_cat3&lt;=400:StudySTOP -0.4475108 0.3564638 -1.2554172 0.21 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.3954279 0.2513465 1.5732378 0.12 ns folate_cat3&gt;=800:StudySTOP 0.1736266 0.2514567 0.6904830 0.49 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.49 (0.70, 3.13) 1 SCOPE: &gt;400 to &lt;800/None 0.99 (0.57, 1.70) 1 SCOPE: &gt;=800/None 1.00 (0.57, 1.75) 1 SCOPE: &gt;=800/&lt;=400 0.67 (0.33, 1.37) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.01 (0.60, 1.70) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 1.51 (0.74, 3.09) 1 STOP: &lt;=400/None 0.95 (0.43, 2.08) 1 STOP: &gt;400 to &lt;800/None 1.46 (0.86, 2.48) 0.5 STOP: &gt;=800/None 1.19 (0.72, 1.95) 1 STOP: &gt;=800/&lt;=400 1.25 (0.66, 2.37) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.81 (0.63, 1.05) 0.2 STOP: &lt;=400/&gt;400 to &lt;800 0.65 (0.33, 1.26) 0.8 None: STOP/SCOPE 0.91 (0.48, 1.72) 1 &lt;=400: STOP/SCOPE 0.58 (0.24, 1.40) 1 &gt;400 to &lt;800: STOP/SCOPE 1.35 (0.89, 2.04) 0.5 &gt;=800: STOP/SCOPE 1.08 (0.74, 1.58) 1 P-value adjustment: bonferroni method for 16 tests "],["folateb12-2.html", "25.5 Folate:B12", " 25.5 Folate:B12 25.5.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.8437735 0.3154361 15.3557991 &lt;0.0001 *** folate_cat2&lt;800 0.2833134 0.2528220 1.1206045 0.26 ns folate_cat2&gt;=800 0.8306646 0.2644430 3.1411854 0.002 ** StudySTOP 0.1523818 0.2790535 0.5460667 0.59 ns f1_age -0.0085058 0.0081616 -1.0421703 0.30 ns BMI 0.0024161 0.0051331 0.4706847 0.64 ns folate_cat2&lt;800:StudySTOP 0.0452688 0.3214590 0.1408231 0.89 ns folate_cat2&gt;=800:StudySTOP -0.5104023 0.3206115 -1.5919650 0.11 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.33 (0.65, 2.70) 1 SCOPE: &gt;=800/None 2.29 (1.09, 4.81) 0.02 SCOPE: &gt;=800/&lt;800 1.73 (1.00, 2.99) 0.05 STOP: &lt;800/None 1.39 (0.79, 2.43) 0.9 STOP: &gt;=800/None 1.38 (0.82, 2.31) 0.8 STOP: &gt;=800/&lt;800 0.99 (0.73, 1.35) 1 None: STOP/SCOPE 1.16 (0.53, 2.55) 1 &lt;800: STOP/SCOPE 1.22 (0.78, 1.91) 1 &gt;=800: STOP/SCOPE 0.70 (0.45, 1.08) 0.2 P-value adjustment: bonferroni method for 9 tests 25.5.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.8613142 0.3168580 15.3422477 &lt;0.0001 *** folate_cat3&lt;=400 0.2181486 0.3336562 0.6538127 0.51 ns folate_cat3&gt;400 to &lt;800 0.3109780 0.2644590 1.1759023 0.24 ns folate_cat3&gt;=800 0.8352292 0.2649048 3.1529408 0.002 ** StudySTOP 0.1546143 0.2794161 0.5533480 0.58 ns f1_age -0.0091697 0.0082767 -1.1078956 0.27 ns BMI 0.0023501 0.0051439 0.4568637 0.65 ns folate_cat3&lt;=400:StudySTOP 0.5136869 0.5135157 1.0003334 0.32 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.0117183 0.3319665 -0.0352998 0.97 ns folate_cat3&gt;=800:StudySTOP -0.5139940 0.3210680 -1.6008883 0.11 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.24 (0.46, 3.37) 1 SCOPE: &gt;400 to &lt;800/None 1.36 (0.62, 3.01) 1 SCOPE: &gt;=800/None 2.31 (1.04, 5.09) 0.03 SCOPE: &gt;=800/&lt;=400 1.85 (0.79, 4.37) 0.5 SCOPE: &gt;=800/&gt;400 to &lt;800 1.69 (0.89, 3.19) 0.2 SCOPE: &lt;=400/&gt;400 to &lt;800 0.91 (0.38, 2.19) 1 STOP: &lt;=400/None 2.08 (0.64, 6.79) 1 STOP: &gt;400 to &lt;800/None 1.35 (0.74, 2.46) 1 STOP: &gt;=800/None 1.38 (0.79, 2.40) 1 STOP: &gt;=800/&lt;=400 0.66 (0.23, 1.93) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.02 (0.73, 1.43) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.54 (0.52, 4.61) 1 None: STOP/SCOPE 1.17 (0.51, 2.69) 1 &lt;=400: STOP/SCOPE 1.95 (0.54, 7.09) 1 &gt;400 to &lt;800: STOP/SCOPE 1.15 (0.67, 1.98) 1 &gt;=800: STOP/SCOPE 0.70 (0.44, 1.11) 0.3 P-value adjustment: bonferroni method for 16 tests "],["folateactive-b12-2.html", "25.6 Folate:Active B12", " 25.6 Folate:Active B12 25.6.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.9260522 0.3899437 15.1972011 &lt;0.0001 *** folate_cat2&lt;800 0.3880133 0.2819468 1.3761935 0.17 ns folate_cat2&gt;=800 0.6595157 0.3098732 2.1283405 0.04 * StudySTOP 0.2951983 0.3507993 0.8415018 0.40 ns f1_age 0.0101010 0.0117715 0.8580891 0.39 ns BMI -0.0070774 0.0066683 -1.0613454 0.29 ns folate_cat2&lt;800:StudySTOP -0.4002364 0.4034024 -0.9921518 0.32 ns folate_cat2&gt;=800:StudySTOP -0.4219525 0.4168368 -1.0122727 0.31 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.47 (0.66, 3.27) 1 SCOPE: &gt;=800/None 1.93 (0.81, 4.64) 0.3 SCOPE: &gt;=800/&lt;800 1.31 (0.62, 2.76) 1 STOP: &lt;800/None 0.99 (0.44, 2.22) 1 STOP: &gt;=800/None 1.27 (0.58, 2.76) 1 STOP: &gt;=800/&lt;800 1.28 (0.88, 1.88) 0.6 None: STOP/SCOPE 1.34 (0.50, 3.62) 1 &lt;800: STOP/SCOPE 0.90 (0.51, 1.60) 1 &gt;=800: STOP/SCOPE 0.88 (0.49, 1.59) 1 P-value adjustment: bonferroni method for 9 tests 25.6.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.0015948 0.3878359 15.4745723 &lt;0.0001 *** folate_cat3&lt;=400 -0.0617109 0.4041316 -0.1527001 0.88 ns folate_cat3&gt;400 to &lt;800 0.5479045 0.2939973 1.8636378 0.07 ns folate_cat3&gt;=800 0.6818582 0.3061684 2.2270690 0.03 * StudySTOP 0.3091771 0.3459999 0.8935756 0.37 ns f1_age 0.0080535 0.0118350 0.6804760 0.50 ns BMI -0.0080027 0.0065930 -1.2138159 0.23 ns folate_cat3&lt;=400:StudySTOP 0.5829995 0.5833756 0.9993553 0.32 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.6282949 0.4113705 -1.5273212 0.13 ns folate_cat3&gt;=800:StudySTOP -0.4466416 0.4115291 -1.0853220 0.28 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 0.94 (0.28, 3.19) 1 SCOPE: &gt;400 to &lt;800/None 1.73 (0.71, 4.20) 1 SCOPE: &gt;=800/None 1.98 (0.78, 4.99) 0.4 SCOPE: &gt;=800/&lt;=400 2.10 (0.65, 6.77) 0.9 SCOPE: &gt;=800/&gt;400 to &lt;800 1.14 (0.49, 2.66) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.54 (0.17, 1.76) 1 STOP: &lt;=400/None 1.68 (0.47, 6.09) 1 STOP: &gt;400 to &lt;800/None 0.92 (0.39, 2.19) 1 STOP: &gt;=800/None 1.27 (0.56, 2.86) 1 STOP: &gt;=800/&lt;=400 0.75 (0.26, 2.14) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.37 (0.90, 2.09) 0.4 STOP: &lt;=400/&gt;400 to &lt;800 1.83 (0.61, 5.43) 1 None: STOP/SCOPE 1.36 (0.48, 3.87) 1 &lt;=400: STOP/SCOPE 2.44 (0.58, 10.32) 1 &gt;400 to &lt;800: STOP/SCOPE 0.73 (0.37, 1.44) 1 &gt;=800: STOP/SCOPE 0.87 (0.47, 1.62) 1 P-value adjustment: bonferroni method for 16 tests "],["fa-supp-3-categories-17.html", "26 FA supp: 3 categories", " 26 FA supp: 3 categories Characteristic None (n=22) &lt;800 (n=71) &gt;=800 (n=142) Total (n=235) P-value Prolactin: Median (IQ range) 101.0 (73.4-288.8) 65.7 (42.7-123.5) 77.0 (47.8-111.6) 77.0 (45.6-120.5) 0.11 HPL: Median (IQ range) 87.0 (56.7-137.4) 66.4 (42.4-94.0) 59.6 (36.0-97.7) 65.0 (39.3-99.9) 0.14 GH2: Median (IQ range) 2.6 (1.9-3.3) 1.5 (1.0-2.8) 1.3 (0.9-2.3) 1.5 (1.0-2.6) 0.008 LME for duplicated or repeated measures shown on next page. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat2&quot; mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(mod1)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) mod_sum &lt;- lapply(mod_ls,extract.ci.mod,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) names(mod_sum) &lt;- names(mod_em_sum) &lt;- names(mod_em_est) &lt;- names(mod_ls) "],["prolactin-16.html", "26.1 Prolactin", " 26.1 Prolactin cat(&quot;\\n&lt;b&gt;Model summary&lt;/b&gt;\\n&quot;) Model summary mod_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Var Effect P (Intercept) 9.94 (3.32, 29.63) &lt;0.0001 folate_cat2&lt;800 1.52 (0.80, 2.89) 0.21 folate_cat2&gt;=800 1.52 (0.78, 2.95) 0.22 StudySTOP 1.77 (0.87, 3.62) 0.12 GA_samp 1.14 (1.08, 1.21) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.57 (0.26, 1.21) 0.15 folate_cat2&gt;=800:StudySTOP 0.63 (0.29, 1.37) 0.25 cat(&quot;\\n&lt;b&gt;Estimated marginal means&lt;/b&gt;\\n&quot;) Estimated marginal means mod_em_est[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 49.87 17.56 151.96 24.88 99.97 &lt;800 SCOPE 75.79 17.46 75.27 47.89 119.93 &gt;=800 SCOPE 75.78 18.19 81.20 47.00 122.18 None STOP 88.19 21.25 89.07 54.64 142.34 &lt;800 STOP 75.79 14.36 39.76 51.67 111.15 &gt;=800 STOP 84.87 14.28 25.46 60.03 120.00 if(!any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=lower.CL,ymax=upper.CL,group=Study,color=Study))} if(any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=asymp.LCL,ymax=asymp.UCL,group=Study,color=Study))} p1 &lt;- p1 + geom_pointrange(size=0.7,position=position_dodge(width=0.2)) + geom_errorbar(width=0.08,size=1,position=position_dodge(width=0.2))+ scale_y_continuous(limits=c(0,NA),expand=expansion(mult=c(0,0.1))) + labs(title=&quot;Estimated marginal means (95% CI)&quot;,x=dat_labels[fvarc],y=dat_labels[varc]) + theme_bw() + theme(axis.title=element_text(size=16,face=&quot;bold&quot;),axis.text=element_text(color=&quot;black&quot;,size=14), plot.title=element_text(face=&quot;bold&quot;,color=&quot;black&quot;,size=14), panel.grid.major.x=element_blank(), legend.position=&quot;bottom&quot;,legend.title=element_text(size=15,face=&quot;bold&quot;),legend.text=element_text(size=14)) print(p1) cat(&quot;\\n\\n\\n&lt;br /&gt;&lt;b&gt;Post-hoc comparisons&lt;/b&gt;&lt;br /&gt;\\n&quot;) Post-hoc comparisons mod_em_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.52 (0.69, 3.34) 0.4 &gt;=800 / None Study: SCOPE 1.52 (0.67, 3.43) 0.4 &gt;=800 / &lt;800 Study: SCOPE 1.00 (0.60, 1.66) 1.0 &lt;800 / None Study: STOP 0.86 (0.52, 1.41) 0.8 &gt;=800 / None Study: STOP 0.96 (0.60, 1.54) 1.0 &gt;=800 / &lt;800 Study: STOP 1.12 (0.84, 1.49) 0.6 STOP / SCOPE Folic acid supplement (μg): None 1.77 (0.85, 3.67) 0.1 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.00 (0.65, 1.54) 1.0 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.12 (0.74, 1.69) 0.6 "],["hpl-16.html", "26.2 HPL", " 26.2 HPL Model summary Var Effect P (Intercept) 1.84 (0.97, 3.46) 0.06 folate_cat2&lt;800 1.00 (0.68, 1.47) 0.99 folate_cat2&gt;=800 0.97 (0.65, 1.45) 0.88 StudySTOP 1.12 (0.73, 1.73) 0.61 GA_samp 1.33 (1.29, 1.38) &lt;0.0001 folate_cat2&lt;800:StudySTOP 1.03 (0.65, 1.63) 0.91 folate_cat2&gt;=800:StudySTOP 1.10 (0.69, 1.76) 0.69 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 64.96 12.54 129.26 44.33 95.18 &lt;800 SCOPE 65.19 6.22 144.08 53.99 78.71 &gt;=800 SCOPE 63.02 6.92 120.77 50.71 78.31 None STOP 72.79 8.66 209.98 57.57 92.04 &lt;800 STOP 74.97 5.38 128.75 65.04 86.41 &gt;=800 STOP 77.87 3.74 54.97 70.72 85.74 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.00 (0.62, 1.62) 1.0 &gt;=800 / None Study: SCOPE 0.97 (0.59, 1.59) 1.0 &gt;=800 / &lt;800 Study: SCOPE 0.97 (0.72, 1.30) 1.0 &lt;800 / None Study: STOP 1.03 (0.75, 1.41) 1.0 &gt;=800 / None Study: STOP 1.07 (0.80, 1.44) 0.9 &gt;=800 / &lt;800 Study: STOP 1.04 (0.87, 1.24) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.12 (0.72, 1.75) 0.6 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.15 (0.90, 1.47) 0.3 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.24 (0.97, 1.58) 0.09 "],["gh2-16.html", "26.3 GH2", " 26.3 GH2 Model summary Var Effect P (Intercept) 0.17 (0.08, 0.40) &lt;0.0001 folate_cat2&lt;800 0.85 (0.49, 1.47) 0.57 folate_cat2&gt;=800 0.92 (0.52, 1.63) 0.77 StudySTOP 0.97 (0.53, 1.77) 0.92 GA_samp 1.22 (1.17, 1.28) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.94 (0.49, 1.77) 0.84 folate_cat2&gt;=800:StudySTOP 0.96 (0.49, 1.84) 0.90 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 2.15 0.58 188.13 1.26 3.67 &lt;800 SCOPE 1.83 0.24 160.82 1.41 2.37 &gt;=800 SCOPE 1.97 0.32 176.83 1.43 2.71 None STOP 2.08 0.32 207.38 1.53 2.82 &lt;800 STOP 1.66 0.15 142.83 1.38 2.00 &gt;=800 STOP 1.83 0.11 61.09 1.61 2.07 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.85 (0.44, 1.66) 0.8 &gt;=800 / None Study: SCOPE 0.92 (0.45, 1.85) 1.0 &gt;=800 / &lt;800 Study: SCOPE 1.08 (0.70, 1.65) 0.9 &lt;800 / None Study: STOP 0.80 (0.53, 1.21) 0.4 &gt;=800 / None Study: STOP 0.88 (0.60, 1.29) 0.7 &gt;=800 / &lt;800 Study: STOP 1.10 (0.87, 1.39) 0.6 STOP / SCOPE Folic acid supplement (μg): None 0.97 (0.53, 1.79) 0.9 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.91 (0.65, 1.26) 0.6 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.93 (0.65, 1.32) 0.7 "],["insulin-14.html", "26.4 Insulin", " 26.4 Insulin Model summary Var Effect P (Intercept) 14.05 (2.32, 85.15) 0.004 folate_cat2&lt;800 1.46 (0.41, 5.13) 0.56 folate_cat2&gt;=800 1.03 (0.30, 3.60) 0.96 StudySTOP 1.22 (0.31, 4.87) 0.78 GA_samp 1.04 (0.95, 1.14) 0.36 folate_cat2&lt;800:StudySTOP 0.45 (0.10, 1.94) 0.28 folate_cat2&gt;=800:StudySTOP 0.63 (0.15, 2.65) 0.53 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 23.08 14.52 Inf 6.72 79.23 &lt;800 SCOPE 33.64 8.14 Inf 20.94 54.04 &gt;=800 SCOPE 23.78 5.08 Inf 15.65 36.14 None STOP 28.18 9.68 Inf 14.37 55.23 &lt;800 STOP 18.47 2.61 Inf 13.99 24.37 &gt;=800 STOP 18.36 1.80 Inf 15.15 22.26 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.46 (0.32, 6.56) 0.8 &gt;=800 / None Study: SCOPE 1.03 (0.23, 4.60) 1.0 &gt;=800 / &lt;800 Study: SCOPE 0.71 (0.38, 1.30) 0.4 &lt;800 / None Study: STOP 0.66 (0.27, 1.59) 0.5 &gt;=800 / None Study: STOP 0.65 (0.28, 1.53) 0.5 &gt;=800 / &lt;800 Study: STOP 0.99 (0.68, 1.45) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.22 (0.31, 4.87) 0.8 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.55 (0.30, 0.99) 0.05 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.77 (0.47, 1.28) 0.3 "],["homa-ir-14.html", "26.5 HOMA-IR", " 26.5 HOMA-IR Model summary Var Effect P (Intercept) 3.93 (0.55, 28.34) 0.17 folate_cat2&lt;800 1.59 (0.40, 6.35) 0.51 folate_cat2&gt;=800 1.12 (0.29, 4.39) 0.87 StudySTOP 1.07 (0.23, 4.92) 0.93 GA_samp 1.03 (0.94, 1.13) 0.52 folate_cat2&lt;800:StudySTOP 0.41 (0.08, 2.06) 0.28 folate_cat2&gt;=800:StudySTOP 0.57 (0.12, 2.72) 0.48 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.76 3.97 Inf 1.49 22.25 &lt;800 SCOPE 9.15 2.51 Inf 5.34 15.68 &gt;=800 SCOPE 6.46 1.43 Inf 4.19 9.96 None STOP 6.18 2.35 Inf 2.93 13.04 &lt;800 STOP 4.05 0.61 Inf 3.01 5.45 &gt;=800 STOP 3.94 0.42 Inf 3.20 4.86 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.59 (0.30, 8.34) 0.8 &gt;=800 / None Study: SCOPE 1.12 (0.22, 5.73) 1.0 &gt;=800 / &lt;800 Study: SCOPE 0.71 (0.36, 1.40) 0.5 &lt;800 / None Study: STOP 0.65 (0.25, 1.73) 0.6 &gt;=800 / None Study: STOP 0.64 (0.25, 1.63) 0.5 &gt;=800 / &lt;800 Study: STOP 0.97 (0.65, 1.46) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.07 (0.23, 4.92) 0.9 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.44 (0.23, 0.85) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.61 (0.36, 1.03) 0.07 "],["glucose-14.html", "26.6 Glucose", " 26.6 Glucose Model summary Var Effect P (Intercept) 5.24 (3.74, 7.35) &lt;0.0001 folate_cat2&lt;800 1.25 (1.05, 1.49) 0.01 folate_cat2&gt;=800 1.15 (1.00, 1.32) 0.06 StudySTOP 0.95 (0.82, 1.11) 0.52 GA_samp 1.00 (0.98, 1.02) 0.87 folate_cat2&lt;800:StudySTOP 0.81 (0.67, 0.98) 0.03 folate_cat2&gt;=800:StudySTOP 0.88 (0.74, 1.04) 0.13 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.13 0.26 Inf 4.64 5.67 &lt;800 SCOPE 6.40 0.40 Inf 5.67 7.23 &gt;=800 SCOPE 5.88 0.33 Inf 5.27 6.56 None STOP 4.88 0.26 Inf 4.40 5.41 &lt;800 STOP 4.91 0.14 Inf 4.65 5.19 &gt;=800 STOP 4.90 0.12 Inf 4.67 5.13 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.25 (1.01, 1.54) 0.03 &gt;=800 / None Study: SCOPE 1.15 (0.97, 1.36) 0.1 &gt;=800 / &lt;800 Study: SCOPE 0.92 (0.74, 1.14) 0.6 &lt;800 / None Study: STOP 1.01 (0.88, 1.15) 1.0 &gt;=800 / None Study: STOP 1.00 (0.88, 1.14) 1.0 &gt;=800 / &lt;800 Study: STOP 1.00 (0.94, 1.06) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.95 (0.82, 1.11) 0.5 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.77 (0.68, 0.86) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.83 (0.73, 0.95) 0.005 "],["fa-supp-4-categories-17.html", "27 FA supp: 4 categories", " 27 FA supp: 4 categories Characteristic None (n=22) &lt;=400 (n=9) &gt;400 to &lt;800 (n=62) &gt;=800 (n=142) Total (n=235) P-value Prolactin: Median (IQ range) 101.0 (73.4-288.8) 38.0 (19.0-57.8) 73.5 (44.1-128.2) 77.0 (47.8-111.6) 77.0 (45.6-120.5) 0.05 HPL: Median (IQ range) 87.0 (56.7-137.4) 66.4 (55.5-67.2) 66.5 (42.2-100.4) 59.6 (36.0-97.7) 65.0 (39.3-99.9) 0.27 GH2: Median (IQ range) 2.6 (1.9-3.3) 1.6 (1.2-3.6) 1.5 (1.0-2.7) 1.3 (0.9-2.3) 1.5 (1.0-2.6) 0.02 Insulin: Mean (SD) 59.7 (73.2) 47.2 (47.2) 35.9 (46.9) 29.4 (37.9) 34.1 (44.7) 0.06 HOMA.IR: Mean (SD) 16.4 (24.4) 15.2 (18.8) 9.1 (13.9) 7.4 (12.9) 8.8 (14.7) 0.07 GLUC3_mmol.L: Mean (SD) 5.3 (1.0) 6.2 (1.7) 5.3 (0.9) 5.1 (0.9) 5.2 (1.0) 0.007 LME or GEE for duplicated or repeated measures. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat3&quot; "],["prolactin-17.html", "27.1 Prolactin", " 27.1 Prolactin Model summary Var Effect P (Intercept) 10.34 (3.48, 30.62) &lt;0.0001 folate_cat3&lt;=400 1.70 (0.78, 3.69) 0.19 folate_cat3&gt;400 to &lt;800 1.46 (0.76, 2.82) 0.26 folate_cat3&gt;=800 1.51 (0.78, 2.92) 0.23 StudySTOP 1.73 (0.85, 3.54) 0.14 GA_samp 1.14 (1.08, 1.20) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.25 (0.08, 0.76) 0.02 folate_cat3&gt;400 to &lt;800:StudySTOP 0.62 (0.29, 1.33) 0.23 folate_cat3&gt;=800:StudySTOP 0.64 (0.30, 1.37) 0.26 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 50.63 17.79 152.13 25.29 101.39 &lt;=400 SCOPE 85.97 28.85 169.08 44.32 166.76 &gt;400 to &lt;800 SCOPE 74.15 17.70 84.81 46.13 119.20 &gt;=800 SCOPE 76.45 18.35 81.34 47.42 123.25 None STOP 87.80 21.11 88.69 54.46 141.56 &lt;=400 STOP 36.94 15.22 216.61 16.40 83.21 &gt;400 to &lt;800 STOP 79.33 15.13 40.95 53.97 116.59 &gt;=800 STOP 84.60 14.22 25.43 59.86 119.55 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.70 (0.59, 4.87) 0.6 &gt;400 to &lt;800 / None Study: SCOPE 1.46 (0.60, 3.55) 0.7 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.86 (0.39, 1.92) 1.0 &gt;=800 / None Study: SCOPE 1.51 (0.62, 3.68) 0.6 &gt;=800 / &lt;=400 Study: SCOPE 0.89 (0.39, 2.01) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.03 (0.57, 1.87) 1.0 &lt;=400 / None Study: STOP 0.42 (0.14, 1.25) 0.2 &gt;400 to &lt;800 / None Study: STOP 0.90 (0.52, 1.56) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 2.15 (0.78, 5.91) 0.2 &gt;=800 / None Study: STOP 0.96 (0.58, 1.61) 1.0 &gt;=800 / &lt;=400 Study: STOP 2.29 (0.85, 6.20) 0.1 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.07 (0.78, 1.47) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.73 (0.84, 3.59) 0.1 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.43 (0.16, 1.14) 0.09 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.07 (0.68, 1.67) 0.8 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.11 (0.73, 1.67) 0.6 "],["hpl-17.html", "27.2 HPL", " 27.2 HPL Model summary Var Effect P (Intercept) 1.81 (0.96, 3.39) 0.07 folate_cat3&lt;=400 0.90 (0.58, 1.40) 0.64 folate_cat3&gt;400 to &lt;800 1.06 (0.71, 1.57) 0.79 folate_cat3&gt;=800 0.97 (0.65, 1.45) 0.89 StudySTOP 1.13 (0.73, 1.74) 0.59 GA_samp 1.33 (1.29, 1.38) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.62 (0.82, 3.17) 0.17 folate_cat3&gt;400 to &lt;800:StudySTOP 0.95 (0.59, 1.53) 0.84 folate_cat3&gt;=800:StudySTOP 1.10 (0.69, 1.76) 0.69 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 64.60 12.51 130.74 44.04 94.75 &lt;=400 SCOPE 58.00 8.84 150.26 42.91 78.38 &gt;400 to &lt;800 SCOPE 68.31 7.37 156.98 55.21 84.52 &gt;=800 SCOPE 62.80 6.92 121.92 50.49 78.10 None STOP 72.88 8.67 207.91 57.65 92.15 &lt;=400 STOP 105.93 25.45 224.07 65.98 170.07 &gt;400 to &lt;800 STOP 73.24 5.40 135.42 63.30 84.73 &gt;=800 STOP 77.96 3.76 54.43 70.78 85.86 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.90 (0.49, 1.65) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 1.06 (0.62, 1.82) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.18 (0.76, 1.83) 0.8 &gt;=800 / None Study: SCOPE 0.97 (0.56, 1.68) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.08 (0.69, 1.69) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 0.92 (0.64, 1.31) 0.9 &lt;=400 / None Study: STOP 1.45 (0.73, 2.89) 0.5 &gt;400 to &lt;800 / None Study: STOP 1.00 (0.71, 1.43) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.69 (0.37, 1.31) 0.4 &gt;=800 / None Study: STOP 1.07 (0.77, 1.48) 0.9 &gt;=800 / &lt;=400 Study: STOP 0.74 (0.39, 1.37) 0.6 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.06 (0.87, 1.30) 0.8 STOP / SCOPE Folic acid supplement (μg): None 1.13 (0.72, 1.76) 0.6 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.83 (1.03, 3.23) 0.04 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.07 (0.82, 1.40) 0.6 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.24 (0.97, 1.59) 0.08 "],["gh2-17.html", "27.3 GH2", " 27.3 GH2 Model summary Var Effect P (Intercept) 0.18 (0.08, 0.41) &lt;0.0001 folate_cat3&lt;=400 0.76 (0.40, 1.45) 0.40 folate_cat3&gt;400 to &lt;800 0.89 (0.51, 1.57) 0.70 folate_cat3&gt;=800 0.92 (0.51, 1.63) 0.77 StudySTOP 0.96 (0.53, 1.77) 0.91 GA_samp 1.22 (1.17, 1.28) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.01 (0.40, 2.54) 0.98 folate_cat3&gt;400 to &lt;800:StudySTOP 0.90 (0.46, 1.73) 0.75 folate_cat3&gt;=800:StudySTOP 0.96 (0.49, 1.85) 0.90 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 2.16 0.59 187.34 1.26 3.70 &lt;=400 SCOPE 1.64 0.34 178.95 1.08 2.48 &gt;400 to &lt;800 SCOPE 1.92 0.29 183.34 1.43 2.59 &gt;=800 SCOPE 1.98 0.32 177.81 1.43 2.72 None STOP 2.08 0.32 205.93 1.53 2.83 &lt;=400 STOP 1.60 0.51 209.76 0.86 3.00 &gt;400 to &lt;800 STOP 1.66 0.16 150.84 1.38 2.01 &gt;=800 STOP 1.82 0.11 61.76 1.61 2.07 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.76 (0.32, 1.79) 0.8 &gt;400 to &lt;800 / None Study: SCOPE 0.89 (0.42, 1.91) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.17 (0.63, 2.18) 0.9 &gt;=800 / None Study: SCOPE 0.92 (0.42, 1.99) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.20 (0.64, 2.27) 0.9 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.03 (0.62, 1.71) 1.0 &lt;=400 / None Study: STOP 0.77 (0.31, 1.91) 0.9 &gt;400 to &lt;800 / None Study: STOP 0.80 (0.51, 1.27) 0.6 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.04 (0.45, 2.40) 1.0 &gt;=800 / None Study: STOP 0.88 (0.57, 1.34) 0.9 &gt;=800 / &lt;=400 Study: STOP 1.14 (0.50, 2.59) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.10 (0.84, 1.42) 0.8 STOP / SCOPE Folic acid supplement (μg): None 0.96 (0.52, 1.79) 0.9 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.98 (0.46, 2.09) 1.0 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.87 (0.60, 1.24) 0.4 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.92 (0.65, 1.32) 0.7 "],["insulin-15.html", "27.4 Insulin", " 27.4 Insulin Model summary Var Effect P (Intercept) 14.34 (2.36, 87.13) 0.004 folate_cat3&lt;=400 1.92 (0.48, 7.65) 0.36 folate_cat3&gt;400 to &lt;800 1.33 (0.37, 4.79) 0.66 folate_cat3&gt;=800 1.03 (0.29, 3.60) 0.96 StudySTOP 1.22 (0.30, 4.86) 0.78 GA_samp 1.04 (0.95, 1.13) 0.38 folate_cat3&lt;=400:StudySTOP 0.37 (0.07, 1.84) 0.22 folate_cat3&gt;400 to &lt;800:StudySTOP 0.49 (0.11, 2.15) 0.34 folate_cat3&gt;=800:StudySTOP 0.63 (0.15, 2.65) 0.53 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 23.17 14.59 Inf 6.74 79.63 &lt;=400 SCOPE 44.38 17.03 Inf 20.92 94.17 &gt;400 to &lt;800 SCOPE 30.84 8.38 Inf 18.11 52.52 &gt;=800 SCOPE 23.86 5.10 Inf 15.70 36.27 None STOP 28.19 9.68 Inf 14.39 55.25 &lt;=400 STOP 19.90 4.21 Inf 13.15 30.13 &gt;400 to &lt;800 STOP 18.34 2.74 Inf 13.68 24.58 &gt;=800 STOP 18.34 1.80 Inf 15.13 22.23 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.92 (0.31, 11.76) 0.8 &gt;400 to &lt;800 / None Study: SCOPE 1.33 (0.25, 7.13) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.69 (0.24, 2.03) 0.8 &gt;=800 / None Study: SCOPE 1.03 (0.20, 5.31) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.54 (0.20, 1.48) 0.4 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 0.77 (0.37, 1.62) 0.8 &lt;=400 / None Study: STOP 0.71 (0.24, 2.04) 0.8 &gt;400 to &lt;800 / None Study: STOP 0.65 (0.24, 1.73) 0.7 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.92 (0.49, 1.74) 1.0 &gt;=800 / None Study: STOP 0.65 (0.26, 1.66) 0.6 &gt;=800 / &lt;=400 Study: STOP 0.92 (0.52, 1.62) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.00 (0.65, 1.54) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.22 (0.30, 4.86) 0.8 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.45 (0.18, 1.11) 0.08 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.59 (0.31, 1.13) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.77 (0.46, 1.27) 0.3 "],["homa-ir-15.html", "27.5 HOMA-IR", " 27.5 HOMA-IR Model summary Var Effect P (Intercept) 4.11 (0.57, 29.72) 0.16 folate_cat3&lt;=400 2.43 (0.51, 11.52) 0.26 folate_cat3&gt;400 to &lt;800 1.37 (0.33, 5.61) 0.67 folate_cat3&gt;=800 1.12 (0.29, 4.39) 0.87 StudySTOP 1.07 (0.23, 4.89) 0.94 GA_samp 1.03 (0.94, 1.13) 0.56 folate_cat3&lt;=400:StudySTOP 0.26 (0.04, 1.56) 0.14 folate_cat3&gt;400 to &lt;800:StudySTOP 0.48 (0.09, 2.45) 0.38 folate_cat3&gt;=800:StudySTOP 0.57 (0.12, 2.72) 0.48 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.81 4.01 Inf 1.50 22.49 &lt;=400 SCOPE 14.14 6.46 Inf 5.78 34.60 &gt;400 to &lt;800 SCOPE 7.94 2.45 Inf 4.34 14.55 &gt;=800 SCOPE 6.51 1.44 Inf 4.22 10.03 None STOP 6.19 2.35 Inf 2.94 13.05 &lt;=400 STOP 3.95 0.81 Inf 2.64 5.92 &gt;400 to &lt;800 STOP 4.05 0.65 Inf 2.95 5.54 &gt;=800 STOP 3.93 0.42 Inf 3.19 4.85 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 2.43 (0.32, 18.68) 0.7 &gt;400 to &lt;800 / None Study: SCOPE 1.37 (0.21, 8.71) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.56 (0.16, 2.02) 0.7 &gt;=800 / None Study: SCOPE 1.12 (0.19, 6.70) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.46 (0.14, 1.51) 0.3 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 0.82 (0.36, 1.88) 0.9 &lt;=400 / None Study: STOP 0.64 (0.21, 1.99) 0.7 &gt;400 to &lt;800 / None Study: STOP 0.65 (0.22, 1.91) 0.7 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.02 (0.54, 1.94) 1.0 &gt;=800 / None Study: STOP 0.63 (0.23, 1.78) 0.7 &gt;=800 / &lt;=400 Study: STOP 0.99 (0.57, 1.73) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.97 (0.61, 1.55) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.07 (0.23, 4.89) 0.9 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.28 (0.10, 0.78) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.51 (0.25, 1.04) 0.07 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.60 (0.36, 1.02) 0.06 "],["glucose-15.html", "27.6 Glucose", " 27.6 Glucose Model summary Var Effect P (Intercept) 5.74 (4.48, 7.34) &lt;0.0001 folate_cat3&lt;=400 1.45 (1.17, 1.78) 0.0006 folate_cat3&gt;400 to &lt;800 1.11 (0.97, 1.27) 0.12 folate_cat3&gt;=800 1.14 (0.99, 1.31) 0.06 StudySTOP 0.94 (0.81, 1.08) 0.36 GA_samp 0.99 (0.98, 1.01) 0.33 folate_cat3&lt;=400:StudySTOP 0.63 (0.50, 0.80) &lt;0.0001 folate_cat3&gt;400 to &lt;800:StudySTOP 0.90 (0.76, 1.07) 0.23 folate_cat3&gt;=800:StudySTOP 0.87 (0.74, 1.03) 0.11 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.20 0.24 Inf 4.75 5.70 &lt;=400 SCOPE 7.52 0.73 Inf 6.23 9.09 &gt;400 to &lt;800 SCOPE 5.79 0.31 Inf 5.22 6.43 &gt;=800 SCOPE 5.94 0.32 Inf 5.34 6.60 None STOP 4.87 0.25 Inf 4.41 5.39 &lt;=400 STOP 4.47 0.09 Inf 4.29 4.65 &gt;400 to &lt;800 STOP 4.89 0.12 Inf 4.66 5.14 &gt;=800 STOP 4.85 0.10 Inf 4.66 5.05 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.45 (1.10, 1.90) 0.003 &gt;400 to &lt;800 / None Study: SCOPE 1.11 (0.93, 1.33) 0.4 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.77 (0.58, 1.03) 0.09 &gt;=800 / None Study: SCOPE 1.14 (0.95, 1.37) 0.2 &gt;=800 / &lt;=400 Study: SCOPE 0.79 (0.59, 1.05) 0.2 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.03 (0.84, 1.25) 1.0 &lt;=400 / None Study: STOP 0.92 (0.80, 1.05) 0.3 &gt;400 to &lt;800 / None Study: STOP 1.00 (0.87, 1.15) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.10 (1.03, 1.16) 0.0009 &gt;=800 / None Study: STOP 0.99 (0.87, 1.14) 1.0 &gt;=800 / &lt;=400 Study: STOP 1.09 (1.04, 1.13) &lt;0.0001 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.99 (0.93, 1.06) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.94 (0.81, 1.08) 0.4 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.59 (0.49, 0.72) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.84 (0.75, 0.95) 0.005 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.82 (0.73, 0.92) 0.0007 "],["age-groups-2.html", "28 Age groups", " 28 Age groups Descriptives with univariate P-values. Characteristic &lt;35 yrs (n=229) &gt;=35 yrs (n=27) Total (n=256) P-value PRL (ng/ml): Median (IQ range) 76.7 (45.6-121.8) 59.4 (42.7-110.7) 73.3 (45.3-120.9) 0.31 hPL (μg/ml): Median (IQ range) 66.2 (41.0-99.9) 35.4 (24.5-66.5) 61.4 (37.6-98.5) 0.006 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.2 (1.0-1.8) 1.5 (1.0-2.6) 0.41 Insulin (uU/ml): Median (IQ range) 17.7 (9.2-42.2) 13.0 (9.9-23.8) 17.3 (9.4-40.4) 0.37 HOMA-IR: Median (IQ range) 3.9 (1.9-9.6) 3.0 (2.2-5.9) 3.8 (1.9-9.1) 0.43 Glucose (mmol/L): Median (IQ range) 4.9 (4.5-5.6) 4.9 (4.6-5.3) 4.9 (4.5-5.6) 0.50 Within SCOPE Characteristic &lt;35 yrs (n=56) &gt;=35 yrs (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 92.0 (66.0-164.6) 25.7 (14.6-36.7) 92.0 (62.0-147.2) 0.01 hPL (μg/ml): Median (IQ range) 106.6 (91.4-134.3) 36.0 (36.0-36.0) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.2) 1.8 (1.8-1.8) 2.7 (1.6-4.2) 0.69 Insulin (uU/ml): Median (IQ range) 34.0 (16.6-52.7) 52.7 (35.0-70.4) 34.0 (16.6-55.4) 0.64 HOMA-IR: Median (IQ range) 8.1 (3.6-14.0) 13.7 (9.1-18.4) 8.1 (3.6-17.4) 0.70 Glucose (mmol/L): Median (IQ range) 5.8 (5.2-6.7) 5.8 (5.8-5.9) 5.8 (5.2-6.6) 0.93 Serum folate concentration (nM): Median (IQ range) 38.8 (31.7-43.8) 86.0 (63.5-108.6) 40.1 (32.0-43.8) 0.23 B12 concentration (pM): Median (IQ range) 254.5 (194.8-335.0) 205.0 (200.0-210.0) 253.5 (194.2-333.0) 0.31 Folate:B12 ratio: Median (IQ range) 152.8 (114.2-196.8) 410.0 (309.9-510.1) 158.9 (116.5-210.2) 0.11 Active B12 concentration (pM): Median (IQ range) 68.0 (55.0-85.5) 67.5 (50.8-84.2) 68.0 (55.0-86.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 553.8 (431.4-648.6) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) 0.65 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 4.1 (3.5-4.7) 3.9 (3.6-4.6) 0.94 Within STOP Characteristic &lt;35 yrs (n=173) &gt;=35 yrs (n=25) Total (n=198) P-value PRL (ng/ml): Median (IQ range) 73.0 (42.6-114.0) 62.6 (43.5-114.4) 68.8 (42.6-114.0) 0.83 hPL (μg/ml): Median (IQ range) 59.4 (37.8-85.3) 34.8 (24.4-67.2) 57.0 (35.8-84.1) 0.03 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.1 (1.0-2.0) 1.3 (0.9-2.2) 0.67 Insulin (uU/ml): Median (IQ range) 16.8 (8.5-36.9) 12.9 (9.6-23.8) 16.4 (8.7-36.0) 0.44 HOMA-IR: Median (IQ range) 3.5 (1.7-8.3) 2.8 (2.1-5.2) 3.4 (1.8-7.9) 0.53 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.2) 4.9 (4.5-5.3) 4.8 (4.5-5.2) 0.81 Serum folate concentration (nM): Median (IQ range) 39.7 (35.1-44.7) 41.3 (38.5-64.4) 40.1 (35.5-45.2) 0.08 B12 concentration (pM): Median (IQ range) 272.5 (221.2-345.8) 282.0 (187.0-376.0) 273.0 (217.5-348.5) 0.87 Folate:B12 ratio: Median (IQ range) 148.0 (114.1-217.6) 169.4 (102.0-285.2) 148.0 (112.4-225.9) 0.46 Active B12 concentration (pM): Median (IQ range) 75.0 (56.5-92.5) 75.0 (62.8-96.8) 75.0 (57.0-93.0) 1.00 Folate:Active B12 ratio: Median (IQ range) 521.2 (418.5-762.9) 809.3 (456.7-1008.0) 531.9 (417.3-788.4) 0.14 Homocysteine concentration (μM): Median (IQ range) 4.7 (4.0-5.4) 4.9 (4.5-5.2) 4.8 (4.0-5.3) 0.64 Red cell folate (nmol/L): Median (IQ range) 1536.5 (1311.0-1792.0) 1715.0 (1300.0-1792.0) 1543.0 (1300.0-1792.0) 0.23 mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ # if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) #mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log # mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} # if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))#} return(mod1)}) #mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) #mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) mod_em &lt;- foreach(ind1=1:length(mod_ls)) %dofuture% { if(!any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)} return(em1)} mod_em2 &lt;- foreach(ind2=1:length(mod_ls)) %dofuture% { if(!any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)} return(em2)} names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls)) %dofuture% { extract.ci.mod(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- c(hormone_var,insulin_var) mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-18.html", "28.1 Prolactin", " 28.1 Prolactin LME for repeated measures. Model summary Var Effect P (Intercept) 9.72 (3.79, 24.92) &lt;0.0001 Age_gp&gt;=35 yrs 0.45 (0.21, 0.93) 0.03 StudySTOP 1.15 (0.83, 1.59) 0.41 GA_samp 1.18 (1.11, 1.25) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 2.25 (1.01, 5.02) 0.05 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 70.04 10.16 Inf 52.71 93.06 &gt;=35 yrs SCOPE 31.35 11.34 Inf 15.43 63.68 &lt;35 yrs STOP 80.36 5.10 Inf 70.96 91.01 &gt;=35 yrs STOP 80.96 13.54 Inf 58.33 112.35 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.45 (0.21, 0.93) 0.03 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.01 (0.72, 1.41) 1.0 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.15 (0.83, 1.59) 0.4 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 2.58 (1.17, 5.71) 0.02 "],["hpl-18.html", "28.2 HPL", " 28.2 HPL LME for repeated measures. Model summary Var Effect P (Intercept) 1.54 (0.87, 2.70) 0.13 Age_gp&gt;=35 yrs 0.91 (0.68, 1.23) 0.55 StudySTOP 1.27 (1.06, 1.53) 0.01 GA_samp 1.35 (1.30, 1.40) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.79 (0.56, 1.12) 0.18 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 61.20 4.96 Inf 52.21 71.75 &gt;=35 yrs SCOPE 55.90 7.81 Inf 42.51 73.51 &lt;35 yrs STOP 77.95 2.54 Inf 73.13 83.09 &gt;=35 yrs STOP 56.16 4.84 Inf 47.44 66.49 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.91 (0.68, 1.23) 0.6 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.72 (0.60, 0.86) 0.0003 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.27 (1.06, 1.53) 0.01 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.00 (0.73, 1.39) 1.0 "],["gh2-18.html", "28.3 GH2", " 28.3 GH2 LME for repeated measures. Model summary Var Effect P (Intercept) 0.12 (0.06, 0.25) &lt;0.0001 Age_gp&gt;=35 yrs 0.76 (0.55, 1.04) 0.09 StudySTOP 0.96 (0.74, 1.26) 0.79 GA_samp 1.25 (1.19, 1.31) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.47 (0.99, 2.18) 0.05 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 1.84 0.20 Inf 1.50 2.27 &gt;=35 yrs SCOPE 1.40 0.19 Inf 1.06 1.83 &lt;35 yrs STOP 1.78 0.10 Inf 1.59 1.98 &gt;=35 yrs STOP 1.98 0.21 Inf 1.62 2.43 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.76 (0.55, 1.04) 0.09 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.12 (0.90, 1.39) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.96 (0.74, 1.26) 0.8 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.42 (1.01, 2.01) 0.05 "],["insulin-16.html", "28.4 Insulin", " 28.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 15.57 (4.30, 56.37) &lt;0.0001 Age_gp&gt;=35 yrs 1.41 (0.72, 2.76) 0.32 StudySTOP 0.71 (0.44, 1.14) 0.16 GA_samp 1.05 (0.96, 1.13) 0.28 Age_gp&gt;=35 yrs:StudySTOP 0.60 (0.28, 1.26) 0.17 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 26.75 5.54 Inf 17.82 40.14 &gt;=35 yrs SCOPE 37.70 12.23 Inf 19.96 71.20 &lt;35 yrs STOP 19.06 1.59 Inf 16.18 22.44 &gt;=35 yrs STOP 16.02 2.46 Inf 11.86 21.65 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.41 (0.72, 2.76) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.84 (0.61, 1.17) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.71 (0.44, 1.14) 0.2 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.42 (0.21, 0.88) 0.02 "],["homa-ir-16.html", "28.5 HOMA-IR", " 28.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 4.74 (1.19, 18.83) 0.03 Age_gp&gt;=35 yrs 1.36 (0.68, 2.72) 0.38 StudySTOP 0.57 (0.34, 0.95) 0.03 GA_samp 1.03 (0.95, 1.13) 0.44 Age_gp&gt;=35 yrs:StudySTOP 0.62 (0.29, 1.32) 0.21 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 7.21 1.62 Inf 4.64 11.19 &gt;=35 yrs SCOPE 9.82 3.22 Inf 5.17 18.66 &lt;35 yrs STOP 4.10 0.37 Inf 3.44 4.90 &gt;=35 yrs STOP 3.45 0.54 Inf 2.54 4.68 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.36 (0.68, 2.72) 0.4 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.84 (0.60, 1.17) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.57 (0.34, 0.95) 0.03 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.35 (0.17, 0.73) 0.005 "],["glucose-16.html", "28.6 Glucose", " 28.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 6.42 (4.89, 8.42) &lt;0.0001 Age_gp&gt;=35 yrs 0.96 (0.88, 1.05) 0.41 StudySTOP 0.80 (0.74, 0.88) &lt;0.0001 GA_samp 1.00 (0.97, 1.02) 0.69 Age_gp&gt;=35 yrs:StudySTOP 1.02 (0.92, 1.13) 0.69 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 6.06 0.25 Inf 5.58 6.57 &gt;=35 yrs SCOPE 5.82 0.08 Inf 5.66 5.99 &lt;35 yrs STOP 4.87 0.11 Inf 4.66 5.09 &gt;=35 yrs STOP 4.78 0.11 Inf 4.57 5.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.96 (0.88, 1.05) 0.4 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.98 (0.94, 1.02) 0.4 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.80 (0.74, 0.88) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.82 (0.77, 0.88) &lt;0.0001 "],["bmi-groups-2.html", "29 BMI groups", " 29 BMI groups Underweight and Normal merged into one group due to low numbers. Descriptives with univariate P-values. Characteristic Underweight/Normal (n=69) Overweight (n=53) Obese (n=134) Total (n=256) P-value PRL (ng/ml): Median (IQ range) 87.0 (49.4-151.6) 77.0 (35.9-111.0) 66.0 (45.0-108.6) 73.3 (45.3-120.9) 0.15 hPL (μg/ml): Median (IQ range) 85.3 (53.5-111.4) 79.6 (45.6-99.8) 50.2 (34.6-76.8) 61.4 (37.6-98.5) 0.0001 GH2 (ng/ml): Median (IQ range) 1.7 (1.1-2.7) 1.4 (0.9-2.9) 1.3 (1.0-2.3) 1.5 (1.0-2.6) 0.23 Insulin (uU/ml): Median (IQ range) 10.2 (5.5-30.5) 12.6 (8.5-20.1) 24.6 (13.4-47.1) 17.3 (9.4-40.4) &lt;0.0001 HOMA-IR: Median (IQ range) 2.1 (1.1-7.1) 2.7 (1.7-4.4) 5.5 (2.8-11.2) 3.8 (1.9-9.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.9 (4.4-5.2) 4.8 (4.5-5.6) 5.1 (4.6-5.8) 4.9 (4.5-5.6) 0.02 Within SCOPE Characteristic Underweight/Normal (n=14) Overweight (n=13) Obese (n=31) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 119.0 (86.9-144.9) 133.7 (87.4-214.9) 66.0 (55.9-111.0) 92.0 (62.0-147.2) 0.16 hPL (μg/ml): Median (IQ range) 106.6 (100.2-178.0) 98.8 (91.4-114.2) 106.6 (80.8-133.7) 106.2 (85.6-134.2) 0.80 GH2 (ng/ml): Median (IQ range) 2.6 (1.9-3.9) 4.2 (3.2-5.6) 1.9 (1.5-3.0) 2.7 (1.6-4.2) 0.13 Insulin (uU/ml): Median (IQ range) 25.1 (8.8-38.2) 17.1 (16.6-62.4) 41.4 (24.5-76.7) 34.0 (16.6-55.4) 0.07 HOMA-IR: Median (IQ range) 6.0 (2.0-11.1) 4.3 (3.5-18.6) 10.0 (4.9-20.1) 8.1 (3.6-17.4) 0.16 Glucose (mmol/L): Median (IQ range) 5.3 (5.1-6.4) 5.9 (5.6-6.4) 5.9 (5.6-6.7) 5.8 (5.2-6.6) 0.59 Serum folate concentration (nM): Median (IQ range) 43.6 (39.0-44.6) 36.9 (31.7-45.9) 39.6 (31.5-43.0) 40.1 (32.0-43.8) 0.44 B12 concentration (pM): Median (IQ range) 289.0 (170.5-372.5) 263.5 (224.2-309.8) 240.0 (192.0-301.0) 253.5 (194.2-333.0) 0.57 Folate:B12 ratio: Median (IQ range) 155.4 (114.2-232.5) 145.1 (121.9-190.5) 169.4 (118.7-199.0) 158.9 (116.5-210.2) 0.80 Active B12 concentration (pM): Median (IQ range) 83.5 (66.2-99.2) 58.5 (54.5-77.0) 77.0 (53.0-85.0) 68.0 (55.0-86.0) 0.59 Folate:Active B12 ratio: Median (IQ range) 553.9 (377.4-674.3) 535.8 (321.6-763.8) 553.8 (516.5-577.4) 553.8 (424.7-660.3) 0.89 Homocysteine concentration (μM): Median (IQ range) 4.3 (3.9-5.1) 4.0 (3.5-4.6) 3.7 (3.5-4.3) 3.9 (3.6-4.6) 0.06 Within STOP Characteristic Underweight/Normal (n=55) Overweight (n=40) Obese (n=103) Total (n=198) P-value PRL (ng/ml): Median (IQ range) 84.9 (48.4-151.6) 68.8 (33.6-110.6) 66.6 (43.3-107.8) 68.8 (42.6-114.0) 0.24 hPL (μg/ml): Median (IQ range) 69.6 (50.6-108.8) 68.0 (40.0-94.5) 47.1 (32.5-66.9) 57.0 (35.8-84.1) 0.0001 GH2 (ng/ml): Median (IQ range) 1.7 (1.1-2.1) 1.2 (0.8-2.5) 1.3 (0.9-2.2) 1.3 (0.9-2.2) 0.15 Insulin (uU/ml): Median (IQ range) 9.3 (5.3-28.2) 11.1 (7.7-17.6) 23.8 (12.9-44.6) 16.4 (8.7-36.0) &lt;0.0001 HOMA-IR: Median (IQ range) 1.8 (1.1-6.2) 2.4 (1.7-3.8) 5.0 (2.6-10.2) 3.4 (1.8-7.9) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.3-5.1) 4.7 (4.5-5.0) 4.9 (4.5-5.4) 4.8 (4.5-5.2) 0.03 Serum folate concentration (nM): Median (IQ range) 41.9 (37.2-54.0) 40.7 (37.0-55.6) 39.2 (34.4-43.8) 40.1 (35.5-45.2) 0.13 B12 concentration (pM): Median (IQ range) 297.5 (246.0-348.8) 258.0 (197.5-358.5) 269.5 (215.1-335.0) 273.0 (217.5-348.5) 0.15 Folate:B12 ratio: Median (IQ range) 136.4 (109.7-197.4) 153.1 (114.8-261.1) 150.2 (113.0-220.0) 148.0 (112.4-225.9) 0.76 Active B12 concentration (pM): Median (IQ range) 68.0 (55.0-79.0) 71.0 (54.0-104.5) 78.0 (61.5-92.5) 75.0 (57.0-93.0) 0.44 Folate:Active B12 ratio: Median (IQ range) 521.2 (457.3-770.2) 774.9 (426.9-879.1) 513.8 (411.6-650.2) 531.9 (417.3-788.4) 0.37 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.0-5.3) 4.8 (4.0-5.7) 4.8 (4.0-5.2) 4.8 (4.0-5.3) 0.83 Red cell folate (nmol/L): Median (IQ range) 1453.0 (1179.0-1767.0) 1770.0 (1417.0-1792.0) 1539.5 (1317.5-1792.0) 1543.0 (1300.0-1792.0) 0.02 "],["prolactin-19.html", "29.1 Prolactin", " 29.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 10.43 (3.76, 28.92) &lt;0.0001 BMI_gp4Overweight 1.34 (0.62, 2.92) 0.46 BMI_gp4Obese 0.70 (0.34, 1.40) 0.31 StudySTOP 1.29 (0.65, 2.57) 0.47 GA_samp 1.18 (1.11, 1.25) &lt;0.0001 BMI_gp4Overweight:StudySTOP 0.62 (0.26, 1.47) 0.28 BMI_gp4Obese:StudySTOP 1.08 (0.51, 2.29) 0.84 Estimated marginal means BMI_gp4 Study response SE df asymp.LCL asymp.UCL Underweight/Normal SCOPE 74.82 24.58 Inf 39.29 142.44 Overweight SCOPE 100.39 23.12 Inf 63.92 157.66 Obese SCOPE 52.06 8.87 Inf 37.28 72.69 Underweight/Normal STOP 96.47 11.17 Inf 76.88 121.06 Overweight STOP 80.16 12.67 Inf 58.80 109.28 Obese STOP 72.62 4.85 Inf 63.70 82.78 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Overweight / (Underweight/Normal) Study: SCOPE 1.34 (0.53, 3.40) 0.7 Obese / (Underweight/Normal) Study: SCOPE 0.70 (0.30, 1.61) 0.6 Obese / Overweight Study: SCOPE 0.52 (0.29, 0.93) 0.02 Overweight / (Underweight/Normal) Study: STOP 0.83 (0.53, 1.31) 0.6 Obese / (Underweight/Normal) Study: STOP 0.75 (0.56, 1.02) 0.07 Obese / Overweight Study: STOP 0.91 (0.61, 1.36) 0.8 STOP / SCOPE Maternal BMI: Underweight/Normal 1.29 (0.65, 2.57) 0.5 STOP / SCOPE Maternal BMI: Overweight 0.80 (0.46, 1.38) 0.4 STOP / SCOPE Maternal BMI: Obese 1.39 (0.95, 2.05) 0.09 "],["hpl-19.html", "29.2 HPL", " 29.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.80 (1.03, 3.15) 0.04 BMI_gp4Overweight 0.97 (0.72, 1.29) 0.81 BMI_gp4Obese 0.89 (0.69, 1.14) 0.36 StudySTOP 1.39 (1.11, 1.73) 0.004 GA_samp 1.34 (1.29, 1.38) &lt;0.0001 BMI_gp4Overweight:StudySTOP 0.90 (0.64, 1.25) 0.52 BMI_gp4Obese:StudySTOP 0.78 (0.59, 1.03) 0.08 Estimated marginal means BMI_gp4 Study response SE df asymp.LCL asymp.UCL Underweight/Normal SCOPE 66.28 6.85 Inf 54.12 81.18 Overweight SCOPE 64.01 8.29 Inf 49.66 82.51 Obese SCOPE 58.98 5.85 Inf 48.55 71.64 Underweight/Normal STOP 92.12 3.94 Inf 84.71 100.19 Overweight STOP 79.77 5.46 Inf 69.75 91.22 Obese STOP 64.10 2.49 Inf 59.39 69.18 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Overweight / (Underweight/Normal) Study: SCOPE 0.97 (0.68, 1.37) 1.0 Obese / (Underweight/Normal) Study: SCOPE 0.89 (0.66, 1.20) 0.6 Obese / Overweight Study: SCOPE 0.92 (0.65, 1.30) 0.8 Overweight / (Underweight/Normal) Study: STOP 0.87 (0.72, 1.04) 0.2 Obese / (Underweight/Normal) Study: STOP 0.70 (0.60, 0.80) &lt;0.0001 Obese / Overweight Study: STOP 0.80 (0.68, 0.96) 0.009 STOP / SCOPE Maternal BMI: Underweight/Normal 1.39 (1.11, 1.73) 0.004 STOP / SCOPE Maternal BMI: Overweight 1.25 (0.92, 1.70) 0.2 STOP / SCOPE Maternal BMI: Obese 1.09 (0.88, 1.35) 0.4 "],["gh2-19.html", "29.3 GH2", " 29.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.15 (0.07, 0.31) &lt;0.0001 BMI_gp4Overweight 0.99 (0.59, 1.66) 0.97 BMI_gp4Obese 0.67 (0.43, 1.04) 0.07 StudySTOP 0.92 (0.58, 1.47) 0.73 GA_samp 1.25 (1.19, 1.31) &lt;0.0001 BMI_gp4Overweight:StudySTOP 0.78 (0.44, 1.37) 0.38 BMI_gp4Obese:StudySTOP 1.22 (0.75, 1.99) 0.42 Estimated marginal means BMI_gp4 Study response SE df asymp.LCL asymp.UCL Underweight/Normal SCOPE 2.29 0.49 Inf 1.50 3.47 Overweight SCOPE 2.27 0.39 Inf 1.61 3.19 Obese SCOPE 1.53 0.15 Inf 1.26 1.84 Underweight/Normal STOP 2.10 0.20 Inf 1.75 2.52 Overweight STOP 1.62 0.15 Inf 1.35 1.93 Obese STOP 1.72 0.10 Inf 1.53 1.92 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Overweight / (Underweight/Normal) Study: SCOPE 0.99 (0.54, 1.84) 1.0 Obese / (Underweight/Normal) Study: SCOPE 0.67 (0.39, 1.14) 0.2 Obese / Overweight Study: SCOPE 0.67 (0.44, 1.02) 0.07 Overweight / (Underweight/Normal) Study: STOP 0.77 (0.58, 1.03) 0.08 Obese / (Underweight/Normal) Study: STOP 0.82 (0.64, 1.04) 0.1 Obese / Overweight Study: STOP 1.06 (0.84, 1.34) 0.8 STOP / SCOPE Maternal BMI: Underweight/Normal 0.92 (0.58, 1.47) 0.7 STOP / SCOPE Maternal BMI: Overweight 0.71 (0.47, 1.08) 0.1 STOP / SCOPE Maternal BMI: Obese 1.13 (0.89, 1.43) 0.3 "],["insulin-17.html", "29.4 Insulin", " 29.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 7.06 (2.02, 24.64) 0.002 BMI_gp4Overweight 1.74 (0.91, 3.33) 0.09 BMI_gp4Obese 3.27 (1.96, 5.43) &lt;0.0001 StudySTOP 0.94 (0.54, 1.65) 0.83 GA_samp 1.05 (0.97, 1.14) 0.22 BMI_gp4Overweight:StudySTOP 0.67 (0.32, 1.43) 0.31 BMI_gp4Obese:StudySTOP 0.66 (0.36, 1.19) 0.17 Estimated marginal means BMI_gp4 Study response SE df asymp.LCL asymp.UCL Underweight/Normal SCOPE 12.97 3.16 Inf 8.05 20.91 Overweight SCOPE 22.60 6.17 Inf 13.23 38.60 Obese SCOPE 42.37 7.96 Inf 29.32 61.23 Underweight/Normal STOP 12.22 1.60 Inf 9.45 15.81 Overweight STOP 14.37 2.21 Inf 10.63 19.42 Obese STOP 26.17 2.58 Inf 21.58 31.75 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Overweight / (Underweight/Normal) Study: SCOPE 1.74 (0.80, 3.78) 0.2 Obese / (Underweight/Normal) Study: SCOPE 3.27 (1.78, 6.00) &lt;0.0001 Obese / Overweight Study: SCOPE 1.87 (0.98, 3.60) 0.06 Overweight / (Underweight/Normal) Study: STOP 1.18 (0.74, 1.86) 0.7 Obese / (Underweight/Normal) Study: STOP 2.14 (1.48, 3.09) &lt;0.0001 Obese / Overweight Study: STOP 1.82 (1.22, 2.72) 0.001 STOP / SCOPE Maternal BMI: Underweight/Normal 0.94 (0.54, 1.65) 0.8 STOP / SCOPE Maternal BMI: Overweight 0.64 (0.33, 1.22) 0.2 STOP / SCOPE Maternal BMI: Obese 0.62 (0.39, 0.98) 0.04 "],["homa-ir-17.html", "29.5 HOMA-IR", " 29.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.13 (0.54, 8.44) 0.28 BMI_gp4Overweight 1.71 (0.78, 3.77) 0.18 BMI_gp4Obese 3.24 (1.75, 5.99) 0.0002 StudySTOP 0.72 (0.38, 1.38) 0.32 GA_samp 1.04 (0.96, 1.14) 0.35 BMI_gp4Overweight:StudySTOP 0.69 (0.29, 1.69) 0.42 BMI_gp4Obese:StudySTOP 0.71 (0.35, 1.42) 0.33 Estimated marginal means BMI_gp4 Study response SE df asymp.LCL asymp.UCL Underweight/Normal SCOPE 3.53 1.03 Inf 2.00 6.25 Overweight SCOPE 6.05 1.97 Inf 3.20 11.44 Obese SCOPE 11.43 2.39 Inf 7.59 17.23 Underweight/Normal STOP 2.54 0.35 Inf 1.94 3.33 Overweight STOP 3.02 0.50 Inf 2.19 4.17 Obese STOP 5.81 0.63 Inf 4.70 7.18 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Overweight / (Underweight/Normal) Study: SCOPE 1.71 (0.67, 4.40) 0.4 Obese / (Underweight/Normal) Study: SCOPE 3.24 (1.55, 6.76) 0.0005 Obese / Overweight Study: SCOPE 1.89 (0.86, 4.15) 0.1 Overweight / (Underweight/Normal) Study: STOP 1.19 (0.73, 1.93) 0.7 Obese / (Underweight/Normal) Study: STOP 2.29 (1.54, 3.39) &lt;0.0001 Obese / Overweight Study: STOP 1.92 (1.25, 2.96) 0.001 STOP / SCOPE Maternal BMI: Underweight/Normal 0.72 (0.38, 1.38) 0.3 STOP / SCOPE Maternal BMI: Overweight 0.50 (0.24, 1.06) 0.07 STOP / SCOPE Maternal BMI: Obese 0.51 (0.30, 0.85) 0.009 "],["glucose-17.html", "29.6 Glucose", " 29.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 6.52 (4.87, 8.73) &lt;0.0001 BMI_gp4Overweight 1.09 (0.85, 1.39) 0.51 BMI_gp4Obese 0.91 (0.78, 1.06) 0.23 StudySTOP 0.78 (0.67, 0.91) 0.001 GA_samp 1.00 (0.98, 1.01) 0.62 BMI_gp4Overweight:StudySTOP 0.91 (0.71, 1.17) 0.45 BMI_gp4Obese:StudySTOP 1.14 (0.97, 1.35) 0.11 Estimated marginal means BMI_gp4 Study response SE df asymp.LCL asymp.UCL Underweight/Normal SCOPE 6.16 0.43 Inf 5.38 7.07 Overweight SCOPE 6.70 0.68 Inf 5.50 8.17 Obese SCOPE 5.60 0.25 Inf 5.14 6.11 Underweight/Normal STOP 4.79 0.13 Inf 4.55 5.04 Overweight STOP 4.72 0.10 Inf 4.54 4.92 Obese STOP 4.98 0.12 Inf 4.75 5.21 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Overweight / (Underweight/Normal) Study: SCOPE 1.09 (0.81, 1.46) 0.8 Obese / (Underweight/Normal) Study: SCOPE 0.91 (0.75, 1.10) 0.5 Obese / Overweight Study: SCOPE 0.84 (0.64, 1.10) 0.3 Overweight / (Underweight/Normal) Study: STOP 0.99 (0.93, 1.05) 0.9 Obese / (Underweight/Normal) Study: STOP 1.04 (0.97, 1.11) 0.3 Obese / Overweight Study: STOP 1.05 (1.00, 1.11) 0.04 STOP / SCOPE Maternal BMI: Underweight/Normal 0.78 (0.67, 0.91) 0.001 STOP / SCOPE Maternal BMI: Overweight 0.71 (0.58, 0.86) 0.0005 STOP / SCOPE Maternal BMI: Obese 0.89 (0.80, 0.99) 0.03 "],["age-bmi-groups-2.html", "30 Age &amp; BMI groups", " 30 Age &amp; BMI groups Age &gt;=35 yrs (obese or non-obese) merged into one group due to low numbers. Descriptives with univariate P-values. Characteristic &lt;35y, non-obese (n=112) &lt;35y, obese (n=117) &gt;=35y (n=27) Total (n=256) P-value PRL (ng/ml): Median (IQ range) 81.4 (43.4-131.9) 73.3 (46.7-113.2) 59.4 (42.7-110.7) 73.3 (45.3-120.9) 0.48 hPL (μg/ml): Median (IQ range) 83.2 (51.0-108.8) 55.7 (37.4-79.9) 35.4 (24.5-66.5) 61.4 (37.6-98.5) 0.0001 GH2 (ng/ml): Median (IQ range) 1.7 (1.0-2.9) 1.3 (1.0-2.3) 1.2 (1.0-1.8) 1.5 (1.0-2.6) 0.31 Insulin (uU/ml): Median (IQ range) 11.9 (6.6-30.3) 26.6 (15.7-50.8) 13.0 (9.9-23.8) 17.3 (9.4-40.4) &lt;0.0001 HOMA-IR: Median (IQ range) 2.4 (1.4-6.4) 5.9 (3.3-12.1) 3.0 (2.2-5.9) 3.8 (1.9-9.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.3) 5.1 (4.6-5.8) 4.9 (4.6-5.3) 4.9 (4.5-5.6) 0.04 Within SCOPE Characteristic &lt;35y, non-obese (n=27) &lt;35y, obese (n=29) &gt;=35y (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 119.0 (87.4-179.1) 79.6 (59.7-120.5) 25.7 (14.6-36.7) 92.0 (62.0-147.2) 0.03 hPL (μg/ml): Median (IQ range) 105.8 (91.4-170.8) 113.3 (90.4-133.9) 36.0 (36.0-36.0) 106.2 (85.6-134.2) 0.25 GH2 (ng/ml): Median (IQ range) 3.3 (2.6-4.5) 2.0 (1.5-3.1) 1.8 (1.8-1.8) 2.7 (1.6-4.2) 0.28 Insulin (uU/ml): Median (IQ range) 17.1 (11.5-39.8) 41.4 (27.2-67.4) 52.7 (35.0-70.4) 34.0 (16.6-55.4) 0.08 HOMA-IR: Median (IQ range) 4.3 (3.1-11.4) 10.0 (5.6-17.4) 13.7 (9.1-18.4) 8.1 (3.6-17.4) 0.18 Glucose (mmol/L): Median (IQ range) 5.6 (5.1-6.4) 6.0 (5.6-6.7) 5.8 (5.8-5.9) 5.8 (5.2-6.6) 0.70 Serum folate concentration (nM): Median (IQ range) 41.3 (34.2-44.6) 38.0 (31.1-42.9) 86.0 (63.5-108.6) 40.1 (32.0-43.8) 0.35 B12 concentration (pM): Median (IQ range) 268.0 (212.5-350.0) 245.0 (192.0-314.0) 205.0 (200.0-210.0) 253.5 (194.2-333.0) 0.40 Folate:B12 ratio: Median (IQ range) 150.3 (114.2-232.5) 167.7 (115.9-185.4) 410.0 (309.9-510.1) 158.9 (116.5-210.2) 0.25 Active B12 concentration (pM): Median (IQ range) 63.0 (56.5-99.2) 77.0 (54.0-82.5) 67.5 (50.8-84.2) 68.0 (55.0-86.0) 0.97 Folate:Active B12 ratio: Median (IQ range) 540.4 (321.6-674.3) 553.8 (524.6-575.9) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) 0.81 Homocysteine concentration (μM): Median (IQ range) 4.2 (3.8-4.8) 3.7 (3.5-4.2) 4.1 (3.5-4.7) 3.9 (3.6-4.6) 0.14 Within STOP Characteristic &lt;35y, non-obese (n=85) &lt;35y, obese (n=88) &gt;=35y (n=25) Total (n=198) P-value PRL (ng/ml): Median (IQ range) 73.7 (41.0-122.2) 73.0 (44.0-111.6) 62.6 (43.5-114.4) 68.8 (42.6-114.0) 0.94 hPL (μg/ml): Median (IQ range) 69.4 (46.6-106.0) 50.2 (36.2-72.4) 34.8 (24.4-67.2) 57.0 (35.8-84.1) 0.0004 GH2 (ng/ml): Median (IQ range) 1.6 (0.9-2.2) 1.3 (0.9-2.2) 1.1 (1.0-2.0) 1.3 (0.9-2.2) 0.60 Insulin (uU/ml): Median (IQ range) 11.1 (6.3-26.3) 24.6 (13.6-47.0) 12.9 (9.6-23.8) 16.4 (8.7-36.0) &lt;0.0001 HOMA-IR: Median (IQ range) 2.1 (1.2-6.0) 5.5 (2.7-11.0) 2.8 (2.1-5.2) 3.4 (1.8-7.9) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.9 (4.5-5.4) 4.9 (4.5-5.3) 4.8 (4.5-5.2) 0.04 Serum folate concentration (nM): Median (IQ range) 40.7 (36.4-51.8) 39.0 (34.3-43.5) 41.3 (38.5-64.4) 40.1 (35.5-45.2) 0.04 B12 concentration (pM): Median (IQ range) 285.0 (232.5-358.5) 268.0 (217.2-306.0) 282.0 (187.0-376.0) 273.0 (217.5-348.5) 0.14 Folate:B12 ratio: Median (IQ range) 144.2 (107.9-222.2) 150.6 (116.9-211.0) 169.4 (102.0-285.2) 148.0 (112.4-225.9) 0.57 Active B12 concentration (pM): Median (IQ range) 69.0 (55.0-92.0) 78.0 (58.8-92.5) 75.0 (62.8-96.8) 75.0 (57.0-93.0) 0.68 Folate:Active B12 ratio: Median (IQ range) 569.2 (444.4-830.6) 509.1 (409.1-642.7) 809.3 (456.7-1008.0) 531.9 (417.3-788.4) 0.15 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.0-5.5) 4.8 (4.0-5.3) 4.9 (4.5-5.2) 4.8 (4.0-5.3) 0.88 Red cell folate (nmol/L): Median (IQ range) 1542.0 (1280.0-1792.0) 1526.0 (1320.2-1789.5) 1715.0 (1300.0-1792.0) 1543.0 (1300.0-1792.0) 0.47 "],["prolactin-20.html", "30.1 Prolactin", " 30.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 12.05 (4.70, 30.87) &lt;0.0001 Age_BMI_gp2&lt;35y, obese 0.67 (0.42, 1.06) 0.09 Age_BMI_gp2&gt;=35y 0.37 (0.16, 0.81) 0.01 StudySTOP 1.03 (0.65, 1.63) 0.91 GA_samp 1.17 (1.11, 1.25) &lt;0.0001 Age_BMI_gp2&lt;35y, obese:StudySTOP 1.24 (0.74, 2.08) 0.42 Age_BMI_gp2&gt;=35y:StudySTOP 2.51 (1.05, 6.01) 0.04 Estimated marginal means Age_BMI_gp2 Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 85.82 18.21 Inf 56.63 130.07 &lt;35y, obese SCOPE 57.47 8.38 Inf 43.18 76.49 &gt;=35y SCOPE 31.39 11.36 Inf 15.45 63.79 &lt;35y, non-obese STOP 88.16 8.59 Inf 72.83 106.71 &lt;35y, obese STOP 73.23 5.41 Inf 63.35 84.64 &gt;=35y STOP 80.90 13.53 Inf 58.29 112.28 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.67 (0.39, 1.16) 0.2 &gt;=35y / (&lt;35y, non-obese) Study: SCOPE 0.37 (0.14, 0.95) 0.04 &gt;=35y / &lt;35y, obese Study: SCOPE 0.55 (0.23, 1.31) 0.2 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.83 (0.63, 1.10) 0.3 &gt;=35y / (&lt;35y, non-obese) Study: STOP 0.92 (0.59, 1.43) 0.9 &gt;=35y / &lt;35y, obese Study: STOP 1.10 (0.73, 1.67) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.03 (0.65, 1.63) 0.9 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.27 (0.90, 1.79) 0.2 STOP / SCOPE Maternal age, BMI: &gt;=35y 2.58 (1.16, 5.70) 0.02 "],["hpl-20.html", "30.2 HPL", " 30.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.62 (0.91, 2.89) 0.10 Age_BMI_gp2&lt;35y, obese 0.91 (0.71, 1.17) 0.46 Age_BMI_gp2&gt;=35y 0.87 (0.64, 1.19) 0.39 StudySTOP 1.39 (1.12, 1.73) 0.003 GA_samp 1.34 (1.30, 1.39) &lt;0.0001 Age_BMI_gp2&lt;35y, obese:StudySTOP 0.84 (0.64, 1.10) 0.21 Age_BMI_gp2&gt;=35y:StudySTOP 0.72 (0.50, 1.04) 0.08 Estimated marginal means Age_BMI_gp2 Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 64.04 6.01 Inf 53.27 76.98 &lt;35y, obese SCOPE 58.37 6.54 Inf 46.86 72.70 &gt;=35y SCOPE 55.96 7.82 Inf 42.56 73.58 &lt;35y, non-obese STOP 89.01 3.89 Inf 81.70 96.98 &lt;35y, obese STOP 68.39 2.70 Inf 63.30 73.88 &gt;=35y STOP 56.14 4.84 Inf 47.40 66.47 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.91 (0.68, 1.22) 0.7 &gt;=35y / (&lt;35y, non-obese) Study: SCOPE 0.87 (0.60, 1.27) 0.7 &gt;=35y / &lt;35y, obese Study: SCOPE 0.96 (0.64, 1.43) 1.0 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.77 (0.67, 0.88) &lt;0.0001 &gt;=35y / (&lt;35y, non-obese) Study: STOP 0.63 (0.50, 0.79) &lt;0.0001 &gt;=35y / &lt;35y, obese Study: STOP 0.82 (0.66, 1.02) 0.09 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.39 (1.12, 1.73) 0.003 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.17 (0.92, 1.49) 0.2 STOP / SCOPE Maternal age, BMI: &gt;=35y 1.00 (0.73, 1.39) 1.0 "],["gh2-20.html", "30.3 GH2", " 30.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.14 (0.07, 0.31) &lt;0.0001 Age_BMI_gp2&lt;35y, obese 0.68 (0.50, 0.92) 0.01 Age_BMI_gp2&gt;=35y 0.62 (0.42, 0.90) 0.01 StudySTOP 0.83 (0.58, 1.18) 0.29 GA_samp 1.25 (1.19, 1.31) &lt;0.0001 Age_BMI_gp2&lt;35y, obese:StudySTOP 1.33 (0.93, 1.90) 0.12 Age_BMI_gp2&gt;=35y:StudySTOP 1.72 (1.10, 2.70) 0.02 Estimated marginal means Age_BMI_gp2 Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 2.27 0.33 Inf 1.71 3.01 &lt;35y, obese SCOPE 1.54 0.17 Inf 1.24 1.90 &gt;=35y SCOPE 1.40 0.19 Inf 1.06 1.83 &lt;35y, non-obese STOP 1.87 0.15 Inf 1.60 2.19 &lt;35y, obese STOP 1.69 0.10 Inf 1.50 1.90 &gt;=35y STOP 1.98 0.21 Inf 1.62 2.43 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.68 (0.47, 0.98) 0.04 &gt;=35y / (&lt;35y, non-obese) Study: SCOPE 0.62 (0.39, 0.96) 0.03 &gt;=35y / &lt;35y, obese Study: SCOPE 0.91 (0.61, 1.35) 0.8 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.90 (0.73, 1.12) 0.5 &gt;=35y / (&lt;35y, non-obese) Study: STOP 1.06 (0.79, 1.42) 0.9 &gt;=35y / &lt;35y, obese Study: STOP 1.17 (0.89, 1.54) 0.4 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.83 (0.58, 1.18) 0.3 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.10 (0.85, 1.43) 0.5 STOP / SCOPE Maternal age, BMI: &gt;=35y 1.42 (1.01, 2.01) 0.05 "],["insulin-18.html", "30.4 Insulin", " 30.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 10.33 (2.95, 36.17) 0.0003 Age_BMI_gp2&lt;35y, obese 2.56 (1.62, 4.06) &lt;0.0001 Age_BMI_gp2&gt;=35y 2.19 (1.09, 4.38) 0.03 StudySTOP 0.76 (0.45, 1.27) 0.29 GA_samp 1.04 (0.96, 1.13) 0.30 Age_BMI_gp2&lt;35y, obese:StudySTOP 0.81 (0.47, 1.39) 0.44 Age_BMI_gp2&gt;=35y:StudySTOP 0.56 (0.26, 1.21) 0.14 Estimated marginal means Age_BMI_gp2 Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 17.32 3.78 Inf 11.29 26.55 &lt;35y, obese SCOPE 44.40 8.76 Inf 30.15 65.37 &gt;=35y SCOPE 37.85 12.22 Inf 20.11 71.25 &lt;35y, non-obese STOP 13.13 1.46 Inf 10.56 16.31 &lt;35y, obese STOP 27.23 2.90 Inf 22.10 33.54 &gt;=35y STOP 16.00 2.46 Inf 11.84 21.61 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.56 (1.48, 4.44) 0.0002 &gt;=35y / (&lt;35y, non-obese) Study: SCOPE 2.19 (0.95, 5.01) 0.07 &gt;=35y / &lt;35y, obese Study: SCOPE 0.85 (0.39, 1.87) 0.9 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 2.07 (1.48, 2.91) &lt;0.0001 &gt;=35y / (&lt;35y, non-obese) Study: STOP 1.22 (0.80, 1.86) 0.5 &gt;=35y / &lt;35y, obese Study: STOP 0.59 (0.39, 0.89) 0.008 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.76 (0.45, 1.27) 0.3 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.61 (0.38, 0.99) 0.05 STOP / SCOPE Maternal age, BMI: &gt;=35y 0.42 (0.20, 0.87) 0.02 "],["homa-ir-18.html", "30.5 HOMA-IR", " 30.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.13 (0.80, 12.25) 0.10 Age_BMI_gp2&lt;35y, obese 2.58 (1.50, 4.44) 0.0006 Age_BMI_gp2&gt;=35y 2.10 (1.01, 4.36) 0.05 StudySTOP 0.58 (0.33, 1.04) 0.07 GA_samp 1.03 (0.95, 1.13) 0.45 Age_BMI_gp2&lt;35y, obese:StudySTOP 0.86 (0.46, 1.60) 0.63 Age_BMI_gp2&gt;=35y:StudySTOP 0.60 (0.27, 1.35) 0.22 Estimated marginal means Age_BMI_gp2 Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 4.69 1.16 Inf 2.88 7.62 &lt;35y, obese SCOPE 12.11 2.70 Inf 7.83 18.75 &gt;=35y SCOPE 9.84 3.22 Inf 5.19 18.68 &lt;35y, non-obese STOP 2.73 0.32 Inf 2.17 3.45 &lt;35y, obese STOP 6.06 0.71 Inf 4.81 7.63 &gt;=35y STOP 3.44 0.54 Inf 2.53 4.67 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.58 (1.35, 4.94) 0.002 &gt;=35y / (&lt;35y, non-obese) Study: SCOPE 2.10 (0.88, 5.03) 0.1 &gt;=35y / &lt;35y, obese Study: SCOPE 0.81 (0.36, 1.85) 0.8 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 2.22 (1.54, 3.20) &lt;0.0001 &gt;=35y / (&lt;35y, non-obese) Study: STOP 1.26 (0.81, 1.95) 0.4 &gt;=35y / &lt;35y, obese Study: STOP 0.57 (0.37, 0.88) 0.007 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.58 (0.33, 1.04) 0.07 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.50 (0.29, 0.86) 0.01 STOP / SCOPE Maternal age, BMI: &gt;=35y 0.35 (0.17, 0.73) 0.005 "],["glucose-18.html", "30.6 Glucose", " 30.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 6.71 (5.17, 8.70) &lt;0.0001 Age_BMI_gp2&lt;35y, obese 0.86 (0.72, 1.03) 0.10 Age_BMI_gp2&gt;=35y 0.90 (0.79, 1.03) 0.13 StudySTOP 0.74 (0.65, 0.85) &lt;0.0001 GA_samp 1.00 (0.98, 1.02) 0.77 Age_BMI_gp2&lt;35y, obese:StudySTOP 1.22 (1.01, 1.46) 0.04 Age_BMI_gp2&gt;=35y:StudySTOP 1.11 (0.96, 1.29) 0.14 Estimated marginal means Age_BMI_gp2 Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 6.45 0.42 Inf 5.68 7.34 &lt;35y, obese SCOPE 5.57 0.28 Inf 5.05 6.14 &gt;=35y SCOPE 5.82 0.08 Inf 5.66 5.98 &lt;35y, non-obese STOP 4.78 0.12 Inf 4.55 5.01 &lt;35y, obese STOP 5.01 0.13 Inf 4.76 5.27 &gt;=35y STOP 4.79 0.11 Inf 4.59 5.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.86 (0.70, 1.06) 0.2 &gt;=35y / (&lt;35y, non-obese) Study: SCOPE 0.90 (0.77, 1.06) 0.3 &gt;=35y / &lt;35y, obese Study: SCOPE 1.04 (0.93, 1.17) 0.6 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.05 (0.99, 1.11) 0.1 &gt;=35y / (&lt;35y, non-obese) Study: STOP 1.00 (0.95, 1.06) 1.0 &gt;=35y / &lt;35y, obese Study: STOP 0.96 (0.90, 1.02) 0.2 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.74 (0.65, 0.85) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.90 (0.80, 1.02) 0.09 STOP / SCOPE Maternal age, BMI: &gt;=35y 0.82 (0.77, 0.88) &lt;0.0001 "],["mets-5.html", "31 MetS", " 31 MetS Descriptives with univariate P-values. Characteristic No MetS (n=173) MetS (n=68) Total (n=241) P-value PRL (ng/ml): Median (IQ range) 73.6 (47.5-122.7) 64.1 (41.6-110.2) 71.9 (44.4-114.1) 0.19 hPL (μg/ml): Median (IQ range) 64.3 (37.8-100.2) 55.7 (37.4-79.8) 60.2 (37.4-91.8) 0.22 GH2 (ng/ml): Median (IQ range) 1.4 (1.0-2.5) 1.5 (1.0-2.4) 1.4 (1.0-2.4) 0.97 Insulin (uU/ml): Median (IQ range) 13.4 (7.7-30.2) 34.0 (17.6-58.7) 17.1 (9.4-38.5) &lt;0.0001 HOMA-IR: Median (IQ range) 3.0 (1.5-6.9) 8.3 (4.4-17.1) 3.8 (1.9-8.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.2) 5.8 (5.1-6.4) 5.0 (4.5-5.6) &lt;0.0001 Within SCOPE Characteristic No MetS (n=29) MetS (n=28) Total (n=57) P-value PRL (ng/ml): Median (IQ range) 119.0 (74.7-180.2) 73.7 (54.6-101.6) 92.0 (62.0-147.2) 0.09 hPL (μg/ml): Median (IQ range) 117.2 (105.8-161.5) 96.2 (77.6-113.5) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 3.0 (1.6-4.4) 2.0 (1.6-3.1) 2.7 (1.6-4.2) 0.49 Insulin (uU/ml): Median (IQ range) 19.6 (12.1-43.2) 39.9 (17.6-82.7) 31.9 (16.6-51.0) 0.15 HOMA-IR: Median (IQ range) 5.1 (3.1-11.4) 9.8 (4.4-23.2) 8.1 (3.6-17.4) 0.15 Glucose (mmol/L): Median (IQ range) 5.5 (5.0-6.3) 6.1 (5.8-6.7) 5.8 (5.2-6.6) 0.01 Serum folate concentration (nM): Median (IQ range) 39.7 (31.7-44.0) 39.6 (31.9-42.3) 39.6 (31.9-43.8) 0.90 B12 concentration (pM): Median (IQ range) 274.0 (196.2-341.5) 240.0 (193.5-296.5) 254.0 (193.5-334.0) 0.39 Folate:B12 ratio: Median (IQ range) 152.8 (112.5-184.8) 167.7 (121.8-210.6) 155.4 (115.4-210.6) 0.59 Active B12 concentration (pM): Median (IQ range) 85.0 (58.0-99.5) 60.0 (53.0-79.0) 66.5 (54.5-89.2) 0.28 Folate:Active B12 ratio: Median (IQ range) 516.5 (418.5-688.3) 560.9 (424.7-636.8) 546.6 (419.7-674.3) 0.61 Homocysteine concentration (μM): Median (IQ range) 4.1 (3.8-4.7) 3.7 (3.5-4.1) 3.9 (3.6-4.6) 0.10 Within STOP Characteristic No MetS (n=144) MetS (n=40) Total (n=184) P-value PRL (ng/ml): Median (IQ range) 70.4 (43.4-111.5) 56.2 (38.6-110.4) 68.4 (42.3-111.0) 0.21 hPL (μg/ml): Median (IQ range) 59.4 (35.3-85.7) 50.0 (36.2-65.0) 55.6 (35.3-83.0) 0.06 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.1) 1.2 (0.8-2.0) 1.3 (0.9-2.1) 0.39 Insulin (uU/ml): Median (IQ range) 13.0 (7.3-28.6) 32.5 (18.4-52.3) 16.2 (8.7-35.0) &lt;0.0001 HOMA-IR: Median (IQ range) 2.6 (1.5-6.1) 7.6 (3.9-14.9) 3.4 (1.7-7.6) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.5-5.1) 5.3 (4.8-6.1) 4.8 (4.5-5.2) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.7 (36.0-54.3) 37.2 (33.8-41.7) 40.0 (35.1-45.2) 0.02 B12 concentration (pM): Median (IQ range) 278.0 (218.0-358.5) 264.0 (207.0-306.0) 273.5 (216.8-352.0) 0.24 Folate:B12 ratio: Median (IQ range) 147.7 (110.8-230.6) 149.8 (114.6-211.8) 148.0 (111.9-227.3) 0.94 Active B12 concentration (pM): Median (IQ range) 75.5 (56.0-90.2) 73.0 (57.5-92.2) 75.5 (56.0-91.8) 0.92 Folate:Active B12 ratio: Median (IQ range) 531.9 (420.0-836.9) 551.8 (417.2-693.7) 536.4 (420.0-811.7) 0.73 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.4) 4.8 (4.1-5.2) 4.8 (4.0-5.3) 0.92 Red cell folate (nmol/L): Median (IQ range) 1544.0 (1327.5-1792.0) 1536.0 (1280.5-1792.0) 1543.5 (1304.0-1792.0) 0.52 "],["prolactin-21.html", "31.1 Prolactin", " 31.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 18.36 (6.75, 49.91) &lt;0.0001 metab.C1MetS 0.64 (0.40, 1.02) 0.06 StudySTOP 0.87 (0.57, 1.32) 0.50 GA_samp 1.14 (1.07, 1.22) 0.0001 metab.C1MetS:StudySTOP 1.53 (0.86, 2.70) 0.15 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 87.62 17.25 Inf 59.57 128.89 MetS SCOPE 55.85 11.09 Inf 37.85 82.41 No MetS STOP 75.85 5.03 Inf 66.61 86.37 MetS STOP 73.81 10.85 Inf 55.33 98.46 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.64 (0.40, 1.02) 0.06 MetS / No MetS Study: STOP 0.97 (0.71, 1.33) 0.9 STOP / SCOPE MetS: No MetS 0.87 (0.57, 1.32) 0.5 STOP / SCOPE MetS: MetS 1.32 (0.79, 2.20) 0.3 "],["hpl-21.html", "31.2 HPL", " 31.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.51 (0.80, 2.86) 0.20 metab.C1MetS 0.96 (0.76, 1.20) 0.72 StudySTOP 1.24 (0.99, 1.55) 0.06 GA_samp 1.35 (1.30, 1.41) &lt;0.0001 metab.C1MetS:StudySTOP 0.92 (0.69, 1.22) 0.56 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 60.58 6.27 Inf 49.46 74.20 MetS SCOPE 58.07 5.73 Inf 47.87 70.45 No MetS STOP 75.20 2.47 Inf 70.51 80.21 MetS STOP 66.28 5.47 Inf 56.38 77.91 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.96 (0.76, 1.20) 0.7 MetS / No MetS Study: STOP 0.88 (0.75, 1.04) 0.1 STOP / SCOPE MetS: No MetS 1.24 (0.99, 1.55) 0.06 STOP / SCOPE MetS: MetS 1.14 (0.86, 1.51) 0.4 "],["gh2-21.html", "31.3 GH2", " 31.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.17 (0.07, 0.39) &lt;0.0001 metab.C1MetS 0.70 (0.53, 0.94) 0.02 StudySTOP 0.81 (0.58, 1.15) 0.25 GA_samp 1.23 (1.17, 1.30) &lt;0.0001 metab.C1MetS:StudySTOP 1.36 (0.96, 1.93) 0.08 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.14 0.32 Inf 1.60 2.87 MetS SCOPE 1.51 0.15 Inf 1.24 1.83 No MetS STOP 1.74 0.10 Inf 1.55 1.96 MetS STOP 1.68 0.17 Inf 1.38 2.04 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.70 (0.53, 0.94) 0.02 MetS / No MetS Study: STOP 0.96 (0.79, 1.17) 0.7 STOP / SCOPE MetS: No MetS 0.81 (0.58, 1.15) 0.2 STOP / SCOPE MetS: MetS 1.11 (0.80, 1.54) 0.5 "],["insulin-19.html", "31.4 Insulin", " 31.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 10.11 (2.82, 36.32) 0.0004 metab.C1MetS 1.99 (1.21, 3.30) 0.007 StudySTOP 0.82 (0.48, 1.39) 0.46 GA_samp 1.05 (0.97, 1.14) 0.21 metab.C1MetS:StudySTOP 1.11 (0.61, 2.02) 0.73 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 18.78 4.52 Inf 11.72 30.11 MetS SCOPE 37.44 7.64 Inf 25.10 55.86 No MetS STOP 15.43 1.29 Inf 13.10 18.16 MetS STOP 34.22 5.10 Inf 25.55 45.84 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.99 (1.21, 3.30) 0.007 MetS / No MetS Study: STOP 2.22 (1.61, 3.05) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.82 (0.48, 1.39) 0.5 STOP / SCOPE MetS: MetS 0.91 (0.53, 1.57) 0.7 "],["homa-ir-19.html", "31.5 HOMA-IR", " 31.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.69 (0.69, 10.47) 0.15 metab.C1MetS 2.05 (1.16, 3.62) 0.01 StudySTOP 0.66 (0.37, 1.18) 0.16 GA_samp 1.05 (0.96, 1.14) 0.26 metab.C1MetS:StudySTOP 1.24 (0.63, 2.43) 0.53 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 4.91 1.29 Inf 2.94 8.23 MetS SCOPE 10.09 2.25 Inf 6.51 15.62 No MetS STOP 3.26 0.29 Inf 2.74 3.87 MetS STOP 8.29 1.39 Inf 5.97 11.52 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.05 (1.16, 3.62) 0.01 MetS / No MetS Study: STOP 2.55 (1.79, 3.63) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.66 (0.37, 1.18) 0.2 STOP / SCOPE MetS: MetS 0.82 (0.46, 1.48) 0.5 "],["glucose-19.html", "31.6 Glucose", " 31.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.52 (4.03, 7.56) &lt;0.0001 metab.C1MetS 1.12 (0.92, 1.35) 0.26 StudySTOP 0.85 (0.75, 0.96) 0.008 GA_samp 1.00 (0.98, 1.02) 0.85 metab.C1MetS:StudySTOP 1.01 (0.83, 1.23) 0.93 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 5.67 0.29 Inf 5.13 6.28 MetS SCOPE 6.33 0.44 Inf 5.53 7.25 No MetS STOP 4.83 0.11 Inf 4.62 5.05 MetS STOP 5.44 0.19 Inf 5.08 5.82 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.12 (0.92, 1.35) 0.3 MetS / No MetS Study: STOP 1.13 (1.06, 1.20) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.85 (0.75, 0.96) 0.008 STOP / SCOPE MetS: MetS 0.86 (0.75, 0.98) 0.02 "],["birthweight-centile-2.html", "32 Birthweight centile", " 32 Birthweight centile Descriptives with univariate P-values. Characteristic &lt;=90th centile (n=223) &gt;90th centile (n=31) Total (n=254) P-value PRL (ng/ml): Median (IQ range) 67.2 (43.9-113.0) 101.2 (82.0-181.8) 73.6 (45.6-121.8) 0.001 hPL (μg/ml): Median (IQ range) 61.3 (38.1-98.8) 67.2 (34.2-86.3) 61.4 (37.4-98.0) 0.93 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.3 (1.0-2.7) 1.5 (1.0-2.6) 0.97 Insulin (uU/ml): Median (IQ range) 17.6 (9.6-39.0) 16.8 (8.0-47.2) 17.6 (9.5-40.5) 0.98 HOMA-IR: Median (IQ range) 3.9 (2.0-8.9) 3.3 (1.8-10.2) 3.8 (1.9-9.2) 0.90 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.6) 4.8 (4.5-5.4) 4.9 (4.5-5.6) 0.21 Within SCOPE Characteristic &lt;=90th centile (n=50) &gt;90th centile (n=8) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 87.6 (59.0-138.5) 114.4 (93.1-148.1) 92.0 (62.0-147.2) 0.58 hPL (μg/ml): Median (IQ range) 105.8 (86.1-152.6) 107.3 (95.5-119.5) 106.2 (85.6-134.2) 1.00 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.0) 3.4 (2.3-4.3) 2.7 (1.6-4.2) 0.81 Insulin (uU/ml): Median (IQ range) 31.9 (16.6-54.1) 39.9 (21.0-58.3) 34.0 (16.6-55.4) 0.84 HOMA-IR: Median (IQ range) 7.4 (3.7-16.1) 10.1 (5.4-14.6) 8.1 (3.6-17.4) 0.82 Glucose (mmol/L): Median (IQ range) 5.9 (5.2-6.6) 5.6 (5.4-6.0) 5.8 (5.2-6.6) 0.50 Serum folate concentration (nM): Median (IQ range) 39.6 (32.2-43.8) 41.4 (32.1-43.7) 40.1 (32.0-43.8) 0.93 B12 concentration (pM): Median (IQ range) 245.0 (192.0-332.0) 257.0 (245.0-324.5) 253.5 (194.2-333.0) 0.29 Folate:B12 ratio: Median (IQ range) 167.7 (118.7-211.5) 122.6 (114.2-155.7) 158.9 (116.5-210.2) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (53.0-81.5) 85.0 (77.0-104.0) 68.0 (55.0-86.0) 0.14 Folate:Active B12 ratio: Median (IQ range) 559.7 (436.8-674.3) 438.2 (424.7-516.5) 553.8 (424.7-660.3) 0.32 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 3.8 (3.7-4.2) 3.9 (3.6-4.6) 0.66 Within STOP Characteristic &lt;=90th centile (n=173) &gt;90th centile (n=23) Total (n=196) P-value PRL (ng/ml): Median (IQ range) 64.1 (42.3-111.0) 99.2 (82.6-186.0) 70.4 (43.2-114.3) 0.002 hPL (μg/ml): Median (IQ range) 57.0 (36.2-83.8) 56.7 (33.7-81.4) 57.0 (35.5-83.8) 0.85 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.3 (0.9-1.9) 1.3 (0.9-2.2) 0.80 Insulin (uU/ml): Median (IQ range) 16.4 (8.8-34.8) 16.5 (8.6-46.0) 16.4 (8.8-36.5) 0.77 HOMA-IR: Median (IQ range) 3.4 (1.8-7.5) 3.3 (1.9-9.8) 3.4 (1.8-8.1) 0.87 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.3) 4.5 (4.4-5.0) 4.8 (4.5-5.2) 0.07 Serum folate concentration (nM): Median (IQ range) 39.8 (35.2-44.7) 43.8 (38.4-65.7) 40.1 (35.6-45.2) 0.05 B12 concentration (pM): Median (IQ range) 275.5 (216.8-354.5) 270.0 (207.0-293.5) 273.0 (216.0-349.0) 0.35 Folate:B12 ratio: Median (IQ range) 145.9 (108.9-220.0) 163.2 (132.0-288.2) 148.0 (113.6-227.7) 0.08 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-90.2) 82.0 (69.0-103.0) 75.0 (56.5-92.5) 0.31 Folate:Active B12 ratio: Median (IQ range) 529.7 (418.5-783.6) 531.9 (439.6-840.5) 531.9 (418.5-792.6) 0.72 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.4) 4.6 (3.8-4.8) 4.8 (4.0-5.3) 0.06 Red cell folate (nmol/L): Median (IQ range) 1514.0 (1292.8-1792.0) 1792.0 (1584.5-1792.0) 1544.0 (1317.0-1792.0) 0.003 "],["prolactin-22.html", "32.1 Prolactin", " 32.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 7.33 (2.55, 21.09) 0.0002 BW_gp&gt;90th centile 1.60 (1.14, 2.24) 0.007 StudySTOP 1.27 (0.86, 1.87) 0.23 GA_samp 1.19 (1.11, 1.27) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.06 (0.61, 1.85) 0.84 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 60.33 10.32 Inf 43.15 84.35 &gt;90th centile SCOPE 96.25 12.53 Inf 74.57 124.24 &lt;=90th centile STOP 76.64 4.76 Inf 67.86 86.55 &gt;90th centile STOP 129.54 28.79 Inf 83.81 200.24 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.60 (1.14, 2.24) 0.007 &gt;90th centile / &lt;=90th centile Study: STOP 1.69 (1.08, 2.64) 0.02 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.27 (0.86, 1.87) 0.2 STOP / SCOPE Birthweight centile: &gt;90th centile 1.35 (0.80, 2.27) 0.3 "],["hpl-22.html", "32.2 HPL", " 32.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.50 (0.87, 2.57) 0.14 BW_gp&gt;90th centile 1.42 (1.10, 1.82) 0.006 StudySTOP 1.26 (1.06, 1.50) 0.008 GA_samp 1.34 (1.30, 1.39) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.71 (0.52, 0.97) 0.03 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 58.89 4.63 Inf 50.48 68.71 &gt;90th centile SCOPE 83.47 9.66 Inf 66.53 104.74 &lt;=90th centile STOP 74.43 2.23 Inf 70.18 78.93 &gt;90th centile STOP 75.31 7.33 Inf 62.23 91.15 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.42 (1.10, 1.82) 0.006 &gt;90th centile / &lt;=90th centile Study: STOP 1.01 (0.84, 1.22) 0.9 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.26 (1.06, 1.50) 0.008 STOP / SCOPE Birthweight centile: &gt;90th centile 0.90 (0.66, 1.23) 0.5 "],["gh2-22.html", "32.3 GH2", " 32.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.12 (0.06, 0.24) &lt;0.0001 BW_gp&gt;90th centile 1.17 (0.93, 1.48) 0.19 StudySTOP 1.02 (0.79, 1.33) 0.87 GA_samp 1.25 (1.19, 1.31) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.77 (0.55, 1.08) 0.13 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 1.78 0.19 Inf 1.44 2.20 &gt;90th centile SCOPE 2.08 0.21 Inf 1.71 2.54 &lt;=90th centile STOP 1.82 0.10 Inf 1.64 2.02 &gt;90th centile STOP 1.65 0.21 Inf 1.28 2.11 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.17 (0.93, 1.48) 0.2 &gt;90th centile / &lt;=90th centile Study: STOP 0.90 (0.70, 1.16) 0.4 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.02 (0.79, 1.33) 0.9 STOP / SCOPE Birthweight centile: &gt;90th centile 0.79 (0.55, 1.13) 0.2 "],["insulin-20.html", "32.4 Insulin", " 32.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 18.19 (5.19, 63.72) &lt;0.0001 BW_gp&gt;90th centile 0.54 (0.24, 1.23) 0.14 StudySTOP 0.62 (0.39, 0.97) 0.04 GA_samp 1.04 (0.96, 1.13) 0.31 BW_gp&gt;90th centile:StudySTOP 2.12 (0.82, 5.52) 0.12 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 29.87 5.85 Inf 20.35 43.85 &gt;90th centile SCOPE 16.10 6.56 Inf 7.24 35.79 &lt;=90th centile STOP 18.48 1.49 Inf 15.79 21.64 &gt;90th centile STOP 21.14 5.05 Inf 13.23 33.76 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 0.54 (0.24, 1.23) 0.1 &gt;90th centile / &lt;=90th centile Study: STOP 1.14 (0.70, 1.85) 0.6 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.62 (0.39, 0.97) 0.04 STOP / SCOPE Birthweight centile: &gt;90th centile 1.31 (0.51, 3.38) 0.6 "],["homa-ir-20.html", "32.5 HOMA-IR", " 32.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 5.43 (1.39, 21.16) 0.01 BW_gp&gt;90th centile 0.56 (0.24, 1.30) 0.18 StudySTOP 0.50 (0.30, 0.83) 0.007 GA_samp 1.03 (0.95, 1.12) 0.47 BW_gp&gt;90th centile:StudySTOP 1.94 (0.73, 5.12) 0.18 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 7.98 1.75 Inf 5.19 12.26 &gt;90th centile SCOPE 4.50 1.80 Inf 2.05 9.87 &lt;=90th centile STOP 4.01 0.35 Inf 3.38 4.75 &gt;90th centile STOP 4.37 1.07 Inf 2.71 7.07 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 0.56 (0.24, 1.30) 0.2 &gt;90th centile / &lt;=90th centile Study: STOP 1.09 (0.66, 1.80) 0.7 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.50 (0.30, 0.83) 0.007 STOP / SCOPE Birthweight centile: &gt;90th centile 0.97 (0.38, 2.50) 1.0 "],["glucose-20.html", "32.6 Glucose", " 32.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 6.43 (4.92, 8.42) &lt;0.0001 BW_gp&gt;90th centile 0.96 (0.84, 1.11) 0.61 StudySTOP 0.81 (0.74, 0.88) &lt;0.0001 GA_samp 1.00 (0.97, 1.02) 0.69 BW_gp&gt;90th centile:StudySTOP 0.98 (0.85, 1.14) 0.84 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 6.07 0.27 Inf 5.56 6.62 &gt;90th centile SCOPE 5.86 0.27 Inf 5.34 6.42 &lt;=90th centile STOP 4.90 0.11 Inf 4.69 5.12 &gt;90th centile STOP 4.66 0.13 Inf 4.41 4.91 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 0.96 (0.84, 1.11) 0.6 &gt;90th centile / &lt;=90th centile Study: STOP 0.95 (0.91, 0.99) 0.02 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.81 (0.74, 0.88) &lt;0.0001 STOP / SCOPE Birthweight centile: &gt;90th centile 0.80 (0.70, 0.90) 0.0002 "],["hormone-models-2.html", "33 Hormone Models", " 33 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 11 0 15wks 39 193 "],["raw-plots-2.html", "33.1 Raw plots", " 33.1 Raw plots "],["scope-vs-stop-2.html", "33.2 SCOPE vs STOP", " 33.2 SCOPE vs STOP Fit LME models for Prolactin, HPL and GH2. Fit GEE models for Insulin and HOMA-IR. Outcomes: Prolactin, hPL, GH2, Insulin, HOMA-IR, Glucose (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME or GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       LME only: Random intercepts for Study ID and Plate       GEE only: Independence correlation structure 33.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 2.473411 1 0.1 ns Study 1.757843 1 0.2 ns GA_samp 8.736573 1 0.003 ** Study:GA_samp 1.550230 1 0.2 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 11.118300 1 0.0009 *** Study 5.570424 1 0.02 * GA_samp 33.105635 1 &lt;0.0001 *** Study:GA_samp 7.350297 1 0.007 ** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 1.122593 1 0.3 ns Study 5.234170 1 0.02 * GA_samp 8.992223 1 0.003 ** Study:GA_samp 5.263896 1 0.02 * Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 0.395 0.395 0.5 ns 3 GA_samp 1 Inf 1.567 1.567 0.2 ns 2 Study:GA_samp 1 Inf 0.731 0.731 0.4 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 0.298 0.298 0.6 ns 3 GA_samp 1 Inf 1.230 1.230 0.3 ns 2 Study:GA_samp 1 Inf 0.765 0.765 0.4 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 0.006 0.006 0.9 ns 3 GA_samp 1 Inf 0.003 0.003 1.0 ns 2 Study:GA_samp 1 Inf 0.086 0.086 0.8 ns 33.2.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 1.64 (-0.41, 3.67) 0.12 StudySTOP 1.46 (-0.69, 3.61) 0.19 GA_samp 0.20 (0.07, 0.33) 0.004 StudySTOP:GA_samp -0.09 (-0.24, 0.05) 0.21 hPL (μg/ml) Var Effect P (Intercept) 1.82 (0.67, 2.96) 0.001 StudySTOP -1.38 (-2.58, -0.17) 0.02 GA_samp 0.21 (0.13, 0.28) &lt;0.0001 StudySTOP:GA_samp 0.11 (0.03, 0.19) 0.008 GH2 (ng/ml) Var Effect P (Intercept) -0.69 (-2.09, 0.78) 0.30 StudySTOP -1.61 (-3.17, -0.09) 0.03 GA_samp 0.13 (0.03, 0.22) 0.006 StudySTOP:GA_samp 0.11 (0.01, 0.21) 0.03 Insulin (uU/ml) Var Effect P (Intercept) 1.37 (-2.34, 5.08) 0.47 StudySTOP 1.23 (-2.61, 5.07) 0.53 GA_samp 0.14 (-0.10, 0.38) 0.26 StudySTOP:GA_samp -0.11 (-0.37, 0.14) 0.39 HOMA-IR Var Effect P (Intercept) 0.11 (-3.61, 3.83) 0.95 StudySTOP 1.08 (-2.79, 4.95) 0.58 GA_samp 0.13 (-0.11, 0.37) 0.29 StudySTOP:GA_samp -0.12 (-0.38, 0.14) 0.38 Glucose (mmol/L) Var Effect P (Intercept) 1.71 (0.58, 2.85) 0.003 StudySTOP -0.04 (-1.19, 1.10) 0.94 GA_samp 0.00 (-0.07, 0.08) 0.90 StudySTOP:GA_samp -0.01 (-0.09, 0.07) 0.77 33.2.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. PRL (ng/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 37.84059 14.97325 183.71665 17.33445 82.60489 STOP 10 64.25777 10.79816 25.61462 45.47803 90.79244 SCOPE 16 125.40320 24.78532 46.73448 84.25636 186.64422 STOP 16 122.20695 26.05851 61.88348 79.79445 187.16261 hPL (μg/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 48.12118 9.400344 116.3177 32.68197 70.85399 STOP 10 35.67218 1.710800 43.9918 32.38566 39.29222 SCOPE 16 165.09165 11.552861 112.4283 143.71802 189.64396 STOP 16 234.19079 20.961034 179.3138 196.27551 279.43032 GH2 (ng/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 1.764828 0.4232374 27.87312 1.0797268 2.884636 STOP 10 1.052072 0.0640941 50.34783 0.9309196 1.188992 SCOPE 16 3.744028 0.3480694 126.03402 3.1148611 4.500281 STOP 16 4.304273 0.5007060 185.72738 3.4216229 5.414615 Insulin (uU/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 15.42851 10.443696 Inf 4.09391 58.14466 STOP 10 17.37172 1.623285 Inf 14.46449 20.86328 SCOPE 16 35.06535 5.621541 Inf 25.61042 48.01086 STOP 16 20.27501 4.212605 Inf 13.49286 30.46618 HOMA-IR Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 4.151566 2.7843932 Inf 1.115126 15.456106 STOP 10 3.826518 0.3878844 Inf 3.137036 4.667538 SCOPE 16 9.138816 1.7090499 Inf 6.334418 13.184787 STOP 16 4.200316 0.9587402 Inf 2.685292 6.570106 Glucose (mmol/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 5.833361 1.0212224 Inf 4.139067 8.221199 STOP 10 4.947693 0.0651983 Inf 4.821543 5.077144 SCOPE 16 6.006065 0.4569785 Inf 5.173987 6.971957 STOP 16 4.740833 0.1711949 Inf 4.416896 5.088528 33.2.5 Comparisons Hormone Contrast GA_samp Ratio of Geometric means (95% CI) P-value PRL (ng/ml) STOP / SCOPE 10 1.70 (0.81, 3.58) 0.2 PRL (ng/ml) STOP / SCOPE 16 0.97 (0.67, 1.42) 0.9 hPL (μg/ml) STOP / SCOPE 10 0.74 (0.50, 1.10) 0.1 hPL (μg/ml) STOP / SCOPE 16 1.42 (1.15, 1.75) 0.001 GH2 (ng/ml) STOP / SCOPE 10 0.60 (0.36, 0.99) 0.05 GH2 (ng/ml) STOP / SCOPE 16 1.15 (0.87, 1.51) 0.3 Insulin (uU/ml) STOP / SCOPE 10 1.13 (0.30, 4.30) 0.9 Insulin (uU/ml) STOP / SCOPE 16 0.58 (0.35, 0.97) 0.04 HOMA-IR STOP / SCOPE 10 0.92 (0.24, 3.48) 0.9 HOMA-IR STOP / SCOPE 16 0.46 (0.26, 0.82) 0.008 Glucose (mmol/L) STOP / SCOPE 10 0.85 (0.60, 1.20) 0.3 Glucose (mmol/L) STOP / SCOPE 16 0.79 (0.67, 0.93) 0.005 33.2.6 Barplots by Study Barplots in this section may be misleading due to involvement of Study by GA interaction. 33.2.7 Plots for GA "],["folate-3.html", "33.3 Folate", " 33.3 Folate 33.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 28.8877868 1 &lt;0.0001 *** Folate 0.0716672 1 0.8 ns Study 0.1542094 1 0.7 ns GA_samp 20.3225866 1 &lt;0.0001 *** Folate:Study 0.0092019 1 0.9 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 4.6343389 1 0.03 * Folate 0.2677523 1 0.6 ns Study 0.4571143 1 0.5 ns GA_samp 315.8716375 1 &lt;0.0001 *** Folate:Study 0.5568254 1 0.5 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 22.5067527 1 &lt;0.0001 *** Folate 0.9603731 1 0.3 ns Study 1.3118341 1 0.3 ns GA_samp 94.5221604 1 &lt;0.0001 *** Folate:Study 1.0202298 1 0.3 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 3.490 3.490 0.06 ns 3 Study 1 Inf 2.492 2.492 0.1 ns 4 GA_samp 1 Inf 0.842 0.842 0.4 ns 2 Folate:Study 1 Inf 0.214 0.214 0.6 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 5.087 5.087 0.02 * 3 Study 1 Inf 4.830 4.830 0.03 * 4 GA_samp 1 Inf 0.376 0.376 0.5 ns 2 Folate:Study 1 Inf 0.326 0.326 0.6 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 3.720 3.720 0.05 ns 3 Study 1 Inf 11.156 11.156 0.0008 *** 4 GA_samp 1 Inf 0.399 0.399 0.5 ns 2 Folate:Study 1 Inf 0.707 0.707 0.4 ns 33.3.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 14.41 (5.73, 36.08) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.29 StudySTOP 1.12 (0.81, 1.54) 0.49 GA_samp 1.14 (1.07, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.68 (1.00, 2.79) 0.05 Folate 1.00 (1.00, 1.00) 0.61 StudySTOP 1.19 (0.99, 1.44) 0.06 GA_samp 1.33 (1.29, 1.38) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.16 (0.08, 0.32) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.94 StudySTOP 0.93 (0.73, 1.19) 0.56 GA_samp 1.22 (1.17, 1.27) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 20.29 (5.34, 77.09) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.12 StudySTOP 0.64 (0.40, 1.02) 0.06 GA_samp 1.04 (0.96, 1.13) 0.36 HOMA-IR Var Effect P (Intercept) 6.54 (1.57, 27.17) 0.010 Folate 1.00 (0.99, 1.00) 0.05 StudySTOP 0.50 (0.31, 0.83) 0.007 GA_samp 1.03 (0.94, 1.12) 0.54 Glucose (mmol/L) Var Effect P (Intercept) 7.10 (5.46, 9.23) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.02 StudySTOP 0.79 (0.73, 0.85) &lt;0.0001 GA_samp 0.99 (0.97, 1.02) 0.52 33.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 71.09997 14.77587 52.90126 46.86346 107.8709 STOP 79.63550 13.19157 23.21525 56.54088 112.1633 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 61.19230 4.864639 120.19700 52.28054 71.62315 STOP 73.06885 3.104208 31.47648 67.00786 79.67806 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.886885 0.2050626 134.01406 1.521934 2.339349 STOP 1.753658 0.0932118 41.23586 1.575194 1.952342 Insulin (uU/L) Study response SE df asymp.LCL asymp.UCL SCOPE 29.52587 6.078052 Inf 19.72325 44.20048 STOP 18.86957 1.517939 Inf 16.11714 22.09204 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 8.096180 1.7846778 Inf 5.255886 12.471376 STOP 4.085395 0.3543849 Inf 3.446650 4.842515 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 6.192877 0.2571009 Inf 5.708925 6.717854 STOP 4.892629 0.1106908 Inf 4.680419 5.114461 33.3.4 Comparisons Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Folate41.7 / Folate40.7 SCOPE 1.00 (1.00, 1.00) 0.3 PRL (ng/ml) Folate41.7 / Folate40.7 STOP 1.00 (1.00, 1.00) 0.3 hPL (μg/ml) Folate41.7 / Folate40.7 SCOPE 1.00 (1.00, 1.00) 0.6 hPL (μg/ml) Folate41.7 / Folate40.7 STOP 1.00 (1.00, 1.00) 0.6 GH2 (ng/ml) Folate41.7 / Folate40.7 SCOPE 1.00 (1.00, 1.00) 0.9 GH2 (ng/ml) Folate41.7 / Folate40.7 STOP 1.00 (1.00, 1.00) 0.9 Insulin (uU/ml) Folate41.7 / Folate40.7 SCOPE 1.00 (1.00, 1.00) 0.1 Insulin (uU/ml) Folate41.7 / Folate40.7 STOP 1.00 (1.00, 1.00) 0.1 HOMA-IR Folate41.7 / Folate40.7 SCOPE 1.00 (0.99, 1.00) 0.05 HOMA-IR Folate41.7 / Folate40.7 STOP 1.00 (0.99, 1.00) 0.05 Glucose (mmol/L) Folate41.7 / Folate40.7 SCOPE 1.00 (1.00, 1.00) 0.02 Glucose (mmol/L) Folate41.7 / Folate40.7 STOP 1.00 (1.00, 1.00) 0.02 33.3.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.3.6 Plots "],["folate-categories-1.html", "33.4 Folate (categories)", " 33.4 Folate (categories) Folate range (&lt;45.3 vs &gt;=45.3) 33.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 33.6502151 1 &lt;0.0001 *** Folate_gp 0.0759394 1 0.8 ns Study 0.5650209 1 0.5 ns GA_samp 20.0130767 1 &lt;0.0001 *** Folate_gp:Study 0.0676829 1 0.8 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 5.342630 1 0.02 * Folate_gp 2.298542 1 0.1 ns Study 2.161174 1 0.1 ns GA_samp 317.190802 1 &lt;0.0001 *** Folate_gp:Study 1.573336 1 0.2 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 29.5105258 1 &lt;0.0001 *** Folate_gp 0.5252367 1 0.5 ns Study 0.4103290 1 0.5 ns GA_samp 94.1392050 1 &lt;0.0001 *** Folate_gp:Study 0.1495187 1 0.7 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 5.245 5.245 0.02 * 3 Study 1 Inf 3.750 3.750 0.05 ns 4 GA_samp 1 Inf 0.920 0.920 0.3 ns 2 Folate_gp:Study 1 Inf 0.015 0.015 0.9 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 6.900 6.900 0.009 ** 3 Study 1 Inf 7.383 7.383 0.007 ** 4 GA_samp 1 Inf 0.449 0.449 0.5 ns 2 Folate_gp:Study 1 Inf 0.116 0.116 0.7 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 8.911 8.911 0.003 ** 3 Study 1 Inf 27.555 27.555 &lt;0.0001 *** 4 GA_samp 1 Inf 0.478 0.478 0.5 ns 2 Folate_gp:Study 1 Inf 2.501 2.501 0.1 ns 33.4.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 15.44 (6.19, 38.40) &lt;0.0001 Folate_gp≥45.3 1.01 (0.82, 1.24) 0.93 StudySTOP 1.12 (0.82, 1.55) 0.48 GA_samp 1.13 (1.07, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.74 (1.04, 2.87) 0.03 Folate_gp≥45.3 0.94 (0.83, 1.07) 0.37 StudySTOP 1.20 (1.00, 1.44) 0.05 GA_samp 1.33 (1.29, 1.38) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.16 (0.09, 0.32) &lt;0.0001 Folate_gp≥45.3 0.92 (0.78, 1.09) 0.33 StudySTOP 0.93 (0.73, 1.20) 0.59 GA_samp 1.22 (1.17, 1.27) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 18.50 (4.95, 69.20) &lt;0.0001 Folate_gp≥45.3 0.75 (0.57, 0.97) 0.03 StudySTOP 0.65 (0.41, 1.04) 0.07 GA_samp 1.04 (0.96, 1.13) 0.34 HOMA-IR Var Effect P (Intercept) 5.72 (1.39, 23.54) 0.02 Folate_gp≥45.3 0.70 (0.53, 0.93) 0.01 StudySTOP 0.52 (0.32, 0.85) 0.009 GA_samp 1.03 (0.94, 1.13) 0.50 Glucose (mmol/L) Var Effect P (Intercept) 6.89 (5.31, 8.95) &lt;0.0001 Folate_gp≥45.3 0.90 (0.85, 0.96) 0.002 StudySTOP 0.79 (0.73, 0.85) &lt;0.0001 GA_samp 0.99 (0.97, 1.01) 0.51 33.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 72.05286 15.20468 56.19899 47.21477 109.9574 STOP 80.95288 13.51384 24.25452 57.37005 114.2298 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 60.17924 4.912917 121.14938 51.19825 70.73564 STOP 72.16384 3.267865 41.06058 65.85731 79.07429 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.835249 0.2048767 142.13560 1.471824 2.288412 STOP 1.714043 0.0983096 52.70028 1.527755 1.923047 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 26.11216 5.075430 Inf 17.83998 38.22004 STOP 17.05872 1.464529 Inf 14.41680 20.18477 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 6.954116 1.443253 Inf 4.630033 10.444791 STOP 3.609646 0.333788 Inf 3.011293 4.326893 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.960279 0.2147877 Inf 5.553826 6.396479 STOP 4.710949 0.0946799 Inf 4.528987 4.900222 33.4.4 Comparisons (Overall) Hormone Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) ≥45.3 / &lt;45.3 1.01 (0.82, 1.25) 0.9 hPL (μg/ml) ≥45.3 / &lt;45.3 0.94 (0.83, 1.07) 0.4 GH2 (ng/ml) ≥45.3 / &lt;45.3 0.92 (0.78, 1.09) 0.3 Insulin (uU/ml) ≥45.3 / &lt;45.3 0.75 (0.57, 0.97) 0.03 HOMA-IR ≥45.3 / &lt;45.3 0.70 (0.53, 0.93) 0.01 Glucose (mmol/L) ≥45.3 / &lt;45.3 0.90 (0.85, 0.96) 0.002 33.4.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.4.6 Plots "],["b12-3.html", "33.5 B12", " 33.5 B12 33.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 19.1588240 1 &lt;0.0001 *** B12 1.7685130 1 0.2 ns Study 1.3894630 1 0.2 ns GA_samp 20.5955284 1 &lt;0.0001 *** B12:Study 0.9997984 1 0.3 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 0.2575183 1 0.6 ns B12 3.3000490 1 0.07 ns Study 8.2723140 1 0.004 ** GA_samp 333.6759676 1 &lt;0.0001 *** B12:Study 4.0852948 1 0.04 * GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 34.4484224 1 &lt;0.0001 *** B12 1.2840040 1 0.3 ns Study 0.7046147 1 0.4 ns GA_samp 114.5064198 1 &lt;0.0001 *** B12:Study 0.7066501 1 0.4 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 3.634 3.634 0.06 ns 3 Study 1 Inf 2.684 2.684 0.1 ns 4 GA_samp 1 Inf 0.706 0.706 0.4 ns 2 B12:Study 1 Inf 0.973 0.973 0.3 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 2.725 2.725 0.10 ns 3 Study 1 Inf 3.060 3.060 0.08 ns 4 GA_samp 1 Inf 0.292 0.292 0.6 ns 2 B12:Study 1 Inf 0.561 0.561 0.5 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 0.050 0.050 0.8 ns 3 Study 1 Inf 3.602 3.602 0.06 ns 4 GA_samp 1 Inf 0.243 0.243 0.6 ns 2 B12:Study 1 Inf 0.009 0.009 0.9 ns 33.5.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 14.07 (5.55, 35.49) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.25 StudySTOP 1.11 (0.81, 1.52) 0.53 GA_samp 1.13 (1.07, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.17 (0.64, 2.12) 0.61 B12 1.00 (1.00, 1.00) 0.07 StudySTOP 1.74 (1.20, 2.55) 0.005 GA_samp 1.34 (1.30, 1.39) &lt;0.0001 B12:StudySTOP 1.00 (1.00, 1.00) 0.05 GH2 (ng/ml) Var Effect P (Intercept) 0.11 (0.06, 0.22) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.31 StudySTOP 1.02 (0.81, 1.29) 0.85 GA_samp 1.24 (1.19, 1.29) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 24.45 (6.43, 92.92) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.07 StudySTOP 0.65 (0.41, 1.01) 0.06 GA_samp 1.03 (0.95, 1.12) 0.41 HOMA-IR Var Effect P (Intercept) 7.57 (1.79, 31.93) 0.006 B12 1.00 (1.00, 1.00) 0.08 StudySTOP 0.51 (0.32, 0.83) 0.007 GA_samp 1.02 (0.94, 1.12) 0.60 Glucose (mmol/L) Var Effect P (Intercept) 6.66 (5.00, 8.88) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.77 StudySTOP 0.79 (0.73, 0.86) &lt;0.0001 GA_samp 0.99 (0.97, 1.02) 0.63 33.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 73.72646 15.24405 52.80949 48.69659 111.6216 STOP 81.60376 13.44571 23.17142 58.04193 114.7304 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 63.46718 5.128348 107.624 54.07385 74.49225 STOP 73.77854 3.062191 31.805 67.79608 80.28891 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.767604 0.1832952 133.77534 1.439834 2.16999 STOP 1.809009 0.0935599 40.47779 1.629527 2.00826 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 27.59461 5.329078 Inf 18.89905 40.29105 STOP 17.86612 1.409637 Inf 15.30630 20.85403 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 7.467598 1.5526156 Inf 4.968262 11.224251 STOP 3.835829 0.3258385 Inf 3.247529 4.530702 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 6.125908 0.2464818 Inf 5.661370 6.628563 STOP 4.843695 0.1053213 Inf 4.641606 5.054583 33.5.4 Comparisons Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) B12376.5 / B12276.5 SCOPE 1.04 (0.97, 1.11) 0.2 PRL (ng/ml) B12376.5 / B12276.5 STOP 1.04 (0.97, 1.11) 0.2 hPL (μg/ml) B12376.5 / B12276.5 SCOPE 1.11 (0.99, 1.24) 0.07 hPL (μg/ml) B12376.5 / B12276.5 STOP 0.98 (0.94, 1.02) 0.4 GH2 (ng/ml) B12376.5 / B12276.5 SCOPE 1.03 (0.97, 1.08) 0.3 GH2 (ng/ml) B12376.5 / B12276.5 STOP 1.03 (0.97, 1.08) 0.3 Insulin (uU/ml) B12376.5 / B12276.5 SCOPE 0.92 (0.83, 1.01) 0.07 Insulin (uU/ml) B12376.5 / B12276.5 STOP 0.92 (0.83, 1.01) 0.07 HOMA-IR B12376.5 / B12276.5 SCOPE 0.91 (0.82, 1.01) 0.08 HOMA-IR B12376.5 / B12276.5 STOP 0.91 (0.82, 1.01) 0.08 Glucose (mmol/L) B12376.5 / B12276.5 SCOPE 1.00 (0.97, 1.02) 0.8 Glucose (mmol/L) B12376.5 / B12276.5 STOP 1.00 (0.97, 1.02) 0.8 33.5.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 73.00664 15.06560 52.44310 48.25712 110.4494 STOP 80.80704 13.28582 22.96874 57.50787 113.5458 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 61.84483 4.770209 108.14783 53.07691 72.06114 STOP 74.15276 3.026155 29.75089 68.22106 80.60020 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.755476 0.1818003 131.10262 1.430282 2.154608 STOP 1.796597 0.0911438 38.16912 1.621269 1.990885 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 28.21420 5.465730 Inf 19.30059 41.24438 STOP 18.26727 1.412773 Inf 15.69793 21.25713 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 7.640793 1.5968818 Inf 5.072736 11.508922 STOP 3.924793 0.3272153 Inf 3.333120 4.621496 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 6.131210 0.2501140 Inf 5.660081 6.641555 STOP 4.847888 0.1041656 Inf 4.647966 5.056408 33.5.6 Comparisons (50 unit increase) Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) B12326.5 / B12276.5 SCOPE 1.02 (0.99, 1.05) 0.2 PRL (ng/ml) B12326.5 / B12276.5 STOP 1.02 (0.99, 1.05) 0.2 hPL (μg/ml) B12326.5 / B12276.5 SCOPE 1.05 (1.00, 1.11) 0.07 hPL (μg/ml) B12326.5 / B12276.5 STOP 0.99 (0.97, 1.01) 0.4 GH2 (ng/ml) B12326.5 / B12276.5 SCOPE 1.01 (0.99, 1.04) 0.3 GH2 (ng/ml) B12326.5 / B12276.5 STOP 1.01 (0.99, 1.04) 0.3 Insulin (uU/ml) B12326.5 / B12276.5 SCOPE 0.96 (0.91, 1.00) 0.07 Insulin (uU/ml) B12326.5 / B12276.5 STOP 0.96 (0.91, 1.00) 0.07 HOMA-IR B12326.5 / B12276.5 SCOPE 0.96 (0.91, 1.01) 0.08 HOMA-IR B12326.5 / B12276.5 STOP 0.96 (0.91, 1.01) 0.08 Glucose (mmol/L) B12326.5 / B12276.5 SCOPE 1.00 (0.99, 1.01) 0.8 Glucose (mmol/L) B12326.5 / B12276.5 STOP 1.00 (0.99, 1.01) 0.8 33.5.7 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.5.8 Plots "],["folateb12-3.html", "33.6 Folate:B12", " 33.6 Folate:B12 33.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 33.9677450 1 &lt;0.0001 *** folate_B12 0.2922864 1 0.6 ns Study 0.0030706 1 1.0 ns GA_samp 20.0938411 1 &lt;0.0001 *** folate_B12:Study 0.9826171 1 0.3 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 6.6942890 1 0.010 * folate_B12 4.6512349 1 0.03 * Study 0.0693763 1 0.8 ns GA_samp 323.6089803 1 &lt;0.0001 *** folate_B12:Study 4.1665896 1 0.04 * GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 24.247063 1 &lt;0.0001 *** folate_B12 3.087119 1 0.08 ns Study 2.290189 1 0.1 ns GA_samp 96.394483 1 &lt;0.0001 *** folate_B12:Study 2.838209 1 0.09 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.139 0.139 0.7 ns 3 Study 1 Inf 1.655 1.655 0.2 ns 4 GA_samp 1 Inf 0.991 0.991 0.3 ns 2 folate_B12:Study 1 Inf 0.164 0.164 0.7 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.363 0.363 0.5 ns 3 Study 1 Inf 3.897 3.897 0.05 ns 4 GA_samp 1 Inf 0.502 0.502 0.5 ns 2 folate_B12:Study 1 Inf 0.043 0.043 0.8 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 1.315 1.315 0.3 ns 3 Study 1 Inf 16.057 16.057 &lt;0.0001 *** 4 GA_samp 1 Inf 0.185 0.185 0.7 ns 2 folate_B12:Study 1 Inf 0.265 0.265 0.6 ns 33.6.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 14.82 (5.93, 36.94) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.33 StudySTOP 1.12 (0.82, 1.55) 0.48 GA_samp 1.13 (1.07, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.96 (1.16, 3.25) 0.01 folate_B12 1.00 (1.00, 1.00) 0.03 StudySTOP 1.03 (0.82, 1.30) 0.79 GA_samp 1.34 (1.29, 1.38) &lt;0.0001 folate_B12:StudySTOP 1.00 (1.00, 1.00) 0.04 GH2 (ng/ml) Var Effect P (Intercept) 0.16 (0.09, 0.32) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.61 StudySTOP 0.93 (0.73, 1.19) 0.56 GA_samp 1.22 (1.17, 1.27) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 17.79 (4.81, 65.85) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.48 StudySTOP 0.65 (0.41, 1.03) 0.07 GA_samp 1.04 (0.96, 1.13) 0.32 HOMA-IR Var Effect P (Intercept) 5.50 (1.36, 22.29) 0.02 folate_B12 1.00 (1.00, 1.00) 0.37 StudySTOP 0.51 (0.31, 0.85) 0.009 GA_samp 1.03 (0.95, 1.13) 0.48 Glucose (mmol/L) Var Effect P (Intercept) 6.73 (5.15, 8.78) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.21 StudySTOP 0.79 (0.73, 0.86) &lt;0.0001 GA_samp 0.99 (0.97, 1.02) 0.65 33.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 71.60574 14.86257 52.74518 47.21980 108.5854 STOP 80.40635 13.27427 22.96752 57.14272 113.1409 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 62.09345 4.870901 111.51851 53.15462 72.53548 STOP 73.39619 3.059959 29.65228 67.40274 79.92256 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.888354 0.2043171 133.89526 1.524561 2.338957 STOP 1.755293 0.0921474 39.51082 1.578531 1.951848 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 28.59453 5.779733 Inf 19.24119 42.49462 STOP 18.55478 1.473926 Inf 15.87959 21.68065 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 7.759125 1.6807764 Inf 5.074883 11.863134 STOP 3.995353 0.3419368 Inf 3.378363 4.725025 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 6.134155 0.2493014 Inf 5.664487 6.642765 STOP 4.863797 0.1061501 Inf 4.660134 5.076361 33.6.4 Comparisons Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) folate_B12241.85 / folate_B12141.85 SCOPE 1.02 (0.98, 1.07) 0.3 PRL (ng/ml) folate_B12241.85 / folate_B12141.85 STOP 1.02 (0.98, 1.07) 0.3 hPL (μg/ml) folate_B12241.85 / folate_B12141.85 SCOPE 0.93 (0.88, 0.99) 0.03 hPL (μg/ml) folate_B12241.85 / folate_B12141.85 STOP 1.00 (0.97, 1.03) 0.9 GH2 (ng/ml) folate_B12241.85 / folate_B12141.85 SCOPE 0.99 (0.96, 1.03) 0.6 GH2 (ng/ml) folate_B12241.85 / folate_B12141.85 STOP 0.99 (0.96, 1.03) 0.6 Insulin (uU/ml) folate_B12241.85 / folate_B12141.85 SCOPE 0.98 (0.94, 1.03) 0.5 Insulin (uU/ml) folate_B12241.85 / folate_B12141.85 STOP 0.98 (0.94, 1.03) 0.5 HOMA-IR folate_B12241.85 / folate_B12141.85 SCOPE 0.98 (0.92, 1.03) 0.4 HOMA-IR folate_B12241.85 / folate_B12141.85 STOP 0.98 (0.92, 1.03) 0.4 Glucose (mmol/L) folate_B12241.85 / folate_B12141.85 SCOPE 0.99 (0.97, 1.01) 0.2 Glucose (mmol/L) folate_B12241.85 / folate_B12141.85 STOP 0.99 (0.97, 1.01) 0.2 33.6.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.6.6 Plots "],["active-b12-3.html", "33.7 Active B12", " 33.7 Active B12 33.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 11.6236886 1 0.0007 *** Active.B12 0.6246244 1 0.4 ns Study 1.2553100 1 0.3 ns GA_samp 5.8859994 1 0.02 * Active.B12:Study 1.2215246 1 0.3 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 0.2236814 1 0.6 ns Active.B12 5.8074322 1 0.02 * Study 6.2629796 1 0.01 * GA_samp 273.7672393 1 &lt;0.0001 *** Active.B12:Study 3.3981099 1 0.07 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 21.2907592 1 &lt;0.0001 *** Active.B12 1.8527297 1 0.2 ns Study 0.6170155 1 0.4 ns GA_samp 67.9422285 1 &lt;0.0001 *** Active.B12:Study 1.4044250 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 2.149 2.149 0.1 ns 3 Study 1 Inf 2.603 2.603 0.1 ns 4 GA_samp 1 Inf 0.110 0.110 0.7 ns 2 Active.B12:Study 1 Inf 0.543 0.543 0.5 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 2.224 2.224 0.1 ns 3 Study 1 Inf 3.529 3.529 0.06 ns 4 GA_samp 1 Inf 0.005 0.005 0.9 ns 2 Active.B12:Study 1 Inf 0.674 0.674 0.4 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 2.640 2.640 0.1 ns 3 Study 1 Inf 6.084 6.084 0.01 * 4 GA_samp 1 Inf 0.720 0.720 0.4 ns 2 Active.B12:Study 1 Inf 1.825 1.825 0.2 ns 33.7.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 21.63 (5.61, 82.51) &lt;0.0001 Active.B12 1.00 (0.99, 1.00) 0.66 StudySTOP 1.08 (0.68, 1.71) 0.75 GA_samp 1.10 (1.02, 1.19) 0.02 hPL (μg/ml) Var Effect P (Intercept) 1.64 (0.93, 2.89) 0.09 Active.B12 1.00 (1.00, 1.00) 0.10 StudySTOP 1.23 (1.00, 1.52) 0.05 GA_samp 1.32 (1.28, 1.37) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.15 (0.07, 0.32) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.50 StudySTOP 0.90 (0.67, 1.20) 0.48 GA_samp 1.22 (1.16, 1.28) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 39.49 (8.20, 190.17) &lt;0.0001 Active.B12 1.00 (0.99, 1.00) 0.20 StudySTOP 0.52 (0.30, 0.92) 0.02 GA_samp 1.02 (0.92, 1.13) 0.69 HOMA-IR Var Effect P (Intercept) 14.10 (2.54, 78.34) 0.002 Active.B12 1.00 (0.99, 1.00) 0.20 StudySTOP 0.41 (0.22, 0.77) 0.005 GA_samp 1.00 (0.90, 1.11) 1.00 Glucose (mmol/L) Var Effect P (Intercept) 7.89 (5.95, 10.47) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.10 StudySTOP 0.75 (0.67, 0.85) &lt;0.0001 GA_samp 0.99 (0.97, 1.02) 0.60 33.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 65.16846 16.81754 63.11382 38.91177 109.1425 STOP 70.25568 13.11414 23.90948 47.78970 103.2829 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 63.01763 5.794362 110.67270 52.52068 75.61254 STOP 77.78576 3.503714 42.71103 71.03001 85.18406 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.924916 0.2445933 123.7220 1.496869 2.475368 STOP 1.731100 0.0978188 129.1443 1.547991 1.935868 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 35.62240 8.801762 Inf 21.94846 57.81524 STOP 18.68387 1.919051 Inf 15.27702 22.85047 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 9.620282 2.6685058 Inf 5.585714 16.569023 STOP 3.965654 0.4371071 Inf 3.195160 4.921947 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 6.296768 0.3973147 Inf 5.564273 7.125691 STOP 4.743145 0.1192833 Inf 4.515022 4.982794 33.7.4 Comparisons Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Active.B1284 / Active.B1274 SCOPE 0.99 (0.94, 1.04) 0.7 PRL (ng/ml) Active.B1284 / Active.B1274 STOP 0.99 (0.94, 1.04) 0.7 hPL (μg/ml) Active.B1284 / Active.B1274 SCOPE 1.02 (1.00, 1.05) 0.1 hPL (μg/ml) Active.B1284 / Active.B1274 STOP 1.02 (1.00, 1.05) 0.1 GH2 (ng/ml) Active.B1284 / Active.B1274 SCOPE 1.01 (0.98, 1.05) 0.5 GH2 (ng/ml) Active.B1284 / Active.B1274 STOP 1.01 (0.98, 1.05) 0.5 Insulin (uU/ml) Active.B1284 / Active.B1274 SCOPE 0.96 (0.90, 1.02) 0.2 Insulin (uU/ml) Active.B1284 / Active.B1274 STOP 0.96 (0.90, 1.02) 0.2 HOMA-IR Active.B1284 / Active.B1274 SCOPE 0.95 (0.89, 1.03) 0.2 HOMA-IR Active.B1284 / Active.B1274 STOP 0.95 (0.89, 1.03) 0.2 Glucose (mmol/L) Active.B1284 / Active.B1274 SCOPE 0.98 (0.96, 1.00) 0.1 Glucose (mmol/L) Active.B1284 / Active.B1274 STOP 0.98 (0.96, 1.00) 0.1 33.7.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.7.6 Plots "],["folateactive-b12-3.html", "33.8 Folate:Active B12", " 33.8 Folate:Active B12 33.8.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 20.5247122 1 &lt;0.0001 *** folate_Active.B12 0.2046304 1 0.7 ns Study 0.1774470 1 0.7 ns GA_samp 5.7550523 1 0.02 * folate_Active.B12:Study 1.5548965 1 0.2 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 7.3102776 1 0.007 ** folate_Active.B12 1.3533178 1 0.2 ns Study 0.6031323 1 0.4 ns GA_samp 258.3921759 1 &lt;0.0001 *** folate_Active.B12:Study 1.1451088 1 0.3 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 16.440828 1 &lt;0.0001 *** folate_Active.B12 1.537335 1 0.2 ns Study 1.947533 1 0.2 ns GA_samp 63.660804 1 &lt;0.0001 *** folate_Active.B12:Study 1.522339 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 2.833 2.833 0.09 ns 3 Study 1 Inf 3.140 3.140 0.08 ns 4 GA_samp 1 Inf 0.115 0.115 0.7 ns 2 folate_Active.B12:Study 1 Inf 0.324 0.324 0.6 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 3.875 3.875 0.05 ns 3 Study 1 Inf 4.741 4.741 0.03 * 4 GA_samp 1 Inf 0.003 0.003 1.0 ns 2 folate_Active.B12:Study 1 Inf 0.505 0.505 0.5 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 3.417 3.417 0.06 ns 3 Study 1 Inf 14.255 14.255 0.0002 *** 4 GA_samp 1 Inf 0.254 0.254 0.6 ns 2 folate_Active.B12:Study 1 Inf 0.284 0.284 0.6 ns 33.8.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 17.41 (4.81, 62.38) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.16 StudySTOP 1.09 (0.69, 1.74) 0.71 GA_samp 1.11 (1.02, 1.20) 0.02 hPL (μg/ml) Var Effect P (Intercept) 2.00 (1.16, 3.49) 0.01 folate_Active.B12 1.00 (1.00, 1.00) 0.65 StudySTOP 1.23 (0.99, 1.52) 0.07 GA_samp 1.32 (1.27, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.17 (0.08, 0.36) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.77 StudySTOP 0.89 (0.66, 1.19) 0.42 GA_samp 1.22 (1.16, 1.28) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 33.12 (6.83, 160.73) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.10 StudySTOP 0.51 (0.29, 0.90) 0.02 GA_samp 1.02 (0.92, 1.12) 0.73 HOMA-IR Var Effect P (Intercept) 11.87 (2.09, 67.39) 0.005 folate_Active.B12 1.00 (1.00, 1.00) 0.05 StudySTOP 0.39 (0.21, 0.74) 0.004 GA_samp 1.00 (0.90, 1.11) 0.97 Glucose (mmol/L) Var Effect P (Intercept) 7.32 (5.19, 10.32) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.02 StudySTOP 0.75 (0.66, 0.85) &lt;0.0001 GA_samp 0.99 (0.96, 1.02) 0.59 33.8.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 65.06218 16.8057 62.36164 38.82500 109.0299 STOP 71.03805 13.3150 23.79888 48.24036 104.6096 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 62.34814 5.785205 108.66196 51.87428 74.93675 STOP 76.38136 3.454009 43.94094 69.72780 83.66981 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.922595 0.2446548 124.1097 1.494527 2.473271 STOP 1.703955 0.0968332 128.6104 1.522742 1.906734 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 37.36909 9.264831 Inf 22.98667 60.75037 STOP 18.89762 1.976098 Inf 15.39565 23.19615 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 10.197376 2.8523662 Inf 5.893781 17.643424 STOP 4.014914 0.4481325 Inf 3.226025 4.996717 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 6.330844 0.4339601 Inf 5.534958 7.241172 STOP 4.756231 0.1286443 Inf 4.510659 5.015172 33.8.4 Comparisons Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) folate_Active.B121058.44 / folate_Active.B12558.44 SCOPE 1.06 (0.98, 1.15) 0.2 PRL (ng/ml) folate_Active.B121058.44 / folate_Active.B12558.44 STOP 1.06 (0.98, 1.15) 0.2 hPL (μg/ml) folate_Active.B121058.44 / folate_Active.B12558.44 SCOPE 0.99 (0.95, 1.03) 0.6 hPL (μg/ml) folate_Active.B121058.44 / folate_Active.B12558.44 STOP 0.99 (0.95, 1.03) 0.6 GH2 (ng/ml) folate_Active.B121058.44 / folate_Active.B12558.44 SCOPE 0.99 (0.94, 1.05) 0.8 GH2 (ng/ml) folate_Active.B121058.44 / folate_Active.B12558.44 STOP 0.99 (0.94, 1.05) 0.8 Insulin (uU/ml) folate_Active.B121058.44 / folate_Active.B12558.44 SCOPE 0.94 (0.88, 1.01) 0.10 Insulin (uU/ml) folate_Active.B121058.44 / folate_Active.B12558.44 STOP 0.94 (0.88, 1.01) 0.10 HOMA-IR folate_Active.B121058.44 / folate_Active.B12558.44 SCOPE 0.93 (0.86, 1.00) 0.05 HOMA-IR folate_Active.B121058.44 / folate_Active.B12558.44 STOP 0.93 (0.86, 1.00) 0.05 Glucose (mmol/L) folate_Active.B121058.44 / folate_Active.B12558.44 SCOPE 0.97 (0.95, 1.00) 0.02 Glucose (mmol/L) folate_Active.B121058.44 / folate_Active.B12558.44 STOP 0.97 (0.95, 1.00) 0.02 33.8.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.8.6 Plots "],["homocysteine-3.html", "33.9 Homocysteine", " 33.9 Homocysteine 33.9.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 10.317495 1 0.001 ** Homocysteine 1.609800 1 0.2 ns Study 3.440566 1 0.06 ns GA_samp 18.308313 1 &lt;0.0001 *** Homocysteine:Study 2.942559 1 0.09 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 3.8904562 1 0.05 ns Homocysteine 0.5264440 1 0.5 ns Study 1.3187370 1 0.3 ns GA_samp 320.8313438 1 &lt;0.0001 *** Homocysteine:Study 0.1966252 1 0.7 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 9.9110678 1 0.002 ** Homocysteine 0.5427003 1 0.5 ns Study 0.0000171 1 1.0 ns GA_samp 104.9065657 1 &lt;0.0001 *** Homocysteine:Study 0.0067309 1 0.9 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 18.331 18.331 &lt;0.0001 *** 3 Study 1 Inf 9.003 9.003 0.003 ** 4 GA_samp 1 Inf 0.497 0.497 0.5 ns 2 Homocysteine:Study 1 Inf 7.177 7.177 0.007 ** HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 20.968 20.968 &lt;0.0001 *** 3 Study 1 Inf 13.031 13.031 0.0003 *** 4 GA_samp 1 Inf 0.153 0.153 0.7 ns 2 Homocysteine:Study 1 Inf 9.075 9.075 0.003 ** Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 9.007 9.007 0.003 ** 3 Study 1 Inf 12.012 12.012 0.0005 *** 4 GA_samp 1 Inf 0.764 0.764 0.4 ns 2 Homocysteine:Study 1 Inf 6.536 6.536 0.01 * 33.9.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 19.85 (7.23, 54.23) &lt;0.0001 Homocysteine 0.96 (0.88, 1.05) 0.37 StudySTOP 1.13 (0.82, 1.55) 0.46 GA_samp 1.13 (1.07, 1.19) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 2.43 (1.37, 4.24) 0.002 Homocysteine 0.92 (0.87, 0.97) 0.003 StudySTOP 1.27 (1.07, 1.53) 0.007 GA_samp 1.33 (1.29, 1.38) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.18 (0.09, 0.38) &lt;0.0001 Homocysteine 0.94 (0.87, 1.00) 0.07 StudySTOP 1.04 (0.82, 1.31) 0.75 GA_samp 1.23 (1.18, 1.28) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 204.81 (35.07, 1195.99) &lt;0.0001 Homocysteine 0.58 (0.44, 0.75) &lt;0.0001 StudySTOP 0.12 (0.03, 0.48) 0.003 GA_samp 1.03 (0.95, 1.11) 0.48 Homocysteine:StudySTOP 1.52 (1.12, 2.07) 0.007 HOMA-IR Var Effect P (Intercept) 98.06 (15.09, 637.29) &lt;0.0001 Homocysteine 0.52 (0.39, 0.70) &lt;0.0001 StudySTOP 0.06 (0.01, 0.28) 0.0003 GA_samp 1.02 (0.93, 1.11) 0.70 Homocysteine:StudySTOP 1.68 (1.20, 2.35) 0.003 Glucose (mmol/L) Var Effect P (Intercept) 12.11 (8.11, 18.09) &lt;0.0001 Homocysteine 0.87 (0.79, 0.96) 0.004 StudySTOP 0.46 (0.30, 0.72) 0.0005 GA_samp 0.99 (0.97, 1.01) 0.38 Homocysteine:StudySTOP 1.14 (1.03, 1.26) 0.01 33.9.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 71.18965 14.79000 53.53742 46.93395 107.9808 STOP 80.27600 13.22001 22.96009 57.09790 112.8629 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 57.78913 4.455741 118.90472 49.60675 67.32115 STOP 73.66759 3.016144 29.70947 67.75598 80.09499 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 1.710109 0.1783390 139.12443 1.391481 2.101698 STOP 1.777680 0.0898705 38.08152 1.604758 1.969235 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 20.53547 4.131751 Inf 13.84338 30.46260 STOP 18.30740 1.390771 Inf 15.77476 21.24665 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 5.178813 1.1487381 Inf 3.352903 7.999069 STOP 3.931310 0.3218741 Inf 3.348463 4.615609 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.554999 0.2329685 Inf 5.116651 6.030900 STOP 4.826860 0.0926674 Inf 4.648610 5.011945 33.9.4 Comparisons Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Homocysteine5.3 / Homocysteine4.3 SCOPE 0.96 (0.88, 1.05) 0.4 PRL (ng/ml) Homocysteine5.3 / Homocysteine4.3 STOP 0.96 (0.88, 1.05) 0.4 hPL (μg/ml) Homocysteine5.3 / Homocysteine4.3 SCOPE 0.92 (0.87, 0.97) 0.003 hPL (μg/ml) Homocysteine5.3 / Homocysteine4.3 STOP 0.92 (0.87, 0.97) 0.003 GH2 (ng/ml) Homocysteine5.3 / Homocysteine4.3 SCOPE 0.94 (0.87, 1.00) 0.07 GH2 (ng/ml) Homocysteine5.3 / Homocysteine4.3 STOP 0.94 (0.87, 1.00) 0.07 Insulin (uU/ml) Homocysteine5.3 / Homocysteine4.3 SCOPE 0.58 (0.44, 0.75) &lt;0.0001 Insulin (uU/ml) Homocysteine5.3 / Homocysteine4.3 STOP 0.88 (0.75, 1.02) 0.10 HOMA-IR Homocysteine5.3 / Homocysteine4.3 SCOPE 0.52 (0.39, 0.70) &lt;0.0001 HOMA-IR Homocysteine5.3 / Homocysteine4.3 STOP 0.87 (0.74, 1.03) 0.10 Glucose (mmol/L) Homocysteine5.3 / Homocysteine4.3 SCOPE 0.87 (0.79, 0.96) 0.004 Glucose (mmol/L) Homocysteine5.3 / Homocysteine4.3 STOP 0.99 (0.97, 1.01) 0.5 33.9.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.9.6 Plots "],["red-cell-folate-1.html", "33.10 Red cell folate", " 33.10 Red cell folate 33.10.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 40.028499 1 &lt;0.0001 *** ns(rcfolate, 3) 1.960676 3 0.6 ns GA_samp 6.148700 1 0.01 * hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 1.0424502 1 0.3 ns ns(rcfolate, 3) 0.7310778 3 0.9 ns GA_samp 249.6341984 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 23.962818 1 &lt;0.0001 *** ns(rcfolate, 3) 3.481161 3 0.3 ns GA_samp 77.928194 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.121 0.121 0.7 ns GA_samp 1 Inf 0.050 0.050 0.8 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.102 0.102 0.7 ns GA_samp 1 Inf 0.012 0.012 0.9 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.169 0.169 0.7 ns GA_samp 1 Inf 0.010 0.010 0.9 ns 33.10.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 54.20 (15.88, 184.71) &lt;0.0001 ns(rcfolate, 3)1 0.65 (0.28, 1.48) 0.30 ns(rcfolate, 3)2 0.26 (0.04, 1.76) 0.17 ns(rcfolate, 3)3 1.13 (0.77, 1.65) 0.53 GA_samp 1.09 (1.02, 1.16) 0.01 hPL (μg/ml) Var Effect P (Intercept) 1.48 (0.70, 3.12) 0.31 ns(rcfolate, 3)1 0.88 (0.53, 1.46) 0.63 ns(rcfolate, 3)2 0.90 (0.27, 2.93) 0.86 ns(rcfolate, 3)3 0.92 (0.74, 1.15) 0.47 GA_samp 1.38 (1.33, 1.44) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.09 (0.04, 0.24) &lt;0.0001 ns(rcfolate, 3)1 0.88 (0.46, 1.74) 0.69 ns(rcfolate, 3)2 1.58 (0.03, 7.29) 0.55 ns(rcfolate, 3)3 0.81 (0.39, 1.06) 0.13 GA_samp 1.26 (1.19, 1.32) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 11.50 (2.61, 50.72) 0.001 ns(rcfolate, 3)1 1.44 (0.59, 3.51) 0.42 ns(rcfolate, 3)2 1.85 (0.23, 15.03) 0.56 ns(rcfolate, 3)3 1.23 (0.75, 2.03) 0.41 GA_samp 1.01 (0.92, 1.11) 0.82 HOMA-IR Var Effect P (Intercept) 2.66 (0.49, 14.34) 0.26 ns(rcfolate, 3)1 1.44 (0.51, 4.07) 0.49 ns(rcfolate, 3)2 1.85 (0.16, 21.90) 0.62 ns(rcfolate, 3)3 1.20 (0.70, 2.06) 0.51 GA_samp 1.01 (0.91, 1.11) 0.91 Glucose (mmol/L) Var Effect P (Intercept) 4.74 (3.47, 6.47) &lt;0.0001 ns(rcfolate, 3)1 1.02 (0.81, 1.28) 0.88 ns(rcfolate, 3)2 1.08 (0.64, 1.84) 0.77 ns(rcfolate, 3)3 0.96 (0.89, 1.04) 0.30 GA_samp 1.00 (0.99, 1.02) 0.92 33.10.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.10.4 Plots "],["red-cell-folate-categories-1.html", "33.11 Red cell folate (categories)", " 33.11 Red cell folate (categories) Within reference ranges (360 to 1400 vs &gt;1400). 33.11.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 66.5937314 1 &lt;0.0001 *** rcfolate_gp 0.0003442 1 1.0 ns GA_samp 6.7620024 1 0.009 ** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 2.426195 1 0.1 ns rcfolate_gp 1.379069 1 0.2 ns GA_samp 259.712793 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 53.760515 1 &lt;0.0001 *** rcfolate_gp 2.299812 1 0.1 ns GA_samp 79.243310 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 0.672 0.672 0.4 ns GA_samp 1 Inf 0.064 0.064 0.8 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 0.549 0.549 0.5 ns GA_samp 1 Inf 0.011 0.011 0.9 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 0.354 0.354 0.6 ns GA_samp 1 Inf 0.017 0.017 0.9 ns 33.11.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 28.52 (12.78, 63.56) &lt;0.0001 rcfolate_gp&gt;1400 1.00 (0.80, 1.24) 0.99 GA_samp 1.09 (1.02, 1.16) 0.01 hPL (μg/ml) Var Effect P (Intercept) 1.44 (0.91, 2.27) 0.12 rcfolate_gp&gt;1400 0.92 (0.81, 1.05) 0.24 GA_samp 1.38 (1.33, 1.44) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.12 (0.07, 0.21) &lt;0.0001 rcfolate_gp&gt;1400 0.88 (0.75, 1.04) 0.13 GA_samp 1.25 (1.19, 1.32) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 14.60 (4.99, 42.72) &lt;0.0001 rcfolate_gp&gt;1400 1.14 (0.84, 1.54) 0.41 GA_samp 1.01 (0.92, 1.11) 0.80 HOMA-IR Var Effect P (Intercept) 3.43 (1.05, 11.20) 0.04 rcfolate_gp&gt;1400 1.13 (0.81, 1.58) 0.46 GA_samp 1.01 (0.91, 1.11) 0.92 Glucose (mmol/L) Var Effect P (Intercept) 5.02 (4.23, 5.95) &lt;0.0001 rcfolate_gp&gt;1400 0.99 (0.94, 1.03) 0.55 GA_samp 1.00 (0.98, 1.01) 0.90 33.11.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.11.4 Estimated marginal means Outcome rcfolate_gp response SE df lower.CL upper.CL PRL (ng/ml) 360 to 1400 74.850 13.823 30.270 51.341 109.125 PRL (ng/ml) &gt;1400 74.695 12.921 23.634 52.252 106.776 hPL (μg/ml) 360 to 1400 57.436 3.456 47.568 50.890 64.825 hPL (μg/ml) &gt;1400 53.114 2.527 22.847 48.133 58.611 GH2 (ng/ml) 360 to 1400 1.534 0.108 50.739 1.331 1.767 GH2 (ng/ml) &gt;1400 1.352 0.072 23.928 1.211 1.510 Insulin (uU/ml) 360 to 1400 16.727 2.137 Inf 13.022 21.485 Insulin (uU/ml) &gt;1400 19.005 1.697 Inf 15.954 22.640 HOMA-IR 360 to 1400 3.650 0.508 Inf 2.779 4.795 HOMA-IR &gt;1400 4.137 0.397 Inf 3.427 4.995 Glucose (mmol/L) 360 to 1400 4.961 0.089 Inf 4.791 5.138 Glucose (mmol/L) &gt;1400 4.896 0.067 Inf 4.766 5.030 33.11.5 Plots 33.11.6 Post-hoc comparisons Outcome Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) &gt;1400 / 360 to 1400 1.00 (0.80, 1.25) 1.0 hPL (μg/ml) &gt;1400 / 360 to 1400 0.92 (0.81, 1.05) 0.2 GH2 (ng/ml) &gt;1400 / 360 to 1400 0.88 (0.75, 1.04) 0.1 Insulin (uU/ml) &gt;1400 / 360 to 1400 1.14 (0.84, 1.54) 0.4 HOMA-IR &gt;1400 / 360 to 1400 1.13 (0.81, 1.58) 0.5 Glucose (mmol/L) &gt;1400 / 360 to 1400 0.99 (0.94, 1.03) 0.6 "],["red-cell-folate-categories-2-1.html", "33.12 Red cell folate (categories 2)", " 33.12 Red cell folate (categories 2) Over detection limit (360 to 1789 vs &gt;=1790). 33.12.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 67.7928366 1 &lt;0.0001 *** rcfolate_gp2 0.2274177 1 0.6 ns GA_samp 6.9642618 1 0.008 ** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 2.0537537 1 0.2 ns rcfolate_gp2 0.0711219 1 0.8 ns GA_samp 254.3527012 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 55.8484656 1 &lt;0.0001 *** rcfolate_gp2 0.5226945 1 0.5 ns GA_samp 76.2704230 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 0.175 0.175 0.7 ns GA_samp 1 Inf 0.076 0.076 0.8 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 0.103 0.103 0.7 ns GA_samp 1 Inf 0.018 0.018 0.9 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 2.362 2.362 0.1 ns GA_samp 1 Inf 0.007 0.007 0.9 ns 33.12.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 28.56 (12.89, 63.20) &lt;0.0001 rcfolate_gp2≥1790 0.95 (0.76, 1.18) 0.63 GA_samp 1.09 (1.02, 1.16) 0.009 hPL (μg/ml) Var Effect P (Intercept) 1.40 (0.88, 2.20) 0.15 rcfolate_gp2≥1790 0.98 (0.86, 1.12) 0.79 GA_samp 1.38 (1.33, 1.44) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.11 (0.06, 0.20) &lt;0.0001 rcfolate_gp2≥1790 0.94 (0.79, 1.19) 0.47 GA_samp 1.25 (1.19, 1.31) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 15.34 (5.29, 44.53) &lt;0.0001 rcfolate_gp2≥1790 1.07 (0.79, 1.44) 0.68 GA_samp 1.01 (0.92, 1.11) 0.78 HOMA-IR Var Effect P (Intercept) 3.60 (1.11, 11.62) 0.03 rcfolate_gp2≥1790 1.05 (0.77, 1.44) 0.75 GA_samp 1.01 (0.91, 1.12) 0.89 Glucose (mmol/L) Var Effect P (Intercept) 5.00 (4.25, 5.89) &lt;0.0001 rcfolate_gp2≥1790 0.97 (0.93, 1.01) 0.12 GA_samp 1.00 (0.98, 1.01) 0.93 33.12.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 33.12.4 Estimated marginal means Outcome rcfolate_gp2 response SE df lower.CL upper.CL PRL (ng/ml) 360 to 1789 76.063 13.133 23.492 53.239 108.672 PRL (ng/ml) ≥1790 72.119 13.329 30.372 49.455 105.170 hPL (μg/ml) 360 to 1789 54.886 2.568 21.740 49.807 60.483 hPL (μg/ml) ≥1790 53.905 3.359 56.453 47.579 61.072 GH2 (ng/ml) 360 to 1789 1.438 0.072 23.189 1.296 1.596 GH2 (ng/ml) ≥1790 1.352 0.099 67.002 1.169 1.564 Insulin (uU/ml) 360 to 1789 17.821 1.626 Inf 14.904 21.310 Insulin (uU/ml) ≥1790 19.003 2.334 Inf 14.938 24.174 HOMA-IR 360 to 1789 3.898 0.392 Inf 3.201 4.747 HOMA-IR ≥1790 4.105 0.516 Inf 3.209 5.251 Glucose (mmol/L) 360 to 1789 4.968 0.076 Inf 4.821 5.119 Glucose (mmol/L) ≥1790 4.821 0.057 Inf 4.711 4.934 33.12.5 Plots 33.12.6 Post-hoc comparisons Outcome Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) ≥1790 / 360 to 1789 0.95 (0.76, 1.18) 0.6 hPL (μg/ml) ≥1790 / 360 to 1789 0.98 (0.86, 1.12) 0.8 GH2 (ng/ml) ≥1790 / 360 to 1789 0.94 (0.79, 1.11) 0.5 Insulin (uU/ml) ≥1790 / 360 to 1789 1.07 (0.79, 1.44) 0.7 HOMA-IR ≥1790 / 360 to 1789 1.05 (0.77, 1.44) 0.7 Glucose (mmol/L) ≥1790 / 360 to 1789 0.97 (0.93, 1.01) 0.1 "],["session-info-6.html", "34 Session info", " 34 Session info Results generated on: 2023-08-17 11:30:54.889263 Click for more details sessionInfo() ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.3 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] splines grid stats graphics grDevices utils datasets ## [8] methods base ## ## other attached packages: ## [1] ggpubr_0.6.0 car_3.1-2 carData_3.0-5 xlsx_0.6.5 ## [5] geepack_1.3.9 doFuture_1.0.0 future_1.32.0 foreach_1.5.2 ## [9] emmeans_1.8.5 lmerTest_3.1-3 lme4_1.1-33 Matrix_1.6-0 ## [13] readxl_1.4.2 fontawesome_0.5.1 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [17] knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.3 ## [21] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [25] Hmisc_5.1-0 ## ## loaded via a namespace (and not attached): ## [1] remotes_2.4.2 sandwich_3.0-1 rlang_1.1.1 ## [4] multcomp_1.4-18 compiler_4.3.1 mgcv_1.9-0 ## [7] systemfonts_1.0.4 callr_3.7.3 vctrs_0.6.3 ## [10] rvest_1.0.3 stringr_1.5.0 pkgconfig_2.0.3 ## [13] crayon_1.5.2 fastmap_1.1.1 backports_1.4.1 ## [16] ellipsis_0.3.2 labeling_0.4.2 utf8_1.2.3 ## [19] sessioninfo_1.2.2 ps_1.7.5 nloptr_2.0.0 ## [22] purrr_1.0.1 xfun_0.39 cachem_1.0.8 ## [25] jsonlite_1.8.4 highr_0.10 xlsxjars_0.6.1 ## [28] broom_1.0.4 parallel_4.3.1 prettyunits_1.1.1 ## [31] cluster_2.1.4 R6_2.5.1 bslib_0.4.2 ## [34] stringi_1.7.12 parallelly_1.36.0 boot_1.3-28 ## [37] pkgload_1.3.2 rpart_4.1.19 jquerylib_0.1.4 ## [40] cellranger_1.1.0 numDeriv_2016.8-1.1 estimability_1.4.1 ## [43] Rcpp_1.0.11 bookdown_0.34 iterators_1.0.14 ## [46] future.apply_1.8.1 zoo_1.8-9 base64enc_0.1-3 ## [49] nnet_7.3-19 tidyselect_1.2.0 abind_1.4-5 ## [52] rstudioapi_0.14 yaml_2.3.7 codetools_0.2-19 ## [55] processx_3.8.1 listenv_0.8.0 pkgbuild_1.4.0 ## [58] lattice_0.21-8 tibble_3.2.1 withr_2.5.0 ## [61] coda_0.19-4 evaluate_0.21 foreign_0.8-82 ## [64] survival_3.5-5 rJava_1.0-6 xml2_1.3.3 ## [67] pillar_1.9.0 checkmate_2.0.0 generics_0.1.3 ## [70] munsell_0.5.0 scales_1.2.1 minqa_1.2.4 ## [73] globals_0.16.2 xtable_1.8-4 glue_1.6.2 ## [76] tools_4.3.1 data.table_1.14.8 ggsignif_0.6.4 ## [79] webshot_0.5.4 fs_1.6.2 mvtnorm_1.1-3 ## [82] tidyr_1.3.0 colorspace_2.1-0 nlme_3.1-162 ## [85] htmlTable_2.4.0 Formula_1.2-4 cli_3.6.1 ## [88] fansi_1.0.4 viridisLite_0.4.2 svglite_2.1.0 ## [91] dplyr_1.1.2 gtable_0.3.3 rstatix_0.7.2 ## [94] sass_0.4.6 digest_0.6.33 pbkrtest_0.5.2 ## [97] TH.data_1.1-0 farver_2.1.1 memoise_2.0.1 ## [100] htmltools_0.5.5 lifecycle_1.0.3 httr_1.4.2 ## [103] MASS_7.3-60 "],["part-non-gdm-cases.html", "(PART*) Non-GDM Cases", " (PART*) Non-GDM Cases "],["descriptives-3.html", "35 Descriptives", " 35 Descriptives Descriptives on raw data. Tables in this section are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value PRL (ng/ml): Mean (SD) 187.4 (184.8) 106.3 (116.6) 142.2 (156.0) &lt;0.0001 hPL (μg/ml): Mean (SD) 186.1 (54.2) 74.7 (49.9) 124.6 (75.9) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.7 (2.8) 1.9 (1.7) 3.2 (2.7) &lt;0.0001 Insulin (uU/ml): Mean (SD) 23.8 (27.0) 16.6 (22.1) 19.8 (24.7) &lt;0.0001 HOMA-IR: Mean (SD) 6.1 (7.6) 3.7 (5.5) 4.8 (6.6) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.6) 5.1 (0.8) &lt;0.0001 Number of available samples Var SCOPE: Available N(%) STOP: Available N(%) PRL (ng/ml) 788 (73.4%) 988 (94.3%) hPL (μg/ml) 788 (73.4%) 971 (92.7%) GH2 (ng/ml) 795 (74.1%) 975 (93.0%) Insulin (uU/ml) 814 (75.9%) 1003 (95.7%) HOMA-IR 809 (75.4%) 1003 (95.7%) Glucose (mmol/L) 1065 (99.3%) 1036 (98.9%) "],["by-study-3.html", "35.1 By Study", " 35.1 By Study 35.1.1 Demographics Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 26.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.21 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1054 (98.2) 1020 (97.3) 2074 (97.8) &gt;=35 19 (1.8) 28 (2.7) 47 (2.2) Maternal BMI: Median (IQ range) 25.4 (22.1-30.4) 25.8 (22.6-30.6) 25.6 (22.4-30.5) 0.15 Maternal BMI (category): N(%) 0.22 Missing 0 (0.0) 1 (0.1) 1 (0.0) &lt;20 115 (10.7) 81 (7.7) 196 (9.2) &gt;=20 to &lt;25 377 (35.1) 377 (36.0) 754 (35.5) &gt;=25 to &lt;30 301 (28.1) 304 (29.0) 605 (28.5) &gt;=30 to &lt;40 234 (21.8) 236 (22.5) 470 (22.2) &gt;=40 46 (4.3) 49 (4.7) 95 (4.5) SEI: Median (IQ range) 25.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-34.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 987 (92.0) 889 (84.8) 1876 (88.4) Maori 5 (0.5) 1 (0.1) 6 (0.3) Pacific Islander 1 (0.1) 4 (0.4) 5 (0.2) South East and Far East 36 (3.4) 41 (3.9) 77 (3.6) Indian 3 (0.3) 40 (3.8) 43 (2.0) African 4 (0.4) 16 (1.5) 20 (0.9) Middle-eastern 5 (0.5) 19 (1.8) 24 (1.1) Hispanic 0 (0.0) 4 (0.4) 4 (0.2) Aboriginal 21 (2.0) 18 (1.7) 39 (1.8) China and Japan 0 (0.0) 14 (1.3) 14 (0.7) Other 11 (1.0) 2 (0.2) 13 (0.6) Smoking: N(%) &lt;0.0001 Missing 0 (0.0) 6 (0.6) 6 (0.3) No 813 (75.8) 870 (83.0) 1683 (79.3) Yes 260 (24.2) 172 (16.4) 432 (20.4) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 126 (12.0) 126 (5.9) None 230 (21.4) 76 (7.3) 306 (14.4) &lt;800 571 (53.2) 214 (20.4) 785 (37.0) &gt;=800 272 (25.3) 632 (60.3) 904 (42.6) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 126 (12.0) 126 (5.9) None 230 (21.4) 76 (7.3) 306 (14.4) &lt;=400 105 (9.8) 12 (1.1) 117 (5.5) &gt;400 to &lt;800 466 (43.4) 202 (19.3) 668 (31.5) &gt;=800 272 (25.3) 632 (60.3) 904 (42.6) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 13 (1.2) 13 (0.6) &lt;1-3x/month 110 (10.3) 73 (7.0) 183 (8.6) 1-6x/week 417 (38.9) 309 (29.5) 726 (34.2) &gt;=1-&lt;3x/day 367 (34.2) 516 (49.2) 883 (41.6) &gt;=3x/day 179 (16.7) 137 (13.1) 316 (14.9) Leafy vege (1st trim): N(%) 0.01 Missing 0 (0.0) 13 (1.2) 13 (0.6) &lt;1-3x/month 103 (9.6) 108 (10.3) 211 (9.9) 1-2x/week 249 (23.2) 239 (22.8) 488 (23.0) 3-6x/week 430 (40.1) 351 (33.5) 781 (36.8) &gt;=1x/day 291 (27.1) 337 (32.2) 628 (29.6) Fast food (1st trim): N(%) &lt;0.0001 Missing 216 (20.1) 147 (14.0) 363 (17.1) Never 15 (1.4) 42 (4.0) 57 (2.7) &gt;0-&lt;2x/week 102 (9.5) 174 (16.6) 276 (13.0) &gt;=2-&lt;4x/week 436 (40.6) 397 (37.9) 833 (39.3) &gt;=4x/week 304 (28.3) 288 (27.5) 592 (27.9) Vigorous exercise: N(%) 0.67 Missing 3 (0.3) 9 (0.9) 12 (0.6) Never 694 (64.7) 652 (62.2) 1346 (63.5) Once a week 264 (24.6) 255 (24.3) 519 (24.5) 2-3/wk 84 (7.8) 99 (9.4) 183 (8.6) 4-6/wk 14 (1.3) 18 (1.7) 32 (1.5) Daily 12 (1.1) 14 (1.3) 26 (1.2) More than once a day 2 (0.2) 1 (0.1) 3 (0.1) Moderate exercise: N(%) 0.35 Missing 3 (0.3) 10 (1.0) 13 (0.6) Never 453 (42.2) 405 (38.6) 858 (40.5) Once a week 278 (25.9) 263 (25.1) 541 (25.5) 2-3/wk 219 (20.4) 233 (22.2) 452 (21.3) 4-6/wk 51 (4.8) 60 (5.7) 111 (5.2) Daily 62 (5.8) 64 (6.1) 126 (5.9) More than once a day 7 (0.7) 13 (1.2) 20 (0.9) Recreational walking: N(%) 0.11 Missing 3 (0.3) 11 (1.0) 14 (0.7) Never 250 (23.3) 225 (21.5) 475 (22.4) Once a week 334 (31.1) 364 (34.7) 698 (32.9) 2-3/wk 283 (26.4) 249 (23.8) 532 (25.1) 4-6/wk 75 (7.0) 81 (7.7) 156 (7.4) Daily 102 (9.5) 105 (10.0) 207 (9.8) More than once a day 26 (2.4) 13 (1.2) 39 (1.8) Serum folate concentration (nM): Median (IQ range) 35.9 (28.1-42.6) 40.5 (36.4-45.3) 39.0 (32.9-43.9) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.2) 4.8 (1.2) &lt;0.0001 B12 concentration (pM): Median (IQ range) 245.0 (195.0-308.5) 280.0 (218.0-357.0) 261.0 (205.0-334.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.7 (102.3-207.5) 153.5 (115.1-221.2) 148.7 (108.4-216.5) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.1 (24.0) 67.8 (25.2) 63.6 (24.9) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 615.4 (432.4-902.3) 663.1 (475.7-951.1) 628.7 (453.0-925.0) 0.008 Vitamin D: Median (IQ range) 58.0 (42.0-76.4) 61.0 (46.0-77.0) 59.8 (43.7-76.6) 0.01 UIC (ug/L): Median (IQ range) 105.0 (66.3-163.6) 197.8 (120.4-327.6) 152.5 (89.2-259.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.4) 1.0 (0.7-1.5) 0.06 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.05 Haemoglobin (g/L): Mean (SD) 129.1 (9.3) 131.3 (9.6) 130.2 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 35.1.2 MetS Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value MetS: N(%) &lt;0.0001 Missing 9 (0.8) 74 (7.1) 83 (3.9) No 898 (83.7) 907 (86.5) 1805 (85.1) Yes 166 (15.5) 67 (6.4) 233 (11.0) MetS: number of criteria met: Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-97.0) 81.5 (74.0-92.0) 84.0 (76.0-95.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.6 (0.8) 5.1 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.7) 1.1 (0.9-1.4) 1.2 (1.0-1.6) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.6) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.1 (0.8) 2.4 (0.7) 2.8 (0.8) &lt;0.0001 Systolic BP (mmHg): Mean (SD) 109.1 (10.1) 115.3 (10.4) 112.1 (10.7) &lt;0.0001 Diastolic BP (mmHg): Mean (SD) 64.2 (7.9) 70.2 (8.4) 67.1 (8.7) &lt;0.0001 MAP (mmHg): Mean (SD) 79.2 (7.7) 85.2 (8.1) 82.1 (8.4) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 1 (0.1) 23 (2.2) 24 (1.1) &lt;80 cm 290 (27.0) 447 (42.7) 737 (34.7) &gt;=80 cm 782 (72.9) 578 (55.2) 1360 (64.1) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 12 (1.1) 12 (0.6) &lt;1.7 mmol/L 782 (72.9) 907 (86.5) 1689 (79.6) &gt;=1.7 mmol/L 291 (27.1) 129 (12.3) 420 (19.8) MetS criteria: HDL: N(%) 0.009 Missing 0 (0.0) 12 (1.1) 12 (0.6) &gt;=1.3 mmol/L 958 (89.3) 885 (84.4) 1843 (86.9) &lt;1.3 mmol/L 115 (10.7) 151 (14.4) 266 (12.5) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 8 (0.7) 12 (1.1) 20 (0.9) &lt;5.6 mmol/L 624 (58.2) 963 (91.9) 1587 (74.8) &gt;=5.6 mmol/L 441 (41.1) 73 (7.0) 514 (24.2) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;130 mmHg 1043 (97.2) 909 (86.7) 1952 (92.0) &gt;=130 mmHg 30 (2.8) 95 (9.1) 125 (5.9) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;85 mmHg 1068 (99.5) 955 (91.1) 2023 (95.4) &gt;=85 mmHg 5 (0.5) 49 (4.7) 54 (2.5) MetS criteria: BP: N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;130/85 mmHg 1041 (97.0) 887 (84.6) 1928 (90.9) &gt;=130/85 mmHg 32 (3.0) 117 (11.2) 149 (7.0) CRP (mg/L): Median (IQ range) 4.7 (2.4-8.9) 3.3 (1.4-6.2) 3.9 (1.9-7.5) &lt;0.0001 35.1.3 Outcomes Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value Gestational age at birth (weeks): Median (IQ range) 40.0 (38.9-40.9) 39.7 (38.7-40.7) 39.9 (38.9-40.7) 0.003 Birthweight (g): Median (IQ range) 3410.0 (3070.0-3735.0) 3402.0 (3040.0-3715.0) 3405.0 (3060.0-3730.0) 0.46 Birthweight centile: Mean (SD) 46.7 (29.4) 47.6 (29.5) 47.1 (29.4) 0.47 Baby sex: N(%) 0.14 Missing 0 (0.0) 3 (0.3) 3 (0.1) Male 525 (48.9) 546 (52.1) 1071 (50.5) Female 548 (51.1) 499 (47.6) 1047 (49.4) Mode of delivery: N(%) 0.01 Missing 0 (0.0) 3 (0.3) 3 (0.1) Unassisted vaginal 581 (54.1) 522 (49.8) 1103 (52.0) Operative vaginal 177 (16.5) 229 (21.9) 406 (19.1) Pre-labour LSCS 66 (6.2) 70 (6.7) 136 (6.4) LSCS in labour 249 (23.2) 224 (21.4) 473 (22.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) Induction of Labour: N(%) &lt;0.0001 Missing 1 (0.1) 0 (0.0) 1 (0.0) No 760 (70.8) 546 (52.1) 1306 (61.6) Yes 312 (29.1) 502 (47.9) 814 (38.4) "],["folate-vs-fa-supplement-3.html", "36 Folate vs FA supplement", " 36 Folate vs FA supplement 36.0.1 FA supp (3 categories) Characteristic None (n=306) &lt;800 (n=785) &gt;=800 (n=904) Total (n=1995) P-value Serum folate concentration (nM): Median (IQ range) 28.8 (19.6-35.7) 38.4 (32.1-43.7) 41.2 (36.7-56.4) 39.1 (32.9-44.1) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.2 (1.5) 4.7 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 243.0 (192.0-303.0) 253.5 (200.0-326.8) 273.5 (215.0-353.8) 261.0 (205.0-334.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.4 (24.6) 61.1 (24.8) 67.5 (24.9) 63.9 (25.0) 0.0001 Folate:B12 ratio: Median (IQ range) 115.3 (78.1-161.3) 149.8 (111.9-218.4) 160.1 (118.3-236.4) 149.5 (108.7-217.1) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (331.8-693.3) 641.0 (476.3-943.8) 670.5 (485.2-1036.5) 626.2 (450.3-937.0) &lt;0.0001 Vitamin D: Median (IQ range) 53.0 (39.9-69.1) 58.0 (42.0-75.8) 64.0 (47.0-79.0) 60.0 (43.8-77.0) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=230) &lt;800 (n=571) &gt;=800 (n=272) Total (n=1073) P-value Serum folate concentration (nM): Median (IQ range) 25.7 (17.5-33.3) 37.2 (30.2-43.2) 39.8 (34.4-47.2) 35.9 (28.1-42.6) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (186.0-297.0) 248.0 (196.0-318.0) 248.5 (199.0-303.8) 245.0 (195.0-308.5) 0.008 Active B12 concentration (pM): Mean (SD) 56.0 (22.4) 59.4 (24.0) 64.9 (24.7) 60.1 (24.0) 0.006 Folate:B12 ratio: Median (IQ range) 108.4 (74.3-153.1) 143.7 (108.2-211.0) 165.1 (118.8-247.7) 142.7 (102.3-207.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 461.7 (343.8-710.6) 636.7 (476.2-935.5) 653.3 (483.0-1082.9) 615.4 (432.4-902.3) &lt;0.0001 Vitamin D: Median (IQ range) 51.9 (39.1-68.5) 55.1 (40.0-74.7) 68.0 (50.9-83.9) 58.0 (42.0-76.4) &lt;0.0001 Click here for table within STOP Characteristic None (n=76) &lt;800 (n=214) &gt;=800 (n=632) Total (n=922) P-value Serum folate concentration (nM): Median (IQ range) 36.4 (30.7-40.5) 40.5 (35.9-48.2) 41.6 (37.6-58.0) 40.9 (36.8-54.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.4 (1.5) 5.2 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 278.0 (215.0-331.0) 265.5 (208.2-349.5) 281.0 (225.8-370.5) 280.0 (220.0-363.0) 0.08 Active B12 concentration (pM): Mean (SD) 75.8 (26.0) 66.6 (26.6) 68.8 (25.0) 69.0 (25.5) 0.17 Folate:B12 ratio: Median (IQ range) 132.7 (100.7-188.3) 166.4 (120.2-227.4) 157.0 (117.9-227.6) 155.4 (116.2-223.0) 0.008 Folate:Active B12 ratio: Median (IQ range) 501.3 (325.8-682.9) 687.8 (476.6-944.4) 684.1 (491.4-1022.0) 665.1 (470.7-974.0) 0.001 Vitamin D: Median (IQ range) 58.0 (44.0-70.5) 64.0 (48.8-79.2) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.15 36.0.2 FA supp (4 categories) Characteristic None (n=306) &lt;=400 (n=117) &gt;400 to &lt;800 (n=668) &gt;=800 (n=904) Total (n=1995) P-value Serum folate concentration (nM): Median (IQ range) 28.8 (19.6-35.7) 36.5 (28.3-42.6) 38.7 (32.7-43.9) 41.2 (36.7-56.4) 39.1 (32.9-44.1) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.2 (1.5) 4.5 (1.0) 4.7 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 243.0 (192.0-303.0) 265.0 (200.2-350.5) 252.0 (200.0-322.0) 273.5 (215.0-353.8) 261.0 (205.0-334.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.4 (24.6) 60.6 (26.3) 61.2 (24.6) 67.5 (24.9) 63.9 (25.0) 0.0005 Folate:B12 ratio: Median (IQ range) 115.3 (78.1-161.3) 135.0 (106.1-186.1) 154.0 (113.6-224.4) 160.1 (118.3-236.4) 149.5 (108.7-217.1) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (331.8-693.3) 540.9 (429.0-894.7) 654.6 (481.7-956.3) 670.5 (485.2-1036.5) 626.2 (450.3-937.0) &lt;0.0001 Vitamin D: Median (IQ range) 53.0 (39.9-69.1) 49.0 (37.0-68.0) 59.0 (43.3-77.1) 64.0 (47.0-79.0) 60.0 (43.8-77.0) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=230) &lt;=400 (n=105) &gt;400 to &lt;800 (n=466) &gt;=800 (n=272) Total (n=1073) P-value Serum folate concentration (nM): Median (IQ range) 25.7 (17.5-33.3) 35.5 (27.4-41.7) 37.5 (30.7-43.5) 39.8 (34.4-47.2) 35.9 (28.1-42.6) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.0) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (186.0-297.0) 250.5 (196.8-345.0) 247.5 (196.2-309.8) 248.5 (199.0-303.8) 245.0 (195.0-308.5) 0.01 Active B12 concentration (pM): Mean (SD) 56.0 (22.4) 60.0 (26.7) 59.3 (23.5) 64.9 (24.7) 60.1 (24.0) 0.02 Folate:B12 ratio: Median (IQ range) 108.4 (74.3-153.1) 132.0 (100.9-184.7) 146.0 (111.9-220.1) 165.1 (118.8-247.7) 142.7 (102.3-207.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 461.7 (343.8-710.6) 540.9 (415.3-911.7) 643.6 (484.0-967.9) 653.3 (483.0-1082.9) 615.4 (432.4-902.3) &lt;0.0001 Vitamin D: Median (IQ range) 51.9 (39.1-68.5) 48.1 (35.7-63.5) 56.7 (41.2-75.8) 68.0 (50.9-83.9) 58.0 (42.0-76.4) &lt;0.0001 Click here for table within STOP Characteristic None (n=76) &lt;=400 (n=12) &gt;400 to &lt;800 (n=202) &gt;=800 (n=632) Total (n=922) P-value Serum folate concentration (nM): Median (IQ range) 36.4 (30.7-40.5) 42.2 (37.2-49.7) 40.2 (35.9-48.2) 41.6 (37.6-58.0) 40.9 (36.8-54.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.4 (1.5) 5.0 (0.9) 5.2 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 278.0 (215.0-331.0) 314.5 (247.5-367.8) 263.5 (208.2-347.0) 281.0 (225.8-370.5) 280.0 (220.0-363.0) 0.08 Active B12 concentration (pM): Mean (SD) 75.8 (26.0) 68.0 (23.3) 66.6 (26.9) 68.8 (25.0) 69.0 (25.5) 0.32 Folate:B12 ratio: Median (IQ range) 132.7 (100.7-188.3) 165.0 (135.9-197.8) 166.4 (119.0-229.8) 157.0 (117.9-227.6) 155.4 (116.2-223.0) 0.02 Folate:Active B12 ratio: Median (IQ range) 501.3 (325.8-682.9) 550.8 (476.6-682.4) 693.8 (476.6-951.1) 684.1 (491.4-1022.0) 665.1 (470.7-974.0) 0.003 Vitamin D: Median (IQ range) 58.0 (44.0-70.5) 63.5 (46.8-81.8) 64.0 (49.0-79.2) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.28 "],["folate-4.html", "36.1 Folate", " 36.1 Folate 36.1.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0195001 0.0709341 42.567663 &lt;0.0001 *** folate_cat2&lt;800 0.4412790 0.0397662 11.096823 &lt;0.0001 *** folate_cat2&gt;=800 0.5604632 0.0455447 12.305789 &lt;0.0001 *** StudySTOP 0.4207432 0.0650454 6.468453 &lt;0.0001 *** f1_age 0.0142630 0.0023325 6.114775 &lt;0.0001 *** BMI -0.0054463 0.0017083 -3.188041 0.001 ** folate_cat2&lt;800:StudySTOP -0.3023242 0.0758476 -3.985942 &lt;0.0001 *** folate_cat2&gt;=800:StudySTOP -0.3194344 0.0739224 -4.321214 &lt;0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.55 (1.39, 1.74) &lt;0.0001 SCOPE: &gt;=800/None 1.75 (1.54, 1.99) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.13 (1.02, 1.25) 0.01 STOP: &lt;800/None 1.15 (0.96, 1.38) 0.3 STOP: &gt;=800/None 1.27 (1.08, 1.50) 0.0004 STOP: &gt;=800/&lt;800 1.11 (1.00, 1.23) 0.07 None: STOP/SCOPE 1.52 (1.27, 1.82) &lt;0.0001 &lt;800: STOP/SCOPE 1.13 (1.01, 1.26) 0.03 &gt;=800: STOP/SCOPE 1.11 (1.00, 1.22) 0.04 P-value adjustment: bonferroni method for 9 tests 36.1.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0180544 0.0708888 42.574513 &lt;0.0001 *** folate_cat3&lt;=400 0.3481479 0.0591598 5.884877 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4625453 0.0409775 11.287793 &lt;0.0001 *** folate_cat3&gt;=800 0.5598897 0.0455145 12.301336 &lt;0.0001 *** StudySTOP 0.4202729 0.0650014 6.465601 &lt;0.0001 *** f1_age 0.0144531 0.0023333 6.194261 &lt;0.0001 *** BMI -0.0055471 0.0017084 -3.246946 0.001 ** folate_cat3&lt;=400:StudySTOP -0.1752279 0.1602884 -1.093204 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.3259543 0.0769183 -4.237670 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3191359 0.0738719 -4.320124 &lt;0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.42 (1.19, 1.69) &lt;0.0001 SCOPE: &gt;400 to &lt;800/None 1.59 (1.41, 1.79) &lt;0.0001 SCOPE: &gt;=800/None 1.75 (1.53, 2.00) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.24 (1.04, 1.46) 0.003 SCOPE: &gt;=800/&gt;400 to &lt;800 1.10 (0.98, 1.23) 0.2 SCOPE: &lt;=400/&gt;400 to &lt;800 0.89 (0.76, 1.05) 0.5 STOP: &lt;=400/None 1.19 (0.76, 1.85) 1 STOP: &gt;400 to &lt;800/None 1.15 (0.95, 1.39) 0.6 STOP: &gt;=800/None 1.27 (1.07, 1.51) 0.0007 STOP: &gt;=800/&lt;=400 1.07 (0.71, 1.62) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.99, 1.25) 0.1 STOP: &lt;=400/&gt;400 to &lt;800 1.04 (0.68, 1.58) 1 None: STOP/SCOPE 1.52 (1.26, 1.85) &lt;0.0001 &lt;=400: STOP/SCOPE 1.28 (0.83, 1.97) 1 &gt;400 to &lt;800: STOP/SCOPE 1.10 (0.97, 1.24) 0.4 &gt;=800: STOP/SCOPE 1.11 (1.00, 1.23) 0.07 P-value adjustment: bonferroni method for 16 tests "],["b12-4.html", "36.2 B12", " 36.2 B12 36.2.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4432875 0.0554134 98.230564 &lt;0.0001 *** folate_cat2&lt;800 0.0897374 0.0310652 2.888679 0.004 ** folate_cat2&gt;=800 0.0918943 0.0355793 2.582803 0.010 ** StudySTOP 0.1679117 0.0508131 3.304493 0.0010 *** f1_age 0.0089578 0.0018222 4.916009 &lt;0.0001 *** BMI -0.0086781 0.0013345 -6.502625 &lt;0.0001 *** folate_cat2&lt;800:StudySTOP -0.1099905 0.0592518 -1.856324 0.06 ns folate_cat2&gt;=800:StudySTOP -0.0388230 0.0577478 -0.672286 0.50 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.09 (1.00, 1.19) 0.04 SCOPE: &gt;=800/None 1.10 (0.99, 1.21) 0.09 SCOPE: &gt;=800/&lt;800 1.00 (0.93, 1.09) 1 STOP: &lt;800/None 0.98 (0.85, 1.13) 1 STOP: &gt;=800/None 1.05 (0.93, 1.20) 1 STOP: &gt;=800/&lt;800 1.08 (0.99, 1.17) 0.1 None: STOP/SCOPE 1.18 (1.03, 1.36) 0.009 &lt;800: STOP/SCOPE 1.06 (0.97, 1.16) 0.6 &gt;=800: STOP/SCOPE 1.14 (1.05, 1.23) &lt;0.0001 P-value adjustment: bonferroni method for 9 tests 36.2.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4435688 0.0554174 98.2284389 &lt;0.0001 *** folate_cat3&lt;=400 0.1126354 0.0462483 2.4354519 0.01 * folate_cat3&gt;400 to &lt;800 0.0845870 0.0320342 2.6405179 0.008 ** folate_cat3&gt;=800 0.0921606 0.0355811 2.5901563 0.010 ** StudySTOP 0.1681312 0.0508150 3.3086952 0.0010 *** f1_age 0.0088664 0.0018241 4.8608072 &lt;0.0001 *** BMI -0.0086139 0.0013356 -6.4496620 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.0061763 0.1253058 -0.0492897 0.96 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1125545 0.0601310 -1.8718208 0.06 ns folate_cat3&gt;=800:StudySTOP -0.0389661 0.0577495 -0.6747438 0.50 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.12 (0.98, 1.28) 0.2 SCOPE: &gt;400 to &lt;800/None 1.09 (0.99, 1.20) 0.1 SCOPE: &gt;=800/None 1.10 (0.99, 1.22) 0.2 SCOPE: &gt;=800/&lt;=400 0.98 (0.86, 1.12) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.01 (0.92, 1.10) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 1.03 (0.91, 1.16) 1 STOP: &lt;=400/None 1.11 (0.79, 1.57) 1 STOP: &gt;400 to &lt;800/None 0.97 (0.84, 1.13) 1 STOP: &gt;=800/None 1.05 (0.92, 1.21) 1 STOP: &gt;=800/&lt;=400 0.95 (0.69, 1.31) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.08 (0.99, 1.19) 0.1 STOP: &lt;=400/&gt;400 to &lt;800 1.14 (0.82, 1.59) 1 None: STOP/SCOPE 1.18 (1.02, 1.38) 0.02 &lt;=400: STOP/SCOPE 1.18 (0.84, 1.65) 1 &gt;400 to &lt;800: STOP/SCOPE 1.06 (0.96, 1.16) 1 &gt;=800: STOP/SCOPE 1.14 (1.05, 1.24) &lt;0.0001 P-value adjustment: bonferroni method for 16 tests "],["homocysteine-4.html", "36.3 Homocysteine", " 36.3 Homocysteine 36.3.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5803518 0.0329891 47.9052520 &lt;0.0001 *** folate_cat2&lt;800 -0.1153064 0.0184924 -6.2353415 &lt;0.0001 *** folate_cat2&gt;=800 -0.1532420 0.0211796 -7.2353493 &lt;0.0001 *** StudySTOP 0.0519769 0.0302479 1.7183633 0.09 ns f1_age 0.0001994 0.0010851 0.1837468 0.85 ns BMI 0.0003653 0.0007950 0.4594926 0.65 ns folate_cat2&lt;800:StudySTOP 0.0832587 0.0352711 2.3605332 0.02 * folate_cat2&gt;=800:StudySTOP 0.0606637 0.0343790 1.7645588 0.08 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 0.89 (0.85, 0.94) &lt;0.0001 SCOPE: &gt;=800/None 0.86 (0.81, 0.91) &lt;0.0001 SCOPE: &gt;=800/&lt;800 0.96 (0.92, 1.01) 0.2 STOP: &lt;800/None 0.97 (0.89, 1.05) 1 STOP: &gt;=800/None 0.91 (0.84, 0.98) 0.006 STOP: &gt;=800/&lt;800 0.94 (0.90, 0.99) 0.007 None: STOP/SCOPE 1.05 (0.97, 1.15) 0.8 &lt;800: STOP/SCOPE 1.14 (1.09, 1.21) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.07, 1.17) &lt;0.0001 P-value adjustment: bonferroni method for 9 tests 36.3.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5803492 0.0330064 47.8800287 &lt;0.0001 *** folate_cat3&lt;=400 -0.1164678 0.0275430 -4.2285786 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 -0.1150574 0.0190778 -6.0309416 &lt;0.0001 *** folate_cat3&gt;=800 -0.1532750 0.0211903 -7.2332687 &lt;0.0001 *** StudySTOP 0.0519496 0.0302627 1.7166229 0.09 ns f1_age 0.0002110 0.0010867 0.1941431 0.85 ns BMI 0.0003559 0.0007960 0.4471406 0.65 ns folate_cat3&lt;=400:StudySTOP 0.0569956 0.0746252 0.7637582 0.45 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0846906 0.0358107 2.3649513 0.02 * folate_cat3&gt;=800:StudySTOP 0.0606816 0.0343955 1.7642287 0.08 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 0.89 (0.82, 0.97) 0.0004 SCOPE: &gt;400 to &lt;800/None 0.89 (0.84, 0.94) &lt;0.0001 SCOPE: &gt;=800/None 0.86 (0.81, 0.91) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 0.96 (0.89, 1.04) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.96 (0.91, 1.01) 0.5 SCOPE: &lt;=400/&gt;400 to &lt;800 1.00 (0.93, 1.08) 1 STOP: &lt;=400/None 0.94 (0.77, 1.16) 1 STOP: &gt;400 to &lt;800/None 0.97 (0.89, 1.06) 1 STOP: &gt;=800/None 0.91 (0.84, 0.99) 0.01 STOP: &gt;=800/&lt;=400 0.97 (0.80, 1.17) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.94 (0.89, 0.99) 0.01 STOP: &lt;=400/&gt;400 to &lt;800 0.97 (0.80, 1.18) 1 None: STOP/SCOPE 1.05 (0.96, 1.15) 1 &lt;=400: STOP/SCOPE 1.12 (0.91, 1.36) 1 &gt;400 to &lt;800: STOP/SCOPE 1.15 (1.08, 1.21) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.07, 1.18) &lt;0.0001 P-value adjustment: bonferroni method for 16 tests "],["active-b12-4.html", "36.4 Active B12", " 36.4 Active B12 36.4.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6980884 0.0763676 48.424841 &lt;0.0001 *** folate_cat2&lt;800 0.0471307 0.0414837 1.136125 0.26 ns folate_cat2&gt;=800 0.1297728 0.0472991 2.743666 0.006 ** StudySTOP 0.3091637 0.0734053 4.211734 &lt;0.0001 *** f1_age 0.0064396 0.0026120 2.465416 0.01 * BMI 0.0040889 0.0018164 2.251133 0.02 * folate_cat2&lt;800:StudySTOP -0.2226759 0.0869102 -2.562136 0.01 * folate_cat2&gt;=800:StudySTOP -0.2562549 0.0829307 -3.089988 0.002 ** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.05 (0.93, 1.18) 1 SCOPE: &gt;=800/None 1.14 (1.00, 1.30) 0.06 SCOPE: &gt;=800/&lt;800 1.09 (0.97, 1.21) 0.3 STOP: &lt;800/None 0.84 (0.68, 1.04) 0.2 STOP: &gt;=800/None 0.88 (0.73, 1.07) 0.6 STOP: &gt;=800/&lt;800 1.05 (0.92, 1.20) 1 None: STOP/SCOPE 1.36 (1.11, 1.67) 0.0002 &lt;800: STOP/SCOPE 1.09 (0.96, 1.24) 0.6 &gt;=800: STOP/SCOPE 1.05 (0.95, 1.18) 1 P-value adjustment: bonferroni method for 9 tests 36.4.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6973379 0.0764631 48.3545126 &lt;0.0001 *** folate_cat3&lt;=400 0.0405931 0.0657792 0.6171119 0.54 ns folate_cat3&gt;400 to &lt;800 0.0484049 0.0427084 1.1333819 0.26 ns folate_cat3&gt;=800 0.1297245 0.0473434 2.7400769 0.006 ** StudySTOP 0.3091290 0.0734729 4.2073860 &lt;0.0001 *** f1_age 0.0064570 0.0026171 2.4672468 0.01 * BMI 0.0041026 0.0018205 2.2535753 0.02 * folate_cat3&lt;=400:StudySTOP -0.1471015 0.2172174 -0.6772086 0.50 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2271048 0.0880167 -2.5802485 0.01 * folate_cat3&gt;=800:StudySTOP -0.2562589 0.0830069 -3.0872007 0.002 ** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.04 (0.86, 1.27) 1 SCOPE: &gt;400 to &lt;800/None 1.05 (0.92, 1.19) 1 SCOPE: &gt;=800/None 1.14 (0.99, 1.31) 0.1 SCOPE: &gt;=800/&lt;=400 1.09 (0.90, 1.32) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.08 (0.96, 1.22) 0.7 SCOPE: &lt;=400/&gt;400 to &lt;800 0.99 (0.83, 1.19) 1 STOP: &lt;=400/None 0.90 (0.49, 1.66) 1 STOP: &gt;400 to &lt;800/None 0.84 (0.67, 1.05) 0.3 STOP: &gt;=800/None 0.88 (0.72, 1.08) 1 STOP: &gt;=800/&lt;=400 0.98 (0.55, 1.76) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.05 (0.92, 1.21) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.07 (0.59, 1.95) 1 None: STOP/SCOPE 1.36 (1.10, 1.69) 0.0005 &lt;=400: STOP/SCOPE 1.18 (0.64, 2.15) 1 &gt;400 to &lt;800: STOP/SCOPE 1.09 (0.94, 1.26) 1 &gt;=800: STOP/SCOPE 1.05 (0.94, 1.18) 1 P-value adjustment: bonferroni method for 16 tests "],["folateb12-4.html", "36.5 Folate:B12", " 36.5 Folate:B12 36.5.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.4839678 0.0859224 52.186248 &lt;0.0001 *** folate_cat2&lt;800 0.3515417 0.0481688 7.298120 &lt;0.0001 *** folate_cat2&gt;=800 0.4685689 0.0551682 8.493461 &lt;0.0001 *** StudySTOP 0.2528315 0.0787894 3.208953 0.001 ** f1_age 0.0053052 0.0028254 1.877666 0.06 ns BMI 0.0032318 0.0020693 1.561776 0.12 ns folate_cat2&lt;800:StudySTOP -0.1923338 0.0918741 -2.093449 0.04 * folate_cat2&gt;=800:StudySTOP -0.2806114 0.0895421 -3.133850 0.002 ** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.42 (1.24, 1.62) &lt;0.0001 SCOPE: &gt;=800/None 1.60 (1.37, 1.86) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.12 (0.99, 1.27) 0.08 STOP: &lt;800/None 1.17 (0.94, 1.46) 0.4 STOP: &gt;=800/None 1.21 (0.99, 1.47) 0.08 STOP: &gt;=800/&lt;800 1.03 (0.90, 1.17) 1 None: STOP/SCOPE 1.29 (1.03, 1.60) 0.01 &lt;800: STOP/SCOPE 1.06 (0.93, 1.21) 1 &gt;=800: STOP/SCOPE 0.97 (0.86, 1.10) 1 P-value adjustment: bonferroni method for 9 tests 36.5.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.4822409 0.0858558 52.2065982 &lt;0.0001 *** folate_cat3&lt;=400 0.2355125 0.0716504 3.2869649 0.001 ** folate_cat3&gt;400 to &lt;800 0.3779583 0.0496292 7.6156379 &lt;0.0001 *** folate_cat3&gt;=800 0.4677291 0.0551242 8.4849982 &lt;0.0001 *** StudySTOP 0.2521417 0.0787254 3.2027996 0.001 ** f1_age 0.0055867 0.0028259 1.9769187 0.05 * BMI 0.0030668 0.0020691 1.4821567 0.14 ns folate_cat3&lt;=400:StudySTOP -0.1690516 0.1941308 -0.8708129 0.38 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2133998 0.0931584 -2.2907193 0.02 * folate_cat3&gt;=800:StudySTOP -0.2801698 0.0894689 -3.1314781 0.002 ** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.27 (1.02, 1.56) 0.02 SCOPE: &gt;400 to &lt;800/None 1.46 (1.26, 1.69) &lt;0.0001 SCOPE: &gt;=800/None 1.60 (1.36, 1.88) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.26 (1.03, 1.55) 0.01 SCOPE: &gt;=800/&gt;400 to &lt;800 1.09 (0.95, 1.25) 0.8 SCOPE: &lt;=400/&gt;400 to &lt;800 0.87 (0.72, 1.05) 0.5 STOP: &lt;=400/None 1.07 (0.63, 1.82) 1 STOP: &gt;400 to &lt;800/None 1.18 (0.93, 1.49) 0.6 STOP: &gt;=800/None 1.21 (0.98, 1.49) 0.1 STOP: &gt;=800/&lt;=400 1.13 (0.68, 1.86) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.02 (0.89, 1.18) 1 STOP: &lt;=400/&gt;400 to &lt;800 0.91 (0.54, 1.51) 1 None: STOP/SCOPE 1.29 (1.02, 1.62) 0.02 &lt;=400: STOP/SCOPE 1.09 (0.64, 1.84) 1 &gt;400 to &lt;800: STOP/SCOPE 1.04 (0.89, 1.21) 1 &gt;=800: STOP/SCOPE 0.97 (0.86, 1.10) 1 P-value adjustment: bonferroni method for 16 tests "],["folateactive-b12-4.html", "36.6 Folate:Active B12", " 36.6 Folate:Active B12 36.6.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.2810192 0.1140552 55.0699938 &lt;0.0001 *** folate_cat2&lt;800 0.3740757 0.0619561 6.0377567 &lt;0.0001 *** folate_cat2&gt;=800 0.3883312 0.0706413 5.4972288 &lt;0.0001 *** StudySTOP 0.0857247 0.1096311 0.7819377 0.43 ns f1_age 0.0053972 0.0039010 1.3835457 0.17 ns BMI -0.0092511 0.0027128 -3.4101743 0.0007 *** folate_cat2&lt;800:StudySTOP -0.0550874 0.1298007 -0.4244002 0.67 ns folate_cat2&gt;=800:StudySTOP -0.0307098 0.1238572 -0.2479454 0.80 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.45 (1.22, 1.73) &lt;0.0001 SCOPE: &gt;=800/None 1.47 (1.21, 1.79) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.01 (0.86, 1.19) 1 STOP: &lt;800/None 1.38 (1.00, 1.89) 0.05 STOP: &gt;=800/None 1.43 (1.08, 1.90) 0.005 STOP: &gt;=800/&lt;800 1.04 (0.86, 1.26) 1 None: STOP/SCOPE 1.09 (0.80, 1.48) 1 &lt;800: STOP/SCOPE 1.03 (0.85, 1.25) 1 &gt;=800: STOP/SCOPE 1.06 (0.90, 1.24) 1 P-value adjustment: bonferroni method for 9 tests 36.6.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.2814862 0.1140582 55.0726442 &lt;0.0001 *** folate_cat3&lt;=400 0.2647887 0.0981212 2.6985892 0.007 ** folate_cat3&gt;400 to &lt;800 0.3955118 0.0637070 6.2082937 &lt;0.0001 *** folate_cat3&gt;=800 0.3877620 0.0706209 5.4907517 &lt;0.0001 *** StudySTOP 0.0854620 0.1095978 0.7797788 0.44 ns f1_age 0.0056461 0.0039038 1.4462841 0.15 ns BMI -0.0094702 0.0027156 -3.4873739 0.0005 *** folate_cat3&lt;=400:StudySTOP -0.1607504 0.3240179 -0.4961157 0.62 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.0672470 0.1312923 -0.5121931 0.61 ns folate_cat3&gt;=800:StudySTOP -0.0306324 0.1238193 -0.2473956 0.80 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.30 (0.97, 1.74) 0.1 SCOPE: &gt;400 to &lt;800/None 1.49 (1.23, 1.79) &lt;0.0001 SCOPE: &gt;=800/None 1.47 (1.20, 1.82) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.13 (0.85, 1.50) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.99 (0.83, 1.19) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.88 (0.67, 1.15) 1 STOP: &lt;=400/None 1.11 (0.44, 2.77) 1 STOP: &gt;400 to &lt;800/None 1.39 (0.99, 1.95) 0.07 STOP: &gt;=800/None 1.43 (1.05, 1.94) 0.008 STOP: &gt;=800/&lt;=400 1.29 (0.54, 3.09) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.03 (0.83, 1.27) 1 STOP: &lt;=400/&gt;400 to &lt;800 0.80 (0.33, 1.94) 1 None: STOP/SCOPE 1.09 (0.79, 1.51) 1 &lt;=400: STOP/SCOPE 0.93 (0.38, 2.29) 1 &gt;400 to &lt;800: STOP/SCOPE 1.02 (0.82, 1.26) 1 &gt;=800: STOP/SCOPE 1.06 (0.89, 1.26) 1 P-value adjustment: bonferroni method for 16 tests "],["fa-supp-3-categories-25.html", "37 FA supp: 3 categories", " 37 FA supp: 3 categories Characteristic None (n=306) &lt;800 (n=785) &gt;=800 (n=904) Total (n=1995) P-value Prolactin: Median (IQ range) 133.2 (82.1-210.7) 120.2 (74.6-192.6) 82.7 (51.4-139.9) 104.3 (60.8-173.9) &lt;0.0001 HPL: Median (IQ range) 161.1 (113.8-202.6) 156.2 (91.2-199.8) 75.2 (45.1-145.0) 126.7 (57.5-183.5) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.4-5.2) 3.4 (2.2-4.8) 1.8 (1.0-3.5) 2.8 (1.3-4.4) &lt;0.0001 LME for duplicated or repeated measures shown on next page. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat2&quot; mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(mod1)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) mod_sum &lt;- lapply(mod_ls,extract.ci.mod,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) names(mod_sum) &lt;- names(mod_em_sum) &lt;- names(mod_em_est) &lt;- names(mod_ls) "],["prolactin-23.html", "37.1 Prolactin", " 37.1 Prolactin cat(&quot;\\n&lt;b&gt;Model summary&lt;/b&gt;\\n&quot;) Model summary mod_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Var Effect P (Intercept) 13.99 (9.29, 21.05) &lt;0.0001 folate_cat2&lt;800 1.02 (0.91, 1.14) 0.72 folate_cat2&gt;=800 1.10 (0.97, 1.25) 0.14 StudySTOP 1.14 (0.93, 1.38) 0.20 GA_samp 1.16 (1.13, 1.18) &lt;0.0001 folate_cat2&lt;800:StudySTOP 1.03 (0.84, 1.27) 0.76 folate_cat2&gt;=800:StudySTOP 0.77 (0.63, 0.95) 0.01 cat(&quot;\\n&lt;b&gt;Estimated marginal means&lt;/b&gt;\\n&quot;) Estimated marginal means mod_em_est[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 97.15 8.44 137.30 81.81 115.36 &lt;800 SCOPE 99.09 7.87 96.74 84.64 116.01 &gt;=800 SCOPE 106.78 9.07 125.89 90.26 126.31 None STOP 110.39 11.40 264.55 90.07 135.28 &lt;800 STOP 116.19 9.80 122.91 98.32 137.32 &gt;=800 STOP 93.87 7.19 84.15 80.60 109.33 if(!any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=lower.CL,ymax=upper.CL,group=Study,color=Study))} if(any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=asymp.LCL,ymax=asymp.UCL,group=Study,color=Study))} p1 &lt;- p1 + geom_pointrange(size=0.7,position=position_dodge(width=0.2)) + geom_errorbar(width=0.08,size=1,position=position_dodge(width=0.2))+ scale_y_continuous(limits=c(0,NA),expand=expansion(mult=c(0,0.1))) + labs(title=&quot;Estimated marginal means (95% CI)&quot;,x=dat_labels[fvarc],y=dat_labels[varc]) + theme_bw() + theme(axis.title=element_text(size=16,face=&quot;bold&quot;),axis.text=element_text(color=&quot;black&quot;,size=14), plot.title=element_text(face=&quot;bold&quot;,color=&quot;black&quot;,size=14), panel.grid.major.x=element_blank(), legend.position=&quot;bottom&quot;,legend.title=element_text(size=15,face=&quot;bold&quot;),legend.text=element_text(size=14)) print(p1) cat(&quot;\\n\\n\\n&lt;br /&gt;&lt;b&gt;Post-hoc comparisons&lt;/b&gt;&lt;br /&gt;\\n&quot;) Post-hoc comparisons mod_em_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.02 (0.89, 1.16) 0.9 &gt;=800 / None Study: SCOPE 1.10 (0.94, 1.28) 0.3 &gt;=800 / &lt;800 Study: SCOPE 1.08 (0.95, 1.22) 0.4 &lt;800 / None Study: STOP 1.05 (0.86, 1.29) 0.8 &gt;=800 / None Study: STOP 0.85 (0.70, 1.03) 0.1 &gt;=800 / &lt;800 Study: STOP 0.81 (0.71, 0.91) 0.0002 STOP / SCOPE Folic acid supplement (μg): None 1.14 (0.93, 1.38) 0.2 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.17 (1.01, 1.36) 0.03 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.88 (0.76, 1.01) 0.08 "],["hpl-23.html", "37.2 HPL", " 37.2 HPL Model summary Var Effect P (Intercept) 2.00 (1.61, 2.47) &lt;0.0001 folate_cat2&lt;800 0.98 (0.93, 1.04) 0.61 folate_cat2&gt;=800 1.00 (0.93, 1.07) 0.92 StudySTOP 1.12 (1.00, 1.24) 0.04 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.99 (0.88, 1.10) 0.80 folate_cat2&gt;=800:StudySTOP 0.96 (0.86, 1.07) 0.49 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 97.36 3.42 386.14 90.87 104.32 &lt;800 SCOPE 95.85 2.80 201.01 90.48 101.54 &gt;=800 SCOPE 97.02 3.23 322.54 90.87 103.59 None STOP 108.66 5.04 870.42 99.20 119.01 &lt;800 STOP 105.48 3.57 339.88 98.69 112.75 &gt;=800 STOP 104.19 2.87 159.74 98.67 110.02 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.98 (0.92, 1.06) 0.9 &gt;=800 / None Study: SCOPE 1.00 (0.92, 1.08) 1.0 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.95, 1.08) 0.9 &lt;800 / None Study: STOP 0.97 (0.87, 1.09) 0.8 &gt;=800 / None Study: STOP 0.96 (0.87, 1.06) 0.6 &gt;=800 / &lt;800 Study: STOP 0.99 (0.92, 1.06) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.12 (1.00, 1.24) 0.04 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.10 (1.02, 1.19) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.07 (0.99, 1.16) 0.07 "],["gh2-23.html", "37.3 GH2", " 37.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 folate_cat2&lt;800 1.00 (0.92, 1.08) 0.96 folate_cat2&gt;=800 1.05 (0.96, 1.16) 0.28 StudySTOP 1.15 (0.99, 1.32) 0.06 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.85 (0.73, 0.99) 0.04 folate_cat2&gt;=800:StudySTOP 0.81 (0.70, 0.94) 0.006 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 2.46 0.10 1009.86 2.27 2.67 &lt;800 SCOPE 2.46 0.08 526.11 2.31 2.62 &gt;=800 SCOPE 2.59 0.10 898.76 2.40 2.80 None STOP 2.82 0.17 1559.00 2.51 3.17 &lt;800 STOP 2.40 0.09 942.72 2.22 2.59 &gt;=800 STOP 2.41 0.07 414.90 2.28 2.55 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.00 (0.91, 1.10) 1.0 &gt;=800 / None Study: SCOPE 1.05 (0.94, 1.18) 0.5 &gt;=800 / &lt;800 Study: SCOPE 1.05 (0.96, 1.16) 0.4 &lt;800 / None Study: STOP 0.85 (0.73, 0.99) 0.03 &gt;=800 / None Study: STOP 0.85 (0.74, 0.98) 0.02 &gt;=800 / &lt;800 Study: STOP 1.00 (0.92, 1.10) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.15 (0.99, 1.32) 0.07 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.98 (0.88, 1.08) 0.7 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.93 (0.84, 1.03) 0.2 "],["insulin-21.html", "37.4 Insulin", " 37.4 Insulin Model summary Var Effect P (Intercept) 12.13 (7.15, 20.57) &lt;0.0001 folate_cat2&lt;800 0.92 (0.78, 1.09) 0.35 folate_cat2&gt;=800 0.91 (0.75, 1.11) 0.35 StudySTOP 0.70 (0.54, 0.91) 0.007 GA_samp 1.02 (0.98, 1.05) 0.34 folate_cat2&lt;800:StudySTOP 1.20 (0.90, 1.59) 0.21 folate_cat2&gt;=800:StudySTOP 1.13 (0.85, 1.49) 0.40 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 15.07 1.16 Inf 12.96 17.53 &lt;800 SCOPE 13.92 0.84 Inf 12.36 15.68 &gt;=800 SCOPE 13.74 1.08 Inf 11.79 16.02 None STOP 10.58 1.05 Inf 8.71 12.85 &lt;800 STOP 11.72 0.85 Inf 10.17 13.51 &gt;=800 STOP 10.88 0.55 Inf 9.86 12.00 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.92 (0.76, 1.13) 0.6 &gt;=800 / None Study: SCOPE 0.91 (0.72, 1.15) 0.6 &gt;=800 / &lt;800 Study: SCOPE 0.99 (0.81, 1.21) 1.0 &lt;800 / None Study: STOP 1.11 (0.84, 1.45) 0.7 &gt;=800 / None Study: STOP 1.03 (0.81, 1.31) 1.0 &gt;=800 / &lt;800 Study: STOP 0.93 (0.78, 1.10) 0.6 STOP / SCOPE Folic acid supplement (μg): None 0.70 (0.54, 0.91) 0.007 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.84 (0.68, 1.04) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.79 (0.64, 0.97) 0.03 "],["homa-ir-21.html", "37.5 HOMA-IR", " 37.5 HOMA-IR Model summary Var Effect P (Intercept) 3.07 (1.76, 5.34) &lt;0.0001 folate_cat2&lt;800 0.92 (0.77, 1.09) 0.33 folate_cat2&gt;=800 0.90 (0.73, 1.11) 0.34 StudySTOP 0.60 (0.46, 0.79) 0.0003 GA_samp 1.01 (0.98, 1.05) 0.45 folate_cat2&lt;800:StudySTOP 1.20 (0.89, 1.63) 0.22 folate_cat2&gt;=800:StudySTOP 1.14 (0.85, 1.54) 0.39 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 3.67 0.30 Inf 3.12 4.30 &lt;800 SCOPE 3.36 0.21 Inf 2.96 3.80 &gt;=800 SCOPE 3.31 0.28 Inf 2.81 3.91 None STOP 2.20 0.23 Inf 1.79 2.71 &lt;800 STOP 2.43 0.19 Inf 2.09 2.82 &gt;=800 STOP 2.27 0.12 Inf 2.05 2.52 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.92 (0.74, 1.13) 0.6 &gt;=800 / None Study: SCOPE 0.90 (0.71, 1.16) 0.6 &gt;=800 / &lt;800 Study: SCOPE 0.99 (0.80, 1.22) 1.0 &lt;800 / None Study: STOP 1.10 (0.83, 1.47) 0.7 &gt;=800 / None Study: STOP 1.03 (0.80, 1.34) 1.0 &gt;=800 / &lt;800 Study: STOP 0.94 (0.78, 1.12) 0.7 STOP / SCOPE Folic acid supplement (μg): None 0.60 (0.46, 0.79) 0.0003 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.72 (0.58, 0.90) 0.004 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.69 (0.55, 0.85) 0.0008 "],["glucose-21.html", "37.6 Glucose", " 37.6 Glucose Model summary Var Effect P (Intercept) 5.52 (4.98, 6.11) &lt;0.0001 folate_cat2&lt;800 1.01 (0.98, 1.05) 0.43 folate_cat2&gt;=800 1.02 (0.98, 1.06) 0.38 StudySTOP 0.89 (0.84, 0.94) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.51 folate_cat2&lt;800:StudySTOP 0.98 (0.92, 1.04) 0.55 folate_cat2&gt;=800:StudySTOP 0.97 (0.92, 1.03) 0.28 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.36 0.09 Inf 5.20 5.54 &lt;800 SCOPE 5.44 0.05 Inf 5.34 5.54 &gt;=800 SCOPE 5.46 0.08 Inf 5.30 5.63 None STOP 4.76 0.09 Inf 4.59 4.95 &lt;800 STOP 4.74 0.09 Inf 4.57 4.91 &gt;=800 STOP 4.70 0.04 Inf 4.62 4.78 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.01 (0.97, 1.05) 0.7 &gt;=800 / None Study: SCOPE 1.02 (0.97, 1.07) 0.7 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.97, 1.05) 1.0 &lt;800 / None Study: STOP 0.99 (0.94, 1.06) 1.0 &gt;=800 / None Study: STOP 0.99 (0.94, 1.03) 0.8 &gt;=800 / &lt;800 Study: STOP 0.99 (0.95, 1.04) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.89 (0.84, 0.94) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.87 (0.84, 0.91) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.83, 0.89) &lt;0.0001 "],["fa-supp-4-categories-25.html", "38 FA supp: 4 categories", " 38 FA supp: 4 categories Characteristic None (n=306) &lt;=400 (n=117) &gt;400 to &lt;800 (n=668) &gt;=800 (n=904) Total (n=1995) P-value Prolactin: Median (IQ range) 133.2 (82.1-210.7) 132.8 (94.5-219.2) 117.1 (72.9-186.4) 82.7 (51.4-139.9) 104.3 (60.8-173.9) &lt;0.0001 HPL: Median (IQ range) 161.1 (113.8-202.6) 174.1 (145.4-207.1) 153.7 (80.9-196.8) 75.2 (45.1-145.0) 126.7 (57.5-183.5) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.4-5.2) 4.0 (3.1-6.0) 3.3 (2.0-4.7) 1.8 (1.0-3.5) 2.8 (1.3-4.4) &lt;0.0001 Insulin: Mean (SD) 20.5 (22.6) 24.6 (30.2) 21.7 (26.5) 18.2 (22.9) 20.0 (24.6) 0.01 HOMA.IR: Mean (SD) 5.0 (6.0) 6.4 (9.0) 5.3 (6.9) 4.3 (6.3) 4.8 (6.7) 0.003 GLUC3_mmol.L: Mean (SD) 5.2 (0.8) 5.4 (0.8) 5.2 (0.8) 5.0 (0.7) 5.1 (0.8) &lt;0.0001 LME or GEE for duplicated or repeated measures. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat3&quot; "],["prolactin-24.html", "38.1 Prolactin", " 38.1 Prolactin Model summary Var Effect P (Intercept) 13.85 (9.20, 20.85) &lt;0.0001 folate_cat3&lt;=400 1.05 (0.90, 1.23) 0.53 folate_cat3&gt;400 to &lt;800 1.01 (0.90, 1.13) 0.84 folate_cat3&gt;=800 1.10 (0.97, 1.25) 0.14 StudySTOP 1.14 (0.94, 1.39) 0.19 GA_samp 1.16 (1.13, 1.18) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.18 (0.77, 1.80) 0.45 folate_cat3&gt;400 to &lt;800:StudySTOP 1.03 (0.84, 1.27) 0.78 folate_cat3&gt;=800:StudySTOP 0.77 (0.63, 0.95) 0.01 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 97.06 8.44 137.53 81.73 115.26 &lt;=400 SCOPE 102.11 10.16 228.21 83.93 124.22 &gt;400 to &lt;800 SCOPE 98.19 7.94 104.04 83.65 115.27 &gt;=800 SCOPE 106.68 9.06 125.99 90.18 126.19 None STOP 110.57 11.42 264.79 90.22 135.51 &lt;=400 STOP 136.98 27.73 1355.53 92.07 203.77 &gt;400 to &lt;800 STOP 115.23 9.78 125.88 97.41 136.30 &gt;=800 STOP 94.00 7.20 84.23 80.71 109.48 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.05 (0.85, 1.30) 0.9 &gt;400 to &lt;800 / None Study: SCOPE 1.01 (0.87, 1.18) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.96 (0.79, 1.17) 1.0 &gt;=800 / None Study: SCOPE 1.10 (0.93, 1.30) 0.5 &gt;=800 / &lt;=400 Study: SCOPE 1.04 (0.85, 1.29) 0.9 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.09 (0.94, 1.26) 0.5 &lt;=400 / None Study: STOP 1.24 (0.74, 2.08) 0.7 &gt;400 to &lt;800 / None Study: STOP 1.04 (0.83, 1.31) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.84 (0.51, 1.38) 0.8 &gt;=800 / None Study: STOP 0.85 (0.69, 1.05) 0.2 &gt;=800 / &lt;=400 Study: STOP 0.69 (0.42, 1.12) 0.2 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.82 (0.71, 0.94) 0.0009 STOP / SCOPE Folic acid supplement (μg): None 1.14 (0.94, 1.39) 0.2 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.34 (0.89, 2.02) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.17 (1.01, 1.36) 0.04 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.88 (0.76, 1.02) 0.08 "],["hpl-24.html", "38.2 HPL", " 38.2 HPL Model summary Var Effect P (Intercept) 1.98 (1.60, 2.46) &lt;0.0001 folate_cat3&lt;=400 1.01 (0.93, 1.10) 0.82 folate_cat3&gt;400 to &lt;800 0.98 (0.92, 1.04) 0.48 folate_cat3&gt;=800 1.00 (0.93, 1.07) 0.92 StudySTOP 1.12 (1.01, 1.24) 0.04 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.05 (0.83, 1.31) 0.70 folate_cat3&gt;400 to &lt;800:StudySTOP 0.99 (0.88, 1.10) 0.82 folate_cat3&gt;=800:StudySTOP 0.96 (0.86, 1.07) 0.49 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 97.29 3.42 385.43 90.79 104.24 &lt;=400 SCOPE 98.28 4.29 723.76 90.21 107.07 &gt;400 to &lt;800 SCOPE 95.13 2.90 234.04 89.58 101.02 &gt;=800 SCOPE 96.95 3.23 321.94 90.80 103.52 None STOP 108.77 5.05 868.11 99.30 119.14 &lt;=400 STOP 114.87 11.80 1598.51 93.91 140.52 &gt;400 to &lt;800 STOP 105.00 3.60 353.78 98.16 112.33 &gt;=800 STOP 104.27 2.88 159.65 98.74 110.11 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.01 (0.90, 1.13) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.98 (0.90, 1.06) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.97 (0.87, 1.08) 0.9 &gt;=800 / None Study: SCOPE 1.00 (0.91, 1.09) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.99 (0.88, 1.10) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.02 (0.94, 1.10) 0.9 &lt;=400 / None Study: STOP 1.06 (0.80, 1.39) 1.0 &gt;400 to &lt;800 / None Study: STOP 0.97 (0.85, 1.09) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.91 (0.70, 1.19) 0.8 &gt;=800 / None Study: STOP 0.96 (0.86, 1.07) 0.8 &gt;=800 / &lt;=400 Study: STOP 0.91 (0.70, 1.17) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.99 (0.92, 1.07) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.12 (1.01, 1.24) 0.04 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.17 (0.94, 1.45) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.10 (1.02, 1.20) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.08 (1.00, 1.16) 0.06 "],["gh2-24.html", "38.3 GH2", " 38.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.05, 0.10) &lt;0.0001 folate_cat3&lt;=400 1.08 (0.96, 1.21) 0.22 folate_cat3&gt;400 to &lt;800 0.98 (0.90, 1.06) 0.59 folate_cat3&gt;=800 1.05 (0.96, 1.16) 0.29 StudySTOP 1.14 (0.99, 1.32) 0.07 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.71 (0.52, 0.96) 0.03 folate_cat3&gt;400 to &lt;800:StudySTOP 0.88 (0.75, 1.02) 0.09 folate_cat3&gt;=800:StudySTOP 0.81 (0.70, 0.94) 0.006 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 2.47 0.10 1014.83 2.28 2.68 &lt;=400 SCOPE 2.66 0.14 1380.59 2.39 2.95 &gt;400 to &lt;800 SCOPE 2.41 0.08 640.35 2.26 2.58 &gt;=800 SCOPE 2.60 0.10 902.59 2.40 2.80 None STOP 2.82 0.17 1558.99 2.51 3.17 &lt;=400 STOP 2.14 0.30 1575.57 1.63 2.82 &gt;400 to &lt;800 STOP 2.41 0.10 982.38 2.23 2.61 &gt;=800 STOP 2.41 0.07 418.47 2.28 2.55 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.08 (0.92, 1.25) 0.6 &gt;400 to &lt;800 / None Study: SCOPE 0.98 (0.88, 1.09) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.91 (0.79, 1.05) 0.3 &gt;=800 / None Study: SCOPE 1.05 (0.93, 1.19) 0.7 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.84, 1.14) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.08 (0.97, 1.20) 0.3 &lt;=400 / None Study: STOP 0.76 (0.52, 1.11) 0.2 &gt;400 to &lt;800 / None Study: STOP 0.86 (0.72, 1.01) 0.08 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.13 (0.78, 1.62) 0.8 &gt;=800 / None Study: STOP 0.85 (0.73, 1.00) 0.04 &gt;=800 / &lt;=400 Study: STOP 1.12 (0.79, 1.60) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.00 (0.90, 1.10) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.14 (0.99, 1.32) 0.07 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.81 (0.60, 1.09) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.00 (0.90, 1.12) 1.0 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.93 (0.84, 1.03) 0.2 "],["insulin-22.html", "38.4 Insulin", " 38.4 Insulin Model summary Var Effect P (Intercept) 12.33 (7.27, 20.90) &lt;0.0001 folate_cat3&lt;=400 0.88 (0.67, 1.16) 0.37 folate_cat3&gt;400 to &lt;800 0.93 (0.79, 1.11) 0.44 folate_cat3&gt;=800 0.91 (0.75, 1.11) 0.35 StudySTOP 0.70 (0.54, 0.90) 0.006 GA_samp 1.02 (0.98, 1.05) 0.37 folate_cat3&lt;=400:StudySTOP 0.99 (0.51, 1.95) 0.99 folate_cat3&gt;400 to &lt;800:StudySTOP 1.20 (0.90, 1.60) 0.21 folate_cat3&gt;=800:StudySTOP 1.13 (0.85, 1.49) 0.40 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 15.11 1.16 Inf 12.99 17.56 &lt;=400 SCOPE 13.32 1.71 Inf 10.36 17.13 &gt;400 to &lt;800 SCOPE 14.12 0.90 Inf 12.46 15.99 &gt;=800 SCOPE 13.77 1.08 Inf 11.81 16.05 None STOP 10.56 1.05 Inf 8.69 12.83 &lt;=400 STOP 9.25 2.78 Inf 5.14 16.66 &gt;400 to &lt;800 STOP 11.86 0.87 Inf 10.28 13.70 &gt;=800 STOP 10.86 0.54 Inf 9.84 11.98 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.88 (0.61, 1.27) 0.8 &gt;400 to &lt;800 / None Study: SCOPE 0.93 (0.75, 1.17) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.06 (0.75, 1.50) 1.0 &gt;=800 / None Study: SCOPE 0.91 (0.71, 1.17) 0.8 &gt;=800 / &lt;=400 Study: SCOPE 1.03 (0.72, 1.49) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 0.98 (0.78, 1.22) 1.0 &lt;=400 / None Study: STOP 0.88 (0.39, 1.96) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.12 (0.83, 1.52) 0.7 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.28 (0.59, 2.80) 0.8 &gt;=800 / None Study: STOP 1.03 (0.79, 1.34) 1.0 &gt;=800 / &lt;=400 Study: STOP 1.17 (0.55, 2.53) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.91 (0.76, 1.10) 0.6 STOP / SCOPE Folic acid supplement (μg): None 0.70 (0.54, 0.90) 0.006 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.69 (0.36, 1.33) 0.3 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.84 (0.68, 1.04) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.79 (0.64, 0.97) 0.02 "],["homa-ir-22.html", "38.5 HOMA-IR", " 38.5 HOMA-IR Model summary Var Effect P (Intercept) 3.12 (1.79, 5.42) &lt;0.0001 folate_cat3&lt;=400 0.87 (0.65, 1.16) 0.34 folate_cat3&gt;400 to &lt;800 0.93 (0.77, 1.12) 0.43 folate_cat3&gt;=800 0.90 (0.73, 1.11) 0.34 StudySTOP 0.60 (0.46, 0.79) 0.0002 GA_samp 1.01 (0.98, 1.05) 0.49 folate_cat3&lt;=400:StudySTOP 1.03 (0.50, 2.10) 0.94 folate_cat3&gt;400 to &lt;800:StudySTOP 1.20 (0.89, 1.63) 0.23 folate_cat3&gt;=800:StudySTOP 1.14 (0.85, 1.54) 0.39 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 3.67 0.30 Inf 3.13 4.31 &lt;=400 SCOPE 3.19 0.43 Inf 2.44 4.15 &gt;400 to &lt;800 SCOPE 3.41 0.23 Inf 2.99 3.89 &gt;=800 SCOPE 3.32 0.28 Inf 2.82 3.92 None STOP 2.20 0.23 Inf 1.79 2.70 &lt;=400 STOP 1.96 0.63 Inf 1.04 3.66 &gt;400 to &lt;800 STOP 2.46 0.19 Inf 2.11 2.86 &gt;=800 STOP 2.27 0.12 Inf 2.05 2.51 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.87 (0.59, 1.27) 0.8 &gt;400 to &lt;800 / None Study: SCOPE 0.93 (0.73, 1.18) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.07 (0.74, 1.54) 1.0 &gt;=800 / None Study: SCOPE 0.90 (0.69, 1.19) 0.8 &gt;=800 / &lt;=400 Study: SCOPE 1.04 (0.71, 1.53) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 0.97 (0.76, 1.24) 1.0 &lt;=400 / None Study: STOP 0.89 (0.38, 2.09) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.12 (0.81, 1.54) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.26 (0.55, 2.88) 0.9 &gt;=800 / None Study: STOP 1.03 (0.78, 1.37) 1.0 &gt;=800 / &lt;=400 Study: STOP 1.16 (0.51, 2.62) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.92 (0.76, 1.13) 0.7 STOP / SCOPE Folic acid supplement (μg): None 0.60 (0.46, 0.79) 0.0002 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.61 (0.31, 1.23) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.72 (0.58, 0.90) 0.004 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.68 (0.55, 0.85) 0.0007 "],["glucose-22.html", "38.6 Glucose", " 38.6 Glucose Model summary Var Effect P (Intercept) 5.43 (4.92, 6.00) &lt;0.0001 folate_cat3&lt;=400 1.01 (0.96, 1.06) 0.73 folate_cat3&gt;400 to &lt;800 1.01 (0.98, 1.05) 0.39 folate_cat3&gt;=800 1.02 (0.98, 1.06) 0.38 StudySTOP 0.89 (0.85, 0.94) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.73 folate_cat3&lt;=400:StudySTOP 1.19 (0.95, 1.49) 0.12 folate_cat3&gt;400 to &lt;800:StudySTOP 0.97 (0.92, 1.02) 0.18 folate_cat3&gt;=800:StudySTOP 0.97 (0.92, 1.03) 0.28 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.35 0.09 Inf 5.19 5.53 &lt;=400 SCOPE 5.40 0.11 Inf 5.18 5.63 &gt;400 to &lt;800 SCOPE 5.43 0.05 Inf 5.33 5.54 &gt;=800 SCOPE 5.45 0.08 Inf 5.29 5.62 None STOP 4.77 0.09 Inf 4.59 4.95 &lt;=400 STOP 5.74 0.63 Inf 4.62 7.12 &gt;400 to &lt;800 STOP 4.67 0.05 Inf 4.57 4.77 &gt;=800 STOP 4.71 0.04 Inf 4.63 4.79 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.01 (0.95, 1.07) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 1.01 (0.97, 1.06) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.01 (0.95, 1.06) 1.0 &gt;=800 / None Study: SCOPE 1.02 (0.97, 1.07) 0.8 &gt;=800 / &lt;=400 Study: SCOPE 1.01 (0.95, 1.08) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.96, 1.05) 1.0 &lt;=400 / None Study: STOP 1.20 (0.90, 1.60) 0.3 &gt;400 to &lt;800 / None Study: STOP 0.98 (0.93, 1.03) 0.7 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.81 (0.61, 1.08) 0.2 &gt;=800 / None Study: STOP 0.99 (0.94, 1.04) 0.9 &gt;=800 / &lt;=400 Study: STOP 0.82 (0.62, 1.09) 0.3 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.01 (0.98, 1.04) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.89 (0.85, 0.94) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.06 (0.85, 1.33) 0.6 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.86 (0.83, 0.89) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.83, 0.90) &lt;0.0001 "],["age-groups-3.html", "39 Age groups", " 39 Age groups Descriptives with univariate P-values. Characteristic &lt;35 yrs (n=2054) &gt;=35 yrs (n=67) Total (n=2121) P-value PRL (ng/ml): Median (IQ range) 102.7 (60.5-169.3) 88.3 (49.1-155.7) 101.8 (60.0-169.0) 0.17 hPL (μg/ml): Median (IQ range) 120.6 (56.7-181.7) 86.8 (53.4-157.2) 117.7 (56.6-181.2) 0.12 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.3) 2.2 (1.2-3.8) 2.7 (1.3-4.3) 0.33 Insulin (uU/ml): Median (IQ range) 11.0 (6.2-23.6) 11.2 (6.3-18.2) 11.0 (6.2-23.4) 0.71 HOMA-IR: Median (IQ range) 2.4 (1.3-5.3) 2.6 (1.3-4.2) 2.4 (1.3-5.3) 0.70 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.6) 4.9 (4.5-5.4) 5.0 (4.6-5.5) 0.17 Within SCOPE Characteristic &lt;35 yrs (n=1047) &gt;=35 yrs (n=26) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 140.9 (92.6-222.8) 166.9 (95.6-295.5) 141.2 (92.6-223.7) 0.43 hPL (μg/ml): Median (IQ range) 180.8 (149.9-217.6) 163.8 (133.3-208.1) 180.6 (149.6-216.9) 0.25 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.7) 4.4 (3.5-6.4) 4.2 (3.2-5.7) 0.47 Insulin (uU/ml): Median (IQ range) 13.8 (6.5-30.1) 19.5 (10.2-37.2) 13.8 (6.6-30.3) 0.22 HOMA-IR: Median (IQ range) 3.3 (1.5-7.5) 4.8 (2.7-10.8) 3.3 (1.6-7.5) 0.12 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.2-5.8) 5.4 (5.0-5.8) 0.29 Serum folate concentration (nM): Median (IQ range) 35.8 (27.9-42.5) 40.3 (34.6-46.5) 35.9 (28.1-42.6) 0.02 B12 concentration (pM): Median (IQ range) 243.0 (194.0-307.0) 265.0 (227.5-365.0) 245.0 (195.0-308.5) 0.08 Folate:B12 ratio: Median (IQ range) 142.6 (101.7-208.7) 162.5 (120.6-200.7) 142.7 (102.3-207.5) 0.31 Active B12 concentration (pM): Median (IQ range) 56.0 (43.0-72.2) 59.0 (46.0-94.0) 56.0 (43.0-73.0) 0.40 Folate:Active B12 ratio: Median (IQ range) 612.1 (436.5-902.1) 685.4 (420.3-904.2) 615.4 (432.4-902.3) 0.64 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.5 (3.9-4.7) 4.4 (3.8-5.0) 0.83 Within STOP Characteristic &lt;35 yrs (n=1007) &gt;=35 yrs (n=41) Total (n=1048) P-value PRL (ng/ml): Median (IQ range) 75.2 (49.5-119.3) 64.1 (43.6-100.6) 75.0 (49.4-118.7) 0.22 hPL (μg/ml): Median (IQ range) 60.4 (40.4-93.1) 61.2 (41.0-90.1) 60.5 (40.5-93.0) 0.78 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.5 (1.0-2.3) 1.4 (0.9-2.4) 0.69 Insulin (uU/ml): Median (IQ range) 9.6 (5.8-18.9) 8.9 (5.0-14.8) 9.6 (5.8-18.5) 0.28 HOMA-IR: Median (IQ range) 2.0 (1.2-4.0) 1.8 (1.0-2.8) 2.0 (1.2-4.0) 0.25 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.7 (4.4-4.9) 4.7 (4.4-5.1) 0.22 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-45.2) 43.4 (40.1-93.9) 40.5 (36.4-45.3) 0.002 B12 concentration (pM): Median (IQ range) 280.0 (218.0-356.5) 272.5 (205.8-363.0) 280.0 (218.0-357.0) 0.71 Folate:B12 ratio: Median (IQ range) 152.6 (114.8-219.0) 185.4 (141.9-297.7) 153.5 (115.1-221.2) 0.007 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-83.5) 62.0 (54.0-96.0) 63.0 (49.0-84.0) 0.82 Folate:Active B12 ratio: Median (IQ range) 663.0 (474.1-946.7) 742.2 (493.6-959.1) 663.1 (475.7-951.1) 0.70 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.9 (4.3-5.8) 4.8 (4.2-5.6) 0.37 Red cell folate (nmol/L): Median (IQ range) 1456.5 (1203.5-1766.2) 1582.0 (1335.5-1757.8) 1466.0 (1206.0-1765.8) 0.17 mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ # if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) #mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log # mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} # if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))#} return(mod1)}) #mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) #mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) mod_em &lt;- foreach(ind1=1:length(mod_ls)) %dofuture% { if(!any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)} return(em1)} mod_em2 &lt;- foreach(ind2=1:length(mod_ls)) %dofuture% { if(!any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)} return(em2)} names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls)) %dofuture% { extract.ci.mod(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- c(hormone_var,insulin_var) mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-25.html", "39.1 Prolactin", " 39.1 Prolactin LME for repeated measures. Model summary Var Effect P (Intercept) 14.09 (9.03, 21.98) &lt;0.0001 Age_gp&gt;=35 yrs 1.15 (0.70, 1.88) 0.59 StudySTOP 0.97 (0.85, 1.11) 0.70 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.74 (0.43, 1.26) 0.27 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 102.76 4.19 Inf 94.87 111.30 &gt;=35 yrs SCOPE 117.84 29.76 Inf 71.84 193.32 &lt;35 yrs STOP 100.07 3.80 Inf 92.90 107.81 &gt;=35 yrs STOP 84.79 9.03 Inf 68.81 104.48 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.15 (0.70, 1.88) 0.6 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.85 (0.69, 1.05) 0.1 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.97 (0.85, 1.11) 0.7 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.72 (0.42, 1.24) 0.2 "],["hpl-25.html", "39.2 HPL", " 39.2 HPL LME for repeated measures. Model summary Var Effect P (Intercept) 1.98 (1.57, 2.50) &lt;0.0001 Age_gp&gt;=35 yrs 0.95 (0.83, 1.08) 0.45 StudySTOP 1.08 (1.02, 1.14) 0.008 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.00 (0.82, 1.21) 0.96 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 94.56 1.83 Inf 91.03 98.22 &gt;=35 yrs SCOPE 89.90 6.06 Inf 78.77 102.60 &lt;35 yrs STOP 102.11 1.51 Inf 99.19 105.11 &gt;=35 yrs STOP 96.64 7.22 Inf 83.47 111.88 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.95 (0.83, 1.08) 0.4 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.95 (0.82, 1.10) 0.5 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.08 (1.02, 1.14) 0.008 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.07 (0.88, 1.31) 0.5 "],["gh2-25.html", "39.3 GH2", " 39.3 GH2 LME for repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 Age_gp&gt;=35 yrs 1.17 (0.92, 1.50) 0.20 StudySTOP 1.03 (0.95, 1.12) 0.43 GA_samp 1.31 (1.29, 1.33) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.77 (0.56, 1.05) 0.10 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 2.37 0.06 Inf 2.26 2.49 &gt;=35 yrs SCOPE 2.79 0.35 Inf 2.18 3.56 &lt;35 yrs STOP 2.45 0.06 Inf 2.34 2.56 &gt;=35 yrs STOP 2.21 0.21 Inf 1.84 2.67 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.17 (0.92, 1.50) 0.2 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.90 (0.75, 1.09) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.03 (0.95, 1.12) 0.4 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.79 (0.58, 1.08) 0.1 "],["insulin-23.html", "39.4 Insulin", " 39.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 11.29 (6.96, 18.30) &lt;0.0001 Age_gp&gt;=35 yrs 1.29 (0.91, 1.82) 0.15 StudySTOP 0.79 (0.68, 0.93) 0.003 GA_samp 1.02 (0.99, 1.05) 0.30 Age_gp&gt;=35 yrs:StudySTOP 0.63 (0.42, 0.96) 0.03 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 14.01 0.69 Inf 12.72 15.44 &gt;=35 yrs SCOPE 18.10 3.17 Inf 12.84 25.52 &lt;35 yrs STOP 11.11 0.46 Inf 10.25 12.05 &gt;=35 yrs STOP 9.08 1.04 Inf 7.25 11.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.29 (0.91, 1.82) 0.1 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.82 (0.65, 1.03) 0.08 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.79 (0.68, 0.93) 0.003 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.50 (0.33, 0.76) 0.001 "],["homa-ir-23.html", "39.5 HOMA-IR", " 39.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.80 (1.69, 4.64) &lt;0.0001 Age_gp&gt;=35 yrs 1.42 (0.97, 2.06) 0.07 StudySTOP 0.69 (0.58, 0.81) &lt;0.0001 GA_samp 1.01 (0.98, 1.05) 0.39 Age_gp&gt;=35 yrs:StudySTOP 0.57 (0.36, 0.89) 0.01 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 3.37 0.18 Inf 3.05 3.74 &gt;=35 yrs SCOPE 4.78 0.91 Inf 3.29 6.95 &lt;35 yrs STOP 2.32 0.10 Inf 2.13 2.53 &gt;=35 yrs STOP 1.86 0.23 Inf 1.47 2.36 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.42 (0.97, 2.06) 0.07 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.80 (0.63, 1.02) 0.08 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.69 (0.58, 0.81) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.39 (0.25, 0.61) &lt;0.0001 "],["glucose-23.html", "39.6 Glucose", " 39.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.52 (5.05, 6.03) &lt;0.0001 Age_gp&gt;=35 yrs 1.05 (0.97, 1.14) 0.19 StudySTOP 0.87 (0.85, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.64 Age_gp&gt;=35 yrs:StudySTOP 0.94 (0.86, 1.02) 0.12 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 5.42 0.05 Inf 5.32 5.51 &gt;=35 yrs SCOPE 5.70 0.22 Inf 5.28 6.16 &lt;35 yrs STOP 4.72 0.04 Inf 4.65 4.79 &gt;=35 yrs STOP 4.65 0.06 Inf 4.53 4.78 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.05 (0.97, 1.14) 0.2 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.99 (0.96, 1.01) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.87 (0.85, 0.89) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.82 (0.75, 0.89) &lt;0.0001 "],["bmi-groups-3.html", "40 BMI groups", " 40 BMI groups Descriptives with univariate P-values. Characteristic Underweight (n=55) Normal (n=895) Overweight (n=605) Obese (n=565) Total (n=2120) P-value PRL (ng/ml): Median (IQ range) 112.4 (72.9-216.6) 105.8 (63.6-170.5) 103.2 (61.0-181.1) 94.2 (52.6-151.0) 101.8 (60.0-169.0) 0.009 hPL (μg/ml): Median (IQ range) 164.7 (90.3-220.8) 132.5 (62.8-199.0) 117.9 (56.0-174.7) 93.4 (45.6-154.4) 117.7 (56.6-181.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.3 (2.8-6.2) 3.1 (1.4-4.9) 2.6 (1.2-4.0) 2.4 (1.1-3.4) 2.7 (1.3-4.3) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 6.2 (4.4-12.5) 7.6 (4.6-16.2) 11.7 (6.8-26.1) 16.2 (10.2-30.9) 11.0 (6.2-23.4) &lt;0.0001 HOMA-IR: Median (IQ range) 1.5 (0.9-3.0) 1.7 (1.0-3.8) 2.6 (1.4-5.7) 3.6 (2.2-7.1) 2.4 (1.3-5.3) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.9 (4.4-5.5) 5.0 (4.6-5.5) 5.0 (4.6-5.6) 5.1 (4.7-5.6) 5.0 (4.6-5.5) 0.02 Within SCOPE Characteristic Underweight (n=34) Normal (n=458) Overweight (n=301) Obese (n=280) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 168.8 (90.4-271.0) 142.3 (96.5-221.2) 148.2 (97.1-237.7) 133.2 (82.4-211.1) 141.2 (92.6-223.7) 0.10 hPL (μg/ml): Median (IQ range) 213.7 (167.4-258.0) 198.6 (169.6-229.4) 172.7 (148.8-208.6) 157.3 (130.7-188.0) 180.6 (149.6-216.9) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 5.1 (4.3-6.5) 4.8 (3.6-6.5) 4.0 (3.1-5.4) 3.4 (2.7-4.4) 4.2 (3.2-5.7) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 8.8 (4.7-12.5) 9.4 (5.0-22.6) 17.9 (9.0-38.1) 19.2 (10.6-35.3) 13.8 (6.6-30.3) &lt;0.0001 HOMA-IR: Median (IQ range) 1.8 (1.1-3.3) 2.2 (1.2-5.7) 4.2 (1.9-8.6) 4.5 (2.4-9.0) 3.3 (1.6-7.5) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.8-5.8) 5.3 (5.0-5.7) 5.4 (5.0-5.9) 5.3 (5.0-5.9) 5.4 (5.0-5.8) 0.18 Serum folate concentration (nM): Median (IQ range) 29.3 (22.4-38.1) 36.0 (29.0-43.0) 35.8 (28.9-41.1) 35.8 (25.6-43.0) 35.9 (28.1-42.6) 0.13 B12 concentration (pM): Median (IQ range) 269.0 (207.5-330.5) 253.0 (197.8-319.0) 240.0 (199.0-309.0) 230.0 (185.0-290.5) 245.0 (195.0-308.5) 0.005 Folate:B12 ratio: Median (IQ range) 115.9 (74.5-201.5) 141.6 (102.3-205.7) 143.2 (106.1-198.6) 145.9 (102.5-219.1) 142.7 (102.3-207.5) 0.35 Active B12 concentration (pM): Median (IQ range) 52.5 (39.5-71.5) 54.0 (42.0-71.0) 56.0 (43.2-72.0) 61.0 (45.2-75.0) 56.0 (43.0-73.0) 0.13 Folate:Active B12 ratio: Median (IQ range) 613.6 (414.7-845.3) 649.1 (457.9-983.6) 618.7 (466.7-891.8) 537.6 (392.3-819.3) 615.4 (432.4-902.3) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.2-5.3) 4.4 (3.9-5.2) 4.3 (3.7-4.8) 4.4 (3.8-5.1) 4.4 (3.8-5.0) 0.01 Within STOP Characteristic Underweight (n=21) Normal (n=437) Overweight (n=304) Obese (n=285) Total (n=1047) P-value PRL (ng/ml): Median (IQ range) 91.8 (50.0-112.4) 76.4 (51.1-122.1) 75.2 (52.2-115.3) 69.3 (45.6-113.5) 75.0 (49.4-118.7) 0.21 hPL (μg/ml): Median (IQ range) 87.7 (64.9-139.2) 66.3 (44.7-105.0) 60.5 (41.8-96.2) 50.4 (33.6-72.2) 60.5 (40.5-93.0) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.5 (1.5-4.0) 1.5 (0.9-2.5) 1.4 (0.8-2.2) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.0001 Insulin (uU/ml): Median (IQ range) 4.8 (4.4-12.5) 7.2 (4.1-12.5) 9.3 (6.4-17.7) 15.4 (9.6-27.2) 9.6 (5.8-18.5) &lt;0.0001 HOMA-IR: Median (IQ range) 1.0 (0.9-2.8) 1.5 (0.8-2.7) 2.0 (1.2-4.0) 3.3 (2.0-6.0) 2.0 (1.2-4.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.4 (4.3-4.9) 4.7 (4.3-5.0) 4.8 (4.4-5.1) 4.8 (4.5-5.1) 4.7 (4.4-5.1) 0.0006 Serum folate concentration (nM): Median (IQ range) 34.2 (29.1-40.0) 40.8 (36.9-54.0) 40.5 (36.3-45.7) 40.3 (36.0-45.3) 40.5 (36.4-45.3) 0.001 B12 concentration (pM): Median (IQ range) 340.0 (207.0-412.0) 293.0 (227.0-375.5) 282.0 (218.8-352.8) 258.0 (205.0-324.2) 280.0 (218.0-357.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 106.3 (69.0-161.8) 152.6 (109.4-222.4) 147.6 (116.3-215.1) 169.8 (123.0-233.2) 153.5 (115.1-221.4) 0.003 Active B12 concentration (pM): Median (IQ range) 48.0 (40.0-50.0) 65.5 (47.2-84.0) 62.0 (47.0-82.8) 64.0 (52.0-86.5) 63.0 (49.0-84.0) 0.31 Folate:Active B12 ratio: Median (IQ range) 711.3 (619.0-840.3) 674.7 (493.3-990.3) 670.7 (457.2-973.9) 628.6 (471.3-867.2) 663.6 (476.4-952.0) 0.56 Homocysteine concentration (μM): Median (IQ range) 5.4 (4.7-6.0) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.8 (4.3-5.7) 4.8 (4.2-5.6) 0.07 Red cell folate (nmol/L): Median (IQ range) 1270.0 (1035.0-1464.0) 1454.0 (1212.0-1747.0) 1469.0 (1200.0-1787.0) 1496.0 (1228.5-1769.5) 1466.0 (1206.0-1765.8) 0.09 "],["prolactin-26.html", "40.1 Prolactin", " 40.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 15.04 (8.63, 26.19) &lt;0.0001 BMI_gp3Normal 0.98 (0.70, 1.36) 0.89 BMI_gp3Overweight 1.03 (0.74, 1.44) 0.86 BMI_gp3Obese 0.83 (0.60, 1.16) 0.27 StudySTOP 0.98 (0.62, 1.55) 0.93 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.99 (0.63, 1.57) 0.97 BMI_gp3Overweight:StudySTOP 1.00 (0.63, 1.60) 0.99 BMI_gp3Obese:StudySTOP 0.96 (0.61, 1.53) 0.88 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 108.29 18.22 Inf 77.88 150.59 Normal SCOPE 105.91 5.09 Inf 96.39 116.36 Overweight SCOPE 111.65 6.79 Inf 99.11 125.77 Obese SCOPE 89.91 5.01 Inf 80.61 100.29 Underweight STOP 105.97 16.77 Inf 77.70 144.52 Normal STOP 102.84 5.14 Inf 93.23 113.43 Overweight STOP 109.49 5.94 Inf 98.45 121.78 Obese STOP 84.83 4.85 Inf 75.83 94.90 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.98 (0.64, 1.50) 1.0 Overweight / Underweight Study: SCOPE 1.03 (0.66, 1.60) 1.0 Overweight / Normal Study: SCOPE 1.05 (0.89, 1.24) 0.8 Obese / Underweight Study: SCOPE 0.83 (0.54, 1.28) 0.7 Obese / Normal Study: SCOPE 0.85 (0.73, 0.98) 0.02 Obese / Overweight Study: SCOPE 0.81 (0.67, 0.96) 0.010 Normal / Underweight Study: STOP 0.97 (0.64, 1.47) 1.0 Overweight / Underweight Study: STOP 1.03 (0.68, 1.57) 1.0 Overweight / Normal Study: STOP 1.06 (0.90, 1.25) 0.8 Obese / Underweight Study: STOP 0.80 (0.52, 1.22) 0.5 Obese / Normal Study: STOP 0.82 (0.69, 0.98) 0.02 Obese / Overweight Study: STOP 0.77 (0.65, 0.93) 0.002 STOP / SCOPE Maternal BMI: Underweight 0.98 (0.62, 1.55) 0.9 STOP / SCOPE Maternal BMI: Normal 0.97 (0.83, 1.14) 0.7 STOP / SCOPE Maternal BMI: Overweight 0.98 (0.82, 1.17) 0.8 STOP / SCOPE Maternal BMI: Obese 0.94 (0.79, 1.12) 0.5 "],["hpl-26.html", "40.2 HPL", " 40.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.23 (1.75, 2.85) &lt;0.0001 BMI_gp3Normal 1.00 (0.91, 1.09) 0.96 BMI_gp3Overweight 0.92 (0.84, 1.01) 0.09 BMI_gp3Obese 0.80 (0.73, 0.88) &lt;0.0001 StudySTOP 1.38 (1.15, 1.65) 0.0004 GA_samp 1.33 (1.31, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.78 (0.66, 0.94) 0.007 BMI_gp3Overweight:StudySTOP 0.79 (0.66, 0.95) 0.01 BMI_gp3Obese:StudySTOP 0.73 (0.61, 0.88) 0.0008 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 103.14 4.86 Inf 94.04 113.12 Normal SCOPE 102.91 2.25 Inf 98.60 107.41 Overweight SCOPE 95.21 2.24 Inf 90.92 99.69 Obese SCOPE 82.39 2.22 Inf 78.16 86.85 Underweight STOP 142.20 10.66 Inf 122.78 164.70 Normal STOP 111.37 2.18 Inf 107.19 115.72 Overweight STOP 104.17 2.53 Inf 99.33 109.25 Obese STOP 83.34 2.32 Inf 78.92 88.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.00 (0.89, 1.12) 1.0 Overweight / Underweight Study: SCOPE 0.92 (0.82, 1.04) 0.3 Overweight / Normal Study: SCOPE 0.93 (0.87, 0.98) 0.004 Obese / Underweight Study: SCOPE 0.80 (0.70, 0.91) &lt;0.0001 Obese / Normal Study: SCOPE 0.80 (0.75, 0.86) &lt;0.0001 Obese / Overweight Study: SCOPE 0.87 (0.80, 0.93) &lt;0.0001 Normal / Underweight Study: STOP 0.78 (0.64, 0.95) 0.008 Overweight / Underweight Study: STOP 0.73 (0.60, 0.89) 0.0004 Overweight / Normal Study: STOP 0.94 (0.86, 1.01) 0.1 Obese / Underweight Study: STOP 0.59 (0.48, 0.72) &lt;0.0001 Obese / Normal Study: STOP 0.75 (0.69, 0.82) &lt;0.0001 Obese / Overweight Study: STOP 0.80 (0.73, 0.88) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 1.38 (1.15, 1.65) 0.0004 STOP / SCOPE Maternal BMI: Normal 1.08 (1.02, 1.15) 0.02 STOP / SCOPE Maternal BMI: Overweight 1.09 (1.02, 1.18) 0.02 STOP / SCOPE Maternal BMI: Obese 1.01 (0.93, 1.10) 0.8 "],["gh2-26.html", "40.3 GH2", " 40.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 BMI_gp3Normal 0.99 (0.87, 1.12) 0.84 BMI_gp3Overweight 0.87 (0.76, 1.00) 0.04 BMI_gp3Obese 0.72 (0.63, 0.82) &lt;0.0001 StudySTOP 1.62 (1.13, 2.33) 0.008 GA_samp 1.31 (1.29, 1.33) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.60 (0.42, 0.86) 0.005 BMI_gp3Overweight:StudySTOP 0.60 (0.42, 0.87) 0.007 BMI_gp3Obese:StudySTOP 0.69 (0.48, 0.99) 0.05 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 2.73 0.18 Inf 2.40 3.10 Normal SCOPE 2.70 0.08 Inf 2.55 2.85 Overweight SCOPE 2.38 0.08 Inf 2.22 2.55 Obese SCOPE 1.96 0.06 Inf 1.84 2.09 Underweight STOP 4.43 0.76 Inf 3.17 6.19 Normal STOP 2.61 0.08 Inf 2.46 2.77 Overweight STOP 2.33 0.08 Inf 2.17 2.50 Obese STOP 2.20 0.09 Inf 2.03 2.37 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.99 (0.83, 1.17) 1.0 Overweight / Underweight Study: SCOPE 0.87 (0.73, 1.04) 0.2 Overweight / Normal Study: SCOPE 0.88 (0.80, 0.97) 0.004 Obese / Underweight Study: SCOPE 0.72 (0.60, 0.85) &lt;0.0001 Obese / Normal Study: SCOPE 0.73 (0.67, 0.79) &lt;0.0001 Obese / Overweight Study: SCOPE 0.83 (0.74, 0.92) &lt;0.0001 Normal / Underweight Study: STOP 0.59 (0.38, 0.92) 0.01 Overweight / Underweight Study: STOP 0.53 (0.34, 0.82) 0.001 Overweight / Normal Study: STOP 0.89 (0.80, 1.00) 0.05 Obese / Underweight Study: STOP 0.50 (0.32, 0.77) 0.0003 Obese / Normal Study: STOP 0.84 (0.75, 0.95) 0.001 Obese / Overweight Study: STOP 0.94 (0.83, 1.07) 0.7 STOP / SCOPE Maternal BMI: Underweight 1.62 (1.13, 2.33) 0.008 STOP / SCOPE Maternal BMI: Normal 0.97 (0.88, 1.06) 0.5 STOP / SCOPE Maternal BMI: Overweight 0.98 (0.88, 1.09) 0.7 STOP / SCOPE Maternal BMI: Obese 1.12 (1.00, 1.25) 0.04 "],["insulin-24.html", "40.4 Insulin", " 40.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 6.76 (3.67, 12.44) &lt;0.0001 BMI_gp3Normal 1.22 (0.83, 1.81) 0.32 BMI_gp3Overweight 1.84 (1.24, 2.74) 0.002 BMI_gp3Obese 2.27 (1.53, 3.37) &lt;0.0001 StudySTOP 0.88 (0.53, 1.48) 0.64 GA_samp 1.02 (0.99, 1.05) 0.21 BMI_gp3Normal:StudySTOP 0.86 (0.52, 1.44) 0.57 BMI_gp3Overweight:StudySTOP 0.80 (0.47, 1.34) 0.39 BMI_gp3Obese:StudySTOP 1.01 (0.60, 1.70) 0.97 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 8.76 1.72 Inf 5.96 12.86 Normal SCOPE 10.70 0.69 Inf 9.43 12.14 Overweight SCOPE 16.14 1.13 Inf 14.07 18.52 Obese SCOPE 19.90 1.40 Inf 17.34 22.83 Underweight STOP 7.74 1.30 Inf 5.57 10.76 Normal STOP 8.15 0.42 Inf 7.37 9.01 Overweight STOP 11.38 0.63 Inf 10.21 12.69 Obese STOP 17.80 1.00 Inf 15.94 19.87 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.22 (0.73, 2.04) 0.7 Overweight / Underweight Study: SCOPE 1.84 (1.10, 3.10) 0.01 Overweight / Normal Study: SCOPE 1.51 (1.22, 1.87) &lt;0.0001 Obese / Underweight Study: SCOPE 2.27 (1.35, 3.81) 0.0003 Obese / Normal Study: SCOPE 1.86 (1.51, 2.30) &lt;0.0001 Obese / Overweight Study: SCOPE 1.23 (0.98, 1.54) 0.08 Normal / Underweight Study: STOP 1.05 (0.68, 1.63) 1.0 Overweight / Underweight Study: STOP 1.47 (0.95, 2.28) 0.1 Overweight / Normal Study: STOP 1.40 (1.19, 1.64) &lt;0.0001 Obese / Underweight Study: STOP 2.30 (1.48, 3.57) &lt;0.0001 Obese / Normal Study: STOP 2.18 (1.86, 2.57) &lt;0.0001 Obese / Overweight Study: STOP 1.56 (1.32, 1.86) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.88 (0.53, 1.48) 0.6 STOP / SCOPE Maternal BMI: Normal 0.76 (0.63, 0.92) 0.004 STOP / SCOPE Maternal BMI: Overweight 0.70 (0.58, 0.86) 0.0004 STOP / SCOPE Maternal BMI: Obese 0.89 (0.73, 1.09) 0.3 "],["homa-ir-24.html", "40.5 HOMA-IR", " 40.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 1.65 (0.88, 3.08) 0.12 BMI_gp3Normal 1.24 (0.84, 1.84) 0.29 BMI_gp3Overweight 1.87 (1.26, 2.79) 0.002 BMI_gp3Obese 2.33 (1.57, 3.47) &lt;0.0001 StudySTOP 0.75 (0.45, 1.26) 0.28 GA_samp 1.02 (0.99, 1.05) 0.28 BMI_gp3Normal:StudySTOP 0.87 (0.52, 1.45) 0.58 BMI_gp3Overweight:StudySTOP 0.82 (0.48, 1.37) 0.44 BMI_gp3Obese:StudySTOP 1.05 (0.62, 1.77) 0.86 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 2.08 0.41 Inf 1.41 3.05 Normal SCOPE 2.57 0.18 Inf 2.25 2.94 Overweight SCOPE 3.88 0.29 Inf 3.35 4.50 Obese SCOPE 4.84 0.37 Inf 4.17 5.62 Underweight STOP 1.56 0.26 Inf 1.12 2.17 Normal STOP 1.67 0.09 Inf 1.51 1.86 Overweight STOP 2.38 0.14 Inf 2.12 2.67 Obese STOP 3.81 0.23 Inf 3.39 4.29 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.24 (0.74, 2.07) 0.7 Overweight / Underweight Study: SCOPE 1.87 (1.11, 3.16) 0.01 Overweight / Normal Study: SCOPE 1.51 (1.20, 1.90) &lt;0.0001 Obese / Underweight Study: SCOPE 2.33 (1.39, 3.93) 0.0002 Obese / Normal Study: SCOPE 1.88 (1.50, 2.36) &lt;0.0001 Obese / Overweight Study: SCOPE 1.25 (0.98, 1.59) 0.09 Normal / Underweight Study: STOP 1.07 (0.69, 1.66) 1.0 Overweight / Underweight Study: STOP 1.53 (0.98, 2.37) 0.07 Overweight / Normal Study: STOP 1.42 (1.20, 1.68) &lt;0.0001 Obese / Underweight Study: STOP 2.44 (1.57, 3.81) &lt;0.0001 Obese / Normal Study: STOP 2.28 (1.92, 2.70) &lt;0.0001 Obese / Overweight Study: STOP 1.60 (1.33, 1.92) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.75 (0.45, 1.26) 0.3 STOP / SCOPE Maternal BMI: Normal 0.65 (0.54, 0.79) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.61 (0.50, 0.75) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.79 (0.64, 0.97) 0.03 "],["glucose-24.html", "40.6 Glucose", " 40.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.32 (4.83, 5.87) &lt;0.0001 BMI_gp3Normal 1.02 (0.97, 1.07) 0.43 BMI_gp3Overweight 1.04 (0.99, 1.10) 0.14 BMI_gp3Obese 1.04 (0.99, 1.09) 0.14 StudySTOP 0.86 (0.81, 0.92) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.74 BMI_gp3Normal:StudySTOP 1.00 (0.94, 1.07) 0.93 BMI_gp3Overweight:StudySTOP 1.00 (0.93, 1.08) 0.94 BMI_gp3Obese:StudySTOP 1.02 (0.95, 1.09) 0.60 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 5.26 0.12 Inf 5.02 5.50 Normal SCOPE 5.36 0.06 Inf 5.25 5.47 Overweight SCOPE 5.48 0.09 Inf 5.30 5.66 Obese SCOPE 5.45 0.07 Inf 5.32 5.59 Underweight STOP 4.55 0.09 Inf 4.37 4.73 Normal STOP 4.65 0.05 Inf 4.55 4.74 Overweight STOP 4.75 0.07 Inf 4.62 4.88 Obese STOP 4.80 0.06 Inf 4.69 4.91 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.02 (0.96, 1.08) 0.9 Overweight / Underweight Study: SCOPE 1.04 (0.97, 1.12) 0.4 Overweight / Normal Study: SCOPE 1.02 (0.98, 1.07) 0.6 Obese / Underweight Study: SCOPE 1.04 (0.97, 1.11) 0.5 Obese / Normal Study: SCOPE 1.02 (0.98, 1.05) 0.6 Obese / Overweight Study: SCOPE 1.00 (0.95, 1.05) 1.0 Normal / Underweight Study: STOP 1.02 (0.97, 1.08) 0.7 Overweight / Underweight Study: STOP 1.04 (0.98, 1.11) 0.3 Overweight / Normal Study: STOP 1.02 (0.98, 1.07) 0.5 Obese / Underweight Study: STOP 1.06 (1.00, 1.12) 0.08 Obese / Normal Study: STOP 1.03 (0.99, 1.07) 0.1 Obese / Overweight Study: STOP 1.01 (0.96, 1.06) 0.9 STOP / SCOPE Maternal BMI: Underweight 0.86 (0.81, 0.92) &lt;0.0001 STOP / SCOPE Maternal BMI: Normal 0.87 (0.84, 0.90) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.87 (0.83, 0.91) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.88 (0.85, 0.91) &lt;0.0001 "],["age-bmi-groups-3.html", "41 Age &amp; BMI groups", " 41 Age &amp; BMI groups Descriptives with univariate P-values. Characteristic &lt;35y, non-obese (n=1511) &lt;35y, obese (n=542) &gt;=35y, non-obese (n=44) &gt;=35y, obese (n=23) Total (n=2120) P-value PRL (ng/ml): Median (IQ range) 105.5 (62.7-177.1) 94.7 (54.5-150.5) 89.9 (58.8-166.9) 55.1 (39.8-138.5) 101.8 (60.0-169.0) 0.006 hPL (μg/ml): Median (IQ range) 131.4 (60.7-192.3) 95.7 (46.3-154.5) 90.4 (59.6-161.9) 83.1 (37.9-137.1) 117.7 (56.6-181.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 3.0 (1.3-4.6) 2.4 (1.1-3.5) 2.3 (1.2-4.5) 1.6 (1.1-2.9) 2.7 (1.3-4.3) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 9.2 (5.2-20.9) 16.6 (10.3-31.2) 9.0 (4.8-17.5) 12.1 (9.6-20.8) 11.0 (6.2-23.4) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.1-4.6) 3.7 (2.2-7.5) 2.1 (1.0-4.0) 2.7 (2.0-4.3) 2.4 (1.3-5.3) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.7-5.6) 5.0 (4.6-5.4) 4.7 (4.4-5.0) 5.0 (4.6-5.5) 0.007 Within SCOPE Characteristic &lt;35y, non-obese (n=773) &lt;35y, obese (n=274) &gt;=35y, non-obese (n=20) &gt;=35y, obese (n=6) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 145.7 (96.6-224.3) 133.2 (82.4-212.1) 221.6 (95.6-347.0) 132.3 (83.7-157.5) 141.2 (92.6-223.7) 0.06 hPL (μg/ml): Median (IQ range) 190.5 (158.0-224.1) 156.4 (130.7-187.4) 163.8 (133.3-208.1) 179.3 (149.1-202.5) 180.6 (149.6-216.9) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.5 (3.4-6.1) 3.4 (2.7-4.4) 4.4 (3.5-6.4) 4.9 (3.5-6.9) 4.2 (3.2-5.7) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 12.3 (5.8-29.1) 19.1 (10.5-34.6) 16.9 (9.1-26.6) 48.4 (12.1-52.4) 13.8 (6.6-30.3) &lt;0.0001 HOMA-IR: Median (IQ range) 2.9 (1.3-7.1) 4.4 (2.3-8.7) 4.5 (2.4-7.0) 12.3 (2.8-15.7) 3.3 (1.6-7.5) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.4 (4.9-5.8) 5.3 (5.0-5.9) 5.4 (5.2-5.8) 5.5 (5.1-6.1) 5.4 (5.0-5.8) 0.67 Serum folate concentration (nM): Median (IQ range) 35.8 (28.4-42.2) 35.8 (25.4-43.1) 41.4 (35.3-49.6) 34.9 (32.3-37.6) 35.9 (28.1-42.6) 0.08 B12 concentration (pM): Median (IQ range) 248.0 (198.0-316.0) 230.0 (185.0-291.0) 297.0 (248.0-367.0) 227.5 (208.2-249.0) 245.0 (195.0-308.5) 0.003 Folate:B12 ratio: Median (IQ range) 141.6 (101.8-203.6) 145.2 (100.7-220.7) 152.3 (116.9-202.9) 174.2 (146.0-195.2) 142.7 (102.3-207.5) 0.52 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-71.0) 61.0 (46.0-75.0) 53.5 (47.5-98.5) 74.0 (39.0-93.0) 56.0 (43.0-73.0) 0.13 Folate:Active B12 ratio: Median (IQ range) 630.2 (456.0-932.6) 537.9 (392.2-819.8) 791.6 (567.9-977.4) 420.3 (400.0-817.9) 615.4 (432.4-902.3) 0.03 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.4 (3.8-5.1) 4.5 (3.9-4.7) 4.3 (3.9-4.6) 4.4 (3.8-5.0) 0.96 Within STOP Characteristic &lt;35y, non-obese (n=738) &lt;35y, obese (n=268) &gt;=35y, non-obese (n=24) &gt;=35y, obese (n=17) Total (n=1047) P-value PRL (ng/ml): Median (IQ range) 76.7 (51.5-120.0) 69.4 (45.9-113.4) 72.9 (49.1-91.1) 54.2 (39.8-116.4) 75.0 (49.4-118.7) 0.13 hPL (μg/ml): Median (IQ range) 64.7 (43.3-100.8) 50.5 (33.8-71.4) 62.5 (53.4-83.5) 47.1 (33.1-94.5) 60.5 (40.5-93.0) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.6 (1.0-2.2) 1.4 (1.0-2.4) 1.4 (0.9-2.4) 0.03 Insulin (uU/ml): Median (IQ range) 8.1 (4.8-14.4) 15.8 (10.0-28.0) 5.3 (4.0-14.2) 11.1 (8.8-15.0) 9.6 (5.8-18.5) &lt;0.0001 HOMA-IR: Median (IQ range) 1.7 (1.0-3.1) 3.5 (2.0-6.2) 1.1 (0.8-2.8) 2.4 (1.7-2.8) 2.0 (1.2-4.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.8 (4.5-5.2) 4.7 (4.4-5.0) 4.6 (4.4-4.8) 4.7 (4.4-5.1) 0.002 Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.3) 40.0 (35.9-45.1) 43.2 (40.2-71.3) 43.6 (39.8-99.6) 40.5 (36.4-45.3) 0.01 B12 concentration (pM): Median (IQ range) 288.0 (224.0-369.0) 258.0 (207.0-322.0) 309.0 (232.0-348.5) 246.0 (200.0-363.0) 280.0 (218.0-357.0) 0.0003 Folate:B12 ratio: Median (IQ range) 149.8 (110.8-218.2) 166.0 (121.6-224.9) 168.2 (127.4-284.3) 203.6 (145.8-292.3) 153.5 (115.1-221.4) 0.006 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-83.0) 64.0 (52.0-87.0) 68.0 (54.0-99.0) 57.0 (54.0-70.0) 63.0 (49.0-84.0) 0.61 Folate:Active B12 ratio: Median (IQ range) 670.9 (481.8-978.8) 616.7 (465.4-866.7) 527.9 (427.3-960.5) 747.4 (613.4-954.8) 663.6 (476.4-952.0) 0.32 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.5) 4.8 (4.2-5.7) 4.9 (4.2-6.0) 4.9 (4.3-5.5) 4.8 (4.2-5.6) 0.82 Red cell folate (nmol/L): Median (IQ range) 1451.0 (1197.0-1763.5) 1492.0 (1223.0-1770.0) 1582.0 (1352.5-1761.2) 1577.5 (1327.2-1738.5) 1466.0 (1206.0-1765.8) 0.42 "],["prolactin-27.html", "41.1 Prolactin", " 41.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 14.90 (9.60, 23.14) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.85 (0.76, 0.94) 0.001 Age_BMI_gp&gt;=35y, non-obese 1.41 (0.95, 2.10) 0.09 Age_BMI_gp&gt;=35y, obese 0.55 (0.15, 2.07) 0.38 StudySTOP 0.99 (0.86, 1.14) 0.89 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 0.94 (0.80, 1.11) 0.48 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.56 (0.35, 0.91) 0.02 Age_BMI_gp&gt;=35y, obese:StudySTOP 1.46 (0.37, 5.74) 0.59 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 107.37 4.67 Inf 98.60 116.92 &lt;35y, obese SCOPE 90.82 4.87 Inf 81.77 100.88 &gt;=35y, non-obese SCOPE 151.29 30.62 Inf 101.75 224.95 &gt;=35y, obese SCOPE 58.97 40.01 Inf 15.60 222.95 &lt;35y, non-obese STOP 106.28 4.38 Inf 98.04 115.22 &lt;35y, obese STOP 84.83 5.02 Inf 75.53 95.26 &gt;=35y, non-obese STOP 84.48 10.97 Inf 65.50 108.96 &gt;=35y, obese STOP 84.94 14.93 Inf 60.18 119.88 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.85 (0.74, 0.97) 0.007 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.41 (0.84, 2.37) 0.3 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.67 (0.98, 2.82) 0.06 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.55 (0.10, 3.13) 0.8 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 0.65 (0.11, 3.71) 0.9 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.39 (0.06, 2.39) 0.5 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.80 (0.68, 0.94) 0.002 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.79 (0.57, 1.11) 0.3 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.00 (0.70, 1.42) 1.0 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.80 (0.51, 1.26) 0.6 &gt;=35y, obese / &lt;35y, obese Study: STOP 1.00 (0.63, 1.60) 1.0 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 1.01 (0.58, 1.75) 1.0 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.99 (0.86, 1.14) 0.9 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.93 (0.79, 1.11) 0.4 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.56 (0.35, 0.90) 0.02 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 1.44 (0.36, 5.71) 0.6 "],["hpl-27.html", "41.2 HPL", " 41.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.13 (1.70, 2.67) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.82 (0.78, 0.86) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 0.93 (0.81, 1.07) 0.32 Age_BMI_gp&gt;=35y, obese 0.84 (0.65, 1.09) 0.18 StudySTOP 1.10 (1.04, 1.16) 0.002 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 0.93 (0.86, 1.01) 0.08 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 1.10 (0.90, 1.34) 0.35 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.85 (0.59, 1.21) 0.36 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 99.80 1.93 Inf 96.08 103.67 &lt;35y, obese SCOPE 82.16 2.23 Inf 77.91 86.64 &gt;=35y, non-obese SCOPE 93.04 6.65 Inf 80.88 107.02 &gt;=35y, obese SCOPE 83.79 11.07 Inf 64.67 108.57 &lt;35y, non-obese STOP 109.30 1.68 Inf 106.05 112.65 &lt;35y, obese STOP 83.88 2.36 Inf 79.37 88.64 &gt;=35y, non-obese STOP 112.10 8.10 Inf 97.30 129.16 &gt;=35y, obese STOP 77.65 9.87 Inf 60.53 99.61 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.82 (0.77, 0.88) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.93 (0.78, 1.12) 0.8 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.13 (0.94, 1.37) 0.3 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.84 (0.60, 1.18) 0.5 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.02 (0.72, 1.44) 1.0 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.90 (0.61, 1.32) 0.9 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.77 (0.71, 0.83) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 1.03 (0.85, 1.24) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.34 (1.10, 1.63) 0.0008 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.71 (0.51, 0.99) 0.04 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.93 (0.66, 1.29) 0.9 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.69 (0.48, 1.01) 0.06 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.10 (1.04, 1.16) 0.002 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.02 (0.94, 1.11) 0.6 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 1.20 (0.98, 1.48) 0.07 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.93 (0.65, 1.33) 0.7 "],["gh2-27.html", "41.3 GH2", " 41.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.76 (0.71, 0.81) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 1.11 (0.84, 1.46) 0.45 Age_BMI_gp&gt;=35y, obese 1.04 (0.62, 1.74) 0.88 StudySTOP 0.99 (0.91, 1.08) 0.85 GA_samp 1.31 (1.29, 1.33) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 1.16 (1.04, 1.29) 0.007 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.90 (0.64, 1.27) 0.55 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.69 (0.38, 1.26) 0.23 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 2.55 0.07 Inf 2.43 2.69 &lt;35y, obese SCOPE 1.94 0.06 Inf 1.82 2.07 &gt;=35y, non-obese SCOPE 2.84 0.40 Inf 2.16 3.74 &gt;=35y, obese SCOPE 2.66 0.70 Inf 1.59 4.44 &lt;35y, non-obese STOP 2.53 0.06 Inf 2.41 2.66 &lt;35y, obese STOP 2.23 0.09 Inf 2.06 2.41 &gt;=35y, non-obese STOP 2.53 0.26 Inf 2.07 3.10 &gt;=35y, obese STOP 1.83 0.28 Inf 1.35 2.47 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.76 (0.70, 0.82) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.11 (0.78, 1.59) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.46 (1.02, 2.10) 0.04 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.04 (0.53, 2.04) 1.0 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.37 (0.70, 2.69) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.94 (0.44, 2.00) 1.0 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.88 (0.79, 0.99) 0.02 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 1.00 (0.76, 1.31) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.14 (0.86, 1.51) 0.6 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.72 (0.48, 1.08) 0.2 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.82 (0.54, 1.24) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.72 (0.45, 1.17) 0.3 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.99 (0.91, 1.08) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.15 (1.03, 1.28) 0.02 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.89 (0.63, 1.26) 0.5 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.69 (0.38, 1.25) 0.2 "],["insulin-25.html", "41.4 Insulin", " 41.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 9.66 (5.99, 15.58) &lt;0.0001 Age_BMI_gp&lt;35y, obese 1.60 (1.38, 1.85) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 1.25 (0.86, 1.81) 0.24 Age_BMI_gp&gt;=35y, obese 2.23 (1.16, 4.27) 0.02 StudySTOP 0.76 (0.64, 0.89) 0.0007 GA_samp 1.02 (0.99, 1.05) 0.23 Age_BMI_gp&lt;35y, obese:StudySTOP 1.22 (1.01, 1.47) 0.04 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.63 (0.38, 1.03) 0.07 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.58 (0.29, 1.16) 0.12 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 12.38 0.66 Inf 11.16 13.74 &lt;35y, obese SCOPE 19.78 1.41 Inf 17.21 22.74 &gt;=35y, non-obese SCOPE 15.47 2.91 Inf 10.70 22.37 &gt;=35y, obese SCOPE 27.58 9.14 Inf 14.40 52.80 &lt;35y, non-obese STOP 9.35 0.41 Inf 8.57 10.20 &lt;35y, obese STOP 18.21 1.07 Inf 16.23 20.42 &gt;=35y, non-obese STOP 7.35 1.22 Inf 5.31 10.18 &gt;=35y, obese STOP 12.08 1.43 Inf 9.59 15.23 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.60 (1.32, 1.93) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.25 (0.77, 2.04) 0.6 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 0.78 (0.47, 1.29) 0.6 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.23 (0.95, 5.23) 0.08 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.39 (0.59, 3.30) 0.8 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 1.78 (0.67, 4.71) 0.4 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.95 (1.67, 2.27) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.79 (0.51, 1.21) 0.5 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.40 (0.26, 0.63) &lt;0.0001 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 1.29 (0.94, 1.77) 0.2 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.66 (0.48, 0.92) 0.008 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 1.64 (0.98, 2.76) 0.07 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.76 (0.64, 0.89) 0.0007 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.92 (0.75, 1.13) 0.4 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.48 (0.29, 0.78) 0.003 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.44 (0.22, 0.88) 0.02 "],["homa-ir-25.html", "41.5 HOMA-IR", " 41.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.38 (1.44, 3.92) 0.0007 Age_BMI_gp&lt;35y, obese 1.62 (1.38, 1.89) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 1.36 (0.91, 2.04) 0.14 Age_BMI_gp&gt;=35y, obese 2.44 (1.19, 5.00) 0.02 StudySTOP 0.65 (0.55, 0.77) &lt;0.0001 GA_samp 1.02 (0.98, 1.05) 0.30 Age_BMI_gp&lt;35y, obese:StudySTOP 1.25 (1.03, 1.53) 0.03 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.58 (0.34, 0.99) 0.04 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.52 (0.24, 1.12) 0.09 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 2.97 0.17 Inf 2.66 3.32 &lt;35y, obese SCOPE 4.80 0.37 Inf 4.13 5.58 &gt;=35y, non-obese SCOPE 4.04 0.83 Inf 2.71 6.04 &gt;=35y, obese SCOPE 7.24 2.65 Inf 3.54 14.83 &lt;35y, non-obese STOP 1.93 0.09 Inf 1.77 2.12 &lt;35y, obese STOP 3.91 0.24 Inf 3.47 4.42 &gt;=35y, non-obese STOP 1.52 0.27 Inf 1.07 2.15 &gt;=35y, obese STOP 2.46 0.31 Inf 1.93 3.14 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.62 (1.31, 1.99) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.36 (0.80, 2.31) 0.4 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 0.84 (0.49, 1.45) 0.9 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.44 (0.95, 6.25) 0.07 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.51 (0.58, 3.90) 0.7 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 1.79 (0.62, 5.22) 0.5 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 2.02 (1.72, 2.38) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.79 (0.50, 1.24) 0.5 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.39 (0.24, 0.62) &lt;0.0001 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 1.27 (0.91, 1.77) 0.2 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.63 (0.44, 0.89) 0.003 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 1.62 (0.93, 2.81) 0.1 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.65 (0.55, 0.77) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.81 (0.66, 1.01) 0.06 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.38 (0.22, 0.64) 0.0004 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.34 (0.16, 0.73) 0.005 "],["glucose-25.html", "41.6 Glucose", " 41.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.47 (5.02, 5.97) &lt;0.0001 Age_BMI_gp&lt;35y, obese 1.01 (0.98, 1.03) 0.63 Age_BMI_gp&gt;=35y, non-obese 1.02 (0.97, 1.06) 0.43 Age_BMI_gp&gt;=35y, obese 1.14 (0.96, 1.36) 0.13 StudySTOP 0.87 (0.84, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.73 Age_BMI_gp&lt;35y, obese:StudySTOP 1.02 (0.98, 1.06) 0.34 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.98 (0.93, 1.04) 0.53 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.86 (0.72, 1.02) 0.09 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 5.40 0.05 Inf 5.30 5.50 &lt;35y, obese SCOPE 5.44 0.07 Inf 5.31 5.57 &gt;=35y, non-obese SCOPE 5.50 0.12 Inf 5.27 5.73 &gt;=35y, obese SCOPE 6.17 0.54 Inf 5.20 7.32 &lt;35y, non-obese STOP 4.69 0.04 Inf 4.60 4.77 &lt;35y, obese STOP 4.81 0.06 Inf 4.69 4.93 &gt;=35y, non-obese STOP 4.68 0.08 Inf 4.53 4.84 &gt;=35y, obese STOP 4.59 0.07 Inf 4.45 4.73 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.01 (0.97, 1.04) 1.0 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.02 (0.96, 1.08) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.01 (0.95, 1.07) 1.0 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.14 (0.91, 1.43) 0.4 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.13 (0.91, 1.42) 0.5 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 1.12 (0.89, 1.41) 0.6 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.03 (0.99, 1.07) 0.3 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 1.00 (0.95, 1.05) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.97 (0.92, 1.03) 0.6 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.98 (0.94, 1.02) 0.6 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.95 (0.91, 1.00) 0.08 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.98 (0.93, 1.04) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.87 (0.84, 0.89) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.88 (0.85, 0.92) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.85 (0.81, 0.90) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.74 (0.63, 0.89) 0.0009 "],["mets-7.html", "42 MetS", " 42 MetS Descriptives with univariate P-values. Characteristic No MetS (n=1805) MetS (n=233) Total (n=2038) P-value PRL (ng/ml): Median (IQ range) 98.3 (58.8-161.4) 124.5 (70.2-202.6) 100.6 (59.5-168.4) 0.0003 hPL (μg/ml): Median (IQ range) 111.4 (55.7-180.8) 145.4 (69.9-187.6) 115.6 (56.2-181.3) 0.03 GH2 (ng/ml): Median (IQ range) 2.6 (1.2-4.3) 3.1 (1.9-4.7) 2.7 (1.3-4.3) 0.005 Insulin (uU/ml): Median (IQ range) 10.2 (5.8-20.6) 29.1 (14.3-53.1) 11.1 (6.3-23.6) &lt;0.0001 HOMA-IR: Median (IQ range) 2.2 (1.2-4.5) 7.6 (3.1-14.1) 2.5 (1.3-5.3) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.4) 5.8 (5.4-6.2) 5.1 (4.6-5.6) &lt;0.0001 Within SCOPE Characteristic No MetS (n=898) MetS (n=166) Total (n=1064) P-value PRL (ng/ml): Median (IQ range) 138.3 (90.4-223.6) 157.2 (105.0-227.6) 140.9 (92.5-223.7) 0.12 hPL (μg/ml): Median (IQ range) 181.9 (152.1-218.4) 169.7 (138.1-204.2) 180.7 (149.1-217.1) 0.03 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.8) 3.9 (2.9-5.4) 4.2 (3.2-5.7) 0.07 Insulin (uU/ml): Median (IQ range) 12.1 (6.2-25.0) 33.9 (17.9-60.1) 13.8 (6.6-30.2) &lt;0.0001 HOMA-IR: Median (IQ range) 2.8 (1.4-5.9) 8.9 (4.4-16.1) 3.3 (1.6-7.5) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.7) 5.9 (5.6-6.3) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 35.9 (28.2-42.7) 35.6 (26.2-42.5) 35.9 (28.2-42.6) 0.49 B12 concentration (pM): Median (IQ range) 248.5 (196.0-316.0) 229.0 (186.0-286.8) 245.0 (195.0-308.8) 0.001 Folate:B12 ratio: Median (IQ range) 141.3 (101.5-205.2) 152.7 (114.0-214.9) 142.8 (102.5-207.8) 0.26 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-72.0) 58.0 (45.0-78.0) 56.0 (43.0-73.0) 0.24 Folate:Active B12 ratio: Median (IQ range) 618.5 (450.0-925.0) 546.7 (392.3-771.2) 615.6 (438.4-903.3) 0.05 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.9) 4.4 (3.8-5.0) 0.07 Within STOP Characteristic No MetS (n=907) MetS (n=67) Total (n=974) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.6-114.5) 73.3 (52.9-116.0) 74.0 (48.6-114.6) 0.68 hPL (μg/ml): Median (IQ range) 60.2 (40.9-90.2) 46.5 (31.3-73.9) 59.4 (40.2-89.6) 0.01 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.4 (0.9-2.2) 1.4 (0.9-2.3) 0.67 Insulin (uU/ml): Median (IQ range) 9.1 (5.7-16.7) 22.5 (11.5-41.4) 9.6 (5.8-18.6) &lt;0.0001 HOMA-IR: Median (IQ range) 1.9 (1.2-3.7) 5.1 (2.7-10.6) 2.0 (1.2-4.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 5.5 (4.8-5.8) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.6 (36.4-45.3) 39.8 (35.4-44.8) 40.5 (36.3-45.3) 0.36 B12 concentration (pM): Median (IQ range) 280.0 (219.0-363.0) 258.0 (200.5-330.5) 280.0 (218.0-356.5) 0.02 Folate:B12 ratio: Median (IQ range) 152.2 (114.8-220.7) 164.8 (128.2-206.1) 152.8 (115.3-220.5) 0.37 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-84.0) 63.0 (53.0-76.0) 63.0 (49.0-84.0) 0.97 Folate:Active B12 ratio: Median (IQ range) 666.1 (471.1-946.7) 550.7 (493.4-726.8) 652.4 (472.0-937.6) 0.10 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.3-5.9) 4.8 (4.3-5.6) 0.90 Red cell folate (nmol/L): Median (IQ range) 1454.0 (1199.5-1751.0) 1491.0 (1257.2-1792.0) 1460.0 (1204.8-1760.0) 0.32 "],["prolactin-28.html", "42.1 Prolactin", " 42.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 16.14 (10.11, 25.78) &lt;0.0001 metab.C1MetS 1.07 (0.93, 1.24) 0.32 StudySTOP 0.93 (0.81, 1.08) 0.35 GA_samp 1.15 (1.12, 1.19) &lt;0.0001 metab.C1MetS:StudySTOP 0.90 (0.71, 1.16) 0.42 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 103.97 4.49 Inf 95.53 113.16 MetS SCOPE 111.68 8.49 Inf 96.22 129.63 No MetS STOP 97.05 3.94 Inf 89.63 105.08 MetS STOP 94.24 9.66 Inf 77.10 115.20 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.07 (0.93, 1.24) 0.3 MetS / No MetS Study: STOP 0.97 (0.79, 1.19) 0.8 STOP / SCOPE MetS: No MetS 0.93 (0.81, 1.08) 0.3 STOP / SCOPE MetS: MetS 0.84 (0.65, 1.10) 0.2 "],["hpl-28.html", "42.2 HPL", " 42.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.23 (1.80, 2.77) &lt;0.0001 metab.C1MetS 0.91 (0.85, 0.96) 0.002 StudySTOP 1.05 (0.99, 1.11) 0.08 GA_samp 1.33 (1.31, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.89 (0.78, 1.00) 0.06 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 97.45 1.81 Inf 93.97 101.05 MetS SCOPE 88.23 2.92 Inf 82.69 94.14 No MetS STOP 102.55 1.59 Inf 99.49 105.71 MetS STOP 82.36 4.35 Inf 74.26 91.34 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.91 (0.85, 0.96) 0.002 MetS / No MetS Study: STOP 0.80 (0.72, 0.89) &lt;0.0001 STOP / SCOPE MetS: No MetS 1.05 (0.99, 1.11) 0.08 STOP / SCOPE MetS: MetS 0.93 (0.82, 1.06) 0.3 "],["gh2-28.html", "42.3 GH2", " 42.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 metab.C1MetS 0.90 (0.82, 0.99) 0.03 StudySTOP 1.01 (0.93, 1.10) 0.74 GA_samp 1.31 (1.29, 1.34) &lt;0.0001 metab.C1MetS:StudySTOP 1.05 (0.89, 1.25) 0.55 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.42 0.06 Inf 2.30 2.55 MetS SCOPE 2.18 0.11 Inf 1.98 2.40 No MetS STOP 2.46 0.06 Inf 2.34 2.58 MetS STOP 2.33 0.17 Inf 2.02 2.69 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.90 (0.82, 0.99) 0.03 MetS / No MetS Study: STOP 0.95 (0.82, 1.10) 0.5 STOP / SCOPE MetS: No MetS 1.01 (0.93, 1.10) 0.7 STOP / SCOPE MetS: MetS 1.07 (0.89, 1.28) 0.5 "],["insulin-26.html", "42.4 Insulin", " 42.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 10.17 (6.15, 16.81) &lt;0.0001 metab.C1MetS 2.48 (2.10, 2.92) &lt;0.0001 StudySTOP 0.85 (0.72, 1.00) 0.05 GA_samp 1.01 (0.98, 1.05) 0.38 metab.C1MetS:StudySTOP 0.89 (0.67, 1.19) 0.44 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 12.30 0.64 Inf 11.11 13.61 MetS SCOPE 30.44 2.51 Inf 25.89 35.79 No MetS STOP 10.47 0.45 Inf 9.62 11.38 MetS STOP 23.16 2.71 Inf 18.41 29.13 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.48 (2.10, 2.92) &lt;0.0001 MetS / No MetS Study: STOP 2.21 (1.76, 2.78) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.85 (0.72, 1.00) 0.05 STOP / SCOPE MetS: MetS 0.76 (0.57, 1.02) 0.07 "],["homa-ir-26.html", "42.5 HOMA-IR", " 42.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.46 (1.46, 4.14) 0.0007 metab.C1MetS 2.79 (2.33, 3.33) &lt;0.0001 StudySTOP 0.75 (0.63, 0.88) 0.0007 GA_samp 1.01 (0.98, 1.05) 0.46 metab.C1MetS:StudySTOP 0.91 (0.67, 1.23) 0.54 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.91 0.16 Inf 2.62 3.24 MetS SCOPE 8.11 0.73 Inf 6.80 9.67 No MetS STOP 2.17 0.10 Inf 1.99 2.37 MetS STOP 5.49 0.70 Inf 4.28 7.04 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.79 (2.33, 3.33) &lt;0.0001 MetS / No MetS Study: STOP 2.53 (1.97, 3.25) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.75 (0.63, 0.88) 0.0007 STOP / SCOPE MetS: MetS 0.68 (0.49, 0.93) 0.02 "],["glucose-26.html", "42.6 Glucose", " 42.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.39 (4.92, 5.90) &lt;0.0001 metab.C1MetS 1.13 (1.10, 1.17) &lt;0.0001 StudySTOP 0.88 (0.85, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.75 metab.C1MetS:StudySTOP 1.01 (0.96, 1.06) 0.60 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 5.32 0.05 Inf 5.23 5.41 MetS SCOPE 6.02 0.08 Inf 5.85 6.19 No MetS STOP 4.67 0.04 Inf 4.60 4.74 MetS STOP 5.36 0.11 Inf 5.15 5.57 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.13 (1.10, 1.17) &lt;0.0001 MetS / No MetS Study: STOP 1.15 (1.10, 1.19) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.88 (0.85, 0.90) &lt;0.0001 STOP / SCOPE MetS: MetS 0.89 (0.85, 0.94) &lt;0.0001 "],["birthweight-centile-3.html", "43 Birthweight centile", " 43 Birthweight centile Descriptives with univariate P-values. Characteristic &lt;=90th centile (n=1910) &gt;90th centile (n=203) Total (n=2113) P-value PRL (ng/ml): Median (IQ range) 101.0 (59.8-165.9) 106.4 (62.4-192.0) 102.0 (60.0-168.9) 0.34 hPL (μg/ml): Median (IQ range) 120.9 (57.0-180.6) 102.8 (56.8-200.2) 119.2 (56.9-181.3) 0.40 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.3) 2.4 (1.2-4.4) 2.7 (1.3-4.3) 0.43 Insulin (uU/ml): Median (IQ range) 11.0 (6.3-23.4) 11.4 (6.0-25.3) 11.0 (6.2-23.4) 0.68 HOMA-IR: Median (IQ range) 2.4 (1.3-5.2) 2.6 (1.3-5.7) 2.4 (1.3-5.3) 0.62 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.0 (4.6-5.6) 5.0 (4.6-5.5) 0.49 Within SCOPE Characteristic &lt;=90th centile (n=977) &gt;90th centile (n=96) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 139.3 (91.1-222.0) 178.4 (120.7-232.7) 141.2 (92.6-223.7) 0.02 hPL (μg/ml): Median (IQ range) 179.2 (149.1-214.8) 206.6 (155.4-239.5) 180.6 (149.6-216.9) 0.005 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.7) 4.6 (3.2-5.7) 4.2 (3.2-5.7) 0.61 Insulin (uU/ml): Median (IQ range) 13.4 (6.6-29.2) 20.7 (7.2-39.4) 13.8 (6.6-30.3) 0.09 HOMA-IR: Median (IQ range) 3.2 (1.6-7.3) 4.8 (1.6-9.4) 3.3 (1.6-7.5) 0.09 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.0-5.9) 5.4 (5.0-5.8) 0.24 Serum folate concentration (nM): Median (IQ range) 35.8 (28.1-42.6) 37.7 (29.4-42.6) 35.9 (28.1-42.6) 0.50 B12 concentration (pM): Median (IQ range) 243.0 (193.0-305.0) 250.5 (202.2-329.8) 245.0 (195.0-308.5) 0.15 Folate:B12 ratio: Median (IQ range) 142.6 (103.5-206.7) 151.4 (96.8-213.0) 142.7 (102.3-207.5) 0.85 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-72.0) 59.0 (44.8-79.2) 56.0 (43.0-73.0) 0.38 Folate:Active B12 ratio: Median (IQ range) 615.4 (429.8-904.2) 608.7 (467.2-871.9) 615.4 (432.4-902.3) 0.63 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.8) 4.4 (3.8-5.0) 0.16 Within STOP Characteristic &lt;=90th centile (n=933) &gt;90th centile (n=107) Total (n=1040) P-value PRL (ng/ml): Median (IQ range) 75.0 (49.5-118.8) 72.6 (47.8-113.4) 74.8 (49.2-118.7) 0.73 hPL (μg/ml): Median (IQ range) 60.5 (39.5-95.7) 60.9 (47.5-88.0) 60.6 (40.5-93.2) 0.31 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-2.2) 1.4 (0.9-2.4) 0.85 Insulin (uU/ml): Median (IQ range) 9.6 (5.8-18.8) 8.3 (5.6-16.4) 9.6 (5.8-18.4) 0.53 HOMA-IR: Median (IQ range) 2.0 (1.2-4.0) 1.8 (1.2-3.7) 2.0 (1.2-4.0) 0.68 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.7 (4.5-5.1) 4.7 (4.4-5.1) 0.38 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-49.6) 40.8 (36.5-44.8) 40.5 (36.4-45.6) 0.89 B12 concentration (pM): Median (IQ range) 280.0 (217.0-356.0) 277.0 (231.0-380.2) 279.0 (218.0-356.5) 0.54 Folate:B12 ratio: Median (IQ range) 153.8 (115.6-222.8) 153.2 (114.4-212.1) 153.8 (115.3-221.7) 0.40 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-84.0) 67.5 (49.2-77.5) 63.0 (49.0-84.0) 0.68 Folate:Active B12 ratio: Median (IQ range) 663.0 (477.8-955.4) 646.1 (462.7-869.2) 663.0 (475.7-948.9) 0.67 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.7 (4.3-5.4) 4.8 (4.2-5.6) 0.32 Red cell folate (nmol/L): Median (IQ range) 1469.0 (1206.0-1766.8) 1445.5 (1206.2-1704.0) 1466.0 (1205.8-1765.2) 0.60 "],["prolactin-29.html", "43.1 Prolactin", " 43.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 14.05 (8.99, 21.97) &lt;0.0001 BW_gp&gt;90th centile 1.28 (1.08, 1.52) 0.005 StudySTOP 0.98 (0.85, 1.12) 0.74 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.79 (0.61, 1.03) 0.08 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 101.19 4.24 Inf 93.22 109.86 &gt;90th centile SCOPE 129.57 11.46 Inf 108.94 154.11 &lt;=90th centile STOP 98.90 3.74 Inf 91.84 106.50 &gt;90th centile STOP 100.28 10.05 Inf 82.39 122.04 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.28 (1.08, 1.52) 0.005 &gt;90th centile / &lt;=90th centile Study: STOP 1.01 (0.83, 1.23) 0.9 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.98 (0.85, 1.12) 0.7 STOP / SCOPE Birthweight centile: &gt;90th centile 0.77 (0.59, 1.02) 0.07 "],["hpl-29.html", "43.2 HPL", " 43.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.94 (1.53, 2.44) &lt;0.0001 BW_gp&gt;90th centile 1.10 (1.01, 1.21) 0.04 StudySTOP 1.08 (1.02, 1.14) 0.01 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.05 (0.94, 1.17) 0.43 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 93.67 1.82 Inf 90.16 97.31 &gt;90th centile SCOPE 103.42 4.95 Inf 94.16 113.59 &lt;=90th centile STOP 100.87 1.54 Inf 97.90 103.93 &gt;90th centile STOP 116.48 3.70 Inf 109.46 123.96 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.10 (1.01, 1.21) 0.04 &gt;90th centile / &lt;=90th centile Study: STOP 1.15 (1.08, 1.23) &lt;0.0001 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.08 (1.02, 1.14) 0.01 STOP / SCOPE Birthweight centile: &gt;90th centile 1.13 (1.00, 1.27) 0.05 "],["gh2-29.html", "43.3 GH2", " 43.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 BW_gp&gt;90th centile 1.00 (0.88, 1.13) 0.98 StudySTOP 1.02 (0.94, 1.10) 0.64 GA_samp 1.31 (1.29, 1.33) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.04 (0.88, 1.23) 0.65 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 2.39 0.06 Inf 2.28 2.51 &gt;90th centile SCOPE 2.38 0.16 Inf 2.10 2.71 &lt;=90th centile STOP 2.43 0.06 Inf 2.32 2.55 &gt;90th centile STOP 2.53 0.14 Inf 2.26 2.83 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.00 (0.88, 1.13) 1.0 &gt;90th centile / &lt;=90th centile Study: STOP 1.04 (0.93, 1.17) 0.5 STOP / SCOPE Birthweight centile: &lt;=90th centile 1.02 (0.94, 1.10) 0.6 STOP / SCOPE Birthweight centile: &gt;90th centile 1.06 (0.89, 1.26) 0.5 "],["insulin-27.html", "43.4 Insulin", " 43.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 11.64 (7.19, 18.85) &lt;0.0001 BW_gp&gt;90th centile 1.19 (0.92, 1.54) 0.20 StudySTOP 0.79 (0.68, 0.92) 0.002 GA_samp 1.01 (0.98, 1.05) 0.38 BW_gp&gt;90th centile:StudySTOP 0.79 (0.58, 1.08) 0.14 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 13.97 0.70 Inf 12.67 15.40 &gt;90th centile SCOPE 16.58 2.17 Inf 12.83 21.42 &lt;=90th centile STOP 11.02 0.45 Inf 10.16 11.94 &gt;90th centile STOP 10.39 0.90 Inf 8.77 12.30 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.19 (0.92, 1.54) 0.2 &gt;90th centile / &lt;=90th centile Study: STOP 0.94 (0.80, 1.11) 0.5 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.79 (0.68, 0.92) 0.002 STOP / SCOPE Birthweight centile: &gt;90th centile 0.63 (0.46, 0.86) 0.004 "],["homa-ir-27.html", "43.5 HOMA-IR", " 43.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.90 (1.75, 4.80) &lt;0.0001 BW_gp&gt;90th centile 1.20 (0.91, 1.58) 0.19 StudySTOP 0.68 (0.58, 0.80) &lt;0.0001 GA_samp 1.01 (0.98, 1.04) 0.49 BW_gp&gt;90th centile:StudySTOP 0.80 (0.58, 1.10) 0.17 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 3.37 0.18 Inf 3.04 3.73 &gt;90th centile SCOPE 4.04 0.56 Inf 3.08 5.29 &lt;=90th centile STOP 2.30 0.10 Inf 2.11 2.50 &gt;90th centile STOP 2.19 0.20 Inf 1.84 2.62 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.20 (0.91, 1.58) 0.2 &gt;90th centile / &lt;=90th centile Study: STOP 0.96 (0.80, 1.14) 0.6 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.68 (0.58, 0.80) &lt;0.0001 STOP / SCOPE Birthweight centile: &gt;90th centile 0.54 (0.39, 0.76) 0.0004 "],["glucose-27.html", "43.6 Glucose", " 43.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.49 (5.03, 5.99) &lt;0.0001 BW_gp&gt;90th centile 1.06 (1.00, 1.11) 0.04 StudySTOP 0.87 (0.85, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.65 BW_gp&gt;90th centile:StudySTOP 1.00 (0.92, 1.08) 0.95 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 5.39 0.05 Inf 5.30 5.48 &gt;90th centile SCOPE 5.70 0.15 Inf 5.42 6.00 &lt;=90th centile STOP 4.69 0.03 Inf 4.62 4.75 &gt;90th centile STOP 4.94 0.15 Inf 4.65 5.26 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.06 (1.00, 1.11) 0.04 &gt;90th centile / &lt;=90th centile Study: STOP 1.06 (0.99, 1.12) 0.09 STOP / SCOPE Birthweight centile: &lt;=90th centile 0.87 (0.85, 0.89) &lt;0.0001 STOP / SCOPE Birthweight centile: &gt;90th centile 0.87 (0.80, 0.94) 0.0005 "],["hormone-models-3.html", "44 Hormone Models", " 44 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 22 0 15wks 465 684 "],["raw-plots-3.html", "44.1 Raw plots", " 44.1 Raw plots "],["scope-vs-stop-3.html", "44.2 SCOPE vs STOP", " 44.2 SCOPE vs STOP Fit LME models for Prolactin, HPL and GH2. Fit GEE models for Insulin and HOMA-IR. Outcomes: Prolactin, hPL, GH2, Insulin, HOMA-IR, Glucose (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME or GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       LME only: Random intercepts for Study ID and Plate       GEE only: Independence correlation structure 44.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 8.706512 1 0.003 ** Study 2.244395 1 0.1 ns GA_samp 30.790407 1 &lt;0.0001 *** Study:GA_samp 2.221336 1 0.1 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 46.94900 1 &lt;0.0001 *** Study 21.66283 1 &lt;0.0001 *** GA_samp 94.21469 1 &lt;0.0001 *** Study:GA_samp 25.95307 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 12.13572 1 0.0005 *** Study 16.86104 1 &lt;0.0001 *** GA_samp 53.71079 1 &lt;0.0001 *** Study:GA_samp 17.66908 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 6.440 6.440 0.01 * 3 GA_samp 1 Inf 3.036 3.036 0.08 ns 2 Study:GA_samp 1 Inf 4.677 4.677 0.03 * HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 7.472 7.472 0.006 ** 3 GA_samp 1 Inf 3.420 3.420 0.06 ns 2 Study:GA_samp 1 Inf 4.874 4.874 0.03 * Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 0.232 0.232 0.6 ns 3 GA_samp 1 Inf 0.008 0.008 0.9 ns 2 Study:GA_samp 1 Inf 0.111 0.111 0.7 ns 44.2.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 1.72 (0.58, 2.87) 0.003 StudySTOP 0.91 (-0.28, 2.10) 0.13 GA_samp 0.21 (0.13, 0.28) &lt;0.0001 StudySTOP:GA_samp -0.06 (-0.14, 0.02) 0.14 hPL (μg/ml) Var Effect P (Intercept) 2.14 (1.52, 2.76) &lt;0.0001 StudySTOP -1.51 (-2.15, -0.87) &lt;0.0001 GA_samp 0.20 (0.16, 0.24) &lt;0.0001 StudySTOP:GA_samp 0.11 (0.07, 0.15) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) -1.33 (-2.10, -0.56) 0.0005 StudySTOP -1.64 (-2.45, -0.83) &lt;0.0001 GA_samp 0.18 (0.13, 0.23) &lt;0.0001 StudySTOP:GA_samp 0.11 (0.06, 0.17) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 4.31 (2.75, 5.87) &lt;0.0001 StudySTOP -2.10 (-3.73, -0.48) 0.01 GA_samp -0.11 (-0.21, -0.01) 0.04 StudySTOP:GA_samp 0.12 (0.01, 0.23) 0.03 HOMA-IR Var Effect P (Intercept) 3.01 (1.39, 4.64) 0.0003 StudySTOP -2.36 (-4.05, -0.67) 0.006 GA_samp -0.12 (-0.22, -0.01) 0.03 StudySTOP:GA_samp 0.13 (0.01, 0.24) 0.03 Glucose (mmol/L) Var Effect P (Intercept) 1.67 (1.34, 1.99) &lt;0.0001 StudySTOP -0.08 (-0.42, 0.26) 0.63 GA_samp 0.00 (-0.02, 0.02) 0.90 StudySTOP:GA_samp -0.00 (-0.03, 0.02) 0.74 44.2.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. PRL (ng/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 44.67877 9.765118 775.60673 29.09173 68.61720 STOP 10 60.90187 4.717695 79.27188 52.20009 71.05425 SCOPE 16 155.26985 12.165875 82.42309 132.86150 181.45757 STOP 16 147.84441 14.552006 197.53829 121.76053 179.51605 hPL (μg/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 60.06118 6.777997 1013.3294 48.13041 74.94940 STOP 10 39.61791 1.055110 108.7181 37.58090 41.76535 SCOPE 16 194.04839 5.259046 113.7242 183.90473 204.75155 STOP 16 247.31102 10.211412 486.6536 228.03943 268.21126 GH2 (ng/ml) Study GA_samp response SE df lower.CL upper.CL SCOPE 10 1.600762 0.2192977 433.4993 1.222895 2.095387 STOP 10 0.948957 0.0264086 216.5576 0.898308 1.002462 SCOPE 16 4.703807 0.1314798 197.9604 4.451542 4.970366 STOP 16 5.462550 0.2814179 922.9232 4.937259 6.043728 Insulin (uU/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 25.31505 7.1937998 Inf 14.504141 44.18404 STOP 10 10.17569 0.4433112 Inf 9.342878 11.08274 SCOPE 16 13.27781 0.7140309 Inf 11.949565 14.75370 STOP 16 10.90728 1.0191172 Inf 9.082069 13.09930 HOMA-IR Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 6.371755 1.8874508 Inf 3.565455 11.386841 STOP 10 2.137866 0.0979181 Inf 1.954312 2.338660 SCOPE 16 3.173325 0.1800916 Inf 2.839275 3.546678 STOP 16 2.273611 0.2215450 Inf 1.878337 2.752067 Glucose (mmol/L) Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 5.361853 0.3217762 Inf 4.766861 6.031111 STOP 10 4.750210 0.0569715 Inf 4.639850 4.863194 SCOPE 16 5.406086 0.0560985 Inf 5.297246 5.517163 STOP 16 4.682279 0.0697641 Inf 4.547522 4.821030 44.2.5 Comparisons Hormone Contrast GA_samp Ratio of Geometric means (95% CI) P-value PRL (ng/ml) STOP / SCOPE 10 1.36 (0.90, 2.07) 0.1 PRL (ng/ml) STOP / SCOPE 16 0.95 (0.81, 1.11) 0.5 hPL (μg/ml) STOP / SCOPE 10 0.66 (0.53, 0.82) 0.0003 hPL (μg/ml) STOP / SCOPE 16 1.27 (1.18, 1.38) &lt;0.0001 GH2 (ng/ml) STOP / SCOPE 10 0.59 (0.45, 0.78) 0.0002 GH2 (ng/ml) STOP / SCOPE 16 1.16 (1.04, 1.29) 0.007 Insulin (uU/ml) STOP / SCOPE 10 0.40 (0.23, 0.71) 0.002 Insulin (uU/ml) STOP / SCOPE 16 0.82 (0.67, 1.01) 0.07 HOMA-IR STOP / SCOPE 10 0.34 (0.19, 0.60) 0.0003 HOMA-IR STOP / SCOPE 16 0.72 (0.57, 0.89) 0.003 Glucose (mmol/L) STOP / SCOPE 10 0.89 (0.79, 1.00) 0.05 Glucose (mmol/L) STOP / SCOPE 16 0.87 (0.84, 0.90) &lt;0.0001 44.2.6 Barplots by Study Barplots in this section may be misleading due to involvement of Study by GA interaction. 44.2.7 Plots for GA "],["folate-5.html", "44.3 Folate", " 44.3 Folate 44.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 129.2308225 1 &lt;0.0001 *** Folate 2.0006170 1 0.2 ns Study 0.5519894 1 0.5 ns GA_samp 130.9134873 1 &lt;0.0001 *** Folate:Study 2.1143312 1 0.1 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 32.2090781 1 &lt;0.0001 *** Folate 0.1917908 1 0.7 ns Study 8.1357120 1 0.004 ** GA_samp 1633.8508884 1 &lt;0.0001 *** Folate:Study 0.0205584 1 0.9 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 329.3390138 1 &lt;0.0001 *** Folate 0.4074204 1 0.5 ns Study 1.3523959 1 0.2 ns GA_samp 806.7098807 1 &lt;0.0001 *** Folate:Study 1.0842100 1 0.3 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 8.298 8.298 0.004 ** 3 Study 1 Inf 11.103 11.103 0.0009 *** 4 GA_samp 1 Inf 0.126 0.126 0.7 ns 2 Folate:Study 1 Inf 1.122 1.122 0.3 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 8.507 8.507 0.004 ** 3 Study 1 Inf 19.086 19.086 &lt;0.0001 *** 4 GA_samp 1 Inf 0.220 0.220 0.6 ns 2 Folate:Study 1 Inf 1.183 1.183 0.3 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 0.001 0.001 1.0 ns 3 Study 1 Inf 42.997 42.997 &lt;0.0001 *** 4 GA_samp 1 Inf 0.215 0.215 0.6 ns 2 Folate:Study 1 Inf 1.230 1.230 0.3 ns 44.3.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 12.75 (8.19, 19.85) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.69 StudySTOP 1.02 (0.89, 1.16) 0.83 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.94 (1.54, 2.43) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.59 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.72 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 17.06 (9.66, 30.13) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.006 StudySTOP 0.72 (0.60, 0.86) 0.0004 GA_samp 0.99 (0.96, 1.03) 0.72 HOMA-IR Var Effect P (Intercept) 4.28 (2.37, 7.76) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.006 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.64 Glucose (mmol/L) Var Effect P (Intercept) 5.56 (4.99, 6.19) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.96 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.60 44.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 96.09899 7.956285 102.42390 81.54608 113.2491 STOP 97.55176 7.571251 79.54175 83.58929 113.8465 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.84074 2.658071 185.6178 84.74693 95.24072 STOP 102.82324 2.703799 116.2500 97.60520 108.32023 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.275956 0.0759402 410.0751 2.131466 2.430241 STOP 2.346964 0.0644066 219.8201 2.223402 2.477393 Insulin (uU/L) Study response SE df asymp.LCL asymp.UCL SCOPE 14.58196 0.9172011 Inf 12.890676 16.49515 STOP 10.49963 0.4816931 Inf 9.596731 11.48748 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.525574 0.2354573 Inf 3.093014 4.018628 STOP 2.195501 0.1052510 Inf 1.998608 2.411792 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.423416 0.0681547 Inf 5.291467 5.558655 STOP 4.715630 0.0419170 Inf 4.634186 4.798506 44.3.4 Comparisons Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.7 PRL (ng/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.7 hPL (μg/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.6 hPL (μg/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.6 GH2 (ng/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.7 GH2 (ng/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.7 Insulin (uU/ml) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.006 Insulin (uU/ml) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.006 HOMA-IR Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.006 HOMA-IR Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.006 Glucose (mmol/L) Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 1.0 Glucose (mmol/L) Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 1.0 44.3.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.3.6 Plots "],["folate-categories-2.html", "44.4 Folate (categories)", " 44.4 Folate (categories) Folate range (&lt;45.3 vs &gt;=45.3) 44.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 130.8498286 1 &lt;0.0001 *** Folate_gp 1.5474194 1 0.2 ns Study 0.0028985 1 1.0 ns GA_samp 129.9037148 1 &lt;0.0001 *** Folate_gp:Study 0.1873616 1 0.7 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 31.8026411 1 &lt;0.0001 *** Folate_gp 0.5247425 1 0.5 ns Study 15.3487117 1 &lt;0.0001 *** GA_samp 1637.3958932 1 &lt;0.0001 *** Folate_gp:Study 1.3445950 1 0.2 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 340.5884144 1 &lt;0.0001 *** Folate_gp 0.8284085 1 0.4 ns Study 0.9187959 1 0.3 ns GA_samp 809.0684784 1 &lt;0.0001 *** Folate_gp:Study 1.6021790 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 4.454 4.454 0.03 * 3 Study 1 Inf 10.576 10.576 0.001 ** 4 GA_samp 1 Inf 0.113 0.113 0.7 ns 2 Folate_gp:Study 1 Inf 0.585 0.585 0.4 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 3.940 3.940 0.05 ns 3 Study 1 Inf 20.069 20.069 &lt;0.0001 *** 4 GA_samp 1 Inf 0.199 0.199 0.7 ns 2 Folate_gp:Study 1 Inf 0.723 0.723 0.4 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Folate_gp 1 Inf 0.361 0.361 0.5 ns 3 Study 1 Inf 53.217 53.217 &lt;0.0001 *** 4 GA_samp 1 Inf 0.198 0.198 0.7 ns 2 Folate_gp:Study 1 Inf 1.123 1.123 0.3 ns 44.4.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 12.92 (8.33, 20.02) &lt;0.0001 Folate_gp≥45.3 0.93 (0.86, 1.02) 0.14 StudySTOP 1.01 (0.88, 1.16) 0.86 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.92 (1.54, 2.41) &lt;0.0001 Folate_gp≥45.3 0.99 (0.95, 1.04) 0.75 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 Folate_gp≥45.3 0.99 (0.93, 1.06) 0.87 StudySTOP 1.03 (0.94, 1.13) 0.53 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 16.05 (9.08, 28.36) &lt;0.0001 Folate_gp≥45.3 0.88 (0.79, 0.99) 0.04 StudySTOP 0.71 (0.60, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.74 HOMA-IR Var Effect P (Intercept) 4.00 (2.21, 7.25) &lt;0.0001 Folate_gp≥45.3 0.89 (0.78, 1.00) 0.06 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.66 Glucose (mmol/L) Var Effect P (Intercept) 5.53 (4.97, 6.16) &lt;0.0001 Folate_gp≥45.3 1.01 (0.98, 1.04) 0.42 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.63 44.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 94.28120 7.881276 105.81912 79.88169 111.2764 STOP 95.46369 7.493420 82.64525 81.66396 111.5953 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.55766 2.703633 200.0909 84.38197 95.0508 STOP 102.42476 2.760721 126.5065 97.10473 108.0363 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.270358 0.0783020 457.2962 2.121580 2.429569 STOP 2.339495 0.0664836 239.7681 2.212127 2.474197 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 13.92731 0.8952145 Inf 12.278749 15.79722 STOP 9.94880 0.4661921 Inf 9.075784 10.90579 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.367075 0.2289763 Inf 2.946912 3.847143 STOP 2.078715 0.1024898 Inf 1.887239 2.289617 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.441858 0.0705402 Inf 5.305343 5.581886 STOP 4.733070 0.0429425 Inf 4.649648 4.817988 44.4.4 Comparisons (Overall) Hormone Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) ≥45.3 / &lt;45.3 0.93 (0.86, 1.02) 0.1 hPL (μg/ml) ≥45.3 / &lt;45.3 0.99 (0.95, 1.04) 0.8 GH2 (ng/ml) ≥45.3 / &lt;45.3 0.99 (0.93, 1.06) 0.9 Insulin (uU/ml) ≥45.3 / &lt;45.3 0.88 (0.79, 0.99) 0.04 HOMA-IR ≥45.3 / &lt;45.3 0.89 (0.78, 1.00) 0.06 Glucose (mmol/L) ≥45.3 / &lt;45.3 1.01 (0.98, 1.04) 0.4 44.4.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.4.6 Plots "],["b12-5.html", "44.5 B12", " 44.5 B12 44.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 113.7952111 1 &lt;0.0001 *** B12 0.0039381 1 0.9 ns Study 0.1835478 1 0.7 ns GA_samp 132.0512503 1 &lt;0.0001 *** B12:Study 0.4161577 1 0.5 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 24.428879 1 &lt;0.0001 *** B12 1.133261 1 0.3 ns Study 3.998083 1 0.05 ns GA_samp 1648.072726 1 &lt;0.0001 *** B12:Study 0.017806 1 0.9 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 336.340208 1 &lt;0.0001 *** B12 6.624419 1 0.01 * Study 1.872150 1 0.2 ns GA_samp 815.254269 1 &lt;0.0001 *** B12:Study 1.840691 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 4.297 4.297 0.04 * 3 Study 1 Inf 7.878 7.878 0.005 ** 4 GA_samp 1 Inf 0.122 0.122 0.7 ns 2 B12:Study 1 Inf 1.131 1.131 0.3 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 3.806 3.806 0.05 ns 3 Study 1 Inf 11.788 11.788 0.0006 *** 4 GA_samp 1 Inf 0.209 0.209 0.6 ns 2 B12:Study 1 Inf 1.079 1.079 0.3 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 2.841 2.841 0.09 ns 3 Study 1 Inf 30.734 30.734 &lt;0.0001 *** 4 GA_samp 1 Inf 0.333 0.333 0.6 ns 2 B12:Study 1 Inf 0.595 0.595 0.4 ns 44.5.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 12.05 (7.69, 18.87) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.41 StudySTOP 1.01 (0.88, 1.16) 0.87 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.81 (1.44, 2.28) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.04 StudySTOP 1.14 (1.06, 1.22) 0.0003 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.01 StudySTOP 1.02 (0.93, 1.12) 0.66 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 18.19 (9.98, 33.15) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.04 StudySTOP 0.72 (0.60, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.71 HOMA-IR Var Effect P (Intercept) 4.54 (2.43, 8.49) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.06 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.63 Glucose (mmol/L) Var Effect P (Intercept) 5.67 (5.09, 6.31) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.10 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.57 44.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 96.44883 7.991495 103.34357 81.83386 113.6739 STOP 97.57641 7.546418 78.86473 83.65432 113.8155 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 90.37671 2.675871 190.0294 85.24966 95.81211 STOP 102.98997 2.681540 114.0150 97.81254 108.44145 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.305636 0.0775524 424.6029 2.158132 2.463223 STOP 2.354790 0.0636642 207.0318 2.232563 2.483709 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.15732 0.8882227 Inf 12.519214 16.00976 STOP 10.17033 0.4597934 Inf 9.307926 11.11264 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.420104 0.2279209 Inf 3.001332 3.897308 STOP 2.123460 0.1003240 Inf 1.935658 2.329483 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.406117 0.0673630 Inf 5.275688 5.539772 STOP 4.711955 0.0397875 Inf 4.634615 4.790586 44.5.4 Comparisons Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) B12363.5 / B12263.5 SCOPE 1.01 (0.98, 1.05) 0.4 PRL (ng/ml) B12363.5 / B12263.5 STOP 1.01 (0.98, 1.05) 0.4 hPL (μg/ml) B12363.5 / B12263.5 SCOPE 1.02 (1.00, 1.04) 0.04 hPL (μg/ml) B12363.5 / B12263.5 STOP 1.02 (1.00, 1.04) 0.04 GH2 (ng/ml) B12363.5 / B12263.5 SCOPE 1.03 (1.01, 1.05) 0.01 GH2 (ng/ml) B12363.5 / B12263.5 STOP 1.03 (1.01, 1.05) 0.01 Insulin (uU/ml) B12363.5 / B12263.5 SCOPE 0.95 (0.91, 1.00) 0.04 Insulin (uU/ml) B12363.5 / B12263.5 STOP 0.95 (0.91, 1.00) 0.04 HOMA-IR B12363.5 / B12263.5 SCOPE 0.95 (0.90, 1.00) 0.06 HOMA-IR B12363.5 / B12263.5 STOP 0.95 (0.90, 1.00) 0.06 Glucose (mmol/L) B12363.5 / B12263.5 SCOPE 0.99 (0.99, 1.00) 0.10 Glucose (mmol/L) B12363.5 / B12263.5 STOP 0.99 (0.99, 1.00) 0.10 44.5.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 96.12350 7.943488 102.26730 81.59159 113.2436 STOP 97.24727 7.514380 78.60051 83.38271 113.4172 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.98138 2.648226 185.8123 84.90570 95.36048 STOP 102.53947 2.664550 113.1569 97.39417 107.95658 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.288290 0.0761590 410.6529 2.143372 2.443006 STOP 2.337074 0.0630674 206.3572 2.215985 2.464780 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.33738 0.8943328 Inf 12.687433 16.20189 STOP 10.29968 0.4592552 Inf 9.437771 11.24031 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.463888 0.2293611 Inf 3.042297 3.943901 STOP 2.150644 0.1002700 Inf 1.962830 2.356429 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.415384 0.0667619 Inf 5.286101 5.547829 STOP 4.720032 0.0401342 Inf 4.642022 4.799353 44.5.6 Comparisons (50 unit increase) Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) B12313.5 / B12263.5 SCOPE 1.01 (0.99, 1.02) 0.4 PRL (ng/ml) B12313.5 / B12263.5 STOP 1.01 (0.99, 1.02) 0.4 hPL (μg/ml) B12313.5 / B12263.5 SCOPE 1.01 (1.00, 1.02) 0.04 hPL (μg/ml) B12313.5 / B12263.5 STOP 1.01 (1.00, 1.02) 0.04 GH2 (ng/ml) B12313.5 / B12263.5 SCOPE 1.02 (1.00, 1.03) 0.01 GH2 (ng/ml) B12313.5 / B12263.5 STOP 1.02 (1.00, 1.03) 0.01 Insulin (uU/ml) B12313.5 / B12263.5 SCOPE 0.98 (0.95, 1.00) 0.04 Insulin (uU/ml) B12313.5 / B12263.5 STOP 0.98 (0.95, 1.00) 0.04 HOMA-IR B12313.5 / B12263.5 SCOPE 0.97 (0.95, 1.00) 0.06 HOMA-IR B12313.5 / B12263.5 STOP 0.97 (0.95, 1.00) 0.06 Glucose (mmol/L) B12313.5 / B12263.5 SCOPE 1.00 (0.99, 1.00) 0.10 Glucose (mmol/L) B12313.5 / B12263.5 STOP 1.00 (0.99, 1.00) 0.10 44.5.7 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.5.8 Plots "],["folateb12-5.html", "44.6 Folate:B12", " 44.6 Folate:B12 44.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 131.619724 1 &lt;0.0001 *** folate_B12 2.967510 1 0.08 ns Study 1.329267 1 0.2 ns GA_samp 131.577880 1 &lt;0.0001 *** folate_B12:Study 5.013235 1 0.03 * hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 32.3040552 1 &lt;0.0001 *** folate_B12 0.1638235 1 0.7 ns Study 9.3893442 1 0.002 ** GA_samp 1638.1363304 1 &lt;0.0001 *** folate_B12:Study 0.0023293 1 1.0 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 320.4006010 1 &lt;0.0001 *** folate_B12 1.3497714 1 0.2 ns Study 0.1266652 1 0.7 ns GA_samp 807.9421439 1 &lt;0.0001 *** folate_B12:Study 0.0677801 1 0.8 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.333 0.333 0.6 ns 3 Study 1 Inf 9.600 9.600 0.002 ** 4 GA_samp 1 Inf 0.076 0.076 0.8 ns 2 folate_B12:Study 1 Inf 0.120 0.120 0.7 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.406 0.406 0.5 ns 3 Study 1 Inf 17.721 17.721 &lt;0.0001 *** 4 GA_samp 1 Inf 0.153 0.153 0.7 ns 2 folate_B12:Study 1 Inf 0.217 0.217 0.6 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.412 0.412 0.5 ns 3 Study 1 Inf 44.737 44.737 &lt;0.0001 *** 4 GA_samp 1 Inf 0.213 0.213 0.6 ns 2 folate_B12:Study 1 Inf 1.231 1.231 0.3 ns 44.6.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 13.46 (8.64, 20.98) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.09 StudySTOP 0.91 (0.77, 1.07) 0.25 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 folate_B12:StudySTOP 1.00 (1.00, 1.00) 0.03 hPL (μg/ml) Var Effect P (Intercept) 1.94 (1.55, 2.43) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.49 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.13 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 15.64 (8.87, 27.58) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.60 StudySTOP 0.71 (0.59, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.79 HOMA-IR Var Effect P (Intercept) 3.91 (2.16, 7.07) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.58 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.96, 1.03) 0.70 Glucose (mmol/L) Var Effect P (Intercept) 5.53 (4.96, 6.16) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.57 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.61 44.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 95.45434 7.888834 102.11034 81.02226 112.4571 STOP 97.32665 7.521490 78.50036 83.44885 113.5124 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.70666 2.645779 184.2667 84.63571 95.08143 STOP 102.63004 2.675395 112.7167 97.46401 108.06989 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.271708 0.0755750 406.0961 2.127895 2.425241 STOP 2.342068 0.0633228 205.9442 2.220493 2.470299 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.41229 0.9070753 Inf 12.739738 16.30443 STOP 10.28088 0.4603074 Inf 9.417142 11.22383 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.481303 0.2322185 Inf 3.05466 3.967535 STOP 2.146647 0.1004986 Inf 1.95844 2.352940 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.423639 0.0673084 Inf 5.293309 5.557179 STOP 4.717079 0.0405035 Inf 4.638358 4.797136 44.6.4 Comparisons Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) folate_B12247.58 / folate_B12147.58 SCOPE 0.96 (0.93, 1.01) 0.09 PRL (ng/ml) folate_B12247.58 / folate_B12147.58 STOP 1.02 (0.99, 1.06) 0.2 hPL (μg/ml) folate_B12247.58 / folate_B12147.58 SCOPE 1.00 (0.98, 1.01) 0.5 hPL (μg/ml) folate_B12247.58 / folate_B12147.58 STOP 1.00 (0.98, 1.01) 0.5 GH2 (ng/ml) folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.97, 1.00) 0.1 GH2 (ng/ml) folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.97, 1.00) 0.1 Insulin (uU/ml) folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.96, 1.02) 0.6 Insulin (uU/ml) folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.96, 1.02) 0.6 HOMA-IR folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.96, 1.02) 0.6 HOMA-IR folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.96, 1.02) 0.6 Glucose (mmol/L) folate_B12247.58 / folate_B12147.58 SCOPE 1.00 (0.99, 1.01) 0.6 Glucose (mmol/L) folate_B12247.58 / folate_B12147.58 STOP 1.00 (0.99, 1.01) 0.6 44.6.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.6.6 Plots "],["active-b12-5.html", "44.7 Active B12", " 44.7 Active B12 44.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 67.4457733 1 &lt;0.0001 *** Active.B12 0.1176992 1 0.7 ns Study 0.1615703 1 0.7 ns GA_samp 58.6983233 1 &lt;0.0001 *** Active.B12:Study 0.0319285 1 0.9 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 6.1178575 1 0.01 * Active.B12 0.0010379 1 1.0 ns Study 3.0037869 1 0.08 ns GA_samp 832.2474984 1 &lt;0.0001 *** Active.B12:Study 0.0508695 1 0.8 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 193.194888 1 &lt;0.0001 *** Active.B12 1.660906 1 0.2 ns Study 2.898371 1 0.09 ns GA_samp 463.652179 1 &lt;0.0001 *** Active.B12:Study 2.181948 1 0.1 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 0.122 0.122 0.7 ns 3 Study 1 Inf 2.404 2.404 0.1 ns 4 GA_samp 1 Inf 0.098 0.098 0.8 ns 2 Active.B12:Study 1 Inf 0.008 0.008 0.9 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 0.136 0.136 0.7 ns 3 Study 1 Inf 4.369 4.369 0.04 * 4 GA_samp 1 Inf 0.177 0.177 0.7 ns 2 Active.B12:Study 1 Inf 0.023 0.023 0.9 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 1.951 1.951 0.2 ns 3 Study 1 Inf 11.796 11.796 0.0006 *** 4 GA_samp 1 Inf 0.769 0.769 0.4 ns 2 Active.B12:Study 1 Inf 0.057 0.057 0.8 ns 44.7.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 14.66 (7.87, 27.29) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.75 StudySTOP 0.91 (0.76, 1.10) 0.34 GA_samp 1.16 (1.11, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.53 (1.09, 2.15) 0.01 Active.B12 1.00 (1.00, 1.00) 0.75 StudySTOP 1.19 (1.08, 1.32) 0.0008 GA_samp 1.36 (1.33, 1.38) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.03, 0.07) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.81 StudySTOP 1.06 (0.93, 1.20) 0.39 GA_samp 1.33 (1.30, 1.37) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 16.87 (7.76, 36.71) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.74 StudySTOP 0.71 (0.57, 0.90) 0.004 GA_samp 0.99 (0.95, 1.04) 0.75 HOMA-IR Var Effect P (Intercept) 4.28 (1.88, 9.74) 0.0005 Active.B12 1.00 (1.00, 1.00) 0.73 StudySTOP 0.62 (0.48, 0.79) 0.0001 GA_samp 0.99 (0.94, 1.04) 0.67 Glucose (mmol/L) Var Effect P (Intercept) 5.66 (4.96, 6.46) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.16 StudySTOP 0.86 (0.83, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.38 44.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 104.01066 9.614865 132.9306 86.63012 124.8783 STOP 94.94685 8.201065 102.8474 79.99860 112.6883 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 90.59169 3.234625 260.1075 84.44106 97.19032 STOP 107.89007 3.433358 166.1723 101.32000 114.88617 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.293938 0.0976149 313.1236 2.109694 2.494272 STOP 2.425388 0.0890781 204.3571 2.255967 2.607534 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.72221 1.1449052 Inf 12.640885 17.14623 STOP 10.51991 0.6520471 Inf 9.316497 11.87877 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.563678 0.2995429 Inf 3.022395 4.201900 STOP 2.196609 0.1440558 Inf 1.931657 2.497902 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.538397 0.0830353 Inf 5.378018 5.703558 STOP 4.767779 0.0589751 Inf 4.653580 4.884780 44.7.4 Comparisons Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Active.B1270 / Active.B1260 SCOPE 1.00 (0.98, 1.03) 0.7 PRL (ng/ml) Active.B1270 / Active.B1260 STOP 1.00 (0.98, 1.03) 0.7 hPL (μg/ml) Active.B1270 / Active.B1260 SCOPE 1.00 (0.99, 1.01) 0.7 hPL (μg/ml) Active.B1270 / Active.B1260 STOP 1.00 (0.99, 1.01) 0.7 GH2 (ng/ml) Active.B1270 / Active.B1260 SCOPE 1.00 (0.99, 1.02) 0.8 GH2 (ng/ml) Active.B1270 / Active.B1260 STOP 1.00 (0.99, 1.02) 0.8 Insulin (uU/ml) Active.B1270 / Active.B1260 SCOPE 0.99 (0.96, 1.03) 0.7 Insulin (uU/ml) Active.B1270 / Active.B1260 STOP 0.99 (0.96, 1.03) 0.7 HOMA-IR Active.B1270 / Active.B1260 SCOPE 0.99 (0.96, 1.03) 0.7 HOMA-IR Active.B1270 / Active.B1260 STOP 0.99 (0.96, 1.03) 0.7 Glucose (mmol/L) Active.B1270 / Active.B1260 SCOPE 1.01 (1.00, 1.01) 0.2 Glucose (mmol/L) Active.B1270 / Active.B1260 STOP 1.01 (1.00, 1.01) 0.2 44.7.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.7.6 Plots "],["folateactive-b12-5.html", "44.8 Folate:Active B12", " 44.8 Folate:Active B12 44.8.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 81.653013 1 &lt;0.0001 *** folate_Active.B12 2.405026 1 0.1 ns Study 5.359313 1 0.02 * GA_samp 60.136224 1 &lt;0.0001 *** folate_Active.B12:Study 7.831834 1 0.005 ** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 6.7473777 1 0.009 ** folate_Active.B12 0.4492223 1 0.5 ns Study 16.2494864 1 &lt;0.0001 *** GA_samp 843.1941108 1 &lt;0.0001 *** folate_Active.B12:Study 4.5843424 1 0.03 * GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 198.6866206 1 &lt;0.0001 *** folate_Active.B12 1.0610568 1 0.3 ns Study 0.0121323 1 0.9 ns GA_samp 468.3134903 1 &lt;0.0001 *** folate_Active.B12:Study 2.2694976 1 0.1 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 1.589 1.589 0.2 ns 3 Study 1 Inf 8.527 8.527 0.003 ** 4 GA_samp 1 Inf 0.097 0.097 0.8 ns 2 folate_Active.B12:Study 1 Inf 1.432 1.432 0.2 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 1.851 1.851 0.2 ns 3 Study 1 Inf 14.060 14.060 0.0002 *** 4 GA_samp 1 Inf 0.177 0.177 0.7 ns 2 folate_Active.B12:Study 1 Inf 1.383 1.383 0.2 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 4.808 4.808 0.03 * 3 Study 1 Inf 41.897 41.897 &lt;0.0001 *** 4 GA_samp 1 Inf 1.163 1.163 0.3 ns 2 folate_Active.B12:Study 1 Inf 0.226 0.226 0.6 ns 44.8.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 15.95 (8.75, 29.04) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.12 StudySTOP 0.77 (0.62, 0.96) 0.02 GA_samp 1.16 (1.12, 1.20) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.005 hPL (μg/ml) Var Effect P (Intercept) 1.54 (1.11, 2.14) 0.010 folate_Active.B12 1.00 (1.00, 1.00) 0.50 StudySTOP 1.28 (1.13, 1.44) &lt;0.0001 GA_samp 1.36 (1.33, 1.38) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.03 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.03, 0.07) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 1.00 StudySTOP 1.06 (0.93, 1.20) 0.39 GA_samp 1.33 (1.30, 1.37) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 16.90 (8.16, 35.02) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.18 StudySTOP 0.71 (0.57, 0.90) 0.004 GA_samp 0.99 (0.95, 1.04) 0.78 HOMA-IR Var Effect P (Intercept) 4.29 (1.98, 9.31) 0.0002 folate_Active.B12 1.00 (1.00, 1.00) 0.15 StudySTOP 0.62 (0.48, 0.79) 0.0001 GA_samp 0.99 (0.94, 1.04) 0.69 Glucose (mmol/L) Var Effect P (Intercept) 6.04 (5.16, 7.06) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.004 StudySTOP 0.86 (0.83, 0.90) &lt;0.0001 GA_samp 0.99 (0.98, 1.00) 0.28 44.8.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 103.52216 9.538256 132.2925 86.27438 124.2181 STOP 95.26028 8.205226 102.5693 80.30054 113.0070 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 90.58383 3.238948 255.1716 84.42475 97.19225 STOP 107.75515 3.443906 164.9170 101.16542 114.77411 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.292618 0.0973988 309.6921 2.108763 2.492503 STOP 2.425090 0.0890729 203.7927 2.255676 2.607228 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.69993 1.1456949 Inf 12.617509 17.12604 STOP 10.50458 0.6474221 Inf 9.309302 11.85333 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.557729 0.2993955 Inf 3.016764 4.195701 STOP 2.192979 0.1431559 Inf 1.929606 2.492300 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.531632 0.0815836 Inf 5.374020 5.693867 STOP 4.765678 0.0585860 Inf 4.652224 4.881899 44.8.4 Comparisons Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.96 (0.92, 1.01) 0.1 PRL (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 1.06 (1.01, 1.12) 0.02 hPL (μg/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 1.01 (0.98, 1.04) 0.5 hPL (μg/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.94, 1.00) 0.02 GH2 (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 1.00 (0.98, 1.02) 1.0 GH2 (ng/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 1.00 (0.98, 1.02) 1.0 Insulin (uU/ml) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.97 (0.93, 1.01) 0.2 Insulin (uU/ml) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.93, 1.01) 0.2 HOMA-IR folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.97 (0.93, 1.01) 0.1 HOMA-IR folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.93, 1.01) 0.1 Glucose (mmol/L) folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.99 (0.99, 1.00) 0.004 Glucose (mmol/L) folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.99 (0.99, 1.00) 0.004 44.8.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.8.6 Plots "],["homocysteine-5.html", "44.9 Homocysteine", " 44.9 Homocysteine 44.9.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 117.9823128 1 &lt;0.0001 *** Homocysteine 2.2161224 1 0.1 ns Study 0.0338807 1 0.9 ns GA_samp 122.0902307 1 &lt;0.0001 *** Homocysteine:Study 0.0959458 1 0.8 ns hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 31.1427141 1 &lt;0.0001 *** Homocysteine 0.6346316 1 0.4 ns Study 3.0978882 1 0.08 ns GA_samp 1551.6084962 1 &lt;0.0001 *** Homocysteine:Study 0.0725759 1 0.8 ns GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 239.2035022 1 &lt;0.0001 *** Homocysteine 1.5409841 1 0.2 ns Study 0.8917925 1 0.3 ns GA_samp 785.9602453 1 &lt;0.0001 *** Homocysteine:Study 1.7161585 1 0.2 ns Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.759 0.759 0.4 ns 3 Study 1 Inf 1.868 1.868 0.2 ns 4 GA_samp 1 Inf 0.138 0.138 0.7 ns 2 Homocysteine:Study 1 Inf 0.001 0.001 1.0 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.548 0.548 0.5 ns 3 Study 1 Inf 3.470 3.470 0.06 ns 4 GA_samp 1 Inf 0.210 0.210 0.6 ns 2 Homocysteine:Study 1 Inf 0.000 0.000 1.0 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.136 0.136 0.7 ns 3 Study 1 Inf 4.358 4.358 0.04 * 4 GA_samp 1 Inf 0.348 0.348 0.6 ns 2 Homocysteine:Study 1 Inf 0.290 0.290 0.6 ns 44.9.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 15.39 (9.51, 24.91) &lt;0.0001 Homocysteine 0.97 (0.94, 1.00) 0.05 StudySTOP 1.02 (0.89, 1.16) 0.81 GA_samp 1.16 (1.13, 1.20) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 2.09 (1.63, 2.68) &lt;0.0001 Homocysteine 0.99 (0.97, 1.00) 0.12 StudySTOP 1.14 (1.06, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.06 (0.04, 0.09) &lt;0.0001 Homocysteine 1.00 (0.97, 1.02) 0.71 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 17.53 (9.25, 33.20) &lt;0.0001 Homocysteine 0.98 (0.93, 1.03) 0.36 StudySTOP 0.71 (0.60, 0.86) 0.0003 GA_samp 0.99 (0.96, 1.03) 0.71 HOMA-IR Var Effect P (Intercept) 4.31 (2.21, 8.39) &lt;0.0001 Homocysteine 0.98 (0.93, 1.03) 0.44 StudySTOP 0.62 (0.51, 0.75) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.64 Glucose (mmol/L) Var Effect P (Intercept) 5.63 (4.88, 6.50) &lt;0.0001 Homocysteine 1.00 (0.99, 1.01) 0.67 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.59 44.9.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. PRL (ng/ml) Study response SE df lower.CL upper.CL SCOPE 95.14832 7.868709 102.32772 80.75415 112.1082 STOP 96.72139 7.491155 79.16093 82.90351 112.8424 hPL (μg/ml) Study response SE df lower.CL upper.CL SCOPE 89.48048 2.644842 186.9890 84.41212 94.85316 STOP 102.27292 2.678403 115.6379 97.10307 107.71801 GH2 (ng/ml) Study response SE df lower.CL upper.CL SCOPE 2.271353 0.0759250 408.5979 2.126899 2.425619 STOP 2.342118 0.0640575 213.6254 2.219195 2.471849 Insulin (uU/ml) Study response SE df asymp.LCL asymp.UCL SCOPE 14.32849 0.9049166 Inf 12.660262 16.21653 STOP 10.23459 0.4633987 Inf 9.365476 11.18435 HOMA-IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.462311 0.2324445 Inf 3.035429 3.949226 STOP 2.138542 0.1012539 Inf 1.949018 2.346496 Glucose (mmol/L) Study response SE df asymp.LCL asymp.UCL SCOPE 5.418600 0.0647559 Inf 5.293156 5.547017 STOP 4.712809 0.0395282 Inf 4.635969 4.790924 44.9.4 Comparisons Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value PRL (ng/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 0.97 (0.94, 1.00) 0.05 PRL (ng/ml) Homocysteine5.6 / Homocysteine4.6 STOP 0.97 (0.94, 1.00) 0.05 hPL (μg/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 0.99 (0.97, 1.00) 0.1 hPL (μg/ml) Homocysteine5.6 / Homocysteine4.6 STOP 0.99 (0.97, 1.00) 0.1 GH2 (ng/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 1.00 (0.97, 1.02) 0.7 GH2 (ng/ml) Homocysteine5.6 / Homocysteine4.6 STOP 1.00 (0.97, 1.02) 0.7 Insulin (uU/ml) Homocysteine5.6 / Homocysteine4.6 SCOPE 0.98 (0.93, 1.03) 0.4 Insulin (uU/ml) Homocysteine5.6 / Homocysteine4.6 STOP 0.98 (0.93, 1.03) 0.4 HOMA-IR Homocysteine5.6 / Homocysteine4.6 SCOPE 0.98 (0.93, 1.03) 0.4 HOMA-IR Homocysteine5.6 / Homocysteine4.6 STOP 0.98 (0.93, 1.03) 0.4 Glucose (mmol/L) Homocysteine5.6 / Homocysteine4.6 SCOPE 1.00 (0.99, 1.01) 0.7 Glucose (mmol/L) Homocysteine5.6 / Homocysteine4.6 STOP 1.00 (0.99, 1.01) 0.7 44.9.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.9.6 Plots "],["red-cell-folate-2.html", "44.10 Red cell folate", " 44.10 Red cell folate 44.10.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 43.64894 1 &lt;0.0001 *** ns(rcfolate, 3) 5.76169 3 0.1 ns GA_samp 70.48397 1 &lt;0.0001 *** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 10.1918551 1 0.001 ** ns(rcfolate, 3) 0.1840576 3 1.0 ns GA_samp 1109.0784596 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 94.062933 1 &lt;0.0001 *** ns(rcfolate, 3) 6.776213 3 0.08 ns GA_samp 558.762160 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.363 0.363 0.5 ns GA_samp 1 Inf 0.389 0.389 0.5 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.345 0.345 0.6 ns GA_samp 1 Inf 0.266 0.266 0.6 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.171 0.171 0.7 ns GA_samp 1 Inf 1.236 1.236 0.3 ns 44.10.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 17.37 (7.46, 40.43) &lt;0.0001 ns(rcfolate, 3)1 0.80 (0.49, 1.32) 0.39 ns(rcfolate, 3)2 0.89 (0.18, 4.41) 0.89 ns(rcfolate, 3)3 1.01 (0.80, 1.27) 0.92 GA_samp 1.15 (1.11, 1.18) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 2.13 (1.34, 3.40) 0.001 ns(rcfolate, 3)1 0.95 (0.72, 1.25) 0.72 ns(rcfolate, 3)2 0.87 (0.36, 2.10) 0.75 ns(rcfolate, 3)3 0.99 (0.87, 1.12) 0.86 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.04 (0.02, 0.08) &lt;0.0001 ns(rcfolate, 3)1 0.93 (0.64, 1.37) 0.73 ns(rcfolate, 3)2 1.52 (0.44, 5.27) 0.51 ns(rcfolate, 3)3 0.90 (0.75, 1.07) 0.24 GA_samp 1.35 (1.32, 1.38) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 11.14 (4.71, 26.36) &lt;0.0001 ns(rcfolate, 3)1 0.80 (0.48, 1.31) 0.37 ns(rcfolate, 3)2 0.65 (0.13, 3.15) 0.59 ns(rcfolate, 3)3 1.07 (0.85, 1.35) 0.57 GA_samp 1.01 (0.97, 1.06) 0.53 HOMA-IR Var Effect P (Intercept) 2.42 (0.93, 6.32) 0.07 ns(rcfolate, 3)1 0.79 (0.45, 1.38) 0.41 ns(rcfolate, 3)2 0.63 (0.10, 3.76) 0.61 ns(rcfolate, 3)3 1.09 (0.85, 1.40) 0.50 GA_samp 1.01 (0.97, 1.06) 0.61 Glucose (mmol/L) Var Effect P (Intercept) 5.04 (4.04, 6.30) &lt;0.0001 ns(rcfolate, 3)1 1.00 (0.88, 1.13) 1.00 ns(rcfolate, 3)2 0.96 (0.60, 1.52) 0.86 ns(rcfolate, 3)3 1.06 (1.00, 1.13) 0.05 GA_samp 1.00 (0.99, 1.00) 0.27 44.10.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.10.4 Plots "],["red-cell-folate-categories-3.html", "44.11 Red cell folate (categories)", " 44.11 Red cell folate (categories) Within reference ranges (360 to 1400 vs &gt;1400). 44.11.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 176.5298310 1 &lt;0.0001 *** rcfolate_gp 0.0020879 1 1.0 ns GA_samp 75.7290268 1 &lt;0.0001 *** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 41.4726214 1 &lt;0.0001 *** rcfolate_gp 0.2775494 1 0.6 ns GA_samp 1126.6013558 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 420.04231 1 &lt;0.0001 *** rcfolate_gp 6.18705 1 0.01 * GA_samp 572.93929 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 0.418 0.418 0.5 ns GA_samp 1 Inf 0.761 0.761 0.4 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 0.435 0.435 0.5 ns GA_samp 1 Inf 0.646 0.646 0.4 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate_gp 1 Inf 4.135 4.135 0.04 * GA_samp 1 Inf 0.457 0.457 0.5 ns 44.11.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 14.79 (9.94, 22.00) &lt;0.0001 rcfolate_gp&gt;1400 1.00 (0.90, 1.11) 0.96 GA_samp 1.15 (1.12, 1.19) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 1.98 (1.61, 2.44) &lt;0.0001 rcfolate_gp&gt;1400 1.02 (0.96, 1.08) 0.60 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.04, 0.06) &lt;0.0001 rcfolate_gp&gt;1400 0.90 (0.83, 0.98) 0.01 GA_samp 1.35 (1.32, 1.39) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 8.11 (5.00, 13.13) &lt;0.0001 rcfolate_gp&gt;1400 1.04 (0.92, 1.19) 0.52 GA_samp 1.02 (0.98, 1.06) 0.38 HOMA-IR Var Effect P (Intercept) 1.71 (1.04, 2.82) 0.03 rcfolate_gp&gt;1400 1.05 (0.91, 1.20) 0.51 GA_samp 1.02 (0.97, 1.06) 0.42 Glucose (mmol/L) Var Effect P (Intercept) 4.78 (4.35, 5.25) &lt;0.0001 rcfolate_gp&gt;1400 1.04 (1.00, 1.07) 0.04 GA_samp 1.00 (0.99, 1.00) 0.50 44.11.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.11.4 Estimated marginal means Outcome rcfolate_gp response SE df lower.CL upper.CL PRL (ng/ml) 360 to 1400 74.847 6.442 75.895 63.057 88.843 PRL (ng/ml) &gt;1400 74.659 6.331 71.843 63.048 88.409 hPL (μg/ml) 360 to 1400 61.851 2.053 74.734 57.894 66.078 hPL (μg/ml) &gt;1400 62.844 2.025 67.509 58.930 67.018 GH2 (ng/ml) 360 to 1400 1.529 0.063 96.552 1.410 1.658 GH2 (ng/ml) &gt;1400 1.378 0.054 85.205 1.274 1.490 Insulin (uU/ml) 360 to 1400 10.052 0.468 Inf 9.176 11.013 Insulin (uU/ml) &gt;1400 10.498 0.504 Inf 9.556 11.533 HOMA-IR 360 to 1400 2.104 0.102 Inf 1.913 2.314 HOMA-IR &gt;1400 2.204 0.112 Inf 1.996 2.434 Glucose (mmol/L) 360 to 1400 4.648 0.056 Inf 4.540 4.759 Glucose (mmol/L) &gt;1400 4.818 0.062 Inf 4.698 4.941 44.11.5 Plots 44.11.6 Post-hoc comparisons Outcome Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) &gt;1400 / 360 to 1400 1.00 (0.90, 1.11) 1.0 hPL (μg/ml) &gt;1400 / 360 to 1400 1.02 (0.96, 1.08) 0.6 GH2 (ng/ml) &gt;1400 / 360 to 1400 0.90 (0.83, 0.98) 0.01 Insulin (uU/ml) &gt;1400 / 360 to 1400 1.04 (0.92, 1.19) 0.5 HOMA-IR &gt;1400 / 360 to 1400 1.05 (0.91, 1.20) 0.5 Glucose (mmol/L) &gt;1400 / 360 to 1400 1.04 (1.00, 1.07) 0.04 "],["red-cell-folate-categories-2-2.html", "44.12 Red cell folate (categories 2)", " 44.12 Red cell folate (categories 2) Over detection limit (360 to 1789 vs &gt;=1790). 44.12.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. PRL (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 180.256937 1 &lt;0.0001 *** rcfolate_gp2 4.092289 1 0.04 * GA_samp 71.304099 1 &lt;0.0001 *** hPL (μg/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 42.3880663 1 &lt;0.0001 *** rcfolate_gp2 0.2369317 1 0.6 ns GA_samp 1115.0372969 1 &lt;0.0001 *** GH2 (ng/ml) Chisq Df Pr(&gt;Chisq) (Intercept) 424.0485398 1 &lt;0.0001 *** rcfolate_gp2 0.0362665 1 0.8 ns GA_samp 553.8496342 1 &lt;0.0001 *** Insulin (uU/ml) model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 5.039 5.039 0.02 * GA_samp 1 Inf 0.370 0.370 0.5 ns HOMA-IR model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 5.570 5.570 0.02 * GA_samp 1 Inf 0.271 0.271 0.6 ns Glucose (mmol/L) model term df1 df2 F.ratio Chisq p.value rcfolate_gp2 1 Inf 4.972 4.972 0.03 * GA_samp 1 Inf 1.108 1.108 0.3 ns 44.12.2 Model summary Ratio of Geometric means (95% CI) PRL (ng/ml) Var Effect P (Intercept) 15.04 (10.13, 22.34) &lt;0.0001 rcfolate_gp2≥1790 1.14 (1.00, 1.29) 0.04 GA_samp 1.15 (1.11, 1.18) &lt;0.0001 hPL (μg/ml) Var Effect P (Intercept) 2.00 (1.62, 2.46) &lt;0.0001 rcfolate_gp2≥1790 1.02 (0.95, 1.09) 0.63 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 GH2 (ng/ml) Var Effect P (Intercept) 0.05 (0.03, 0.06) &lt;0.0001 rcfolate_gp2≥1790 0.99 (0.90, 1.09) 0.85 GA_samp 1.35 (1.32, 1.38) &lt;0.0001 Insulin (uU/ml) Var Effect P (Intercept) 8.46 (5.22, 13.72) &lt;0.0001 rcfolate_gp2≥1790 1.23 (1.03, 1.47) 0.02 GA_samp 1.01 (0.97, 1.06) 0.54 HOMA-IR Var Effect P (Intercept) 1.80 (1.09, 2.96) 0.02 rcfolate_gp2≥1790 1.25 (1.04, 1.51) 0.02 GA_samp 1.01 (0.97, 1.06) 0.60 Glucose (mmol/L) Var Effect P (Intercept) 4.89 (4.46, 5.36) &lt;0.0001 rcfolate_gp2≥1790 1.06 (1.01, 1.12) 0.03 GA_samp 1.00 (0.99, 1.00) 0.29 44.12.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 44.12.4 Estimated marginal means Outcome rcfolate_gp2 response SE df lower.CL upper.CL PRL (ng/ml) 360 to 1789 72.674 5.958 63.383 61.693 85.609 PRL (ng/ml) ≥1790 82.714 7.863 110.212 68.511 99.861 hPL (μg/ml) 360 to 1789 62.143 1.865 51.975 58.510 66.001 hPL (μg/ml) ≥1790 63.218 2.526 144.272 58.417 68.414 GH2 (ng/ml) 360 to 1789 1.449 0.052 61.530 1.348 1.558 GH2 (ng/ml) ≥1790 1.435 0.075 206.783 1.295 1.590 Insulin (uU/ml) 360 to 1789 9.833 0.351 Inf 9.168 10.545 Insulin (uU/ml) ≥1790 12.070 1.012 Inf 10.241 14.226 HOMA-IR 360 to 1789 2.052 0.077 Inf 1.906 2.210 HOMA-IR ≥1790 2.570 0.224 Inf 2.166 3.050 Glucose (mmol/L) 360 to 1789 4.669 0.039 Inf 4.593 4.747 Glucose (mmol/L) ≥1790 4.954 0.125 Inf 4.715 5.204 44.12.5 Plots 44.12.6 Post-hoc comparisons Outcome Contrast Ratio of Geometric means (95% CI) P-value PRL (ng/ml) ≥1790 / 360 to 1789 1.14 (1.00, 1.29) 0.04 hPL (μg/ml) ≥1790 / 360 to 1789 1.02 (0.95, 1.09) 0.6 GH2 (ng/ml) ≥1790 / 360 to 1789 0.99 (0.90, 1.09) 0.8 Insulin (uU/ml) ≥1790 / 360 to 1789 1.23 (1.03, 1.47) 0.02 HOMA-IR ≥1790 / 360 to 1789 1.25 (1.04, 1.51) 0.02 Glucose (mmol/L) ≥1790 / 360 to 1789 1.06 (1.01, 1.12) 0.03 "],["session-info-7.html", "45 Session info", " 45 Session info Results generated on: 2023-08-17 11:33:13.989533 Click for more details sessionInfo() ## R version 4.3.1 (2023-06-16) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.3 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] splines grid stats graphics grDevices utils datasets ## [8] methods base ## ## other attached packages: ## [1] ggpubr_0.6.0 car_3.1-2 carData_3.0-5 xlsx_0.6.5 ## [5] geepack_1.3.9 doFuture_1.0.0 future_1.32.0 foreach_1.5.2 ## [9] emmeans_1.8.5 lmerTest_3.1-3 lme4_1.1-33 Matrix_1.6-0 ## [13] readxl_1.4.2 fontawesome_0.5.1 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [17] knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.3 ## [21] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [25] Hmisc_5.1-0 ## ## loaded via a namespace (and not attached): ## [1] remotes_2.4.2 sandwich_3.0-1 rlang_1.1.1 ## [4] multcomp_1.4-18 compiler_4.3.1 mgcv_1.9-0 ## [7] systemfonts_1.0.4 callr_3.7.3 vctrs_0.6.3 ## [10] rvest_1.0.3 stringr_1.5.0 pkgconfig_2.0.3 ## [13] crayon_1.5.2 fastmap_1.1.1 backports_1.4.1 ## [16] ellipsis_0.3.2 labeling_0.4.2 utf8_1.2.3 ## [19] sessioninfo_1.2.2 ps_1.7.5 nloptr_2.0.0 ## [22] purrr_1.0.1 xfun_0.39 cachem_1.0.8 ## [25] jsonlite_1.8.4 highr_0.10 xlsxjars_0.6.1 ## [28] broom_1.0.4 parallel_4.3.1 prettyunits_1.1.1 ## [31] cluster_2.1.4 R6_2.5.1 bslib_0.4.2 ## [34] stringi_1.7.12 parallelly_1.36.0 boot_1.3-28 ## [37] pkgload_1.3.2 rpart_4.1.19 jquerylib_0.1.4 ## [40] cellranger_1.1.0 numDeriv_2016.8-1.1 estimability_1.4.1 ## [43] Rcpp_1.0.11 bookdown_0.34 iterators_1.0.14 ## [46] future.apply_1.8.1 zoo_1.8-9 base64enc_0.1-3 ## [49] nnet_7.3-19 tidyselect_1.2.0 abind_1.4-5 ## [52] rstudioapi_0.14 yaml_2.3.7 codetools_0.2-19 ## [55] processx_3.8.1 listenv_0.8.0 pkgbuild_1.4.0 ## [58] lattice_0.21-8 tibble_3.2.1 withr_2.5.0 ## [61] coda_0.19-4 evaluate_0.21 foreign_0.8-82 ## [64] survival_3.5-5 rJava_1.0-6 xml2_1.3.3 ## [67] pillar_1.9.0 checkmate_2.0.0 generics_0.1.3 ## [70] munsell_0.5.0 scales_1.2.1 minqa_1.2.4 ## [73] globals_0.16.2 xtable_1.8-4 glue_1.6.2 ## [76] tools_4.3.1 data.table_1.14.8 ggsignif_0.6.4 ## [79] webshot_0.5.4 fs_1.6.2 mvtnorm_1.1-3 ## [82] tidyr_1.3.0 colorspace_2.1-0 nlme_3.1-162 ## [85] htmlTable_2.4.0 Formula_1.2-4 cli_3.6.1 ## [88] fansi_1.0.4 viridisLite_0.4.2 svglite_2.1.0 ## [91] dplyr_1.1.2 gtable_0.3.3 rstatix_0.7.2 ## [94] sass_0.4.6 digest_0.6.33 pbkrtest_0.5.2 ## [97] TH.data_1.1-0 farver_2.1.1 memoise_2.0.1 ## [100] htmltools_0.5.5 lifecycle_1.0.3 httr_1.4.2 ## [103] MASS_7.3-60 "],["part-gdm-vs-uncomplicated.html", "(PART*) GDM vs Uncomplicated", " (PART*) GDM vs Uncomplicated "],["descriptives-4.html", "46 Descriptives", " 46 Descriptives Results in this section are from univariate analyses. Characteristic Uncomplicated (n=1292) GDM (n=251) Total (n=1543) P-value PRL (ng/ml): Mean (SD) 134.1 (155.0) 101.1 (94.7) 128.7 (147.3) &lt;0.0001 hPL (μg/ml): Mean (SD) 121.4 (76.6) 76.2 (52.6) 114.2 (75.1) &lt;0.0001 GH2 (ng/ml): Mean (SD) 3.0 (2.2) 1.9 (1.4) 2.8 (2.1) &lt;0.0001 Insulin (uU/ml): Mean (SD) 18.0 (20.5) 33.7 (43.9) 20.6 (26.6) &lt;0.0001 HOMA-IR: Mean (SD) 4.3 (5.5) 8.6 (14.2) 5.0 (7.8) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.1 (0.8) 5.2 (1.0) 5.1 (0.8) 0.13 Number of available samples Var Uncomplicated: Available N(%) GDM: Available N(%) PRL (ng/ml) 1101 (85.2%) 216 (86.1%) hPL (μg/ml) 1087 (84.1%) 206 (82.1%) GH2 (ng/ml) 1094 (84.7%) 205 (81.7%) Insulin (uU/ml) 1132 (87.6%) 227 (90.4%) HOMA-IR 1131 (87.5%) 226 (90.0%) Glucose (mmol/L) 1279 (99.0%) 250 (99.6%) "],["within-scope.html", "46.1 Within SCOPE", " 46.1 Within SCOPE 46.1.1 Hormones Characteristic Uncomplicated (n=598) GDM (n=58) Total (n=656) P-value PRL (ng/ml): Mean (SD) 184.4 (193.4) 118.8 (86.5) 180.6 (189.4) 0.001 hPL (μg/ml): Mean (SD) 188.4 (57.8) 116.5 (49.3) 184.4 (59.7) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.6 (2.0) 3.1 (2.0) 4.5 (2.0) 0.0009 Insulin (uU/ml): Mean (SD) 21.8 (23.0) 50.4 (55.0) 23.8 (27.5) 0.004 HOMA-IR: Mean (SD) 5.6 (6.8) 14.8 (18.7) 6.3 (8.5) 0.007 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 6.0 (1.1) 5.5 (0.8) 0.0004 46.1.2 Demographics Characteristic Uncomplicated (n=604) GDM (n=58) Total (n=662) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-26.0) 28.0 (25.0-32.0) 23.0 (20.0-27.0) &lt;0.0001 Maternal age (yrs): N(%) 0.38 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 591 (97.8) 56 (96.6) 647 (97.7) &gt;=35 13 (2.2) 2 (3.4) 15 (2.3) Maternal BMI: Median (IQ range) 25.1 (22.0-29.1) 30.6 (25.4-36.3) 25.3 (22.2-30.1) &lt;0.0001 Maternal BMI (category): N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 64 (10.6) 1 (1.7) 65 (9.8) &gt;=20 to &lt;25 228 (37.7) 13 (22.4) 241 (36.4) &gt;=25 to &lt;30 176 (29.1) 13 (22.4) 189 (28.5) &gt;=30 to &lt;40 117 (19.4) 24 (41.4) 141 (21.3) &gt;=40 19 (3.1) 7 (12.1) 26 (3.9) SEI: Median (IQ range) 24.0 (20.0-30.0) 27.0 (20.2-34.0) 24.0 (20.0-33.0) 0.15 Ethnicity: N(%) 0.36 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 555 (91.9) 51 (87.9) 606 (91.5) Maori 3 (0.5) 0 (0.0) 3 (0.5) Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0) South East and Far East 25 (4.1) 4 (6.9) 29 (4.4) Indian 2 (0.3) 1 (1.7) 3 (0.5) African 3 (0.5) 0 (0.0) 3 (0.5) Middle-eastern 4 (0.7) 0 (0.0) 4 (0.6) Hispanic 0 (0.0) 0 (0.0) 0 (0.0) Aboriginal 9 (1.5) 1 (1.7) 10 (1.5) China and Japan 0 (0.0) 0 (0.0) 0 (0.0) Other 3 (0.5) 1 (1.7) 4 (0.6) Smoking: N(%) 0.25 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 476 (78.8) 50 (86.2) 526 (79.5) Yes 128 (21.2) 8 (13.8) 136 (20.5) Folic acid supplement (μg): N(%) 0.07 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 122 (20.2) 9 (15.5) 131 (19.8) &lt;800 335 (55.5) 27 (46.6) 362 (54.7) &gt;=800 147 (24.3) 22 (37.9) 169 (25.5) Folic acid supplement (μg): N(%) 0.15 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 122 (20.2) 9 (15.5) 131 (19.8) &lt;=400 66 (10.9) 6 (10.3) 72 (10.9) &gt;400 to &lt;800 269 (44.5) 21 (36.2) 290 (43.8) &gt;=800 147 (24.3) 22 (37.9) 169 (25.5) Fruit (1st trim): N(%) 0.03 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 58 (9.6) 3 (5.2) 61 (9.2) 1-6x/week 222 (36.8) 19 (32.8) 241 (36.4) &gt;=1-&lt;3x/day 221 (36.6) 32 (55.2) 253 (38.2) &gt;=3x/day 103 (17.1) 4 (6.9) 107 (16.2) Leafy vege (1st trim): N(%) 0.07 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 60 (9.9) 3 (5.2) 63 (9.5) 1-2x/week 144 (23.8) 13 (22.4) 157 (23.7) 3-6x/week 220 (36.4) 31 (53.4) 251 (37.9) &gt;=1x/day 180 (29.8) 11 (19.0) 191 (28.9) Fast food (1st trim): N(%) 1.00 Missing 114 (18.9) 9 (15.5) 123 (18.6) Never 12 (2.0) 1 (1.7) 13 (2.0) &gt;0-&lt;2x/week 62 (10.3) 6 (10.3) 68 (10.3) &gt;=2-&lt;4x/week 249 (41.2) 25 (43.1) 274 (41.4) &gt;=4x/week 167 (27.6) 17 (29.3) 184 (27.8) Vigorous exercise: N(%) 0.29 Missing 3 (0.5) 0 (0.0) 3 (0.5) Never 390 (64.6) 38 (65.5) 428 (64.7) Once a week 148 (24.5) 19 (32.8) 167 (25.2) 2-3/wk 50 (8.3) 1 (1.7) 51 (7.7) 4-6/wk 7 (1.2) 0 (0.0) 7 (1.1) Daily 6 (1.0) 0 (0.0) 6 (0.9) More than once a day 0 (0.0) 0 (0.0) 0 (0.0) Moderate exercise: N(%) 0.39 Missing 3 (0.5) 0 (0.0) 3 (0.5) Never 248 (41.1) 30 (51.7) 278 (42.0) Once a week 146 (24.2) 16 (27.6) 162 (24.5) 2-3/wk 134 (22.2) 8 (13.8) 142 (21.5) 4-6/wk 36 (6.0) 1 (1.7) 37 (5.6) Daily 35 (5.8) 3 (5.2) 38 (5.7) More than once a day 2 (0.3) 0 (0.0) 2 (0.3) Recreational walking: N(%) 0.64 Missing 3 (0.5) 0 (0.0) 3 (0.5) Never 147 (24.3) 9 (15.5) 156 (23.6) Once a week 187 (31.0) 21 (36.2) 208 (31.4) 2-3/wk 161 (26.7) 17 (29.3) 178 (26.9) 4-6/wk 44 (7.3) 5 (8.6) 49 (7.4) Daily 52 (8.6) 6 (10.3) 58 (8.8) More than once a day 10 (1.7) 0 (0.0) 10 (1.5) Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.0) 40.1 (32.0-43.8) 36.8 (29.1-43.4) 0.09 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 4.1 (0.9) 4.5 (1.1) 0.002 B12 concentration (pM): Median (IQ range) 248.0 (195.5-316.0) 253.5 (194.2-333.0) 249.0 (195.0-316.5) 0.80 Folate:B12 ratio: Median (IQ range) 142.6 (104.0-207.4) 158.9 (116.5-210.2) 143.2 (105.3-208.5) 0.29 Active B12 concentration (pM): Mean (SD) 58.8 (23.4) 72.7 (26.4) 59.9 (23.9) 0.01 Folate:Active B12 ratio: Median (IQ range) 617.0 (458.5-931.9) 553.8 (424.7-660.3) 612.3 (452.1-926.2) 0.20 Vitamin D: Median (IQ range) 56.3 (40.2-76.1) 55.8 (44.6-72.0) 56.3 (40.7-75.8) 0.99 UIC (ug/L): Median (IQ range) 109.8 (66.5-164.3) 132.7 (68.3-167.0) 111.1 (66.6-164.5) 0.62 HCG (MoM): Median (IQ range) 1.1 (0.7-1.6) 1.0 (0.7-1.6) 1.0 (0.7-1.6) 0.59 PAPP-A (MoM): Median (IQ range) 1.1 (0.8-1.5) 0.9 (0.5-1.4) 1.1 (0.7-1.5) 0.09 Haemoglobin (g/L): Mean (SD) 128.3 (9.1) 130.9 (9.4) 128.5 (9.2) 0.04 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.04 46.1.3 MetS Characteristic Uncomplicated (n=604) GDM (n=58) Total (n=662) P-value MetS: N(%) &lt;0.0001 Missing 3 (0.5) 1 (1.7) 4 (0.6) No 525 (86.9) 29 (50.0) 554 (83.7) Yes 76 (12.6) 28 (48.3) 104 (15.7) MetS: number of criteria met: Median (IQ range) 1.0 (0.0-1.0) 2.0 (1.0-2.0) 1.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 86.0 (79.0-95.0) 97.0 (87.0-109.0) 86.0 (79.0-97.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.4 (0.9) 5.5 (0.9) 5.4 (0.9) 0.38 Triglyceride (mmol/L): Median (IQ range) 1.3 (1.1-1.6) 1.8 (1.6-2.4) 1.4 (1.1-1.7) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.8 (0.4) 1.6 (0.3) 1.8 (0.4) 0.003 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 6.0 (1.1) 5.5 (0.8) 0.0004 LDL (mmol/L): Mean (SD) 3.0 (0.7) 3.0 (0.8) 3.0 (0.7) 0.64 Systolic BP (mmHg): Mean (SD) 107.8 (9.3) 112.9 (12.0) 108.2 (9.7) 0.002 Diastolic BP (mmHg): Mean (SD) 63.4 (7.5) 68.6 (8.9) 63.9 (7.8) &lt;0.0001 MAP (mmHg): Mean (SD) 78.2 (7.1) 83.4 (8.9) 78.7 (7.4) &lt;0.0001 MetS criteria: Waist circumference: N(%) 0.04 Missing 0 (0.0) 1 (1.7) 1 (0.2) &lt;80 cm 168 (27.8) 8 (13.8) 176 (26.6) &gt;=80 cm 436 (72.2) 49 (84.5) 485 (73.3) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1.7 mmol/L 468 (77.5) 23 (39.7) 491 (74.2) &gt;=1.7 mmol/L 136 (22.5) 35 (60.3) 171 (25.8) MetS criteria: HDL: N(%) 0.04 Missing 0 (0.0) 0 (0.0) 0 (0.0) &gt;=1.3 mmol/L 554 (91.7) 48 (82.8) 602 (90.9) &lt;1.3 mmol/L 50 (8.3) 10 (17.2) 60 (9.1) MetS criteria: Glucose: N(%) 0.0005 Missing 3 (0.5) 1 (1.7) 4 (0.6) &lt;5.6 mmol/L 341 (56.5) 18 (31.0) 359 (54.2) &gt;=5.6 mmol/L 260 (43.0) 39 (67.2) 299 (45.2) MetS criteria: sBP: N(%) 0.02 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;130 mmHg 596 (98.7) 54 (93.1) 650 (98.2) &gt;=130 mmHg 8 (1.3) 4 (6.9) 12 (1.8) MetS criteria: dBP: N(%) 0.04 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;85 mmHg 602 (99.7) 56 (96.6) 658 (99.4) &gt;=85 mmHg 2 (0.3) 2 (3.4) 4 (0.6) MetS criteria: BP: N(%) 0.002 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;130/85 mmHg 595 (98.5) 53 (91.4) 648 (97.9) &gt;=130/85 mmHg 9 (1.5) 5 (8.6) 14 (2.1) CRP (mg/L): Median (IQ range) 4.3 (2.3-7.7) 7.8 (4.4-12.5) 4.5 (2.4-8.0) &lt;0.0001 46.1.4 Outcomes Characteristic Uncomplicated (n=604) GDM (n=58) Total (n=662) P-value Gestational age at birth (weeks): Median (IQ range) 40.3 (39.4-41.0) 38.9 (38.1-40.0) 40.1 (39.2-41.0) &lt;0.0001 Birthweight (g): Median (IQ range) 3542.5 (3290.0-3825.0) 3260.0 (2825.0-3728.8) 3530.0 (3264.2-3825.0) 0.0002 Birthweight centile: Mean (SD) 54.2 (25.1) 47.6 (31.9) 53.6 (25.8) 0.13 Baby sex: N(%) 0.92 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 291 (48.2) 27 (46.6) 318 (48.0) Female 313 (51.8) 31 (53.4) 344 (52.0) Mode of delivery: N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 361 (59.8) 19 (32.8) 380 (57.4) Operative vaginal 103 (17.1) 7 (12.1) 110 (16.6) Pre-labour LSCS 24 (4.0) 10 (17.2) 34 (5.1) LSCS in labour 116 (19.2) 22 (37.9) 138 (20.8) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["within-stop.html", "46.2 Within STOP", " 46.2 Within STOP 46.2.1 Hormones Characteristic Uncomplicated (n=694) GDM (n=193) Total (n=887) P-value PRL (ng/ml): Mean (SD) 101.3 (112.3) 98.5 (95.8) 100.7 (108.8) 0.74 hPL (μg/ml): Mean (SD) 76.7 (50.5) 70.4 (50.6) 75.4 (50.6) 0.14 GH2 (ng/ml): Mean (SD) 1.9 (1.5) 1.7 (1.2) 1.9 (1.5) 0.17 Insulin (uU/ml): Mean (SD) 15.4 (18.2) 30.6 (41.0) 18.8 (25.9) &lt;0.0001 HOMA-IR: Mean (SD) 3.4 (4.3) 7.5 (13.0) 4.3 (7.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 4.8 (0.6) 4.9 (0.8) 4.8 (0.7) 0.006 46.2.2 Demographics Characteristic Uncomplicated (n=711) GDM (n=198) Total (n=909) P-value Maternal age (yrs): Median (IQ range) 25.0 (22.0-29.0) 28.0 (24.0-31.0) 26.0 (22.0-29.0) &lt;0.0001 Maternal age (yrs): N(%) 0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 694 (97.6) 181 (91.4) 875 (96.3) &gt;=35 17 (2.4) 17 (8.6) 34 (3.7) Maternal BMI: Median (IQ range) 25.3 (22.4-29.5) 30.9 (24.6-37.6) 26.0 (22.6-31.3) &lt;0.0001 Maternal BMI (category): N(%) &lt;0.0001 Missing 1 (0.1) 0 (0.0) 1 (0.1) &lt;20 55 (7.7) 8 (4.0) 63 (6.9) &gt;=20 to &lt;25 278 (39.1) 47 (23.7) 325 (35.8) &gt;=25 to &lt;30 212 (29.8) 40 (20.2) 252 (27.7) &gt;=30 to &lt;40 136 (19.1) 68 (34.3) 204 (22.4) &gt;=40 29 (4.1) 35 (17.7) 64 (7.0) SEI: Median (IQ range) 29.0 (22.0-45.0) 28.5 (20.0-45.0) 29.0 (21.0-45.0) 0.94 Ethnicity: N(%) 0.0010 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 595 (83.7) 141 (71.2) 736 (81.0) Maori 0 (0.0) 1 (0.5) 1 (0.1) Pacific Islander 3 (0.4) 0 (0.0) 3 (0.3) South East and Far East 30 (4.2) 24 (12.1) 54 (5.9) Indian 27 (3.8) 17 (8.6) 44 (4.8) African 11 (1.5) 5 (2.5) 16 (1.8) Middle-eastern 18 (2.5) 4 (2.0) 22 (2.4) Hispanic 2 (0.3) 1 (0.5) 3 (0.3) Aboriginal 13 (1.8) 3 (1.5) 16 (1.8) China and Japan 10 (1.4) 2 (1.0) 12 (1.3) Other 2 (0.3) 0 (0.0) 2 (0.2) Smoking: N(%) 0.34 Missing 6 (0.8) 0 (0.0) 6 (0.7) No 602 (84.7) 163 (82.3) 765 (84.2) Yes 103 (14.5) 35 (17.7) 138 (15.2) Folic acid supplement (μg): N(%) 0.63 Missing 87 (12.2) 21 (10.6) 108 (11.9) None 49 (6.9) 13 (6.6) 62 (6.8) &lt;800 134 (18.8) 44 (22.2) 178 (19.6) &gt;=800 441 (62.0) 120 (60.6) 561 (61.7) Folic acid supplement (μg): N(%) 0.71 Missing 87 (12.2) 21 (10.6) 108 (11.9) None 49 (6.9) 13 (6.6) 62 (6.8) &lt;=400 7 (1.0) 3 (1.5) 10 (1.1) &gt;400 to &lt;800 127 (17.9) 41 (20.7) 168 (18.5) &gt;=800 441 (62.0) 120 (60.6) 561 (61.7) Fruit (1st trim): N(%) 0.14 Missing 11 (1.5) 3 (1.5) 14 (1.5) &lt;1-3x/month 47 (6.6) 16 (8.1) 63 (6.9) 1-6x/week 203 (28.6) 66 (33.3) 269 (29.6) &gt;=1-&lt;3x/day 349 (49.1) 96 (48.5) 445 (49.0) &gt;=3x/day 101 (14.2) 17 (8.6) 118 (13.0) Leafy vege (1st trim): N(%) 0.79 Missing 11 (1.5) 4 (2.0) 15 (1.7) &lt;1-3x/month 73 (10.3) 21 (10.6) 94 (10.3) 1-2x/week 159 (22.4) 42 (21.2) 201 (22.1) 3-6x/week 235 (33.1) 72 (36.4) 307 (33.8) &gt;=1x/day 233 (32.8) 59 (29.8) 292 (32.1) Fast food (1st trim): N(%) 0.22 Missing 93 (13.1) 24 (12.1) 117 (12.9) Never 30 (4.2) 11 (5.6) 41 (4.5) &gt;0-&lt;2x/week 118 (16.6) 34 (17.2) 152 (16.7) &gt;=2-&lt;4x/week 261 (36.7) 84 (42.4) 345 (38.0) &gt;=4x/week 209 (29.4) 45 (22.7) 254 (27.9) Vigorous exercise: N(%) 0.99 Missing 5 (0.7) 3 (1.5) 8 (0.9) Never 439 (61.7) 124 (62.6) 563 (61.9) Once a week 179 (25.2) 48 (24.2) 227 (25.0) 2-3/wk 63 (8.9) 16 (8.1) 79 (8.7) 4-6/wk 12 (1.7) 4 (2.0) 16 (1.8) Daily 12 (1.7) 3 (1.5) 15 (1.7) More than once a day 1 (0.1) 0 (0.0) 1 (0.1) Moderate exercise: N(%) 0.006 Missing 7 (1.0) 4 (2.0) 11 (1.2) Never 266 (37.4) 87 (43.9) 353 (38.8) Once a week 173 (24.3) 54 (27.3) 227 (25.0) 2-3/wk 156 (21.9) 42 (21.2) 198 (21.8) 4-6/wk 49 (6.9) 3 (1.5) 52 (5.7) Daily 48 (6.8) 6 (3.0) 54 (5.9) More than once a day 12 (1.7) 2 (1.0) 14 (1.5) Recreational walking: N(%) 0.15 Missing 8 (1.1) 3 (1.5) 11 (1.2) Never 158 (22.2) 33 (16.7) 191 (21.0) Once a week 233 (32.8) 81 (40.9) 314 (34.5) 2-3/wk 170 (23.9) 49 (24.7) 219 (24.1) 4-6/wk 53 (7.5) 12 (6.1) 65 (7.2) Daily 83 (11.7) 17 (8.6) 100 (11.0) More than once a day 6 (0.8) 3 (1.5) 9 (1.0) Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.2) 40.1 (35.5-45.2) 40.5 (36.3-45.2) 0.41 Homocysteine concentration (μM): Mean (SD) 5.0 (1.1) 4.8 (1.0) 4.9 (1.1) 0.03 B12 concentration (pM): Median (IQ range) 277.5 (219.0-355.0) 273.0 (217.5-348.5) 276.0 (219.0-354.0) 0.54 Folate:B12 ratio: Median (IQ range) 155.9 (115.7-222.4) 148.0 (112.4-225.9) 153.9 (115.0-222.5) 0.43 Active B12 concentration (pM): Mean (SD) 66.7 (24.7) 76.6 (26.1) 69.0 (25.3) 0.0007 Folate:Active B12 ratio: Median (IQ range) 670.7 (493.5-950.5) 531.9 (417.3-788.4) 634.4 (475.9-919.4) 0.0004 Vitamin D: Median (IQ range) 61.0 (45.0-76.0) 60.0 (44.5-77.5) 61.0 (45.0-76.0) 0.49 UIC (ug/L): Median (IQ range) 199.0 (127.1-320.1) 220.6 (139.0-344.1) 205.2 (127.6-324.8) 0.11 HCG (MoM): Median (IQ range) 1.0 (0.7-1.5) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 1.00 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.7-1.3) 1.0 (0.7-1.4) 0.26 Haemoglobin (g/L): Mean (SD) 130.8 (9.7) 132.2 (10.0) 131.1 (9.8) 0.09 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.02 Red cell folate (nmol/L): Mean (SD) 1417.2 (325.0) 1492.9 (307.2) 1433.8 (322.5) 0.004 46.2.3 MetS Characteristic Uncomplicated (n=711) GDM (n=198) Total (n=909) P-value MetS: N(%) &lt;0.0001 Missing 51 (7.2) 14 (7.1) 65 (7.2) No 624 (87.8) 144 (72.7) 768 (84.5) Yes 36 (5.1) 40 (20.2) 76 (8.4) MetS: number of criteria met: Median (IQ range) 0.0 (0.0-1.0) 0.0 (0.0-1.5) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 81.0 (74.0-89.0) 91.0 (78.0-107.5) 82.0 (75.0-93.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 4.6 (0.8) 4.7 (0.9) 4.6 (0.8) 0.27 Triglyceride (mmol/L): Median (IQ range) 1.1 (0.9-1.4) 1.2 (0.9-1.6) 1.1 (0.9-1.4) 0.001 HDL (mmol/L): Mean (SD) 1.7 (0.3) 1.5 (0.3) 1.6 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 4.8 (0.7) 4.9 (0.8) 4.8 (0.7) 0.008 LDL (mmol/L): Mean (SD) 2.4 (0.7) 2.6 (0.7) 2.5 (0.7) 0.001 Systolic BP (mmHg): Mean (SD) 113.9 (9.7) 118.8 (11.6) 115.0 (10.3) &lt;0.0001 Diastolic BP (mmHg): Mean (SD) 69.4 (8.2) 73.5 (9.9) 70.3 (8.7) &lt;0.0001 MAP (mmHg): Mean (SD) 84.2 (7.7) 88.6 (9.6) 85.2 (8.3) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 11 (1.5) 3 (1.5) 14 (1.5) &lt;80 cm 329 (46.3) 54 (27.3) 383 (42.1) &gt;=80 cm 371 (52.2) 141 (71.2) 512 (56.3) MetS criteria: Triglyceride: N(%) 0.0002 Missing 10 (1.4) 1 (0.5) 11 (1.2) &lt;1.7 mmol/L 627 (88.2) 156 (78.8) 783 (86.1) &gt;=1.7 mmol/L 74 (10.4) 41 (20.7) 115 (12.7) MetS criteria: HDL: N(%) 0.02 Missing 10 (1.4) 1 (0.5) 11 (1.2) &gt;=1.3 mmol/L 606 (85.2) 156 (78.8) 762 (83.8) &lt;1.3 mmol/L 95 (13.4) 41 (20.7) 136 (15.0) MetS criteria: Glucose: N(%) 0.09 Missing 10 (1.4) 1 (0.5) 11 (1.2) &lt;5.6 mmol/L 648 (91.1) 174 (87.9) 822 (90.4) &gt;=5.6 mmol/L 53 (7.5) 23 (11.6) 76 (8.4) MetS criteria: sBP: N(%) &lt;0.0001 Missing 33 (4.6) 11 (5.6) 44 (4.8) &lt;130 mmHg 634 (89.2) 155 (78.3) 789 (86.8) &gt;=130 mmHg 44 (6.2) 32 (16.2) 76 (8.4) MetS criteria: dBP: N(%) &lt;0.0001 Missing 33 (4.6) 11 (5.6) 44 (4.8) &lt;85 mmHg 654 (92.0) 162 (81.8) 816 (89.8) &gt;=85 mmHg 24 (3.4) 25 (12.6) 49 (5.4) MetS criteria: BP: N(%) &lt;0.0001 Missing 33 (4.6) 11 (5.6) 44 (4.8) &lt;130/85 mmHg 622 (87.5) 145 (73.2) 767 (84.4) &gt;=130/85 mmHg 56 (7.9) 42 (21.2) 98 (10.8) CRP (mg/L): Median (IQ range) 3.1 (1.3-6.0) 3.9 (2.1-8.1) 3.3 (1.4-6.5) 0.001 46.2.4 Outcomes Characteristic Uncomplicated (n=711) GDM (n=198) Total (n=909) P-value Gestational age at birth (weeks): Median (IQ range) 40.0 (39.1-40.9) 38.9 (38.1-39.7) 39.9 (38.9-40.6) &lt;0.0001 Birthweight (g): Median (IQ range) 3506.0 (3250.0-3786.0) 3350.0 (3020.0-3645.0) 3467.0 (3220.0-3761.5) &lt;0.0001 Birthweight centile: Mean (SD) 53.3 (26.1) 52.5 (30.3) 53.1 (27.1) 0.75 Baby sex: N(%) 1.00 Missing 0 (0.0) 1 (0.5) 1 (0.1) Male 356 (50.1) 98 (49.5) 454 (49.9) Female 355 (49.9) 99 (50.0) 454 (49.9) Mode of delivery: N(%) 0.01 Missing 0 (0.0) 1 (0.5) 1 (0.1) Unassisted vaginal 382 (53.7) 91 (46.0) 473 (52.0) Operative vaginal 147 (20.7) 34 (17.2) 181 (19.9) Pre-labour LSCS 35 (4.9) 19 (9.6) 54 (5.9) LSCS in labour 147 (20.7) 53 (26.8) 200 (22.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-gdm.html", "46.3 SCOPE vs STOP (GDM)", " 46.3 SCOPE vs STOP (GDM) 46.3.1 Hormones Characteristic SCOPE (n=58) STOP (n=193) Total (n=251) P-value PRL (ng/ml): Mean (SD) 118.8 (86.5) 98.5 (95.8) 101.1 (94.7) 0.27 hPL (μg/ml): Mean (SD) 116.5 (49.3) 70.4 (50.6) 76.2 (52.6) &lt;0.0001 GH2 (ng/ml): Mean (SD) 3.1 (2.0) 1.7 (1.2) 1.9 (1.4) 0.003 Insulin (uU/ml): Mean (SD) 50.4 (55.0) 30.6 (41.0) 33.7 (43.9) 0.05 HOMA-IR: Mean (SD) 14.8 (18.7) 7.5 (13.0) 8.6 (14.2) 0.04 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 46.3.2 Demographics Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Maternal age (yrs): Median (IQ range) 28.0 (25.0-32.0) 28.0 (24.0-31.0) 28.0 (24.0-32.0) 0.95 Maternal age (yrs): N(%) 0.26 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 56 (96.6) 181 (91.4) 237 (92.6) &gt;=35 2 (3.4) 17 (8.6) 19 (7.4) Maternal BMI: Median (IQ range) 30.6 (25.4-36.3) 30.9 (24.6-37.6) 30.6 (24.6-37.3) 0.85 Maternal BMI (category): N(%) 0.74 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 1 (1.7) 8 (4.0) 9 (3.5) &gt;=20 to &lt;25 13 (22.4) 47 (23.7) 60 (23.4) &gt;=25 to &lt;30 13 (22.4) 40 (20.2) 53 (20.7) &gt;=30 to &lt;40 24 (41.4) 68 (34.3) 92 (35.9) &gt;=40 7 (12.1) 35 (17.7) 42 (16.4) SEI: Median (IQ range) 27.0 (20.2-34.0) 28.5 (20.0-45.0) 28.0 (20.0-45.0) 0.19 Ethnicity: N(%) 0.19 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 51 (87.9) 141 (71.2) 192 (75.0) Maori 0 (0.0) 1 (0.5) 1 (0.4) Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0) South East and Far East 4 (6.9) 24 (12.1) 28 (10.9) Indian 1 (1.7) 17 (8.6) 18 (7.0) African 0 (0.0) 5 (2.5) 5 (2.0) Middle-eastern 0 (0.0) 4 (2.0) 4 (1.6) Hispanic 0 (0.0) 1 (0.5) 1 (0.4) Aboriginal 1 (1.7) 3 (1.5) 4 (1.6) China and Japan 0 (0.0) 2 (1.0) 2 (0.8) Other 1 (1.7) 0 (0.0) 1 (0.4) Smoking: N(%) 0.62 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 50 (86.2) 163 (82.3) 213 (83.2) Yes 8 (13.8) 35 (17.7) 43 (16.8) Folic acid supplement (μg): N(%) 0.0003 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;800 27 (46.6) 44 (22.2) 71 (27.7) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Folic acid supplement (μg): N(%) 0.0001 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;=400 6 (10.3) 3 (1.5) 9 (3.5) &gt;400 to &lt;800 21 (36.2) 41 (20.7) 62 (24.2) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Fruit (1st trim): N(%) 0.86 Missing 0 (0.0) 3 (1.5) 3 (1.2) &lt;1-3x/month 3 (5.2) 16 (8.1) 19 (7.4) 1-6x/week 19 (32.8) 66 (33.3) 85 (33.2) &gt;=1-&lt;3x/day 32 (55.2) 96 (48.5) 128 (50.0) &gt;=3x/day 4 (6.9) 17 (8.6) 21 (8.2) Leafy vege (1st trim): N(%) 0.10 Missing 0 (0.0) 4 (2.0) 4 (1.6) &lt;1-3x/month 3 (5.2) 21 (10.6) 24 (9.4) 1-2x/week 13 (22.4) 42 (21.2) 55 (21.5) 3-6x/week 31 (53.4) 72 (36.4) 103 (40.2) &gt;=1x/day 11 (19.0) 59 (29.8) 70 (27.3) Fast food (1st trim): N(%) 0.36 Missing 9 (15.5) 24 (12.1) 33 (12.9) Never 1 (1.7) 11 (5.6) 12 (4.7) &gt;0-&lt;2x/week 6 (10.3) 34 (17.2) 40 (15.6) &gt;=2-&lt;4x/week 25 (43.1) 84 (42.4) 109 (42.6) &gt;=4x/week 17 (29.3) 45 (22.7) 62 (24.2) Vigorous exercise: N(%) 0.25 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 38 (65.5) 124 (62.6) 162 (63.3) Once a week 19 (32.8) 48 (24.2) 67 (26.2) 2-3/wk 1 (1.7) 16 (8.1) 17 (6.6) 4-6/wk 0 (0.0) 4 (2.0) 4 (1.6) Daily 0 (0.0) 3 (1.5) 3 (1.2) More than once a day 0 (0.0) 0 (0.0) 0 (0.0) Moderate exercise: N(%) 0.68 Missing 0 (0.0) 4 (2.0) 4 (1.6) Never 30 (51.7) 87 (43.9) 117 (45.7) Once a week 16 (27.6) 54 (27.3) 70 (27.3) 2-3/wk 8 (13.8) 42 (21.2) 50 (19.5) 4-6/wk 1 (1.7) 3 (1.5) 4 (1.6) Daily 3 (5.2) 6 (3.0) 9 (3.5) More than once a day 0 (0.0) 2 (1.0) 2 (0.8) Recreational walking: N(%) 0.88 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 9 (15.5) 33 (16.7) 42 (16.4) Once a week 21 (36.2) 81 (40.9) 102 (39.8) 2-3/wk 17 (29.3) 49 (24.7) 66 (25.8) 4-6/wk 5 (8.6) 12 (6.1) 17 (6.6) Daily 6 (10.3) 17 (8.6) 23 (9.0) More than once a day 0 (0.0) 3 (1.5) 3 (1.2) Serum folate concentration (nM): Median (IQ range) 40.1 (32.0-43.8) 40.1 (35.5-45.2) 40.1 (35.0-44.8) 0.26 Homocysteine concentration (μM): Mean (SD) 4.1 (0.9) 4.8 (1.0) 4.7 (1.0) &lt;0.0001 B12 concentration (pM): Median (IQ range) 253.5 (194.2-333.0) 273.0 (217.5-348.5) 270.0 (215.0-345.5) 0.16 Folate:B12 ratio: Median (IQ range) 158.9 (116.5-210.2) 148.0 (112.4-225.9) 149.3 (113.3-220.0) 0.79 Active B12 concentration (pM): Mean (SD) 72.7 (26.4) 76.6 (26.1) 75.7 (26.1) 0.48 Folate:Active B12 ratio: Median (IQ range) 553.8 (424.7-660.3) 531.9 (417.3-788.4) 536.7 (418.1-784.2) 0.97 Vitamin D: Median (IQ range) 55.8 (44.6-72.0) 60.0 (44.5-77.5) 59.0 (44.3-75.1) 0.52 UIC (ug/L): Median (IQ range) 132.7 (68.3-167.0) 220.6 (139.0-344.1) 206.4 (124.8-323.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.1 (0.7-1.6) 1.0 (0.7-1.6) 0.92 PAPP-A (MoM): Median (IQ range) 0.9 (0.5-1.4) 0.9 (0.7-1.3) 0.9 (0.7-1.4) 0.53 Haemoglobin (g/L): Mean (SD) 130.9 (9.4) 132.2 (10.0) 131.9 (9.8) 0.38 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.07 46.3.3 MetS Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value MetS: N(%) 0.0001 Missing 1 (1.7) 14 (7.1) 15 (5.9) No 29 (50.0) 144 (72.7) 173 (67.6) Yes 28 (48.3) 40 (20.2) 68 (26.6) MetS: number of criteria met: Median (IQ range) 2.0 (1.0-2.0) 0.0 (0.0-1.5) 1.0 (0.0-2.0) &lt;0.0001 Waist (cm): Median (IQ range) 97.0 (87.0-109.0) 91.0 (78.0-107.5) 93.0 (80.0-108.0) 0.03 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.7 (0.9) 4.9 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.8 (1.6-2.4) 1.2 (0.9-1.6) 1.3 (1.0-1.8) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.6 (0.3) 1.5 (0.3) 1.6 (0.3) 0.09 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.8) 2.6 (0.7) 2.7 (0.7) 0.004 Systolic BP (mmHg): Mean (SD) 112.9 (12.0) 118.8 (11.6) 117.4 (11.9) 0.001 Diastolic BP (mmHg): Mean (SD) 68.6 (8.9) 73.5 (9.9) 72.3 (9.9) 0.0005 MAP (mmHg): Mean (SD) 83.4 (8.9) 88.6 (9.6) 87.4 (9.7) 0.0002 MetS criteria: Waist circumference: N(%) 0.05 Missing 1 (1.7) 3 (1.5) 4 (1.6) &lt;80 cm 8 (13.8) 54 (27.3) 62 (24.2) &gt;=80 cm 49 (84.5) 141 (71.2) 190 (74.2) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 1 (0.5) 1 (0.4) &lt;1.7 mmol/L 23 (39.7) 156 (78.8) 179 (69.9) &gt;=1.7 mmol/L 35 (60.3) 41 (20.7) 76 (29.7) MetS criteria: HDL: N(%) 0.68 Missing 0 (0.0) 1 (0.5) 1 (0.4) &gt;=1.3 mmol/L 48 (82.8) 156 (78.8) 204 (79.7) &lt;1.3 mmol/L 10 (17.2) 41 (20.7) 51 (19.9) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 1 (1.7) 1 (0.5) 2 (0.8) &lt;5.6 mmol/L 18 (31.0) 174 (87.9) 192 (75.0) &gt;=5.6 mmol/L 39 (67.2) 23 (11.6) 62 (24.2) MetS criteria: sBP: N(%) 0.06 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130 mmHg 54 (93.1) 155 (78.3) 209 (81.6) &gt;=130 mmHg 4 (6.9) 32 (16.2) 36 (14.1) MetS criteria: dBP: N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;85 mmHg 56 (96.6) 162 (81.8) 218 (85.2) &gt;=85 mmHg 2 (3.4) 25 (12.6) 27 (10.5) MetS criteria: BP: N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130/85 mmHg 53 (91.4) 145 (73.2) 198 (77.3) &gt;=130/85 mmHg 5 (8.6) 42 (21.2) 47 (18.4) CRP (mg/L): Median (IQ range) 7.8 (4.4-12.5) 3.9 (2.1-8.1) 4.5 (2.4-9.1) &lt;0.0001 46.3.4 Outcomes Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Gestational age at birth (weeks): Median (IQ range) 38.9 (38.1-40.0) 38.9 (38.1-39.7) 38.9 (38.1-39.9) 0.91 Birthweight (g): Median (IQ range) 3260.0 (2825.0-3728.8) 3350.0 (3020.0-3645.0) 3330.0 (2990.5-3650.0) 0.61 Birthweight centile: Mean (SD) 47.6 (31.9) 52.5 (30.3) 51.4 (30.7) 0.30 Baby sex: N(%) 0.78 Missing 0 (0.0) 1 (0.5) 1 (0.4) Male 27 (46.6) 98 (49.5) 125 (48.8) Female 31 (53.4) 99 (50.0) 130 (50.8) Mode of delivery: N(%) 0.08 Missing 0 (0.0) 1 (0.5) 1 (0.4) Unassisted vaginal 19 (32.8) 91 (46.0) 110 (43.0) Operative vaginal 7 (12.1) 34 (17.2) 41 (16.0) Pre-labour LSCS 10 (17.2) 19 (9.6) 29 (11.3) LSCS in labour 22 (37.9) 53 (26.8) 75 (29.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-uncomplicated.html", "46.4 SCOPE vs STOP (Uncomplicated)", " 46.4 SCOPE vs STOP (Uncomplicated) 46.4.1 Hormones Characteristic SCOPE (n=598) STOP (n=694) Total (n=1292) P-value PRL (ng/ml): Mean (SD) 184.4 (193.4) 101.3 (112.3) 134.1 (155.0) &lt;0.0001 hPL (μg/ml): Mean (SD) 188.4 (57.8) 76.7 (50.5) 121.4 (76.6) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.6 (2.0) 1.9 (1.5) 3.0 (2.2) &lt;0.0001 Insulin (uU/ml): Mean (SD) 21.8 (23.0) 15.4 (18.2) 18.0 (20.5) &lt;0.0001 HOMA-IR: Mean (SD) 5.6 (6.8) 3.4 (4.3) 4.3 (5.5) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.6) 5.1 (0.8) &lt;0.0001 46.4.2 Demographics Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-26.0) 25.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.92 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 591 (97.8) 694 (97.6) 1285 (97.7) &gt;=35 13 (2.2) 17 (2.4) 30 (2.3) Maternal BMI: Median (IQ range) 25.1 (22.0-29.1) 25.3 (22.4-29.5) 25.2 (22.2-29.4) 0.27 Maternal BMI (category): N(%) 0.41 Missing 0 (0.0) 1 (0.1) 1 (0.1) &lt;20 64 (10.6) 55 (7.7) 119 (9.0) &gt;=20 to &lt;25 228 (37.7) 278 (39.1) 506 (38.5) &gt;=25 to &lt;30 176 (29.1) 212 (29.8) 388 (29.5) &gt;=30 to &lt;40 117 (19.4) 136 (19.1) 253 (19.2) &gt;=40 19 (3.1) 29 (4.1) 48 (3.7) SEI: Median (IQ range) 24.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-36.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 555 (91.9) 595 (83.7) 1150 (87.5) Maori 3 (0.5) 0 (0.0) 3 (0.2) Pacific Islander 0 (0.0) 3 (0.4) 3 (0.2) South East and Far East 25 (4.1) 30 (4.2) 55 (4.2) Indian 2 (0.3) 27 (3.8) 29 (2.2) African 3 (0.5) 11 (1.5) 14 (1.1) Middle-eastern 4 (0.7) 18 (2.5) 22 (1.7) Hispanic 0 (0.0) 2 (0.3) 2 (0.2) Aboriginal 9 (1.5) 13 (1.8) 22 (1.7) China and Japan 0 (0.0) 10 (1.4) 10 (0.8) Other 3 (0.5) 2 (0.3) 5 (0.4) Smoking: N(%) 0.002 Missing 0 (0.0) 6 (0.8) 6 (0.5) No 476 (78.8) 602 (84.7) 1078 (82.0) Yes 128 (21.2) 103 (14.5) 231 (17.6) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;800 335 (55.5) 134 (18.8) 469 (35.7) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;=400 66 (10.9) 7 (1.0) 73 (5.6) &gt;400 to &lt;800 269 (44.5) 127 (17.9) 396 (30.1) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 58 (9.6) 47 (6.6) 105 (8.0) 1-6x/week 222 (36.8) 203 (28.6) 425 (32.3) &gt;=1-&lt;3x/day 221 (36.6) 349 (49.1) 570 (43.3) &gt;=3x/day 103 (17.1) 101 (14.2) 204 (15.5) Leafy vege (1st trim): N(%) 0.52 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 60 (9.9) 73 (10.3) 133 (10.1) 1-2x/week 144 (23.8) 159 (22.4) 303 (23.0) 3-6x/week 220 (36.4) 235 (33.1) 455 (34.6) &gt;=1x/day 180 (29.8) 233 (32.8) 413 (31.4) Fast food (1st trim): N(%) 0.001 Missing 114 (18.9) 93 (13.1) 207 (15.7) Never 12 (2.0) 30 (4.2) 42 (3.2) &gt;0-&lt;2x/week 62 (10.3) 118 (16.6) 180 (13.7) &gt;=2-&lt;4x/week 249 (41.2) 261 (36.7) 510 (38.8) &gt;=4x/week 167 (27.6) 209 (29.4) 376 (28.6) Vigorous exercise: N(%) 0.71 Missing 3 (0.5) 5 (0.7) 8 (0.6) Never 390 (64.6) 439 (61.7) 829 (63.0) Once a week 148 (24.5) 179 (25.2) 327 (24.9) 2-3/wk 50 (8.3) 63 (8.9) 113 (8.6) 4-6/wk 7 (1.2) 12 (1.7) 19 (1.4) Daily 6 (1.0) 12 (1.7) 18 (1.4) More than once a day 0 (0.0) 1 (0.1) 1 (0.1) Moderate exercise: N(%) 0.16 Missing 3 (0.5) 7 (1.0) 10 (0.8) Never 248 (41.1) 266 (37.4) 514 (39.1) Once a week 146 (24.2) 173 (24.3) 319 (24.3) 2-3/wk 134 (22.2) 156 (21.9) 290 (22.1) 4-6/wk 36 (6.0) 49 (6.9) 85 (6.5) Daily 35 (5.8) 48 (6.8) 83 (6.3) More than once a day 2 (0.3) 12 (1.7) 14 (1.1) Recreational walking: N(%) 0.24 Missing 3 (0.5) 8 (1.1) 11 (0.8) Never 147 (24.3) 158 (22.2) 305 (23.2) Once a week 187 (31.0) 233 (32.8) 420 (31.9) 2-3/wk 161 (26.7) 170 (23.9) 331 (25.2) 4-6/wk 44 (7.3) 53 (7.5) 97 (7.4) Daily 52 (8.6) 83 (11.7) 135 (10.3) More than once a day 10 (1.7) 6 (0.8) 16 (1.2) Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.0) 40.5 (36.4-45.2) 39.2 (33.8-44.2) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 248.0 (195.5-316.0) 277.5 (219.0-355.0) 262.0 (206.0-339.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.6 (104.0-207.4) 155.9 (115.7-222.4) 150.5 (109.3-217.2) 0.0006 Active B12 concentration (pM): Mean (SD) 58.8 (23.4) 66.7 (24.7) 62.9 (24.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 617.0 (458.5-931.9) 670.7 (493.5-950.5) 634.4 (480.9-941.9) 0.05 Vitamin D: Median (IQ range) 56.3 (40.2-76.1) 61.0 (45.0-76.0) 59.3 (43.0-76.0) 0.02 UIC (ug/L): Median (IQ range) 109.8 (66.5-164.3) 199.0 (127.1-320.1) 156.1 (93.2-257.5) &lt;0.0001 HCG (MoM): Median (IQ range) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.6) 0.26 PAPP-A (MoM): Median (IQ range) 1.1 (0.8-1.5) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.07 Haemoglobin (g/L): Mean (SD) 128.3 (9.1) 130.8 (9.7) 129.7 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 46.4.3 MetS Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value MetS: N(%) &lt;0.0001 Missing 3 (0.5) 51 (7.2) 54 (4.1) No 525 (86.9) 624 (87.8) 1149 (87.4) Yes 76 (12.6) 36 (5.1) 112 (8.5) MetS: number of criteria met: Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 86.0 (79.0-95.0) 81.0 (74.0-89.0) 83.0 (76.0-93.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.4 (0.9) 4.6 (0.8) 5.0 (0.9) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.3 (1.1-1.6) 1.1 (0.9-1.4) 1.2 (0.9-1.5) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.8 (0.4) 1.7 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.7) 2.4 (0.7) 2.7 (0.8) &lt;0.0001 Systolic BP (mmHg): Mean (SD) 107.8 (9.3) 113.9 (9.7) 111.0 (10.0) &lt;0.0001 Diastolic BP (mmHg): Mean (SD) 63.4 (7.5) 69.4 (8.2) 66.6 (8.4) &lt;0.0001 MAP (mmHg): Mean (SD) 78.2 (7.1) 84.2 (7.7) 81.4 (8.0) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;80 cm 168 (27.8) 329 (46.3) 497 (37.8) &gt;=80 cm 436 (72.2) 371 (52.2) 807 (61.4) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 10 (1.4) 10 (0.8) &lt;1.7 mmol/L 468 (77.5) 627 (88.2) 1095 (83.3) &gt;=1.7 mmol/L 136 (22.5) 74 (10.4) 210 (16.0) MetS criteria: HDL: N(%) 0.003 Missing 0 (0.0) 10 (1.4) 10 (0.8) &gt;=1.3 mmol/L 554 (91.7) 606 (85.2) 1160 (88.2) &lt;1.3 mmol/L 50 (8.3) 95 (13.4) 145 (11.0) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 3 (0.5) 10 (1.4) 13 (1.0) &lt;5.6 mmol/L 341 (56.5) 648 (91.1) 989 (75.2) &gt;=5.6 mmol/L 260 (43.0) 53 (7.5) 313 (23.8) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;130 mmHg 596 (98.7) 634 (89.2) 1230 (93.5) &gt;=130 mmHg 8 (1.3) 44 (6.2) 52 (4.0) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;85 mmHg 602 (99.7) 654 (92.0) 1256 (95.5) &gt;=85 mmHg 2 (0.3) 24 (3.4) 26 (2.0) MetS criteria: BP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;130/85 mmHg 595 (98.5) 622 (87.5) 1217 (92.5) &gt;=130/85 mmHg 9 (1.5) 56 (7.9) 65 (4.9) CRP (mg/L): Median (IQ range) 4.3 (2.3-7.7) 3.1 (1.3-6.0) 3.6 (1.7-6.9) &lt;0.0001 46.4.4 Outcomes Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Gestational age at birth (weeks): Median (IQ range) 40.3 (39.4-41.0) 40.0 (39.1-40.9) 40.1 (39.3-40.9) 0.010 Birthweight (g): Median (IQ range) 3542.5 (3290.0-3825.0) 3506.0 (3250.0-3786.0) 3526.0 (3270.0-3810.0) 0.03 Birthweight centile: Mean (SD) 54.2 (25.1) 53.3 (26.1) 53.7 (25.7) 0.52 Baby sex: N(%) 0.53 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 291 (48.2) 356 (50.1) 647 (49.2) Female 313 (51.8) 355 (49.9) 668 (50.8) Mode of delivery: N(%) 0.15 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 361 (59.8) 382 (53.7) 743 (56.5) Operative vaginal 103 (17.1) 147 (20.7) 250 (19.0) Pre-labour LSCS 24 (4.0) 35 (4.9) 59 (4.5) LSCS in labour 116 (19.2) 147 (20.7) 263 (20.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["folate-vs-fa-supplement-4.html", "47 Folate vs FA supplement", " 47 Folate vs FA supplement Within Uncomplicated Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 36.5 (29.7-42.0) 39.0 (32.7-44.4) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.8 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 255.0 (193.8-338.5) 254.5 (200.0-332.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 56.7 (21.6) 60.4 (23.7) 66.9 (25.0) 62.9 (24.5) 0.0009 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 141.7 (108.7-186.1) 152.4 (111.9-234.0) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 563.0 (487.9-894.8) 649.1 (483.2-1041.9) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.001 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 49.0 (35.7-69.0) 58.8 (42.1-76.4) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Within GDM Characteristic None (n=22) &lt;=400 (n=9) &gt;400 to &lt;800 (n=62) &gt;=800 (n=142) Total (n=235) P-value Serum folate concentration (nM): Median (IQ range) 30.4 (26.5-40.2) 41.3 (36.3-54.4) 39.8 (33.8-44.0) 41.2 (37.9-58.0) 40.7 (35.9-45.2) 0.0002 Homocysteine concentration (μM): Mean (SD) 4.6 (1.0) 4.1 (0.9) 4.6 (1.0) 4.6 (0.9) 4.6 (1.0) 0.43 B12 concentration (pM): Median (IQ range) 260.5 (175.2-314.0) 268.0 (222.0-292.0) 268.5 (218.0-303.5) 278.0 (220.0-353.0) 271.5 (216.8-345.8) 0.55 Active B12 concentration (pM): Mean (SD) 65.2 (22.4) 80.3 (35.3) 84.4 (26.1) 74.1 (24.1) 76.4 (25.5) 0.09 Folate:B12 ratio: Median (IQ range) 123.5 (80.3-170.6) 162.4 (135.4-220.6) 153.1 (112.8-215.4) 160.1 (117.5-256.9) 150.7 (116.1-227.3) 0.10 Folate:Active B12 ratio: Median (IQ range) 510.1 (409.2-591.5) 715.7 (399.3-826.4) 524.9 (427.0-593.3) 565.1 (429.3-895.6) 539.5 (424.7-784.2) 0.30 Vitamin D: Median (IQ range) 45.4 (29.4-69.3) 68.6 (44.3-74.0) 57.6 (45.2-72.7) 61.0 (46.8-76.5) 59.0 (44.5-75.2) 0.23 Click here for table within SCOPE Within Uncomplicated Characteristic None (n=122) &lt;=400 (n=66) &gt;400 to &lt;800 (n=269) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 35.6 (28.9-41.6) 38.4 (30.4-44.2) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 251.0 (192.5-338.0) 252.0 (198.0-318.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.01 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 55.3 (21.3) 59.9 (23.2) 65.1 (26.7) 58.8 (23.4) 0.001 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 131.6 (107.4-184.5) 146.9 (107.8-228.4) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 563.0 (507.4-920.2) 629.2 (483.2-997.7) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.06 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 47.1 (35.5-62.8) 55.6 (40.0-75.8) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Within GDM Characteristic None (n=9) &lt;=400 (n=6) &gt;400 to &lt;800 (n=21) &gt;=800 (n=22) Total (n=58) P-value Serum folate concentration (nM): Median (IQ range) 26.7 (21.7-29.6) 36.8 (32.7-40.3) 41.5 (32.6-43.7) 42.5 (38.4-65.4) 40.1 (32.0-43.8) 0.002 Homocysteine concentration (μM): Mean (SD) 4.3 (1.1) 3.7 (0.7) 4.2 (0.9) 4.1 (0.8) 4.1 (0.9) 0.52 B12 concentration (pM): Median (IQ range) 200.5 (171.8-265.5) 280.0 (259.8-348.2) 271.5 (228.5-333.0) 237.5 (192.0-342.8) 253.5 (194.2-333.0) 0.25 Active B12 concentration (pM): Mean (SD) 66.6 (22.5) 102.7 (39.7) 68.4 (21.1) 71.7 (27.1) 72.7 (26.4) 0.22 Folate:B12 ratio: Median (IQ range) 125.3 (68.1-178.3) 138.4 (125.8-157.2) 144.0 (111.7-170.7) 210.6 (147.3-391.7) 158.9 (116.5-210.2) 0.03 Folate:Active B12 ratio: Median (IQ range) 447.5 (321.0-553.6) 320.2 (289.2-478.5) 558.4 (516.5-660.3) 674.9 (540.9-1118.7) 553.8 (424.7-660.3) 0.12 Vitamin D: Median (IQ range) 45.4 (29.8-79.0) 56.5 (33.3-70.7) 51.7 (45.9-68.3) 65.5 (51.4-75.2) 55.8 (44.6-72.0) 0.27 Click here for table within STOP Within Uncomplicated Characteristic None (n=49) &lt;=400 (n=7) &gt;400 to &lt;800 (n=127) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 42.1 (36.6-56.3) 39.8 (35.4-44.5) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.006 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.1 (1.1) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 261.0 (203.5-315.5) 260.0 (205.0-346.5) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.12 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 68.0 (23.3) 61.8 (25.3) 67.6 (24.4) 67.4 (25.0) 0.09 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 180.2 (165.0-201.9) 168.0 (116.3-248.2) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.52 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 550.8 (476.6-682.4) 805.2 (504.9-1155.7) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.08 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 76.0 (63.5-104.0) 63.0 (49.0-78.5) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 Within GDM Characteristic None (n=13) &lt;=400 (n=3) &gt;400 to &lt;800 (n=41) &gt;=800 (n=120) Total (n=177) P-value Serum folate concentration (nM): Median (IQ range) 35.6 (30.1-42.0) 54.4 (49.5-57.2) 39.4 (34.6-44.5) 41.1 (37.5-56.3) 40.7 (36.1-53.6) 0.02 Homocysteine concentration (μM): Mean (SD) 4.7 (0.9) 4.9 (0.8) 4.8 (1.1) 4.7 (0.9) 4.7 (1.0) 0.96 B12 concentration (pM): Median (IQ range) 279.0 (243.8-381.5) 182.0 (181.0-227.0) 268.5 (218.0-284.2) 285.0 (224.0-358.5) 275.5 (221.2-348.8) 0.20 Active B12 concentration (pM): Mean (SD) 63.4 (24.8) 58.0 (6.2) 90.2 (25.6) 74.5 (23.8) 77.6 (25.2) 0.01 Folate:B12 ratio: Median (IQ range) 123.5 (102.6-144.2) 244.5 (232.5-273.4) 162.0 (116.1-254.6) 150.2 (116.3-228.4) 150.6 (116.1-231.2) 0.09 Folate:Active B12 ratio: Median (IQ range) 633.8 (487.5-645.7) 836.9 (815.8-984.5) 512.7 (419.6-590.5) 542.1 (424.7-838.0) 534.2 (427.0-788.4) 0.13 Vitamin D: Median (IQ range) 45.0 (29.0-54.8) 89.0 (77.0-107.5) 59.0 (45.0-79.0) 60.5 (46.0-77.5) 60.0 (44.8-78.0) 0.07 "],["folate-6.html", "47.1 Folate", " 47.1 Folate 47.1.1 FA supp (4 categories) 47.1.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.1399572 0.0855977 36.6827453 &lt;0.0001 *** folate_cat3&lt;=400 0.3208489 0.0761262 4.2146996 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4278112 0.0544222 7.8609650 &lt;0.0001 *** folate_cat3&gt;=800 0.4835980 0.0606742 7.9704096 &lt;0.0001 *** GDM_newGDM -0.0397839 0.1721949 -0.2310397 0.82 ns StudySTOP 0.4921357 0.0816951 6.0240567 &lt;0.0001 *** f1_age 0.0112472 0.0026639 4.2220630 &lt;0.0001 *** BMI -0.0057626 0.0020148 -2.8601916 0.004 ** folate_cat3&lt;=400:StudySTOP -0.2268403 0.2045541 -1.1089498 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4154404 0.0966373 -4.2989640 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3624643 0.0935050 -3.8764160 0.0001 *** GDM_newGDM:StudySTOP -0.1610481 0.2292030 -0.7026438 0.48 ns folate_cat3&lt;=400:GDM_newGDM 0.0538187 0.2649672 0.2031146 0.84 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.0774336 0.2104068 0.3680183 0.71 ns folate_cat3&gt;=800:GDM_newGDM 0.2060160 0.2085974 0.9876249 0.32 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.2222605 0.4449148 0.4995575 0.62 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP 0.1121351 0.2730231 0.4107164 0.68 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.0024625 0.2623842 -0.0093852 0.99 ns 47.1.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 26.20464 1.202445 1365 23.94885 28.67290 &lt;=400 Uncomplicated SCOPE 36.11778 2.212519 1365 32.02813 40.72965 &gt;400 to &lt;800 Uncomplicated SCOPE 40.19520 1.235041 1365 37.84399 42.69249 &gt;=800 Uncomplicated SCOPE 42.50129 1.694192 1365 39.30441 45.95819 None GDM SCOPE 25.18258 4.184828 1365 18.17701 34.88816 &lt;=400 GDM SCOPE 36.62826 7.034441 1365 25.13034 53.38685 &gt;400 to &lt;800 GDM SCOPE 41.73739 4.907584 1365 33.13982 52.56546 &gt;=800 GDM SCOPE 50.18753 5.598147 1365 40.32410 62.46360 None Uncomplicated STOP 42.86571 2.909471 1365 37.52185 48.97064 &lt;=400 Uncomplicated STOP 47.09095 8.354940 1365 33.24927 66.69493 &gt;400 to &lt;800 Uncomplicated STOP 43.39928 1.839161 1365 39.93729 47.16138 &gt;=800 Uncomplicated STOP 48.38578 1.092631 1365 46.28914 50.57738 None GDM STOP 35.06629 4.757825 1365 26.87172 45.75980 &lt;=400 GDM STOP 50.77114 13.801248 1365 29.78704 86.53794 &gt;400 to &lt;800 GDM STOP 42.91321 3.235427 1365 37.01331 49.75354 &gt;=800 GDM STOP 48.51764 2.153078 1365 44.47257 52.93064 47.1.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.05 (0.89, 1.22) 0.6 GDM / Uncomplicated STOP 0.97 (0.80, 1.16) 0.7 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.27 (1.14, 1.42) &lt;0.0001 STOP / SCOPE GDM 1.18 (0.95, 1.46) 0.1 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.23 (0.95, 1.60) 0.2 &gt;400 to &lt;800 / None Uncomplicated 1.25 (1.10, 1.41) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.01 (0.79, 1.30) 1.0 &gt;=800 / None Uncomplicated 1.35 (1.20, 1.53) &lt;0.0001 &gt;=800 / &lt;=400 Uncomplicated 1.10 (0.86, 1.41) 0.8 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.09 (0.99, 1.19) 0.08 &lt;=400 / None GDM 1.45 (0.87, 2.42) 0.2 &gt;400 to &lt;800 / None GDM 1.42 (1.03, 1.98) 0.03 &gt;400 to &lt;800 / &lt;=400 GDM 0.98 (0.62, 1.56) 1.0 &gt;=800 / None GDM 1.66 (1.21, 2.28) 0.0002 &gt;=800 / &lt;=400 GDM 1.14 (0.73, 1.80) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.17 (0.92, 1.48) 0.3 "],["b12-6.html", "47.2 B12", " 47.2 B12 47.2.1 FA supp (4 categories) 47.2.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4116552 0.0697337 77.6046002 &lt;0.0001 *** folate_cat3&lt;=400 0.1120120 0.0620416 1.8054332 0.07 ns folate_cat3&gt;400 to &lt;800 0.1126241 0.0443532 2.5392534 0.01 * folate_cat3&gt;=800 0.1220442 0.0494484 2.4681099 0.01 * GDM_newGDM 0.0044797 0.1403359 0.0319213 0.97 ns StudySTOP 0.1721404 0.0665802 2.5854604 0.010 ** f1_age 0.0105511 0.0021709 4.8602930 &lt;0.0001 *** BMI -0.0093831 0.0016412 -5.7171869 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.1900321 0.1667084 -1.1399074 0.25 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1590529 0.0787579 -2.0195174 0.04 * folate_cat3&gt;=800:StudySTOP -0.0712129 0.0762051 -0.9344900 0.35 ns GDM_newGDM:StudySTOP 0.0374712 0.1867968 0.2005987 0.84 ns folate_cat3&lt;=400:GDM_newGDM 0.1084600 0.2159441 0.5022598 0.62 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.1056298 0.1714782 0.6159955 0.54 ns folate_cat3&gt;=800:GDM_newGDM -0.1997495 0.1700035 -1.1749724 0.24 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP -0.3352256 0.3625985 -0.9245089 0.36 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP -0.1461003 0.2225095 -0.6566023 0.51 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP 0.1628004 0.2138174 0.7613993 0.45 ns 47.2.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 226.2103 8.459507 1366 210.2094 243.4292 &lt;=400 Uncomplicated SCOPE 253.0222 12.631972 1366 229.4168 279.0564 &gt;400 to &lt;800 Uncomplicated SCOPE 253.1771 6.339766 1366 241.0409 265.9244 &gt;=800 Uncomplicated SCOPE 255.5733 8.302739 1366 239.7940 272.3910 None GDM SCOPE 227.2260 30.774075 1366 174.2105 296.3750 &lt;=400 GDM SCOPE 283.2747 44.337362 1366 208.3828 385.0823 &gt;400 to &lt;800 GDM SCOPE 282.6470 27.085473 1366 234.2088 341.1031 &gt;=800 GDM SCOPE 210.2379 19.112046 1366 175.8986 251.2810 None Uncomplicated STOP 268.7027 14.863538 1366 241.0712 299.5014 &lt;=400 Uncomplicated STOP 248.5355 35.937115 1366 187.1541 330.0483 &gt;400 to &lt;800 Uncomplicated STOP 256.5124 8.859134 1366 239.7090 274.4936 &gt;=800 Uncomplicated STOP 282.7143 5.202929 1366 272.6898 293.1074 None GDM STOP 280.2148 30.985543 1366 225.5712 348.0957 &lt;=400 GDM STOP 206.5972 45.769284 1366 133.7775 319.0552 &gt;400 to &lt;800 GDM STOP 256.8924 15.784764 1366 227.7208 289.8009 &gt;=800 GDM STOP 284.1320 10.228097 1366 264.7596 304.9219 47.2.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.01 (0.89, 1.14) 0.9 GDM / Uncomplicated STOP 0.97 (0.83, 1.12) 0.7 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.07 (0.98, 1.17) 0.1 STOP / SCOPE GDM 1.03 (0.86, 1.22) 0.8 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.02 (0.82, 1.26) 1.0 &gt;400 to &lt;800 / None Uncomplicated 1.03 (0.93, 1.14) 0.8 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.02 (0.83, 1.25) 1.0 &gt;=800 / None Uncomplicated 1.09 (0.99, 1.20) 0.1 &gt;=800 / &lt;=400 Uncomplicated 1.07 (0.88, 1.31) 0.8 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.05 (0.98, 1.13) 0.2 &lt;=400 / None GDM 0.96 (0.63, 1.45) 1.0 &gt;400 to &lt;800 / None GDM 1.07 (0.82, 1.40) 0.9 &gt;400 to &lt;800 / &lt;=400 GDM 1.11 (0.76, 1.63) 0.9 &gt;=800 / None GDM 0.97 (0.75, 1.25) 1.0 &gt;=800 / &lt;=400 GDM 1.01 (0.70, 1.46) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.91 (0.75, 1.10) 0.6 "],["homocysteine-6.html", "47.3 Homocysteine", " 47.3 Homocysteine 47.3.1 FA supp (4 categories) 47.3.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5903682 0.0401107 39.6495138 &lt;0.0001 *** folate_cat3&lt;=400 -0.1267169 0.0356823 -3.5512578 0.0004 *** folate_cat3&gt;400 to &lt;800 -0.1120650 0.0255091 -4.3931472 &lt;0.0001 *** folate_cat3&gt;=800 -0.1618704 0.0284397 -5.6917114 &lt;0.0001 *** GDM_newGDM -0.1555095 0.0807119 -1.9267223 0.05 ns StudySTOP 0.0302688 0.0382927 0.7904602 0.43 ns f1_age 0.0003975 0.0012492 0.3181905 0.75 ns BMI -0.0001537 0.0009451 -0.1626695 0.87 ns folate_cat3&lt;=400:StudySTOP 0.1176184 0.0958795 1.2267310 0.22 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.1273798 0.0452963 2.8121475 0.005 ** folate_cat3&gt;=800:StudySTOP 0.0861223 0.0438326 1.9648008 0.05 * GDM_newGDM:StudySTOP 0.0614192 0.1074330 0.5716978 0.57 ns folate_cat3&lt;=400:GDM_newGDM -0.0267895 0.1241967 -0.2157024 0.83 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.0958406 0.0986228 0.9717896 0.33 ns folate_cat3&gt;=800:GDM_newGDM 0.1055810 0.0977747 1.0798393 0.28 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.0758389 0.2085424 0.3636619 0.72 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP -0.0982402 0.1279726 -0.7676657 0.44 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.0322823 0.1229762 -0.2625089 0.79 ns 47.3.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 4.934164 0.1061282 1364 4.730303 5.146811 &lt;=400 Uncomplicated SCOPE 4.346914 0.1248138 1364 4.108835 4.598789 &gt;400 to &lt;800 Uncomplicated SCOPE 4.411074 0.0635298 1364 4.288191 4.537478 &gt;=800 Uncomplicated SCOPE 4.196760 0.0784123 1364 4.045723 4.353436 None GDM SCOPE 4.223541 0.3289847 1364 3.625059 4.920829 &lt;=400 GDM SCOPE 3.622511 0.3260914 1364 3.036114 4.322164 &gt;400 to &lt;800 GDM SCOPE 4.155569 0.2290313 1364 3.729713 4.630049 &gt;=800 GDM SCOPE 3.992367 0.2087343 1364 3.603191 4.423578 None Uncomplicated STOP 5.085799 0.1617990 1364 4.778098 5.413314 &lt;=400 Uncomplicated STOP 5.039735 0.4191122 1364 4.281122 5.932774 &gt;400 to &lt;800 Uncomplicated STOP 5.164286 0.1025783 1364 4.966928 5.369486 &gt;=800 Uncomplicated STOP 4.714788 0.0500265 1364 4.617665 4.813954 None GDM STOP 4.629097 0.2943973 1364 4.086149 5.244189 &lt;=400 GDM STOP 4.817777 0.6138537 1364 3.752279 6.185834 &gt;400 to &lt;800 GDM STOP 4.689270 0.1657206 1364 4.375188 5.025899 &gt;=800 GDM STOP 4.617772 0.0956053 1364 4.433980 4.809183 47.3.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 0.89 (0.83, 0.96) 0.003 GDM / Uncomplicated STOP 0.94 (0.86, 1.02) 0.1 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.12 (1.07, 1.18) &lt;0.0001 STOP / SCOPE GDM 1.17 (1.06, 1.30) 0.002 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 0.93 (0.83, 1.06) 0.5 &gt;400 to &lt;800 / None Uncomplicated 0.95 (0.90, 1.01) 0.1 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.02 (0.91, 1.15) 1.0 &gt;=800 / None Uncomplicated 0.89 (0.84, 0.94) &lt;0.0001 &gt;=800 / &lt;=400 Uncomplicated 0.95 (0.85, 1.07) 0.7 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 0.93 (0.89, 0.97) &lt;0.0001 &lt;=400 / None GDM 0.94 (0.74, 1.20) 0.9 &gt;400 to &lt;800 / None GDM 1.00 (0.86, 1.16) 1.0 &gt;400 to &lt;800 / &lt;=400 GDM 1.06 (0.85, 1.31) 0.9 &gt;=800 / None GDM 0.97 (0.84, 1.13) 1.0 &gt;=800 / &lt;=400 GDM 1.03 (0.83, 1.27) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.97 (0.87, 1.09) 0.9 "],["active-b12-6.html", "47.4 Active B12", " 47.4 Active B12 47.4.1 FA supp (4 categories) 47.4.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6233607 0.0937463 38.6506907 &lt;0.0001 *** folate_cat3&lt;=400 0.0766874 0.0825455 0.9290314 0.35 ns folate_cat3&gt;400 to &lt;800 0.1511533 0.0566633 2.6675710 0.008 ** folate_cat3&gt;=800 0.2172425 0.0623839 3.4823484 0.0005 *** GDM_newGDM 0.2765502 0.1518351 1.8213850 0.07 ns StudySTOP 0.4289330 0.0906163 4.7335061 &lt;0.0001 *** f1_age 0.0071521 0.0030595 2.3376384 0.02 * BMI 0.0029547 0.0022062 1.3392607 0.18 ns folate_cat3&lt;=400:StudySTOP -0.2181906 0.2225446 -0.9804356 0.33 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4324177 0.1103958 -3.9169775 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3895496 0.1034255 -3.7664740 0.0002 *** GDM_newGDM:StudySTOP -0.5422062 0.2421764 -2.2388890 0.03 * folate_cat3&lt;=400:GDM_newGDM 0.3072266 0.2769116 1.1094753 0.27 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM -0.1724478 0.2011184 -0.8574437 0.39 ns folate_cat3&gt;=800:GDM_newGDM -0.2463271 0.1998625 -1.2324827 0.22 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP -0.2266852 0.4442534 -0.5102610 0.61 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP 0.8406211 0.2913885 2.8848813 0.004 ** folate_cat3&gt;=800:GDM_newGDM:StudySTOP 0.5925950 0.2813713 2.1060964 0.04 * 47.4.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 48.60880 2.249452 714 44.38715 53.23197 &lt;=400 Uncomplicated SCOPE 52.48314 3.621908 714 45.83296 60.09824 &gt;400 to &lt;800 Uncomplicated SCOPE 56.54054 1.920890 714 52.89229 60.44042 &gt;=800 Uncomplicated SCOPE 60.40350 2.550434 714 55.59818 65.62414 None GDM SCOPE 64.09426 9.283304 714 48.23066 85.17557 &lt;=400 GDM SCOPE 94.09160 20.798071 714 60.96509 145.21802 &gt;400 to &lt;800 GDM SCOPE 62.74383 8.038391 714 48.79043 80.68772 &gt;=800 GDM SCOPE 62.25695 7.682712 714 48.86168 79.32449 None Uncomplicated STOP 74.64456 5.855827 714 63.98946 87.07387 &lt;=400 Uncomplicated STOP 64.79538 12.403687 714 44.49622 94.35502 &gt;400 to &lt;800 Uncomplicated STOP 56.34385 2.993251 714 50.76331 62.53788 &gt;=800 Uncomplicated STOP 62.82986 1.652831 714 59.66725 66.16011 None GDM STOP 57.23020 9.828922 714 40.84967 80.17924 &lt;=400 GDM STOP 53.84555 11.961786 714 34.81243 83.28471 &gt;400 to &lt;800 GDM STOP 84.26702 6.512383 714 72.40404 98.07368 &gt;=800 GDM STOP 68.10445 3.467001 714 61.62681 75.26295 47.4.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.28 (1.09, 1.51) 0.003 GDM / Uncomplicated STOP 1.01 (0.84, 1.21) 0.9 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.18 (1.05, 1.33) 0.005 STOP / SCOPE GDM 0.93 (0.75, 1.15) 0.5 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 0.97 (0.73, 1.29) 1.0 &gt;400 to &lt;800 / None Uncomplicated 0.94 (0.81, 1.08) 0.6 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 0.97 (0.74, 1.27) 1.0 &gt;=800 / None Uncomplicated 1.02 (0.89, 1.17) 1.0 &gt;=800 / &lt;=400 Uncomplicated 1.06 (0.81, 1.38) 1.0 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.09 (0.98, 1.21) 0.1 &lt;=400 / None GDM 1.18 (0.72, 1.93) 0.8 &gt;400 to &lt;800 / None GDM 1.20 (0.85, 1.70) 0.5 &gt;400 to &lt;800 / &lt;=400 GDM 1.02 (0.65, 1.60) 1.0 &gt;=800 / None GDM 1.08 (0.77, 1.50) 0.9 &gt;=800 / &lt;=400 GDM 0.91 (0.59, 1.41) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.90 (0.69, 1.16) 0.7 "],["folateb12-6.html", "47.5 Folate:B12", " 47.5 Folate:B12 47.5.1 FA supp (4 categories) 47.5.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.6335377 0.1052659 44.0174748 &lt;0.0001 *** folate_cat3&lt;=400 0.2088131 0.0936180 2.2304788 0.03 * folate_cat3&gt;400 to &lt;800 0.3151588 0.0669271 4.7089865 &lt;0.0001 *** folate_cat3&gt;=800 0.3614655 0.0746156 4.8443694 &lt;0.0001 *** GDM_newGDM -0.0445885 0.2117610 -0.2105603 0.83 ns StudySTOP 0.3199886 0.1004665 3.1850268 0.001 ** f1_age 0.0007311 0.0032760 0.2231551 0.82 ns BMI 0.0036867 0.0024777 1.4879379 0.14 ns folate_cat3&lt;=400:StudySTOP -0.0368547 0.2515556 -0.1465073 0.88 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2564593 0.1188422 -2.1579825 0.03 * folate_cat3&gt;=800:StudySTOP -0.2913260 0.1149901 -2.5334872 0.01 * GDM_newGDM:StudySTOP -0.1986224 0.2818682 -0.7046642 0.48 ns folate_cat3&lt;=400:GDM_newGDM -0.0547758 0.3258501 -0.1681011 0.87 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM -0.0282800 0.2587530 -0.1092933 0.91 ns folate_cat3&gt;=800:GDM_newGDM 0.4055958 0.2565279 1.5810985 0.11 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.5572382 0.5471451 1.0184468 0.31 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP 0.2581876 0.3357570 0.7689716 0.44 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.1691998 0.3226735 -0.5243683 0.60 ns 47.5.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 115.8641 6.538249 1365 103.72242 129.4271 &lt;=400 Uncomplicated SCOPE 142.7694 10.755408 1365 123.15550 165.5071 &gt;400 to &lt;800 Uncomplicated SCOPE 158.7891 6.000030 1365 147.44444 171.0066 &gt;=800 Uncomplicated SCOPE 166.3150 8.153002 1365 151.06615 183.1030 None GDM SCOPE 110.8114 22.645785 1365 74.21224 165.4600 &lt;=400 GDM SCOPE 129.2653 30.529578 1365 81.33335 205.4448 &gt;400 to &lt;800 GDM SCOPE 147.6299 21.347269 1365 111.16839 196.0501 &gt;=800 GDM SCOPE 238.6244 32.733242 1365 182.32569 312.3071 None Uncomplicated STOP 159.5579 13.318273 1365 135.45825 187.9451 &lt;=400 Uncomplicated STOP 189.4954 41.345700 1365 123.51270 290.7273 &gt;400 to &lt;800 Uncomplicated STOP 169.2042 8.818076 1365 152.76057 187.4178 &gt;=800 Uncomplicated STOP 171.1510 4.752923 1365 162.07656 180.7334 None GDM STOP 125.1103 20.875526 1365 90.18578 173.5593 &lt;=400 GDM STOP 245.5785 82.095130 1365 127.46388 473.1441 &gt;400 to &lt;800 GDM STOP 166.9681 15.481028 1365 139.20068 200.2745 &gt;=800 GDM STOP 169.9886 9.276955 1365 152.73025 189.1971 47.5.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.04 (0.86, 1.26) 0.7 GDM / Uncomplicated STOP 1.00 (0.80, 1.25) 1.0 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.19 (1.04, 1.36) 0.009 STOP / SCOPE GDM 1.15 (0.88, 1.49) 0.3 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.21 (0.88, 1.67) 0.4 &gt;400 to &lt;800 / None Uncomplicated 1.21 (1.03, 1.40) 0.009 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.00 (0.73, 1.36) 1.0 &gt;=800 / None Uncomplicated 1.24 (1.07, 1.44) 0.001 &gt;=800 / &lt;=400 Uncomplicated 1.03 (0.76, 1.39) 1.0 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.03 (0.92, 1.15) 0.9 &lt;=400 / None GDM 1.51 (0.81, 2.83) 0.3 &gt;400 to &lt;800 / None GDM 1.33 (0.89, 2.00) 0.3 &gt;400 to &lt;800 / &lt;=400 GDM 0.88 (0.50, 1.56) 0.9 &gt;=800 / None GDM 1.71 (1.16, 2.52) 0.002 &gt;=800 / &lt;=400 GDM 1.13 (0.65, 1.97) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.28 (0.96, 1.71) 0.1 "],["folateactive-b12-6.html", "47.6 Folate:Active B12", " 47.6 Folate:Active B12 47.6.1 FA supp (4 categories) 47.6.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5433082 0.1434489 45.6142102 &lt;0.0001 *** folate_cat3&lt;=400 0.1712593 0.1262044 1.3570002 0.18 ns folate_cat3&gt;400 to &lt;800 0.2432297 0.0866328 2.8075940 0.005 ** folate_cat3&gt;=800 0.1988297 0.0953792 2.0846235 0.04 * GDM_newGDM -0.3402459 0.2321425 -1.4656770 0.14 ns StudySTOP 0.0302317 0.1385442 0.2182095 0.83 ns f1_age 0.0012772 0.0046780 0.2730187 0.78 ns BMI -0.0094699 0.0033778 -2.8036160 0.005 ** folate_cat3&lt;=400:StudySTOP -0.1645965 0.3402498 -0.4837521 0.63 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0939664 0.1687858 0.5567202 0.58 ns folate_cat3&gt;=800:StudySTOP 0.0683435 0.1581294 0.4321996 0.67 ns GDM_newGDM:StudySTOP 0.3203723 0.3702667 0.8652474 0.39 ns folate_cat3&lt;=400:GDM_newGDM -0.2036292 0.4233719 -0.4809701 0.63 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.3233856 0.3074920 1.0516879 0.29 ns folate_cat3&gt;=800:GDM_newGDM 0.5511296 0.3055733 1.8035920 0.07 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.7429180 0.6792218 1.0937782 0.27 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP -0.7568308 0.4455080 -1.6988042 0.09 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.5901214 0.4302630 -1.3715364 0.17 ns 47.6.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 550.3577 38.93965 713 478.9799 632.3723 &lt;=400 Uncomplicated SCOPE 653.1637 68.91670 713 530.9544 803.5018 &gt;400 to &lt;800 Uncomplicated SCOPE 701.9051 36.46014 713 633.8521 777.2645 &gt;=800 Uncomplicated SCOPE 671.4222 43.34609 713 591.4933 762.1519 None GDM SCOPE 391.6320 86.72432 713 253.5506 604.9112 &lt;=400 GDM SCOPE 379.1579 128.13661 713 195.2841 736.1617 &gt;400 to &lt;800 GDM SCOPE 690.1700 135.18736 713 469.8325 1013.8392 &gt;=800 GDM SCOPE 829.0511 156.42210 713 572.4095 1200.7587 None Uncomplicated STOP 567.2500 68.03864 713 448.2330 717.8691 &lt;=400 Uncomplicated STOP 571.0421 167.13133 713 321.4525 1014.4240 &gt;400 to &lt;800 Uncomplicated STOP 794.7251 64.55022 713 677.5822 932.1202 &gt;=800 Uncomplicated STOP 740.9797 29.80313 713 684.7180 801.8644 None GDM STOP 556.0880 146.01823 713 332.0886 931.1788 &lt;=400 GDM STOP 959.9471 326.04485 713 492.7721 1870.0295 &gt;400 to &lt;800 GDM STOP 505.0601 59.67734 713 400.4931 636.9292 &gt;=800 GDM STOP 698.6206 54.89786 713 598.7422 815.1600 47.6.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 0.84 (0.65, 1.08) 0.2 GDM / Uncomplicated STOP 1.00 (0.75, 1.32) 1.0 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.03 (0.86, 1.23) 0.7 STOP / SCOPE GDM 1.22 (0.88, 1.69) 0.2 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.09 (0.71, 1.69) 1.0 &gt;400 to &lt;800 / None Uncomplicated 1.34 (1.08, 1.66) 0.003 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.22 (0.80, 1.86) 0.6 &gt;=800 / None Uncomplicated 1.26 (1.03, 1.55) 0.02 &gt;=800 / &lt;=400 Uncomplicated 1.15 (0.76, 1.74) 0.8 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 0.94 (0.81, 1.11) 0.8 &lt;=400 / None GDM 1.29 (0.61, 2.76) 0.8 &gt;400 to &lt;800 / None GDM 1.27 (0.75, 2.15) 0.7 &gt;400 to &lt;800 / &lt;=400 GDM 0.98 (0.49, 1.94) 1.0 &gt;=800 / None GDM 1.63 (0.98, 2.72) 0.07 &gt;=800 / &lt;=400 GDM 1.26 (0.65, 2.46) 0.8 &gt;=800 / &gt;400 to &lt;800 GDM 1.29 (0.87, 1.91) 0.3 "],["age-groups-4.html", "48 Age groups", " 48 Age groups Descriptives with univariate P-values. Within Uncomplicated Characteristic &lt;35 yrs (n=1251) &gt;=35 yrs (n=41) Total (n=1292) P-value PRL (ng/ml): Median (IQ range) 97.6 (59.0-158.9) 74.6 (43.8-99.7) 96.8 (58.3-157.1) 0.01 hPL (μg/ml): Median (IQ range) 108.9 (54.6-179.9) 81.6 (43.8-136.1) 108.1 (54.6-179.4) 0.08 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.1) 2.1 (1.4-3.4) 2.5 (1.2-4.1) 0.54 Insulin (uU/ml): Median (IQ range) 10.8 (6.0-21.9) 10.3 (6.3-16.8) 10.8 (6.1-21.7) 0.69 HOMA-IR: Median (IQ range) 2.4 (1.3-5.1) 2.5 (1.3-3.7) 2.4 (1.3-5.0) 0.68 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 4.9 (4.5-5.4) 5.0 (4.6-5.5) 0.38 Within GDM Characteristic &lt;35 yrs (n=226) &gt;=35 yrs (n=25) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 76.7 (45.6-121.8) 59.4 (42.7-110.7) 73.3 (45.3-120.9) 0.31 hPL (μg/ml): Median (IQ range) 66.2 (41.0-99.9) 35.4 (24.5-66.5) 61.4 (37.6-98.5) 0.006 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.2 (1.0-1.8) 1.5 (1.0-2.6) 0.41 Insulin (uU/ml): Median (IQ range) 17.7 (9.2-42.2) 13.0 (9.9-23.8) 17.3 (9.4-40.4) 0.37 HOMA-IR: Median (IQ range) 3.9 (1.9-9.6) 3.0 (2.2-5.9) 3.8 (1.9-9.1) 0.43 Glucose (mmol/L): Median (IQ range) 5.0 (4.5-5.6) 4.9 (4.6-5.3) 4.9 (4.5-5.6) 0.66 Click here for table within SCOPE Within Uncomplicated Characteristic &lt;35 yrs (n=582) &gt;=35 yrs (n=16) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 140.1 (95.6-215.5) 101.2 (74.7-174.9) 139.9 (94.7-215.5) 0.20 hPL (μg/ml): Median (IQ range) 183.5 (151.1-220.8) 168.6 (123.6-206.2) 183.5 (149.9-220.6) 0.17 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.6) 3.8 (3.1-5.6) 4.2 (3.2-5.6) 0.70 Insulin (uU/ml): Median (IQ range) 14.4 (6.5-29.1) 19.5 (10.0-35.6) 14.4 (6.5-29.1) 0.37 HOMA-IR: Median (IQ range) 3.3 (1.5-7.2) 4.5 (2.5-9.7) 3.3 (1.5-7.2) 0.28 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.2-5.8) 5.4 (5.0-5.8) 0.60 Serum folate concentration (nM): Median (IQ range) 36.7 (28.5-43.1) 35.0 (31.9-42.9) 36.6 (28.6-43.1) 0.96 B12 concentration (pM): Median (IQ range) 248.0 (195.0-316.0) 255.0 (216.0-338.0) 248.0 (195.0-316.0) 0.75 Folate:B12 ratio: Median (IQ range) 143.1 (103.4-210.5) 138.1 (116.9-200.6) 143.0 (104.5-208.8) 0.95 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-72.0) 52.0 (48.0-83.5) 54.0 (42.5-72.0) 0.54 Folate:Active B12 ratio: Median (IQ range) 618.0 (464.9-963.5) 420.3 (380.1-751.7) 617.5 (461.2-937.5) 0.20 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.3 (3.9-4.6) 4.4 (3.8-4.9) 0.92 Within GDM Characteristic &lt;35 yrs (n=56) &gt;=35 yrs (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 92.0 (66.0-164.6) 25.7 (14.6-36.7) 92.0 (62.0-147.2) 0.01 hPL (μg/ml): Median (IQ range) 106.6 (91.4-134.3) 36.0 (36.0-36.0) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.2) 1.8 (1.8-1.8) 2.7 (1.6-4.2) 0.69 Insulin (uU/ml): Median (IQ range) 34.0 (16.6-52.7) 52.7 (35.0-70.4) 34.0 (16.6-55.4) 0.64 HOMA-IR: Median (IQ range) 8.1 (3.6-14.0) 13.7 (9.1-18.4) 8.1 (3.6-17.4) 0.70 Glucose (mmol/L): Median (IQ range) 5.8 (5.2-6.7) 5.8 (5.8-5.9) 5.8 (5.2-6.6) 0.93 Serum folate concentration (nM): Median (IQ range) 38.8 (31.7-43.8) 86.0 (63.5-108.6) 40.1 (32.0-43.8) 0.23 B12 concentration (pM): Median (IQ range) 254.5 (194.8-335.0) 205.0 (200.0-210.0) 253.5 (194.2-333.0) 0.31 Folate:B12 ratio: Median (IQ range) 152.8 (114.2-196.8) 410.0 (309.9-510.1) 158.9 (116.5-210.2) 0.11 Active B12 concentration (pM): Median (IQ range) 68.0 (55.0-85.5) 67.5 (50.8-84.2) 68.0 (55.0-86.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 553.8 (431.4-648.6) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) 0.65 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 4.1 (3.5-4.7) 3.9 (3.6-4.6) 0.94 Click here for table within STOP Within Uncomplicated Characteristic &lt;35 yrs (n=669) &gt;=35 yrs (n=25) Total (n=694) P-value PRL (ng/ml): Median (IQ range) 73.2 (49.2-114.9) 52.6 (38.2-90.3) 72.9 (48.6-113.6) 0.08 hPL (μg/ml): Median (IQ range) 62.2 (41.7-96.7) 68.1 (39.3-83.4) 62.4 (41.4-96.2) 0.91 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.6 (1.1-2.2) 1.4 (0.9-2.4) 0.53 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-44.9) 44.8 (41.2-99.7) 40.5 (36.4-45.2) 0.0010 B12 concentration (pM): Median (IQ range) 279.0 (220.5-355.0) 267.5 (220.2-370.5) 279.0 (220.5-356.0) 0.96 Folate:B12 ratio: Median (IQ range) 153.9 (114.8-219.0) 175.4 (140.1-335.7) 155.4 (115.1-222.2) 0.03 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.2) 61.5 (54.2-91.2) 63.0 (48.0-80.8) 0.71 Folate:Active B12 ratio: Median (IQ range) 670.3 (492.7-949.5) 689.4 (493.6-1059.1) 670.3 (491.4-950.5) 0.93 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.9 (4.5-5.8) 4.8 (4.3-5.6) 0.30 Within GDM Characteristic &lt;35 yrs (n=170) &gt;=35 yrs (n=23) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 73.0 (42.6-114.0) 62.6 (43.5-114.4) 68.8 (42.6-114.0) 0.83 hPL (μg/ml): Median (IQ range) 59.4 (37.8-85.3) 34.8 (24.4-67.2) 57.0 (35.8-84.1) 0.03 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.1 (1.0-2.0) 1.3 (0.9-2.2) 0.67 Serum folate concentration (nM): Median (IQ range) 39.7 (35.0-44.5) 43.7 (39.1-64.9) 40.2 (35.4-45.1) 0.04 B12 concentration (pM): Median (IQ range) 272.0 (220.5-346.5) 298.0 (190.5-381.5) 273.5 (216.8-352.0) 0.90 Folate:B12 ratio: Median (IQ range) 147.7 (112.4-206.3) 169.4 (97.5-284.9) 148.0 (111.3-220.6) 0.56 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-91.0) 74.0 (62.0-78.0) 74.5 (56.2-90.2) 0.77 Folate:Active B12 ratio: Median (IQ range) 521.2 (419.2-757.8) 836.9 (594.2-1038.7) 531.9 (419.6-786.4) 0.05 Homocysteine concentration (μM): Median (IQ range) 4.7 (4.0-5.4) 4.8 (4.5-5.2) 4.8 (4.0-5.3) 0.91 "],["prolactin-30.html", "48.1 Prolactin", " 48.1 Prolactin LME for repeated measures. 48.1.1 Model summary Var Effect P (Intercept) 13.80 (9.30, 20.49) &lt;0.0001 Age_gp&gt;=35 yrs 0.84 (0.59, 1.20) 0.33 GDM_newGDM 0.96 (0.78, 1.19) 0.73 StudySTOP 0.99 (0.87, 1.12) 0.82 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.91 (0.58, 1.42) 0.68 GDM_newGDM:StudySTOP 1.10 (0.87, 1.39) 0.41 Age_gp&gt;=35 yrs:GDM_newGDM 0.57 (0.25, 1.32) 0.19 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 2.18 (0.87, 5.47) 0.10 48.1.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 95.85 7.74 102.70 81.65 112.50 &gt;=35 yrs SCOPE Uncomplicated 80.30 15.71 1190.90 54.70 117.86 &lt;35 yrs STOP Uncomplicated 94.44 7.08 76.41 81.35 109.65 &gt;=35 yrs STOP Uncomplicated 71.98 10.71 774.58 53.75 96.40 &lt;35 yrs SCOPE GDM 92.32 11.75 491.62 71.90 118.55 &gt;=35 yrs SCOPE GDM 44.15 16.91 577.40 20.80 93.70 &lt;35 yrs STOP GDM 100.29 8.94 147.81 84.09 119.62 &gt;=35 yrs STOP GDM 95.06 14.40 795.34 70.61 127.99 48.1.3 Post-hoc comparisons 48.1.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE Uncomplicated 0.84 (0.58, 1.20) 0.3 &gt;=35 yrs / &lt;35 yrs STOP Uncomplicated 0.76 (0.59, 0.99) 0.04 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.48 (0.22, 1.03) 0.06 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.95 (0.72, 1.25) 0.7 48.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.8033017 0.8492204 838.1331 0.7155440 4.544650 0.211 ns STOP/SCOPE (Uncomplicated) 0.9097827 0.2062110 1431.2352 0.5832321 1.419169 0.677 ns STOP/SCOPE (GDM) 1.9821235 0.8176655 637.3703 0.8817085 4.455910 0.098 ns GDM/Uncomplicated (SCOPE) 0.5708094 0.2452270 721.7561 0.2455782 1.326760 0.192 ns GDM/Uncomplicated (STOP) 1.2436098 0.2404574 1407.1881 0.8510575 1.817228 0.260 ns "],["hpl-30.html", "48.2 HPL", " 48.2 HPL LME for repeated measures. 48.2.1 Model summary Var Effect P (Intercept) 1.92 (1.57, 2.36) &lt;0.0001 Age_gp&gt;=35 yrs 0.89 (0.74, 1.08) 0.24 GDM_newGDM 0.93 (0.84, 1.03) 0.18 StudySTOP 1.14 (1.06, 1.22) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.12 (0.88, 1.41) 0.36 GDM_newGDM:StudySTOP 1.09 (0.97, 1.23) 0.13 Age_gp&gt;=35 yrs:GDM_newGDM 1.02 (0.66, 1.59) 0.92 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 0.70 (0.43, 1.13) 0.15 48.2.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 86.97 2.54 189.21 82.10 92.12 &gt;=35 yrs SCOPE Uncomplicated 77.57 7.63 1440.36 63.97 94.08 &lt;35 yrs STOP Uncomplicated 98.96 2.51 107.96 94.11 104.05 &gt;=35 yrs STOP Uncomplicated 98.65 7.25 1356.95 85.41 113.94 &lt;35 yrs SCOPE GDM 80.99 4.51 679.61 72.60 90.34 &gt;=35 yrs SCOPE GDM 73.91 14.63 474.34 50.10 109.05 &lt;35 yrs STOP GDM 100.88 3.66 343.33 93.93 108.34 &gt;=35 yrs STOP GDM 71.87 5.36 1294.42 62.09 83.19 48.2.3 Post-hoc comparisons 48.2.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE Uncomplicated 0.89 (0.74, 1.08) 0.2 &gt;=35 yrs / &lt;35 yrs STOP Uncomplicated 1.00 (0.87, 1.15) 1.0 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.91 (0.61, 1.36) 0.7 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.71 (0.61, 0.83) &lt;0.0001 48.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8724134 0.2156989 720.6900 0.5369253 1.4175252 0.581 ns STOP/SCOPE (Uncomplicated) 1.1175774 0.1343859 1419.0147 0.8827452 1.4148808 0.355 ns STOP/SCOPE (GDM) 0.7806291 0.1683624 543.2569 0.5110361 1.1924435 0.251 ns GDM/Uncomplicated (SCOPE) 1.0231517 0.2293448 594.4515 0.6587938 1.5890245 0.919 ns GDM/Uncomplicated (STOP) 0.7146726 0.0742161 1391.4911 0.5829564 0.8761495 0.001 ** "],["gh2-30.html", "48.3 GH2", " 48.3 GH2 LME for repeated measures. 48.3.1 Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 Age_gp&gt;=35 yrs 0.95 (0.74, 1.23) 0.70 GDM_newGDM 0.90 (0.78, 1.05) 0.19 StudySTOP 0.98 (0.90, 1.07) 0.68 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.07 (0.78, 1.46) 0.69 GDM_newGDM:StudySTOP 1.13 (0.95, 1.34) 0.16 Age_gp&gt;=35 yrs:GDM_newGDM 0.85 (0.44, 1.65) 0.64 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 1.29 (0.63, 2.65) 0.48 48.3.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 2.26 0.07 450.31 2.11 2.41 &gt;=35 yrs SCOPE Uncomplicated 2.15 0.28 1415.94 1.66 2.77 &lt;35 yrs STOP Uncomplicated 2.21 0.06 214.88 2.10 2.33 &gt;=35 yrs STOP Uncomplicated 2.25 0.22 1484.42 1.86 2.72 &lt;35 yrs SCOPE GDM 2.04 0.16 1108.15 1.75 2.37 &gt;=35 yrs SCOPE GDM 1.65 0.50 802.72 0.91 3.01 &lt;35 yrs STOP GDM 2.26 0.10 539.32 2.08 2.45 &gt;=35 yrs STOP GDM 2.53 0.25 1426.51 2.07 3.08 48.3.3 Post-hoc comparisons 48.3.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE Uncomplicated 0.95 (0.74, 1.23) 0.7 &gt;=35 yrs / &lt;35 yrs STOP Uncomplicated 1.01 (0.84, 1.23) 0.9 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.81 (0.44, 1.50) 0.5 &gt;=35 yrs / &lt;35 yrs STOP GDM 1.12 (0.91, 1.37) 0.3 48.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.4698123 0.5391396 1057.3628 0.7156095 3.018893 0.294 ns STOP/SCOPE (Uncomplicated) 1.0666101 0.1728880 1461.3444 0.7761026 1.465859 0.691 ns STOP/SCOPE (GDM) 1.3780222 0.4533225 880.2743 0.7225273 2.628198 0.330 ns GDM/Uncomplicated (SCOPE) 0.8535475 0.2885458 963.1589 0.4396560 1.657076 0.640 ns GDM/Uncomplicated (STOP) 1.1027530 0.1570264 1466.3815 0.8340102 1.458093 0.492 ns "],["insulin-28.html", "48.4 Insulin", " 48.4 Insulin GEE for repeated measures. 48.4.1 Model summary Var Effect P (Intercept) 12.92 (7.66, 21.81) &lt;0.0001 Age_gp&gt;=35 yrs 1.26 (0.82, 1.93) 0.29 GDM_newGDM 2.19 (1.59, 3.01) &lt;0.0001 StudySTOP 0.76 (0.64, 0.91) 0.002 GA_samp 1.01 (0.97, 1.04) 0.76 Age_gp&gt;=35 yrs:StudySTOP 0.64 (0.38, 1.07) 0.09 GDM_newGDM:StudySTOP 0.81 (0.56, 1.15) 0.24 Age_gp&gt;=35 yrs:GDM_newGDM 1.07 (0.51, 2.27) 0.85 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 0.97 (0.41, 2.32) 0.95 48.4.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 13.82 0.87 Inf 12.22 15.63 &gt;=35 yrs SCOPE Uncomplicated 17.42 3.79 Inf 11.38 26.68 &lt;35 yrs STOP Uncomplicated 10.52 0.44 Inf 9.69 11.42 &gt;=35 yrs STOP Uncomplicated 8.46 1.24 Inf 6.35 11.28 &lt;35 yrs SCOPE GDM 30.24 4.90 Inf 22.02 41.53 &gt;=35 yrs SCOPE GDM 40.93 11.26 Inf 23.87 70.18 &lt;35 yrs STOP GDM 18.56 1.52 Inf 15.81 21.79 &gt;=35 yrs STOP GDM 15.61 2.38 Inf 11.58 21.05 48.4.3 Post-hoc comparisons 48.4.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE Uncomplicated 1.26 (0.82, 1.93) 0.3 &gt;=35 yrs / &lt;35 yrs STOP Uncomplicated 0.80 (0.60, 1.08) 0.1 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 1.35 (0.73, 2.51) 0.3 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.84 (0.61, 1.17) 0.3 48.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.3967798 0.1759183 Inf 0.1664012 0.9461122 0.037 * STOP/SCOPE (Uncomplicated) 0.6383914 0.1686954 Inf 0.3803263 1.0715630 0.089 ns STOP/SCOPE (GDM) 0.6215306 0.2211962 Inf 0.3094061 1.2485220 0.181 ns GDM/Uncomplicated (SCOPE) 1.0737975 0.4109668 Inf 0.5071637 2.2735090 0.852 ns GDM/Uncomplicated (STOP) 1.0454370 0.2346315 Inf 0.6733787 1.6230667 0.843 ns "],["homa-ir-28.html", "48.5 HOMA-IR", " 48.5 HOMA-IR GEE for repeated measures. 48.5.1 Model summary Var Effect P (Intercept) 3.30 (1.90, 5.72) &lt;0.0001 Age_gp&gt;=35 yrs 1.34 (0.84, 2.13) 0.22 GDM_newGDM 2.38 (1.67, 3.40) &lt;0.0001 StudySTOP 0.66 (0.55, 0.79) &lt;0.0001 GA_samp 1.00 (0.97, 1.04) 0.95 Age_gp&gt;=35 yrs:StudySTOP 0.59 (0.33, 1.03) 0.06 GDM_newGDM:StudySTOP 0.77 (0.51, 1.14) 0.19 Age_gp&gt;=35 yrs:GDM_newGDM 0.98 (0.44, 2.18) 0.97 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 1.09 (0.43, 2.72) 0.86 48.5.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 3.35 0.22 Inf 2.94 3.81 &gt;=35 yrs SCOPE Uncomplicated 4.48 1.05 Inf 2.82 7.10 &lt;35 yrs STOP Uncomplicated 2.19 0.10 Inf 2.01 2.39 &gt;=35 yrs STOP Uncomplicated 1.72 0.27 Inf 1.26 2.35 &lt;35 yrs SCOPE GDM 7.98 1.44 Inf 5.60 11.35 &gt;=35 yrs SCOPE GDM 10.51 2.95 Inf 6.06 18.23 &lt;35 yrs STOP GDM 4.00 0.35 Inf 3.37 4.76 &gt;=35 yrs STOP GDM 3.36 0.52 Inf 2.49 4.55 48.5.3 Post-hoc comparisons 48.5.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE Uncomplicated 1.34 (0.84, 2.13) 0.2 &gt;=35 yrs / &lt;35 yrs STOP Uncomplicated 0.78 (0.57, 1.08) 0.1 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 1.32 (0.69, 2.51) 0.4 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.84 (0.60, 1.18) 0.3 48.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.3739222 0.1750465 Inf 0.1493836 0.9359647 0.036 * STOP/SCOPE (Uncomplicated) 0.5863093 0.1675235 Inf 0.3349012 1.0264476 0.062 ns STOP/SCOPE (GDM) 0.6377559 0.2364667 Inf 0.3083519 1.3190535 0.225 ns GDM/Uncomplicated (SCOPE) 0.9842875 0.3987915 Inf 0.4448886 2.1776731 0.969 ns GDM/Uncomplicated (STOP) 1.0706554 0.2520065 Inf 0.6749901 1.6982517 0.772 ns "],["glucose-28.html", "48.6 Glucose", " 48.6 Glucose GEE for repeated measures. 48.6.1 Model summary Var Effect P (Intercept) 5.59 (5.00, 6.25) &lt;0.0001 Age_gp&gt;=35 yrs 1.06 (0.95, 1.17) 0.30 GDM_newGDM 1.11 (1.00, 1.24) 0.06 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.52 Age_gp&gt;=35 yrs:StudySTOP 0.93 (0.84, 1.04) 0.20 GDM_newGDM:StudySTOP 0.93 (0.83, 1.04) 0.23 Age_gp&gt;=35 yrs:GDM_newGDM 0.91 (0.79, 1.06) 0.23 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 1.09 (0.93, 1.28) 0.27 48.6.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 5.42 0.07 Inf 5.29 5.55 &gt;=35 yrs SCOPE Uncomplicated 5.72 0.30 Inf 5.17 6.33 &lt;35 yrs STOP Uncomplicated 4.72 0.04 Inf 4.63 4.80 &gt;=35 yrs STOP Uncomplicated 4.63 0.08 Inf 4.48 4.80 &lt;35 yrs SCOPE GDM 6.02 0.32 Inf 5.44 6.67 &gt;=35 yrs SCOPE GDM 5.81 0.06 Inf 5.69 5.94 &lt;35 yrs STOP GDM 4.89 0.07 Inf 4.75 5.03 &gt;=35 yrs STOP GDM 4.79 0.09 Inf 4.62 4.97 48.6.3 Post-hoc comparisons 48.6.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE Uncomplicated 1.06 (0.95, 1.17) 0.3 &gt;=35 yrs / &lt;35 yrs STOP Uncomplicated 0.98 (0.95, 1.02) 0.3 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.96 (0.87, 1.07) 0.5 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.98 (0.94, 1.02) 0.4 48.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9468606 0.0758078 Inf 0.8093511 1.107733 0.495 ns STOP/SCOPE (Uncomplicated) 0.9308189 0.0515651 Inf 0.8350466 1.037575 0.196 ns STOP/SCOPE (GDM) 1.0172340 0.0591792 Inf 0.9076133 1.140095 0.769 ns GDM/Uncomplicated (SCOPE) 0.9138292 0.0688681 Inf 0.7883457 1.059286 0.232 ns GDM/Uncomplicated (STOP) 0.9986671 0.0283507 Inf 0.9446183 1.055808 0.963 ns "],["bmi-groups-4.html", "49 BMI groups", " 49 BMI groups Descriptives with univariate P-values. Within Uncomplicated Characteristic Underweight (n=32) Normal (n=580) Overweight (n=382) Obese (n=298) Total (n=1292) P-value PRL (ng/ml): Median (IQ range) 103.1 (78.8-182.4) 103.2 (64.2-160.3) 97.3 (56.9-164.2) 80.6 (48.1-131.6) 96.8 (58.3-157.1) 0.0003 hPL (μg/ml): Median (IQ range) 144.8 (88.1-242.9) 121.0 (61.1-195.3) 109.6 (54.2-172.4) 75.7 (41.7-145.4) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.1 (1.5-5.9) 2.9 (1.3-4.7) 2.5 (1.2-3.9) 2.2 (1.0-3.3) 2.5 (1.2-4.1) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 6.1 (4.4-12.4) 7.7 (4.6-16.6) 11.6 (6.8-23.3) 15.4 (9.6-31.6) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.4 (0.9-2.8) 1.7 (1.0-3.7) 2.6 (1.4-5.4) 3.6 (2.1-7.0) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.4-5.3) 5.0 (4.6-5.4) 5.0 (4.6-5.6) 5.1 (4.7-5.6) 5.0 (4.6-5.5) 0.02 Within GDM Characteristic Underweight (n=3) Normal (n=65) Overweight (n=51) Obese (n=132) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 92.0 (51.9-158.9) 77.0 (35.9-111.0) 66.0 (45.0-108.6) 73.3 (45.3-120.9) 0.03 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 87.0 (53.6-115.5) 79.6 (45.6-99.8) 50.2 (34.6-76.8) 61.4 (37.6-98.5) 0.0004 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.7 (1.1-2.9) 1.4 (0.9-2.9) 1.3 (1.0-2.3) 1.5 (1.0-2.6) 0.34 Insulin (uU/ml): Median (IQ range) 4.5 (3.7-6.8) 11.1 (5.7-30.9) 12.6 (8.5-20.1) 24.6 (13.4-47.1) 17.3 (9.4-40.4) &lt;0.0001 HOMA-IR: Median (IQ range) 0.8 (0.7-1.2) 2.2 (1.2-7.3) 2.7 (1.7-4.4) 5.5 (2.8-11.2) 3.8 (1.9-9.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.1 (4.0-4.5) 4.9 (4.4-5.2) 4.8 (4.6-5.6) 5.1 (4.6-5.8) 4.9 (4.5-5.6) 0.02 Click here for table within SCOPE Within Uncomplicated Characteristic Underweight (n=16) Normal (n=272) Overweight (n=175) Obese (n=135) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 187.3 (146.2-325.0) 142.3 (97.1-212.7) 139.1 (97.5-222.1) 130.4 (82.4-194.3) 139.9 (94.7-215.5) 0.10 hPL (μg/ml): Median (IQ range) 262.2 (219.0-278.0) 197.4 (170.3-230.2) 172.9 (150.5-210.5) 153.3 (130.2-181.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 6.2 (4.6-6.5) 4.7 (3.5-6.5) 4.0 (3.2-5.2) 3.4 (2.6-4.4) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 9.0 (6.0-11.4) 10.6 (5.2-22.4) 17.7 (9.0-29.6) 20.3 (9.7-36.3) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 1.9 (1.4-2.4) 2.5 (1.2-5.7) 4.0 (2.0-7.5) 4.7 (2.3-9.3) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.2 (4.8-5.8) 5.3 (5.0-5.7) 5.5 (5.0-6.0) 5.4 (5.1-5.9) 5.4 (5.0-5.8) 0.15 Serum folate concentration (nM): Median (IQ range) 29.2 (24.9-36.1) 37.5 (29.7-43.8) 37.2 (30.1-41.2) 35.4 (24.8-43.1) 36.6 (28.6-43.1) 0.06 B12 concentration (pM): Median (IQ range) 288.0 (252.0-355.0) 256.0 (198.0-325.0) 249.0 (199.0-312.0) 226.0 (180.2-286.2) 248.0 (195.0-316.0) 0.005 Folate:B12 ratio: Median (IQ range) 105.6 (74.6-117.3) 146.9 (104.6-208.2) 144.7 (107.1-208.8) 143.3 (103.3-211.0) 143.0 (104.5-208.8) 0.23 Active B12 concentration (pM): Median (IQ range) 63.5 (53.5-78.0) 53.0 (41.0-72.5) 54.0 (43.0-70.5) 60.0 (43.5-72.5) 54.0 (42.5-72.0) 0.39 Folate:Active B12 ratio: Median (IQ range) 491.8 (337.4-589.7) 642.4 (464.2-1054.8) 643.8 (496.6-965.2) 537.9 (403.0-698.7) 617.5 (461.2-937.5) 0.010 Homocysteine concentration (μM): Median (IQ range) 4.5 (4.2-5.3) 4.4 (3.9-5.0) 4.2 (3.8-4.9) 4.4 (3.8-5.0) 4.4 (3.8-4.9) 0.20 Within GDM Characteristic Underweight (n=0) Normal (n=14) Overweight (n=13) Obese (n=31) Total (n=58) P-value PRL (ng/ml): Median (IQ range) NA (NA-NA) 119.0 (86.9-144.9) 133.7 (87.4-214.9) 66.0 (55.9-111.0) 92.0 (62.0-147.2) – hPL (μg/ml): Median (IQ range) NA (NA-NA) 106.6 (100.2-178.0) 98.8 (91.4-114.2) 106.6 (80.8-133.7) 106.2 (85.6-134.2) – GH2 (ng/ml): Median (IQ range) NA (NA-NA) 2.6 (1.9-3.9) 4.2 (3.2-5.6) 1.9 (1.5-3.0) 2.7 (1.6-4.2) – Insulin (uU/ml): Median (IQ range) NA (NA-NA) 25.1 (8.8-38.2) 17.1 (16.6-62.4) 41.4 (24.5-76.7) 34.0 (16.6-55.4) – HOMA-IR: Median (IQ range) NA (NA-NA) 6.0 (2.0-11.1) 4.3 (3.5-18.6) 10.0 (4.9-20.1) 8.1 (3.6-17.4) – Glucose (mmol/L): Median (IQ range) NA (NA-NA) 5.3 (5.1-6.4) 5.9 (5.6-6.4) 5.9 (5.6-6.7) 5.8 (5.2-6.6) – Serum folate concentration (nM): Median (IQ range) NA (NA-NA) 43.6 (39.0-44.6) 36.9 (31.7-45.9) 39.6 (31.5-43.0) 40.1 (32.0-43.8) – B12 concentration (pM): Median (IQ range) NA (NA-NA) 289.0 (170.5-372.5) 263.5 (224.2-309.8) 240.0 (192.0-301.0) 253.5 (194.2-333.0) – Folate:B12 ratio: Median (IQ range) NA (NA-NA) 155.4 (114.2-232.5) 145.1 (121.9-190.5) 169.4 (118.7-199.0) 158.9 (116.5-210.2) – Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 83.5 (66.2-99.2) 58.5 (54.5-77.0) 77.0 (53.0-85.0) 68.0 (55.0-86.0) – Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 553.9 (377.4-674.3) 535.8 (321.6-763.8) 553.8 (516.5-577.4) 553.8 (424.7-660.3) – Homocysteine concentration (μM): Median (IQ range) NA (NA-NA) 4.3 (3.9-5.1) 4.0 (3.5-4.6) 3.7 (3.5-4.3) 3.9 (3.6-4.6) – Click here for table within STOP Within Uncomplicated Characteristic Underweight (n=16) Normal (n=308) Overweight (n=207) Obese (n=163) Total (n=694) P-value PRL (ng/ml): Median (IQ range) 91.6 (47.1-99.5) 78.8 (53.8-120.4) 72.9 (49.1-115.1) 62.1 (40.3-99.3) 72.9 (48.6-113.6) 0.003 hPL (μg/ml): Median (IQ range) 90.3 (64.3-140.4) 67.3 (45.7-101.5) 61.0 (42.3-97.2) 50.5 (34.5-73.3) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.6 (1.4-3.5) 1.5 (1.0-2.4) 1.5 (0.8-2.3) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.03 Serum folate concentration (nM): Median (IQ range) 35.0 (29.9-40.4) 40.8 (37.0-52.4) 40.4 (36.3-45.0) 40.5 (35.7-46.9) 40.5 (36.4-45.2) 0.008 B12 concentration (pM): Median (IQ range) 349.5 (240.0-494.2) 288.0 (228.0-369.0) 276.0 (214.5-339.0) 260.5 (217.8-335.2) 279.0 (220.5-356.0) 0.03 Folate:B12 ratio: Median (IQ range) 98.0 (68.5-159.2) 154.8 (114.8-225.9) 149.5 (120.1-215.2) 168.3 (117.6-233.6) 155.4 (115.1-222.2) 0.03 Active B12 concentration (pM): Median (IQ range) 50.0 (48.0-82.0) 63.0 (46.0-79.0) 63.0 (49.0-83.0) 62.0 (51.0-76.0) 63.0 (48.0-80.8) 0.78 Folate:Active B12 ratio: Median (IQ range) 602.0 (490.9-735.8) 693.3 (532.0-964.9) 670.9 (460.9-951.1) 644.4 (520.0-929.8) 670.3 (491.4-950.5) 0.67 Homocysteine concentration (μM): Median (IQ range) 5.3 (4.7-5.7) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.9 (4.3-5.7) 4.8 (4.3-5.6) 0.15 Within GDM Characteristic Underweight (n=3) Normal (n=51) Overweight (n=38) Obese (n=101) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 86.0 (50.3-158.9) 68.8 (33.6-110.6) 66.6 (43.3-107.8) 68.8 (42.6-114.0) 0.07 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 69.0 (51.5-110.6) 68.0 (40.0-94.5) 47.1 (32.5-66.9) 57.0 (35.8-84.1) 0.0004 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.7 (1.1-2.2) 1.2 (0.8-2.5) 1.3 (0.9-2.2) 1.3 (0.9-2.2) 0.25 Serum folate concentration (nM): Median (IQ range) 42.7 (41.5-42.9) 41.3 (36.8-54.0) 40.7 (36.7-56.8) 39.2 (34.4-43.8) 40.2 (35.4-45.1) 0.24 B12 concentration (pM): Median (IQ range) 345.0 (307.0-492.5) 292.0 (237.0-348.8) 257.0 (189.0-360.0) 269.5 (215.4-338.0) 273.5 (216.8-352.0) 0.23 Folate:B12 ratio: Median (IQ range) 117.1 (91.9-138.7) 136.4 (109.7-197.4) 164.8 (114.1-265.0) 149.2 (111.7-217.8) 148.0 (111.3-220.6) 0.57 Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 68.0 (55.0-79.0) 67.0 (48.0-95.8) 78.0 (61.0-91.0) 74.5 (56.2-90.2) Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 521.2 (457.3-770.2) 785.3 (497.1-883.3) 512.7 (410.8-645.7) 531.9 (419.6-786.4) Homocysteine concentration (μM): Median (IQ range) 4.5 (4.0-4.5) 4.7 (4.0-5.4) 4.8 (4.0-5.7) 4.8 (4.0-5.2) 4.8 (4.0-5.3) 0.65 "],["prolactin-31.html", "49.1 Prolactin", " 49.1 Prolactin LME for repeated measures. 49.1.1 Model summary Var Effect P (Intercept) 18.47 (10.62, 32.11) &lt;0.0001 BMI_gp3Normal 0.80 (0.54, 1.18) 0.27 BMI_gp3Overweight 0.82 (0.55, 1.21) 0.32 BMI_gp3Obese 0.69 (0.46, 1.04) 0.08 GDM_newGDM 0.56 (0.24, 1.32) 0.19 StudySTOP 0.73 (0.44, 1.20) 0.22 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.35 (0.82, 2.24) 0.24 BMI_gp3Overweight:StudySTOP 1.31 (0.79, 2.19) 0.30 BMI_gp3Obese:StudySTOP 1.24 (0.74, 2.08) 0.42 GDM_newGDM:StudySTOP 1.45 (1.05, 2.02) 0.03 BMI_gp3Normal:GDM_newGDM 1.71 (0.67, 4.34) 0.26 BMI_gp3Overweight:GDM_newGDM 2.30 (0.89, 5.89) 0.09 BMI_gp3Obese:GDM_newGDM 1.38 (0.62, 3.09) 0.43 BMI_gp3Normal:GDM_newGDM:StudySTOP 0.86 (0.50, 1.48) 0.59 BMI_gp3Overweight:GDM_newGDM:StudySTOP 0.51 (0.29, 0.90) 0.02 49.1.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 124.06 26.05 1281.02 82.17 187.29 Normal SCOPE Uncomplicated 99.36 8.58 137.02 83.77 117.86 Overweight SCOPE Uncomplicated 101.34 9.27 170.66 84.60 121.39 Obese SCOPE Uncomplicated 85.91 8.51 228.46 70.68 104.42 Underweight STOP Uncomplicated 90.10 15.75 1059.44 63.94 126.96 Normal STOP Uncomplicated 97.55 7.66 95.27 83.47 114.01 Overweight STOP Uncomplicated 96.75 8.05 118.95 82.05 114.08 Obese STOP Uncomplicated 77.25 6.98 158.72 64.62 92.34 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 95.01 19.80 936.62 63.11 143.02 Overweight SCOPE GDM 130.34 27.64 1268.69 85.98 197.59 Obese SCOPE GDM 66.37 10.16 714.25 49.15 89.64 Underweight STOP GDM 73.30 27.76 1434.82 34.87 154.07 Normal STOP GDM 116.71 13.43 377.07 93.08 146.34 Overweight STOP GDM 92.90 11.64 494.58 72.62 118.83 Obese STOP GDM 86.74 8.53 217.91 71.46 105.28 49.1.3 Post-hoc comparisons 49.1.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE Uncomplicated 0.80 (0.48, 1.34) 0.7 Overweight / Underweight SCOPE Uncomplicated 0.82 (0.49, 1.37) 0.7 Overweight / Normal SCOPE Uncomplicated 1.02 (0.86, 1.22) 1.0 Obese / Underweight SCOPE Uncomplicated 0.69 (0.41, 1.18) 0.3 Obese / Normal SCOPE Uncomplicated 0.86 (0.70, 1.06) 0.3 Obese / Overweight SCOPE Uncomplicated 0.85 (0.68, 1.05) 0.2 Normal / Underweight STOP Uncomplicated 1.08 (0.71, 1.65) 1.0 Overweight / Underweight STOP Uncomplicated 1.07 (0.70, 1.65) 1.0 Overweight / Normal STOP Uncomplicated 0.99 (0.85, 1.15) 1.0 Obese / Underweight STOP Uncomplicated 0.86 (0.55, 1.33) 0.8 Obese / Normal STOP Uncomplicated 0.79 (0.66, 0.94) 0.004 Obese / Overweight STOP Uncomplicated 0.80 (0.67, 0.95) 0.007 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 1.37 (0.68, 2.79) 0.7 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.70 (0.38, 1.28) 0.4 Obese / Overweight SCOPE GDM 0.51 (0.28, 0.93) 0.02 Normal / Underweight STOP GDM 1.59 (0.60, 4.25) 0.6 Overweight / Underweight STOP GDM 1.27 (0.47, 3.40) 0.9 Overweight / Normal STOP GDM 0.80 (0.57, 1.12) 0.3 Obese / Underweight STOP GDM 1.18 (0.45, 3.11) 1.0 Obese / Normal STOP GDM 0.74 (0.56, 0.98) 0.03 Obese / Overweight STOP GDM 0.93 (0.69, 1.26) 0.9 49.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.7804428 0.2197400 1426.505 0.4492363 1.355836 0.379 ns STOP/SCOPE (Uncomplicated) 1.3518183 0.3501843 1424.535 0.8132606 2.247020 0.245 ns STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/Uncomplicated (SCOPE) NA NA NA NA NA NA GDM/Uncomplicated (STOP) 1.4705950 0.6108418 1390.375 0.6510600 3.321736 0.353 ns "],["hpl-31.html", "49.2 HPL", " 49.2 HPL LME for repeated measures. 49.2.1 Model summary Var Effect P (Intercept) 2.23 (1.68, 2.97) &lt;0.0001 BMI_gp3Normal 0.97 (0.79, 1.20) 0.81 BMI_gp3Overweight 0.91 (0.74, 1.12) 0.39 BMI_gp3Obese 0.78 (0.63, 0.96) 0.02 GDM_newGDM 1.07 (0.68, 1.66) 0.77 StudySTOP 1.33 (1.02, 1.72) 0.04 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.83 (0.64, 1.08) 0.16 BMI_gp3Overweight:StudySTOP 0.84 (0.64, 1.09) 0.19 BMI_gp3Obese:StudySTOP 0.81 (0.62, 1.06) 0.13 GDM_newGDM:StudySTOP 1.00 (0.85, 1.18) 0.98 BMI_gp3Normal:GDM_newGDM 0.85 (0.52, 1.37) 0.50 BMI_gp3Overweight:GDM_newGDM 0.87 (0.54, 1.41) 0.58 BMI_gp3Obese:GDM_newGDM 0.90 (0.59, 1.37) 0.62 BMI_gp3Normal:GDM_newGDM:StudySTOP 1.23 (0.94, 1.60) 0.14 BMI_gp3Overweight:GDM_newGDM:StudySTOP 1.10 (0.84, 1.44) 0.50 49.2.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 97.10 10.23 1459.51 78.97 119.38 Normal SCOPE Uncomplicated 94.65 3.06 351.25 88.82 100.85 Overweight SCOPE Uncomplicated 88.65 3.18 481.96 82.62 95.12 Obese SCOPE Uncomplicated 75.75 2.99 603.55 70.10 81.85 Underweight STOP Uncomplicated 128.70 10.90 1394.98 109.00 151.96 Normal STOP Uncomplicated 103.87 2.82 195.95 98.45 109.58 Overweight STOP Uncomplicated 98.38 3.01 285.94 92.63 104.49 Obese STOP Uncomplicated 81.64 2.90 366.51 76.13 87.55 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 85.51 8.40 645.73 70.52 103.70 Overweight SCOPE GDM 82.71 7.52 940.81 69.19 98.87 Obese SCOPE GDM 72.76 5.00 655.21 63.57 83.27 Underweight STOP GDM 137.13 26.82 1421.34 93.44 201.25 Normal STOP GDM 114.76 5.92 956.92 103.72 126.98 Overweight STOP GDM 100.63 5.90 1162.87 89.70 112.89 Obese STOP GDM 78.28 3.21 577.27 72.23 84.84 49.2.3 Post-hoc comparisons 49.2.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE Uncomplicated 0.97 (0.74, 1.28) 1.0 Overweight / Underweight SCOPE Uncomplicated 0.91 (0.70, 1.20) 0.8 Overweight / Normal SCOPE Uncomplicated 0.94 (0.85, 1.03) 0.3 Obese / Underweight SCOPE Uncomplicated 0.78 (0.59, 1.03) 0.10 Obese / Normal SCOPE Uncomplicated 0.80 (0.72, 0.89) &lt;0.0001 Obese / Overweight SCOPE Uncomplicated 0.85 (0.77, 0.95) 0.001 Normal / Underweight STOP Uncomplicated 0.81 (0.65, 1.00) 0.06 Overweight / Underweight STOP Uncomplicated 0.76 (0.61, 0.95) 0.010 Overweight / Normal STOP Uncomplicated 0.95 (0.88, 1.02) 0.3 Obese / Underweight STOP Uncomplicated 0.63 (0.51, 0.79) &lt;0.0001 Obese / Normal STOP Uncomplicated 0.79 (0.72, 0.86) &lt;0.0001 Obese / Overweight STOP Uncomplicated 0.83 (0.76, 0.91) &lt;0.0001 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 0.97 (0.69, 1.35) 1.0 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.85 (0.63, 1.14) 0.5 Obese / Overweight SCOPE GDM 0.88 (0.67, 1.16) 0.6 Normal / Underweight STOP GDM 0.84 (0.50, 1.40) 0.8 Overweight / Underweight STOP GDM 0.73 (0.44, 1.23) 0.4 Overweight / Normal STOP GDM 0.88 (0.73, 1.05) 0.2 Obese / Underweight STOP GDM 0.57 (0.34, 0.95) 0.02 Obese / Normal STOP GDM 0.68 (0.59, 0.79) &lt;0.0001 Obese / Overweight STOP GDM 0.78 (0.66, 0.92) 0.0004 49.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9013170 0.1318169 1427.718 0.6765258 1.200800 0.478 ns STOP/SCOPE (Uncomplicated) 0.8279005 0.1116091 1424.218 0.6355215 1.078515 0.161 ns STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/Uncomplicated (SCOPE) NA NA NA NA NA NA GDM/Uncomplicated (STOP) 1.0369922 0.2249165 1394.778 0.6776343 1.586922 0.867 ns "],["gh2-31.html", "49.3 GH2", " 49.3 GH2 LME for repeated measures. 49.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.12) &lt;0.0001 BMI_gp3Normal 1.04 (0.79, 1.38) 0.78 BMI_gp3Overweight 0.92 (0.69, 1.22) 0.55 BMI_gp3Obese 0.77 (0.58, 1.02) 0.07 GDM_newGDM 0.63 (0.34, 1.18) 0.15 StudySTOP 1.41 (0.98, 2.02) 0.07 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.64 (0.45, 0.92) 0.02 BMI_gp3Overweight:StudySTOP 0.69 (0.48, 1.00) 0.05 BMI_gp3Obese:StudySTOP 0.78 (0.53, 1.13) 0.18 GDM_newGDM:StudySTOP 1.24 (0.98, 1.58) 0.08 BMI_gp3Normal:GDM_newGDM 1.50 (0.75, 2.99) 0.25 BMI_gp3Overweight:GDM_newGDM 1.84 (0.93, 3.64) 0.08 BMI_gp3Obese:GDM_newGDM 1.35 (0.75, 2.44) 0.32 BMI_gp3Normal:GDM_newGDM:StudySTOP 0.95 (0.64, 1.43) 0.82 BMI_gp3Overweight:GDM_newGDM:StudySTOP 0.65 (0.44, 0.96) 0.03 49.3.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 2.42 0.35 1487.90 1.83 3.21 Normal SCOPE Uncomplicated 2.52 0.10 701.12 2.33 2.73 Overweight SCOPE Uncomplicated 2.22 0.10 903.12 2.03 2.43 Obese SCOPE Uncomplicated 1.86 0.10 1038.75 1.68 2.06 Underweight STOP Uncomplicated 3.41 0.40 1479.55 2.71 4.29 Normal STOP Uncomplicated 2.27 0.07 453.93 2.13 2.42 Overweight STOP Uncomplicated 2.17 0.08 612.00 2.02 2.33 Obese STOP Uncomplicated 2.03 0.09 528.47 1.87 2.22 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 2.40 0.36 1102.60 1.78 3.23 Overweight SCOPE GDM 2.60 0.35 1280.20 1.99 3.39 Obese SCOPE GDM 1.60 0.16 953.27 1.31 1.95 Underweight STOP GDM 2.69 0.73 1376.28 1.57 4.60 Normal STOP GDM 2.57 0.17 1215.58 2.25 2.93 Overweight STOP GDM 2.05 0.16 1324.58 1.76 2.38 Obese STOP GDM 2.17 0.11 795.49 1.96 2.40 49.3.3 Post-hoc comparisons 49.3.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE Uncomplicated 1.04 (0.72, 1.50) 1.0 Overweight / Underweight SCOPE Uncomplicated 0.92 (0.63, 1.33) 0.9 Overweight / Normal SCOPE Uncomplicated 0.88 (0.78, 1.00) 0.05 Obese / Underweight SCOPE Uncomplicated 0.77 (0.53, 1.12) 0.3 Obese / Normal SCOPE Uncomplicated 0.74 (0.64, 0.85) &lt;0.0001 Obese / Overweight SCOPE Uncomplicated 0.84 (0.72, 0.98) 0.02 Normal / Underweight STOP Uncomplicated 0.67 (0.49, 0.90) 0.004 Overweight / Underweight STOP Uncomplicated 0.64 (0.47, 0.87) 0.0010 Overweight / Normal STOP Uncomplicated 0.95 (0.86, 1.06) 0.7 Obese / Underweight STOP Uncomplicated 0.60 (0.44, 0.82) 0.0001 Obese / Normal STOP Uncomplicated 0.89 (0.79, 1.01) 0.09 Obese / Overweight STOP Uncomplicated 0.94 (0.82, 1.07) 0.6 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 1.08 (0.65, 1.81) 1.0 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.67 (0.42, 1.05) 0.1 Obese / Overweight SCOPE GDM 0.62 (0.40, 0.94) 0.02 Normal / Underweight STOP GDM 0.95 (0.47, 1.96) 1.0 Overweight / Underweight STOP GDM 0.76 (0.37, 1.57) 0.8 Overweight / Normal STOP GDM 0.80 (0.62, 1.02) 0.09 Obese / Underweight STOP GDM 0.81 (0.40, 1.64) 0.9 Obese / Normal STOP GDM 0.84 (0.69, 1.03) 0.1 Obese / Overweight STOP GDM 1.06 (0.85, 1.32) 0.9 49.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.1327493 0.2280461 1488.513 0.7631848 1.681272 0.536 ns STOP/SCOPE (Uncomplicated) 0.6397739 0.1190934 1482.053 0.4440650 0.921736 0.017 * STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/Uncomplicated (SCOPE) NA NA NA NA NA NA GDM/Uncomplicated (STOP) 1.4329362 0.4352380 1393.517 0.7896949 2.600126 0.236 ns "],["insulin-29.html", "49.4 Insulin", " 49.4 Insulin GEE for repeated measures. 49.4.1 Model summary Var Effect P (Intercept) 7.09 (3.53, 14.27) &lt;0.0001 BMI_gp3Normal 1.33 (0.82, 2.16) 0.24 BMI_gp3Overweight 1.77 (1.09, 2.87) 0.02 BMI_gp3Obese 2.49 (1.53, 4.06) 0.0002 GDM_newGDM 1.88 (1.46, 2.42) &lt;0.0001 StudySTOP 0.81 (0.44, 1.49) 0.50 GA_samp 1.01 (0.98, 1.05) 0.48 BMI_gp3Normal:StudySTOP 0.92 (0.50, 1.70) 0.80 BMI_gp3Overweight:StudySTOP 0.90 (0.49, 1.65) 0.73 BMI_gp3Obese:StudySTOP 1.03 (0.55, 1.90) 0.94 GDM_newGDM:StudySTOP 0.77 (0.57, 1.03) 0.08 49.4.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 8.28 1.99 Inf 5.17 13.27 Normal SCOPE Uncomplicated 11.05 0.90 Inf 9.41 12.97 Overweight SCOPE Uncomplicated 14.67 1.22 Inf 12.47 17.27 Obese SCOPE Uncomplicated 20.66 1.87 Inf 17.30 24.66 Underweight STOP Uncomplicated 6.73 1.26 Inf 4.67 9.70 Normal STOP Uncomplicated 8.29 0.44 Inf 7.47 9.21 Overweight STOP Uncomplicated 10.70 0.60 Inf 9.59 11.94 Obese STOP Uncomplicated 17.21 1.08 Inf 15.23 19.46 Underweight SCOPE GDM 15.56 4.24 Inf 9.11 26.56 Normal SCOPE GDM 20.76 3.02 Inf 15.60 27.61 Overweight SCOPE GDM 27.56 3.97 Inf 20.78 36.54 Obese SCOPE GDM 38.80 4.95 Inf 30.21 49.83 Underweight STOP GDM 9.74 1.92 Inf 6.61 14.34 Normal STOP GDM 12.00 1.04 Inf 10.12 14.23 Overweight STOP GDM 15.48 1.37 Inf 13.02 18.40 Obese STOP GDM 24.90 1.92 Inf 21.41 28.96 49.4.3 Post-hoc comparisons 49.4.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE Uncomplicated 1.33 (0.71, 2.51) 0.6 Overweight / Underweight SCOPE Uncomplicated 1.77 (0.94, 3.34) 0.09 Overweight / Normal SCOPE Uncomplicated 1.33 (1.02, 1.72) 0.03 Obese / Underweight SCOPE Uncomplicated 2.49 (1.32, 4.72) 0.001 Obese / Normal SCOPE Uncomplicated 1.87 (1.43, 2.44) &lt;0.0001 Obese / Overweight SCOPE Uncomplicated 1.41 (1.07, 1.85) 0.006 Normal / Underweight STOP Uncomplicated 1.23 (0.76, 2.00) 0.7 Overweight / Underweight STOP Uncomplicated 1.59 (0.98, 2.59) 0.07 Overweight / Normal STOP Uncomplicated 1.29 (1.09, 1.53) 0.0007 Obese / Underweight STOP Uncomplicated 2.56 (1.56, 4.18) &lt;0.0001 Obese / Normal STOP Uncomplicated 2.08 (1.73, 2.49) &lt;0.0001 Obese / Overweight STOP Uncomplicated 1.61 (1.33, 1.94) &lt;0.0001 Normal / Underweight SCOPE GDM 1.33 (0.71, 2.51) 0.6 Overweight / Underweight SCOPE GDM 1.77 (0.94, 3.34) 0.09 Overweight / Normal SCOPE GDM 1.33 (1.02, 1.72) 0.03 Obese / Underweight SCOPE GDM 2.49 (1.32, 4.72) 0.001 Obese / Normal SCOPE GDM 1.87 (1.43, 2.44) &lt;0.0001 Obese / Overweight SCOPE GDM 1.41 (1.07, 1.85) 0.006 Normal / Underweight STOP GDM 1.23 (0.76, 2.00) 0.7 Overweight / Underweight STOP GDM 1.59 (0.98, 2.59) 0.07 Overweight / Normal STOP GDM 1.29 (1.09, 1.53) 0.0007 Obese / Underweight STOP GDM 2.56 (1.56, 4.18) &lt;0.0001 Obese / Normal STOP GDM 2.08 (1.73, 2.49) &lt;0.0001 Obese / Overweight STOP GDM 1.61 (1.33, 1.94) &lt;0.0001 49.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.3777576 0.4618989 Inf 0.714174 2.657918 0.339 ns STOP/SCOPE (Uncomplicated) 0.9236378 0.2863924 Inf 0.503002 1.696031 0.798 ns STOP/SCOPE (GDM) 0.9236378 0.2863924 Inf 0.503002 1.696031 0.798 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.000000 1.000000 NA "],["homa-ir-29.html", "49.5 HOMA-IR", " 49.5 HOMA-IR GEE for repeated measures. 49.5.1 Model summary Var Effect P (Intercept) 1.71 (0.84, 3.49) 0.14 BMI_gp3Normal 1.39 (0.87, 2.23) 0.17 BMI_gp3Overweight 1.87 (1.16, 3.00) 0.010 BMI_gp3Obese 2.65 (1.64, 4.27) &lt;0.0001 GDM_newGDM 2.04 (1.52, 2.73) &lt;0.0001 StudySTOP 0.70 (0.39, 1.28) 0.25 GA_samp 1.01 (0.97, 1.04) 0.63 BMI_gp3Normal:StudySTOP 0.91 (0.50, 1.66) 0.76 BMI_gp3Overweight:StudySTOP 0.88 (0.48, 1.62) 0.69 BMI_gp3Obese:StudySTOP 1.05 (0.57, 1.94) 0.88 GDM_newGDM:StudySTOP 0.72 (0.52, 1.01) 0.06 49.5.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 1.91 0.45 Inf 1.21 3.03 Normal SCOPE Uncomplicated 2.66 0.23 Inf 2.25 3.16 Overweight SCOPE Uncomplicated 3.57 0.32 Inf 2.99 4.27 Obese SCOPE Uncomplicated 5.06 0.50 Inf 4.17 6.14 Underweight STOP Uncomplicated 1.35 0.25 Inf 0.93 1.95 Normal STOP Uncomplicated 1.71 0.09 Inf 1.53 1.90 Overweight STOP Uncomplicated 2.22 0.13 Inf 1.97 2.49 Obese STOP Uncomplicated 3.74 0.25 Inf 3.28 4.26 Underweight SCOPE GDM 3.90 1.08 Inf 2.26 6.71 Normal SCOPE GDM 5.43 0.89 Inf 3.93 7.49 Overweight SCOPE GDM 7.28 1.20 Inf 5.27 10.05 Obese SCOPE GDM 10.31 1.50 Inf 7.75 13.72 Underweight STOP GDM 1.99 0.40 Inf 1.34 2.94 Normal STOP GDM 2.52 0.23 Inf 2.10 3.01 Overweight STOP GDM 3.27 0.31 Inf 2.72 3.94 Obese STOP GDM 5.51 0.46 Inf 4.68 6.49 49.5.3 Post-hoc comparisons 49.5.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE Uncomplicated 1.39 (0.75, 2.58) 0.5 Overweight / Underweight SCOPE Uncomplicated 1.87 (1.00, 3.48) 0.05 Overweight / Normal SCOPE Uncomplicated 1.34 (1.01, 1.78) 0.04 Obese / Underweight SCOPE Uncomplicated 2.65 (1.41, 4.96) 0.0004 Obese / Normal SCOPE Uncomplicated 1.90 (1.42, 2.54) &lt;0.0001 Obese / Overweight SCOPE Uncomplicated 1.42 (1.05, 1.91) 0.01 Normal / Underweight STOP Uncomplicated 1.27 (0.78, 2.07) 0.6 Overweight / Underweight STOP Uncomplicated 1.65 (1.00, 2.70) 0.05 Overweight / Normal STOP Uncomplicated 1.30 (1.09, 1.56) 0.001 Obese / Underweight STOP Uncomplicated 2.78 (1.69, 4.57) &lt;0.0001 Obese / Normal STOP Uncomplicated 2.19 (1.81, 2.65) &lt;0.0001 Obese / Overweight STOP Uncomplicated 1.68 (1.38, 2.06) &lt;0.0001 Normal / Underweight SCOPE GDM 1.39 (0.75, 2.58) 0.5 Overweight / Underweight SCOPE GDM 1.87 (1.00, 3.48) 0.05 Overweight / Normal SCOPE GDM 1.34 (1.01, 1.78) 0.04 Obese / Underweight SCOPE GDM 2.65 (1.41, 4.96) 0.0004 Obese / Normal SCOPE GDM 1.90 (1.42, 2.54) &lt;0.0001 Obese / Overweight SCOPE GDM 1.42 (1.05, 1.91) 0.01 Normal / Underweight STOP GDM 1.27 (0.78, 2.07) 0.6 Overweight / Underweight STOP GDM 1.65 (1.00, 2.70) 0.05 Overweight / Normal STOP GDM 1.30 (1.09, 1.56) 0.001 Obese / Underweight STOP GDM 2.78 (1.69, 4.57) &lt;0.0001 Obese / Normal STOP GDM 2.19 (1.81, 2.65) &lt;0.0001 Obese / Overweight STOP GDM 1.68 (1.38, 2.06) &lt;0.0001 49.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.3526010 0.4564660 Inf 0.6980915 2.620759 0.371 ns STOP/SCOPE (Uncomplicated) 0.9106654 0.2797197 Inf 0.4987743 1.662699 0.761 ns STOP/SCOPE (GDM) 0.9106654 0.2797197 Inf 0.4987743 1.662699 0.761 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["glucose-29.html", "49.6 Glucose", " 49.6 Glucose GEE for repeated measures. 49.6.1 Model summary Var Effect P (Intercept) 5.24 (4.60, 5.97) &lt;0.0001 BMI_gp3Normal 1.05 (0.98, 1.14) 0.16 BMI_gp3Overweight 1.08 (0.99, 1.18) 0.08 BMI_gp3Obese 1.04 (0.96, 1.13) 0.29 GDM_newGDM 1.11 (1.00, 1.23) 0.05 StudySTOP 0.88 (0.81, 0.96) 0.005 GA_samp 1.00 (0.99, 1.01) 0.62 BMI_gp3Normal:StudySTOP 0.98 (0.90, 1.07) 0.66 BMI_gp3Overweight:StudySTOP 0.97 (0.87, 1.07) 0.52 BMI_gp3Obese:StudySTOP 1.03 (0.93, 1.13) 0.60 GDM_newGDM:StudySTOP 0.93 (0.83, 1.03) 0.16 49.6.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 5.12 0.19 Inf 4.77 5.50 Normal SCOPE Uncomplicated 5.40 0.09 Inf 5.23 5.58 Overweight SCOPE Uncomplicated 5.53 0.14 Inf 5.27 5.81 Obese SCOPE Uncomplicated 5.35 0.12 Inf 5.11 5.59 Underweight STOP Uncomplicated 4.51 0.11 Inf 4.30 4.73 Normal STOP Uncomplicated 4.66 0.05 Inf 4.56 4.77 Overweight STOP Uncomplicated 4.71 0.08 Inf 4.56 4.87 Obese STOP Uncomplicated 4.83 0.07 Inf 4.69 4.98 Underweight SCOPE GDM 5.68 0.35 Inf 5.04 6.40 Normal SCOPE GDM 5.99 0.29 Inf 5.46 6.58 Overweight SCOPE GDM 6.14 0.37 Inf 5.45 6.92 Obese SCOPE GDM 5.93 0.27 Inf 5.42 6.48 Underweight STOP GDM 4.63 0.13 Inf 4.39 4.89 Normal STOP GDM 4.79 0.08 Inf 4.63 4.96 Overweight STOP GDM 4.84 0.09 Inf 4.67 5.02 Obese STOP GDM 4.96 0.08 Inf 4.81 5.12 49.6.3 Post-hoc comparisons 49.6.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE Uncomplicated 1.05 (0.96, 1.16) 0.5 Overweight / Underweight SCOPE Uncomplicated 1.08 (0.97, 1.21) 0.3 Overweight / Normal SCOPE Uncomplicated 1.02 (0.95, 1.11) 0.9 Obese / Underweight SCOPE Uncomplicated 1.04 (0.94, 1.16) 0.7 Obese / Normal SCOPE Uncomplicated 0.99 (0.93, 1.05) 1.0 Obese / Overweight SCOPE Uncomplicated 0.97 (0.88, 1.06) 0.8 Normal / Underweight STOP Uncomplicated 1.03 (0.97, 1.10) 0.6 Overweight / Underweight STOP Uncomplicated 1.05 (0.97, 1.12) 0.4 Overweight / Normal STOP Uncomplicated 1.01 (0.96, 1.06) 0.9 Obese / Underweight STOP Uncomplicated 1.07 (1.00, 1.15) 0.06 Obese / Normal STOP Uncomplicated 1.04 (0.99, 1.08) 0.2 Obese / Overweight STOP Uncomplicated 1.02 (0.97, 1.08) 0.6 Normal / Underweight SCOPE GDM 1.05 (0.96, 1.16) 0.5 Overweight / Underweight SCOPE GDM 1.08 (0.97, 1.21) 0.3 Overweight / Normal SCOPE GDM 1.02 (0.95, 1.11) 0.9 Obese / Underweight SCOPE GDM 1.04 (0.94, 1.16) 0.7 Obese / Normal SCOPE GDM 0.99 (0.93, 1.05) 1.0 Obese / Overweight SCOPE GDM 0.97 (0.88, 1.06) 0.8 Normal / Underweight STOP GDM 1.03 (0.97, 1.10) 0.6 Overweight / Underweight STOP GDM 1.05 (0.97, 1.12) 0.4 Overweight / Normal STOP GDM 1.01 (0.96, 1.06) 0.9 Obese / Underweight STOP GDM 1.07 (1.00, 1.15) 0.06 Obese / Normal STOP GDM 1.04 (0.99, 1.08) 0.2 Obese / Overweight STOP GDM 1.02 (0.97, 1.08) 0.6 49.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9078294 0.0553357 Inf 0.8056014 1.023030 0.113 ns STOP/SCOPE (Uncomplicated) 0.9800936 0.0445386 Inf 0.8965742 1.071393 0.658 ns STOP/SCOPE (GDM) 0.9800936 0.0445386 Inf 0.8965742 1.071393 0.658 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["age-bmi-groups-4.html", "50 Age &amp; BMI groups", " 50 Age &amp; BMI groups Descriptives with univariate P-values. Within Uncomplicated Characteristic &lt;35 yrs, non-obese (n=968) &lt;35 yrs, obese (n=283) &gt;=35 yrs, non-obese (n=26) &gt;=35 yrs, obese (n=15) Total (n=1292) P-value PRL (ng/ml): Median (IQ range) 102.6 (62.6-164.4) 81.7 (49.5-132.4) 79.2 (52.1-95.7) 45.1 (32.3-103.1) 96.8 (58.3-157.1) &lt;0.0001 hPL (μg/ml): Median (IQ range) 120.8 (58.4-189.2) 73.8 (43.5-145.4) 81.8 (58.5-136.1) 81.2 (33.9-129.1) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.4) 2.2 (1.0-3.3) 2.1 (1.2-3.7) 2.1 (1.6-3.0) 2.5 (1.2-4.1) 0.0004 Insulin (uU/ml): Median (IQ range) 9.3 (5.2-19.2) 16.1 (9.7-31.6) 8.5 (4.6-16.8) 11.6 (8.8-23.2) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.1-4.4) 3.6 (2.2-7.0) 2.1 (0.9-3.7) 2.6 (1.7-5.2) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.7-5.6) 5.0 (4.4-5.4) 4.7 (4.5-5.2) 5.0 (4.6-5.5) 0.02 Within GDM Characteristic &lt;35 yrs, non-obese (n=110) &lt;35 yrs, obese (n=116) &gt;=35 yrs, non-obese (n=9) &gt;=35 yrs, obese (n=16) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 81.4 (43.4-131.9) 73.3 (46.7-113.2) 110.7 (89.5-156.8) 51.4 (41.1-62.6) 73.3 (45.3-120.9) 0.08 hPL (μg/ml): Median (IQ range) 83.2 (51.0-108.8) 55.7 (37.4-79.9) 68.1 (47.9-126.8) 25.8 (19.4-35.7) 61.4 (37.6-98.5) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.7 (1.0-2.9) 1.3 (1.0-2.3) 1.2 (1.0-2.2) 1.3 (1.0-1.8) 1.5 (1.0-2.6) 0.47 Insulin (uU/ml): Median (IQ range) 11.9 (6.6-30.3) 26.6 (15.7-50.8) 9.4 (7.8-13.3) 16.9 (12.5-27.9) 17.3 (9.4-40.4) &lt;0.0001 HOMA-IR: Median (IQ range) 2.4 (1.4-6.4) 5.9 (3.3-12.1) 2.0 (1.4-3.0) 3.9 (2.5-6.8) 3.8 (1.9-9.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.4) 5.1 (4.6-5.8) 4.8 (4.5-5.2) 5.0 (4.8-5.4) 4.9 (4.5-5.6) 0.05 Click here for table within SCOPE Within Uncomplicated Characteristic &lt;35 yrs, non-obese (n=453) &lt;35 yrs, obese (n=129) &gt;=35 yrs, non-obese (n=10) &gt;=35 yrs, obese (n=6) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 142.7 (100.7-221.2) 131.3 (82.8-196.2) 134.9 (82.4-210.6) 85.0 (45.7-124.5) 139.9 (94.7-215.5) 0.12 hPL (μg/ml): Median (IQ range) 192.3 (157.8-226.8) 153.3 (130.7-180.3) 168.6 (136.6-202.0) 160.7 (98.5-202.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.4 (3.4-6.0) 3.4 (2.6-4.4) 3.8 (3.4-4.7) 4.5 (2.7-6.9) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/ml): Median (IQ range) 13.4 (5.8-25.7) 20.1 (9.7-34.8) 11.3 (8.1-20.2) 50.4 (39.0-53.5) 14.4 (6.5-29.1) 0.0007 HOMA-IR: Median (IQ range) 3.1 (1.3-6.4) 4.6 (2.3-9.0) 2.7 (2.1-4.8) 14.0 (10.0-15.8) 3.3 (1.5-7.2) 0.001 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.1-5.9) 5.4 (5.2-5.8) 5.5 (5.1-6.1) 5.4 (5.0-5.8) 0.90 Serum folate concentration (nM): Median (IQ range) 37.0 (29.3-43.1) 35.5 (24.7-43.3) 40.3 (34.0-43.1) 32.7 (31.3-36.9) 36.6 (28.6-43.1) 0.52 B12 concentration (pM): Median (IQ range) 253.5 (199.0-320.5) 226.0 (181.5-288.8) 313.0 (235.5-352.5) 227.5 (181.2-249.0) 248.0 (195.0-316.0) 0.01 Folate:B12 ratio: Median (IQ range) 143.1 (104.6-208.7) 143.3 (102.9-216.0) 119.2 (114.4-177.6) 153.9 (126.0-192.9) 143.0 (104.5-208.8) 0.97 Active B12 concentration (pM): Median (IQ range) 53.5 (42.0-72.0) 60.0 (43.2-71.0) 48.0 (48.0-48.0) 74.0 (52.0-93.0) 54.0 (42.5-72.0) 0.43 Folate:Active B12 ratio: Median (IQ range) 638.6 (472.9-1019.3) 548.7 (449.2-703.5) 794.8 (740.1-849.5) 400.0 (360.2-420.3) 617.5 (461.2-937.5) 0.01 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-4.9) 4.4 (3.8-5.0) 4.3 (4.0-4.6) 4.3 (3.9-4.6) 4.4 (3.8-4.9) 1.00 Within GDM Characteristic &lt;35 yrs, non-obese (n=27) &lt;35 yrs, obese (n=29) &gt;=35 yrs, non-obese (n=0) &gt;=35 yrs, obese (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 119.0 (87.4-179.1) 79.6 (59.7-120.5) NA (NA-NA) 25.7 (14.6-36.7) 92.0 (62.0-147.2) – hPL (μg/ml): Median (IQ range) 105.8 (91.4-170.8) 113.3 (90.4-133.9) NA (NA-NA) 36.0 (36.0-36.0) 106.2 (85.6-134.2) – GH2 (ng/ml): Median (IQ range) 3.3 (2.6-4.5) 2.0 (1.5-3.1) NA (NA-NA) 1.8 (1.8-1.8) 2.7 (1.6-4.2) – Insulin (uU/ml): Median (IQ range) 17.1 (11.5-39.8) 41.4 (27.2-67.4) NA (NA-NA) 52.7 (35.0-70.4) 34.0 (16.6-55.4) – HOMA-IR: Median (IQ range) 4.3 (3.1-11.4) 10.0 (5.6-17.4) NA (NA-NA) 13.7 (9.1-18.4) 8.1 (3.6-17.4) – Glucose (mmol/L): Median (IQ range) 5.6 (5.1-6.4) 6.0 (5.6-6.7) NA (NA-NA) 5.8 (5.8-5.9) 5.8 (5.2-6.6) – Serum folate concentration (nM): Median (IQ range) 41.3 (34.2-44.6) 38.0 (31.1-42.9) NA (NA-NA) 86.0 (63.5-108.6) 40.1 (32.0-43.8) – B12 concentration (pM): Median (IQ range) 268.0 (212.5-350.0) 245.0 (192.0-314.0) NA (NA-NA) 205.0 (200.0-210.0) 253.5 (194.2-333.0) – Folate:B12 ratio: Median (IQ range) 150.3 (114.2-232.5) 167.7 (115.9-185.4) NA (NA-NA) 410.0 (309.9-510.1) 158.9 (116.5-210.2) – Active B12 concentration (pM): Median (IQ range) 63.0 (56.5-99.2) 77.0 (54.0-82.5) NA (NA-NA) 67.5 (50.8-84.2) 68.0 (55.0-86.0) – Folate:Active B12 ratio: Median (IQ range) 540.4 (321.6-674.3) 553.8 (524.6-575.9) NA (NA-NA) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) – Homocysteine concentration (μM): Median (IQ range) 4.2 (3.8-4.8) 3.7 (3.5-4.2) NA (NA-NA) 4.1 (3.5-4.7) 3.9 (3.6-4.6) – Click here for table within STOP Within Uncomplicated Characteristic &lt;35 yrs, non-obese (n=515) &lt;35 yrs, obese (n=154) &gt;=35 yrs, non-obese (n=16) &gt;=35 yrs, obese (n=9) Total (n=694) P-value PRL (ng/ml): Median (IQ range) 76.3 (52.4-119.1) 62.9 (40.9-99.3) 72.9 (50.0-90.3) 41.2 (32.3-60.9) 72.9 (48.6-113.6) 0.001 hPL (μg/ml): Median (IQ range) 66.5 (44.4-101.1) 50.5 (34.5-71.7) 68.1 (49.4-83.4) 60.2 (33.9-90.7) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.6 (1.1-2.1) 1.6 (1.3-2.4) 1.4 (0.9-2.4) 0.10 Serum folate concentration (nM): Median (IQ range) 40.4 (36.5-44.8) 40.0 (35.4-44.9) 44.8 (41.0-83.9) 67.8 (41.9-101.1) 40.5 (36.4-45.2) 0.006 B12 concentration (pM): Median (IQ range) 285.0 (223.5-362.0) 260.5 (218.0-331.0) 267.5 (235.5-370.5) 274.5 (191.2-381.8) 279.0 (220.5-356.0) 0.20 Folate:B12 ratio: Median (IQ range) 152.2 (114.8-218.8) 166.1 (116.2-223.3) 171.2 (128.5-335.7) 247.5 (164.3-392.4) 155.4 (115.1-222.2) 0.12 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-81.0) 62.0 (51.2-76.0) 68.0 (55.0-100.0) 55.0 (51.5-61.0) 63.0 (48.0-80.8) 0.76 Folate:Active B12 ratio: Median (IQ range) 686.8 (485.9-954.7) 637.7 (516.0-914.2) 527.9 (444.1-965.5) 765.5 (689.4-1420.2) 670.3 (491.4-950.5) 0.76 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.5) 4.9 (4.3-5.7) 5.2 (4.5-6.1) 4.9 (4.6-5.4) 4.8 (4.3-5.6) 0.55 Within GDM Characteristic &lt;35 yrs, non-obese (n=83) &lt;35 yrs, obese (n=87) &gt;=35 yrs, non-obese (n=9) &gt;=35 yrs, obese (n=14) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 73.7 (41.0-122.2) 73.0 (44.0-111.6) 110.7 (89.5-156.8) 52.3 (42.3-65.6) 68.8 (42.6-114.0) 0.27 hPL (μg/ml): Median (IQ range) 69.4 (46.6-106.0) 50.2 (36.2-72.4) 68.1 (47.9-126.8) 25.0 (18.5-34.8) 57.0 (35.8-84.1) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.6 (0.9-2.2) 1.3 (0.9-2.2) 1.2 (1.0-2.2) 1.1 (1.0-1.8) 1.3 (0.9-2.2) 0.74 Serum folate concentration (nM): Median (IQ range) 40.7 (36.2-47.4) 38.9 (34.3-43.1) 44.2 (41.0-64.4) 41.0 (35.9-64.4) 40.2 (35.4-45.1) 0.03 B12 concentration (pM): Median (IQ range) 285.0 (231.0-360.0) 266.0 (216.4-306.0) 194.0 (148.0-319.0) 330.0 (222.2-388.5) 273.5 (216.8-352.0) 0.05 Folate:B12 ratio: Median (IQ range) 143.3 (106.3-212.0) 150.2 (116.7-204.1) 197.4 (136.4-447.2) 127.1 (91.8-262.1) 148.0 (111.3-220.6) 0.29 Active B12 concentration (pM): Median (IQ range) 68.5 (55.0-89.0) 78.0 (58.0-91.0) 62.0 (49.0-65.0) 77.0 (75.5-84.2) 74.5 (56.2-90.2) 0.47 Folate:Active B12 ratio: Median (IQ range) 573.3 (461.9-838.0) 505.4 (407.4-633.8) 836.9 (781.6-1038.7) 755.0 (548.3-1065.0) 531.9 (419.6-786.4) 0.09 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.0-5.5) 4.8 (4.0-5.3) 4.9 (4.1-5.3) 4.8 (4.5-4.9) 4.8 (4.0-5.3) 0.99 "],["prolactin-32.html", "50.1 Prolactin", " 50.1 Prolactin LME for repeated measures. 50.1.1 Model summary Var Effect P (Intercept) 14.76 (9.96, 21.88) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.87 (0.75, 1.00) 0.06 Age_BMI_gp&gt;=35 yrs, non-obese 1.00 (0.63, 1.61) 1.00 Age_BMI_gp&gt;=35 yrs, obese 0.61 (0.35, 1.04) 0.07 GDM_newGDM 1.10 (0.82, 1.46) 0.53 StudySTOP 0.97 (0.86, 1.11) 0.70 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.92 (0.77, 1.12) 0.41 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.77 (0.44, 1.36) 0.37 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.97 (0.48, 1.96) 0.94 GDM_newGDM:StudySTOP 0.96 (0.70, 1.32) 0.79 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM 0.73 (0.49, 1.11) 0.14 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 1.55 (0.92, 2.61) 0.10 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 0.63 (0.25, 1.62) 0.34 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 1.47 (0.92, 2.35) 0.10 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 1.90 (0.63, 5.73) 0.25 50.1.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 100.58 8.23 111.44 85.52 118.29 &lt;35 yrs, obese SCOPE Uncomplicated 87.12 8.72 236.95 71.54 106.10 &gt;=35 yrs, non-obese SCOPE Uncomplicated 100.72 25.24 1329.03 61.61 164.66 &gt;=35 yrs, obese SCOPE Uncomplicated 60.86 17.27 1438.69 34.88 106.19 &lt;35 yrs, non-obese STOP Uncomplicated 98.02 7.36 79.92 84.41 113.83 &lt;35 yrs, obese STOP Uncomplicated 78.47 7.13 162.64 65.58 93.90 &gt;=35 yrs, non-obese STOP Uncomplicated 75.85 13.07 1038.23 54.10 106.36 &gt;=35 yrs, obese STOP Uncomplicated 57.66 13.78 1358.05 36.08 92.15 &lt;35 yrs, non-obese SCOPE GDM 110.24 17.48 852.13 80.76 150.49 &lt;35 yrs, obese SCOPE GDM 70.15 11.27 795.11 51.17 96.15 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 42.20 15.96 548.60 20.08 88.69 &lt;35 yrs, non-obese STOP GDM 102.97 10.44 244.27 84.32 125.73 &lt;35 yrs, obese STOP GDM 89.23 9.01 240.90 73.13 108.87 &gt;=35 yrs, non-obese STOP GDM 123.39 26.63 1252.79 80.80 188.42 &gt;=35 yrs, obese STOP GDM 72.97 13.68 1141.69 50.51 105.42 50.1.3 Post-hoc comparisons 50.1.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.87 (0.71, 1.05) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 1.00 (0.54, 1.86) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE Uncomplicated 1.16 (0.61, 2.20) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.61 (0.30, 1.23) 0.3 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE Uncomplicated 0.70 (0.34, 1.44) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE Uncomplicated 0.60 (0.24, 1.55) 0.5 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.80 (0.68, 0.94) 0.003 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.77 (0.51, 1.17) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP Uncomplicated 0.97 (0.63, 1.48) 1.0 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.59 (0.32, 1.07) 0.10 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP Uncomplicated 0.73 (0.40, 1.34) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP Uncomplicated 0.76 (0.37, 1.55) 0.8 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.64 (0.39, 1.05) 0.09 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.38 (0.14, 1.06) 0.07 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 0.60 (0.22, 1.67) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.87 (0.68, 1.11) 0.4 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 1.20 (0.69, 2.08) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.38 (0.80, 2.40) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.71 (0.44, 1.14) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.82 (0.51, 1.31) 0.7 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.59 (0.30, 1.17) 0.2 50.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.6623506 0.3079152 1426.749 0.2660990 1.648666 0.376 ns STOP/SCOPE (Uncomplicated) 0.9241665 0.0890523 1408.484 0.7649944 1.116457 0.413 ns STOP/SCOPE (GDM) 1.3619455 0.2941015 1241.372 0.8915999 2.080412 0.153 ns GDM/Uncomplicated (SCOPE) 0.7345357 0.1538749 1198.389 0.4869875 1.107919 0.141 ns GDM/Uncomplicated (STOP) 1.0824864 0.1244474 1409.912 0.8639338 1.356327 0.491 ns "],["hpl-32.html", "50.2 HPL", " 50.2 HPL LME for repeated measures. 50.2.1 Model summary Var Effect P (Intercept) 2.11 (1.73, 2.57) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.83 (0.77, 0.89) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.98 (0.76, 1.26) 0.87 Age_BMI_gp&gt;=35 yrs, obese 0.72 (0.56, 0.94) 0.02 GDM_newGDM 0.91 (0.80, 1.04) 0.17 StudySTOP 1.11 (1.04, 1.19) 0.002 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.98 (0.89, 1.07) 0.61 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.06 (0.79, 1.43) 0.71 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.02 (0.72, 1.46) 0.90 GDM_newGDM:StudySTOP 1.21 (1.04, 1.40) 0.02 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM 1.05 (0.87, 1.28) 0.60 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 0.82 (0.62, 1.07) 0.14 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 1.17 (0.73, 1.87) 0.52 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 0.87 (0.70, 1.10) 0.25 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 0.56 (0.32, 0.98) 0.04 50.2.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 92.17 2.67 234.61 87.06 97.59 &lt;35 yrs, obese SCOPE Uncomplicated 76.29 3.07 622.35 70.50 82.56 &gt;=35 yrs, non-obese SCOPE Uncomplicated 90.22 11.63 1430.69 70.06 116.18 &gt;=35 yrs, obese SCOPE Uncomplicated 66.77 9.08 1233.43 51.14 87.18 &lt;35 yrs, non-obese STOP Uncomplicated 102.37 2.50 125.98 97.54 107.44 &lt;35 yrs, obese STOP Uncomplicated 82.64 2.99 384.58 76.97 88.73 &gt;=35 yrs, non-obese STOP Uncomplicated 106.05 8.97 1437.11 89.83 125.20 &gt;=35 yrs, obese STOP Uncomplicated 75.89 9.17 1445.02 59.88 96.18 &lt;35 yrs, non-obese SCOPE GDM 83.86 5.80 778.40 73.21 96.06 &lt;35 yrs, obese SCOPE GDM 73.15 5.29 678.56 63.47 84.31 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 71.10 13.54 452.43 48.90 103.37 &lt;35 yrs, non-obese STOP GDM 112.25 4.86 665.32 103.10 122.22 &lt;35 yrs, obese STOP GDM 83.48 3.59 653.02 76.72 90.84 &gt;=35 yrs, non-obese STOP GDM 94.88 10.15 1223.16 76.92 117.04 &gt;=35 yrs, obese STOP GDM 54.64 5.07 1435.02 45.54 65.55 50.2.3 Post-hoc comparisons 50.2.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.83 (0.75, 0.91) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.98 (0.70, 1.36) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE Uncomplicated 1.18 (0.84, 1.66) 0.6 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.72 (0.51, 1.03) 0.08 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE Uncomplicated 0.88 (0.61, 1.25) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE Uncomplicated 0.74 (0.46, 1.19) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.81 (0.74, 0.88) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP Uncomplicated 1.04 (0.84, 1.28) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP Uncomplicated 1.28 (1.03, 1.60) 0.02 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.74 (0.54, 1.01) 0.06 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP Uncomplicated 0.92 (0.67, 1.26) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP Uncomplicated 0.72 (0.49, 1.04) 0.09 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.87 (0.69, 1.11) 0.5 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.85 (0.51, 1.42) 0.8 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 0.97 (0.58, 1.63) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.74 (0.65, 0.85) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.85 (0.64, 1.12) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.14 (0.85, 1.51) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.49 (0.38, 0.62) &lt;0.0001 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.65 (0.51, 0.84) &lt;0.0001 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.58 (0.40, 0.82) 0.0004 50.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.7926550 0.1892968 1411.0593 0.4961708 1.266302 0.331 ns STOP/SCOPE (Uncomplicated) 0.9753258 0.0481629 1380.9412 0.8852774 1.074534 0.613 ns STOP/SCOPE (GDM) 0.8525700 0.0899444 856.0971 0.6931110 1.048714 0.131 ns GDM/Uncomplicated (SCOPE) 1.0538514 0.1059063 733.1645 0.8651608 1.283695 0.602 ns GDM/Uncomplicated (STOP) 0.9212122 0.0560185 1440.8980 0.8176266 1.037921 0.177 ns "],["gh2-32.html", "50.3 GH2", " 50.3 GH2 LME for repeated measures. 50.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.11) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.77 (0.70, 0.86) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.94 (0.68, 1.30) 0.71 Age_BMI_gp&gt;=35 yrs, obese 0.84 (0.57, 1.25) 0.40 GDM_newGDM 1.04 (0.85, 1.28) 0.69 StudySTOP 0.94 (0.86, 1.03) 0.20 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.17 (1.03, 1.34) 0.02 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.09 (0.73, 1.62) 0.67 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.06 (0.63, 1.76) 0.84 GDM_newGDM:StudySTOP 0.99 (0.79, 1.24) 0.91 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM 0.83 (0.61, 1.11) 0.21 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 1.11 (0.75, 1.62) 0.61 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 0.77 (0.37, 1.61) 0.49 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 1.23 (0.88, 1.73) 0.23 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 1.50 (0.65, 3.51) 0.35 50.3.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 2.40 0.08 508.78 2.24 2.57 &lt;35 yrs, obese SCOPE Uncomplicated 1.85 0.10 1086.33 1.67 2.06 &gt;=35 yrs, non-obese SCOPE Uncomplicated 2.25 0.38 1327.35 1.62 3.12 &gt;=35 yrs, obese SCOPE Uncomplicated 2.03 0.40 1464.96 1.37 2.99 &lt;35 yrs, non-obese STOP Uncomplicated 2.26 0.06 278.45 2.14 2.38 &lt;35 yrs, obese STOP Uncomplicated 2.05 0.09 570.40 1.88 2.24 &gt;=35 yrs, non-obese STOP Uncomplicated 2.31 0.26 1479.53 1.85 2.90 &gt;=35 yrs, obese STOP Uncomplicated 2.01 0.34 1388.55 1.44 2.80 &lt;35 yrs, non-obese SCOPE GDM 2.50 0.26 1388.47 2.04 3.06 &lt;35 yrs, obese SCOPE GDM 1.59 0.17 969.19 1.29 1.97 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 1.63 0.49 793.88 0.90 2.95 &lt;35 yrs, non-obese STOP GDM 2.32 0.13 946.17 2.08 2.59 &lt;35 yrs, obese STOP GDM 2.14 0.12 914.45 1.92 2.38 &gt;=35 yrs, non-obese STOP GDM 2.63 0.40 1488.56 1.95 3.55 &gt;=35 yrs, obese STOP GDM 2.41 0.31 1386.86 1.87 3.10 50.3.3 Post-hoc comparisons 50.3.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.77 (0.67, 0.89) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.94 (0.61, 1.44) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE Uncomplicated 1.21 (0.78, 1.89) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.84 (0.51, 1.41) 0.8 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE Uncomplicated 1.09 (0.65, 1.84) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE Uncomplicated 0.90 (0.46, 1.75) 1.0 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.91 (0.81, 1.02) 0.1 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP Uncomplicated 1.03 (0.76, 1.38) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP Uncomplicated 1.13 (0.83, 1.54) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.89 (0.58, 1.38) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP Uncomplicated 0.98 (0.63, 1.53) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP Uncomplicated 0.87 (0.52, 1.46) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.64 (0.44, 0.92) 0.010 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.65 (0.29, 1.48) 0.5 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.02 (0.45, 2.33) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.92 (0.77, 1.11) 0.7 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 1.13 (0.75, 1.71) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.23 (0.82, 1.85) 0.6 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.04 (0.73, 1.47) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 1.12 (0.79, 1.59) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.91 (0.55, 1.52) 1.0 50.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.1147321 0.3718226 1465.062 0.5794483 2.144502 0.745 ns STOP/SCOPE (Uncomplicated) 1.1740137 0.0810988 1463.692 1.0252387 1.344378 0.020 * STOP/SCOPE (GDM) 1.4462095 0.2303471 1341.423 1.0581139 1.976651 0.021 * GDM/Uncomplicated (SCOPE) 0.8250411 0.1266625 1280.320 0.6104825 1.115008 0.211 ns GDM/Uncomplicated (STOP) 1.0163274 0.0851217 1491.086 0.8623509 1.197797 0.847 ns "],["insulin-30.html", "50.4 Insulin", " 50.4 Insulin GEE for repeated measures. 50.4.1 Model summary Var Effect P (Intercept) 10.73 (6.38, 18.03) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 1.66 (1.38, 2.00) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.97 (0.66, 1.42) 0.88 Age_BMI_gp&gt;=35 yrs, obese 2.05 (1.26, 3.34) 0.004 GDM_newGDM 1.89 (1.45, 2.47) &lt;0.0001 StudySTOP 0.74 (0.62, 0.89) 0.001 GA_samp 1.01 (0.98, 1.04) 0.53 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.17 (0.93, 1.47) 0.18 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.89 (0.54, 1.48) 0.66 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.63 (0.36, 1.08) 0.09 GDM_newGDM:StudySTOP 0.78 (0.58, 1.06) 0.12 50.4.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 12.31 0.81 Inf 10.81 14.01 &lt;35 yrs, obese SCOPE Uncomplicated 20.39 1.89 Inf 17.00 24.46 &gt;=35 yrs, non-obese SCOPE Uncomplicated 11.94 2.30 Inf 8.18 17.42 &gt;=35 yrs, obese SCOPE Uncomplicated 25.23 6.30 Inf 15.47 41.15 &lt;35 yrs, non-obese STOP Uncomplicated 9.11 0.40 Inf 8.35 9.93 &lt;35 yrs, obese STOP Uncomplicated 17.64 1.14 Inf 15.54 20.02 &gt;=35 yrs, non-obese STOP Uncomplicated 7.89 1.32 Inf 5.68 10.96 &gt;=35 yrs, obese STOP Uncomplicated 11.69 1.46 Inf 9.16 14.92 &lt;35 yrs, non-obese SCOPE GDM 23.27 3.33 Inf 17.57 30.81 &lt;35 yrs, obese SCOPE GDM 38.55 5.31 Inf 29.44 50.50 &gt;=35 yrs, non-obese SCOPE GDM 22.57 5.33 Inf 14.20 35.86 &gt;=35 yrs, obese SCOPE GDM 47.71 12.07 Inf 29.06 78.32 &lt;35 yrs, non-obese STOP GDM 13.48 1.12 Inf 11.45 15.87 &lt;35 yrs, obese STOP GDM 26.10 2.13 Inf 22.25 30.62 &gt;=35 yrs, non-obese STOP GDM 11.68 2.00 Inf 8.35 16.34 &gt;=35 yrs, obese STOP GDM 17.30 2.13 Inf 13.59 22.02 50.4.3 Post-hoc comparisons 50.4.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 1.66 (1.30, 2.11) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.97 (0.59, 1.60) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE Uncomplicated 0.59 (0.34, 0.99) 0.05 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 2.05 (1.08, 3.89) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE Uncomplicated 1.24 (0.65, 2.37) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE Uncomplicated 2.11 (0.95, 4.69) 0.07 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 1.94 (1.63, 2.30) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.87 (0.56, 1.33) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP Uncomplicated 0.45 (0.29, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 1.28 (0.93, 1.77) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP Uncomplicated 0.66 (0.48, 0.92) 0.008 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP Uncomplicated 1.48 (0.89, 2.47) 0.2 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 1.66 (1.30, 2.11) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM 0.97 (0.59, 1.60) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM 0.59 (0.34, 0.99) 0.05 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 2.05 (1.08, 3.89) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.24 (0.65, 2.37) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM 2.11 (0.95, 4.69) 0.07 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.94 (1.63, 2.30) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.87 (0.56, 1.33) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 0.45 (0.29, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.28 (0.93, 1.77) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.66 (0.48, 0.92) 0.008 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 1.48 (0.89, 2.47) 0.2 50.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9761825 0.3734941 Inf 0.4611641 2.066363 0.950 ns STOP/SCOPE (Uncomplicated) 1.1686509 0.1354989 Inf 0.9310918 1.466821 0.179 ns STOP/SCOPE (GDM) 1.1686509 0.1354989 Inf 0.9310918 1.466821 0.179 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["homa-ir-30.html", "50.5 HOMA-IR", " 50.5 HOMA-IR GEE for repeated measures. 50.5.1 Model summary Var Effect P (Intercept) 2.71 (1.57, 4.68) 0.0004 Age_BMI_gp&lt;35 yrs, obese 1.68 (1.37, 2.06) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.01 (0.67, 1.53) 0.96 Age_BMI_gp&gt;=35 yrs, obese 2.13 (1.24, 3.68) 0.006 GDM_newGDM 2.05 (1.51, 2.79) &lt;0.0001 StudySTOP 0.63 (0.52, 0.77) &lt;0.0001 GA_samp 1.01 (0.97, 1.04) 0.69 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.22 (0.95, 1.56) 0.12 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.86 (0.50, 1.47) 0.57 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.61 (0.33, 1.11) 0.11 GDM_newGDM:StudySTOP 0.74 (0.52, 1.04) 0.08 50.5.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 2.97 0.21 Inf 2.59 3.41 &lt;35 yrs, obese SCOPE Uncomplicated 4.99 0.50 Inf 4.09 6.08 &gt;=35 yrs, non-obese SCOPE Uncomplicated 3.00 0.63 Inf 1.99 4.53 &gt;=35 yrs, obese SCOPE Uncomplicated 6.34 1.77 Inf 3.68 10.95 &lt;35 yrs, non-obese STOP Uncomplicated 1.88 0.09 Inf 1.71 2.06 &lt;35 yrs, obese STOP Uncomplicated 3.84 0.26 Inf 3.35 4.39 &gt;=35 yrs, non-obese STOP Uncomplicated 1.62 0.29 Inf 1.14 2.30 &gt;=35 yrs, obese STOP Uncomplicated 2.44 0.31 Inf 1.90 3.14 &lt;35 yrs, non-obese SCOPE GDM 6.10 0.99 Inf 4.44 8.38 &lt;35 yrs, obese SCOPE GDM 10.23 1.60 Inf 7.52 13.91 &gt;=35 yrs, non-obese SCOPE GDM 6.16 1.61 Inf 3.69 10.28 &gt;=35 yrs, obese SCOPE GDM 13.02 3.67 Inf 7.49 22.63 &lt;35 yrs, non-obese STOP GDM 2.84 0.25 Inf 2.38 3.38 &lt;35 yrs, obese STOP GDM 5.80 0.52 Inf 4.87 6.91 &gt;=35 yrs, non-obese STOP GDM 2.45 0.44 Inf 1.72 3.50 &gt;=35 yrs, obese STOP GDM 3.69 0.46 Inf 2.89 4.72 50.5.3 Post-hoc comparisons 50.5.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 1.68 (1.29, 2.19) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 1.01 (0.58, 1.75) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE Uncomplicated 0.60 (0.34, 1.07) 0.1 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 2.13 (1.04, 4.36) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE Uncomplicated 1.27 (0.62, 2.62) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE Uncomplicated 2.11 (0.87, 5.11) 0.1 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 2.04 (1.70, 2.45) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.86 (0.55, 1.36) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP Uncomplicated 0.42 (0.27, 0.67) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 1.30 (0.94, 1.81) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP Uncomplicated 0.64 (0.45, 0.90) 0.004 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP Uncomplicated 1.51 (0.88, 2.57) 0.2 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 1.68 (1.29, 2.19) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM 1.01 (0.58, 1.75) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM 0.60 (0.34, 1.07) 0.1 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 2.13 (1.04, 4.36) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.27 (0.62, 2.62) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM 2.11 (0.87, 5.11) 0.1 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 2.04 (1.70, 2.45) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.86 (0.55, 1.36) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 0.42 (0.27, 0.67) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.30 (0.94, 1.81) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.64 (0.45, 0.90) 0.004 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 1.51 (0.88, 2.57) 0.2 50.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9270661 0.3862837 Inf 0.4096734 2.097895 0.856 ns STOP/SCOPE (Uncomplicated) 1.2187621 0.1532544 Inf 0.9525412 1.559388 0.116 ns STOP/SCOPE (GDM) 1.2187621 0.1532544 Inf 0.9525412 1.559388 0.116 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["glucose-30.html", "50.6 Glucose", " 50.6 Glucose GEE for repeated measures. 50.6.1 Model summary Var Effect P (Intercept) 5.57 (4.99, 6.21) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.98 (0.93, 1.03) 0.36 Age_BMI_gp&gt;=35 yrs, non-obese 1.00 (0.94, 1.06) 0.95 Age_BMI_gp&gt;=35 yrs, obese 1.05 (0.91, 1.22) 0.50 GDM_newGDM 1.11 (1.00, 1.24) 0.05 StudySTOP 0.86 (0.83, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.65 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.06 (1.00, 1.13) 0.07 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.99 (0.93, 1.07) 0.87 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.95 (0.81, 1.10) 0.49 GDM_newGDM:StudySTOP 0.93 (0.83, 1.03) 0.17 50.6.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 5.45 0.08 Inf 5.31 5.60 &lt;35 yrs, obese SCOPE Uncomplicated 5.32 0.12 Inf 5.08 5.57 &gt;=35 yrs, non-obese SCOPE Uncomplicated 5.44 0.17 Inf 5.12 5.78 &gt;=35 yrs, obese SCOPE Uncomplicated 5.73 0.42 Inf 4.96 6.62 &lt;35 yrs, non-obese STOP Uncomplicated 4.68 0.05 Inf 4.59 4.78 &lt;35 yrs, obese STOP Uncomplicated 4.84 0.08 Inf 4.69 4.99 &gt;=35 yrs, non-obese STOP Uncomplicated 4.64 0.08 Inf 4.50 4.80 &gt;=35 yrs, obese STOP Uncomplicated 4.66 0.10 Inf 4.47 4.87 &lt;35 yrs, non-obese SCOPE GDM 6.06 0.33 Inf 5.45 6.74 &lt;35 yrs, obese SCOPE GDM 5.92 0.28 Inf 5.39 6.49 &gt;=35 yrs, non-obese SCOPE GDM 6.05 0.36 Inf 5.38 6.80 &gt;=35 yrs, obese SCOPE GDM 6.37 0.48 Inf 5.50 7.38 &lt;35 yrs, non-obese STOP GDM 4.82 0.08 Inf 4.67 4.97 &lt;35 yrs, obese STOP GDM 4.98 0.08 Inf 4.82 5.15 &gt;=35 yrs, non-obese STOP GDM 4.78 0.09 Inf 4.61 4.96 &gt;=35 yrs, obese STOP GDM 4.80 0.10 Inf 4.60 5.01 50.6.3 Post-hoc comparisons 50.6.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 0.98 (0.91, 1.04) 0.8 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 1.00 (0.92, 1.08) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE Uncomplicated 1.02 (0.93, 1.12) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE Uncomplicated 1.05 (0.87, 1.27) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE Uncomplicated 1.08 (0.89, 1.30) 0.7 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE Uncomplicated 1.05 (0.86, 1.29) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 1.03 (0.99, 1.08) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP Uncomplicated 0.99 (0.95, 1.04) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP Uncomplicated 0.96 (0.91, 1.01) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP Uncomplicated 1.00 (0.94, 1.05) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP Uncomplicated 0.96 (0.91, 1.02) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP Uncomplicated 1.00 (0.94, 1.07) 1.0 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.98 (0.91, 1.04) 0.8 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM 1.00 (0.92, 1.08) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM 1.02 (0.93, 1.12) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 1.05 (0.87, 1.27) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.08 (0.89, 1.30) 0.7 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM 1.05 (0.86, 1.29) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.03 (0.99, 1.08) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.99 (0.95, 1.04) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 0.96 (0.91, 1.01) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.00 (0.94, 1.05) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.96 (0.91, 1.02) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 1.00 (0.94, 1.07) 1.0 50.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.048150 0.0902902 Inf 0.8853170 1.240932 0.585 ns STOP/SCOPE (Uncomplicated) 1.059262 0.0335696 Inf 0.9954682 1.127143 0.069 ns STOP/SCOPE (GDM) 1.059262 0.0335696 Inf 0.9954682 1.127143 0.069 ns GDM/Uncomplicated (SCOPE) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA "],["mets-12.html", "51 MetS", " 51 MetS Descriptives with univariate P-values. Within Uncomplicated Characteristic No MetS (n=1140) MetS (n=111) Total (n=1251) P-value PRL (ng/ml): Median (IQ range) 95.2 (57.7-150.3) 107.5 (66.8-182.2) 96.3 (58.2-154.4) 0.11 hPL (μg/ml): Median (IQ range) 100.5 (54.0-179.2) 143.6 (59.4-179.6) 105.2 (54.1-179.5) 0.21 GH2 (ng/ml): Median (IQ range) 2.4 (1.2-4.1) 3.0 (1.6-4.6) 2.5 (1.2-4.1) 0.07 Insulin (uU/ml): Median (IQ range) 9.9 (5.7-19.6) 28.0 (14.4-51.6) 10.8 (6.1-21.9) &lt;0.0001 HOMA-IR: Median (IQ range) 2.1 (1.2-4.5) 7.4 (3.6-14.1) 2.4 (1.3-5.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.9 (4.6-5.4) 5.8 (5.5-6.2) 5.0 (4.6-5.5) &lt;0.0001 Within GDM Characteristic No MetS (n=172) MetS (n=68) Total (n=240) P-value PRL (ng/ml): Median (IQ range) 73.6 (47.5-122.7) 64.1 (41.6-110.2) 71.9 (44.4-114.1) 0.19 hPL (μg/ml): Median (IQ range) 64.3 (37.8-100.2) 55.7 (37.4-79.8) 60.2 (37.4-91.8) 0.22 GH2 (ng/ml): Median (IQ range) 1.4 (1.0-2.5) 1.5 (1.0-2.4) 1.4 (1.0-2.4) 0.97 Insulin (uU/ml): Median (IQ range) 13.4 (7.7-30.2) 34.0 (17.6-58.7) 17.1 (9.4-38.5) &lt;0.0001 HOMA-IR: Median (IQ range) 3.0 (1.5-6.9) 8.3 (4.4-17.1) 3.8 (1.9-8.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.2) 5.8 (5.1-6.4) 5.0 (4.5-5.6) &lt;0.0001 Click here for table within SCOPE Within Uncomplicated Characteristic No MetS (n=520) MetS (n=75) Total (n=595) P-value PRL (ng/ml): Median (IQ range) 138.1 (92.3-218.7) 154.1 (105.0-204.0) 139.7 (94.2-215.5) 0.50 hPL (μg/ml): Median (IQ range) 185.1 (151.8-222.3) 169.0 (146.8-201.1) 183.5 (149.7-220.6) 0.04 GH2 (ng/ml): Median (IQ range) 4.2 (3.3-5.7) 4.1 (2.8-5.4) 4.2 (3.2-5.6) 0.29 Insulin (uU/ml): Median (IQ range) 12.5 (6.1-24.7) 33.9 (20.3-60.0) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 2.8 (1.4-5.8) 8.9 (4.7-15.9) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.7) 5.9 (5.6-6.2) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.9 (28.3-43.4) 35.2 (30.2-42.5) 36.8 (28.8-43.2) 0.75 B12 concentration (pM): Median (IQ range) 253.0 (198.0-322.0) 220.0 (173.0-293.0) 248.5 (196.0-316.8) 0.005 Folate:B12 ratio: Median (IQ range) 141.6 (101.7-205.3) 155.1 (118.5-217.2) 143.0 (104.6-209.7) 0.18 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-73.0) 51.0 (43.5-68.0) 54.0 (42.0-72.2) 0.65 Folate:Active B12 ratio: Median (IQ range) 617.0 (460.8-986.7) 620.0 (505.1-746.5) 618.0 (462.5-946.3) 0.75 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.3 (3.8-4.6) 4.4 (3.8-4.9) 0.39 Within GDM Characteristic No MetS (n=29) MetS (n=28) Total (n=57) P-value PRL (ng/ml): Median (IQ range) 119.0 (74.7-180.2) 73.7 (54.6-101.6) 92.0 (62.0-147.2) 0.09 hPL (μg/ml): Median (IQ range) 117.2 (105.8-161.5) 96.2 (77.6-113.5) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 3.0 (1.6-4.4) 2.0 (1.6-3.1) 2.7 (1.6-4.2) 0.49 Insulin (uU/ml): Median (IQ range) 19.6 (12.1-43.2) 39.9 (17.6-82.7) 31.9 (16.6-51.0) 0.15 HOMA-IR: Median (IQ range) 5.1 (3.1-11.4) 9.8 (4.4-23.2) 8.1 (3.6-17.4) 0.15 Glucose (mmol/L): Median (IQ range) 5.5 (5.0-6.3) 6.1 (5.8-6.7) 5.8 (5.2-6.6) 0.01 Serum folate concentration (nM): Median (IQ range) 39.7 (31.7-44.0) 39.6 (31.9-42.3) 39.6 (31.9-43.8) 0.90 B12 concentration (pM): Median (IQ range) 274.0 (196.2-341.5) 240.0 (193.5-296.5) 254.0 (193.5-334.0) 0.39 Folate:B12 ratio: Median (IQ range) 152.8 (112.5-184.8) 167.7 (121.8-210.6) 155.4 (115.4-210.6) 0.59 Active B12 concentration (pM): Median (IQ range) 85.0 (58.0-99.5) 60.0 (53.0-79.0) 66.5 (54.5-89.2) 0.28 Folate:Active B12 ratio: Median (IQ range) 516.5 (418.5-688.3) 560.9 (424.7-636.8) 546.6 (419.7-674.3) 0.61 Homocysteine concentration (μM): Median (IQ range) 4.1 (3.8-4.7) 3.7 (3.5-4.1) 3.9 (3.6-4.6) 0.10 Click here for table within STOP Within Uncomplicated Characteristic No MetS (n=620) MetS (n=36) Total (n=656) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.5-112.3) 65.1 (46.2-98.4) 72.6 (48.4-111.3) 0.28 hPL (μg/ml): Median (IQ range) 60.9 (41.3-91.0) 50.6 (34.5-71.3) 60.5 (41.1-90.6) 0.07 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.5 (0.8-2.0) 1.4 (0.9-2.3) 0.37 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-45.1) 40.3 (37.2-45.0) 40.5 (36.3-45.1) 0.85 B12 concentration (pM): Median (IQ range) 279.5 (220.8-356.8) 247.0 (201.0-335.5) 278.0 (219.5-356.0) 0.13 Folate:B12 ratio: Median (IQ range) 153.6 (114.8-224.2) 172.4 (143.0-203.7) 155.4 (115.3-222.9) 0.27 Active B12 concentration (pM): Median (IQ range) 63.0 (48.8-81.0) 62.0 (56.0-74.0) 63.0 (49.0-81.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 670.3 (486.7-943.6) 633.9 (493.7-726.8) 666.1 (487.3-939.1) 0.64 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.9 (4.5-5.5) 4.8 (4.3-5.6) 0.92 Within GDM Characteristic No MetS (n=143) MetS (n=40) Total (n=183) P-value PRL (ng/ml): Median (IQ range) 70.4 (43.4-111.5) 56.2 (38.6-110.4) 68.4 (42.3-111.0) 0.21 hPL (μg/ml): Median (IQ range) 59.4 (35.3-85.7) 50.0 (36.2-65.0) 55.6 (35.3-83.0) 0.06 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.1) 1.2 (0.8-2.0) 1.3 (0.9-2.1) 0.39 Serum folate concentration (nM): Median (IQ range) 40.7 (36.0-54.0) 37.2 (33.8-41.7) 40.0 (35.1-45.2) 0.02 B12 concentration (pM): Median (IQ range) 278.0 (217.0-359.2) 264.0 (207.0-306.0) 275.0 (216.0-353.0) 0.23 Folate:B12 ratio: Median (IQ range) 147.4 (109.7-228.7) 149.8 (114.6-211.8) 147.7 (111.7-223.1) 0.98 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-88.0) 73.0 (57.5-92.2) 75.0 (56.0-91.0) 0.99 Folate:Active B12 ratio: Median (IQ range) 531.9 (419.9-818.0) 551.8 (417.2-693.7) 534.2 (419.9-798.9) 0.77 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.4) 4.8 (4.1-5.2) 4.8 (4.0-5.3) 0.92 "],["prolactin-33.html", "51.1 Prolactin", " 51.1 Prolactin LME for repeated measures. 51.1.1 Model summary Var Effect P (Intercept) 15.21 (10.06, 23.00) &lt;0.0001 metab.C1MetS 1.03 (0.86, 1.23) 0.78 GDM_newGDM 1.11 (0.84, 1.46) 0.47 StudySTOP 0.96 (0.84, 1.10) 0.54 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 metab.C1MetS:StudySTOP 0.90 (0.68, 1.19) 0.46 GDM_newGDM:StudySTOP 0.97 (0.73, 1.31) 0.86 metab.C1MetS:GDM_newGDM 0.65 (0.43, 0.98) 0.04 metab.C1MetS:GDM_newGDM:StudySTOP 1.52 (0.91, 2.55) 0.11 51.1.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 96.45 7.94 109.25 81.93 113.54 MetS SCOPE Uncomplicated 98.98 11.27 359.48 79.12 123.81 No MetS STOP Uncomplicated 92.45 7.00 78.65 79.52 107.48 MetS STOP Uncomplicated 85.56 10.94 512.96 66.55 110.00 No MetS SCOPE GDM 106.63 16.45 788.06 78.76 144.35 MetS SCOPE GDM 70.78 11.48 759.63 51.48 97.30 No MetS STOP GDM 99.58 9.16 164.77 83.03 119.42 MetS STOP GDM 90.70 11.60 507.78 70.55 116.60 51.1.3 Post-hoc comparisons 51.1.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE Uncomplicated 1.03 (0.86, 1.23) 0.8 MetS / No MetS STOP Uncomplicated 0.93 (0.75, 1.14) 0.5 MetS / No MetS SCOPE GDM 0.66 (0.46, 0.97) 0.03 MetS / No MetS STOP GDM 0.91 (0.73, 1.14) 0.4 51.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.2374301 0.3264023 1264.204 0.7375312 2.0761606 0.419 ns STOP/SCOPE (Uncomplicated) 0.9018147 0.1271878 1381.642 0.6838525 1.1892472 0.464 ns STOP/SCOPE (GDM) 1.3721557 0.3062313 1190.378 0.8856107 2.1260032 0.157 ns GDM/Uncomplicated (SCOPE) 0.6468335 0.1370211 1176.512 0.4268681 0.9801471 0.040 * GDM/Uncomplicated (STOP) 0.9841892 0.1551743 1371.595 0.7223597 1.3409225 0.920 ns "],["hpl-33.html", "51.2 HPL", " 51.2 HPL LME for repeated measures. 51.2.1 Model summary Var Effect P (Intercept) 2.05 (1.67, 2.53) &lt;0.0001 metab.C1MetS 0.91 (0.83, 0.99) 0.04 GDM_newGDM 0.96 (0.84, 1.09) 0.51 StudySTOP 1.12 (1.05, 1.20) 0.001 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.97 (0.84, 1.12) 0.68 GDM_newGDM:StudySTOP 1.05 (0.91, 1.21) 0.49 metab.C1MetS:GDM_newGDM 1.04 (0.85, 1.27) 0.73 metab.C1MetS:GDM_newGDM:StudySTOP 0.96 (0.74, 1.25) 0.77 51.2.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 87.90 2.62 203.33 82.88 93.23 MetS SCOPE Uncomplicated 79.66 4.00 912.87 72.18 87.92 No MetS STOP Uncomplicated 98.62 2.53 113.34 93.74 103.76 MetS STOP Uncomplicated 86.69 5.27 1153.56 76.93 97.68 No MetS SCOPE GDM 84.15 5.75 826.16 73.59 96.22 MetS SCOPE GDM 79.05 5.87 704.63 68.33 91.46 No MetS STOP GDM 99.30 3.73 385.45 92.23 106.92 MetS STOP GDM 87.01 5.23 1107.51 77.33 97.89 51.2.3 Post-hoc comparisons 51.2.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE Uncomplicated 0.91 (0.83, 0.99) 0.04 MetS / No MetS STOP Uncomplicated 0.88 (0.78, 0.98) 0.03 MetS / No MetS SCOPE GDM 0.94 (0.78, 1.13) 0.5 MetS / No MetS STOP GDM 0.88 (0.78, 0.99) 0.03 51.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9047120 0.1203686 1095.0285 0.6968443 1.174586 0.452 ns STOP/SCOPE (Uncomplicated) 0.9699470 0.0719962 1378.6476 0.8385141 1.121981 0.681 ns STOP/SCOPE (GDM) 0.9327437 0.1032235 919.9378 0.7506522 1.159007 0.529 ns GDM/Uncomplicated (SCOPE) 1.0366034 0.1074394 835.1597 0.8457876 1.270469 0.729 ns GDM/Uncomplicated (STOP) 0.9968435 0.0836478 1379.8101 0.8455468 1.175212 0.970 ns "],["gh2-33.html", "51.3 GH2", " 51.3 GH2 LME for repeated measures. 51.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 metab.C1MetS 0.90 (0.79, 1.02) 0.10 GDM_newGDM 1.03 (0.85, 1.26) 0.75 StudySTOP 0.96 (0.88, 1.06) 0.43 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 metab.C1MetS:StudySTOP 1.10 (0.90, 1.35) 0.35 GDM_newGDM:StudySTOP 1.01 (0.82, 1.25) 0.95 metab.C1MetS:GDM_newGDM 0.76 (0.56, 1.04) 0.08 metab.C1MetS:GDM_newGDM:StudySTOP 1.30 (0.88, 1.90) 0.18 51.3.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 2.28 0.08 478.04 2.13 2.44 MetS SCOPE Uncomplicated 2.05 0.14 1340.37 1.79 2.33 No MetS STOP Uncomplicated 2.20 0.06 232.82 2.08 2.32 MetS STOP Uncomplicated 2.17 0.18 1372.17 1.85 2.54 No MetS SCOPE GDM 2.36 0.24 1313.97 1.94 2.87 MetS SCOPE GDM 1.61 0.18 1057.92 1.30 2.00 No MetS STOP GDM 2.29 0.10 603.84 2.09 2.50 MetS STOP GDM 2.23 0.18 1292.03 1.91 2.62 51.3.3 Post-hoc comparisons 51.3.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE Uncomplicated 0.90 (0.79, 1.02) 0.10 MetS / No MetS STOP Uncomplicated 0.99 (0.84, 1.16) 0.9 MetS / No MetS SCOPE GDM 0.68 (0.52, 0.90) 0.008 MetS / No MetS STOP GDM 0.98 (0.83, 1.16) 0.8 51.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.5755532 0.3083808 1343.816 1.0731945 2.313064 0.020 * STOP/SCOPE (Uncomplicated) 1.1017095 0.1141060 1431.468 0.8991497 1.349902 0.350 ns STOP/SCOPE (GDM) 1.4300987 0.2375745 1271.659 1.0323473 1.981099 0.031 * GDM/Uncomplicated (SCOPE) 0.7619268 0.1195626 1256.150 0.5600318 1.036606 0.083 ns GDM/Uncomplicated (STOP) 0.9890361 0.1157988 1430.538 0.7860804 1.244392 0.925 ns "],["insulin-31.html", "51.4 Insulin", " 51.4 Insulin GEE for repeated measures. 51.4.1 Model summary Var Effect P (Intercept) 10.91 (6.36, 18.69) &lt;0.0001 metab.C1MetS 2.51 (2.01, 3.14) &lt;0.0001 GDM_newGDM 1.74 (1.14, 2.66) 0.01 StudySTOP 0.82 (0.69, 0.99) 0.04 GA_samp 1.01 (0.98, 1.04) 0.59 metab.C1MetS:StudySTOP 0.78 (0.54, 1.13) 0.19 GDM_newGDM:StudySTOP 0.85 (0.54, 1.34) 0.49 metab.C1MetS:GDM_newGDM 0.79 (0.46, 1.38) 0.41 metab.C1MetS:GDM_newGDM:StudySTOP 1.40 (0.70, 2.83) 0.34 51.4.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 12.33 0.81 Inf 10.85 14.02 MetS SCOPE Uncomplicated 30.94 3.41 Inf 24.92 38.41 No MetS STOP Uncomplicated 10.15 0.44 Inf 9.32 11.06 MetS STOP Uncomplicated 19.92 2.91 Inf 14.97 26.52 No MetS SCOPE GDM 21.47 4.58 Inf 14.13 32.63 MetS SCOPE GDM 42.76 6.66 Inf 31.52 58.02 No MetS STOP GDM 15.08 1.24 Inf 12.83 17.71 MetS STOP GDM 32.98 4.83 Inf 24.74 43.96 51.4.3 Post-hoc comparisons 51.4.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE Uncomplicated 2.51 (2.01, 3.14) &lt;0.0001 MetS / No MetS STOP Uncomplicated 1.96 (1.47, 2.63) &lt;0.0001 MetS / No MetS SCOPE GDM 1.99 (1.20, 3.30) 0.007 MetS / No MetS STOP GDM 2.19 (1.59, 3.00) &lt;0.0001 51.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.8588782 0.3068673 Inf 0.4263901 1.730040 0.670 ns STOP/SCOPE (Uncomplicated) 0.7821066 0.1466311 Inf 0.5416026 1.129409 0.190 ns STOP/SCOPE (GDM) 1.0981601 0.3342823 Inf 0.6047252 1.994221 0.758 ns GDM/Uncomplicated (SCOPE) 0.7939556 0.2237288 Inf 0.4570208 1.379293 0.413 ns GDM/Uncomplicated (STOP) 1.1147973 0.2453719 Inf 0.7241735 1.716126 0.621 ns "],["homa-ir-31.html", "51.5 HOMA-IR", " 51.5 HOMA-IR GEE for repeated measures. 51.5.1 Model summary Var Effect P (Intercept) 2.63 (1.50, 4.60) 0.0007 metab.C1MetS 2.85 (2.24, 3.63) &lt;0.0001 GDM_newGDM 1.92 (1.20, 3.07) 0.007 StudySTOP 0.72 (0.60, 0.87) 0.0008 GA_samp 1.01 (0.97, 1.04) 0.65 metab.C1MetS:StudySTOP 0.80 (0.54, 1.20) 0.28 GDM_newGDM:StudySTOP 0.79 (0.48, 1.30) 0.35 metab.C1MetS:GDM_newGDM 0.72 (0.39, 1.34) 0.30 metab.C1MetS:GDM_newGDM:StudySTOP 1.53 (0.70, 3.35) 0.29 51.5.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 2.93 0.20 Inf 2.56 3.35 MetS SCOPE Uncomplicated 8.33 0.99 Inf 6.60 10.52 No MetS STOP Uncomplicated 2.11 0.10 Inf 1.93 2.31 MetS STOP Uncomplicated 4.81 0.77 Inf 3.51 6.59 No MetS SCOPE GDM 5.61 1.33 Inf 3.52 8.92 MetS SCOPE GDM 11.50 2.04 Inf 8.12 16.30 No MetS STOP GDM 3.18 0.28 Inf 2.68 3.77 MetS STOP GDM 7.99 1.32 Inf 5.77 11.05 51.5.3 Post-hoc comparisons 51.5.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE Uncomplicated 2.85 (2.24, 3.63) &lt;0.0001 MetS / No MetS STOP Uncomplicated 2.28 (1.65, 3.14) &lt;0.0001 MetS / No MetS SCOPE GDM 2.05 (1.16, 3.63) 0.01 MetS / No MetS STOP GDM 2.51 (1.76, 3.58) &lt;0.0001 51.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9799646 0.3910973 Inf 0.4482307 2.142492 0.960 ns STOP/SCOPE (Uncomplicated) 0.7998569 0.1640606 Inf 0.5350819 1.195651 0.276 ns STOP/SCOPE (GDM) 1.2251749 0.4197975 Inf 0.6259504 2.398039 0.553 ns GDM/Uncomplicated (SCOPE) 0.7201415 0.2275098 Inf 0.3877064 1.337620 0.299 ns GDM/Uncomplicated (STOP) 1.1030713 0.2696007 Inf 0.6832225 1.780922 0.688 ns "],["glucose-31.html", "51.6 Glucose", " 51.6 Glucose GEE for repeated measures. 51.6.1 Model summary Var Effect P (Intercept) 5.31 (4.76, 5.93) &lt;0.0001 metab.C1MetS 1.12 (1.09, 1.16) &lt;0.0001 GDM_newGDM 1.07 (0.97, 1.18) 0.20 StudySTOP 0.88 (0.85, 0.91) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.96 metab.C1MetS:StudySTOP 1.04 (0.97, 1.11) 0.27 GDM_newGDM:StudySTOP 0.96 (0.87, 1.07) 0.46 metab.C1MetS:GDM_newGDM 0.99 (0.81, 1.21) 0.95 metab.C1MetS:GDM_newGDM:StudySTOP 0.97 (0.78, 1.20) 0.79 51.6.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 5.33 0.07 Inf 5.20 5.46 MetS SCOPE Uncomplicated 5.99 0.10 Inf 5.80 6.19 No MetS STOP Uncomplicated 4.69 0.04 Inf 4.61 4.77 MetS STOP Uncomplicated 5.46 0.15 Inf 5.17 5.77 No MetS SCOPE GDM 5.70 0.29 Inf 5.16 6.29 MetS SCOPE GDM 6.36 0.53 Inf 5.41 7.48 No MetS STOP GDM 4.81 0.07 Inf 4.68 4.95 MetS STOP GDM 5.42 0.16 Inf 5.12 5.74 51.6.3 Post-hoc comparisons 51.6.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE Uncomplicated 1.12 (1.09, 1.16) &lt;0.0001 MetS / No MetS STOP Uncomplicated 1.17 (1.10, 1.23) &lt;0.0001 MetS / No MetS SCOPE GDM 1.12 (0.92, 1.36) 0.3 MetS / No MetS STOP GDM 1.13 (1.06, 1.20) 0.0001 51.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0458155 0.1136258 Inf 0.8452277 1.294007 0.680 ns STOP/SCOPE (Uncomplicated) 1.0373786 0.0342887 Inf 0.9723046 1.106808 0.267 ns STOP/SCOPE (GDM) 1.0081329 0.1045116 Inf 0.8227636 1.235266 0.938 ns GDM/Uncomplicated (SCOPE) 0.9932065 0.1003173 Inf 0.8148266 1.210637 0.946 ns GDM/Uncomplicated (STOP) 0.9652060 0.0401921 Inf 0.8895598 1.047285 0.395 ns "],["birthweight-centile-4.html", "52 Birthweight centile", " 52 Birthweight centile Descriptives with univariate P-values. Within Uncomplicated Characteristic &lt;=90th centile (n=1159) &gt;90th centile (n=130) Total (n=1289) P-value PRL (ng/ml): Median (IQ range) 97.0 (57.9-155.7) 96.1 (62.2-159.9) 96.9 (58.2-157.3) 0.89 hPL (μg/ml): Median (IQ range) 111.1 (54.6-179.0) 93.2 (54.6-184.1) 108.1 (54.6-179.7) 0.90 GH2 (ng/ml): Median (IQ range) 2.6 (1.2-4.1) 2.0 (1.1-4.1) 2.5 (1.2-4.1) 0.31 Insulin (uU/ml): Median (IQ range) 10.7 (6.1-21.4) 11.1 (5.8-22.7) 10.8 (6.0-21.7) 0.67 HOMA-IR: Median (IQ range) 2.4 (1.3-5.0) 2.6 (1.3-5.2) 2.4 (1.3-5.0) 0.54 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.6-5.6) 5.0 (4.6-5.5) 0.28 Within GDM Characteristic &lt;=90th centile (n=219) &gt;90th centile (n=30) Total (n=249) P-value PRL (ng/ml): Median (IQ range) 67.2 (43.9-113.0) 101.2 (82.0-181.8) 73.6 (45.6-121.8) 0.001 hPL (μg/ml): Median (IQ range) 61.3 (38.1-98.8) 67.2 (34.2-86.3) 61.4 (37.4-98.0) 0.93 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.3 (1.0-2.7) 1.5 (1.0-2.6) 0.97 Insulin (uU/ml): Median (IQ range) 17.6 (9.6-39.0) 16.8 (8.0-47.2) 17.6 (9.5-40.5) 0.98 HOMA-IR: Median (IQ range) 3.9 (2.0-8.9) 3.3 (1.8-10.2) 3.8 (1.9-9.2) 0.90 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.6) 4.9 (4.5-5.4) 5.0 (4.5-5.6) 0.31 Click here for table within SCOPE Within Uncomplicated Characteristic &lt;=90th centile (n=544) &gt;90th centile (n=54) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 139.1 (92.8-215.5) 156.5 (106.3-223.3) 139.9 (94.7-215.5) 0.30 hPL (μg/ml): Median (IQ range) 181.5 (148.0-217.8) 206.6 (159.9-259.2) 183.5 (149.9-220.6) 0.02 GH2 (ng/ml): Median (IQ range) 4.1 (3.2-5.6) 4.6 (3.5-6.0) 4.2 (3.2-5.6) 0.36 Insulin (uU/ml): Median (IQ range) 14.1 (6.4-27.4) 19.8 (7.2-39.0) 14.4 (6.5-29.1) 0.14 HOMA-IR: Median (IQ range) 3.2 (1.5-6.8) 4.8 (1.8-9.4) 3.3 (1.5-7.2) 0.10 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.1-6.0) 5.4 (5.0-5.8) 0.09 Serum folate concentration (nM): Median (IQ range) 36.5 (28.6-43.4) 38.0 (28.3-42.4) 36.6 (28.6-43.1) 0.86 B12 concentration (pM): Median (IQ range) 248.0 (195.0-315.0) 244.5 (201.8-325.2) 248.0 (195.0-316.0) 0.72 Folate:B12 ratio: Median (IQ range) 143.0 (105.1-208.8) 147.5 (100.7-204.7) 143.0 (104.5-208.8) 0.79 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-72.0) 56.0 (44.5-76.5) 54.0 (42.5-72.0) 0.41 Folate:Active B12 ratio: Median (IQ range) 618.0 (452.1-963.5) 575.0 (478.4-872.4) 617.5 (461.2-937.5) 0.91 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-4.9) 4.3 (3.7-4.9) 4.4 (3.8-4.9) 0.65 Within GDM Characteristic &lt;=90th centile (n=50) &gt;90th centile (n=8) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 87.6 (59.0-138.5) 114.4 (93.1-148.1) 92.0 (62.0-147.2) 0.58 hPL (μg/ml): Median (IQ range) 105.8 (86.1-152.6) 107.3 (95.5-119.5) 106.2 (85.6-134.2) 1.00 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.0) 3.4 (2.3-4.3) 2.7 (1.6-4.2) 0.81 Insulin (uU/ml): Median (IQ range) 31.9 (16.6-54.1) 39.9 (21.0-58.3) 34.0 (16.6-55.4) 0.84 HOMA-IR: Median (IQ range) 7.4 (3.7-16.1) 10.1 (5.4-14.6) 8.1 (3.6-17.4) 0.82 Glucose (mmol/L): Median (IQ range) 5.9 (5.2-6.6) 5.6 (5.4-6.0) 5.8 (5.2-6.6) 0.50 Serum folate concentration (nM): Median (IQ range) 39.6 (32.2-43.8) 41.4 (32.1-43.7) 40.1 (32.0-43.8) 0.93 B12 concentration (pM): Median (IQ range) 245.0 (192.0-332.0) 257.0 (245.0-324.5) 253.5 (194.2-333.0) 0.29 Folate:B12 ratio: Median (IQ range) 167.7 (118.7-211.5) 122.6 (114.2-155.7) 158.9 (116.5-210.2) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (53.0-81.5) 85.0 (77.0-104.0) 68.0 (55.0-86.0) 0.14 Folate:Active B12 ratio: Median (IQ range) 559.7 (436.8-674.3) 438.2 (424.7-516.5) 553.8 (424.7-660.3) 0.32 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 3.8 (3.7-4.2) 3.9 (3.6-4.6) 0.66 Click here for table within STOP Within Uncomplicated Characteristic &lt;=90th centile (n=615) &gt;90th centile (n=76) Total (n=691) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.7-114.6) 68.7 (47.2-104.7) 72.9 (48.6-113.5) 0.68 hPL (μg/ml): Median (IQ range) 63.5 (41.0-98.8) 58.5 (48.5-86.7) 62.4 (41.4-96.7) 0.98 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-1.9) 1.4 (0.9-2.4) 0.33 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-45.3) 41.3 (37.2-44.8) 40.5 (36.4-45.2) 0.53 B12 concentration (pM): Median (IQ range) 277.0 (217.0-354.0) 286.0 (233.0-374.0) 278.5 (220.8-355.2) 0.24 Folate:B12 ratio: Median (IQ range) 155.4 (116.2-224.2) 160.8 (109.9-210.6) 155.5 (115.1-222.4) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.0) 68.5 (52.2-90.2) 63.0 (48.0-81.0) 0.18 Folate:Active B12 ratio: Median (IQ range) 670.5 (502.6-964.3) 646.1 (459.1-843.8) 670.2 (490.7-948.9) 0.32 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.4-5.5) 4.8 (4.3-5.6) 0.96 Within GDM Characteristic &lt;=90th centile (n=169) &gt;90th centile (n=22) Total (n=191) P-value PRL (ng/ml): Median (IQ range) 64.1 (42.3-111.0) 99.2 (82.6-186.0) 70.4 (43.2-114.3) 0.002 hPL (μg/ml): Median (IQ range) 57.0 (36.2-83.8) 56.7 (33.7-81.4) 57.0 (35.5-83.8) 0.85 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.3 (0.9-1.9) 1.3 (0.9-2.2) 0.80 Serum folate concentration (nM): Median (IQ range) 39.9 (35.1-44.7) 43.1 (38.3-63.6) 40.2 (35.5-45.2) 0.08 B12 concentration (pM): Median (IQ range) 275.5 (216.8-356.5) 269.5 (198.0-297.2) 273.5 (215.9-353.0) 0.34 Folate:B12 ratio: Median (IQ range) 145.9 (107.6-218.0) 162.5 (130.5-251.1) 148.0 (111.6-221.1) 0.12 Active B12 concentration (pM): Median (IQ range) 74.5 (56.0-88.0) 77.0 (68.8-96.2) 74.5 (56.0-88.8) 0.43 Folate:Active B12 ratio: Median (IQ range) 539.3 (419.9-784.7) 531.8 (431.4-817.4) 531.9 (419.8-790.5) 0.98 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.3) 4.5 (3.8-4.8) 4.7 (4.0-5.3) 0.06 "],["prolactin-34.html", "52.1 Prolactin", " 52.1 Prolactin LME for repeated measures. 52.1.1 Model summary Var Effect P (Intercept) 12.94 (8.70, 19.24) &lt;0.0001 BW_gp&gt;90th centile 1.18 (0.97, 1.45) 0.09 GDM_newGDM 0.92 (0.74, 1.14) 0.43 StudySTOP 1.00 (0.88, 1.13) 0.97 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.93 (0.72, 1.19) 0.56 GDM_newGDM:StudySTOP 1.13 (0.89, 1.44) 0.30 BW_gp&gt;90th centile:GDM_newGDM 1.15 (0.60, 2.19) 0.67 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 1.16 (0.57, 2.38) 0.68 52.1.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 93.18 7.55 105.00 79.35 109.43 &gt;90th centile SCOPE Uncomplicated 110.42 13.51 458.37 86.82 140.43 &lt;=90th centile STOP Uncomplicated 92.99 6.98 77.66 80.08 107.98 &gt;90th centile STOP Uncomplicated 102.36 10.47 251.92 83.69 125.20 &lt;=90th centile SCOPE GDM 85.31 10.98 507.83 66.25 109.85 &gt;90th centile SCOPE GDM 116.21 35.53 1039.60 63.79 211.72 &lt;=90th centile STOP GDM 96.44 8.60 149.35 80.86 115.04 &gt;90th centile STOP GDM 141.86 21.51 804.69 105.34 191.05 52.1.3 Post-hoc comparisons 52.1.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE Uncomplicated 1.18 (0.97, 1.45) 0.09 &gt;90th centile / &lt;=90th centile STOP Uncomplicated 1.10 (0.95, 1.28) 0.2 &gt;90th centile / &lt;=90th centile SCOPE GDM 1.36 (0.74, 2.51) 0.3 &gt;90th centile / &lt;=90th centile STOP GDM 1.47 (1.12, 1.94) 0.006 52.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0031710 0.3668862 1118.284 0.4894753 2.055981 0.993 ns STOP/SCOPE (Uncomplicated) 0.9290065 0.1186387 1401.109 0.7231396 1.193481 0.564 ns STOP/SCOPE (GDM) 1.0798320 0.3701594 1071.725 0.5511121 2.115789 0.823 ns GDM/Uncomplicated (SCOPE) 1.1495773 0.3775124 1052.036 0.6035151 2.189718 0.671 ns GDM/Uncomplicated (STOP) 1.3362128 0.2139029 1409.313 0.9761059 1.829171 0.070 ns "],["hpl-34.html", "52.2 HPL", " 52.2 HPL LME for repeated measures. 52.2.1 Model summary Var Effect P (Intercept) 1.85 (1.51, 2.27) &lt;0.0001 BW_gp&gt;90th centile 1.15 (1.03, 1.28) 0.01 GDM_newGDM 0.91 (0.82, 1.01) 0.08 StudySTOP 1.14 (1.07, 1.22) 0.0001 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.00 (0.88, 1.15) 0.97 GDM_newGDM:StudySTOP 1.08 (0.96, 1.22) 0.20 BW_gp&gt;90th centile:GDM_newGDM 1.21 (0.88, 1.67) 0.24 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 0.74 (0.52, 1.07) 0.11 52.2.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 85.47 2.52 198.46 80.64 90.58 &gt;90th centile SCOPE Uncomplicated 98.07 5.58 1063.99 87.71 109.64 &lt;=90th centile STOP Uncomplicated 97.71 2.49 111.79 92.90 102.78 &gt;90th centile STOP Uncomplicated 112.40 5.14 756.69 102.74 122.96 &lt;=90th centile SCOPE GDM 77.80 4.41 671.88 69.61 86.95 &gt;90th centile SCOPE GDM 108.15 15.94 578.84 80.97 144.45 &lt;=90th centile STOP GDM 96.28 3.49 346.45 89.65 103.40 &gt;90th centile STOP GDM 99.81 7.67 1372.55 85.84 116.06 52.2.3 Post-hoc comparisons 52.2.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE Uncomplicated 1.15 (1.03, 1.28) 0.01 &gt;90th centile / &lt;=90th centile STOP Uncomplicated 1.15 (1.06, 1.25) 0.0009 &gt;90th centile / &lt;=90th centile SCOPE GDM 1.39 (1.03, 1.88) 0.03 &gt;90th centile / &lt;=90th centile STOP GDM 1.04 (0.89, 1.21) 0.6 52.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.7476478 0.1381842 773.5571 0.5201480 1.074650 0.116 ns STOP/SCOPE (Uncomplicated) 1.0024878 0.0686687 1375.6882 0.8764394 1.146664 0.971 ns STOP/SCOPE (GDM) 0.7457924 0.1281386 693.8980 0.5322466 1.045016 0.088 ns GDM/Uncomplicated (SCOPE) 1.2115322 0.1970244 633.1960 0.8803268 1.667347 0.238 ns GDM/Uncomplicated (STOP) 0.9013092 0.0795092 1409.0366 0.7580891 1.071587 0.239 ns "],["gh2-34.html", "52.3 GH2", " 52.3 GH2 LME for repeated measures. 52.3.1 Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 BW_gp&gt;90th centile 1.07 (0.92, 1.23) 0.39 GDM_newGDM 0.89 (0.76, 1.04) 0.13 StudySTOP 0.98 (0.90, 1.08) 0.71 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.99 (0.82, 1.19) 0.91 GDM_newGDM:StudySTOP 1.18 (0.99, 1.40) 0.06 BW_gp&gt;90th centile:GDM_newGDM 1.06 (0.66, 1.70) 0.82 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 0.85 (0.50, 1.44) 0.54 52.3.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 2.24 0.08 471.07 2.10 2.40 &gt;90th centile SCOPE Uncomplicated 2.39 0.18 1396.84 2.06 2.77 &lt;=90th centile STOP Uncomplicated 2.21 0.06 223.72 2.09 2.32 &gt;90th centile STOP Uncomplicated 2.33 0.14 1243.02 2.07 2.61 &lt;=90th centile SCOPE GDM 1.99 0.16 1135.89 1.70 2.33 &gt;90th centile SCOPE GDM 2.24 0.49 844.40 1.46 3.44 &lt;=90th centile STOP GDM 2.31 0.10 542.15 2.12 2.51 &gt;90th centile STOP GDM 2.18 0.22 1464.87 1.79 2.65 52.3.3 Post-hoc comparisons 52.3.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE Uncomplicated 1.07 (0.92, 1.23) 0.4 &gt;90th centile / &lt;=90th centile STOP Uncomplicated 1.05 (0.94, 1.18) 0.4 &gt;90th centile / &lt;=90th centile SCOPE GDM 1.12 (0.72, 1.77) 0.6 &gt;90th centile / &lt;=90th centile STOP GDM 0.94 (0.77, 1.16) 0.6 52.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8300292 0.2242689 1055.9174 0.4884723 1.410415 0.491 ns STOP/SCOPE (Uncomplicated) 0.9898510 0.0934756 1471.6718 0.8224723 1.191293 0.914 ns STOP/SCOPE (GDM) 0.8385396 0.2123336 987.7004 0.5101751 1.378250 0.487 ns GDM/Uncomplicated (SCOPE) 1.0558885 0.2550816 943.8044 0.6572350 1.696350 0.822 ns GDM/Uncomplicated (STOP) 0.8944823 0.1069154 1471.3225 0.7075316 1.130831 0.351 ns "],["insulin-32.html", "52.4 Insulin", " 52.4 Insulin GEE for repeated measures. 52.4.1 Model summary Var Effect P (Intercept) 13.06 (7.73, 22.08) &lt;0.0001 BW_gp&gt;90th centile 1.16 (0.83, 1.62) 0.37 GDM_newGDM 2.43 (1.79, 3.30) &lt;0.0001 StudySTOP 0.76 (0.64, 0.91) 0.002 GA_samp 1.00 (0.97, 1.04) 0.82 BW_gp&gt;90th centile:StudySTOP 0.83 (0.56, 1.22) 0.34 GDM_newGDM:StudySTOP 0.71 (0.50, 1.00) 0.05 BW_gp&gt;90th centile:GDM_newGDM 0.46 (0.19, 1.11) 0.09 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 2.60 (0.93, 7.27) 0.07 52.4.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 13.75 0.88 Inf 12.14 15.58 &gt;90th centile SCOPE Uncomplicated 15.98 2.66 Inf 11.53 22.16 &lt;=90th centile STOP Uncomplicated 10.46 0.44 Inf 9.63 11.37 &gt;90th centile STOP Uncomplicated 10.07 1.00 Inf 8.30 12.23 &lt;=90th centile SCOPE GDM 33.42 5.13 Inf 24.74 45.16 &gt;90th centile SCOPE GDM 17.83 7.03 Inf 8.24 38.61 &lt;=90th centile STOP GDM 18.01 1.42 Inf 15.44 21.01 &gt;90th centile STOP GDM 20.66 4.93 Inf 12.93 32.99 52.4.3 Post-hoc comparisons 52.4.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE Uncomplicated 1.16 (0.83, 1.62) 0.4 &gt;90th centile / &lt;=90th centile STOP Uncomplicated 0.96 (0.79, 1.17) 0.7 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.53 (0.23, 1.21) 0.1 &gt;90th centile / &lt;=90th centile STOP GDM 1.15 (0.71, 1.86) 0.6 52.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.7812368 0.9360468 Inf 0.6359339 4.989205 0.272 ns STOP/SCOPE (Uncomplicated) 0.8284024 0.1626572 Inf 0.5637773 1.217237 0.338 ns STOP/SCOPE (GDM) 2.1502072 1.0480854 Inf 0.8271328 5.589660 0.116 ns GDM/Uncomplicated (SCOPE) 0.4590172 0.2077239 Inf 0.1890714 1.114377 0.085 ns GDM/Uncomplicated (STOP) 1.1914284 0.3181725 Inf 0.7059167 2.010863 0.512 ns "],["homa-ir-32.html", "52.5 HOMA-IR", " 52.5 HOMA-IR GEE for repeated measures. 52.5.1 Model summary Var Effect P (Intercept) 3.31 (1.90, 5.76) &lt;0.0001 BW_gp&gt;90th centile 1.20 (0.85, 1.70) 0.30 GDM_newGDM 2.64 (1.86, 3.75) &lt;0.0001 StudySTOP 0.66 (0.54, 0.79) &lt;0.0001 GA_samp 1.00 (0.97, 1.04) 0.99 BW_gp&gt;90th centile:StudySTOP 0.81 (0.54, 1.22) 0.32 GDM_newGDM:StudySTOP 0.68 (0.46, 1.01) 0.05 BW_gp&gt;90th centile:GDM_newGDM 0.47 (0.19, 1.14) 0.10 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 2.41 (0.84, 6.87) 0.10 52.5.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 3.32 0.23 Inf 2.91 3.79 &gt;90th centile SCOPE Uncomplicated 3.99 0.70 Inf 2.84 5.62 &lt;=90th centile STOP Uncomplicated 2.18 0.10 Inf 2.00 2.38 &gt;90th centile STOP Uncomplicated 2.13 0.22 Inf 1.73 2.62 &lt;=90th centile SCOPE GDM 8.76 1.55 Inf 6.19 12.39 &gt;90th centile SCOPE GDM 4.90 1.89 Inf 2.30 10.45 &lt;=90th centile STOP GDM 3.91 0.33 Inf 3.31 4.62 &gt;90th centile STOP GDM 4.28 1.05 Inf 2.65 6.92 52.5.3 Post-hoc comparisons 52.5.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE Uncomplicated 1.20 (0.85, 1.70) 0.3 &gt;90th centile / &lt;=90th centile STOP Uncomplicated 0.98 (0.79, 1.20) 0.8 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.56 (0.24, 1.28) 0.2 &gt;90th centile / &lt;=90th centile STOP GDM 1.09 (0.66, 1.81) 0.7 52.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.5935500 0.8527789 Inf 0.5582776 4.548636 0.384 ns STOP/SCOPE (Uncomplicated) 0.8138401 0.1679260 Inf 0.5431303 1.219478 0.318 ns STOP/SCOPE (GDM) 1.9580629 0.9669252 Inf 0.7438556 5.154240 0.174 ns GDM/Uncomplicated (SCOPE) 0.4654494 0.2133441 Inf 0.1895459 1.142959 0.095 ns GDM/Uncomplicated (STOP) 1.1198505 0.3091731 Inf 0.6518635 1.923815 0.682 ns "],["glucose-32.html", "52.6 Glucose", " 52.6 Glucose GEE for repeated measures. 52.6.1 Model summary Var Effect P (Intercept) 5.51 (4.93, 6.16) &lt;0.0001 BW_gp&gt;90th centile 1.07 (1.00, 1.13) 0.04 GDM_newGDM 1.12 (0.99, 1.26) 0.06 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.65 BW_gp&gt;90th centile:StudySTOP 1.00 (0.91, 1.10) 1.00 GDM_newGDM:StudySTOP 0.94 (0.83, 1.06) 0.31 BW_gp&gt;90th centile:GDM_newGDM 0.91 (0.78, 1.06) 0.21 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 0.98 (0.83, 1.17) 0.86 52.6.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 5.39 0.07 Inf 5.26 5.52 &gt;90th centile SCOPE Uncomplicated 5.74 0.17 Inf 5.41 6.10 &lt;=90th centile STOP Uncomplicated 4.68 0.04 Inf 4.61 4.76 &gt;90th centile STOP Uncomplicated 4.99 0.19 Inf 4.63 5.38 &lt;=90th centile SCOPE GDM 6.03 0.34 Inf 5.40 6.72 &gt;90th centile SCOPE GDM 5.82 0.24 Inf 5.37 6.31 &lt;=90th centile STOP GDM 4.92 0.07 Inf 4.78 5.06 &gt;90th centile STOP GDM 4.68 0.09 Inf 4.50 4.86 52.6.3 Post-hoc comparisons 52.6.3.1 Within Groups Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE Uncomplicated 1.07 (1.00, 1.13) 0.04 &gt;90th centile / &lt;=90th centile STOP Uncomplicated 1.07 (0.99, 1.15) 0.10 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.97 (0.84, 1.11) 0.6 &gt;90th centile / &lt;=90th centile STOP GDM 0.95 (0.91, 0.99) 0.02 52.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9847103 0.0885723 Inf 0.8255529 1.1745513 0.864 ns STOP/SCOPE (Uncomplicated) 1.0002131 0.0492606 Inf 0.9081776 1.1015756 0.997 ns STOP/SCOPE (GDM) 0.9845004 0.0735805 Inf 0.8503507 1.1398134 0.834 ns GDM/Uncomplicated (SCOPE) 0.9066157 0.0703320 Inf 0.7787357 1.0554954 0.206 ns GDM/Uncomplicated (STOP) 0.8923733 0.0395243 Inf 0.8181743 0.9733013 0.010 * "],["hormone-models-4.html", "53 Hormone Models ", " 53 Hormone Models "],["scope-vs-stop-4.html", "53.1 SCOPE vs STOP", " 53.1 SCOPE vs STOP - Outcomes: Prolactin, hPL, GH2, Insulin, HOME-IR, glucose (all outcomes log-transformed) - Independent variables: Study, GDM_new, BMI, Ethnicity (Caucasian/non-Caucasian), smoking (yes/no), GA at sampling - Model fitted: LME or GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       Random intercepts for Study ID and Plate 53.1.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 186.2873571 1 &lt;0.0001 *** Study 2.3744735 1 0.1 ns GDM_new 0.8352147 1 0.4 ns BMI 2.3632920 1 0.1 ns Ethnicity_cauc 89.8462847 1 &lt;0.0001 *** f10c_any_cig_1st_vst 27.6014746 1 &lt;0.0001 *** GA_samp 145.4047280 1 &lt;0.0001 *** Study:GDM_new 2.0357209 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 114.7698430 1 &lt;0.0001 *** Study 7.2736070 1 0.007 ** GDM_new 1.2866802 1 0.3 ns BMI 122.0690428 1 &lt;0.0001 *** Ethnicity_cauc 2.9326031 1 0.09 ns f10c_any_cig_1st_vst 0.2523666 1 0.6 ns GA_samp 2038.4734597 1 &lt;0.0001 *** Study:GDM_new 1.9535696 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 222.6039862 1 &lt;0.0001 *** Study 0.8028006 1 0.4 ns GDM_new 1.2852257 1 0.3 ns BMI 27.8356406 1 &lt;0.0001 *** Ethnicity_cauc 0.6462443 1 0.4 ns f10c_any_cig_1st_vst 0.4132299 1 0.5 ns GA_samp 862.5535317 1 &lt;0.0001 *** Study:GDM_new 3.4900314 1 0.06 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.941 21.941 &lt;0.0001 *** 3 GDM_new 1 Inf 32.023 32.023 &lt;0.0001 *** 4 BMI 1 Inf 228.774 228.774 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 16.948 16.948 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 0.127 0.127 0.7 ns 7 GA_samp 1 Inf 0.547 0.547 0.5 ns 2 Study:GDM_new 1 Inf 4.128 4.128 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 35.890 35.890 &lt;0.0001 *** 3 GDM_new 1 Inf 29.826 29.826 &lt;0.0001 *** 4 BMI 1 Inf 225.782 225.782 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 17.023 17.023 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 0.075 0.075 0.8 ns 7 GA_samp 1 Inf 0.242 0.242 0.6 ns 2 Study:GDM_new 1 Inf 4.391 4.391 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 54.379 54.379 &lt;0.0001 *** 3 GDM_new 1 Inf 3.763 3.763 0.05 ns 4 BMI 1 Inf 8.487 8.487 0.004 ** 5 Ethnicity_cauc 1 Inf 1.174 1.174 0.3 ns 6 f10c_any_cig_1st_vst 1 Inf 0.002 0.002 1.0 ns 7 GA_samp 1 Inf 0.289 0.289 0.6 ns 2 Study:GDM_new 1 Inf 1.683 1.683 0.2 ns 53.1.2 Model Summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.88 (2.47, 3.30) &lt;0.0001 StudySTOP -0.10 (-0.22, 0.03) 0.12 GDM_newGDM -0.09 (-0.29, 0.11) 0.36 BMI -0.00 (-0.01, 0.00) 0.12 Ethnicity_caucNo 0.46 (0.37, 0.56) &lt;0.0001 f10c_any_cig_1st_vstYes -0.23 (-0.32, -0.14) &lt;0.0001 GA_samp 0.14 (0.12, 0.16) &lt;0.0001 StudySTOP:GDM_newGDM 0.16 (-0.06, 0.37) 0.15 HPL Var Effect P (Intercept) 1.18 (0.96, 1.39) &lt;0.0001 StudySTOP 0.09 (0.02, 0.15) 0.007 GDM_newGDM -0.06 (-0.15, 0.04) 0.26 BMI -0.02 (-0.02, -0.01) &lt;0.0001 Ethnicity_caucNo 0.05 (-0.01, 0.10) 0.09 f10c_any_cig_1st_vstYes 0.01 (-0.03, 0.06) 0.62 GA_samp 0.29 (0.27, 0.30) &lt;0.0001 StudySTOP:GDM_newGDM 0.08 (-0.03, 0.19) 0.16 GH2 Var Effect P (Intercept) -2.25 (-2.54, -1.95) &lt;0.0001 StudySTOP -0.04 (-0.13, 0.05) 0.37 GDM_newGDM -0.09 (-0.23, 0.06) 0.26 BMI -0.01 (-0.01, -0.01) &lt;0.0001 Ethnicity_caucNo 0.03 (-0.04, 0.10) 0.42 f10c_any_cig_1st_vstYes 0.02 (-0.04, 0.09) 0.52 GA_samp 0.26 (0.24, 0.27) &lt;0.0001 StudySTOP:GDM_newGDM 0.16 (-0.01, 0.32) 0.06 Insulin Var Effect P (Intercept) 1.07 (0.54, 1.60) &lt;0.0001 StudySTOP -0.31 (-0.48, -0.14) 0.0003 GDM_newGDM 0.55 (0.31, 0.79) &lt;0.0001 BMI 0.05 (0.05, 0.06) &lt;0.0001 Ethnicity_caucNo 0.30 (0.16, 0.45) &lt;0.0001 f10c_any_cig_1st_vstYes -0.02 (-0.15, 0.10) 0.72 GA_samp 0.01 (-0.02, 0.04) 0.46 StudySTOP:GDM_newGDM -0.28 (-0.55, -0.01) 0.04 HOMA.IR Var Effect P (Intercept) -0.38 (-0.94, 0.17) 0.18 StudySTOP -0.46 (-0.64, -0.28) &lt;0.0001 GDM_newGDM 0.62 (0.34, 0.90) &lt;0.0001 BMI 0.06 (0.05, 0.06) &lt;0.0001 Ethnicity_caucNo 0.32 (0.17, 0.47) &lt;0.0001 f10c_any_cig_1st_vstYes -0.02 (-0.15, 0.12) 0.78 GA_samp 0.01 (-0.03, 0.04) 0.62 StudySTOP:GDM_newGDM -0.33 (-0.64, -0.02) 0.04 GLUC3_mmol.L Var Effect P (Intercept) 1.65 (1.53, 1.76) &lt;0.0001 StudySTOP -0.14 (-0.18, -0.11) &lt;0.0001 GDM_newGDM 0.09 (-0.02, 0.20) 0.09 BMI 0.00 (0.00, 0.00) 0.004 Ethnicity_caucNo 0.01 (-0.01, 0.04) 0.28 f10c_any_cig_1st_vstYes 0.00 (-0.03, 0.03) 0.97 GA_samp -0.00 (-0.01, 0.01) 0.59 StudySTOP:GDM_newGDM -0.07 (-0.18, 0.04) 0.19 53.1.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 53.1.4 Results 53.1.4.1 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling, BMI, ethnicity and smoking. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 109.56262 9.305789 118.0932 92.60115 129.6309 STOP Uncomplicated 99.54973 7.854561 88.1698 85.10303 116.4488 SCOPE GDM 99.89480 12.472731 445.2661 78.15798 127.6769 STOP GDM 106.18421 9.423807 137.5003 89.09337 126.5536 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 89.30254 2.778154 308.6675 83.99997 94.93983 STOP Uncomplicated 97.65092 2.612781 168.6963 92.62681 102.94753 SCOPE GDM 84.38702 4.573660 701.9769 75.86859 93.86189 STOP GDM 99.76871 3.433946 352.9937 93.23866 106.75611 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.304031 0.0891074 713.3547 2.135564 2.485789 STOP Uncomplicated 2.212179 0.0685501 355.4472 2.081390 2.351187 SCOPE GDM 2.115925 0.1647247 1117.7141 1.816195 2.465121 STOP GDM 2.372943 0.1005954 556.9857 2.183353 2.578995 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 16.35528 1.1990823 Inf 14.16616 18.88267 STOP Uncomplicated 12.00574 0.6450841 Inf 10.80569 13.33905 SCOPE GDM 28.32869 3.5746105 Inf 22.12173 36.27722 STOP GDM 15.68505 1.1803706 Inf 13.53409 18.17785 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 4.011720 0.3145035 Inf 3.440326 4.678014 STOP Uncomplicated 2.526515 0.1430172 Inf 2.261197 2.822965 SCOPE GDM 7.432129 1.0767853 Inf 5.594857 9.872734 STOP GDM 3.354657 0.2712629 Inf 2.862983 3.930770 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.467687 0.0818211 Inf 5.309650 5.630429 STOP Uncomplicated 4.746897 0.0485391 Inf 4.652709 4.842992 SCOPE GDM 6.005111 0.2972873 Inf 5.449814 6.616988 STOP GDM 4.849296 0.0683255 Inf 4.717212 4.985078 53.1.5 Comparisons Prolactin contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (Uncomplicated) 0.909 0.057 1440.121 0.804 1.027 0.124 ns STOP/SCOPE (GDM_new) 1.063 0.122 1271.507 0.849 1.330 0.594 ns GDM_new/Uncomplicated (SCOPE) 0.912 0.092 1206.203 0.748 1.112 0.361 ns GDM_new/Uncomplicated (STOP) 1.067 0.056 1412.722 0.963 1.182 0.217 ns HPL contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (Uncomplicated) 1.093 0.036 1449.240 1.025 1.167 0.007 ** STOP/SCOPE (GDM_new) 1.182 0.069 1046.878 1.054 1.326 0.004 ** GDM_new/Uncomplicated (SCOPE) 0.945 0.047 734.683 0.857 1.042 0.257 ns GDM_new/Uncomplicated (STOP) 1.022 0.029 1437.110 0.966 1.081 0.454 ns GH2 contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (Uncomplicated) 0.960 0.044 1294.983 0.878 1.050 0.370 ns STOP/SCOPE (GDM_new) 1.121 0.097 1340.588 0.947 1.328 0.184 ns GDM_new/Uncomplicated (SCOPE) 0.918 0.069 1260.805 0.793 1.064 0.257 ns GDM_new/Uncomplicated (STOP) 1.073 0.043 1494.387 0.992 1.159 0.077 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (Uncomplicated) 0.734 0.063 Inf 0.621 0.868 0.0003 *** STOP/SCOPE (GDM_new) 0.554 0.080 Inf 0.417 0.735 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE) 1.732 0.211 Inf 1.364 2.199 &lt;0.0001 *** GDM_new/Uncomplicated (STOP) 1.306 0.094 Inf 1.134 1.505 0.0002 *** HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (Uncomplicated) 0.630 0.057 Inf 0.527 0.752 &lt;0.0001 *** STOP/SCOPE (GDM_new) 0.451 0.073 Inf 0.328 0.621 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE) 1.853 0.264 Inf 1.402 2.448 &lt;0.0001 *** GDM_new/Uncomplicated (STOP) 1.328 0.103 Inf 1.141 1.545 0.0002 *** GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (Uncomplicated) 0.868 0.016 Inf 0.838 0.899 &lt;0.0001 *** STOP/SCOPE (GDM_new) 0.808 0.039 Inf 0.734 0.889 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE) 1.098 0.061 Inf 0.984 1.225 0.093 ns GDM_new/Uncomplicated (STOP) 1.022 0.014 Inf 0.994 1.050 0.132 ns 53.1.5.1 Barplots 53.1.6 Comparisons by Timepoint Prolactin contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (Uncomplicated)|10wks 0.909 0.057 1440.121 0.804 1.027 0.124 ns STOP/SCOPE (GDM_new)|10wks 1.063 0.122 1271.507 0.849 1.330 0.594 ns GDM_new/Uncomplicated (SCOPE)|10wks 0.912 0.092 1206.203 0.748 1.112 0.361 ns GDM_new/Uncomplicated (STOP)|10wks 1.067 0.056 1412.722 0.963 1.182 0.217 ns STOP/SCOPE (Uncomplicated)|16wks 0.909 0.057 1440.121 0.804 1.027 0.124 ns STOP/SCOPE (GDM_new)|16wks 1.063 0.122 1271.507 0.849 1.330 0.594 ns GDM_new/Uncomplicated (SCOPE)|16wks 0.912 0.092 1206.203 0.748 1.112 0.361 ns GDM_new/Uncomplicated (STOP)|16wks 1.067 0.056 1412.722 0.963 1.182 0.217 ns 16wks/10wks (Uncomplicated)|SCOPE 2.320 0.162 1435.177 2.023 2.660 &lt;0.0001 *** 16wks/10wks (GDM_new)|SCOPE 2.320 0.162 1435.177 2.023 2.660 &lt;0.0001 *** 16wks/10wks (Uncomplicated)|STOP 2.320 0.162 1435.177 2.023 2.660 &lt;0.0001 *** 16wks/10wks (GDM_new)|STOP 2.320 0.162 1435.177 2.023 2.660 &lt;0.0001 *** HPL contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (Uncomplicated)|10wks 1.093 0.036 1449.240 1.025 1.167 0.007 ** STOP/SCOPE (GDM_new)|10wks 1.182 0.069 1046.878 1.054 1.326 0.004 ** GDM_new/Uncomplicated (SCOPE)|10wks 0.945 0.047 734.683 0.857 1.042 0.257 ns GDM_new/Uncomplicated (STOP)|10wks 1.022 0.029 1437.110 0.966 1.081 0.454 ns STOP/SCOPE (Uncomplicated)|16wks 1.093 0.036 1449.240 1.025 1.167 0.007 ** STOP/SCOPE (GDM_new)|16wks 1.182 0.069 1046.878 1.054 1.326 0.004 ** GDM_new/Uncomplicated (SCOPE)|16wks 0.945 0.047 734.683 0.857 1.042 0.257 ns GDM_new/Uncomplicated (STOP)|16wks 1.022 0.029 1437.110 0.966 1.081 0.454 ns 16wks/10wks (Uncomplicated)|SCOPE 5.574 0.212 1454.688 5.173 6.006 &lt;0.0001 *** 16wks/10wks (GDM_new)|SCOPE 5.574 0.212 1454.688 5.173 6.006 &lt;0.0001 *** 16wks/10wks (Uncomplicated)|STOP 5.574 0.212 1454.688 5.173 6.006 &lt;0.0001 *** 16wks/10wks (GDM_new)|STOP 5.574 0.212 1454.688 5.173 6.006 &lt;0.0001 *** GH2 contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (Uncomplicated)|10wks 0.960 0.044 1294.983 0.878 1.050 0.370 ns STOP/SCOPE (GDM_new)|10wks 1.121 0.097 1340.588 0.947 1.328 0.184 ns GDM_new/Uncomplicated (SCOPE)|10wks 0.918 0.069 1260.805 0.793 1.064 0.257 ns GDM_new/Uncomplicated (STOP)|10wks 1.073 0.043 1494.387 0.992 1.159 0.077 ns STOP/SCOPE (Uncomplicated)|16wks 0.960 0.044 1294.983 0.878 1.050 0.370 ns STOP/SCOPE (GDM_new)|16wks 1.121 0.097 1340.588 0.947 1.328 0.184 ns GDM_new/Uncomplicated (SCOPE)|16wks 0.918 0.069 1260.805 0.793 1.064 0.257 ns GDM_new/Uncomplicated (STOP)|16wks 1.073 0.043 1494.387 0.992 1.159 0.077 ns 16wks/10wks (Uncomplicated)|SCOPE 4.671 0.245 1432.164 4.214 5.177 &lt;0.0001 *** 16wks/10wks (GDM_new)|SCOPE 4.671 0.245 1432.164 4.214 5.177 &lt;0.0001 *** 16wks/10wks (Uncomplicated)|STOP 4.671 0.245 1432.164 4.214 5.177 &lt;0.0001 *** 16wks/10wks (GDM_new)|STOP 4.671 0.245 1432.164 4.214 5.177 &lt;0.0001 *** Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (Uncomplicated)|10wks 0.734 0.063 Inf 0.621 0.868 0.0003 *** STOP/SCOPE (GDM_new)|10wks 0.554 0.080 Inf 0.417 0.735 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE)|10wks 1.732 0.211 Inf 1.364 2.199 &lt;0.0001 *** GDM_new/Uncomplicated (STOP)|10wks 1.306 0.094 Inf 1.134 1.505 0.0002 *** STOP/SCOPE (Uncomplicated)|16wks 0.734 0.063 Inf 0.621 0.868 0.0003 *** STOP/SCOPE (GDM_new)|16wks 0.554 0.080 Inf 0.417 0.735 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE)|16wks 1.732 0.211 Inf 1.364 2.199 &lt;0.0001 *** GDM_new/Uncomplicated (STOP)|16wks 1.306 0.094 Inf 1.134 1.505 0.0002 *** 16wks/10wks (Uncomplicated)|SCOPE 1.075 0.105 Inf 0.887 1.303 0.460 ns 16wks/10wks (GDM_new)|SCOPE 1.075 0.105 Inf 0.887 1.303 0.460 ns 16wks/10wks (Uncomplicated)|STOP 1.075 0.105 Inf 0.887 1.303 0.460 ns 16wks/10wks (GDM_new)|STOP 1.075 0.105 Inf 0.887 1.303 0.460 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (Uncomplicated)|10wks 0.630 0.057 Inf 0.527 0.752 &lt;0.0001 *** STOP/SCOPE (GDM_new)|10wks 0.451 0.073 Inf 0.328 0.621 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE)|10wks 1.853 0.264 Inf 1.402 2.448 &lt;0.0001 *** GDM_new/Uncomplicated (STOP)|10wks 1.328 0.103 Inf 1.141 1.545 0.0002 *** STOP/SCOPE (Uncomplicated)|16wks 0.630 0.057 Inf 0.527 0.752 &lt;0.0001 *** STOP/SCOPE (GDM_new)|16wks 0.451 0.073 Inf 0.328 0.621 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE)|16wks 1.853 0.264 Inf 1.402 2.448 &lt;0.0001 *** GDM_new/Uncomplicated (STOP)|16wks 1.328 0.103 Inf 1.141 1.545 0.0002 *** 16wks/10wks (Uncomplicated)|SCOPE 1.052 0.109 Inf 0.859 1.289 0.623 ns 16wks/10wks (GDM_new)|SCOPE 1.052 0.109 Inf 0.859 1.289 0.623 ns 16wks/10wks (Uncomplicated)|STOP 1.052 0.109 Inf 0.859 1.289 0.623 ns 16wks/10wks (GDM_new)|STOP 1.052 0.109 Inf 0.859 1.289 0.623 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (Uncomplicated)|10wks 0.868 0.016 Inf 0.838 0.899 &lt;0.0001 *** STOP/SCOPE (GDM_new)|10wks 0.808 0.039 Inf 0.734 0.889 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE)|10wks 1.098 0.061 Inf 0.984 1.225 0.093 ns GDM_new/Uncomplicated (STOP)|10wks 1.022 0.014 Inf 0.994 1.050 0.132 ns STOP/SCOPE (Uncomplicated)|16wks 0.868 0.016 Inf 0.838 0.899 &lt;0.0001 *** STOP/SCOPE (GDM_new)|16wks 0.808 0.039 Inf 0.734 0.889 &lt;0.0001 *** GDM_new/Uncomplicated (SCOPE)|16wks 1.098 0.061 Inf 0.984 1.225 0.093 ns GDM_new/Uncomplicated (STOP)|16wks 1.022 0.014 Inf 0.994 1.050 0.132 ns 16wks/10wks (Uncomplicated)|SCOPE 0.988 0.022 Inf 0.946 1.032 0.591 ns 16wks/10wks (GDM_new)|SCOPE 0.988 0.022 Inf 0.946 1.032 0.591 ns 16wks/10wks (Uncomplicated)|STOP 0.988 0.022 Inf 0.946 1.032 0.591 ns 16wks/10wks (GDM_new)|STOP 0.988 0.022 Inf 0.946 1.032 0.591 ns 53.1.6.1 Barplots by Timepoint 53.1.6.2 Plots for GA "],["folate-7.html", "53.2 Folate", " 53.2 Folate 53.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 166.0537558 1 &lt;0.0001 *** Folate 2.4526126 1 0.1 ns GDM_new 0.6482207 1 0.4 ns Study 1.3383219 1 0.2 ns GA_samp 151.3636207 1 &lt;0.0001 *** Folate:GDM_new 0.0737512 1 0.8 ns GDM_new:Study 0.8231549 1 0.4 ns Folate:Study 2.4443463 1 0.1 ns Folate:GDM_new:Study 0.0167006 1 0.9 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 37.7924677 1 &lt;0.0001 *** Folate 0.1029730 1 0.7 ns GDM_new 0.1600993 1 0.7 ns Study 8.2930926 1 0.004 ** GA_samp 1945.3062005 1 &lt;0.0001 *** Folate:GDM_new 0.2718582 1 0.6 ns GDM_new:Study 0.1153311 1 0.7 ns Folate:Study 0.0018958 1 1.0 ns Folate:GDM_new:Study 0.9457358 1 0.3 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 333.7985238 1 &lt;0.0001 *** Folate 0.6363644 1 0.4 ns GDM_new 0.0003137 1 1.0 ns Study 0.2830153 1 0.6 ns GA_samp 873.7248805 1 &lt;0.0001 *** Folate:GDM_new 1.4214832 1 0.2 ns GDM_new:Study 0.0000007 1 1.0 ns Folate:Study 1.4248198 1 0.2 ns Folate:GDM_new:Study 1.7380914 1 0.2 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 9.074 9.074 0.003 ** 5 GDM_new 1 Inf 25.522 25.522 &lt;0.0001 *** 7 Study 1 Inf 9.643 9.643 0.002 ** 8 GA_samp 1 Inf 0.032 0.032 0.9 ns 2 Folate:GDM_new 1 Inf 0.196 0.196 0.7 ns 4 Folate:Study 1 Inf 0.772 0.772 0.4 ns 6 GDM_new:Study 1 Inf 0.977 0.977 0.3 ns 3 Folate:GDM_new:Study 1 Inf 0.006 0.006 0.9 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 11.114 11.114 0.0009 *** 5 GDM_new 1 Inf 26.938 26.938 &lt;0.0001 *** 7 Study 1 Inf 15.817 15.817 &lt;0.0001 *** 8 GA_samp 1 Inf 0.005 0.005 0.9 ns 2 Folate:GDM_new 1 Inf 0.680 0.680 0.4 ns 4 Folate:Study 1 Inf 0.954 0.954 0.3 ns 6 GDM_new:Study 1 Inf 1.300 1.300 0.3 ns 3 Folate:GDM_new:Study 1 Inf 0.001 0.001 1.0 ns GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 3.341 3.341 0.07 ns 5 GDM_new 1 Inf 5.928 5.928 0.01 * 7 Study 1 Inf 17.784 17.784 &lt;0.0001 *** 8 GA_samp 1 Inf 0.589 0.589 0.4 ns 2 Folate:GDM_new 1 Inf 3.209 3.209 0.07 ns 4 Folate:Study 1 Inf 1.075 1.075 0.3 ns 6 GDM_new:Study 1 Inf 1.115 1.115 0.3 ns 3 Folate:GDM_new:Study 1 Inf 0.363 0.363 0.5 ns 53.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.68 (2.27, 3.09) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.11 GDM_newGDM -0.14 (-0.38, 0.10) 0.25 StudySTOP -0.10 (-0.26, 0.07) 0.25 GA_samp 0.15 (0.13, 0.17) &lt;0.0001 Folate:GDM_newGDM 0.00 (-0.00, 0.00) 0.68 GDM_newGDM:StudySTOP 0.17 (-0.06, 0.40) 0.14 Folate:StudySTOP 0.00 (-0.00, 0.00) 0.11 HPL Var Effect P (Intercept) 0.67 (0.46, 0.88) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.55 GDM_newGDM -0.11 (-0.24, 0.01) 0.07 StudySTOP 0.12 (0.03, 0.21) 0.006 GA_samp 0.29 (0.28, 0.30) &lt;0.0001 Folate:GDM_newGDM 0.00 (-0.00, 0.00) 0.36 GDM_newGDM:StudySTOP 0.05 (-0.06, 0.17) 0.38 Folate:StudySTOP 0.00 (-0.00, 0.00) 0.70 GH2 Var Effect P (Intercept) -2.60 (-2.88, -2.32) &lt;0.0001 Folate 0.00 (-0.00, 0.00) 0.63 GDM_newGDM -0.15 (-0.33, 0.02) 0.09 StudySTOP 0.02 (-0.10, 0.13) 0.79 GA_samp 0.26 (0.24, 0.28) &lt;0.0001 Folate:GDM_newGDM 0.00 (-0.00, 0.00) 0.93 GDM_newGDM:StudySTOP 0.18 (0.01, 0.34) 0.04 Folate:StudySTOP -0.00 (-0.00, 0.00) 0.41 Insulin Var Effect P (Intercept) 2.73 (2.19, 3.27) &lt;0.0001 Folate -0.00 (-0.00, -0.00) 0.01 GDM_newGDM 0.88 (0.51, 1.25) &lt;0.0001 StudySTOP -0.36 (-0.58, -0.14) 0.001 GA_samp 0.00 (-0.03, 0.04) 0.86 Folate:GDM_newGDM -0.00 (-0.00, 0.00) 0.62 GDM_newGDM:StudySTOP -0.30 (-0.64, 0.04) 0.09 Folate:StudySTOP 0.00 (-0.00, 0.00) 0.25 HOMA.IR Var Effect P (Intercept) 1.38 (0.82, 1.95) &lt;0.0001 Folate -0.00 (-0.01, -0.00) 0.010 GDM_newGDM 1.01 (0.60, 1.42) &lt;0.0001 StudySTOP -0.52 (-0.75, -0.29) &lt;0.0001 GA_samp -0.00 (-0.04, 0.03) 0.95 Folate:GDM_newGDM -0.00 (-0.00, 0.00) 0.40 GDM_newGDM:StudySTOP -0.36 (-0.73, 0.02) 0.06 Folate:StudySTOP 0.00 (-0.00, 0.00) 0.23 GLUC3_mmol.L Var Effect P (Intercept) 1.74 (1.63, 1.85) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.24 GDM_newGDM 0.17 (0.03, 0.31) 0.02 StudySTOP -0.16 (-0.21, -0.12) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.46 Folate:GDM_newGDM -0.00 (-0.00, -0.00) 0.02 GDM_newGDM:StudySTOP -0.08 (-0.19, 0.04) 0.19 Folate:StudySTOP 0.00 (-0.00, 0.00) 0.18 53.2.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling, BMI, ethnicity and smoking. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 95.35474 7.723286 103.59515 81.20525 111.9697 STOP Uncomplicated 93.06073 7.002133 77.54398 80.11330 108.1006 SCOPE GDM 84.60656 10.669469 473.18347 66.03685 108.3981 STOP GDM 98.14689 8.739906 146.77629 82.30904 117.0322 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 86.36991 2.557252 191.4602 81.47036 91.56411 STOP Uncomplicated 98.38568 2.537038 111.4016 93.48484 103.54344 SCOPE GDM 78.99181 4.442170 657.3481 70.73359 88.21417 STOP GDM 94.84920 3.438940 330.2081 88.31982 101.86128 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.242975 0.0751963 448.4804 2.099957 2.395733 STOP Uncomplicated 2.217601 0.0592679 224.5118 2.103830 2.337523 SCOPE GDM 1.929900 0.1508423 1050.6292 1.655493 2.249790 STOP GDM 2.275996 0.0964418 519.2425 2.094203 2.473569 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 14.31790 0.9047409 Inf 12.650048 16.20564 STOP Uncomplicated 10.58341 0.4578802 Inf 9.722981 11.51999 SCOPE GDM 33.50257 5.9394036 Inf 23.668755 47.42211 STOP GDM 18.43351 1.4688039 Inf 15.768238 21.54928 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 3.479324 0.2344205 Inf 3.048912 3.970497 STOP Uncomplicated 2.207061 0.1000447 Inf 2.019435 2.412119 SCOPE GDM 9.041846 1.7719882 Inf 6.158028 13.276160 STOP GDM 3.998995 0.3427619 Inf 3.380591 4.730522 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.439876 0.0700739 Inf 5.304253 5.578967 STOP Uncomplicated 4.698407 0.0436086 Inf 4.613708 4.784660 SCOPE GDM 6.146121 0.3391490 Inf 5.516085 6.848118 STOP GDM 4.921928 0.0707447 Inf 4.785206 5.062557 53.2.4 Comparisons 53.2.4.1 Within Groups Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Prolactin Folate40.2 / Folate39.2 SCOPE Uncomplicated 0.999 (0.997, 1.000) 0.1 Prolactin Folate40.2 / Folate39.2 STOP Uncomplicated 1.000 (0.999, 1.002) 0.6 Prolactin Folate40.2 / Folate39.2 SCOPE GDM 0.999 (0.996, 1.002) 0.5 Prolactin Folate40.2 / Folate39.2 STOP GDM 1.001 (0.999, 1.003) 0.4 HPL Folate40.2 / Folate39.2 SCOPE Uncomplicated 1.000 (0.999, 1.001) 0.5 HPL Folate40.2 / Folate39.2 STOP Uncomplicated 1.000 (0.999, 1.001) 0.9 HPL Folate40.2 / Folate39.2 SCOPE GDM 1.000 (0.999, 1.002) 0.7 HPL Folate40.2 / Folate39.2 STOP GDM 1.001 (0.999, 1.002) 0.3 GH2 Folate40.2 / Folate39.2 SCOPE Uncomplicated 1.000 (0.999, 1.002) 0.6 GH2 Folate40.2 / Folate39.2 STOP Uncomplicated 1.000 (0.999, 1.001) 0.5 GH2 Folate40.2 / Folate39.2 SCOPE GDM 1.000 (0.998, 1.003) 0.7 GH2 Folate40.2 / Folate39.2 STOP GDM 1.000 (0.998, 1.001) 0.7 Insulin Folate40.2 / Folate39.2 SCOPE Uncomplicated 0.997 (0.995, 1.000) 0.02 Insulin Folate40.2 / Folate39.2 STOP Uncomplicated 0.999 (0.997, 1.000) 0.1 Insulin Folate40.2 / Folate39.2 SCOPE GDM 0.997 (0.992, 1.001) 0.1 Insulin Folate40.2 / Folate39.2 STOP GDM 0.998 (0.995, 1.001) 0.2 HOMA.IR Folate40.2 / Folate39.2 SCOPE Uncomplicated 0.997 (0.995, 0.999) 0.02 HOMA.IR Folate40.2 / Folate39.2 STOP Uncomplicated 0.999 (0.997, 1.000) 0.1 HOMA.IR Folate40.2 / Folate39.2 SCOPE GDM 0.996 (0.991, 1.001) 0.08 HOMA.IR Folate40.2 / Folate39.2 STOP GDM 0.997 (0.994, 1.001) 0.1 GLUC3_mmol.L Folate40.2 / Folate39.2 SCOPE Uncomplicated 1.000 (0.999, 1.000) 0.2 GLUC3_mmol.L Folate40.2 / Folate39.2 STOP Uncomplicated 1.000 (1.000, 1.001) 0.4 GLUC3_mmol.L Folate40.2 / Folate39.2 SCOPE GDM 0.999 (0.997, 1.000) 0.03 GLUC3_mmol.L Folate40.2 / Folate39.2 STOP GDM 0.999 (0.998, 1.000) 0.02 53.2.4.2 Between Groups Below are comparisons of the differences in the change in Serum folate concentration (nM) between groups. I.e. whether the change in Serum folate concentration (nM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.003654 0.0022792 1399.391 0.9991925 1.008135 0.109 ns STOP/SCOPE (Uncomplicated) 1.001825 0.0011375 1399.391 0.9995962 1.004059 0.109 ns STOP/SCOPE (GDM) 1.001825 0.0011375 1399.391 0.9995962 1.004059 0.109 ns GDM/Uncomplicated (SCOPE) 1.000532 0.0012835 1381.003 0.9980172 1.003053 0.679 ns GDM/Uncomplicated (STOP) 1.000532 0.0012835 1381.003 0.9980172 1.003053 0.679 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.000462 0.0011895 1275.512 0.9981314 1.002798 0.698 ns STOP/SCOPE (Uncomplicated) 1.000231 0.0005946 1275.512 0.9990652 1.001398 0.698 ns STOP/SCOPE (GDM) 1.000231 0.0005946 1275.512 0.9990652 1.001398 0.698 ns GDM/Uncomplicated (SCOPE) 1.000644 0.0006994 1355.552 0.9992728 1.002017 0.357 ns GDM/Uncomplicated (STOP) 1.000644 0.0006994 1355.552 0.9992728 1.002017 0.357 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9986413 0.0016430 1457.897 0.9954236 1.001869 0.409 ns STOP/SCOPE (Uncomplicated) 0.9993204 0.0008221 1457.897 0.9977092 1.000934 0.409 ns STOP/SCOPE (GDM) 0.9993204 0.0008221 1457.897 0.9977092 1.000934 0.409 ns GDM/Uncomplicated (SCOPE) 1.0000877 0.0009469 1464.037 0.9982319 1.001947 0.926 ns GDM/Uncomplicated (STOP) 1.0000877 0.0009469 1464.037 0.9982319 1.001947 0.926 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0027485 0.0031331 Inf 0.9966264 1.008908 0.380 ns STOP/SCOPE (Uncomplicated) 1.0014913 0.0014134 Inf 0.9987250 1.004265 0.291 ns STOP/SCOPE (GDM) 1.0012553 0.0027915 Inf 0.9957990 1.006741 0.653 ns GDM/Uncomplicated (SCOPE) 0.9994251 0.0025215 Inf 0.9944952 1.004379 0.820 ns GDM/Uncomplicated (STOP) 0.9991896 0.0018443 Inf 0.9955814 1.002811 0.661 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0033575 0.0034435 Inf 0.9966309 1.010129 0.329 ns STOP/SCOPE (Uncomplicated) 1.0016190 0.0014936 Inf 0.9986959 1.004551 0.278 ns STOP/SCOPE (GDM) 1.0017357 0.0030969 Inf 0.9956843 1.007824 0.575 ns GDM/Uncomplicated (SCOPE) 0.9985275 0.0028413 Inf 0.9929742 1.004112 0.605 ns GDM/Uncomplicated (STOP) 0.9986438 0.0019185 Inf 0.9948906 1.002411 0.480 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0008925 0.0006662 Inf 0.9995876 1.0021991 0.180 ns STOP/SCOPE (Uncomplicated) 1.0004461 0.0003330 Inf 0.9997938 1.0010989 0.180 ns STOP/SCOPE (GDM) 1.0004461 0.0003330 Inf 0.9997938 1.0010989 0.180 ns GDM/Uncomplicated (SCOPE) 0.9988937 0.0004932 Inf 0.9979274 0.9998609 0.025 * GDM/Uncomplicated (STOP) 0.9988937 0.0004932 Inf 0.9979274 0.9998609 0.025 * 53.2.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 53.2.6 Plots "],["b12-7.html", "53.3 B12", " 53.3 B12 53.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 142.6249156 1 &lt;0.0001 *** B12 0.0133596 1 0.9 ns GDM_new 2.0584988 1 0.2 ns Study 0.2833550 1 0.6 ns GA_samp 153.0273355 1 &lt;0.0001 *** B12:GDM_new 1.2736316 1 0.3 ns GDM_new:Study 1.6999725 1 0.2 ns B12:Study 0.2217536 1 0.6 ns B12:GDM_new:Study 0.7321150 1 0.4 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 27.4857978 1 &lt;0.0001 *** B12 1.0580423 1 0.3 ns GDM_new 6.0339287 1 0.01 * Study 3.7853360 1 0.05 ns GA_samp 1979.9428441 1 &lt;0.0001 *** B12:GDM_new 3.8688047 1 0.05 ns GDM_new:Study 7.9375646 1 0.005 ** B12:Study 0.0272714 1 0.9 ns B12:GDM_new:Study 6.5247527 1 0.01 * GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 343.0252955 1 &lt;0.0001 *** B12 6.3264944 1 0.01 * GDM_new 3.1930263 1 0.07 ns Study 0.7898003 1 0.4 ns GA_samp 898.0854142 1 &lt;0.0001 *** B12:GDM_new 1.2319261 1 0.3 ns GDM_new:Study 2.8650730 1 0.09 ns B12:Study 1.7622600 1 0.2 ns B12:GDM_new:Study 0.9244163 1 0.3 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 6.372 6.372 0.01 * 5 GDM_new 1 Inf 12.913 12.913 0.0003 *** 7 Study 1 Inf 7.038 7.038 0.008 ** 8 GA_samp 1 Inf 0.018 0.018 0.9 ns 2 B12:GDM_new 1 Inf 1.272 1.272 0.3 ns 4 B12:Study 1 Inf 1.629 1.629 0.2 ns 6 GDM_new:Study 1 Inf 0.909 0.909 0.3 ns 3 B12:GDM_new:Study 1 Inf 0.302 0.302 0.6 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 4.974 4.974 0.03 * 5 GDM_new 1 Inf 11.314 11.314 0.0008 *** 7 Study 1 Inf 8.376 8.376 0.004 ** 8 GA_samp 1 Inf 0.010 0.010 0.9 ns 2 B12:GDM_new 1 Inf 0.879 0.879 0.3 ns 4 B12:Study 1 Inf 1.091 1.091 0.3 ns 6 GDM_new:Study 1 Inf 0.677 0.677 0.4 ns 3 B12:GDM_new:Study 1 Inf 0.121 0.121 0.7 ns GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 0.355 0.355 0.6 ns 5 GDM_new 1 Inf 0.786 0.786 0.4 ns 7 Study 1 Inf 8.298 8.298 0.004 ** 8 GA_samp 1 Inf 0.579 0.579 0.4 ns 2 B12:GDM_new 1 Inf 0.044 0.044 0.8 ns 4 B12:Study 1 Inf 0.073 0.073 0.8 ns 6 GDM_new:Study 1 Inf 0.267 0.267 0.6 ns 3 B12:GDM_new:Study 1 Inf 0.010 0.010 0.9 ns 53.3.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.58 (2.16, 3.01) &lt;0.0001 B12 0.00 (-0.00, 0.00) 0.72 GDM_newGDM -0.21 (-0.49, 0.08) 0.16 StudySTOP -0.04 (-0.26, 0.19) 0.76 GA_samp 0.15 (0.13, 0.17) &lt;0.0001 B12:GDM_newGDM 0.00 (-0.00, 0.00) 0.36 GDM_newGDM:StudySTOP 0.16 (-0.06, 0.39) 0.16 B12:StudySTOP 0.00 (-0.00, 0.00) 0.84 HPL Var Effect P (Intercept) 0.59 (0.37, 0.81) &lt;0.0001 B12 0.00 (-0.00, 0.00) 0.30 GDM_newGDM -0.36 (-0.65, -0.07) 0.01 StudySTOP 0.12 (-0.00, 0.24) 0.05 GA_samp 0.29 (0.28, 0.31) &lt;0.0001 B12:GDM_newGDM 0.00 (0.00, 0.00) 0.05 GDM_newGDM:StudySTOP 0.46 (0.14, 0.78) 0.005 B12:StudySTOP 0.00 (-0.00, 0.00) 0.87 B12:GDM_newGDM:StudySTOP -0.00 (-0.00, -0.00) 0.01 GH2 Var Effect P (Intercept) -2.77 (-3.07, -2.48) &lt;0.0001 B12 0.00 (0.00, 0.00) 0.004 GDM_newGDM -0.21 (-0.42, 0.00) 0.05 StudySTOP 0.10 (-0.06, 0.26) 0.24 GA_samp 0.26 (0.25, 0.28) &lt;0.0001 B12:GDM_newGDM 0.00 (-0.00, 0.00) 0.56 GDM_newGDM:StudySTOP 0.19 (0.03, 0.36) 0.02 B12:StudySTOP -0.00 (-0.00, 0.00) 0.09 Insulin Var Effect P (Intercept) 2.87 (2.29, 3.46) &lt;0.0001 B12 -0.00 (-0.00, 0.00) 0.05 GDM_newGDM 0.97 (0.54, 1.40) &lt;0.0001 StudySTOP -0.49 (-0.81, -0.16) 0.004 GA_samp 0.00 (-0.03, 0.04) 0.89 B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.27 GDM_newGDM:StudySTOP -0.25 (-0.58, 0.08) 0.14 B12:StudySTOP 0.00 (-0.00, 0.00) 0.20 HOMA.IR Var Effect P (Intercept) 1.51 (0.89, 2.13) &lt;0.0001 B12 -0.00 (-0.00, 0.00) 0.07 GDM_newGDM 1.07 (0.59, 1.55) &lt;0.0001 StudySTOP -0.64 (-0.99, -0.29) 0.0004 GA_samp -0.00 (-0.04, 0.03) 0.92 B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.29 GDM_newGDM:StudySTOP -0.31 (-0.67, 0.06) 0.10 B12:StudySTOP 0.00 (-0.00, 0.00) 0.23 GLUC3_mmol.L Var Effect P (Intercept) 1.76 (1.64, 1.87) &lt;0.0001 B12 -0.00 (-0.00, 0.00) 0.19 GDM_newGDM 0.11 (-0.04, 0.26) 0.16 StudySTOP -0.16 (-0.22, -0.10) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.45 B12:GDM_newGDM 0.00 (-0.00, 0.00) 0.80 GDM_newGDM:StudySTOP -0.08 (-0.20, 0.03) 0.15 B12:StudySTOP 0.00 (-0.00, 0.00) 0.52 53.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 95.12747 7.791555 108.87662 80.87298 111.8944 STOP Uncomplicated 93.83962 7.020651 76.25041 80.84932 108.9171 SCOPE GDM 86.24608 10.930774 483.07616 67.23380 110.6346 STOP GDM 100.23681 8.826828 141.47889 84.22169 119.2973 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 86.68206 2.632632 213.4706 81.64505 92.02982 STOP Uncomplicated 98.85500 2.509604 106.3658 94.00280 103.95767 SCOPE GDM 82.65049 4.849031 610.8268 73.65582 92.74357 STOP GDM 95.63783 3.401521 314.8558 89.17405 102.57015 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.304977 0.0803862 513.1083 2.152340 2.468440 STOP Uncomplicated 2.219625 0.0577786 208.4185 2.108593 2.336504 SCOPE GDM 1.970136 0.1533418 1081.8609 1.691104 2.295208 STOP GDM 2.296205 0.0948462 488.7588 2.117210 2.490332 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 13.55675 0.9031283 Inf 11.89734 15.44761 STOP Uncomplicated 10.35361 0.4308209 Inf 9.54273 11.23339 SCOPE GDM 29.66964 4.3870159 Inf 22.20505 39.64357 STOP GDM 17.64377 1.3367027 Inf 15.20911 20.46817 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 3.289451 0.2333498 Inf 2.862465 3.780129 STOP Uncomplicated 2.157247 0.0942625 Inf 1.980186 2.350140 SCOPE GDM 7.863563 1.2846270 Inf 5.709042 10.831173 STOP GDM 3.797184 0.3091261 Inf 3.237173 4.454073 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.403450 0.0734390 Inf 5.261413 5.549322 STOP Uncomplicated 4.707016 0.0423890 Inf 4.624664 4.790834 SCOPE GDM 6.076550 0.3186762 Inf 5.482984 6.734373 STOP GDM 4.865341 0.0638087 Inf 4.741872 4.992025 53.3.4 Comparisons 53.3.4.1 Within Groups Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Prolactin B12366 / B12266 SCOPE Uncomplicated 1.010 (0.956, 1.067) 0.7 Prolactin B12366 / B12266 STOP Uncomplicated 1.017 (0.978, 1.058) 0.4 Prolactin B12366 / B12266 SCOPE GDM 1.045 (0.958, 1.140) 0.3 Prolactin B12366 / B12266 STOP GDM 1.052 (0.986, 1.123) 0.1 HPL B12366 / B12266 SCOPE Uncomplicated 1.016 (0.986, 1.047) 0.3 HPL B12366 / B12266 STOP Uncomplicated 1.019 (0.997, 1.041) 0.08 HPL B12366 / B12266 SCOPE GDM 1.122 (1.021, 1.233) 0.02 HPL B12366 / B12266 STOP GDM 0.977 (0.942, 1.015) 0.2 GH2 B12366 / B12266 SCOPE Uncomplicated 1.060 (1.018, 1.103) 0.004 GH2 B12366 / B12266 STOP Uncomplicated 1.016 (0.987, 1.045) 0.3 GH2 B12366 / B12266 SCOPE GDM 1.077 (1.011, 1.148) 0.02 GH2 B12366 / B12266 STOP GDM 1.032 (0.984, 1.083) 0.2 Insulin B12366 / B12266 SCOPE Uncomplicated 0.911 (0.830, 1.000) 0.05 Insulin B12366 / B12266 STOP Uncomplicated 0.976 (0.925, 1.029) 0.4 Insulin B12366 / B12266 SCOPE GDM 0.858 (0.751, 0.980) 0.02 Insulin B12366 / B12266 STOP GDM 0.919 (0.835, 1.011) 0.08 HOMA.IR B12366 / B12266 SCOPE Uncomplicated 0.910 (0.824, 1.006) 0.07 HOMA.IR B12366 / B12266 STOP Uncomplicated 0.975 (0.920, 1.034) 0.4 HOMA.IR B12366 / B12266 SCOPE GDM 0.856 (0.741, 0.987) 0.03 HOMA.IR B12366 / B12266 STOP GDM 0.917 (0.827, 1.016) 0.10 GLUC3_mmol.L B12366 / B12266 SCOPE Uncomplicated 0.989 (0.973, 1.005) 0.2 GLUC3_mmol.L B12366 / B12266 STOP Uncomplicated 0.996 (0.986, 1.005) 0.4 GLUC3_mmol.L B12366 / B12266 SCOPE GDM 0.992 (0.960, 1.026) 0.7 GLUC3_mmol.L B12366 / B12266 STOP GDM 0.999 (0.978, 1.020) 0.9 53.3.4.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.013692 0.0682250 1341.524 0.8883123 1.156769 0.840 ns STOP/SCOPE (Uncomplicated) 1.006823 0.0338813 1341.524 0.9425032 1.075532 0.840 ns STOP/SCOPE (GDM) 1.006823 0.0338813 1341.524 0.9425032 1.075532 0.840 ns GDM/Uncomplicated (SCOPE) 1.034630 0.0387836 1372.494 0.9612779 1.113578 0.364 ns GDM/Uncomplicated (STOP) 1.034630 0.0387836 1372.494 0.9612779 1.113578 0.364 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8739563 0.0481123 664.0487 0.7844125 0.9737219 0.015 * STOP/SCOPE (Uncomplicated) 1.0031428 0.0190608 1300.0835 0.9664378 1.0412418 0.869 ns STOP/SCOPE (GDM) 0.8712183 0.0450833 600.1575 0.7870286 0.9644139 0.008 ** GDM/Uncomplicated (SCOPE) 1.1042956 0.0556984 563.4220 1.0001384 1.2193001 0.050 * GDM/Uncomplicated (STOP) 0.9590684 0.0210968 1400.5208 0.9185638 1.0013591 0.058 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9187595 0.0451804 1392.880 0.8342711 1.011804 0.085 ns STOP/SCOPE (Uncomplicated) 0.9585194 0.0235678 1392.880 0.9133844 1.005885 0.085 ns STOP/SCOPE (GDM) 0.9585194 0.0235678 1392.880 0.9133844 1.005885 0.085 ns GDM/Uncomplicated (SCOPE) 1.0164068 0.0280875 1431.273 0.9627764 1.073025 0.556 ns GDM/Uncomplicated (STOP) 1.0164068 0.0280875 1431.273 0.9627764 1.073025 0.556 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.1469112 0.1224671 Inf 0.9303332 1.413908 0.199 ns STOP/SCOPE (Uncomplicated) 1.0709394 0.0571774 Inf 0.9645378 1.189078 0.199 ns STOP/SCOPE (GDM) 1.0709394 0.0571774 Inf 0.9645378 1.189078 0.199 ns GDM/Uncomplicated (SCOPE) 0.9414962 0.0512245 Inf 0.8462658 1.047443 0.268 ns GDM/Uncomplicated (STOP) 0.9414962 0.0512245 Inf 0.8462658 1.047443 0.268 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.1477984 0.1316612 Inf 0.9166981 1.437159 0.229 ns STOP/SCOPE (Uncomplicated) 1.0713535 0.0614462 Inf 0.9574435 1.198816 0.229 ns STOP/SCOPE (GDM) 1.0713535 0.0614462 Inf 0.9574435 1.198816 0.229 ns GDM/Uncomplicated (SCOPE) 0.9398504 0.0551365 Inf 0.8377662 1.054374 0.290 ns GDM/Uncomplicated (STOP) 0.9398504 0.0551365 Inf 0.8377662 1.054374 0.290 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.013107 0.0205779 Inf 0.9735669 1.054252 0.521 ns STOP/SCOPE (Uncomplicated) 1.006532 0.0102222 Inf 0.9866950 1.026768 0.521 ns STOP/SCOPE (GDM) 1.006532 0.0102222 Inf 0.9866950 1.026768 0.521 ns GDM/Uncomplicated (SCOPE) 1.003341 0.0130778 Inf 0.9780336 1.029303 0.798 ns GDM/Uncomplicated (STOP) 1.003341 0.0130778 Inf 0.9780336 1.029303 0.798 ns 53.3.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 94.89006 7.689011 104.38962 80.80501 111.4303 STOP Uncomplicated 93.44643 6.980985 75.81143 80.52703 108.4386 SCOPE GDM 85.30174 10.708996 469.99571 66.65305 109.1681 STOP GDM 98.97089 8.685380 139.61786 83.20617 117.7225 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 86.33838 2.557415 194.8997 81.43912 91.53238 STOP Uncomplicated 98.38586 2.489064 104.9517 93.57222 103.44712 SCOPE GDM 80.30615 4.473273 621.1605 71.98499 89.58919 STOP GDM 96.18367 3.397694 307.3219 89.72505 103.10720 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.271758 0.0764773 464.7386 2.126337 2.427125 STOP Uncomplicated 2.210930 0.0572560 204.9840 2.100877 2.326747 SCOPE GDM 1.933858 0.1486430 1066.7735 1.663122 2.248668 STOP GDM 2.277922 0.0931829 478.3484 2.101989 2.468581 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 13.87606 0.8774446 Inf 12.258601 15.70693 STOP Uncomplicated 10.41744 0.4270716 Inf 9.613143 11.28903 SCOPE GDM 30.82962 4.5440752 Inf 23.094412 41.15565 STOP GDM 18.02213 1.3612571 Inf 15.542210 20.89775 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 3.367533 0.2268849 Inf 2.950956 3.842916 STOP Uncomplicated 2.170726 0.0935500 Inf 1.994902 2.362047 SCOPE GDM 8.176041 1.3385987 Inf 5.931746 11.269472 STOP GDM 3.880629 0.3154237 Inf 3.309140 4.550814 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.418350 0.0700905 Inf 5.282702 5.557481 STOP Uncomplicated 4.712319 0.0423122 Inf 4.630114 4.795983 SCOPE GDM 6.088227 0.3250731 Inf 5.483300 6.759891 STOP GDM 4.866762 0.0636995 Inf 4.743501 4.993226 53.3.6 Comparisons (50 unit increase) 53.3.6.1 Within Groups Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Prolactin B12316 / B12266 SCOPE Uncomplicated 1.005 (0.978, 1.033) 0.7 Prolactin B12316 / B12266 STOP Uncomplicated 1.008 (0.989, 1.028) 0.4 Prolactin B12316 / B12266 SCOPE GDM 1.022 (0.979, 1.068) 0.3 Prolactin B12316 / B12266 STOP GDM 1.026 (0.993, 1.060) 0.1 HPL B12316 / B12266 SCOPE Uncomplicated 1.008 (0.993, 1.023) 0.3 HPL B12316 / B12266 STOP Uncomplicated 1.010 (0.999, 1.021) 0.08 HPL B12316 / B12266 SCOPE GDM 1.059 (1.010, 1.110) 0.02 HPL B12316 / B12266 STOP GDM 0.989 (0.970, 1.007) 0.2 GH2 B12316 / B12266 SCOPE Uncomplicated 1.029 (1.009, 1.050) 0.004 GH2 B12316 / B12266 STOP Uncomplicated 1.008 (0.994, 1.022) 0.3 GH2 B12316 / B12266 SCOPE GDM 1.038 (1.005, 1.071) 0.02 GH2 B12316 / B12266 STOP GDM 1.016 (0.992, 1.041) 0.2 Insulin B12316 / B12266 SCOPE Uncomplicated 0.955 (0.911, 1.000) 0.05 Insulin B12316 / B12266 STOP Uncomplicated 0.988 (0.962, 1.015) 0.4 Insulin B12316 / B12266 SCOPE GDM 0.926 (0.867, 0.990) 0.02 Insulin B12316 / B12266 STOP GDM 0.958 (0.914, 1.005) 0.08 HOMA.IR B12316 / B12266 SCOPE Uncomplicated 0.954 (0.908, 1.003) 0.07 HOMA.IR B12316 / B12266 STOP Uncomplicated 0.988 (0.959, 1.017) 0.4 HOMA.IR B12316 / B12266 SCOPE GDM 0.925 (0.861, 0.994) 0.03 HOMA.IR B12316 / B12266 STOP GDM 0.957 (0.910, 1.008) 0.10 GLUC3_mmol.L B12316 / B12266 SCOPE Uncomplicated 0.995 (0.986, 1.003) 0.2 GLUC3_mmol.L B12316 / B12266 STOP Uncomplicated 0.998 (0.993, 1.003) 0.4 GLUC3_mmol.L B12316 / B12266 SCOPE GDM 0.996 (0.980, 1.013) 0.7 GLUC3_mmol.L B12316 / B12266 STOP GDM 0.999 (0.989, 1.010) 0.9 53.3.6.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.006823 0.0338813 1341.524 0.9425032 1.075532 0.840 ns STOP/SCOPE (Uncomplicated) 1.003406 0.0168832 1341.524 0.9708260 1.037079 0.840 ns STOP/SCOPE (GDM) 1.003406 0.0168832 1341.524 0.9708260 1.037079 0.840 ns GDM/Uncomplicated (SCOPE) 1.017167 0.0190645 1372.494 0.9804478 1.055262 0.364 ns GDM/Uncomplicated (STOP) 1.017167 0.0190645 1372.494 0.9804478 1.055262 0.364 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9348563 0.0257325 664.0487 0.8856707 0.9867735 0.015 * STOP/SCOPE (Uncomplicated) 1.0015702 0.0095155 1300.0835 0.9830757 1.0204126 0.869 ns STOP/SCOPE (GDM) 0.9333907 0.0241503 600.1575 0.8871463 0.9820458 0.008 ** GDM/Uncomplicated (SCOPE) 1.0508547 0.0265015 563.4220 1.0000692 1.1042192 0.050 * GDM/Uncomplicated (STOP) 0.9793204 0.0107712 1400.5208 0.9584173 1.0006793 0.058 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9585194 0.0235678 1392.880 0.9133844 1.005885 0.085 ns STOP/SCOPE (Uncomplicated) 0.9790400 0.0120362 1392.880 0.9557115 1.002938 0.085 ns STOP/SCOPE (GDM) 0.9790400 0.0120362 1392.880 0.9557115 1.002938 0.085 ns GDM/Uncomplicated (SCOPE) 1.0081700 0.0139300 1431.273 0.9812117 1.035869 0.556 ns GDM/Uncomplicated (STOP) 1.0081700 0.0139300 1431.273 0.9812117 1.035869 0.556 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0709394 0.0571774 Inf 0.9645378 1.189078 0.199 ns STOP/SCOPE (Uncomplicated) 1.0348620 0.0276256 Inf 0.9821089 1.090449 0.199 ns STOP/SCOPE (GDM) 1.0348620 0.0276256 Inf 0.9821089 1.090449 0.199 ns GDM/Uncomplicated (SCOPE) 0.9703072 0.0263960 Inf 0.9199271 1.023446 0.268 ns GDM/Uncomplicated (STOP) 0.9703072 0.0263960 Inf 0.9199271 1.023446 0.268 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0713535 0.0614462 Inf 0.9574435 1.198816 0.229 ns STOP/SCOPE (Uncomplicated) 1.0350621 0.0296824 Inf 0.9784904 1.094904 0.229 ns STOP/SCOPE (GDM) 1.0350621 0.0296824 Inf 0.9784904 1.094904 0.229 ns GDM/Uncomplicated (SCOPE) 0.9694588 0.0284367 Inf 0.9152957 1.026827 0.290 ns GDM/Uncomplicated (STOP) 0.9694588 0.0284367 Inf 0.9152957 1.026827 0.290 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.006532 0.0102222 Inf 0.9866950 1.026768 0.521 ns STOP/SCOPE (Uncomplicated) 1.003261 0.0050945 Inf 0.9933252 1.013295 0.521 ns STOP/SCOPE (GDM) 1.003261 0.0050945 Inf 0.9933252 1.013295 0.521 ns GDM/Uncomplicated (SCOPE) 1.001669 0.0065280 Inf 0.9889558 1.014546 0.798 ns GDM/Uncomplicated (STOP) 1.001669 0.0065280 Inf 0.9889558 1.014546 0.798 ns 53.3.7 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 53.3.8 Plots "],["folateb12-7.html", "53.4 Folate:B12", " 53.4 Folate:B12 53.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 169.8724552 1 &lt;0.0001 *** folate_B12 3.7847549 1 0.05 ns GDM_new 0.5764352 1 0.4 ns Study 2.6871647 1 0.1 ns GA_samp 151.7582805 1 &lt;0.0001 *** folate_B12:GDM_new 0.0111970 1 0.9 ns GDM_new:Study 1.1101316 1 0.3 ns folate_B12:Study 5.7254015 1 0.02 * folate_B12:GDM_new:Study 0.0207807 1 0.9 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 37.8071254 1 &lt;0.0001 *** folate_B12 0.0821847 1 0.8 ns GDM_new 0.5570061 1 0.5 ns Study 9.9200537 1 0.002 ** GA_samp 1959.9141332 1 &lt;0.0001 *** folate_B12:GDM_new 5.6137682 1 0.02 * GDM_new:Study 1.5557746 1 0.2 ns folate_B12:Study 0.0319745 1 0.9 ns folate_B12:GDM_new:Study 5.9889500 1 0.01 * GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 325.1881724 1 &lt;0.0001 *** folate_B12 1.0321016 1 0.3 ns GDM_new 0.0016102 1 1.0 ns Study 0.1084480 1 0.7 ns GA_samp 877.5072246 1 &lt;0.0001 *** folate_B12:GDM_new 2.4568213 1 0.1 ns GDM_new:Study 0.0027551 1 1.0 ns folate_B12:Study 0.0171659 1 0.9 ns folate_B12:GDM_new:Study 2.8020725 1 0.09 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.344 0.344 0.6 ns 5 GDM_new 1 Inf 28.664 28.664 &lt;0.0001 *** 7 Study 1 Inf 8.069 8.069 0.005 ** 8 GA_samp 1 Inf 0.082 0.082 0.8 ns 2 folate_B12:GDM_new 1 Inf 0.000 0.000 1.0 ns 4 folate_B12:Study 1 Inf 0.038 0.038 0.8 ns 6 GDM_new:Study 1 Inf 0.602 0.602 0.4 ns 3 folate_B12:GDM_new:Study 1 Inf 0.282 0.282 0.6 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.646 0.646 0.4 ns 5 GDM_new 1 Inf 29.220 29.220 &lt;0.0001 *** 7 Study 1 Inf 14.790 14.790 0.0001 *** 8 GA_samp 1 Inf 0.003 0.003 1.0 ns 2 folate_B12:GDM_new 1 Inf 0.057 0.057 0.8 ns 4 folate_B12:Study 1 Inf 0.000 0.000 1.0 ns 6 GDM_new:Study 1 Inf 0.886 0.886 0.3 ns 3 folate_B12:GDM_new:Study 1 Inf 0.162 0.162 0.7 ns GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.869 0.869 0.4 ns 5 GDM_new 1 Inf 5.757 5.757 0.02 * 7 Study 1 Inf 25.701 25.701 &lt;0.0001 *** 8 GA_samp 1 Inf 0.401 0.401 0.5 ns 2 folate_B12:GDM_new 1 Inf 1.596 1.596 0.2 ns 4 folate_B12:Study 1 Inf 0.626 0.626 0.4 ns 6 GDM_new:Study 1 Inf 1.077 1.077 0.3 ns 3 folate_B12:GDM_new:Study 1 Inf 0.045 0.045 0.8 ns 53.4.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.69 (2.29, 3.09) &lt;0.0001 folate_B12 -0.00 (-0.00, -0.00) 0.04 GDM_newGDM -0.11 (-0.34, 0.13) 0.37 StudySTOP -0.13 (-0.29, 0.02) 0.10 GA_samp 0.15 (0.13, 0.17) &lt;0.0001 folate_B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.95 GDM_newGDM:StudySTOP 0.17 (-0.06, 0.40) 0.15 folate_B12:StudySTOP 0.00 (0.00, 0.00) 0.01 HPL Var Effect P (Intercept) 0.66 (0.45, 0.87) &lt;0.0001 folate_B12 -0.00 (-0.00, 0.00) 0.77 GDM_newGDM 0.06 (-0.10, 0.22) 0.46 StudySTOP 0.14 (0.05, 0.22) 0.002 GA_samp 0.29 (0.28, 0.30) &lt;0.0001 folate_B12:GDM_newGDM -0.00 (-0.00, -0.00) 0.02 GDM_newGDM:StudySTOP -0.11 (-0.29, 0.06) 0.21 folate_B12:StudySTOP -0.00 (-0.00, 0.00) 0.86 folate_B12:GDM_newGDM:StudySTOP 0.00 (0.00, 0.00) 0.01 GH2 Var Effect P (Intercept) -2.55 (-2.82, -2.27) &lt;0.0001 folate_B12 -0.00 (-0.00, 0.00) 0.10 GDM_newGDM -0.14 (-0.31, 0.03) 0.11 StudySTOP -0.04 (-0.15, 0.07) 0.43 GA_samp 0.26 (0.24, 0.28) &lt;0.0001 folate_B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.89 GDM_newGDM:StudySTOP 0.17 (0.00, 0.34) 0.05 folate_B12:StudySTOP 0.00 (-0.00, 0.00) 0.37 Insulin Var Effect P (Intercept) 2.60 (2.07, 3.13) &lt;0.0001 folate_B12 -0.00 (-0.00, 0.00) 0.66 GDM_newGDM 0.84 (0.50, 1.19) &lt;0.0001 StudySTOP -0.31 (-0.52, -0.10) 0.004 GA_samp 0.00 (-0.03, 0.04) 0.77 folate_B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.72 GDM_newGDM:StudySTOP -0.27 (-0.61, 0.07) 0.12 folate_B12:StudySTOP 0.00 (-0.00, 0.00) 0.88 HOMA.IR Var Effect P (Intercept) 1.24 (0.68, 1.81) &lt;0.0001 folate_B12 -0.00 (-0.00, 0.00) 0.56 GDM_newGDM 0.95 (0.57, 1.33) &lt;0.0001 StudySTOP -0.47 (-0.69, -0.25) &lt;0.0001 GA_samp 0.00 (-0.03, 0.04) 0.96 folate_B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.58 GDM_newGDM:StudySTOP -0.33 (-0.71, 0.04) 0.08 folate_B12:StudySTOP 0.00 (-0.00, 0.00) 0.75 GLUC3_mmol.L Var Effect P (Intercept) 1.73 (1.61, 1.84) &lt;0.0001 folate_B12 -0.00 (-0.00, 0.00) 0.64 GDM_newGDM 0.15 (0.01, 0.28) 0.03 StudySTOP -0.16 (-0.20, -0.11) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.53 folate_B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.15 GDM_newGDM:StudySTOP -0.08 (-0.20, 0.04) 0.17 folate_B12:StudySTOP 0.00 (-0.00, 0.00) 0.28 53.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 94.29984 7.625504 102.8302 80.32660 110.7038 STOP Uncomplicated 93.42616 6.988326 75.6675 80.49400 108.4360 SCOPE GDM 84.46162 10.602255 465.7427 65.99816 108.0904 STOP GDM 98.93897 8.704386 140.0553 83.14349 117.7353 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 86.17832 2.538979 188.2151 81.31257 91.33523 STOP Uncomplicated 98.38177 2.495652 104.5259 93.55549 103.45702 SCOPE GDM 80.17900 4.471729 630.3602 71.86149 89.45920 STOP GDM 95.49611 3.390919 309.2910 89.05168 102.40691 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.239282 0.0748675 442.0255 2.096872 2.391365 STOP Uncomplicated 2.209041 0.0576251 202.4688 2.098291 2.325636 SCOPE GDM 1.942566 0.1508117 1034.7015 1.668073 2.262228 STOP GDM 2.269315 0.0938631 485.5939 2.092182 2.461444 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 14.07586 0.8800801 Inf 12.452432 15.91092 STOP Uncomplicated 10.44075 0.4305347 Inf 9.630115 11.31962 SCOPE GDM 32.03042 4.9978966 Inf 23.590902 43.48912 STOP GDM 18.08465 1.3890691 Inf 15.557147 21.02279 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 3.413043 0.2271328 Inf 2.995681 3.888552 STOP Uncomplicated 2.175776 0.0942232 Inf 1.998722 2.368514 SCOPE GDM 8.531524 1.4624141 Inf 6.097048 11.938056 STOP GDM 3.899323 0.3220337 Inf 3.316583 4.584452 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.428502 0.0689608 Inf 5.295011 5.565360 STOP Uncomplicated 4.713930 0.0424742 Inf 4.631413 4.797917 SCOPE GDM 6.085856 0.3238477 Inf 5.483105 6.754867 STOP GDM 4.878311 0.0637282 Inf 4.754991 5.004829 53.4.4 Comparisons 53.4.4.1 Within Groups Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Prolactin folate_B12245.96 / folate_B12145.96 SCOPE Uncomplicated 0.961 (0.924, 0.999) 0.04 Prolactin folate_B12245.96 / folate_B12145.96 STOP Uncomplicated 1.023 (0.991, 1.055) 0.2 Prolactin folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.959 (0.906, 1.016) 0.2 Prolactin folate_B12245.96 / folate_B12145.96 STOP GDM 1.021 (0.980, 1.064) 0.3 HPL folate_B12245.96 / folate_B12145.96 SCOPE Uncomplicated 0.997 (0.976, 1.018) 0.8 HPL folate_B12245.96 / folate_B12145.96 STOP Uncomplicated 0.994 (0.977, 1.012) 0.5 HPL folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.932 (0.885, 0.981) 0.008 HPL folate_B12245.96 / folate_B12145.96 STOP GDM 1.006 (0.982, 1.030) 0.6 GH2 folate_B12245.96 / folate_B12145.96 SCOPE Uncomplicated 0.977 (0.950, 1.005) 0.1 GH2 folate_B12245.96 / folate_B12145.96 STOP Uncomplicated 0.993 (0.970, 1.016) 0.5 GH2 folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.974 (0.934, 1.016) 0.2 GH2 folate_B12245.96 / folate_B12145.96 STOP GDM 0.990 (0.960, 1.020) 0.5 Insulin folate_B12245.96 / folate_B12145.96 SCOPE Uncomplicated 0.990 (0.944, 1.037) 0.7 Insulin folate_B12245.96 / folate_B12145.96 STOP Uncomplicated 0.994 (0.960, 1.029) 0.7 Insulin folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.979 (0.918, 1.045) 0.5 Insulin folate_B12245.96 / folate_B12145.96 STOP GDM 0.983 (0.935, 1.035) 0.5 HOMA.IR folate_B12245.96 / folate_B12145.96 SCOPE Uncomplicated 0.985 (0.938, 1.035) 0.6 HOMA.IR folate_B12245.96 / folate_B12145.96 STOP Uncomplicated 0.995 (0.958, 1.033) 0.8 HOMA.IR folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.968 (0.901, 1.040) 0.4 HOMA.IR folate_B12245.96 / folate_B12145.96 STOP GDM 0.977 (0.925, 1.033) 0.4 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 SCOPE Uncomplicated 0.998 (0.988, 1.007) 0.6 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 STOP Uncomplicated 1.007 (0.995, 1.018) 0.2 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.982 (0.956, 1.009) 0.2 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 STOP GDM 0.991 (0.976, 1.006) 0.2 53.4.4.2 Between Groups Below are comparisons of the differences in the change in Folate:B12 ratio between groups. I.e. whether the change in Folate:B12 ratio are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.1331947 0.0552608 1362.154 1.0298130 1.246955 0.010 * STOP/SCOPE (Uncomplicated) 1.0645162 0.0259558 1362.154 1.0147970 1.116671 0.010 * STOP/SCOPE (GDM) 1.0645162 0.0259558 1362.154 1.0147970 1.116671 0.010 * GDM/Uncomplicated (SCOPE) 0.9985844 0.0250522 1343.765 0.9506285 1.048960 0.955 ns GDM/Uncomplicated (STOP) 0.9985844 0.0250522 1343.765 0.9506285 1.048960 0.955 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0762540 0.0345865 649.9090 1.0104376 1.1463574 0.023 * STOP/SCOPE (Uncomplicated) 0.9974815 0.0140667 1289.1463 0.9702636 1.0254629 0.858 ns STOP/SCOPE (GDM) 1.0789714 0.0311288 549.2789 1.0195256 1.1418832 0.009 ** GDM/Uncomplicated (SCOPE) 0.9349310 0.0265494 504.3811 0.8841983 0.9885745 0.018 * GDM/Uncomplicated (STOP) 1.0113108 0.0153519 1398.9582 0.9816395 1.0418789 0.459 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0319994 0.0364042 1360.679 0.9630000 1.105943 0.372 ns STOP/SCOPE (Uncomplicated) 1.0158737 0.0179177 1360.679 0.9813256 1.051638 0.372 ns STOP/SCOPE (GDM) 1.0158737 0.0179177 1360.679 0.9813256 1.051638 0.372 ns GDM/Uncomplicated (SCOPE) 0.9973472 0.0184678 1391.902 0.9617694 1.034241 0.886 ns GDM/Uncomplicated (STOP) 0.9973472 0.0184678 1391.902 0.9617694 1.034241 0.886 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0087364 0.0565249 Inf 0.9038166 1.125836 0.877 ns STOP/SCOPE (Uncomplicated) 1.0043587 0.0281398 Inf 0.9506927 1.061054 0.877 ns STOP/SCOPE (GDM) 1.0043587 0.0281398 Inf 0.9506927 1.061054 0.877 ns GDM/Uncomplicated (SCOPE) 0.9894412 0.0289828 Inf 0.9342358 1.047909 0.717 ns GDM/Uncomplicated (STOP) 0.9894412 0.0289828 Inf 0.9342358 1.047909 0.717 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0197048 0.0615394 Inf 0.9059501 1.147743 0.746 ns STOP/SCOPE (Uncomplicated) 1.0098043 0.0304709 Inf 0.9518141 1.071328 0.746 ns STOP/SCOPE (GDM) 1.0098043 0.0304709 Inf 0.9518141 1.071328 0.746 ns GDM/Uncomplicated (SCOPE) 0.9823047 0.0316369 Inf 0.9222141 1.046311 0.579 ns GDM/Uncomplicated (STOP) 0.9823047 0.0316369 Inf 0.9222141 1.046311 0.579 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0177933 0.0165485 Inf 0.9858703 1.050750 0.278 ns STOP/SCOPE (Uncomplicated) 1.0088574 0.0082016 Inf 0.9929100 1.025061 0.278 ns STOP/SCOPE (GDM) 1.0088574 0.0082016 Inf 0.9929100 1.025061 0.278 ns GDM/Uncomplicated (SCOPE) 0.9844365 0.0108104 Inf 0.9634748 1.005854 0.153 ns GDM/Uncomplicated (STOP) 0.9844365 0.0108104 Inf 0.9634748 1.005854 0.153 ns 53.4.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 53.4.6 Plots "],["active-b12-7.html", "53.5 Active B12", " 53.5 Active B12 53.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 88.8762058 1 &lt;0.0001 *** Active.B12 0.0117290 1 0.9 ns GDM_new 4.3110413 1 0.04 * Study 0.5770705 1 0.4 ns GA_samp 65.2025645 1 &lt;0.0001 *** Active.B12:GDM_new 2.6142387 1 0.1 ns GDM_new:Study 4.0486148 1 0.04 * Active.B12:Study 0.0000391 1 1.0 ns Active.B12:GDM_new:Study 2.7234579 1 0.10 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 12.1235530 1 0.0005 *** Active.B12 0.0056038 1 0.9 ns GDM_new 9.9531213 1 0.002 ** Study 2.2266179 1 0.1 ns GA_samp 1064.5741775 1 &lt;0.0001 *** Active.B12:GDM_new 6.5685275 1 0.01 * GDM_new:Study 6.1820118 1 0.01 * Active.B12:Study 0.0261088 1 0.9 ns Active.B12:GDM_new:Study 4.0649939 1 0.04 * GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 185.124725 1 &lt;0.0001 *** Active.B12 1.478688 1 0.2 ns GDM_new 3.592857 1 0.06 ns Study 1.010315 1 0.3 ns GA_samp 494.549744 1 &lt;0.0001 *** Active.B12:GDM_new 1.696353 1 0.2 ns GDM_new:Study 2.413833 1 0.1 ns Active.B12:Study 2.065497 1 0.2 ns Active.B12:GDM_new:Study 1.019242 1 0.3 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 2.222 2.222 0.1 ns 5 GDM_new 1 Inf 12.975 12.975 0.0003 *** 7 Study 1 Inf 4.880 4.880 0.03 * 8 GA_samp 1 Inf 0.005 0.005 0.9 ns 2 Active.B12:GDM_new 1 Inf 1.540 1.540 0.2 ns 4 Active.B12:Study 1 Inf 0.565 0.565 0.5 ns 6 GDM_new:Study 1 Inf 1.674 1.674 0.2 ns 3 Active.B12:GDM_new:Study 1 Inf 0.457 0.457 0.5 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 2.321 2.321 0.1 ns 5 GDM_new 1 Inf 11.866 11.866 0.0006 *** 7 Study 1 Inf 6.577 6.577 0.01 * 8 GA_samp 1 Inf 0.145 0.145 0.7 ns 2 Active.B12:GDM_new 1 Inf 1.586 1.586 0.2 ns 4 Active.B12:Study 1 Inf 0.697 0.697 0.4 ns 6 GDM_new:Study 1 Inf 1.694 1.694 0.2 ns 3 Active.B12:GDM_new:Study 1 Inf 0.521 0.521 0.5 ns GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 1.286 1.286 0.3 ns 5 GDM_new 1 Inf 3.887 3.887 0.05 ns 7 Study 1 Inf 8.371 8.371 0.004 ** 8 GA_samp 1 Inf 1.478 1.478 0.2 ns 2 Active.B12:GDM_new 1 Inf 3.835 3.835 0.05 ns 4 Active.B12:Study 1 Inf 1.680 1.680 0.2 ns 6 GDM_new:Study 1 Inf 1.989 1.989 0.2 ns 3 Active.B12:GDM_new:Study 1 Inf 1.380 1.380 0.2 ns 53.5.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.75 (2.17, 3.33) &lt;0.0001 Active.B12 0.00 (-0.00, 0.00) 0.51 GDM_newGDM -0.30 (-0.76, 0.16) 0.20 StudySTOP -0.04 (-0.34, 0.27) 0.82 GA_samp 0.14 (0.10, 0.17) &lt;0.0001 Active.B12:GDM_newGDM 0.00 (-0.00, 0.01) 0.71 GDM_newGDM:StudySTOP 0.22 (-0.10, 0.54) 0.18 Active.B12:StudySTOP -0.00 (-0.01, 0.00) 0.50 HPL Var Effect P (Intercept) 0.54 (0.24, 0.85) 0.0005 Active.B12 0.00 (-0.00, 0.00) 0.94 GDM_newGDM -0.64 (-1.03, -0.24) 0.002 StudySTOP 0.13 (-0.04, 0.31) 0.14 GA_samp 0.30 (0.28, 0.32) &lt;0.0001 Active.B12:GDM_newGDM 0.01 (0.00, 0.01) 0.01 GDM_newGDM:StudySTOP 0.58 (0.12, 1.04) 0.01 Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.87 Active.B12:GDM_newGDM:StudySTOP -0.01 (-0.01, -0.00) 0.04 GH2 Var Effect P (Intercept) -2.78 (-3.17, -2.38) &lt;0.0001 Active.B12 0.00 (-0.00, 0.00) 0.11 GDM_newGDM -0.30 (-0.63, 0.02) 0.07 StudySTOP 0.15 (-0.06, 0.37) 0.16 GA_samp 0.27 (0.24, 0.29) &lt;0.0001 Active.B12:GDM_newGDM 0.00 (-0.00, 0.01) 0.40 GDM_newGDM:StudySTOP 0.19 (-0.03, 0.42) 0.09 Active.B12:StudySTOP -0.00 (-0.01, -0.00) 0.05 Insulin Var Effect P (Intercept) 2.76 (2.02, 3.50) &lt;0.0001 Active.B12 -0.00 (-0.01, 0.00) 0.60 GDM_newGDM 1.29 (0.68, 1.90) &lt;0.0001 StudySTOP -0.39 (-0.81, 0.03) 0.07 GA_samp -0.00 (-0.04, 0.04) 0.98 Active.B12:GDM_newGDM -0.00 (-0.01, 0.00) 0.29 GDM_newGDM:StudySTOP -0.42 (-0.86, 0.01) 0.06 Active.B12:StudySTOP 0.00 (-0.00, 0.01) 0.67 HOMA.IR Var Effect P (Intercept) 1.47 (0.66, 2.27) 0.0003 Active.B12 -0.00 (-0.01, 0.00) 0.55 GDM_newGDM 1.39 (0.69, 2.08) &lt;0.0001 StudySTOP -0.58 (-1.04, -0.12) 0.01 GA_samp -0.01 (-0.05, 0.04) 0.74 Active.B12:GDM_newGDM -0.00 (-0.01, 0.00) 0.28 GDM_newGDM:StudySTOP -0.46 (-0.95, 0.03) 0.07 Active.B12:StudySTOP 0.00 (-0.00, 0.01) 0.61 GLUC3_mmol.L Var Effect P (Intercept) 1.77 (1.62, 1.91) &lt;0.0001 Active.B12 0.00 (-0.00, 0.00) 0.89 GDM_newGDM 0.29 (-0.01, 0.59) 0.06 StudySTOP -0.20 (-0.29, -0.11) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.35 Active.B12:GDM_newGDM -0.00 (-0.00, -0.00) 0.04 GDM_newGDM:StudySTOP -0.13 (-0.31, 0.05) 0.15 Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.32 53.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 102.86520 9.521582 137.37705 85.65996 123.5262 STOP Uncomplicated 90.21700 7.582765 95.51545 76.35309 106.5983 SCOPE GDM 81.00543 13.173215 541.77161 58.85463 111.4930 STOP GDM 88.41300 9.441899 216.02677 71.63109 109.1266 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 87.99884 3.073679 301.7892 82.15347 94.26012 STOP Uncomplicated 101.77698 2.986908 161.3797 96.04619 107.84972 SCOPE GDM 71.62685 5.600898 491.5282 61.42588 83.52188 STOP GDM 99.79654 4.557162 397.7761 91.22779 109.17014 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.330578 0.0998808 363.9985 2.142211 2.535509 STOP Uncomplicated 2.238491 0.0770037 208.2326 2.091718 2.395564 SCOPE GDM 1.908238 0.1917335 555.2210 1.566461 2.324584 STOP GDM 2.227019 0.1242820 383.5627 1.995588 2.485288 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 14.42651 1.1311375 Inf 12.371472 16.82292 STOP Uncomplicated 10.63751 0.6140156 Inf 9.499639 11.91167 SCOPE GDM 40.14113 7.5536756 Inf 27.759541 58.04529 STOP GDM 19.37977 2.1358081 Inf 15.614899 24.05237 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 3.520364 0.2997609 Inf 2.979252 4.159756 STOP Uncomplicated 2.208426 0.1354540 Inf 1.958278 2.490528 SCOPE GDM 10.487870 2.2799730 Inf 6.849256 16.059471 STOP GDM 4.153545 0.4913196 Inf 3.294056 5.237294 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.527781 0.0917408 Inf 5.350866 5.710546 STOP Uncomplicated 4.761846 0.0623612 Inf 4.641176 4.885654 SCOPE GDM 6.409661 0.5594051 Inf 5.401895 7.605433 STOP GDM 4.843211 0.1023149 Inf 4.646773 5.047954 53.5.4 Comparisons 53.5.4.1 Within Groups Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Prolactin Active.B1271 / Active.B1261 SCOPE Uncomplicated 1.011 (0.978, 1.046) 0.5 Prolactin Active.B1271 / Active.B1261 STOP Uncomplicated 0.997 (0.970, 1.025) 0.8 Prolactin Active.B1271 / Active.B1261 SCOPE GDM 1.021 (0.966, 1.078) 0.5 Prolactin Active.B1271 / Active.B1261 STOP GDM 1.006 (0.962, 1.053) 0.8 HPL Active.B1271 / Active.B1261 SCOPE Uncomplicated 1.001 (0.982, 1.020) 0.9 HPL Active.B1271 / Active.B1261 STOP Uncomplicated 1.003 (0.987, 1.018) 0.7 HPL Active.B1271 / Active.B1261 SCOPE GDM 1.068 (1.020, 1.118) 0.005 HPL Active.B1271 / Active.B1261 STOP GDM 1.008 (0.981, 1.036) 0.6 GH2 Active.B1271 / Active.B1261 SCOPE Uncomplicated 1.019 (0.996, 1.043) 0.1 GH2 Active.B1271 / Active.B1261 STOP Uncomplicated 0.990 (0.970, 1.009) 0.3 GH2 Active.B1271 / Active.B1261 SCOPE GDM 1.035 (0.996, 1.076) 0.08 GH2 Active.B1271 / Active.B1261 STOP GDM 1.005 (0.973, 1.038) 0.8 Insulin Active.B1271 / Active.B1261 SCOPE Uncomplicated 0.987 (0.942, 1.035) 0.6 Insulin Active.B1271 / Active.B1261 STOP Uncomplicated 1.000 (0.961, 1.040) 1.0 Insulin Active.B1271 / Active.B1261 SCOPE GDM 0.948 (0.875, 1.027) 0.2 Insulin Active.B1271 / Active.B1261 STOP GDM 0.960 (0.897, 1.028) 0.2 HOMA.IR Active.B1271 / Active.B1261 SCOPE Uncomplicated 0.984 (0.935, 1.036) 0.5 HOMA.IR Active.B1271 / Active.B1261 STOP Uncomplicated 1.001 (0.959, 1.044) 1.0 HOMA.IR Active.B1271 / Active.B1261 SCOPE GDM 0.941 (0.861, 1.028) 0.2 HOMA.IR Active.B1271 / Active.B1261 STOP GDM 0.957 (0.888, 1.031) 0.2 GLUC3_mmol.L Active.B1271 / Active.B1261 SCOPE Uncomplicated 1.001 (0.991, 1.011) 0.9 GLUC3_mmol.L Active.B1271 / Active.B1261 STOP Uncomplicated 1.008 (0.998, 1.019) 0.1 GLUC3_mmol.L Active.B1271 / Active.B1261 SCOPE GDM 0.980 (0.955, 1.004) 0.1 GLUC3_mmol.L Active.B1271 / Active.B1261 STOP GDM 0.987 (0.970, 1.004) 0.1 53.5.4.2 Between Groups Below are comparisons of the differences in the change in Active B12 concentration (pM) between groups. I.e. whether the change in Active B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9714900 0.0413634 702.3499 0.8935810 1.056192 0.497 ns STOP/SCOPE (Uncomplicated) 0.9856419 0.0209830 702.3499 0.9452941 1.027712 0.497 ns STOP/SCOPE (GDM) 0.9856419 0.0209830 702.3499 0.9452941 1.027712 0.497 ns GDM/Uncomplicated (SCOPE) 1.0094327 0.0257837 688.1093 0.9600570 1.061348 0.713 ns GDM/Uncomplicated (STOP) 1.0094327 0.0257837 688.1093 0.9600570 1.061348 0.713 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9455281 0.0286475 699.3782 0.8909229 1.0034800 0.065 ns STOP/SCOPE (Uncomplicated) 1.0019949 0.0123586 714.0996 0.9780228 1.0265546 0.872 ns STOP/SCOPE (GDM) 0.9436455 0.0258363 717.4804 0.8942609 0.9957574 0.034 * GDM/Uncomplicated (SCOPE) 1.0673053 0.0271258 725.2300 1.0153576 1.1219107 0.011 * GDM/Uncomplicated (STOP) 1.0051526 0.0161172 692.7746 0.9740011 1.0373005 0.749 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9428995 0.0282910 723.6672 0.8889615 1.000110 0.050 ns STOP/SCOPE (Uncomplicated) 0.9710301 0.0145675 723.6672 0.9428475 1.000055 0.050 ns STOP/SCOPE (GDM) 0.9710301 0.0145675 723.6672 0.9428475 1.000055 0.050 ns GDM/Uncomplicated (SCOPE) 1.0156009 0.0185906 725.0212 0.9797511 1.052763 0.398 ns GDM/Uncomplicated (STOP) 1.0156009 0.0185906 725.0212 0.9797511 1.052763 0.398 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0256798 0.0615096 Inf 0.9119385 1.153607 0.672 ns STOP/SCOPE (Uncomplicated) 1.0127585 0.0303674 Inf 0.9549547 1.074061 0.672 ns STOP/SCOPE (GDM) 1.0127585 0.0303674 Inf 0.9549547 1.074061 0.672 ns GDM/Uncomplicated (SCOPE) 0.9603312 0.0363751 Inf 0.8916195 1.034338 0.285 ns GDM/Uncomplicated (STOP) 0.9603312 0.0363751 Inf 0.8916195 1.034338 0.285 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0339325 0.0674890 Inf 0.9097683 1.175042 0.609 ns STOP/SCOPE (Uncomplicated) 1.0168247 0.0331861 Inf 0.9538178 1.083994 0.609 ns STOP/SCOPE (GDM) 1.0168247 0.0331861 Inf 0.9538178 1.083994 0.609 ns GDM/Uncomplicated (SCOPE) 0.9558794 0.0399053 Inf 0.8807808 1.037381 0.280 ns GDM/Uncomplicated (STOP) 0.9558794 0.0399053 Inf 0.8807808 1.037381 0.280 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.015044 0.0152556 Inf 0.9855796 1.0453889 0.320 ns STOP/SCOPE (Uncomplicated) 1.007494 0.0075710 Inf 0.9927636 1.0224426 0.320 ns STOP/SCOPE (GDM) 1.007494 0.0075710 Inf 0.9927636 1.0224426 0.320 ns GDM/Uncomplicated (SCOPE) 0.978799 0.0104166 Inf 0.9585944 0.9994295 0.044 * GDM/Uncomplicated (STOP) 0.978799 0.0104166 Inf 0.9585944 0.9994295 0.044 * 53.5.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 53.5.6 Plots "],["folateactive-b12-7.html", "53.6 Folate:Active B12", " 53.6 Folate:Active B12 53.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 105.9654174 1 &lt;0.0001 *** folate_Active.B12 2.8507424 1 0.09 ns GDM_new 1.1655961 1 0.3 ns Study 6.9823448 1 0.008 ** GA_samp 66.5831228 1 &lt;0.0001 *** folate_Active.B12:GDM_new 0.0040185 1 0.9 ns GDM_new:Study 0.9576216 1 0.3 ns folate_Active.B12:Study 7.2599035 1 0.007 ** folate_Active.B12:GDM_new:Study 0.0013920 1 1.0 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 13.9681088 1 0.0002 *** folate_Active.B12 0.4096199 1 0.5 ns GDM_new 0.0935974 1 0.8 ns Study 14.4440520 1 0.0001 *** GA_samp 1058.4296326 1 &lt;0.0001 *** folate_Active.B12:GDM_new 2.3157121 1 0.1 ns GDM_new:Study 0.2657622 1 0.6 ns folate_Active.B12:Study 5.2239565 1 0.02 * folate_Active.B12:GDM_new:Study 4.8125063 1 0.03 * GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 190.2290308 1 &lt;0.0001 *** folate_Active.B12 1.0860066 1 0.3 ns GDM_new 0.1049198 1 0.7 ns Study 1.3273208 1 0.2 ns GA_samp 492.6053979 1 &lt;0.0001 *** folate_Active.B12:GDM_new 1.2525421 1 0.3 ns GDM_new:Study 0.1156740 1 0.7 ns folate_Active.B12:Study 1.9208434 1 0.2 ns folate_Active.B12:GDM_new:Study 0.8227386 1 0.4 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 4.471 4.471 0.03 * 5 GDM_new 1 Inf 27.005 27.005 &lt;0.0001 *** 7 Study 1 Inf 9.213 9.213 0.002 ** 8 GA_samp 1 Inf 0.005 0.005 0.9 ns 2 folate_Active.B12:GDM_new 1 Inf 0.518 0.518 0.5 ns 4 folate_Active.B12:Study 1 Inf 0.028 0.028 0.9 ns 6 GDM_new:Study 1 Inf 0.836 0.836 0.4 ns 3 folate_Active.B12:GDM_new:Study 1 Inf 1.318 1.318 0.3 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 5.750 5.750 0.02 * 5 GDM_new 1 Inf 24.286 24.286 &lt;0.0001 *** 7 Study 1 Inf 13.077 13.077 0.0003 *** 8 GA_samp 1 Inf 0.143 0.143 0.7 ns 2 folate_Active.B12:GDM_new 1 Inf 0.855 0.855 0.4 ns 4 folate_Active.B12:Study 1 Inf 0.001 0.001 1.0 ns 6 GDM_new:Study 1 Inf 0.717 0.717 0.4 ns 3 folate_Active.B12:GDM_new:Study 1 Inf 1.532 1.532 0.2 ns GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 4.993 4.993 0.03 * 5 GDM_new 1 Inf 3.118 3.118 0.08 ns 7 Study 1 Inf 23.055 23.055 &lt;0.0001 *** 8 GA_samp 1 Inf 1.291 1.291 0.3 ns 2 folate_Active.B12:GDM_new 1 Inf 1.879 1.879 0.2 ns 4 folate_Active.B12:Study 1 Inf 0.387 0.387 0.5 ns 6 GDM_new:Study 1 Inf 1.832 1.832 0.2 ns 3 folate_Active.B12:GDM_new:Study 1 Inf 0.193 0.193 0.7 ns 53.6.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.88 (2.33, 3.42) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.08 GDM_newGDM -0.22 (-0.54, 0.10) 0.17 StudySTOP -0.29 (-0.50, -0.08) 0.007 GA_samp 0.14 (0.11, 0.17) &lt;0.0001 folate_Active.B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.95 GDM_newGDM:StudySTOP 0.23 (-0.09, 0.54) 0.16 folate_Active.B12:StudySTOP 0.00 (0.00, 0.00) 0.004 HPL Var Effect P (Intercept) 0.55 (0.26, 0.83) 0.0002 folate_Active.B12 0.00 (-0.00, 0.00) 0.52 GDM_newGDM -0.03 (-0.24, 0.17) 0.76 StudySTOP 0.22 (0.11, 0.33) 0.0002 GA_samp 0.30 (0.28, 0.31) &lt;0.0001 folate_Active.B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.13 GDM_newGDM:StudySTOP -0.06 (-0.29, 0.17) 0.61 folate_Active.B12:StudySTOP -0.00 (-0.00, -0.00) 0.02 folate_Active.B12:GDM_newGDM:StudySTOP 0.00 (0.00, 0.00) 0.03 GH2 Var Effect P (Intercept) -2.63 (-3.00, -2.26) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.19 GDM_newGDM -0.12 (-0.34, 0.10) 0.27 StudySTOP -0.10 (-0.24, 0.04) 0.18 GA_samp 0.27 (0.24, 0.29) &lt;0.0001 folate_Active.B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.50 GDM_newGDM:StudySTOP 0.15 (-0.07, 0.37) 0.17 folate_Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.07 Insulin Var Effect P (Intercept) 2.76 (2.09, 3.44) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.09 GDM_newGDM 1.06 (0.59, 1.53) &lt;0.0001 StudySTOP -0.37 (-0.63, -0.10) 0.006 GA_samp -0.00 (-0.04, 0.04) 0.96 folate_Active.B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.38 GDM_newGDM:StudySTOP -0.44 (-0.90, 0.02) 0.06 folate_Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.39 HOMA.IR Var Effect P (Intercept) 1.46 (0.73, 2.18) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.08 GDM_newGDM 1.15 (0.61, 1.69) &lt;0.0001 StudySTOP -0.53 (-0.81, -0.25) 0.0002 GA_samp -0.01 (-0.05, 0.04) 0.72 folate_Active.B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.28 GDM_newGDM:StudySTOP -0.48 (-1.00, 0.05) 0.07 folate_Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.43 GLUC3_mmol.L Var Effect P (Intercept) 1.81 (1.65, 1.97) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, -0.00) 0.0006 GDM_newGDM 0.16 (-0.03, 0.34) 0.09 StudySTOP -0.16 (-0.21, -0.11) &lt;0.0001 GA_samp -0.01 (-0.02, 0.00) 0.25 folate_Active.B12:GDM_newGDM -0.00 (-0.00, 0.00) 0.11 GDM_newGDM:StudySTOP -0.13 (-0.31, 0.05) 0.17 folate_Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.47 53.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 101.62816 9.314017 132.5548 84.77824 121.8271 STOP Uncomplicated 90.29880 7.578499 94.9709 76.44011 106.6701 SCOPE GDM 81.05772 13.016128 534.6951 59.12887 111.1192 STOP GDM 90.21198 9.467076 203.8058 73.35054 110.9494 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 88.04922 3.026850 288.7021 82.28881 94.21288 STOP Uncomplicated 101.59394 2.988394 163.6881 95.86127 107.66944 SCOPE GDM 75.32856 5.693745 550.9688 64.93511 87.38558 STOP GDM 100.33245 4.462084 371.6288 91.93106 109.50163 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.293818 0.0966457 343.5562 2.111390 2.492009 STOP Uncomplicated 2.235757 0.0771283 204.6502 2.088745 2.393116 SCOPE GDM 1.958147 0.1944361 557.8906 1.611167 2.379852 STOP GDM 2.228177 0.1214521 354.5442 2.001677 2.480307 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 14.52969 1.1290796 Inf 12.47702 16.92006 STOP Uncomplicated 10.62686 0.6103258 Inf 9.49551 11.89300 SCOPE GDM 39.13558 7.9435717 Inf 26.29048 58.25658 STOP GDM 18.48524 1.9016206 Inf 15.10984 22.61467 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 3.552503 0.2995868 Inf 3.011283 4.190996 STOP Uncomplicated 2.206362 0.1346450 Inf 1.957634 2.486692 SCOPE GDM 10.223246 2.4037386 Inf 6.448374 16.207925 STOP GDM 3.937619 0.4329703 Inf 3.174226 4.884607 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.541282 0.0858373 Inf 5.375572 5.712100 STOP Uncomplicated 4.764642 0.0648083 Inf 4.639298 4.893372 SCOPE GDM 6.267473 0.5260221 Inf 5.316822 7.388102 STOP GDM 4.746362 0.0798218 Inf 4.592464 4.905416 53.6.4 Comparisons 53.6.4.1 Within Groups Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE Uncomplicated 0.958 (0.913, 1.005) 0.08 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 STOP Uncomplicated 1.057 (1.006, 1.110) 0.03 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.955 (0.874, 1.045) 0.3 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 1.054 (0.980, 1.133) 0.2 HPL folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE Uncomplicated 1.009 (0.983, 1.035) 0.5 HPL folate_Active.B121123.57 / folate_Active.B12623.57 STOP Uncomplicated 0.965 (0.939, 0.992) 0.01 HPL folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.939 (0.860, 1.026) 0.2 HPL folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 1.010 (0.967, 1.056) 0.6 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE Uncomplicated 0.978 (0.947, 1.011) 0.2 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 STOP Uncomplicated 1.021 (0.986, 1.057) 0.2 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.958 (0.899, 1.022) 0.2 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 1.000 (0.949, 1.055) 1.0 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE Uncomplicated 0.958 (0.912, 1.007) 0.09 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 STOP Uncomplicated 0.989 (0.934, 1.047) 0.7 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.922 (0.847, 1.005) 0.06 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.952 (0.879, 1.031) 0.2 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE Uncomplicated 0.955 (0.907, 1.006) 0.08 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 STOP Uncomplicated 0.985 (0.926, 1.048) 0.6 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.908 (0.826, 0.998) 0.05 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.936 (0.861, 1.018) 0.1 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE Uncomplicated 0.991 (0.986, 0.996) 0.0006 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 STOP Uncomplicated 0.996 (0.984, 1.008) 0.5 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.971 (0.945, 0.998) 0.04 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.976 (0.957, 0.995) 0.02 53.6.4.2 Between Groups Below are comparisons of the differences in the change in Folate:Active B12 ratio between groups. I.e. whether the change in Folate:Active B12 ratio are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.2168295 0.0822859 683.0468 1.065532 1.389610 0.004 ** STOP/SCOPE (Uncomplicated) 1.1030999 0.0372976 683.0468 1.032246 1.178817 0.004 ** STOP/SCOPE (GDM) 1.1030999 0.0372976 683.0468 1.032246 1.178817 0.004 ** GDM/Uncomplicated (SCOPE) 0.9973718 0.0422328 642.2031 0.917795 1.083848 0.950 ns GDM/Uncomplicated (STOP) 0.9973718 0.0422328 642.2031 0.917795 1.083848 0.950 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0293092 0.0555449 422.6078 0.9257213 1.1444885 0.593 ns STOP/SCOPE (Uncomplicated) 0.9569665 0.0184170 709.0099 0.9214827 0.9938168 0.023 * STOP/SCOPE (GDM) 1.0755958 0.0538283 407.0315 0.9748181 1.1867919 0.146 ns GDM/Uncomplicated (SCOPE) 0.9313548 0.0435245 362.4851 0.8495777 1.0210034 0.129 ns GDM/Uncomplicated (STOP) 1.0468090 0.0276512 716.9310 0.9939056 1.1025284 0.084 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0891701 0.0517284 662.4498 0.9921909 1.195628 0.073 ns STOP/SCOPE (Uncomplicated) 1.0436331 0.0247828 662.4498 0.9960878 1.093448 0.073 ns STOP/SCOPE (GDM) 1.0436331 0.0247828 662.4498 0.9960878 1.093448 0.073 ns GDM/Uncomplicated (SCOPE) 0.9796986 0.0299631 662.5828 0.9225964 1.040335 0.503 ns GDM/Uncomplicated (STOP) 0.9796986 0.0299631 662.5828 0.9225964 1.040335 0.503 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0649411 0.0772902 Inf 0.9237363 1.227731 0.386 ns STOP/SCOPE (Uncomplicated) 1.0319598 0.0374482 Inf 0.9611120 1.108030 0.386 ns STOP/SCOPE (GDM) 1.0319598 0.0374482 Inf 0.9611120 1.108030 0.386 ns GDM/Uncomplicated (SCOPE) 0.9623745 0.0419947 Inf 0.8834879 1.048305 0.379 ns GDM/Uncomplicated (STOP) 0.9623745 0.0419947 Inf 0.8834879 1.048305 0.379 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0631318 0.0826268 Inf 0.9129177 1.238063 0.431 ns STOP/SCOPE (Uncomplicated) 1.0310828 0.0400680 Inf 0.9554673 1.112683 0.431 ns STOP/SCOPE (GDM) 1.0310828 0.0400680 Inf 0.9554673 1.112683 0.431 ns GDM/Uncomplicated (SCOPE) 0.9506305 0.0447923 Inf 0.8667710 1.042603 0.283 ns GDM/Uncomplicated (STOP) 0.9506305 0.0447923 Inf 0.8667710 1.042603 0.283 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0099613 0.0139150 Inf 0.9830534 1.037606 0.472 ns STOP/SCOPE (Uncomplicated) 1.0049683 0.0069231 Inf 0.9914905 1.018629 0.472 ns STOP/SCOPE (GDM) 1.0049683 0.0069231 Inf 0.9914905 1.018629 0.472 ns GDM/Uncomplicated (SCOPE) 0.9798727 0.0125141 Inf 0.9556499 1.004709 0.111 ns GDM/Uncomplicated (STOP) 0.9798727 0.0125141 Inf 0.9556499 1.004709 0.111 ns 53.6.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 53.6.6 Plots "],["homocysteine-7.html", "53.7 Homocysteine", " 53.7 Homocysteine 53.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 145.0597858 1 &lt;0.0001 *** Homocysteine 1.4645859 1 0.2 ns GDM_new 2.3423556 1 0.1 ns Study 0.0346867 1 0.9 ns GA_samp 139.7575423 1 &lt;0.0001 *** Homocysteine:GDM_new 1.7444634 1 0.2 ns GDM_new:Study 3.8352749 1 0.05 ns Homocysteine:Study 0.0118213 1 0.9 ns Homocysteine:GDM_new:Study 2.7686048 1 0.10 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 36.4449860 1 &lt;0.0001 *** Homocysteine 0.6556876 1 0.4 ns GDM_new 0.1042487 1 0.7 ns Study 2.8477539 1 0.09 ns GA_samp 1872.6604971 1 &lt;0.0001 *** Homocysteine:GDM_new 0.4873806 1 0.5 ns GDM_new:Study 0.5441908 1 0.5 ns Homocysteine:Study 0.0811476 1 0.8 ns Homocysteine:GDM_new:Study 0.1343363 1 0.7 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 235.4814378 1 &lt;0.0001 *** Homocysteine 1.2749445 1 0.3 ns GDM_new 0.0108539 1 0.9 ns Study 1.0983585 1 0.3 ns GA_samp 857.3642845 1 &lt;0.0001 *** Homocysteine:GDM_new 0.1125577 1 0.7 ns GDM_new:Study 0.5351343 1 0.5 ns Homocysteine:Study 0.9971124 1 0.3 ns Homocysteine:GDM_new:Study 0.0389948 1 0.8 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 19.971 19.971 &lt;0.0001 *** 5 GDM_new 1 Inf 32.054 32.054 &lt;0.0001 *** 7 Study 1 Inf 11.698 11.698 0.0006 *** 8 GA_samp 1 Inf 0.002 0.002 1.0 ns 2 Homocysteine:GDM_new 1 Inf 15.897 15.897 &lt;0.0001 *** 4 Homocysteine:Study 1 Inf 6.473 6.473 0.01 * 6 GDM_new:Study 1 Inf 6.743 6.743 0.009 ** 3 Homocysteine:GDM_new:Study 1 Inf 6.386 6.386 0.01 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 21.949 21.949 &lt;0.0001 *** 5 GDM_new 1 Inf 35.671 35.671 &lt;0.0001 *** 7 Study 1 Inf 17.025 17.025 &lt;0.0001 *** 8 GA_samp 1 Inf 0.034 0.034 0.9 ns 2 Homocysteine:GDM_new 1 Inf 18.293 18.293 &lt;0.0001 *** 4 Homocysteine:Study 1 Inf 8.289 8.289 0.004 ** 6 GDM_new:Study 1 Inf 8.818 8.818 0.003 ** 3 Homocysteine:GDM_new:Study 1 Inf 8.172 8.172 0.004 ** GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 8.564 8.564 0.003 ** 5 GDM_new 1 Inf 9.165 9.165 0.002 ** 7 Study 1 Inf 13.971 13.971 0.0002 *** 8 GA_samp 1 Inf 0.961 0.961 0.3 ns 2 Homocysteine:GDM_new 1 Inf 7.553 7.553 0.006 ** 4 Homocysteine:Study 1 Inf 5.823 5.823 0.02 * 6 GDM_new:Study 1 Inf 7.209 7.209 0.007 ** 3 Homocysteine:GDM_new:Study 1 Inf 7.141 7.141 0.008 ** 53.7.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.79 (2.33, 3.25) &lt;0.0001 Homocysteine -0.02 (-0.07, 0.03) 0.37 GDM_newGDM -0.01 (-0.44, 0.42) 0.96 StudySTOP 0.03 (-0.28, 0.35) 0.83 GA_samp 0.14 (0.12, 0.17) &lt;0.0001 Homocysteine:GDM_newGDM -0.03 (-0.12, 0.06) 0.56 GDM_newGDM:StudySTOP 0.19 (-0.05, 0.43) 0.12 Homocysteine:StudySTOP -0.01 (-0.07, 0.05) 0.74 HPL Var Effect P (Intercept) 0.74 (0.50, 0.98) &lt;0.0001 Homocysteine -0.01 (-0.04, 0.02) 0.45 GDM_newGDM 0.17 (-0.06, 0.40) 0.14 StudySTOP 0.16 (-0.01, 0.33) 0.07 GA_samp 0.29 (0.28, 0.30) &lt;0.0001 Homocysteine:GDM_newGDM -0.07 (-0.11, -0.02) 0.010 GDM_newGDM:StudySTOP 0.11 (-0.01, 0.24) 0.07 Homocysteine:StudySTOP -0.01 (-0.04, 0.03) 0.69 GH2 Var Effect P (Intercept) -2.51 (-2.83, -2.19) &lt;0.0001 Homocysteine -0.02 (-0.06, 0.02) 0.27 GDM_newGDM 0.03 (-0.28, 0.34) 0.85 StudySTOP -0.12 (-0.35, 0.11) 0.30 GA_samp 0.26 (0.24, 0.28) &lt;0.0001 Homocysteine:GDM_newGDM -0.05 (-0.11, 0.02) 0.16 GDM_newGDM:StudySTOP 0.23 (0.06, 0.40) 0.009 Homocysteine:StudySTOP 0.02 (-0.02, 0.07) 0.33 Insulin Var Effect P (Intercept) 2.74 (2.12, 3.37) &lt;0.0001 Homocysteine -0.02 (-0.10, 0.06) 0.60 GDM_newGDM 3.00 (1.82, 4.18) &lt;0.0001 StudySTOP -0.31 (-0.78, 0.16) 0.19 GA_samp 0.00 (-0.03, 0.03) 0.97 Homocysteine:GDM_newGDM -0.53 (-0.81, -0.26) 0.0002 GDM_newGDM:StudySTOP -1.89 (-3.31, -0.46) 0.009 Homocysteine:StudySTOP 0.00 (-0.10, 0.10) 0.98 Homocysteine:GDM_newGDM:StudySTOP 0.41 (0.09, 0.73) 0.01 HOMA.IR Var Effect P (Intercept) 1.37 (0.71, 2.03) &lt;0.0001 Homocysteine -0.02 (-0.10, 0.06) 0.65 GDM_newGDM 3.52 (2.23, 4.82) &lt;0.0001 StudySTOP -0.47 (-0.97, 0.04) 0.07 GA_samp -0.00 (-0.04, 0.03) 0.85 Homocysteine:GDM_newGDM -0.64 (-0.94, -0.33) &lt;0.0001 GDM_newGDM:StudySTOP -2.34 (-3.89, -0.80) 0.003 Homocysteine:StudySTOP 0.00 (-0.10, 0.11) 0.97 Homocysteine:GDM_newGDM:StudySTOP 0.51 (0.16, 0.86) 0.004 GLUC3_mmol.L Var Effect P (Intercept) 1.74 (1.60, 1.87) &lt;0.0001 Homocysteine 0.00 (-0.01, 0.02) 0.90 GDM_newGDM 0.68 (0.23, 1.12) 0.003 StudySTOP -0.12 (-0.22, -0.01) 0.03 GA_samp -0.00 (-0.01, 0.00) 0.33 Homocysteine:GDM_newGDM -0.14 (-0.24, -0.04) 0.005 GDM_newGDM:StudySTOP -0.64 (-1.10, -0.17) 0.007 Homocysteine:StudySTOP -0.01 (-0.03, 0.01) 0.56 Homocysteine:GDM_newGDM:StudySTOP 0.14 (0.04, 0.24) 0.008 53.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. Prolactin Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 94.96759 7.759243 107.35549 80.76736 111.6645 STOP Uncomplicated 93.13168 6.970409 76.08526 80.23430 108.1023 SCOPE GDM 82.02212 11.008890 571.00076 63.01461 106.7630 STOP GDM 97.22880 8.592851 142.95040 81.64422 115.7882 HPL Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 86.42107 2.601200 205.8178 81.44186 91.70471 STOP Uncomplicated 98.01198 2.488169 106.3098 93.20119 103.07109 SCOPE GDM 74.00851 4.536267 804.1712 65.61900 83.47063 STOP GDM 93.98161 3.363938 321.4001 87.59114 100.83832 GH2 Study GDM_new response SE df lower.CL upper.CL SCOPE Uncomplicated 2.223348 0.0765585 475.7601 2.077890 2.378989 STOP Uncomplicated 2.212053 0.0579810 206.6213 2.100646 2.329369 SCOPE GDM 1.802244 0.1524281 1191.9659 1.526681 2.127544 STOP GDM 2.257613 0.0944288 501.2926 2.079507 2.450975 Insulin Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 14.11386 0.9262269 Inf 12.410387 16.05115 STOP Uncomplicated 10.38412 0.4296079 Inf 9.575338 11.26122 SCOPE GDM 19.96015 3.6307532 Inf 13.974303 28.51001 STOP GDM 17.43694 1.3414818 Inf 14.996317 20.27478 HOMA.IR Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 3.426268 0.2408458 Inf 2.985294 3.932382 STOP Uncomplicated 2.163895 0.0941183 Inf 1.987070 2.356454 SCOPE GDM 4.807918 0.9882138 Inf 3.213676 7.193032 STOP GDM 3.750223 0.3083980 Inf 3.191970 4.406109 GLUC3_mmol.L Study GDM_new response SE df asymp.LCL asymp.UCL SCOPE Uncomplicated 5.447121 0.0654643 Inf 5.320313 5.576952 STOP Uncomplicated 4.701641 0.0394811 Inf 4.624892 4.779663 SCOPE GDM 5.340856 0.2627192 Inf 4.849979 5.881416 STOP GDM 4.850957 0.0626863 Inf 4.729637 4.975390 53.7.4 Comparisons 53.7.4.1 Within Groups Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study GDM_new Ratio of Geometric means (95% CI) P-value Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE Uncomplicated 0.978 (0.930, 1.027) 0.4 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP Uncomplicated 0.967 (0.927, 1.009) 0.1 Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.952 (0.860, 1.053) 0.3 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.941 (0.865, 1.024) 0.2 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE Uncomplicated 0.990 (0.964, 1.017) 0.5 HPL Homocysteine5.5 / Homocysteine4.5 STOP Uncomplicated 0.983 (0.961, 1.006) 0.1 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.927 (0.878, 0.979) 0.006 HPL Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.921 (0.879, 0.964) 0.0004 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE Uncomplicated 0.980 (0.946, 1.016) 0.3 GH2 Homocysteine5.5 / Homocysteine4.5 STOP Uncomplicated 1.003 (0.973, 1.035) 0.8 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.934 (0.868, 1.006) 0.07 GH2 Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.956 (0.899, 1.017) 0.2 Insulin Homocysteine5.5 / Homocysteine4.5 SCOPE Uncomplicated 0.979 (0.905, 1.059) 0.6 Insulin Homocysteine5.5 / Homocysteine4.5 STOP Uncomplicated 0.980 (0.926, 1.038) 0.5 Insulin Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.576 (0.442, 0.750) &lt;0.0001 Insulin Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.870 (0.747, 1.014) 0.07 HOMA.IR Homocysteine5.5 / Homocysteine4.5 SCOPE Uncomplicated 0.980 (0.901, 1.067) 0.6 HOMA.IR Homocysteine5.5 / Homocysteine4.5 STOP Uncomplicated 0.982 (0.924, 1.044) 0.6 HOMA.IR Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.518 (0.387, 0.695) &lt;0.0001 HOMA.IR Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.865 (0.736, 1.017) 0.08 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 SCOPE Uncomplicated 1.001 (0.987, 1.015) 0.9 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 STOP Uncomplicated 0.995 (0.980, 1.010) 0.5 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.870 (0.790, 0.958) 0.005 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.993 (0.971, 1.016) 0.5 53.7.4.2 Between Groups Below are comparisons of the differences in the change in Homocysteine concentration (μM) between groups. I.e. whether the change in Homocysteine concentration (μM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9787372 0.0640855 1417.025 0.8607632 1.112880 0.743 ns STOP/SCOPE (Uncomplicated) 0.9893115 0.0323889 1417.025 0.9277733 1.054931 0.743 ns STOP/SCOPE (GDM) 0.9893115 0.0323889 1417.025 0.9277733 1.054931 0.743 ns GDM/Uncomplicated (SCOPE) 0.9732322 0.0452715 1412.965 0.8883569 1.066217 0.560 ns GDM/Uncomplicated (STOP) 0.9732322 0.0452715 1412.965 0.8883569 1.066217 0.560 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9861437 0.0348326 1400.365 0.9201276 1.0568962 0.693 ns STOP/SCOPE (Uncomplicated) 0.9930477 0.0175382 1400.365 0.9592328 1.0280546 0.693 ns STOP/SCOPE (GDM) 0.9930477 0.0175382 1400.365 0.9592328 1.0280546 0.693 ns GDM/Uncomplicated (SCOPE) 0.9366159 0.0236704 1397.986 0.8913147 0.9842196 0.010 ** GDM/Uncomplicated (STOP) 0.9366159 0.0236704 1397.986 0.8913147 0.9842196 0.010 ** GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0475947 0.0496954 1468.841 0.9545111 1.149756 0.327 ns STOP/SCOPE (Uncomplicated) 1.0235207 0.0242767 1468.841 0.9769909 1.072267 0.327 ns STOP/SCOPE (GDM) 1.0235207 0.0242767 1468.841 0.9769909 1.072267 0.327 ns GDM/Uncomplicated (SCOPE) 0.9532964 0.0323553 1427.051 0.8918941 1.018926 0.159 ns GDM/Uncomplicated (STOP) 0.9532964 0.0323553 1427.051 0.8918941 1.018926 0.159 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.5134372 0.2464932 Inf 1.0998398 2.082569 0.011 * STOP/SCOPE (Uncomplicated) 1.0011112 0.0496046 Inf 0.9084598 1.103212 0.982 ns STOP/SCOPE (GDM) 1.5117573 0.2347271 Inf 1.1151106 2.049492 0.008 ** GDM/Uncomplicated (SCOPE) 0.5879472 0.0826295 Inf 0.4463867 0.774400 0.0002 *** GDM/Uncomplicated (STOP) 0.8878469 0.0734313 Inf 0.7549838 1.044091 0.150 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.6721775 0.2986039 Inf 1.1783700 2.3729199 0.004 ** STOP/SCOPE (Uncomplicated) 1.0017903 0.0535375 Inf 0.9021672 1.1124143 0.973 ns STOP/SCOPE (GDM) 1.6691892 0.2844275 Inf 1.1952591 2.3310367 0.003 ** GDM/Uncomplicated (SCOPE) 0.5288124 0.0822546 Inf 0.3898528 0.7173029 &lt;0.0001 *** GDM/Uncomplicated (STOP) 0.8811105 0.0772880 Inf 0.7419351 1.0463931 0.149 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.1337832 0.0589925 Inf 1.0238604 1.2555076 0.016 * STOP/SCOPE (Uncomplicated) 0.9938672 0.0106101 Inf 0.9732879 1.0148816 0.564 ns STOP/SCOPE (GDM) 1.1407794 0.0578375 Inf 1.0328702 1.2599624 0.009 ** GDM/Uncomplicated (SCOPE) 0.8696156 0.0432179 Inf 0.7889047 0.9585839 0.005 ** GDM/Uncomplicated (STOP) 0.9981612 0.0136557 Inf 0.9717522 1.0252879 0.893 ns 53.7.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 53.7.6 Plots "],["part-gdm-vs-non-gdm.html", "(PART*) GDM vs non-GDM", " (PART*) GDM vs non-GDM "],["descriptives-5.html", "54 Descriptives", " 54 Descriptives Results in this section are from univariate analyses. Characteristic non-GDM (n=2088) GDM (n=251) Total (n=2339) P-value PRL (ng/ml): Mean (SD) 142.2 (156.0) 101.1 (94.7) 137.8 (151.1) &lt;0.0001 hPL (μg/ml): Mean (SD) 124.6 (75.9) 76.2 (52.6) 119.5 (75.3) &lt;0.0001 GH2 (ng/ml): Mean (SD) 3.2 (2.7) 1.9 (1.4) 3.0 (2.6) &lt;0.0001 Insulin (uU/ml): Mean (SD) 19.8 (24.7) 33.7 (43.9) 21.4 (27.8) &lt;0.0001 HOMA-IR: Mean (SD) 4.8 (6.6) 8.6 (14.2) 5.2 (7.9) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.1 (0.8) 5.2 (1.0) 5.1 (0.8) 0.27 Number of available samples Var non-GDM: Available N(%) GDM: Available N(%) PRL (ng/ml) 1776 (85.1%) 216 (86.1%) hPL (μg/ml) 1759 (84.2%) 206 (82.1%) GH2 (ng/ml) 1770 (84.8%) 205 (81.7%) Insulin (uU/ml) 1817 (87.0%) 227 (90.4%) HOMA-IR 1812 (86.8%) 226 (90.0%) Glucose (mmol/L) 2068 (99.0%) 250 (99.6%) Folate Characteristic No (n=2121) Yes (n=256) Total (n=2377) P-value Serum folate concentration (nM): Median (IQ range) 39.0 (32.9-43.9) 40.1 (35.0-44.8) 39.1 (33.3-44.1) 0.01 "],["within-scope-1.html", "54.1 Within SCOPE", " 54.1 Within SCOPE 54.1.1 Hormones Characteristic non-GDM (n=1066) GDM (n=58) Total (n=1124) P-value PRL (ng/ml): Mean (SD) 187.4 (184.8) 118.8 (86.5) 185.1 (182.8) 0.0005 hPL (μg/ml): Mean (SD) 186.1 (54.2) 116.5 (49.3) 183.8 (55.4) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.7 (2.8) 3.1 (2.0) 4.7 (2.8) 0.0004 Insulin (uU/ml): Mean (SD) 23.8 (27.0) 50.4 (55.0) 24.9 (29.2) 0.007 HOMA-IR: Mean (SD) 6.1 (7.6) 14.8 (18.7) 6.5 (8.5) 0.01 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 6.0 (1.1) 5.5 (0.8) 0.0004 54.1.2 Demographics Characteristic non-GDM (n=1073) GDM (n=58) Total (n=1131) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 28.0 (25.0-32.0) 23.0 (20.0-27.0) &lt;0.0001 Maternal age (yrs): N(%) 0.29 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1054 (98.2) 56 (96.6) 1110 (98.1) &gt;=35 19 (1.8) 2 (3.4) 21 (1.9) Maternal BMI: Median (IQ range) 25.4 (22.1-30.4) 30.6 (25.4-36.3) 25.5 (22.2-30.8) &lt;0.0001 Maternal BMI (category): N(%) 0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 115 (10.7) 1 (1.7) 116 (10.3) &gt;=20 to &lt;25 377 (35.1) 13 (22.4) 390 (34.5) &gt;=25 to &lt;30 301 (28.1) 13 (22.4) 314 (27.8) &gt;=30 to &lt;40 234 (21.8) 24 (41.4) 258 (22.8) &gt;=40 46 (4.3) 7 (12.1) 53 (4.7) SEI: Median (IQ range) 25.0 (20.0-30.0) 27.0 (20.2-34.0) 26.0 (20.0-30.0) 0.14 Ethnicity: N(%) 0.37 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 987 (92.0) 51 (87.9) 1038 (91.8) Maori 5 (0.5) 0 (0.0) 5 (0.4) Pacific Islander 1 (0.1) 0 (0.0) 1 (0.1) South East and Far East 36 (3.4) 4 (6.9) 40 (3.5) Indian 3 (0.3) 1 (1.7) 4 (0.4) African 4 (0.4) 0 (0.0) 4 (0.4) Middle-eastern 5 (0.5) 0 (0.0) 5 (0.4) Hispanic 0 (0.0) 0 (0.0) 0 (0.0) Aboriginal 21 (2.0) 1 (1.7) 22 (1.9) China and Japan 0 (0.0) 0 (0.0) 0 (0.0) Other 11 (1.0) 1 (1.7) 12 (1.1) Smoking: N(%) 0.10 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 813 (75.8) 50 (86.2) 863 (76.3) Yes 260 (24.2) 8 (13.8) 268 (23.7) Folic acid supplement (μg): N(%) 0.09 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 230 (21.4) 9 (15.5) 239 (21.1) &lt;800 571 (53.2) 27 (46.6) 598 (52.9) &gt;=800 272 (25.3) 22 (37.9) 294 (26.0) Folic acid supplement (μg): N(%) 0.18 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 230 (21.4) 9 (15.5) 239 (21.1) &lt;=400 105 (9.8) 6 (10.3) 111 (9.8) &gt;400 to &lt;800 466 (43.4) 21 (36.2) 487 (43.1) &gt;=800 272 (25.3) 22 (37.9) 294 (26.0) Fruit (1st trim): N(%) 0.010 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 110 (10.3) 3 (5.2) 113 (10.0) 1-6x/week 417 (38.9) 19 (32.8) 436 (38.5) &gt;=1-&lt;3x/day 367 (34.2) 32 (55.2) 399 (35.3) &gt;=3x/day 179 (16.7) 4 (6.9) 183 (16.2) Leafy vege (1st trim): N(%) 0.21 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 103 (9.6) 3 (5.2) 106 (9.4) 1-2x/week 249 (23.2) 13 (22.4) 262 (23.2) 3-6x/week 430 (40.1) 31 (53.4) 461 (40.8) &gt;=1x/day 291 (27.1) 11 (19.0) 302 (26.7) Fast food (1st trim): N(%) 0.97 Missing 216 (20.1) 9 (15.5) 225 (19.9) Never 15 (1.4) 1 (1.7) 16 (1.4) &gt;0-&lt;2x/week 102 (9.5) 6 (10.3) 108 (9.5) &gt;=2-&lt;4x/week 436 (40.6) 25 (43.1) 461 (40.8) &gt;=4x/week 304 (28.3) 17 (29.3) 321 (28.4) Vigorous exercise: N(%) 0.37 Missing 3 (0.3) 0 (0.0) 3 (0.3) Never 694 (64.7) 38 (65.5) 732 (64.7) Once a week 264 (24.6) 19 (32.8) 283 (25.0) 2-3/wk 84 (7.8) 1 (1.7) 85 (7.5) 4-6/wk 14 (1.3) 0 (0.0) 14 (1.2) Daily 12 (1.1) 0 (0.0) 12 (1.1) More than once a day 2 (0.2) 0 (0.0) 2 (0.2) Moderate exercise: N(%) 0.66 Missing 3 (0.3) 0 (0.0) 3 (0.3) Never 453 (42.2) 30 (51.7) 483 (42.7) Once a week 278 (25.9) 16 (27.6) 294 (26.0) 2-3/wk 219 (20.4) 8 (13.8) 227 (20.1) 4-6/wk 51 (4.8) 1 (1.7) 52 (4.6) Daily 62 (5.8) 3 (5.2) 65 (5.7) More than once a day 7 (0.7) 0 (0.0) 7 (0.6) Recreational walking: N(%) 0.63 Missing 3 (0.3) 0 (0.0) 3 (0.3) Never 250 (23.3) 9 (15.5) 259 (22.9) Once a week 334 (31.1) 21 (36.2) 355 (31.4) 2-3/wk 283 (26.4) 17 (29.3) 300 (26.5) 4-6/wk 75 (7.0) 5 (8.6) 80 (7.1) Daily 102 (9.5) 6 (10.3) 108 (9.5) More than once a day 26 (2.4) 0 (0.0) 26 (2.3) Serum folate concentration (nM): Median (IQ range) 35.9 (28.1-42.6) 40.1 (32.0-43.8) 36.0 (28.3-42.8) 0.04 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 4.1 (0.9) 4.6 (1.1) 0.001 B12 concentration (pM): Median (IQ range) 245.0 (195.0-308.5) 253.5 (194.2-333.0) 245.0 (195.0-309.0) 0.60 Folate:B12 ratio: Median (IQ range) 142.7 (102.3-207.5) 158.9 (116.5-210.2) 143.0 (103.3-208.4) 0.28 Active B12 concentration (pM): Mean (SD) 60.1 (24.0) 72.7 (26.4) 60.7 (24.3) 0.02 Folate:Active B12 ratio: Median (IQ range) 615.4 (432.4-902.3) 553.8 (424.7-660.3) 602.8 (431.6-901.5) 0.32 Vitamin D: Median (IQ range) 58.0 (42.0-76.4) 55.8 (44.6-72.0) 57.7 (42.1-76.1) 0.74 UIC (ug/L): Median (IQ range) 105.0 (66.3-163.6) 132.7 (68.3-167.0) 105.7 (66.3-164.1) 0.57 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.6) 1.0 (0.7-1.6) 0.83 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.5-1.4) 1.0 (0.7-1.4) 0.23 Haemoglobin (g/L): Mean (SD) 129.1 (9.3) 130.9 (9.4) 129.2 (9.3) 0.15 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.14 54.1.3 MetS Characteristic non-GDM (n=1073) GDM (n=58) Total (n=1131) P-value MetS: N(%) &lt;0.0001 Missing 9 (0.8) 1 (1.7) 10 (0.9) No 898 (83.7) 29 (50.0) 927 (82.0) Yes 166 (15.5) 28 (48.3) 194 (17.2) MetS: number of criteria met: Median (IQ range) 1.0 (0.0-1.0) 2.0 (1.0-2.0) 1.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-97.0) 97.0 (87.0-109.0) 87.0 (79.0-98.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 5.5 (0.9) 5.5 (0.9) 0.66 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.7) 1.8 (1.6-2.4) 1.4 (1.1-1.8) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) 0.01 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 6.0 (1.1) 5.5 (0.8) 0.0004 LDL (mmol/L): Mean (SD) 3.1 (0.8) 3.0 (0.8) 3.1 (0.8) 0.33 Systolic BP (mmHg): Mean (SD) 109.1 (10.1) 112.9 (12.0) 109.3 (10.2) 0.02 Diastolic BP (mmHg): Mean (SD) 64.2 (7.9) 68.6 (8.9) 64.4 (8.0) 0.0005 MAP (mmHg): Mean (SD) 79.2 (7.7) 83.4 (8.9) 79.4 (7.8) 0.0009 MetS criteria: Waist circumference: N(%) 0.04 Missing 1 (0.1) 1 (1.7) 2 (0.2) &lt;80 cm 290 (27.0) 8 (13.8) 298 (26.3) &gt;=80 cm 782 (72.9) 49 (84.5) 831 (73.5) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1.7 mmol/L 782 (72.9) 23 (39.7) 805 (71.2) &gt;=1.7 mmol/L 291 (27.1) 35 (60.3) 326 (28.8) MetS criteria: HDL: N(%) 0.18 Missing 0 (0.0) 0 (0.0) 0 (0.0) &gt;=1.3 mmol/L 958 (89.3) 48 (82.8) 1006 (88.9) &lt;1.3 mmol/L 115 (10.7) 10 (17.2) 125 (11.1) MetS criteria: Glucose: N(%) 0.0001 Missing 8 (0.7) 1 (1.7) 9 (0.8) &lt;5.6 mmol/L 624 (58.2) 18 (31.0) 642 (56.8) &gt;=5.6 mmol/L 441 (41.1) 39 (67.2) 480 (42.4) MetS criteria: sBP: N(%) 0.09 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;130 mmHg 1043 (97.2) 54 (93.1) 1097 (97.0) &gt;=130 mmHg 30 (2.8) 4 (6.9) 34 (3.0) MetS criteria: dBP: N(%) 0.05 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;85 mmHg 1068 (99.5) 56 (96.6) 1124 (99.4) &gt;=85 mmHg 5 (0.5) 2 (3.4) 7 (0.6) MetS criteria: BP: N(%) 0.05 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;130/85 mmHg 1041 (97.0) 53 (91.4) 1094 (96.7) &gt;=130/85 mmHg 32 (3.0) 5 (8.6) 37 (3.3) CRP (mg/L): Median (IQ range) 4.7 (2.4-8.9) 7.8 (4.4-12.5) 4.9 (2.4-9.0) 0.0007 54.1.4 Outcomes Characteristic non-GDM (n=1073) GDM (n=58) Total (n=1131) P-value Gestational age at birth (weeks): Median (IQ range) 40.0 (38.9-40.9) 38.9 (38.1-40.0) 39.9 (38.9-40.9) &lt;0.0001 Birthweight (g): Median (IQ range) 3410.0 (3070.0-3735.0) 3260.0 (2825.0-3728.8) 3400.0 (3070.0-3737.5) 0.18 Birthweight centile: Mean (SD) 46.7 (29.4) 47.6 (31.9) 46.7 (29.5) 0.83 Baby sex: N(%) 0.83 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 525 (48.9) 27 (46.6) 552 (48.8) Female 548 (51.1) 31 (53.4) 579 (51.2) Mode of delivery: N(%) 0.0003 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 581 (54.1) 19 (32.8) 600 (53.1) Operative vaginal 177 (16.5) 7 (12.1) 184 (16.3) Pre-labour LSCS 66 (6.2) 10 (17.2) 76 (6.7) LSCS in labour 249 (23.2) 22 (37.9) 271 (24.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["within-stop-1.html", "54.2 Within STOP", " 54.2 Within STOP 54.2.1 Hormones Characteristic non-GDM (n=1022) GDM (n=193) Total (n=1215) P-value PRL (ng/ml): Mean (SD) 106.3 (116.6) 98.5 (95.8) 105.0 (113.5) 0.33 hPL (μg/ml): Mean (SD) 74.7 (49.9) 70.4 (50.6) 74.0 (50.0) 0.30 GH2 (ng/ml): Mean (SD) 1.9 (1.7) 1.7 (1.2) 1.9 (1.7) 0.09 Insulin (uU/ml): Mean (SD) 16.6 (22.1) 30.6 (41.0) 18.9 (26.5) &lt;0.0001 HOMA-IR: Mean (SD) 3.7 (5.5) 7.5 (13.0) 4.3 (7.3) &lt;0.0001 Glucose (mmol/L): Mean (SD) 4.8 (0.6) 4.9 (0.8) 4.8 (0.7) 0.003 54.2.2 Demographics Characteristic non-GDM (n=1048) GDM (n=198) Total (n=1246) P-value Maternal age (yrs): Median (IQ range) 26.0 (22.0-29.0) 28.0 (24.0-31.0) 26.0 (22.0-29.0) &lt;0.0001 Maternal age (yrs): N(%) 0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1020 (97.3) 181 (91.4) 1201 (96.4) &gt;=35 28 (2.7) 17 (8.6) 45 (3.6) Maternal BMI: Median (IQ range) 25.8 (22.6-30.6) 30.9 (24.6-37.6) 26.3 (22.7-31.8) &lt;0.0001 Maternal BMI (category): N(%) &lt;0.0001 Missing 1 (0.1) 0 (0.0) 1 (0.1) &lt;20 81 (7.7) 8 (4.0) 89 (7.1) &gt;=20 to &lt;25 377 (36.0) 47 (23.7) 424 (34.0) &gt;=25 to &lt;30 304 (29.0) 40 (20.2) 344 (27.6) &gt;=30 to &lt;40 236 (22.5) 68 (34.3) 304 (24.4) &gt;=40 49 (4.7) 35 (17.7) 84 (6.7) SEI: Median (IQ range) 29.0 (22.0-45.0) 28.5 (20.0-45.0) 29.0 (21.0-45.0) 0.91 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 889 (84.8) 141 (71.2) 1030 (82.7) Maori 1 (0.1) 1 (0.5) 2 (0.2) Pacific Islander 4 (0.4) 0 (0.0) 4 (0.3) South East and Far East 41 (3.9) 24 (12.1) 65 (5.2) Indian 40 (3.8) 17 (8.6) 57 (4.6) African 16 (1.5) 5 (2.5) 21 (1.7) Middle-eastern 19 (1.8) 4 (2.0) 23 (1.8) Hispanic 4 (0.4) 1 (0.5) 5 (0.4) Aboriginal 18 (1.7) 3 (1.5) 21 (1.7) China and Japan 14 (1.3) 2 (1.0) 16 (1.3) Other 2 (0.2) 0 (0.0) 2 (0.2) Smoking: N(%) 0.76 Missing 6 (0.6) 0 (0.0) 6 (0.5) No 870 (83.0) 163 (82.3) 1033 (82.9) Yes 172 (16.4) 35 (17.7) 207 (16.6) Folic acid supplement (μg): N(%) 0.85 Missing 126 (12.0) 21 (10.6) 147 (11.8) None 76 (7.3) 13 (6.6) 89 (7.1) &lt;800 214 (20.4) 44 (22.2) 258 (20.7) &gt;=800 632 (60.3) 120 (60.6) 752 (60.4) Folic acid supplement (μg): N(%) 0.90 Missing 126 (12.0) 21 (10.6) 147 (11.8) None 76 (7.3) 13 (6.6) 89 (7.1) &lt;=400 12 (1.1) 3 (1.5) 15 (1.2) &gt;400 to &lt;800 202 (19.3) 41 (20.7) 243 (19.5) &gt;=800 632 (60.3) 120 (60.6) 752 (60.4) Fruit (1st trim): N(%) 0.28 Missing 13 (1.2) 3 (1.5) 16 (1.3) &lt;1-3x/month 73 (7.0) 16 (8.1) 89 (7.1) 1-6x/week 309 (29.5) 66 (33.3) 375 (30.1) &gt;=1-&lt;3x/day 516 (49.2) 96 (48.5) 612 (49.1) &gt;=3x/day 137 (13.1) 17 (8.6) 154 (12.4) Leafy vege (1st trim): N(%) 0.83 Missing 13 (1.2) 4 (2.0) 17 (1.4) &lt;1-3x/month 108 (10.3) 21 (10.6) 129 (10.4) 1-2x/week 239 (22.8) 42 (21.2) 281 (22.6) 3-6x/week 351 (33.5) 72 (36.4) 423 (33.9) &gt;=1x/day 337 (32.2) 59 (29.8) 396 (31.8) Fast food (1st trim): N(%) 0.37 Missing 147 (14.0) 24 (12.1) 171 (13.7) Never 42 (4.0) 11 (5.6) 53 (4.3) &gt;0-&lt;2x/week 174 (16.6) 34 (17.2) 208 (16.7) &gt;=2-&lt;4x/week 397 (37.9) 84 (42.4) 481 (38.6) &gt;=4x/week 288 (27.5) 45 (22.7) 333 (26.7) Vigorous exercise: N(%) 0.96 Missing 9 (0.9) 3 (1.5) 12 (1.0) Never 652 (62.2) 124 (62.6) 776 (62.3) Once a week 255 (24.3) 48 (24.2) 303 (24.3) 2-3/wk 99 (9.4) 16 (8.1) 115 (9.2) 4-6/wk 18 (1.7) 4 (2.0) 22 (1.8) Daily 14 (1.3) 3 (1.5) 17 (1.4) More than once a day 1 (0.1) 0 (0.0) 1 (0.1) Moderate exercise: N(%) 0.04 Missing 10 (1.0) 4 (2.0) 14 (1.1) Never 405 (38.6) 87 (43.9) 492 (39.5) Once a week 263 (25.1) 54 (27.3) 317 (25.4) 2-3/wk 233 (22.2) 42 (21.2) 275 (22.1) 4-6/wk 60 (5.7) 3 (1.5) 63 (5.1) Daily 64 (6.1) 6 (3.0) 70 (5.6) More than once a day 13 (1.2) 2 (1.0) 15 (1.2) Recreational walking: N(%) 0.44 Missing 11 (1.0) 3 (1.5) 14 (1.1) Never 225 (21.5) 33 (16.7) 258 (20.7) Once a week 364 (34.7) 81 (40.9) 445 (35.7) 2-3/wk 249 (23.8) 49 (24.7) 298 (23.9) 4-6/wk 81 (7.7) 12 (6.1) 93 (7.5) Daily 105 (10.0) 17 (8.6) 122 (9.8) More than once a day 13 (1.2) 3 (1.5) 16 (1.3) Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.3) 40.1 (35.5-45.2) 40.5 (36.3-45.3) 0.38 Homocysteine concentration (μM): Mean (SD) 5.0 (1.2) 4.8 (1.0) 5.0 (1.1) 0.01 B12 concentration (pM): Median (IQ range) 280.0 (218.0-357.0) 273.0 (217.5-348.5) 277.5 (218.0-356.0) 0.43 Folate:B12 ratio: Median (IQ range) 153.5 (115.1-221.2) 148.0 (112.4-225.9) 152.6 (114.8-221.7) 0.53 Active B12 concentration (pM): Mean (SD) 67.8 (25.2) 76.6 (26.1) 69.3 (25.6) 0.002 Folate:Active B12 ratio: Median (IQ range) 663.1 (475.7-951.1) 531.9 (417.3-788.4) 633.8 (460.9-923.1) 0.002 Vitamin D: Median (IQ range) 61.0 (46.0-77.0) 60.0 (44.5-77.5) 61.0 (46.0-77.0) 0.35 UIC (ug/L): Median (IQ range) 197.8 (120.4-327.6) 220.6 (139.0-344.1) 203.2 (124.5-330.8) 0.09 HCG (MoM): Median (IQ range) 1.0 (0.7-1.4) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 0.41 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.7-1.3) 0.9 (0.7-1.4) 0.81 Haemoglobin (g/L): Mean (SD) 131.3 (9.6) 132.2 (10.0) 131.5 (9.6) 0.28 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.06 Red cell folate (nmol/L): Mean (SD) 1427.4 (322.8) 1492.9 (307.2) 1437.8 (321.1) 0.010 54.2.3 MetS Characteristic non-GDM (n=1048) GDM (n=198) Total (n=1246) P-value MetS: N(%) &lt;0.0001 Missing 74 (7.1) 14 (7.1) 88 (7.1) No 907 (86.5) 144 (72.7) 1051 (84.3) Yes 67 (6.4) 40 (20.2) 107 (8.6) MetS: number of criteria met: Median (IQ range) 0.0 (0.0-1.0) 0.0 (0.0-1.5) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 81.5 (74.0-92.0) 91.0 (78.0-107.5) 82.9 (75.0-94.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 4.6 (0.8) 4.7 (0.9) 4.6 (0.8) 0.37 Triglyceride (mmol/L): Median (IQ range) 1.1 (0.9-1.4) 1.2 (0.9-1.6) 1.1 (0.9-1.4) 0.003 HDL (mmol/L): Mean (SD) 1.6 (0.3) 1.5 (0.3) 1.6 (0.3) &lt;0.0001 Glucose (mmol/L): Mean (SD) 4.8 (0.6) 4.9 (0.8) 4.8 (0.7) 0.004 LDL (mmol/L): Mean (SD) 2.4 (0.7) 2.6 (0.7) 2.5 (0.7) 0.004 Systolic BP (mmHg): Mean (SD) 115.3 (10.4) 118.8 (11.6) 115.9 (10.7) 0.0002 Diastolic BP (mmHg): Mean (SD) 70.2 (8.4) 73.5 (9.9) 70.7 (8.7) &lt;0.0001 MAP (mmHg): Mean (SD) 85.2 (8.1) 88.6 (9.6) 85.8 (8.4) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 23 (2.2) 3 (1.5) 26 (2.1) &lt;80 cm 447 (42.7) 54 (27.3) 501 (40.2) &gt;=80 cm 578 (55.2) 141 (71.2) 719 (57.7) MetS criteria: Triglyceride: N(%) 0.003 Missing 12 (1.1) 1 (0.5) 13 (1.0) &lt;1.7 mmol/L 907 (86.5) 156 (78.8) 1063 (85.3) &gt;=1.7 mmol/L 129 (12.3) 41 (20.7) 170 (13.6) MetS criteria: HDL: N(%) 0.04 Missing 12 (1.1) 1 (0.5) 13 (1.0) &gt;=1.3 mmol/L 885 (84.4) 156 (78.8) 1041 (83.5) &lt;1.3 mmol/L 151 (14.4) 41 (20.7) 192 (15.4) MetS criteria: Glucose: N(%) 0.04 Missing 12 (1.1) 1 (0.5) 13 (1.0) &lt;5.6 mmol/L 963 (91.9) 174 (87.9) 1137 (91.3) &gt;=5.6 mmol/L 73 (7.0) 23 (11.6) 96 (7.7) MetS criteria: sBP: N(%) 0.003 Missing 44 (4.2) 11 (5.6) 55 (4.4) &lt;130 mmHg 909 (86.7) 155 (78.3) 1064 (85.4) &gt;=130 mmHg 95 (9.1) 32 (16.2) 127 (10.2) MetS criteria: dBP: N(%) &lt;0.0001 Missing 44 (4.2) 11 (5.6) 55 (4.4) &lt;85 mmHg 955 (91.1) 162 (81.8) 1117 (89.6) &gt;=85 mmHg 49 (4.7) 25 (12.6) 74 (5.9) MetS criteria: BP: N(%) 0.0001 Missing 44 (4.2) 11 (5.6) 55 (4.4) &lt;130/85 mmHg 887 (84.6) 145 (73.2) 1032 (82.8) &gt;=130/85 mmHg 117 (11.2) 42 (21.2) 159 (12.8) CRP (mg/L): Median (IQ range) 3.3 (1.4-6.2) 3.9 (2.1-8.1) 3.4 (1.4-6.6) 0.005 54.2.4 Outcomes Characteristic non-GDM (n=1048) GDM (n=198) Total (n=1246) P-value Gestational age at birth (weeks): Median (IQ range) 39.7 (38.7-40.7) 38.9 (38.1-39.7) 39.6 (38.6-40.4) &lt;0.0001 Birthweight (g): Median (IQ range) 3402.0 (3040.0-3715.0) 3350.0 (3020.0-3645.0) 3390.0 (3040.0-3710.0) 0.19 Birthweight centile: Mean (SD) 47.6 (29.5) 52.5 (30.3) 48.4 (29.6) 0.04 Baby sex: N(%) 0.57 Missing 3 (0.3) 1 (0.5) 4 (0.3) Male 546 (52.1) 98 (49.5) 644 (51.7) Female 499 (47.6) 99 (50.0) 598 (48.0) Mode of delivery: N(%) 0.09 Missing 3 (0.3) 1 (0.5) 4 (0.3) Unassisted vaginal 522 (49.8) 91 (46.0) 613 (49.2) Operative vaginal 229 (21.9) 34 (17.2) 263 (21.1) Pre-labour LSCS 70 (6.7) 19 (9.6) 89 (7.1) LSCS in labour 224 (21.4) 53 (26.8) 277 (22.2) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-gdm-1.html", "54.3 SCOPE vs STOP (GDM)", " 54.3 SCOPE vs STOP (GDM) 54.3.1 Hormones Characteristic SCOPE (n=58) STOP (n=193) Total (n=251) P-value PRL (ng/ml): Mean (SD) 118.8 (86.5) 98.5 (95.8) 101.1 (94.7) 0.27 hPL (μg/ml): Mean (SD) 116.5 (49.3) 70.4 (50.6) 76.2 (52.6) &lt;0.0001 GH2 (ng/ml): Mean (SD) 3.1 (2.0) 1.7 (1.2) 1.9 (1.4) 0.003 Insulin (uU/ml): Mean (SD) 50.4 (55.0) 30.6 (41.0) 33.7 (43.9) 0.05 HOMA-IR: Mean (SD) 14.8 (18.7) 7.5 (13.0) 8.6 (14.2) 0.04 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 54.3.2 Demographics Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Maternal age (yrs): Median (IQ range) 28.0 (25.0-32.0) 28.0 (24.0-31.0) 28.0 (24.0-32.0) 0.95 Maternal age (yrs): N(%) 0.26 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 56 (96.6) 181 (91.4) 237 (92.6) &gt;=35 2 (3.4) 17 (8.6) 19 (7.4) Maternal BMI: Median (IQ range) 30.6 (25.4-36.3) 30.9 (24.6-37.6) 30.6 (24.6-37.3) 0.85 Maternal BMI (category): N(%) 0.74 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 1 (1.7) 8 (4.0) 9 (3.5) &gt;=20 to &lt;25 13 (22.4) 47 (23.7) 60 (23.4) &gt;=25 to &lt;30 13 (22.4) 40 (20.2) 53 (20.7) &gt;=30 to &lt;40 24 (41.4) 68 (34.3) 92 (35.9) &gt;=40 7 (12.1) 35 (17.7) 42 (16.4) SEI: Median (IQ range) 27.0 (20.2-34.0) 28.5 (20.0-45.0) 28.0 (20.0-45.0) 0.19 Ethnicity: N(%) 0.19 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 51 (87.9) 141 (71.2) 192 (75.0) Maori 0 (0.0) 1 (0.5) 1 (0.4) Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0) South East and Far East 4 (6.9) 24 (12.1) 28 (10.9) Indian 1 (1.7) 17 (8.6) 18 (7.0) African 0 (0.0) 5 (2.5) 5 (2.0) Middle-eastern 0 (0.0) 4 (2.0) 4 (1.6) Hispanic 0 (0.0) 1 (0.5) 1 (0.4) Aboriginal 1 (1.7) 3 (1.5) 4 (1.6) China and Japan 0 (0.0) 2 (1.0) 2 (0.8) Other 1 (1.7) 0 (0.0) 1 (0.4) Smoking: N(%) 0.62 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 50 (86.2) 163 (82.3) 213 (83.2) Yes 8 (13.8) 35 (17.7) 43 (16.8) Folic acid supplement (μg): N(%) 0.0003 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;800 27 (46.6) 44 (22.2) 71 (27.7) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Folic acid supplement (μg): N(%) 0.0001 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;=400 6 (10.3) 3 (1.5) 9 (3.5) &gt;400 to &lt;800 21 (36.2) 41 (20.7) 62 (24.2) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Fruit (1st trim): N(%) 0.86 Missing 0 (0.0) 3 (1.5) 3 (1.2) &lt;1-3x/month 3 (5.2) 16 (8.1) 19 (7.4) 1-6x/week 19 (32.8) 66 (33.3) 85 (33.2) &gt;=1-&lt;3x/day 32 (55.2) 96 (48.5) 128 (50.0) &gt;=3x/day 4 (6.9) 17 (8.6) 21 (8.2) Leafy vege (1st trim): N(%) 0.10 Missing 0 (0.0) 4 (2.0) 4 (1.6) &lt;1-3x/month 3 (5.2) 21 (10.6) 24 (9.4) 1-2x/week 13 (22.4) 42 (21.2) 55 (21.5) 3-6x/week 31 (53.4) 72 (36.4) 103 (40.2) &gt;=1x/day 11 (19.0) 59 (29.8) 70 (27.3) Fast food (1st trim): N(%) 0.36 Missing 9 (15.5) 24 (12.1) 33 (12.9) Never 1 (1.7) 11 (5.6) 12 (4.7) &gt;0-&lt;2x/week 6 (10.3) 34 (17.2) 40 (15.6) &gt;=2-&lt;4x/week 25 (43.1) 84 (42.4) 109 (42.6) &gt;=4x/week 17 (29.3) 45 (22.7) 62 (24.2) Vigorous exercise: N(%) 0.25 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 38 (65.5) 124 (62.6) 162 (63.3) Once a week 19 (32.8) 48 (24.2) 67 (26.2) 2-3/wk 1 (1.7) 16 (8.1) 17 (6.6) 4-6/wk 0 (0.0) 4 (2.0) 4 (1.6) Daily 0 (0.0) 3 (1.5) 3 (1.2) More than once a day 0 (0.0) 0 (0.0) 0 (0.0) Moderate exercise: N(%) 0.68 Missing 0 (0.0) 4 (2.0) 4 (1.6) Never 30 (51.7) 87 (43.9) 117 (45.7) Once a week 16 (27.6) 54 (27.3) 70 (27.3) 2-3/wk 8 (13.8) 42 (21.2) 50 (19.5) 4-6/wk 1 (1.7) 3 (1.5) 4 (1.6) Daily 3 (5.2) 6 (3.0) 9 (3.5) More than once a day 0 (0.0) 2 (1.0) 2 (0.8) Recreational walking: N(%) 0.88 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 9 (15.5) 33 (16.7) 42 (16.4) Once a week 21 (36.2) 81 (40.9) 102 (39.8) 2-3/wk 17 (29.3) 49 (24.7) 66 (25.8) 4-6/wk 5 (8.6) 12 (6.1) 17 (6.6) Daily 6 (10.3) 17 (8.6) 23 (9.0) More than once a day 0 (0.0) 3 (1.5) 3 (1.2) Serum folate concentration (nM): Median (IQ range) 40.1 (32.0-43.8) 40.1 (35.5-45.2) 40.1 (35.0-44.8) 0.26 Homocysteine concentration (μM): Mean (SD) 4.1 (0.9) 4.8 (1.0) 4.7 (1.0) &lt;0.0001 B12 concentration (pM): Median (IQ range) 253.5 (194.2-333.0) 273.0 (217.5-348.5) 270.0 (215.0-345.5) 0.16 Folate:B12 ratio: Median (IQ range) 158.9 (116.5-210.2) 148.0 (112.4-225.9) 149.3 (113.3-220.0) 0.79 Active B12 concentration (pM): Mean (SD) 72.7 (26.4) 76.6 (26.1) 75.7 (26.1) 0.48 Folate:Active B12 ratio: Median (IQ range) 553.8 (424.7-660.3) 531.9 (417.3-788.4) 536.7 (418.1-784.2) 0.97 Vitamin D: Median (IQ range) 55.8 (44.6-72.0) 60.0 (44.5-77.5) 59.0 (44.3-75.1) 0.52 UIC (ug/L): Median (IQ range) 132.7 (68.3-167.0) 220.6 (139.0-344.1) 206.4 (124.8-323.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.1 (0.7-1.6) 1.0 (0.7-1.6) 0.92 PAPP-A (MoM): Median (IQ range) 0.9 (0.5-1.4) 0.9 (0.7-1.3) 0.9 (0.7-1.4) 0.53 Haemoglobin (g/L): Mean (SD) 130.9 (9.4) 132.2 (10.0) 131.9 (9.8) 0.38 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.07 54.3.3 MetS Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value MetS: N(%) 0.0001 Missing 1 (1.7) 14 (7.1) 15 (5.9) No 29 (50.0) 144 (72.7) 173 (67.6) Yes 28 (48.3) 40 (20.2) 68 (26.6) MetS: number of criteria met: Median (IQ range) 2.0 (1.0-2.0) 0.0 (0.0-1.5) 1.0 (0.0-2.0) &lt;0.0001 Waist (cm): Median (IQ range) 97.0 (87.0-109.0) 91.0 (78.0-107.5) 93.0 (80.0-108.0) 0.03 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.7 (0.9) 4.9 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.8 (1.6-2.4) 1.2 (0.9-1.6) 1.3 (1.0-1.8) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.6 (0.3) 1.5 (0.3) 1.6 (0.3) 0.09 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.8) 2.6 (0.7) 2.7 (0.7) 0.004 Systolic BP (mmHg): Mean (SD) 112.9 (12.0) 118.8 (11.6) 117.4 (11.9) 0.001 Diastolic BP (mmHg): Mean (SD) 68.6 (8.9) 73.5 (9.9) 72.3 (9.9) 0.0005 MAP (mmHg): Mean (SD) 83.4 (8.9) 88.6 (9.6) 87.4 (9.7) 0.0002 MetS criteria: Waist circumference: N(%) 0.05 Missing 1 (1.7) 3 (1.5) 4 (1.6) &lt;80 cm 8 (13.8) 54 (27.3) 62 (24.2) &gt;=80 cm 49 (84.5) 141 (71.2) 190 (74.2) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 1 (0.5) 1 (0.4) &lt;1.7 mmol/L 23 (39.7) 156 (78.8) 179 (69.9) &gt;=1.7 mmol/L 35 (60.3) 41 (20.7) 76 (29.7) MetS criteria: HDL: N(%) 0.68 Missing 0 (0.0) 1 (0.5) 1 (0.4) &gt;=1.3 mmol/L 48 (82.8) 156 (78.8) 204 (79.7) &lt;1.3 mmol/L 10 (17.2) 41 (20.7) 51 (19.9) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 1 (1.7) 1 (0.5) 2 (0.8) &lt;5.6 mmol/L 18 (31.0) 174 (87.9) 192 (75.0) &gt;=5.6 mmol/L 39 (67.2) 23 (11.6) 62 (24.2) MetS criteria: sBP: N(%) 0.06 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130 mmHg 54 (93.1) 155 (78.3) 209 (81.6) &gt;=130 mmHg 4 (6.9) 32 (16.2) 36 (14.1) MetS criteria: dBP: N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;85 mmHg 56 (96.6) 162 (81.8) 218 (85.2) &gt;=85 mmHg 2 (3.4) 25 (12.6) 27 (10.5) MetS criteria: BP: N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130/85 mmHg 53 (91.4) 145 (73.2) 198 (77.3) &gt;=130/85 mmHg 5 (8.6) 42 (21.2) 47 (18.4) CRP (mg/L): Median (IQ range) 7.8 (4.4-12.5) 3.9 (2.1-8.1) 4.5 (2.4-9.1) &lt;0.0001 54.3.4 Outcomes Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Gestational age at birth (weeks): Median (IQ range) 38.9 (38.1-40.0) 38.9 (38.1-39.7) 38.9 (38.1-39.9) 0.91 Birthweight (g): Median (IQ range) 3260.0 (2825.0-3728.8) 3350.0 (3020.0-3645.0) 3330.0 (2990.5-3650.0) 0.61 Birthweight centile: Mean (SD) 47.6 (31.9) 52.5 (30.3) 51.4 (30.7) 0.30 Baby sex: N(%) 0.78 Missing 0 (0.0) 1 (0.5) 1 (0.4) Male 27 (46.6) 98 (49.5) 125 (48.8) Female 31 (53.4) 99 (50.0) 130 (50.8) Mode of delivery: N(%) 0.08 Missing 0 (0.0) 1 (0.5) 1 (0.4) Unassisted vaginal 19 (32.8) 91 (46.0) 110 (43.0) Operative vaginal 7 (12.1) 34 (17.2) 41 (16.0) Pre-labour LSCS 10 (17.2) 19 (9.6) 29 (11.3) LSCS in labour 22 (37.9) 53 (26.8) 75 (29.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-non-gdm.html", "54.4 SCOPE vs STOP (non-GDM)", " 54.4 SCOPE vs STOP (non-GDM) 54.4.1 Hormones Characteristic SCOPE (n=1066) STOP (n=1022) Total (n=2088) P-value PRL (ng/ml): Mean (SD) 187.4 (184.8) 106.3 (116.6) 142.2 (156.0) &lt;0.0001 hPL (μg/ml): Mean (SD) 186.1 (54.2) 74.7 (49.9) 124.6 (75.9) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.7 (2.8) 1.9 (1.7) 3.2 (2.7) &lt;0.0001 Insulin (uU/ml): Mean (SD) 23.8 (27.0) 16.6 (22.1) 19.8 (24.7) &lt;0.0001 HOMA-IR: Mean (SD) 6.1 (7.6) 3.7 (5.5) 4.8 (6.6) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.6) 5.1 (0.8) &lt;0.0001 54.4.2 Demographics Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 26.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.21 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1054 (98.2) 1020 (97.3) 2074 (97.8) &gt;=35 19 (1.8) 28 (2.7) 47 (2.2) Maternal BMI: Median (IQ range) 25.4 (22.1-30.4) 25.8 (22.6-30.6) 25.6 (22.4-30.5) 0.15 Maternal BMI (category): N(%) 0.22 Missing 0 (0.0) 1 (0.1) 1 (0.0) &lt;20 115 (10.7) 81 (7.7) 196 (9.2) &gt;=20 to &lt;25 377 (35.1) 377 (36.0) 754 (35.5) &gt;=25 to &lt;30 301 (28.1) 304 (29.0) 605 (28.5) &gt;=30 to &lt;40 234 (21.8) 236 (22.5) 470 (22.2) &gt;=40 46 (4.3) 49 (4.7) 95 (4.5) SEI: Median (IQ range) 25.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-34.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 987 (92.0) 889 (84.8) 1876 (88.4) Maori 5 (0.5) 1 (0.1) 6 (0.3) Pacific Islander 1 (0.1) 4 (0.4) 5 (0.2) South East and Far East 36 (3.4) 41 (3.9) 77 (3.6) Indian 3 (0.3) 40 (3.8) 43 (2.0) African 4 (0.4) 16 (1.5) 20 (0.9) Middle-eastern 5 (0.5) 19 (1.8) 24 (1.1) Hispanic 0 (0.0) 4 (0.4) 4 (0.2) Aboriginal 21 (2.0) 18 (1.7) 39 (1.8) China and Japan 0 (0.0) 14 (1.3) 14 (0.7) Other 11 (1.0) 2 (0.2) 13 (0.6) Smoking: N(%) &lt;0.0001 Missing 0 (0.0) 6 (0.6) 6 (0.3) No 813 (75.8) 870 (83.0) 1683 (79.3) Yes 260 (24.2) 172 (16.4) 432 (20.4) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 126 (12.0) 126 (5.9) None 230 (21.4) 76 (7.3) 306 (14.4) &lt;800 571 (53.2) 214 (20.4) 785 (37.0) &gt;=800 272 (25.3) 632 (60.3) 904 (42.6) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 126 (12.0) 126 (5.9) None 230 (21.4) 76 (7.3) 306 (14.4) &lt;=400 105 (9.8) 12 (1.1) 117 (5.5) &gt;400 to &lt;800 466 (43.4) 202 (19.3) 668 (31.5) &gt;=800 272 (25.3) 632 (60.3) 904 (42.6) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 13 (1.2) 13 (0.6) &lt;1-3x/month 110 (10.3) 73 (7.0) 183 (8.6) 1-6x/week 417 (38.9) 309 (29.5) 726 (34.2) &gt;=1-&lt;3x/day 367 (34.2) 516 (49.2) 883 (41.6) &gt;=3x/day 179 (16.7) 137 (13.1) 316 (14.9) Leafy vege (1st trim): N(%) 0.01 Missing 0 (0.0) 13 (1.2) 13 (0.6) &lt;1-3x/month 103 (9.6) 108 (10.3) 211 (9.9) 1-2x/week 249 (23.2) 239 (22.8) 488 (23.0) 3-6x/week 430 (40.1) 351 (33.5) 781 (36.8) &gt;=1x/day 291 (27.1) 337 (32.2) 628 (29.6) Fast food (1st trim): N(%) &lt;0.0001 Missing 216 (20.1) 147 (14.0) 363 (17.1) Never 15 (1.4) 42 (4.0) 57 (2.7) &gt;0-&lt;2x/week 102 (9.5) 174 (16.6) 276 (13.0) &gt;=2-&lt;4x/week 436 (40.6) 397 (37.9) 833 (39.3) &gt;=4x/week 304 (28.3) 288 (27.5) 592 (27.9) Vigorous exercise: N(%) 0.67 Missing 3 (0.3) 9 (0.9) 12 (0.6) Never 694 (64.7) 652 (62.2) 1346 (63.5) Once a week 264 (24.6) 255 (24.3) 519 (24.5) 2-3/wk 84 (7.8) 99 (9.4) 183 (8.6) 4-6/wk 14 (1.3) 18 (1.7) 32 (1.5) Daily 12 (1.1) 14 (1.3) 26 (1.2) More than once a day 2 (0.2) 1 (0.1) 3 (0.1) Moderate exercise: N(%) 0.35 Missing 3 (0.3) 10 (1.0) 13 (0.6) Never 453 (42.2) 405 (38.6) 858 (40.5) Once a week 278 (25.9) 263 (25.1) 541 (25.5) 2-3/wk 219 (20.4) 233 (22.2) 452 (21.3) 4-6/wk 51 (4.8) 60 (5.7) 111 (5.2) Daily 62 (5.8) 64 (6.1) 126 (5.9) More than once a day 7 (0.7) 13 (1.2) 20 (0.9) Recreational walking: N(%) 0.11 Missing 3 (0.3) 11 (1.0) 14 (0.7) Never 250 (23.3) 225 (21.5) 475 (22.4) Once a week 334 (31.1) 364 (34.7) 698 (32.9) 2-3/wk 283 (26.4) 249 (23.8) 532 (25.1) 4-6/wk 75 (7.0) 81 (7.7) 156 (7.4) Daily 102 (9.5) 105 (10.0) 207 (9.8) More than once a day 26 (2.4) 13 (1.2) 39 (1.8) Serum folate concentration (nM): Median (IQ range) 35.9 (28.1-42.6) 40.5 (36.4-45.3) 39.0 (32.9-43.9) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.2) 4.8 (1.2) &lt;0.0001 B12 concentration (pM): Median (IQ range) 245.0 (195.0-308.5) 280.0 (218.0-357.0) 261.0 (205.0-334.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.7 (102.3-207.5) 153.5 (115.1-221.2) 148.7 (108.4-216.5) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.1 (24.0) 67.8 (25.2) 63.6 (24.9) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 615.4 (432.4-902.3) 663.1 (475.7-951.1) 628.7 (453.0-925.0) 0.008 Vitamin D: Median (IQ range) 58.0 (42.0-76.4) 61.0 (46.0-77.0) 59.8 (43.7-76.6) 0.01 UIC (ug/L): Median (IQ range) 105.0 (66.3-163.6) 197.8 (120.4-327.6) 152.5 (89.2-259.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.4) 1.0 (0.7-1.5) 0.06 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.05 Haemoglobin (g/L): Mean (SD) 129.1 (9.3) 131.3 (9.6) 130.2 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 54.4.3 MetS Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value MetS: N(%) &lt;0.0001 Missing 9 (0.8) 74 (7.1) 83 (3.9) No 898 (83.7) 907 (86.5) 1805 (85.1) Yes 166 (15.5) 67 (6.4) 233 (11.0) MetS: number of criteria met: Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-97.0) 81.5 (74.0-92.0) 84.0 (76.0-95.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.6 (0.8) 5.1 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.7) 1.1 (0.9-1.4) 1.2 (1.0-1.6) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.6) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.1 (0.8) 2.4 (0.7) 2.8 (0.8) &lt;0.0001 Systolic BP (mmHg): Mean (SD) 109.1 (10.1) 115.3 (10.4) 112.1 (10.7) &lt;0.0001 Diastolic BP (mmHg): Mean (SD) 64.2 (7.9) 70.2 (8.4) 67.1 (8.7) &lt;0.0001 MAP (mmHg): Mean (SD) 79.2 (7.7) 85.2 (8.1) 82.1 (8.4) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 1 (0.1) 23 (2.2) 24 (1.1) &lt;80 cm 290 (27.0) 447 (42.7) 737 (34.7) &gt;=80 cm 782 (72.9) 578 (55.2) 1360 (64.1) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 12 (1.1) 12 (0.6) &lt;1.7 mmol/L 782 (72.9) 907 (86.5) 1689 (79.6) &gt;=1.7 mmol/L 291 (27.1) 129 (12.3) 420 (19.8) MetS criteria: HDL: N(%) 0.009 Missing 0 (0.0) 12 (1.1) 12 (0.6) &gt;=1.3 mmol/L 958 (89.3) 885 (84.4) 1843 (86.9) &lt;1.3 mmol/L 115 (10.7) 151 (14.4) 266 (12.5) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 8 (0.7) 12 (1.1) 20 (0.9) &lt;5.6 mmol/L 624 (58.2) 963 (91.9) 1587 (74.8) &gt;=5.6 mmol/L 441 (41.1) 73 (7.0) 514 (24.2) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;130 mmHg 1043 (97.2) 909 (86.7) 1952 (92.0) &gt;=130 mmHg 30 (2.8) 95 (9.1) 125 (5.9) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;85 mmHg 1068 (99.5) 955 (91.1) 2023 (95.4) &gt;=85 mmHg 5 (0.5) 49 (4.7) 54 (2.5) MetS criteria: BP: N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;130/85 mmHg 1041 (97.0) 887 (84.6) 1928 (90.9) &gt;=130/85 mmHg 32 (3.0) 117 (11.2) 149 (7.0) CRP (mg/L): Median (IQ range) 4.7 (2.4-8.9) 3.3 (1.4-6.2) 3.9 (1.9-7.5) &lt;0.0001 54.4.4 Outcomes Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value Gestational age at birth (weeks): Median (IQ range) 40.0 (38.9-40.9) 39.7 (38.7-40.7) 39.9 (38.9-40.7) 0.003 Birthweight (g): Median (IQ range) 3410.0 (3070.0-3735.0) 3402.0 (3040.0-3715.0) 3405.0 (3060.0-3730.0) 0.46 Birthweight centile: Mean (SD) 46.7 (29.4) 47.6 (29.5) 47.1 (29.4) 0.47 Baby sex: N(%) 0.14 Missing 0 (0.0) 3 (0.3) 3 (0.1) Male 525 (48.9) 546 (52.1) 1071 (50.5) Female 548 (51.1) 499 (47.6) 1047 (49.4) Mode of delivery: N(%) 0.01 Missing 0 (0.0) 3 (0.3) 3 (0.1) Unassisted vaginal 581 (54.1) 522 (49.8) 1103 (52.0) Operative vaginal 177 (16.5) 229 (21.9) 406 (19.1) Pre-labour LSCS 66 (6.2) 70 (6.7) 136 (6.4) LSCS in labour 249 (23.2) 224 (21.4) 473 (22.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["folate-vs-fa-supplement-5.html", "55 Folate vs FA supplement", " 55 Folate vs FA supplement Within non-GDM Characteristic None (n=306) &lt;=400 (n=117) &gt;400 to &lt;800 (n=668) &gt;=800 (n=904) Total (n=1995) P-value Serum folate concentration (nM): Median (IQ range) 28.8 (19.6-35.7) 36.5 (28.3-42.6) 38.7 (32.7-43.9) 41.2 (36.7-56.4) 39.1 (32.9-44.1) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.2 (1.5) 4.5 (1.0) 4.7 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 243.0 (192.0-303.0) 265.0 (200.2-350.5) 252.0 (200.0-322.0) 273.5 (215.0-353.8) 261.0 (205.0-334.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.4 (24.6) 60.6 (26.3) 61.2 (24.6) 67.5 (24.9) 63.9 (25.0) 0.0005 Folate:B12 ratio: Median (IQ range) 115.3 (78.1-161.3) 135.0 (106.1-186.1) 154.0 (113.6-224.4) 160.1 (118.3-236.4) 149.5 (108.7-217.1) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (331.8-693.3) 540.9 (429.0-894.7) 654.6 (481.7-956.3) 670.5 (485.2-1036.5) 626.2 (450.3-937.0) &lt;0.0001 Vitamin D: Median (IQ range) 53.0 (39.9-69.1) 49.0 (37.0-68.0) 59.0 (43.3-77.1) 64.0 (47.0-79.0) 60.0 (43.8-77.0) &lt;0.0001 Within GDM Characteristic None (n=22) &lt;=400 (n=9) &gt;400 to &lt;800 (n=62) &gt;=800 (n=142) Total (n=235) P-value Serum folate concentration (nM): Median (IQ range) 30.4 (26.5-40.2) 41.3 (36.3-54.4) 39.8 (33.8-44.0) 41.2 (37.9-58.0) 40.7 (35.9-45.2) 0.0002 Homocysteine concentration (μM): Mean (SD) 4.6 (1.0) 4.1 (0.9) 4.6 (1.0) 4.6 (0.9) 4.6 (1.0) 0.43 B12 concentration (pM): Median (IQ range) 260.5 (175.2-314.0) 268.0 (222.0-292.0) 268.5 (218.0-303.5) 278.0 (220.0-353.0) 271.5 (216.8-345.8) 0.55 Active B12 concentration (pM): Mean (SD) 65.2 (22.4) 80.3 (35.3) 84.4 (26.1) 74.1 (24.1) 76.4 (25.5) 0.09 Folate:B12 ratio: Median (IQ range) 123.5 (80.3-170.6) 162.4 (135.4-220.6) 153.1 (112.8-215.4) 160.1 (117.5-256.9) 150.7 (116.1-227.3) 0.10 Folate:Active B12 ratio: Median (IQ range) 510.1 (409.2-591.5) 715.7 (399.3-826.4) 524.9 (427.0-593.3) 565.1 (429.3-895.6) 539.5 (424.7-784.2) 0.30 Vitamin D: Median (IQ range) 45.4 (29.4-69.3) 68.6 (44.3-74.0) 57.6 (45.2-72.7) 61.0 (46.8-76.5) 59.0 (44.5-75.2) 0.23 Click here for table within SCOPE Within non-GDM Characteristic None (n=230) &lt;=400 (n=105) &gt;400 to &lt;800 (n=466) &gt;=800 (n=272) Total (n=1073) P-value Serum folate concentration (nM): Median (IQ range) 25.7 (17.5-33.3) 35.5 (27.4-41.7) 37.5 (30.7-43.5) 39.8 (34.4-47.2) 35.9 (28.1-42.6) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.0) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (186.0-297.0) 250.5 (196.8-345.0) 247.5 (196.2-309.8) 248.5 (199.0-303.8) 245.0 (195.0-308.5) 0.01 Active B12 concentration (pM): Mean (SD) 56.0 (22.4) 60.0 (26.7) 59.3 (23.5) 64.9 (24.7) 60.1 (24.0) 0.02 Folate:B12 ratio: Median (IQ range) 108.4 (74.3-153.1) 132.0 (100.9-184.7) 146.0 (111.9-220.1) 165.1 (118.8-247.7) 142.7 (102.3-207.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 461.7 (343.8-710.6) 540.9 (415.3-911.7) 643.6 (484.0-967.9) 653.3 (483.0-1082.9) 615.4 (432.4-902.3) &lt;0.0001 Vitamin D: Median (IQ range) 51.9 (39.1-68.5) 48.1 (35.7-63.5) 56.7 (41.2-75.8) 68.0 (50.9-83.9) 58.0 (42.0-76.4) &lt;0.0001 Within GDM Characteristic None (n=9) &lt;=400 (n=6) &gt;400 to &lt;800 (n=21) &gt;=800 (n=22) Total (n=58) P-value Serum folate concentration (nM): Median (IQ range) 26.7 (21.7-29.6) 36.8 (32.7-40.3) 41.5 (32.6-43.7) 42.5 (38.4-65.4) 40.1 (32.0-43.8) 0.002 Homocysteine concentration (μM): Mean (SD) 4.3 (1.1) 3.7 (0.7) 4.2 (0.9) 4.1 (0.8) 4.1 (0.9) 0.52 B12 concentration (pM): Median (IQ range) 200.5 (171.8-265.5) 280.0 (259.8-348.2) 271.5 (228.5-333.0) 237.5 (192.0-342.8) 253.5 (194.2-333.0) 0.25 Active B12 concentration (pM): Mean (SD) 66.6 (22.5) 102.7 (39.7) 68.4 (21.1) 71.7 (27.1) 72.7 (26.4) 0.22 Folate:B12 ratio: Median (IQ range) 125.3 (68.1-178.3) 138.4 (125.8-157.2) 144.0 (111.7-170.7) 210.6 (147.3-391.7) 158.9 (116.5-210.2) 0.03 Folate:Active B12 ratio: Median (IQ range) 447.5 (321.0-553.6) 320.2 (289.2-478.5) 558.4 (516.5-660.3) 674.9 (540.9-1118.7) 553.8 (424.7-660.3) 0.12 Vitamin D: Median (IQ range) 45.4 (29.8-79.0) 56.5 (33.3-70.7) 51.7 (45.9-68.3) 65.5 (51.4-75.2) 55.8 (44.6-72.0) 0.27 Click here for table within STOP Within non-GDM Characteristic None (n=76) &lt;=400 (n=12) &gt;400 to &lt;800 (n=202) &gt;=800 (n=632) Total (n=922) P-value Serum folate concentration (nM): Median (IQ range) 36.4 (30.7-40.5) 42.2 (37.2-49.7) 40.2 (35.9-48.2) 41.6 (37.6-58.0) 40.9 (36.8-54.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.4 (1.5) 5.0 (0.9) 5.2 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 278.0 (215.0-331.0) 314.5 (247.5-367.8) 263.5 (208.2-347.0) 281.0 (225.8-370.5) 280.0 (220.0-363.0) 0.08 Active B12 concentration (pM): Mean (SD) 75.8 (26.0) 68.0 (23.3) 66.6 (26.9) 68.8 (25.0) 69.0 (25.5) 0.32 Folate:B12 ratio: Median (IQ range) 132.7 (100.7-188.3) 165.0 (135.9-197.8) 166.4 (119.0-229.8) 157.0 (117.9-227.6) 155.4 (116.2-223.0) 0.02 Folate:Active B12 ratio: Median (IQ range) 501.3 (325.8-682.9) 550.8 (476.6-682.4) 693.8 (476.6-951.1) 684.1 (491.4-1022.0) 665.1 (470.7-974.0) 0.003 Vitamin D: Median (IQ range) 58.0 (44.0-70.5) 63.5 (46.8-81.8) 64.0 (49.0-79.2) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.28 Within GDM Characteristic None (n=13) &lt;=400 (n=3) &gt;400 to &lt;800 (n=41) &gt;=800 (n=120) Total (n=177) P-value Serum folate concentration (nM): Median (IQ range) 35.6 (30.1-42.0) 54.4 (49.5-57.2) 39.4 (34.6-44.5) 41.1 (37.5-56.3) 40.7 (36.1-53.6) 0.02 Homocysteine concentration (μM): Mean (SD) 4.7 (0.9) 4.9 (0.8) 4.8 (1.1) 4.7 (0.9) 4.7 (1.0) 0.96 B12 concentration (pM): Median (IQ range) 279.0 (243.8-381.5) 182.0 (181.0-227.0) 268.5 (218.0-284.2) 285.0 (224.0-358.5) 275.5 (221.2-348.8) 0.20 Active B12 concentration (pM): Mean (SD) 63.4 (24.8) 58.0 (6.2) 90.2 (25.6) 74.5 (23.8) 77.6 (25.2) 0.01 Folate:B12 ratio: Median (IQ range) 123.5 (102.6-144.2) 244.5 (232.5-273.4) 162.0 (116.1-254.6) 150.2 (116.3-228.4) 150.6 (116.1-231.2) 0.09 Folate:Active B12 ratio: Median (IQ range) 633.8 (487.5-645.7) 836.9 (815.8-984.5) 512.7 (419.6-590.5) 542.1 (424.7-838.0) 534.2 (427.0-788.4) 0.13 Vitamin D: Median (IQ range) 45.0 (29.0-54.8) 89.0 (77.0-107.5) 59.0 (45.0-79.0) 60.5 (46.0-77.5) 60.0 (44.8-78.0) 0.07 "],["folate-8.html", "55.1 Folate", " 55.1 Folate 55.1.1 FA supp (4 categories) 55.1.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0528919 0.0668606 45.6605578 &lt;0.0001 *** folate_cat3&lt;=400 0.3518275 0.0587560 5.9879380 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4649705 0.0407018 11.4238245 &lt;0.0001 *** folate_cat3&gt;=800 0.5650408 0.0451551 12.5133278 &lt;0.0001 *** f39_gdm_newGDM 0.0034892 0.1718463 0.0203042 0.98 ns StudySTOP 0.4244351 0.0645591 6.5743687 &lt;0.0001 *** f1_age 0.0129201 0.0021827 5.9194029 &lt;0.0001 *** BMI -0.0056095 0.0015641 -3.5862901 0.0003 *** folate_cat3&lt;=400:StudySTOP -0.1754408 0.1592787 -1.1014703 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.3263096 0.0764343 -4.2691494 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3215653 0.0733970 -4.3811771 &lt;0.0001 *** f39_gdm_newGDM:StudySTOP -0.0989743 0.2267777 -0.4364372 0.66 ns folate_cat3&lt;=400:f39_gdm_newGDM 0.0119271 0.2640464 0.0451703 0.96 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.0362343 0.2102623 0.1723289 0.86 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.1130757 0.2074434 0.5450921 0.59 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.1723689 0.4315894 0.3993815 0.69 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP 0.0254739 0.2702429 0.0942630 0.92 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.0343081 0.2593700 -0.1322749 0.89 ns 55.1.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 25.05059 0.8525770 2095 23.43318 26.77963 &lt;=400 non-GDM SCOPE 35.61350 1.7165847 2095 32.40132 39.14413 &gt;400 to &lt;800 non-GDM SCOPE 39.87971 0.9370133 2095 38.08383 41.76028 &gt;=800 non-GDM SCOPE 44.07700 1.3077944 2095 41.58548 46.71780 None GDM SCOPE 25.13815 4.2374781 2095 18.06198 34.98656 &lt;=400 GDM SCOPE 36.16678 7.0459233 2095 24.68226 52.99498 &gt;400 to &lt;800 GDM SCOPE 41.49576 4.9479757 2095 32.84334 52.42761 &gt;=800 GDM SCOPE 49.52626 5.5930515 2095 39.68742 61.80423 None non-GDM STOP 38.29550 2.1076182 2095 34.37749 42.66004 &lt;=400 non-GDM STOP 45.68268 6.2877261 2095 34.87588 59.83812 &gt;400 to &lt;800 non-GDM STOP 43.99136 1.5068199 2095 41.13340 47.04789 &gt;=800 non-GDM STOP 48.85262 0.9369488 2095 47.04930 50.72506 None GDM STOP 34.80800 4.7914096 2095 26.57305 45.59496 &lt;=400 GDM STOP 49.92540 13.7610924 2095 29.07814 85.71888 &gt;400 to &lt;800 GDM STOP 42.53028 3.2335819 2095 36.63902 49.36880 &gt;=800 GDM STOP 48.04271 2.1441766 2095 44.01654 52.43716 55.1.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.04 (0.90, 1.22) 0.6 GDM / (non-GDM) STOP 0.99 (0.83, 1.17) 0.9 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.24 (1.15, 1.35) &lt;0.0001 STOP / SCOPE GDM 1.17 (0.95, 1.46) 0.1 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.30 (1.06, 1.60) 0.005 &gt;400 to &lt;800 / None non-GDM 1.35 (1.23, 1.49) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.04 (0.85, 1.26) 1.0 &gt;=800 / None non-GDM 1.50 (1.36, 1.65) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 1.15 (0.95, 1.40) 0.2 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.11 (1.03, 1.19) 0.001 &lt;=400 / None GDM 1.44 (0.86, 2.41) 0.3 &gt;400 to &lt;800 / None GDM 1.42 (1.02, 1.98) 0.03 &gt;400 to &lt;800 / &lt;=400 GDM 0.99 (0.62, 1.58) 1.0 &gt;=800 / None GDM 1.65 (1.20, 2.27) 0.0004 &gt;=800 / &lt;=400 GDM 1.15 (0.72, 1.82) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.16 (0.91, 1.47) 0.4 "],["b12-8.html", "55.2 B12", " 55.2 B12 55.2.1 FA supp (4 categories) 55.2.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4377715 0.0532476 102.1224372 &lt;0.0001 *** folate_cat3&lt;=400 0.1122903 0.0468046 2.3991278 0.02 * folate_cat3&gt;400 to &lt;800 0.0843004 0.0324228 2.6000367 0.009 ** folate_cat3&gt;=800 0.0915894 0.0359702 2.5462590 0.01 * f39_gdm_newGDM -0.0122623 0.1368915 -0.0895766 0.93 ns StudySTOP 0.1676752 0.0514273 3.2604325 0.001 ** f1_age 0.0090210 0.0017386 5.1886518 &lt;0.0001 *** BMI -0.0085213 0.0012456 -6.8409060 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.0060563 0.1268803 -0.0477322 0.96 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1125006 0.0608871 -1.8476921 0.06 ns folate_cat3&gt;=800:StudySTOP -0.0387190 0.0584675 -0.6622314 0.51 ns f39_gdm_newGDM:StudySTOP 0.0472084 0.1806496 0.2613257 0.79 ns folate_cat3&lt;=400:f39_gdm_newGDM 0.1192740 0.2103376 0.5670598 0.57 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.1372106 0.1674935 0.8191994 0.41 ns folate_cat3&gt;=800:f39_gdm_newGDM -0.1590593 0.1652480 -0.9625493 0.34 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP -0.5257651 0.3438012 -1.5292709 0.13 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP -0.1976340 0.2152736 -0.9180594 0.36 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP 0.1217768 0.2065885 0.5894656 0.56 ns 55.2.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 227.7876 6.175602 2096 215.9930 240.2263 &lt;=400 non-GDM SCOPE 254.8573 9.785493 2096 236.3717 274.7886 &gt;400 to &lt;800 non-GDM SCOPE 247.8228 4.638413 2096 238.8913 257.0882 &gt;=800 non-GDM SCOPE 249.6358 5.900239 2096 238.3289 261.4791 None GDM SCOPE 225.0114 30.214515 2096 172.9176 292.7992 &lt;=400 GDM SCOPE 283.6428 44.018596 2096 209.2171 384.5442 &gt;400 to &lt;800 GDM SCOPE 280.8055 26.672654 2096 233.0808 338.3021 &gt;=800 GDM SCOPE 210.3308 18.921345 2096 176.3131 250.9118 None non-GDM STOP 269.3708 11.809480 2096 247.1789 293.5550 &lt;=400 non-GDM STOP 299.5624 32.844728 2096 241.6048 371.4232 &gt;400 to &lt;800 non-GDM STOP 261.8806 7.145504 2096 248.2358 276.2753 &gt;=800 non-GDM STOP 283.9957 4.338844 2096 275.6130 292.6333 None GDM STOP 278.9506 30.587795 2096 224.9762 345.8742 &lt;=400 GDM STOP 206.5986 45.362281 2096 134.3146 317.7835 &gt;400 to &lt;800 GDM STOP 255.2928 15.461794 2096 226.7023 287.4891 &gt;=800 GDM STOP 283.3329 10.028021 2096 264.3340 303.6974 55.2.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.01 (0.89, 1.14) 0.8 GDM / (non-GDM) STOP 0.91 (0.79, 1.05) 0.2 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.14 (1.06, 1.21) 0.0001 STOP / SCOPE GDM 1.03 (0.86, 1.22) 0.8 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.12 (0.95, 1.31) 0.3 &gt;400 to &lt;800 / None non-GDM 1.03 (0.95, 1.11) 0.8 &gt;400 to &lt;800 / &lt;=400 non-GDM 0.92 (0.79, 1.08) 0.5 &gt;=800 / None non-GDM 1.07 (1.00, 1.16) 0.07 &gt;=800 / &lt;=400 non-GDM 0.96 (0.83, 1.12) 0.9 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.05 (0.99, 1.11) 0.2 &lt;=400 / None GDM 0.97 (0.64, 1.46) 1.0 &gt;400 to &lt;800 / None GDM 1.07 (0.82, 1.39) 0.9 &gt;400 to &lt;800 / &lt;=400 GDM 1.11 (0.76, 1.61) 0.9 &gt;=800 / None GDM 0.97 (0.75, 1.26) 1.0 &gt;=800 / &lt;=400 GDM 1.01 (0.70, 1.45) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.91 (0.75, 1.10) 0.6 "],["homocysteine-8.html", "55.3 Homocysteine", " 55.3 Homocysteine 55.3.1 FA supp (4 categories) 55.3.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5889477 0.0310049 51.2482479 &lt;0.0001 *** folate_cat3&lt;=400 -0.1162933 0.0272515 -4.2674041 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 -0.1147800 0.0188778 -6.0801583 &lt;0.0001 *** folate_cat3&gt;=800 -0.1527889 0.0209433 -7.2953462 &lt;0.0001 *** f39_gdm_newGDM -0.1555582 0.0797035 -1.9517110 0.05 ns StudySTOP 0.0523273 0.0299430 1.7475655 0.08 ns f1_age 0.0001087 0.0010126 0.1073105 0.91 ns BMI 0.0001147 0.0007257 0.1580232 0.87 ns folate_cat3&lt;=400:StudySTOP 0.0567108 0.0738746 0.7676637 0.44 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0846171 0.0354508 2.3868885 0.02 * folate_cat3&gt;=800:StudySTOP 0.0605118 0.0340452 1.7773955 0.08 ns f39_gdm_newGDM:StudySTOP 0.0403690 0.1051811 0.3838049 0.70 ns folate_cat3&lt;=400:f39_gdm_newGDM -0.0350023 0.1224666 -0.2858109 0.78 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.0991240 0.0975211 1.0164364 0.31 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.0984017 0.0962137 1.0227411 0.31 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.1349603 0.2001742 0.6742140 0.50 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP -0.0567051 0.1253406 -0.4524079 0.65 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.0083027 0.1202852 -0.0690255 0.94 ns 55.3.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 4.927409 0.0777824 2094 4.777207 5.082333 &lt;=400 non-GDM SCOPE 4.386449 0.0980616 2094 4.198295 4.583035 &gt;400 to &lt;800 non-GDM SCOPE 4.393092 0.0478753 2094 4.300200 4.487990 &gt;=800 non-GDM SCOPE 4.229249 0.0582002 2094 4.116639 4.344939 None GDM SCOPE 4.217553 0.3297413 2094 3.618032 4.916415 &lt;=400 GDM SCOPE 3.625381 0.3275809 2094 3.036663 4.328234 &gt;400 to &lt;800 GDM SCOPE 4.152037 0.2296274 2094 3.725276 4.627686 &gt;=800 GDM SCOPE 3.994298 0.2092136 2094 3.604379 4.426399 None non-GDM STOP 5.192112 0.1325333 2094 4.938599 5.458638 &lt;=400 non-GDM STOP 4.891789 0.3122816 2094 4.316158 5.544189 &gt;400 to &lt;800 non-GDM STOP 5.037841 0.0800334 2094 4.883307 5.197265 &gt;=800 non-GDM STOP 4.734440 0.0421866 2094 4.652427 4.817899 None GDM STOP 4.627197 0.2954199 2094 4.082651 5.244375 &lt;=400 GDM STOP 4.817845 0.6159155 2094 3.749488 6.190615 &gt;400 to &lt;800 GDM STOP 4.684257 0.1651837 2094 4.371263 5.019662 &gt;=800 GDM STOP 4.617129 0.0951462 2094 4.434259 4.807542 55.3.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 0.89 (0.83, 0.96) 0.002 GDM / (non-GDM) STOP 0.94 (0.87, 1.02) 0.2 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.11 (1.07, 1.15) &lt;0.0001 STOP / SCOPE GDM 1.17 (1.06, 1.30) 0.002 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 0.92 (0.83, 1.01) 0.08 &gt;400 to &lt;800 / None non-GDM 0.93 (0.89, 0.97) 0.0003 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.02 (0.93, 1.11) 1.0 &gt;=800 / None non-GDM 0.88 (0.85, 0.92) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 0.97 (0.88, 1.06) 0.8 &gt;=800 / &gt;400 to &lt;800 non-GDM 0.95 (0.92, 0.98) 0.0005 &lt;=400 / None GDM 0.95 (0.74, 1.20) 0.9 &gt;400 to &lt;800 / None GDM 1.00 (0.86, 1.17) 1.0 &gt;400 to &lt;800 / &lt;=400 GDM 1.06 (0.85, 1.31) 0.9 &gt;=800 / None GDM 0.97 (0.84, 1.13) 1.0 &gt;=800 / &lt;=400 GDM 1.03 (0.83, 1.27) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.97 (0.87, 1.09) 0.9 "],["active-b12-8.html", "55.4 Active B12", " 55.4 Active B12 55.4.1 FA supp (4 categories) 55.4.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.7064034 0.0723742 51.2116899 &lt;0.0001 *** folate_cat3&lt;=400 0.0408019 0.0650813 0.6269372 0.53 ns folate_cat3&gt;400 to &lt;800 0.0486532 0.0422632 1.1511966 0.25 ns folate_cat3&gt;=800 0.1302236 0.0468160 2.7816063 0.005 ** f39_gdm_newGDM 0.1846099 0.1512249 1.2207637 0.22 ns StudySTOP 0.3095086 0.0727115 4.2566651 &lt;0.0001 *** f1_age 0.0062833 0.0024611 2.5529962 0.01 * BMI 0.0039079 0.0016674 2.3437692 0.02 * folate_cat3&lt;=400:StudySTOP -0.1476278 0.2149912 -0.6866690 0.49 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2267694 0.0871117 -2.6032013 0.009 ** folate_cat3&gt;=800:StudySTOP -0.2561995 0.0821579 -3.1183806 0.002 ** f39_gdm_newGDM:StudySTOP -0.4209300 0.2394739 -1.7577278 0.08 ns folate_cat3&lt;=400:f39_gdm_newGDM 0.3478960 0.2764791 1.2583085 0.21 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM -0.0711430 0.2007666 -0.3543567 0.72 ns folate_cat3&gt;=800:f39_gdm_newGDM -0.1547553 0.1981000 -0.7811977 0.43 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP -0.3001328 0.4464490 -0.6722666 0.50 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP 0.6348743 0.2875216 2.2080926 0.03 * folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP 0.4544318 0.2775590 1.6372439 0.10 ns 55.4.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 53.04455 1.851862 1123 49.53270 56.80539 &lt;=400 non-GDM SCOPE 55.25363 3.047929 1123 49.58562 61.56954 &gt;400 to &lt;800 non-GDM SCOPE 55.68915 1.386598 1123 53.03393 58.47732 &gt;=800 non-GDM SCOPE 60.42215 1.891606 1123 56.82236 64.24999 None GDM SCOPE 63.79929 9.396205 1123 47.78787 85.17536 &lt;=400 GDM SCOPE 94.10770 21.167215 1123 60.52875 146.31492 &gt;400 to &lt;800 GDM SCOPE 62.38047 8.115285 1123 48.32741 80.52000 &gt;=800 GDM SCOPE 62.25322 7.764789 1123 48.73912 79.51444 None non-GDM STOP 72.28675 4.631759 1123 63.74693 81.97060 &lt;=400 non-GDM STOP 64.96281 12.653702 1123 44.32877 95.20153 &gt;400 to &lt;800 non-GDM STOP 60.49282 2.501760 1123 55.77804 65.60612 &gt;=800 non-GDM STOP 63.73060 1.439091 1123 60.96863 66.61770 None GDM STOP 57.07240 9.961485 1123 40.52249 80.38151 &lt;=400 GDM STOP 53.79917 12.138897 1123 34.55483 83.76110 &gt;400 to &lt;800 GDM STOP 83.92603 6.571717 1123 71.97349 97.86351 &gt;=800 GDM STOP 67.89900 3.476383 1123 61.40948 75.07431 55.4.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.24 (1.05, 1.46) 0.01 GDM / (non-GDM) STOP 0.99 (0.83, 1.19) 0.9 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.16 (1.04, 1.30) 0.007 STOP / SCOPE GDM 0.93 (0.75, 1.16) 0.5 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 0.97 (0.73, 1.28) 1.0 &gt;400 to &lt;800 / None non-GDM 0.94 (0.84, 1.05) 0.4 &gt;400 to &lt;800 / &lt;=400 non-GDM 0.97 (0.74, 1.27) 1.0 &gt;=800 / None non-GDM 1.00 (0.90, 1.12) 1.0 &gt;=800 / &lt;=400 non-GDM 1.04 (0.79, 1.35) 1.0 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.07 (0.99, 1.16) 0.1 &lt;=400 / None GDM 1.18 (0.71, 1.95) 0.8 &gt;400 to &lt;800 / None GDM 1.20 (0.84, 1.71) 0.5 &gt;400 to &lt;800 / &lt;=400 GDM 1.02 (0.65, 1.60) 1.0 &gt;=800 / None GDM 1.08 (0.77, 1.51) 0.9 &gt;=800 / &lt;=400 GDM 0.91 (0.59, 1.42) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.90 (0.69, 1.17) 0.7 "],["folateb12-8.html", "55.5 Folate:B12", " 55.5 Folate:B12 55.5.1 FA supp (4 categories) 55.5.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5213369 0.0819238 55.1895486 &lt;0.0001 *** folate_cat3&lt;=400 0.2394912 0.0719933 3.3265742 0.0009 *** folate_cat3&gt;400 to &lt;800 0.3806140 0.0498716 7.6318720 &lt;0.0001 *** folate_cat3&gt;=800 0.4733487 0.0553282 8.5552816 &lt;0.0001 *** f39_gdm_newGDM 0.0155494 0.2105621 0.0738473 0.94 ns StudySTOP 0.2566793 0.0791037 3.2448433 0.001 ** f1_age 0.0039230 0.0026744 1.4668514 0.14 ns BMI 0.0029504 0.0019165 1.5394510 0.12 ns folate_cat3&lt;=400:StudySTOP -0.1693382 0.1951630 -0.8676756 0.39 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2137956 0.0936544 -2.2828135 0.02 * folate_cat3&gt;=800:StudySTOP -0.2828074 0.0899328 -3.1446529 0.002 ** f39_gdm_newGDM:StudySTOP -0.1461777 0.2778691 -0.5260667 0.60 ns folate_cat3&lt;=400:f39_gdm_newGDM -0.1074162 0.3235341 -0.3320089 0.74 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM -0.1009938 0.2576329 -0.3920067 0.70 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.2720636 0.2541788 1.0703630 0.28 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.6979206 0.5288233 1.3197614 0.19 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP 0.2230307 0.3311266 0.6735509 0.50 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.1601713 0.3178042 -0.5039936 0.61 ns 55.5.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 109.9886 4.586729 2095 101.35153 119.3616 &lt;=400 non-GDM SCOPE 139.7517 8.253679 2095 124.46766 156.9126 &gt;400 to &lt;800 non-GDM SCOPE 160.9333 4.633184 2095 152.09896 170.2809 &gt;=800 non-GDM SCOPE 176.5713 6.419297 2095 164.42077 189.6198 None GDM SCOPE 111.7122 23.073558 2095 74.50540 167.4994 &lt;=400 GDM SCOPE 127.4853 30.431814 2095 79.82767 203.5947 &gt;400 to &lt;800 GDM SCOPE 147.7536 21.587468 2095 110.94347 196.7770 &gt;=800 GDM SCOPE 235.4122 32.574822 2095 179.46389 308.8025 None non-GDM STOP 142.1746 9.587512 2095 124.56273 162.2765 &lt;=400 non-GDM STOP 152.5067 25.719993 2095 109.56007 212.2881 &gt;400 to &lt;800 non-GDM STOP 167.9849 7.050241 2095 154.71237 182.3960 &gt;=800 non-GDM STOP 172.0176 4.042413 2095 164.26994 180.1307 None GDM STOP 124.7644 21.043345 2095 89.62727 173.6766 &lt;=400 GDM STOP 241.5520 81.579634 2095 124.55672 468.4401 &gt;400 to &lt;800 GDM STOP 166.5478 15.515451 2095 138.73817 199.9319 &gt;=800 GDM STOP 168.8247 9.232277 2095 151.65635 187.9366 55.5.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.03 (0.85, 1.25) 0.7 GDM / (non-GDM) STOP 1.08 (0.87, 1.34) 0.5 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.09 (0.99, 1.21) 0.08 STOP / SCOPE GDM 1.14 (0.88, 1.49) 0.3 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.17 (0.91, 1.50) 0.4 &gt;400 to &lt;800 / None non-GDM 1.31 (1.17, 1.48) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.13 (0.89, 1.43) 0.6 &gt;=800 / None non-GDM 1.39 (1.24, 1.57) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 1.19 (0.94, 1.51) 0.2 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.06 (0.97, 1.15) 0.3 &lt;=400 / None GDM 1.49 (0.79, 2.80) 0.4 &gt;400 to &lt;800 / None GDM 1.33 (0.88, 2.00) 0.3 &gt;400 to &lt;800 / &lt;=400 GDM 0.89 (0.50, 1.59) 1.0 &gt;=800 / None GDM 1.69 (1.14, 2.50) 0.003 &gt;=800 / &lt;=400 GDM 1.14 (0.65, 2.00) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.27 (0.95, 1.70) 0.2 "],["folateactive-b12-8.html", "55.6 Folate:Active B12", " 55.6 Folate:Active B12 55.6.1 FA supp (4 categories) 55.6.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.2715785 0.1089142 57.5827273 &lt;0.0001 *** folate_cat3&lt;=400 0.2645272 0.0978920 2.7022359 0.007 ** folate_cat3&gt;400 to &lt;800 0.3952297 0.0635701 6.2172232 &lt;0.0001 *** folate_cat3&gt;=800 0.3871869 0.0704183 5.4983870 &lt;0.0001 *** f39_gdm_newGDM -0.1804659 0.2274650 -0.7933788 0.43 ns StudySTOP 0.0850330 0.1093690 0.7774870 0.44 ns f1_age 0.0058488 0.0037021 1.5798784 0.11 ns BMI -0.0092678 0.0025099 -3.6925390 0.0002 *** folate_cat3&lt;=400:StudySTOP -0.1601929 0.3233788 -0.4953722 0.62 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.0676212 0.1310291 -0.5160776 0.61 ns folate_cat3&gt;=800:StudySTOP -0.0306936 0.1235777 -0.2483749 0.80 ns f39_gdm_newGDM:StudySTOP 0.2400103 0.3602046 0.6663166 0.51 ns folate_cat3&lt;=400:f39_gdm_newGDM -0.3173972 0.4158657 -0.7632205 0.45 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.1612432 0.3019829 0.5339481 0.59 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.3197122 0.2979724 1.0729593 0.28 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.7432475 0.6715259 1.1068039 0.27 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP -0.5749122 0.4324757 -1.3293515 0.18 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.4436389 0.4175883 -1.0623837 0.29 ns 55.6.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 470.8393 24.72491 1122 424.7426 521.9389 &lt;=400 non-GDM SCOPE 613.4164 50.89726 1122 521.2572 721.8696 &gt;400 to &lt;800 non-GDM SCOPE 699.0670 26.18145 1122 649.5389 752.3716 &gt;=800 non-GDM SCOPE 693.4671 32.65549 1122 632.2653 760.5931 None GDM SCOPE 393.0949 87.08116 1122 254.5245 607.1069 &lt;=400 GDM SCOPE 372.8517 126.14372 1122 191.9754 724.1472 &gt;400 to &lt;800 GDM SCOPE 685.7574 134.18886 1122 467.1191 1006.7306 &gt;=800 GDM SCOPE 797.0760 149.54154 1122 551.6087 1151.7769 None non-GDM STOP 512.6277 49.40609 1122 424.3032 619.3382 &lt;=400 non-GDM STOP 569.0021 166.70872 1122 320.2254 1011.0484 &gt;400 to &lt;800 non-GDM STOP 711.3456 44.25005 1122 629.6128 803.6886 &gt;=800 non-GDM STOP 732.1923 24.86924 1122 684.9873 782.6504 None GDM STOP 544.0789 142.84048 1122 325.0493 910.6983 &lt;=400 GDM STOP 924.5238 313.77161 1122 475.0279 1799.3557 &gt;400 to &lt;800 GDM STOP 499.2135 58.79765 1122 396.2078 628.9984 &gt;=800 GDM STOP 686.5375 53.35135 1122 589.4478 799.6192 55.6.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 0.87 (0.68, 1.11) 0.3 GDM / (non-GDM) STOP 1.03 (0.79, 1.36) 0.8 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.02 (0.87, 1.20) 0.8 STOP / SCOPE GDM 1.21 (0.88, 1.68) 0.2 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.20 (0.79, 1.82) 0.7 &gt;400 to &lt;800 / None non-GDM 1.44 (1.21, 1.70) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.19 (0.80, 1.79) 0.7 &gt;=800 / None non-GDM 1.45 (1.24, 1.70) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 1.21 (0.81, 1.80) 0.6 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.01 (0.90, 1.14) 1.0 &lt;=400 / None GDM 1.27 (0.59, 2.71) 0.8 &gt;400 to &lt;800 / None GDM 1.27 (0.74, 2.15) 0.7 &gt;400 to &lt;800 / &lt;=400 GDM 1.00 (0.50, 1.97) 1.0 &gt;=800 / None GDM 1.60 (0.96, 2.67) 0.09 &gt;=800 / &lt;=400 GDM 1.26 (0.65, 2.45) 0.8 &gt;=800 / &gt;400 to &lt;800 GDM 1.26 (0.85, 1.87) 0.4 "],["age-groups-5.html", "56 Age groups", " 56 Age groups Descriptives with univariate P-values. Within non-GDM Characteristic &lt;35 yrs (n=2025) &gt;=35 yrs (n=63) Total (n=2088) P-value PRL (ng/ml): Median (IQ range) 102.7 (60.5-169.3) 88.3 (49.1-155.7) 101.8 (60.0-169.0) 0.17 hPL (μg/ml): Median (IQ range) 120.6 (56.7-181.7) 86.8 (53.4-157.2) 117.7 (56.6-181.2) 0.12 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.3) 2.2 (1.2-3.8) 2.7 (1.3-4.3) 0.33 Within GDM Characteristic &lt;35 yrs (n=226) &gt;=35 yrs (n=25) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 76.7 (45.6-121.8) 59.4 (42.7-110.7) 73.3 (45.3-120.9) 0.31 hPL (μg/ml): Median (IQ range) 66.2 (41.0-99.9) 35.4 (24.5-66.5) 61.4 (37.6-98.5) 0.006 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.2 (1.0-1.8) 1.5 (1.0-2.6) 0.41 Click here for table within SCOPE Within non-GDM Characteristic &lt;35 yrs (n=1041) &gt;=35 yrs (n=25) Total (n=1066) P-value PRL (ng/ml): Median (IQ range) 140.9 (92.6-222.8) 166.9 (95.6-295.5) 141.2 (92.6-223.7) 0.43 hPL (μg/ml): Median (IQ range) 180.8 (149.9-217.6) 163.8 (133.3-208.1) 180.6 (149.6-216.9) 0.25 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.7) 4.4 (3.5-6.4) 4.2 (3.2-5.7) 0.47 Serum folate concentration (nM): Median (IQ range) 35.8 (27.9-42.5) 40.8 (35.1-48.1) 36.0 (28.2-42.6) 0.02 B12 concentration (pM): Median (IQ range) 243.0 (194.0-307.8) 268.5 (225.8-366.0) 244.0 (194.8-309.0) 0.09 Folate:B12 ratio: Median (IQ range) 142.7 (102.0-208.9) 164.5 (119.9-200.8) 143.0 (102.7-208.7) 0.28 Active B12 concentration (pM): Median (IQ range) 56.0 (43.0-73.0) 61.0 (44.2-94.2) 56.0 (43.0-73.0) 0.41 Folate:Active B12 ratio: Median (IQ range) 615.6 (438.5-902.6) 751.7 (415.2-945.0) 615.8 (438.3-903.7) 0.62 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.5 (3.9-4.7) 4.4 (3.8-5.0) 0.97 Within GDM Characteristic &lt;35 yrs (n=56) &gt;=35 yrs (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 92.0 (66.0-164.6) 25.7 (14.6-36.7) 92.0 (62.0-147.2) 0.01 hPL (μg/ml): Median (IQ range) 106.6 (91.4-134.3) 36.0 (36.0-36.0) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.2) 1.8 (1.8-1.8) 2.7 (1.6-4.2) 0.69 Serum folate concentration (nM): Median (IQ range) 38.8 (31.7-43.8) 86.0 (63.5-108.6) 40.1 (32.0-43.8) 0.23 B12 concentration (pM): Median (IQ range) 254.5 (194.8-335.0) 205.0 (200.0-210.0) 253.5 (194.2-333.0) 0.31 Folate:B12 ratio: Median (IQ range) 152.8 (114.2-196.8) 410.0 (309.9-510.1) 158.9 (116.5-210.2) 0.11 Active B12 concentration (pM): Median (IQ range) 68.0 (55.0-85.5) 67.5 (50.8-84.2) 68.0 (55.0-86.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 553.8 (431.4-648.6) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) 0.65 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 4.1 (3.5-4.7) 3.9 (3.6-4.6) 0.94 Click here for table within STOP Within non-GDM Characteristic &lt;35 yrs (n=984) &gt;=35 yrs (n=38) Total (n=1022) P-value PRL (ng/ml): Median (IQ range) 75.2 (49.5-119.3) 64.1 (43.6-100.6) 75.0 (49.4-118.7) 0.22 hPL (μg/ml): Median (IQ range) 60.4 (40.4-93.1) 61.2 (41.0-90.1) 60.5 (40.5-93.0) 0.78 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.5 (1.0-2.3) 1.4 (0.9-2.4) 0.69 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-45.1) 44.0 (40.2-97.7) 40.5 (36.4-45.3) 0.001 B12 concentration (pM): Median (IQ range) 280.0 (219.0-357.0) 267.5 (205.2-363.0) 280.0 (218.0-359.0) 0.59 Folate:B12 ratio: Median (IQ range) 152.4 (114.8-218.3) 195.5 (144.0-308.4) 152.8 (115.0-219.2) 0.003 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-84.0) 67.0 (54.0-99.0) 63.0 (49.0-84.0) 0.74 Folate:Active B12 ratio: Median (IQ range) 657.8 (472.3-940.0) 737.0 (482.1-960.5) 659.1 (472.4-943.8) 0.72 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 5.0 (4.3-5.9) 4.8 (4.2-5.6) 0.30 Within GDM Characteristic &lt;35 yrs (n=170) &gt;=35 yrs (n=23) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 73.0 (42.6-114.0) 62.6 (43.5-114.4) 68.8 (42.6-114.0) 0.83 hPL (μg/ml): Median (IQ range) 59.4 (37.8-85.3) 34.8 (24.4-67.2) 57.0 (35.8-84.1) 0.03 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.1 (1.0-2.0) 1.3 (0.9-2.2) 0.67 Serum folate concentration (nM): Median (IQ range) 39.7 (35.0-44.5) 43.7 (39.1-64.9) 40.2 (35.4-45.1) 0.04 B12 concentration (pM): Median (IQ range) 272.0 (220.5-346.5) 298.0 (190.5-381.5) 273.5 (216.8-352.0) 0.90 Folate:B12 ratio: Median (IQ range) 147.7 (112.4-206.3) 169.4 (97.5-284.9) 148.0 (111.3-220.6) 0.56 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-91.0) 74.0 (62.0-78.0) 74.5 (56.2-90.2) 0.77 Folate:Active B12 ratio: Median (IQ range) 521.2 (419.2-757.8) 836.9 (594.2-1038.7) 531.9 (419.6-786.4) 0.05 Homocysteine concentration (μM): Median (IQ range) 4.7 (4.0-5.4) 4.8 (4.5-5.2) 4.8 (4.0-5.3) 0.91 "],["prolactin-35.html", "56.1 Prolactin", " 56.1 Prolactin LME for repeated measures. 56.1.1 Model summary Var Effect P (Intercept) 14.83 (10.39, 21.16) &lt;0.0001 Age_gp&gt;=35 yrs 1.05 (0.78, 1.41) 0.75 f39_gdm_newGDM 1.00 (0.81, 1.23) 0.98 StudySTOP 0.99 (0.89, 1.10) 0.87 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.82 (0.57, 1.18) 0.28 f39_gdm_newGDM:StudySTOP 1.08 (0.86, 1.36) 0.50 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.45 (0.20, 1.01) 0.05 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 2.42 (1.00, 5.88) 0.05 56.1.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 97.40 7.29 86.32 83.94 113.02 &gt;=35 yrs SCOPE non-GDM 102.19 16.88 1206.96 73.90 141.30 &lt;35 yrs STOP non-GDM 96.53 6.91 72.56 83.70 111.34 &gt;=35 yrs STOP non-GDM 82.93 10.44 590.30 64.77 106.19 &lt;35 yrs SCOPE GDM 97.10 12.20 560.59 75.86 124.27 &gt;=35 yrs SCOPE GDM 45.60 17.40 685.28 21.56 96.45 &lt;35 yrs STOP GDM 104.13 9.11 157.60 87.60 123.77 &gt;=35 yrs STOP GDM 97.06 14.73 997.72 72.06 130.74 56.1.3 Post-hoc comparisons 56.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 1.05 (0.78, 1.41) 0.8 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.86 (0.69, 1.06) 0.2 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.47 (0.22, 1.01) 0.05 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.93 (0.71, 1.23) 0.6 56.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.6253865 0.7346368 998.5641 0.6695246 3.945906 0.283 ns STOP/SCOPE (non-GDM) 0.8189002 0.1523983 2105.8011 0.5684997 1.179592 0.283 ns STOP/SCOPE (GDM) 1.9848407 0.8180936 793.3438 0.8837900 4.457612 0.097 ns GDM/non-GDM (SCOPE) 0.4476243 0.1865460 833.6319 0.1975433 1.014297 0.054 ns GDM/non-GDM (STOP) 1.0849465 0.1938309 2116.7011 0.7642758 1.540163 0.648 ns "],["hpl-35.html", "56.2 HPL", " 56.2 HPL LME for repeated measures. 56.2.1 Model summary Var Effect P (Intercept) 1.88 (1.57, 2.27) &lt;0.0001 Age_gp&gt;=35 yrs 0.98 (0.83, 1.15) 0.79 f39_gdm_newGDM 0.95 (0.86, 1.05) 0.30 StudySTOP 1.11 (1.04, 1.17) 0.0007 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.00 (0.82, 1.22) 0.97 f39_gdm_newGDM:StudySTOP 1.09 (0.97, 1.23) 0.14 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.92 (0.60, 1.39) 0.68 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 0.80 (0.50, 1.27) 0.34 56.2.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 89.70 2.38 154.18 85.11 94.53 &gt;=35 yrs SCOPE non-GDM 87.76 7.35 2040.60 74.46 103.43 &lt;35 yrs STOP non-GDM 99.14 2.42 112.11 94.45 104.06 &gt;=35 yrs STOP non-GDM 97.39 5.98 1637.72 86.33 109.86 &lt;35 yrs SCOPE GDM 85.00 4.65 858.56 76.35 94.62 &gt;=35 yrs SCOPE GDM 76.12 14.79 648.26 51.98 111.46 &lt;35 yrs STOP GDM 102.57 3.79 453.82 95.39 110.29 &gt;=35 yrs STOP GDM 73.77 5.63 1874.24 63.52 85.67 56.2.3 Post-hoc comparisons 56.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 0.98 (0.83, 1.15) 0.8 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.98 (0.88, 1.10) 0.8 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.90 (0.61, 1.32) 0.6 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.72 (0.62, 0.84) &lt;0.0001 56.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8063952 0.1895487 949.1484 0.5084072 1.2790399 0.360 ns STOP/SCOPE (non-GDM) 1.0040957 0.1010267 2108.9528 0.8242949 1.2231160 0.968 ns STOP/SCOPE (GDM) 0.8031059 0.1707830 756.0476 0.5290198 1.2191964 0.303 ns GDM/non-GDM (SCOPE) 0.9153488 0.1968573 788.3701 0.6001276 1.3961423 0.681 ns GDM/non-GDM (STOP) 0.7321234 0.0711459 2082.0710 0.6050881 0.8858293 0.001 ** "],["gh2-35.html", "56.3 GH2", " 56.3 GH2 LME for repeated measures. 56.3.1 Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 Age_gp&gt;=35 yrs 1.13 (0.91, 1.42) 0.27 f39_gdm_newGDM 0.90 (0.77, 1.05) 0.17 StudySTOP 0.98 (0.91, 1.07) 0.70 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.81 (0.61, 1.06) 0.13 f39_gdm_newGDM:StudySTOP 1.11 (0.94, 1.32) 0.22 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.72 (0.38, 1.35) 0.31 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 1.72 (0.87, 3.44) 0.12 56.3.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 2.35 0.07 378.65 2.23 2.49 &gt;=35 yrs SCOPE non-GDM 2.67 0.31 2192.55 2.13 3.35 &lt;35 yrs STOP non-GDM 2.32 0.06 250.81 2.21 2.43 &gt;=35 yrs STOP non-GDM 2.13 0.17 2126.29 1.82 2.49 &lt;35 yrs SCOPE GDM 2.12 0.16 1465.24 1.82 2.47 &gt;=35 yrs SCOPE GDM 1.72 0.51 999.06 0.96 3.08 &lt;35 yrs STOP GDM 2.32 0.10 846.98 2.13 2.53 &gt;=35 yrs STOP GDM 2.63 0.27 2157.34 2.15 3.23 56.3.3 Post-hoc comparisons 56.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 1.13 (0.91, 1.42) 0.3 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.92 (0.78, 1.07) 0.3 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.81 (0.45, 1.48) 0.5 &gt;=35 yrs / &lt;35 yrs STOP GDM 1.13 (0.92, 1.40) 0.2 56.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.1288592 0.3964907 1325.781 0.5667584 2.248442 0.730 ns STOP/SCOPE (non-GDM) 0.8090921 0.1134388 2183.237 0.6145949 1.065141 0.131 ns STOP/SCOPE (GDM) 1.3952172 0.4495025 1141.989 0.7415082 2.625232 0.301 ns GDM/non-GDM (SCOPE) 0.7169765 0.2331042 1169.140 0.3788563 1.356861 0.306 ns GDM/non-GDM (STOP) 1.2363710 0.1660310 2179.059 0.9501197 1.608864 0.114 ns "],["insulin-33.html", "56.4 Insulin", " 56.4 Insulin GEE for repeated measures. 56.4.1 Model summary Var Effect P (Intercept) 10.51 (6.67, 16.55) &lt;0.0001 Age_gp&gt;=35 yrs 1.29 (0.92, 1.82) 0.14 f39_gdm_newGDM 2.12 (1.55, 2.89) &lt;0.0001 StudySTOP 0.81 (0.70, 0.94) 0.005 GA_samp 1.02 (0.99, 1.05) 0.16 Age_gp&gt;=35 yrs:StudySTOP 0.63 (0.42, 0.95) 0.03 f39_gdm_newGDM:StudySTOP 0.81 (0.57, 1.15) 0.23 Age_gp&gt;=35 yrs:f39_gdm_newGDM 1.06 (0.52, 2.20) 0.87 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 0.97 (0.42, 2.21) 0.94 56.4.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 13.84 0.68 Inf 12.56 15.24 &gt;=35 yrs SCOPE non-GDM 17.88 3.13 Inf 12.69 25.20 &lt;35 yrs STOP non-GDM 11.18 0.43 Inf 10.37 12.05 &gt;=35 yrs STOP non-GDM 9.12 1.04 Inf 7.29 11.41 &lt;35 yrs SCOPE GDM 29.31 4.67 Inf 21.45 40.05 &gt;=35 yrs SCOPE GDM 40.32 11.59 Inf 22.96 70.82 &lt;35 yrs STOP GDM 19.10 1.56 Inf 16.28 22.40 &gt;=35 yrs STOP GDM 16.06 2.43 Inf 11.94 21.61 56.4.3 Post-hoc comparisons 56.4.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 1.29 (0.92, 1.82) 0.1 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.82 (0.65, 1.03) 0.08 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 1.38 (0.73, 2.60) 0.3 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.84 (0.61, 1.17) 0.3 56.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.3858962 0.1630392 Inf 0.1685940 0.8832812 0.024 * STOP/SCOPE (non-GDM) 0.6312142 0.1333451 Inf 0.4172140 0.9549806 0.029 * STOP/SCOPE (GDM) 0.6113554 0.2235309 Inf 0.2985847 1.2517570 0.178 ns GDM/non-GDM (SCOPE) 1.0645753 0.3937458 Inf 0.5156434 2.1978768 0.866 ns GDM/non-GDM (STOP) 1.0310826 0.2105755 Inf 0.6909627 1.5386232 0.881 ns "],["homa-ir-33.html", "56.5 HOMA-IR", " 56.5 HOMA-IR GEE for repeated measures. 56.5.1 Model summary Var Effect P (Intercept) 2.66 (1.65, 4.29) &lt;0.0001 Age_gp&gt;=35 yrs 1.42 (0.97, 2.06) 0.07 f39_gdm_newGDM 2.31 (1.63, 3.28) &lt;0.0001 StudySTOP 0.70 (0.60, 0.81) &lt;0.0001 GA_samp 1.02 (0.99, 1.05) 0.26 Age_gp&gt;=35 yrs:StudySTOP 0.57 (0.36, 0.88) 0.01 f39_gdm_newGDM:StudySTOP 0.77 (0.52, 1.13) 0.18 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.95 (0.44, 2.03) 0.88 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 1.11 (0.46, 2.64) 0.82 56.5.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 3.34 0.17 Inf 3.02 3.70 &gt;=35 yrs SCOPE non-GDM 4.74 0.90 Inf 3.26 6.89 &lt;35 yrs STOP non-GDM 2.33 0.09 Inf 2.15 2.52 &gt;=35 yrs STOP non-GDM 1.87 0.23 Inf 1.48 2.37 &lt;35 yrs SCOPE GDM 7.72 1.37 Inf 5.45 10.94 &gt;=35 yrs SCOPE GDM 10.34 3.04 Inf 5.81 18.38 &lt;35 yrs STOP GDM 4.12 0.36 Inf 3.47 4.90 &gt;=35 yrs STOP GDM 3.46 0.53 Inf 2.56 4.67 56.5.3 Post-hoc comparisons 56.5.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 1.42 (0.97, 2.06) 0.07 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.80 (0.63, 1.02) 0.07 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 1.34 (0.69, 2.61) 0.4 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.84 (0.60, 1.18) 0.3 56.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.3549995 0.1575795 Inf 0.1487274 0.8473534 0.020 * STOP/SCOPE (non-GDM) 0.5660355 0.1289029 Inf 0.3622431 0.8844783 0.012 * STOP/SCOPE (GDM) 0.6271683 0.2388607 Inf 0.2973029 1.3230282 0.221 ns GDM/non-GDM (SCOPE) 0.9450219 0.3691058 Inf 0.4395217 2.0319051 0.885 ns GDM/non-GDM (STOP) 1.0470859 0.2212622 Inf 0.6920109 1.5843522 0.828 ns "],["glucose-33.html", "56.6 Glucose", " 56.6 Glucose GEE for repeated measures. 56.6.1 Model summary Var Effect P (Intercept) 5.56 (5.07, 6.10) &lt;0.0001 Age_gp&gt;=35 yrs 1.05 (0.97, 1.14) 0.19 f39_gdm_newGDM 1.11 (0.99, 1.24) 0.06 StudySTOP 0.87 (0.85, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.54 Age_gp&gt;=35 yrs:StudySTOP 0.94 (0.86, 1.02) 0.12 f39_gdm_newGDM:StudySTOP 0.93 (0.84, 1.05) 0.24 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.92 (0.80, 1.05) 0.20 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 1.09 (0.94, 1.25) 0.26 56.6.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 5.42 0.05 Inf 5.33 5.52 &gt;=35 yrs SCOPE non-GDM 5.71 0.22 Inf 5.28 6.17 &lt;35 yrs STOP non-GDM 4.71 0.04 Inf 4.64 4.79 &gt;=35 yrs STOP non-GDM 4.65 0.06 Inf 4.53 4.77 &lt;35 yrs SCOPE GDM 6.02 0.32 Inf 5.42 6.68 &gt;=35 yrs SCOPE GDM 5.81 0.06 Inf 5.68 5.93 &lt;35 yrs STOP GDM 4.89 0.07 Inf 4.76 5.02 &gt;=35 yrs STOP GDM 4.80 0.09 Inf 4.63 4.97 56.6.3 Post-hoc comparisons 56.6.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 1.05 (0.97, 1.14) 0.2 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.99 (0.96, 1.01) 0.3 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.97 (0.87, 1.07) 0.5 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.98 (0.94, 1.02) 0.4 56.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9522598 0.0684502 Inf 0.8271217 1.096330 0.496 ns STOP/SCOPE (non-GDM) 0.9367402 0.0393841 Inf 0.8626435 1.017201 0.120 ns STOP/SCOPE (GDM) 1.0165677 0.0595814 Inf 0.9062479 1.140317 0.779 ns GDM/non-GDM (SCOPE) 0.9166381 0.0619673 Inf 0.8028869 1.046505 0.198 ns GDM/non-GDM (STOP) 0.9947525 0.0254572 Inf 0.9460881 1.045920 0.837 ns "],["bmi-groups-5.html", "57 BMI groups", " 57 BMI groups Descriptives with univariate P-values. Within non-GDM Characteristic Underweight (n=55) Normal (n=877) Overweight (n=597) Obese (n=559) Total (n=2088) P-value PRL (ng/ml): Median (IQ range) 112.4 (72.9-216.6) 105.8 (63.6-170.5) 103.2 (61.0-181.1) 94.2 (52.6-151.0) 101.8 (60.0-169.0) 0.009 hPL (μg/ml): Median (IQ range) 164.7 (90.3-220.8) 132.5 (62.8-199.0) 117.9 (56.0-174.7) 93.4 (45.6-154.4) 117.7 (56.6-181.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.3 (2.8-6.2) 3.1 (1.4-4.9) 2.6 (1.2-4.0) 2.4 (1.1-3.4) 2.7 (1.3-4.3) &lt;0.0001 Within GDM Characteristic Underweight (n=3) Normal (n=65) Overweight (n=51) Obese (n=132) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 92.0 (51.9-158.9) 77.0 (35.9-111.0) 66.0 (45.0-108.6) 73.3 (45.3-120.9) 0.03 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 87.0 (53.6-115.5) 79.6 (45.6-99.8) 50.2 (34.6-76.8) 61.4 (37.6-98.5) 0.0004 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.7 (1.1-2.9) 1.4 (0.9-2.9) 1.3 (1.0-2.3) 1.5 (1.0-2.6) 0.34 Click here for table within SCOPE Within non-GDM Characteristic Underweight (n=34) Normal (n=453) Overweight (n=300) Obese (n=279) Total (n=1066) P-value PRL (ng/ml): Median (IQ range) 168.8 (90.4-271.0) 142.3 (96.5-221.2) 148.2 (97.1-237.7) 133.2 (82.4-211.1) 141.2 (92.6-223.7) 0.10 hPL (μg/ml): Median (IQ range) 213.7 (167.4-258.0) 198.6 (169.6-229.4) 172.7 (148.8-208.6) 157.3 (130.7-188.0) 180.6 (149.6-216.9) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 5.1 (4.3-6.5) 4.8 (3.6-6.5) 4.0 (3.1-5.4) 3.4 (2.7-4.4) 4.2 (3.2-5.7) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 29.3 (22.4-38.1) 36.2 (29.1-43.3) 35.8 (29.4-41.1) 35.8 (25.6-43.1) 36.0 (28.2-42.6) 0.11 B12 concentration (pM): Median (IQ range) 269.0 (207.5-330.5) 252.0 (196.5-320.0) 241.5 (199.0-309.0) 230.0 (185.0-290.8) 244.0 (194.8-309.0) 0.006 Folate:B12 ratio: Median (IQ range) 115.9 (74.5-201.5) 141.6 (102.7-206.4) 143.4 (106.6-199.0) 147.0 (102.3-219.7) 143.0 (102.7-208.7) 0.35 Active B12 concentration (pM): Median (IQ range) 52.5 (39.5-71.5) 54.0 (41.8-71.0) 56.0 (44.0-72.0) 61.0 (45.0-75.0) 56.0 (43.0-73.0) 0.14 Folate:Active B12 ratio: Median (IQ range) 613.6 (414.7-845.3) 651.3 (458.7-986.3) 618.9 (468.6-895.6) 537.9 (392.2-819.8) 615.8 (438.3-903.7) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.2-5.3) 4.4 (3.9-5.2) 4.3 (3.7-4.8) 4.4 (3.8-5.1) 4.4 (3.8-5.0) 0.01 Within GDM Characteristic Underweight (n=0) Normal (n=14) Overweight (n=13) Obese (n=31) Total (n=58) P-value PRL (ng/ml): Median (IQ range) NA (NA-NA) 119.0 (86.9-144.9) 133.7 (87.4-214.9) 66.0 (55.9-111.0) 92.0 (62.0-147.2) hPL (μg/ml): Median (IQ range) NA (NA-NA) 106.6 (100.2-178.0) 98.8 (91.4-114.2) 106.6 (80.8-133.7) 106.2 (85.6-134.2) GH2 (ng/ml): Median (IQ range) NA (NA-NA) 2.6 (1.9-3.9) 4.2 (3.2-5.6) 1.9 (1.5-3.0) 2.7 (1.6-4.2) Serum folate concentration (nM): Median (IQ range) NA (NA-NA) 43.6 (39.0-44.6) 36.9 (31.7-45.9) 39.6 (31.5-43.0) 40.1 (32.0-43.8) B12 concentration (pM): Median (IQ range) NA (NA-NA) 289.0 (170.5-372.5) 263.5 (224.2-309.8) 240.0 (192.0-301.0) 253.5 (194.2-333.0) Folate:B12 ratio: Median (IQ range) NA (NA-NA) 155.4 (114.2-232.5) 145.1 (121.9-190.5) 169.4 (118.7-199.0) 158.9 (116.5-210.2) Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 83.5 (66.2-99.2) 58.5 (54.5-77.0) 77.0 (53.0-85.0) 68.0 (55.0-86.0) Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 553.9 (377.4-674.3) 535.8 (321.6-763.8) 553.8 (516.5-577.4) 553.8 (424.7-660.3) Homocysteine concentration (μM): Median (IQ range) NA (NA-NA) 4.3 (3.9-5.1) 4.0 (3.5-4.6) 3.7 (3.5-4.3) 3.9 (3.6-4.6) Click here for table within STOP Within non-GDM Characteristic Underweight (n=21) Normal (n=424) Overweight (n=297) Obese (n=280) Total (n=1022) P-value PRL (ng/ml): Median (IQ range) 91.8 (50.0-112.4) 76.4 (51.1-122.1) 75.2 (52.2-115.3) 69.3 (45.6-113.5) 75.0 (49.4-118.7) 0.21 hPL (μg/ml): Median (IQ range) 87.7 (64.9-139.2) 66.3 (44.7-105.0) 60.5 (41.8-96.2) 50.4 (33.6-72.2) 60.5 (40.5-93.0) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.5 (1.5-4.0) 1.5 (0.9-2.5) 1.4 (0.8-2.2) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.0001 Serum folate concentration (nM): Median (IQ range) 34.2 (29.1-40.0) 40.8 (36.9-54.0) 40.5 (36.3-45.1) 40.2 (36.0-45.3) 40.5 (36.4-45.3) 0.0010 B12 concentration (pM): Median (IQ range) 340.0 (207.0-412.0) 293.0 (227.8-376.2) 282.5 (219.0-354.2) 259.0 (205.5-325.0) 280.0 (218.0-359.0) 0.0001 Folate:B12 ratio: Median (IQ range) 106.3 (69.0-161.8) 153.2 (110.0-222.1) 147.1 (116.2-214.5) 168.3 (122.8-231.7) 152.8 (115.0-219.2) 0.004 Active B12 concentration (pM): Median (IQ range) 48.0 (40.0-50.0) 65.0 (47.0-84.0) 62.0 (47.0-83.0) 64.0 (52.0-87.0) 63.0 (49.0-84.0) 0.30 Folate:Active B12 ratio: Median (IQ range) 711.3 (619.0-840.3) 663.1 (488.1-962.7) 670.3 (452.3-973.9) 628.1 (468.2-867.0) 659.1 (472.4-943.8) 0.62 Homocysteine concentration (μM): Median (IQ range) 5.4 (4.7-6.0) 4.9 (4.2-5.6) 4.8 (4.3-5.5) 4.8 (4.2-5.7) 4.8 (4.2-5.6) 0.09 Within GDM Characteristic Underweight (n=3) Normal (n=51) Overweight (n=38) Obese (n=101) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 86.0 (50.3-158.9) 68.8 (33.6-110.6) 66.6 (43.3-107.8) 68.8 (42.6-114.0) 0.07 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 69.0 (51.5-110.6) 68.0 (40.0-94.5) 47.1 (32.5-66.9) 57.0 (35.8-84.1) 0.0004 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.7 (1.1-2.2) 1.2 (0.8-2.5) 1.3 (0.9-2.2) 1.3 (0.9-2.2) 0.25 Serum folate concentration (nM): Median (IQ range) 42.7 (41.5-42.9) 41.3 (36.8-54.0) 40.7 (36.7-56.8) 39.2 (34.4-43.8) 40.2 (35.4-45.1) 0.24 B12 concentration (pM): Median (IQ range) 345.0 (307.0-492.5) 292.0 (237.0-348.8) 257.0 (189.0-360.0) 269.5 (215.4-338.0) 273.5 (216.8-352.0) 0.23 Folate:B12 ratio: Median (IQ range) 117.1 (91.9-138.7) 136.4 (109.7-197.4) 164.8 (114.1-265.0) 149.2 (111.7-217.8) 148.0 (111.3-220.6) 0.57 Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 68.0 (55.0-79.0) 67.0 (48.0-95.8) 78.0 (61.0-91.0) 74.5 (56.2-90.2) Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 521.2 (457.3-770.2) 785.3 (497.1-883.3) 512.7 (410.8-645.7) 531.9 (419.6-786.4) Homocysteine concentration (μM): Median (IQ range) 4.5 (4.0-4.5) 4.7 (4.0-5.4) 4.8 (4.0-5.7) 4.8 (4.0-5.2) 4.8 (4.0-5.3) 0.65 "],["prolactin-36.html", "57.1 Prolactin", " 57.1 Prolactin LME for duplicated or repeated measures. 57.1.1 Model summary Var Effect P (Intercept) 16.53 (10.71, 25.51) &lt;0.0001 BMI_gp3Normal 0.93 (0.72, 1.21) 0.61 BMI_gp3Overweight 0.98 (0.75, 1.27) 0.86 BMI_gp3Obese 0.83 (0.64, 1.08) 0.17 f39_gdm_newGDM 0.63 (0.27, 1.45) 0.28 StudySTOP 1.00 (0.68, 1.47) 1.00 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.98 (0.66, 1.43) 0.90 BMI_gp3Overweight:StudySTOP 0.98 (0.67, 1.45) 0.94 BMI_gp3Obese:StudySTOP 0.97 (0.66, 1.44) 0.89 f39_gdm_newGDM:StudySTOP 1.29 (0.95, 1.76) 0.11 BMI_gp3Normal:f39_gdm_newGDM 1.62 (0.65, 4.04) 0.31 BMI_gp3Overweight:f39_gdm_newGDM 1.97 (0.78, 4.97) 0.15 BMI_gp3Obese:f39_gdm_newGDM 1.32 (0.60, 2.90) 0.49 BMI_gp3Normal:f39_gdm_newGDM:StudySTOP 0.99 (0.58, 1.67) 0.96 BMI_gp3Overweight:f39_gdm_newGDM:StudySTOP 0.61 (0.35, 1.05) 0.08 57.1.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 106.83 15.64 925.75 80.15 142.40 Normal SCOPE non-GDM 99.80 7.86 107.45 85.38 116.67 Overweight SCOPE non-GDM 104.27 8.58 127.90 88.59 122.72 Obese SCOPE non-GDM 88.75 7.47 139.18 75.15 104.82 Underweight STOP non-GDM 106.76 16.80 1099.72 78.40 145.37 Normal STOP non-GDM 97.30 7.31 89.42 83.81 112.97 Overweight STOP non-GDM 102.53 8.00 103.52 87.84 119.68 Obese STOP non-GDM 86.38 6.82 108.76 73.86 101.02 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 101.12 20.98 1297.60 67.31 151.91 Overweight SCOPE GDM 129.03 27.70 1734.92 84.69 196.59 Obese SCOPE GDM 73.37 11.13 876.35 54.49 98.81 Underweight STOP GDM 86.52 32.72 1988.26 41.20 181.66 Normal STOP GDM 125.81 14.42 431.83 100.44 157.59 Overweight STOP GDM 99.63 12.50 585.06 77.87 127.46 Obese STOP GDM 92.28 8.93 234.74 76.27 111.66 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 57.1.3 Post-hoc comparisons 57.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 0.93 (0.67, 1.31) 1.0 Overweight / Underweight SCOPE non-GDM 0.98 (0.69, 1.38) 1.0 Overweight / Normal SCOPE non-GDM 1.04 (0.91, 1.20) 0.8 Obese / Underweight SCOPE non-GDM 0.83 (0.59, 1.18) 0.5 Obese / Normal SCOPE non-GDM 0.89 (0.77, 1.03) 0.2 Obese / Overweight SCOPE non-GDM 0.85 (0.73, 1.00) 0.04 Normal / Underweight STOP non-GDM 0.91 (0.63, 1.32) 0.9 Overweight / Underweight STOP non-GDM 0.96 (0.66, 1.40) 1.0 Overweight / Normal STOP non-GDM 1.05 (0.93, 1.20) 0.7 Obese / Underweight STOP non-GDM 0.81 (0.55, 1.18) 0.5 Obese / Normal STOP non-GDM 0.89 (0.78, 1.01) 0.10 Obese / Overweight STOP non-GDM 0.84 (0.73, 0.97) 0.010 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 1.28 (0.62, 2.61) 0.8 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.73 (0.40, 1.33) 0.5 Obese / Overweight SCOPE GDM 0.57 (0.31, 1.05) 0.08 Normal / Underweight STOP GDM 1.45 (0.54, 3.88) 0.8 Overweight / Underweight STOP GDM 1.15 (0.43, 3.10) 1.0 Overweight / Normal STOP GDM 0.79 (0.56, 1.12) 0.3 Obese / Underweight STOP GDM 1.07 (0.41, 2.81) 1.0 Obese / Normal STOP GDM 0.73 (0.55, 0.97) 0.03 Obese / Overweight STOP GDM 0.93 (0.68, 1.26) 0.9 57.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8421869 0.1793135 2097.931 0.5547164 1.278633 0.420 ns STOP/SCOPE (non-GDM) 0.9756292 0.1921145 2103.486 0.6630942 1.435471 0.900 ns STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/non-GDM (SCOPE) NA NA NA NA NA NA GDM/non-GDM (STOP) 1.5954904 0.6521256 1987.436 0.7157645 3.556462 0.253 ns "],["hpl-36.html", "57.2 HPL", " 57.2 HPL LME for duplicated or repeated measures. 57.2.1 Model summary Var Effect P (Intercept) 2.08 (1.67, 2.60) &lt;0.0001 BMI_gp3Normal 1.03 (0.90, 1.17) 0.71 BMI_gp3Overweight 0.95 (0.83, 1.09) 0.50 BMI_gp3Obese 0.81 (0.71, 0.93) 0.003 f39_gdm_newGDM 0.99 (0.64, 1.53) 0.95 StudySTOP 1.44 (1.18, 1.76) 0.0003 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.76 (0.63, 0.93) 0.008 BMI_gp3Overweight:StudySTOP 0.75 (0.62, 0.92) 0.006 BMI_gp3Obese:StudySTOP 0.72 (0.59, 0.88) 0.001 f39_gdm_newGDM:StudySTOP 1.03 (0.89, 1.20) 0.70 BMI_gp3Normal:f39_gdm_newGDM 0.94 (0.58, 1.50) 0.79 BMI_gp3Overweight:f39_gdm_newGDM 0.98 (0.62, 1.57) 0.94 BMI_gp3Obese:f39_gdm_newGDM 0.98 (0.65, 1.48) 0.92 BMI_gp3Normal:f39_gdm_newGDM:StudySTOP 1.14 (0.88, 1.47) 0.32 BMI_gp3Overweight:f39_gdm_newGDM:StudySTOP 1.03 (0.80, 1.34) 0.79 57.2.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 96.40 6.83 1897.02 83.89 110.77 Normal SCOPE non-GDM 98.88 2.89 233.03 93.35 104.73 Overweight SCOPE non-GDM 91.92 2.91 313.97 86.37 97.82 Obese SCOPE non-GDM 78.42 2.54 341.89 73.58 83.58 Underweight STOP non-GDM 139.11 10.57 1959.74 119.86 161.46 Normal STOP non-GDM 108.85 2.93 173.24 103.21 114.79 Overweight STOP non-GDM 100.05 2.90 228.03 94.50 105.93 Obese STOP non-GDM 81.29 2.43 252.39 76.64 86.23 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 91.40 8.78 1006.16 75.70 110.35 Overweight SCOPE GDM 89.12 7.96 1096.07 74.80 106.19 Obese SCOPE GDM 75.74 5.10 934.14 66.36 86.44 Underweight STOP GDM 141.34 27.96 2114.82 95.89 208.34 Normal STOP GDM 118.08 6.20 1236.41 106.52 130.90 Overweight STOP GDM 103.41 6.18 1552.14 91.96 116.27 Obese STOP GDM 80.88 3.39 714.35 74.49 87.82 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 57.2.3 Post-hoc comparisons 57.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 1.03 (0.86, 1.22) 1.0 Overweight / Underweight SCOPE non-GDM 0.95 (0.80, 1.14) 0.9 Overweight / Normal SCOPE non-GDM 0.93 (0.86, 1.00) 0.05 Obese / Underweight SCOPE non-GDM 0.81 (0.68, 0.98) 0.02 Obese / Normal SCOPE non-GDM 0.79 (0.74, 0.85) &lt;0.0001 Obese / Overweight SCOPE non-GDM 0.85 (0.79, 0.93) &lt;0.0001 Normal / Underweight STOP non-GDM 0.78 (0.65, 0.95) 0.006 Overweight / Underweight STOP non-GDM 0.72 (0.59, 0.87) &lt;0.0001 Overweight / Normal STOP non-GDM 0.92 (0.86, 0.98) 0.007 Obese / Underweight STOP non-GDM 0.58 (0.48, 0.71) &lt;0.0001 Obese / Normal STOP non-GDM 0.75 (0.70, 0.80) &lt;0.0001 Obese / Overweight STOP non-GDM 0.81 (0.75, 0.87) &lt;0.0001 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 0.98 (0.71, 1.35) 1.0 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.83 (0.62, 1.11) 0.3 Obese / Overweight SCOPE GDM 0.85 (0.65, 1.11) 0.4 Normal / Underweight STOP GDM 0.84 (0.50, 1.40) 0.8 Overweight / Underweight STOP GDM 0.73 (0.43, 1.23) 0.4 Overweight / Normal STOP GDM 0.88 (0.73, 1.05) 0.3 Obese / Underweight STOP GDM 0.57 (0.34, 0.95) 0.03 Obese / Normal STOP GDM 0.68 (0.59, 0.80) &lt;0.0001 Obese / Overweight STOP GDM 0.78 (0.66, 0.92) 0.0008 57.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8636854 0.0954578 2108.684 0.6953821 1.0727232 0.185 ns STOP/SCOPE (non-GDM) 0.7628355 0.0778376 2102.967 0.6244916 0.9318267 0.008 ** STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/non-GDM (SCOPE) NA NA NA NA NA NA GDM/non-GDM (STOP) 1.0677054 0.2299407 2097.823 0.6998921 1.6288151 0.761 ns "],["gh2-36.html", "57.3 GH2", " 57.3 GH2 LME for duplicated or repeated measures. 57.3.1 Model summary Var Effect P (Intercept) 0.09 (0.06, 0.12) &lt;0.0001 BMI_gp3Normal 1.00 (0.83, 1.21) 0.98 BMI_gp3Overweight 0.85 (0.70, 1.03) 0.11 BMI_gp3Obese 0.72 (0.59, 0.87) 0.0007 f39_gdm_newGDM 0.48 (0.26, 0.89) 0.02 StudySTOP 1.61 (1.21, 2.13) 0.0010 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.56 (0.43, 0.75) &lt;0.0001 BMI_gp3Overweight:StudySTOP 0.60 (0.45, 0.79) 0.0004 BMI_gp3Obese:StudySTOP 0.67 (0.50, 0.89) 0.006 f39_gdm_newGDM:StudySTOP 1.24 (0.99, 1.55) 0.06 BMI_gp3Normal:f39_gdm_newGDM 2.00 (1.02, 3.92) 0.04 BMI_gp3Overweight:f39_gdm_newGDM 2.27 (1.17, 4.43) 0.02 BMI_gp3Obese:f39_gdm_newGDM 1.80 (1.01, 3.21) 0.05 BMI_gp3Normal:f39_gdm_newGDM:StudySTOP 0.90 (0.61, 1.34) 0.61 BMI_gp3Overweight:f39_gdm_newGDM:StudySTOP 0.69 (0.47, 1.02) 0.06 57.3.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 2.71 0.26 2172.53 2.24 3.27 Normal SCOPE non-GDM 2.72 0.09 629.61 2.54 2.90 Overweight SCOPE non-GDM 2.31 0.09 887.67 2.14 2.49 Obese SCOPE non-GDM 1.94 0.08 962.58 1.80 2.10 Underweight STOP non-GDM 4.35 0.46 2173.84 3.54 5.35 Normal STOP non-GDM 2.46 0.07 473.61 2.32 2.61 Overweight STOP non-GDM 2.22 0.07 666.00 2.08 2.37 Obese STOP non-GDM 2.09 0.07 696.27 1.95 2.24 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 2.63 0.39 1731.90 1.97 3.52 Overweight SCOPE GDM 2.54 0.36 2086.21 1.93 3.35 Obese SCOPE GDM 1.69 0.16 1356.86 1.40 2.05 Underweight STOP GDM 2.61 0.71 2024.38 1.53 4.44 Normal STOP GDM 2.67 0.19 1823.51 2.33 3.06 Overweight STOP GDM 2.08 0.17 2006.16 1.78 2.43 Obese STOP GDM 2.26 0.12 1251.58 2.04 2.51 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 57.3.3 Post-hoc comparisons 57.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 1.00 (0.78, 1.28) 1.0 Overweight / Underweight SCOPE non-GDM 0.85 (0.66, 1.10) 0.4 Overweight / Normal SCOPE non-GDM 0.85 (0.77, 0.94) 0.0003 Obese / Underweight SCOPE non-GDM 0.72 (0.56, 0.92) 0.004 Obese / Normal SCOPE non-GDM 0.71 (0.64, 0.79) &lt;0.0001 Obese / Overweight SCOPE non-GDM 0.84 (0.75, 0.94) 0.0005 Normal / Underweight STOP non-GDM 0.57 (0.43, 0.74) &lt;0.0001 Overweight / Underweight STOP non-GDM 0.51 (0.39, 0.67) &lt;0.0001 Overweight / Normal STOP non-GDM 0.90 (0.82, 0.99) 0.02 Obese / Underweight STOP non-GDM 0.48 (0.36, 0.63) &lt;0.0001 Obese / Normal STOP non-GDM 0.85 (0.77, 0.94) &lt;0.0001 Obese / Overweight STOP non-GDM 0.94 (0.85, 1.05) 0.5 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 0.97 (0.58, 1.62) 1.0 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.64 (0.41, 1.01) 0.06 Obese / Overweight SCOPE GDM 0.67 (0.43, 1.02) 0.07 Normal / Underweight STOP GDM 1.02 (0.50, 2.09) 1.0 Overweight / Underweight STOP GDM 0.80 (0.39, 1.64) 0.9 Overweight / Normal STOP GDM 0.78 (0.60, 1.01) 0.07 Obese / Underweight STOP GDM 0.87 (0.43, 1.75) 1.0 Obese / Normal STOP GDM 0.85 (0.69, 1.05) 0.2 Obese / Overweight STOP GDM 1.09 (0.86, 1.37) 0.8 57.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.3981898 0.2169345 2167.606 1.031395 1.8954271 0.031 * STOP/SCOPE (non-GDM) 0.5639884 0.0810370 2168.126 0.425497 0.7475562 &lt;0.0001 *** STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/non-GDM (SCOPE) NA NA NA NA NA NA GDM/non-GDM (STOP) 1.8084067 0.5381465 2057.425 1.008895 3.2415011 0.047 * "],["insulin-34.html", "57.4 Insulin", " 57.4 Insulin GEE for repeated measures. 57.4.1 Model summary Var Effect P (Intercept) 6.24 (3.47, 11.24) &lt;0.0001 BMI_gp3Normal 1.21 (0.82, 1.79) 0.34 BMI_gp3Overweight 1.83 (1.23, 2.72) 0.003 BMI_gp3Obese 2.34 (1.58, 3.47) &lt;0.0001 f39_gdm_newGDM 1.85 (1.46, 2.36) &lt;0.0001 StudySTOP 0.83 (0.50, 1.37) 0.46 GA_samp 1.02 (1.00, 1.05) 0.09 BMI_gp3Normal:StudySTOP 0.96 (0.58, 1.59) 0.88 BMI_gp3Overweight:StudySTOP 0.87 (0.52, 1.44) 0.58 BMI_gp3Obese:StudySTOP 1.08 (0.65, 1.80) 0.76 f39_gdm_newGDM:StudySTOP 0.77 (0.58, 1.02) 0.07 57.4.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 8.62 1.69 Inf 5.87 12.66 Normal SCOPE non-GDM 10.44 0.66 Inf 9.21 11.83 Overweight SCOPE non-GDM 15.80 1.09 Inf 13.81 18.08 Obese SCOPE non-GDM 20.16 1.38 Inf 17.63 23.05 Underweight STOP non-GDM 7.12 1.14 Inf 5.19 9.75 Normal STOP non-GDM 8.29 0.39 Inf 7.55 9.10 Overweight STOP non-GDM 11.28 0.59 Inf 10.18 12.50 Obese STOP non-GDM 18.02 0.95 Inf 16.26 19.97 Underweight SCOPE GDM 15.99 3.69 Inf 10.17 25.14 Normal SCOPE GDM 19.35 2.58 Inf 14.90 25.13 Overweight SCOPE GDM 29.29 3.93 Inf 22.52 38.09 Obese SCOPE GDM 37.37 4.61 Inf 29.35 47.59 Underweight STOP GDM 10.19 1.76 Inf 7.26 14.31 Normal STOP GDM 11.86 0.97 Inf 10.10 13.94 Overweight STOP GDM 16.15 1.36 Inf 13.69 19.06 Obese STOP GDM 25.80 1.94 Inf 22.26 29.91 57.4.3 Post-hoc comparisons 57.4.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 1.21 (0.72, 2.02) 0.8 Overweight / Underweight SCOPE non-GDM 1.83 (1.09, 3.08) 0.01 Overweight / Normal SCOPE non-GDM 1.51 (1.23, 1.87) &lt;0.0001 Obese / Underweight SCOPE non-GDM 2.34 (1.39, 3.92) 0.0001 Obese / Normal SCOPE non-GDM 1.93 (1.58, 2.37) &lt;0.0001 Obese / Overweight SCOPE non-GDM 1.28 (1.03, 1.58) 0.02 Normal / Underweight STOP non-GDM 1.16 (0.77, 1.77) 0.8 Overweight / Underweight STOP non-GDM 1.59 (1.04, 2.42) 0.03 Overweight / Normal STOP non-GDM 1.36 (1.17, 1.58) &lt;0.0001 Obese / Underweight STOP non-GDM 2.53 (1.66, 3.86) &lt;0.0001 Obese / Normal STOP non-GDM 2.17 (1.87, 2.53) &lt;0.0001 Obese / Overweight STOP non-GDM 1.60 (1.36, 1.87) &lt;0.0001 Normal / Underweight SCOPE GDM 1.21 (0.72, 2.02) 0.8 Overweight / Underweight SCOPE GDM 1.83 (1.09, 3.08) 0.01 Overweight / Normal SCOPE GDM 1.51 (1.23, 1.87) &lt;0.0001 Obese / Underweight SCOPE GDM 2.34 (1.39, 3.92) 0.0001 Obese / Normal SCOPE GDM 1.93 (1.58, 2.37) &lt;0.0001 Obese / Overweight SCOPE GDM 1.28 (1.03, 1.58) 0.02 Normal / Underweight STOP GDM 1.16 (0.77, 1.77) 0.8 Overweight / Underweight STOP GDM 1.59 (1.04, 2.42) 0.03 Overweight / Normal STOP GDM 1.36 (1.17, 1.58) &lt;0.0001 Obese / Underweight STOP GDM 2.53 (1.66, 3.86) &lt;0.0001 Obese / Normal STOP GDM 2.17 (1.87, 2.53) &lt;0.0001 Obese / Overweight STOP GDM 1.60 (1.36, 1.87) &lt;0.0001 57.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.4462367 0.4019336 Inf 0.8388342 2.493461 0.184 ns STOP/SCOPE (non-GDM) 0.9621984 0.2479405 Inf 0.5806654 1.594422 0.881 ns STOP/SCOPE (GDM) 0.9621984 0.2479405 Inf 0.5806654 1.594422 0.881 ns GDM/non-GDM (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/non-GDM (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["homa-ir-34.html", "57.5 HOMA-IR", " 57.5 HOMA-IR GEE for repeated measures. 57.5.1 Model summary Var Effect P (Intercept) 1.55 (0.84, 2.84) 0.16 BMI_gp3Normal 1.23 (0.83, 1.82) 0.31 BMI_gp3Overweight 1.86 (1.25, 2.77) 0.002 BMI_gp3Obese 2.40 (1.61, 3.57) &lt;0.0001 f39_gdm_newGDM 2.02 (1.52, 2.67) &lt;0.0001 StudySTOP 0.69 (0.42, 1.15) 0.15 GA_samp 1.02 (0.99, 1.05) 0.16 BMI_gp3Normal:StudySTOP 0.98 (0.59, 1.62) 0.92 BMI_gp3Overweight:StudySTOP 0.89 (0.53, 1.49) 0.66 BMI_gp3Obese:StudySTOP 1.14 (0.68, 1.90) 0.62 f39_gdm_newGDM:StudySTOP 0.73 (0.53, 1.00) 0.05 57.5.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 2.05 0.40 Inf 1.40 3.01 Normal SCOPE non-GDM 2.52 0.17 Inf 2.20 2.87 Overweight SCOPE non-GDM 3.81 0.28 Inf 3.30 4.41 Obese SCOPE non-GDM 4.91 0.36 Inf 4.25 5.68 Underweight STOP non-GDM 1.42 0.23 Inf 1.03 1.95 Normal STOP non-GDM 1.70 0.08 Inf 1.54 1.87 Overweight STOP non-GDM 2.35 0.13 Inf 2.11 2.62 Obese STOP non-GDM 3.87 0.22 Inf 3.47 4.31 Underweight SCOPE GDM 4.14 1.00 Inf 2.57 6.65 Normal SCOPE GDM 5.08 0.78 Inf 3.77 6.85 Overweight SCOPE GDM 7.69 1.19 Inf 5.69 10.41 Obese SCOPE GDM 9.92 1.41 Inf 7.51 13.10 Underweight STOP GDM 2.08 0.37 Inf 1.47 2.94 Normal STOP GDM 2.49 0.22 Inf 2.10 2.96 Overweight STOP GDM 3.45 0.31 Inf 2.89 4.12 Obese STOP GDM 5.68 0.46 Inf 4.84 6.66 57.5.3 Post-hoc comparisons 57.5.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 1.23 (0.73, 2.05) 0.7 Overweight / Underweight SCOPE non-GDM 1.86 (1.10, 3.13) 0.01 Overweight / Normal SCOPE non-GDM 1.51 (1.21, 1.90) &lt;0.0001 Obese / Underweight SCOPE non-GDM 2.40 (1.42, 4.03) &lt;0.0001 Obese / Normal SCOPE non-GDM 1.95 (1.57, 2.43) &lt;0.0001 Obese / Overweight SCOPE non-GDM 1.29 (1.02, 1.63) 0.03 Normal / Underweight STOP non-GDM 1.20 (0.79, 1.83) 0.7 Overweight / Underweight STOP non-GDM 1.66 (1.08, 2.54) 0.01 Overweight / Normal STOP non-GDM 1.39 (1.18, 1.62) &lt;0.0001 Obese / Underweight STOP non-GDM 2.73 (1.78, 4.18) &lt;0.0001 Obese / Normal STOP non-GDM 2.28 (1.94, 2.67) &lt;0.0001 Obese / Overweight STOP non-GDM 1.64 (1.39, 1.95) &lt;0.0001 Normal / Underweight SCOPE GDM 1.23 (0.73, 2.05) 0.7 Overweight / Underweight SCOPE GDM 1.86 (1.10, 3.13) 0.01 Overweight / Normal SCOPE GDM 1.51 (1.21, 1.90) &lt;0.0001 Obese / Underweight SCOPE GDM 2.40 (1.42, 4.03) &lt;0.0001 Obese / Normal SCOPE GDM 1.95 (1.57, 2.43) &lt;0.0001 Obese / Overweight SCOPE GDM 1.29 (1.02, 1.63) 0.03 Normal / Underweight STOP GDM 1.20 (0.79, 1.83) 0.7 Overweight / Underweight STOP GDM 1.66 (1.08, 2.54) 0.01 Overweight / Normal STOP GDM 1.39 (1.18, 1.62) &lt;0.0001 Obese / Underweight STOP GDM 2.73 (1.78, 4.18) &lt;0.0001 Obese / Normal STOP GDM 2.28 (1.94, 2.67) &lt;0.0001 Obese / Overweight STOP GDM 1.64 (1.39, 1.95) &lt;0.0001 57.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.4415293 0.4073289 Inf 0.8285178 2.508101 0.196 ns STOP/SCOPE (non-GDM) 0.9757164 0.2528145 Inf 0.5871807 1.621345 0.924 ns STOP/SCOPE (GDM) 0.9757164 0.2528145 Inf 0.5871807 1.621345 0.924 ns GDM/non-GDM (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/non-GDM (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["glucose-34.html", "57.6 Glucose", " 57.6 Glucose GEE for repeated measures. 57.6.1 Model summary Var Effect P (Intercept) 5.36 (4.85, 5.94) &lt;0.0001 BMI_gp3Normal 1.02 (0.97, 1.07) 0.39 BMI_gp3Overweight 1.05 (0.99, 1.12) 0.07 BMI_gp3Obese 1.02 (0.97, 1.08) 0.41 f39_gdm_newGDM 1.11 (1.00, 1.22) 0.05 StudySTOP 0.85 (0.80, 0.91) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.64 BMI_gp3Normal:StudySTOP 1.01 (0.95, 1.08) 0.72 BMI_gp3Overweight:StudySTOP 1.00 (0.93, 1.07) 0.95 BMI_gp3Obese:StudySTOP 1.05 (0.98, 1.12) 0.19 f39_gdm_newGDM:StudySTOP 0.93 (0.84, 1.04) 0.19 57.6.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 5.26 0.12 Inf 5.03 5.51 Normal SCOPE non-GDM 5.38 0.06 Inf 5.25 5.50 Overweight SCOPE non-GDM 5.55 0.10 Inf 5.35 5.75 Obese SCOPE non-GDM 5.38 0.09 Inf 5.21 5.55 Underweight STOP non-GDM 4.50 0.09 Inf 4.33 4.67 Normal STOP non-GDM 4.65 0.05 Inf 4.56 4.74 Overweight STOP non-GDM 4.73 0.06 Inf 4.61 4.85 Obese STOP non-GDM 4.81 0.06 Inf 4.70 4.92 Underweight SCOPE GDM 5.82 0.32 Inf 5.23 6.48 Normal SCOPE GDM 5.94 0.29 Inf 5.40 6.54 Overweight SCOPE GDM 6.13 0.35 Inf 5.48 6.86 Obese SCOPE GDM 5.95 0.28 Inf 5.42 6.52 Underweight STOP GDM 4.64 0.11 Inf 4.43 4.86 Normal STOP GDM 4.79 0.08 Inf 4.64 4.94 Overweight STOP GDM 4.87 0.08 Inf 4.72 5.04 Obese STOP GDM 4.96 0.07 Inf 4.82 5.10 57.6.3 Post-hoc comparisons 57.6.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 1.02 (0.96, 1.09) 0.8 Overweight / Underweight SCOPE non-GDM 1.05 (0.98, 1.14) 0.3 Overweight / Normal SCOPE non-GDM 1.03 (0.98, 1.09) 0.5 Obese / Underweight SCOPE non-GDM 1.02 (0.96, 1.09) 0.8 Obese / Normal SCOPE non-GDM 1.00 (0.96, 1.04) 1.0 Obese / Overweight SCOPE non-GDM 0.97 (0.91, 1.04) 0.7 Normal / Underweight STOP non-GDM 1.03 (0.98, 1.09) 0.4 Overweight / Underweight STOP non-GDM 1.05 (0.99, 1.11) 0.1 Overweight / Normal STOP non-GDM 1.02 (0.98, 1.06) 0.6 Obese / Underweight STOP non-GDM 1.07 (1.01, 1.13) 0.01 Obese / Normal STOP non-GDM 1.03 (1.00, 1.07) 0.05 Obese / Overweight STOP non-GDM 1.02 (0.97, 1.06) 0.7 Normal / Underweight SCOPE GDM 1.02 (0.96, 1.09) 0.8 Overweight / Underweight SCOPE GDM 1.05 (0.98, 1.14) 0.3 Overweight / Normal SCOPE GDM 1.03 (0.98, 1.09) 0.5 Obese / Underweight SCOPE GDM 1.02 (0.96, 1.09) 0.8 Obese / Normal SCOPE GDM 1.00 (0.96, 1.04) 1.0 Obese / Overweight SCOPE GDM 0.97 (0.91, 1.04) 0.7 Normal / Underweight STOP GDM 1.03 (0.98, 1.09) 0.4 Overweight / Underweight STOP GDM 1.05 (0.99, 1.11) 0.1 Overweight / Normal STOP GDM 1.02 (0.98, 1.06) 0.6 Obese / Underweight STOP GDM 1.07 (1.01, 1.13) 0.01 Obese / Normal STOP GDM 1.03 (1.00, 1.07) 0.05 Obese / Overweight STOP GDM 1.02 (0.97, 1.06) 0.7 57.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9345518 0.0408506 Inf 0.8578199 1.018147 0.121 ns STOP/SCOPE (non-GDM) 1.0115679 0.0321997 Inf 0.9503861 1.076688 0.718 ns STOP/SCOPE (GDM) 1.0115679 0.0321997 Inf 0.9503861 1.076688 0.718 ns GDM/non-GDM (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/non-GDM (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["age-bmi-groups-5.html", "58 Age &amp; BMI groups", " 58 Age &amp; BMI groups Descriptives with univariate P-values. Within non-GDM Characteristic &lt;35 yrs, non-obese (n=1488) &lt;35 yrs, obese (n=537) &gt;=35 yrs, non-obese (n=41) &gt;=35 yrs, obese (n=22) Total (n=2088) P-value PRL (ng/ml): Median (IQ range) 105.5 (62.7-177.1) 94.7 (54.5-150.5) 89.9 (58.8-166.9) 55.1 (39.8-138.5) 101.8 (60.0-169.0) 0.006 hPL (μg/ml): Median (IQ range) 131.4 (60.7-192.3) 95.7 (46.3-154.5) 90.4 (59.6-161.9) 83.1 (37.9-137.1) 117.7 (56.6-181.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 3.0 (1.3-4.6) 2.4 (1.1-3.5) 2.3 (1.2-4.5) 1.6 (1.1-2.9) 2.7 (1.3-4.3) &lt;0.0001 Within GDM Characteristic &lt;35 yrs, non-obese (n=110) &lt;35 yrs, obese (n=116) &gt;=35 yrs, non-obese (n=9) &gt;=35 yrs, obese (n=16) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 81.4 (43.4-131.9) 73.3 (46.7-113.2) 110.7 (89.5-156.8) 51.4 (41.1-62.6) 73.3 (45.3-120.9) 0.08 hPL (μg/ml): Median (IQ range) 83.2 (51.0-108.8) 55.7 (37.4-79.9) 68.1 (47.9-126.8) 25.8 (19.4-35.7) 61.4 (37.6-98.5) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.7 (1.0-2.9) 1.3 (1.0-2.3) 1.2 (1.0-2.2) 1.3 (1.0-1.8) 1.5 (1.0-2.6) 0.47 Click here for table within SCOPE Within non-GDM Characteristic &lt;35 yrs, non-obese (n=768) &lt;35 yrs, obese (n=273) &gt;=35 yrs, non-obese (n=19) &gt;=35 yrs, obese (n=6) Total (n=1066) P-value PRL (ng/ml): Median (IQ range) 145.7 (96.6-224.3) 133.2 (82.4-212.1) 221.6 (95.6-347.0) 132.3 (83.7-157.5) 141.2 (92.6-223.7) 0.06 hPL (μg/ml): Median (IQ range) 190.5 (158.0-224.1) 156.4 (130.7-187.4) 163.8 (133.3-208.1) 179.3 (149.1-202.5) 180.6 (149.6-216.9) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.5 (3.4-6.1) 3.4 (2.7-4.4) 4.4 (3.5-6.4) 4.9 (3.5-6.9) 4.2 (3.2-5.7) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 35.8 (28.6-42.3) 35.8 (25.4-43.1) 42.1 (38.5-57.9) 34.9 (32.3-37.6) 36.0 (28.2-42.6) 0.06 B12 concentration (pM): Median (IQ range) 248.0 (198.0-316.8) 230.0 (185.0-291.0) 305.0 (245.2-367.0) 227.5 (208.2-249.0) 244.0 (194.8-309.0) 0.002 Folate:B12 ratio: Median (IQ range) 141.9 (102.2-203.7) 145.5 (100.7-220.8) 157.4 (115.9-204.5) 174.2 (146.0-195.2) 143.0 (102.7-208.7) 0.53 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-71.2) 61.0 (45.8-75.0) 48.0 (47.0-103.0) 74.0 (39.0-93.0) 56.0 (43.0-73.0) 0.15 Folate:Active B12 ratio: Median (IQ range) 631.5 (458.1-936.8) 538.5 (391.8-820.7) 897.8 (606.5-1050.6) 420.3 (400.0-817.9) 615.8 (438.3-903.7) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.4 (3.8-5.1) 4.5 (4.0-4.8) 4.3 (3.9-4.6) 4.4 (3.8-5.0) 0.92 Within GDM Characteristic &lt;35 yrs, non-obese (n=27) &lt;35 yrs, obese (n=29) &gt;=35 yrs, non-obese (n=0) &gt;=35 yrs, obese (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 119.0 (87.4-179.1) 79.6 (59.7-120.5) NA (NA-NA) 25.7 (14.6-36.7) 92.0 (62.0-147.2) hPL (μg/ml): Median (IQ range) 105.8 (91.4-170.8) 113.3 (90.4-133.9) NA (NA-NA) 36.0 (36.0-36.0) 106.2 (85.6-134.2) GH2 (ng/ml): Median (IQ range) 3.3 (2.6-4.5) 2.0 (1.5-3.1) NA (NA-NA) 1.8 (1.8-1.8) 2.7 (1.6-4.2) Serum folate concentration (nM): Median (IQ range) 41.3 (34.2-44.6) 38.0 (31.1-42.9) NA (NA-NA) 86.0 (63.5-108.6) 40.1 (32.0-43.8) B12 concentration (pM): Median (IQ range) 268.0 (212.5-350.0) 245.0 (192.0-314.0) NA (NA-NA) 205.0 (200.0-210.0) 253.5 (194.2-333.0) Folate:B12 ratio: Median (IQ range) 150.3 (114.2-232.5) 167.7 (115.9-185.4) NA (NA-NA) 410.0 (309.9-510.1) 158.9 (116.5-210.2) Active B12 concentration (pM): Median (IQ range) 63.0 (56.5-99.2) 77.0 (54.0-82.5) NA (NA-NA) 67.5 (50.8-84.2) 68.0 (55.0-86.0) Folate:Active B12 ratio: Median (IQ range) 540.4 (321.6-674.3) 553.8 (524.6-575.9) NA (NA-NA) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) Homocysteine concentration (μM): Median (IQ range) 4.2 (3.8-4.8) 3.7 (3.5-4.2) NA (NA-NA) 4.1 (3.5-4.7) 3.9 (3.6-4.6) Click here for table within STOP Within non-GDM Characteristic &lt;35 yrs, non-obese (n=720) &lt;35 yrs, obese (n=264) &gt;=35 yrs, non-obese (n=22) &gt;=35 yrs, obese (n=16) Total (n=1022) P-value PRL (ng/ml): Median (IQ range) 76.7 (51.5-120.0) 69.4 (45.9-113.4) 72.9 (49.1-91.1) 54.2 (39.8-116.4) 75.0 (49.4-118.7) 0.13 hPL (μg/ml): Median (IQ range) 64.7 (43.3-100.8) 50.5 (33.8-71.4) 62.5 (53.4-83.5) 47.1 (33.1-94.5) 60.5 (40.5-93.0) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.6 (1.0-2.2) 1.4 (1.0-2.4) 1.4 (0.9-2.4) 0.03 Serum folate concentration (nM): Median (IQ range) 40.4 (36.4-45.1) 40.0 (35.8-45.1) 43.9 (40.5-74.9) 44.4 (39.7-101.1) 40.5 (36.4-45.3) 0.009 B12 concentration (pM): Median (IQ range) 288.0 (224.0-369.0) 260.5 (208.2-324.2) 290.5 (228.5-355.8) 234.0 (194.5-366.5) 280.0 (218.0-359.0) 0.0004 Folate:B12 ratio: Median (IQ range) 149.0 (111.2-217.2) 165.7 (119.4-223.9) 171.2 (128.1-300.5) 222.6 (164.8-297.7) 152.8 (115.0-219.2) 0.004 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-83.0) 64.0 (52.0-88.0) 68.0 (54.0-99.0) 61.0 (52.5-74.2) 63.0 (49.0-84.0) 0.60 Folate:Active B12 ratio: Median (IQ range) 670.1 (477.1-964.6) 616.7 (465.2-860.8) 527.9 (427.3-960.5) 751.2 (600.8-1025.3) 659.1 (472.4-943.8) 0.38 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.8 (4.2-5.7) 5.0 (4.4-6.0) 4.9 (4.3-5.6) 4.8 (4.2-5.6) 0.76 Within GDM Characteristic &lt;35 yrs, non-obese (n=83) &lt;35 yrs, obese (n=87) &gt;=35 yrs, non-obese (n=9) &gt;=35 yrs, obese (n=14) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 73.7 (41.0-122.2) 73.0 (44.0-111.6) 110.7 (89.5-156.8) 52.3 (42.3-65.6) 68.8 (42.6-114.0) 0.27 hPL (μg/ml): Median (IQ range) 69.4 (46.6-106.0) 50.2 (36.2-72.4) 68.1 (47.9-126.8) 25.0 (18.5-34.8) 57.0 (35.8-84.1) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.6 (0.9-2.2) 1.3 (0.9-2.2) 1.2 (1.0-2.2) 1.1 (1.0-1.8) 1.3 (0.9-2.2) 0.74 Serum folate concentration (nM): Median (IQ range) 40.7 (36.2-47.4) 38.9 (34.3-43.1) 44.2 (41.0-64.4) 41.0 (35.9-64.4) 40.2 (35.4-45.1) 0.03 B12 concentration (pM): Median (IQ range) 285.0 (231.0-360.0) 266.0 (216.4-306.0) 194.0 (148.0-319.0) 330.0 (222.2-388.5) 273.5 (216.8-352.0) 0.05 Folate:B12 ratio: Median (IQ range) 143.3 (106.3-212.0) 150.2 (116.7-204.1) 197.4 (136.4-447.2) 127.1 (91.8-262.1) 148.0 (111.3-220.6) 0.29 Active B12 concentration (pM): Median (IQ range) 68.5 (55.0-89.0) 78.0 (58.0-91.0) 62.0 (49.0-65.0) 77.0 (75.5-84.2) 74.5 (56.2-90.2) 0.47 Folate:Active B12 ratio: Median (IQ range) 573.3 (461.9-838.0) 505.4 (407.4-633.8) 836.9 (781.6-1038.7) 755.0 (548.3-1065.0) 531.9 (419.6-786.4) 0.09 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.0-5.5) 4.8 (4.0-5.3) 4.9 (4.1-5.3) 4.8 (4.5-4.9) 4.8 (4.0-5.3) 0.99 "],["prolactin-37.html", "58.1 Prolactin", " 58.1 Prolactin LME for duplicated or repeated measures. 58.1.1 Model summary Var Effect P (Intercept) 15.65 (10.98, 22.31) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.88 (0.80, 0.98) 0.02 Age_BMI_gp&gt;=35 yrs, non-obese 1.26 (0.90, 1.78) 0.18 Age_BMI_gp&gt;=35 yrs, obese 0.56 (0.32, 0.99) 0.05 f39_gdm_newGDM 1.12 (0.84, 1.49) 0.44 StudySTOP 0.99 (0.89, 1.11) 0.86 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.97 (0.85, 1.12) 0.70 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.64 (0.41, 0.99) 0.04 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.50 (0.78, 2.89) 0.23 f39_gdm_newGDM:StudySTOP 0.98 (0.72, 1.35) 0.92 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM 0.78 (0.52, 1.16) 0.22 Age_BMI_gp&gt;=35 yrs, non-obese:f39_gdm_newGDM 1.50 (0.91, 2.48) 0.12 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM 0.70 (0.27, 1.84) 0.47 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM:StudySTOP 1.28 (0.82, 2.01) 0.28 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM:StudySTOP 1.15 (0.39, 3.38) 0.80 58.1.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 101.41 7.67 91.73 87.26 117.86 &lt;35 yrs, obese SCOPE non-GDM 89.69 7.57 140.71 75.91 105.98 &gt;=35 yrs, non-obese SCOPE non-GDM 128.24 23.96 1504.91 88.88 185.01 &gt;=35 yrs, obese SCOPE non-GDM 56.69 16.92 2081.28 31.56 101.80 &lt;35 yrs, non-obese STOP non-GDM 100.40 7.26 76.82 86.93 115.95 &lt;35 yrs, obese STOP non-GDM 86.45 6.88 112.08 73.83 101.22 &gt;=35 yrs, non-obese STOP non-GDM 80.85 12.39 1039.82 59.85 109.21 &gt;=35 yrs, obese STOP non-GDM 84.11 14.88 1392.01 59.45 118.99 &lt;35 yrs, non-obese SCOPE GDM 113.40 17.94 1055.33 83.13 154.68 &lt;35 yrs, obese SCOPE GDM 78.08 12.45 1004.64 57.09 106.77 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 44.50 16.75 646.83 21.25 93.20 &lt;35 yrs, non-obese STOP GDM 110.40 11.07 268.50 90.62 134.50 &lt;35 yrs, obese STOP GDM 94.92 9.47 263.13 77.99 115.51 &gt;=35 yrs, non-obese STOP GDM 133.35 29.03 1764.81 87.01 204.39 &gt;=35 yrs, obese STOP GDM 74.80 14.12 1533.32 51.66 108.32 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 58.1.3 Post-hoc comparisons 58.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.88 (0.77, 1.01) 0.09 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.26 (0.81, 1.98) 0.5 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 1.43 (0.90, 2.27) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.56 (0.26, 1.18) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 0.63 (0.30, 1.34) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 0.44 (0.19, 1.05) 0.07 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.86 (0.76, 0.97) 0.010 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 0.81 (0.56, 1.15) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 0.94 (0.65, 1.35) 1.0 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.84 (0.55, 1.28) 0.7 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.97 (0.63, 1.50) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 1.04 (0.60, 1.80) 1.0 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.69 (0.42, 1.14) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.39 (0.14, 1.09) 0.08 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 0.57 (0.21, 1.58) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.86 (0.67, 1.11) 0.4 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 1.21 (0.69, 2.11) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.40 (0.80, 2.45) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.68 (0.42, 1.10) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.79 (0.49, 1.27) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.56 (0.28, 1.12) 0.1 58.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.6038951 0.2446757 2095.334 0.2728269 1.336706 0.213 ns STOP/SCOPE (non-GDM) 0.9735268 0.0687869 2114.941 0.8475586 1.118217 0.704 ns STOP/SCOPE (GDM) 1.2486924 0.2730393 1873.284 0.8132260 1.917343 0.310 ns GDM/non-GDM (SCOPE) 0.7784830 0.1584754 1789.207 0.5222196 1.160500 0.219 ns GDM/non-GDM (STOP) 0.9985199 0.1088056 2104.872 0.8064001 1.236411 0.989 ns "],["hpl-37.html", "58.2 HPL", " 58.2 HPL LME for duplicated or repeated measures. 58.2.1 Model summary Var Effect P (Intercept) 2.07 (1.73, 2.47) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.82 (0.77, 0.86) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.97 (0.81, 1.16) 0.71 Age_BMI_gp&gt;=35 yrs, obese 0.85 (0.64, 1.12) 0.24 f39_gdm_newGDM 0.94 (0.82, 1.07) 0.35 StudySTOP 1.10 (1.04, 1.17) 0.0009 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.95 (0.88, 1.02) 0.15 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.10 (0.88, 1.39) 0.41 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.85 (0.61, 1.18) 0.34 f39_gdm_newGDM:StudySTOP 1.16 (1.00, 1.35) 0.05 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM 1.04 (0.86, 1.25) 0.71 Age_BMI_gp&gt;=35 yrs, non-obese:f39_gdm_newGDM 0.80 (0.62, 1.04) 0.09 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM 0.97 (0.61, 1.56) 0.91 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM:StudySTOP 0.93 (0.75, 1.16) 0.52 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM:StudySTOP 0.70 (0.41, 1.20) 0.20 58.2.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 95.88 2.57 171.47 90.93 101.08 &lt;35 yrs, obese SCOPE non-GDM 78.23 2.55 355.35 73.37 83.41 &gt;=35 yrs, non-obese SCOPE non-GDM 92.69 8.72 2106.29 77.08 111.45 &gt;=35 yrs, obese SCOPE non-GDM 81.20 11.68 2013.09 61.24 107.66 &lt;35 yrs, non-obese STOP non-GDM 105.76 2.61 124.95 100.72 111.05 &lt;35 yrs, obese STOP non-GDM 81.88 2.49 271.41 77.12 86.93 &gt;=35 yrs, non-obese STOP non-GDM 112.60 8.40 1951.64 97.27 130.34 &gt;=35 yrs, obese STOP non-GDM 76.30 6.72 2077.64 64.19 90.69 &lt;35 yrs, non-obese SCOPE GDM 90.06 6.12 1012.44 78.81 102.91 &lt;35 yrs, obese SCOPE GDM 76.13 5.41 981.99 66.23 87.52 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 74.16 13.79 653.48 51.48 106.83 &lt;35 yrs, non-obese STOP GDM 115.34 5.11 849.34 105.73 125.83 &lt;35 yrs, obese STOP GDM 86.14 3.79 831.47 79.01 93.91 &gt;=35 yrs, non-obese STOP GDM 98.16 10.59 1779.24 79.45 121.29 &gt;=35 yrs, obese STOP GDM 56.71 5.37 2099.75 47.09 68.29 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 58.2.3 Post-hoc comparisons 58.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.82 (0.76, 0.87) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.97 (0.76, 1.23) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 1.18 (0.93, 1.51) 0.3 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.85 (0.59, 1.22) 0.6 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 1.04 (0.72, 1.50) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 0.88 (0.57, 1.35) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.77 (0.73, 0.83) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 1.06 (0.88, 1.28) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 1.38 (1.13, 1.67) 0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.72 (0.58, 0.90) 0.001 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.93 (0.74, 1.17) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 0.68 (0.51, 0.90) 0.003 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.85 (0.67, 1.07) 0.3 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.82 (0.50, 1.36) 0.8 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 0.97 (0.59, 1.61) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.75 (0.65, 0.85) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.85 (0.64, 1.14) 0.5 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.14 (0.85, 1.52) 0.6 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.49 (0.38, 0.63) &lt;0.0001 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.66 (0.51, 0.85) 0.0001 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.58 (0.40, 0.83) 0.0005 58.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9396717 0.1929036 2073.4934 0.6282498 1.405465 0.762 ns STOP/SCOPE (non-GDM) 0.9488274 0.0348663 2098.1122 0.8828568 1.019728 0.153 ns STOP/SCOPE (GDM) 0.8834649 0.0924350 1240.8815 0.7195202 1.084765 0.237 ns GDM/non-GDM (SCOPE) 1.0360176 0.0983773 997.3312 0.8598867 1.248225 0.710 ns GDM/non-GDM (STOP) 0.9646487 0.0558422 2111.3653 0.8611245 1.080618 0.534 ns "],["gh2-37.html", "58.3 GH2", " 58.3 GH2 LME for duplicated or repeated measures. 58.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.76 (0.70, 0.82) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.11 (0.86, 1.43) 0.44 Age_BMI_gp&gt;=35 yrs, obese 0.94 (0.62, 1.43) 0.77 f39_gdm_newGDM 1.01 (0.83, 1.25) 0.90 StudySTOP 0.95 (0.87, 1.03) 0.18 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.16 (1.05, 1.29) 0.004 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.88 (0.64, 1.23) 0.46 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.82 (0.50, 1.33) 0.42 f39_gdm_newGDM:StudySTOP 0.98 (0.78, 1.24) 0.87 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM 0.87 (0.65, 1.16) 0.34 Age_BMI_gp&gt;=35 yrs, non-obese:f39_gdm_newGDM 1.17 (0.80, 1.71) 0.41 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM 0.71 (0.34, 1.47) 0.36 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM:StudySTOP 1.22 (0.88, 1.69) 0.24 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM:StudySTOP 1.95 (0.86, 4.42) 0.11 58.3.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 2.54 0.08 445.16 2.39 2.69 &lt;35 yrs, obese SCOPE non-GDM 1.93 0.08 1029.88 1.78 2.08 &gt;=35 yrs, non-obese SCOPE non-GDM 2.81 0.37 2192.23 2.17 3.65 &gt;=35 yrs, obese SCOPE non-GDM 2.38 0.51 2167.58 1.56 3.64 &lt;35 yrs, non-obese STOP non-GDM 2.40 0.06 307.93 2.28 2.52 &lt;35 yrs, obese STOP non-GDM 2.12 0.08 786.08 1.97 2.27 &gt;=35 yrs, non-obese STOP non-GDM 2.35 0.24 2178.38 1.92 2.88 &gt;=35 yrs, obese STOP non-GDM 1.84 0.22 2170.77 1.45 2.34 &lt;35 yrs, non-obese SCOPE GDM 2.57 0.27 1863.18 2.09 3.16 &lt;35 yrs, obese SCOPE GDM 1.70 0.18 1367.10 1.38 2.08 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 1.71 0.50 973.30 0.96 3.02 &lt;35 yrs, non-obese STOP GDM 2.39 0.14 1494.93 2.14 2.67 &lt;35 yrs, obese STOP GDM 2.22 0.13 1441.14 1.99 2.49 &gt;=35 yrs, non-obese STOP GDM 2.74 0.43 2191.52 2.01 3.74 &gt;=35 yrs, obese STOP GDM 2.52 0.33 2179.31 1.95 3.27 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 58.3.3 Post-hoc comparisons 58.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.76 (0.69, 0.84) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.11 (0.79, 1.56) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 1.46 (1.03, 2.07) 0.03 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.94 (0.54, 1.63) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 1.24 (0.71, 2.16) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 0.85 (0.44, 1.62) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.88 (0.81, 0.97) 0.002 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 0.98 (0.75, 1.28) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 1.11 (0.85, 1.46) 0.8 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.77 (0.56, 1.05) 0.1 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.87 (0.63, 1.20) 0.7 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 0.78 (0.52, 1.17) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.66 (0.46, 0.95) 0.02 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.66 (0.30, 1.46) 0.5 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.01 (0.46, 2.21) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.93 (0.77, 1.13) 0.8 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 1.15 (0.75, 1.76) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.23 (0.81, 1.88) 0.6 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.06 (0.74, 1.51) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 1.13 (0.79, 1.62) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.92 (0.55, 1.55) 1.0 58.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9915959 0.2979298 2168.702 0.5501033 1.787414 0.978 ns STOP/SCOPE (non-GDM) 1.1622500 0.0602964 2176.458 1.0498215 1.286719 0.004 ** STOP/SCOPE (GDM) 1.4132661 0.2257421 1836.676 1.0331685 1.933200 0.030 * GDM/non-GDM (SCOPE) 0.8685178 0.1280245 1689.474 0.6504542 1.159687 0.339 ns GDM/non-GDM (STOP) 1.0560952 0.0862427 2177.526 0.8998161 1.239517 0.504 ns "],["insulin-35.html", "58.4 Insulin", " 58.4 Insulin GEE for repeated measures. 58.4.1 Model summary Var Effect P (Intercept) 8.88 (5.66, 13.93) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 1.65 (1.44, 1.90) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.26 (0.87, 1.83) 0.22 Age_BMI_gp&gt;=35 yrs, obese 2.02 (1.23, 3.30) 0.005 f39_gdm_newGDM 1.88 (1.45, 2.43) &lt;0.0001 StudySTOP 0.77 (0.66, 0.90) 0.001 GA_samp 1.02 (0.99, 1.05) 0.11 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.19 (1.00, 1.42) 0.05 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.64 (0.41, 1.02) 0.06 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.67 (0.39, 1.15) 0.15 f39_gdm_newGDM:StudySTOP 0.78 (0.58, 1.05) 0.10 58.4.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 12.12 0.64 Inf 10.93 13.44 &lt;35 yrs, obese SCOPE non-GDM 20.02 1.39 Inf 17.48 22.94 &gt;=35 yrs, non-obese SCOPE non-GDM 15.27 2.87 Inf 10.57 22.06 &gt;=35 yrs, obese SCOPE non-GDM 24.46 6.13 Inf 14.97 39.98 &lt;35 yrs, non-obese STOP non-GDM 9.37 0.38 Inf 8.65 10.15 &lt;35 yrs, obese STOP non-GDM 18.43 1.00 Inf 16.57 20.50 &gt;=35 yrs, non-obese STOP non-GDM 7.60 1.06 Inf 5.78 10.00 &gt;=35 yrs, obese STOP non-GDM 12.71 1.36 Inf 10.30 15.69 &lt;35 yrs, non-obese SCOPE GDM 22.78 3.10 Inf 17.44 29.75 &lt;35 yrs, obese SCOPE GDM 37.63 5.02 Inf 28.97 48.88 &gt;=35 yrs, non-obese SCOPE GDM 28.70 6.57 Inf 18.32 44.96 &gt;=35 yrs, obese SCOPE GDM 45.97 11.63 Inf 28.01 75.47 &lt;35 yrs, non-obese STOP GDM 13.71 1.09 Inf 11.73 16.01 &lt;35 yrs, obese STOP GDM 26.97 2.12 Inf 23.11 31.47 &gt;=35 yrs, non-obese STOP GDM 11.12 1.64 Inf 8.33 14.85 &gt;=35 yrs, obese STOP GDM 18.61 2.08 Inf 14.94 23.17 58.4.3 Post-hoc comparisons 58.4.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.65 (1.37, 1.99) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.26 (0.77, 2.05) 0.6 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 0.76 (0.46, 1.26) 0.5 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 2.02 (1.06, 3.84) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 1.22 (0.64, 2.33) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 1.60 (0.72, 3.55) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 1.97 (1.71, 2.27) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 0.81 (0.57, 1.16) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 0.41 (0.29, 0.60) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 1.36 (1.03, 1.79) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.69 (0.52, 0.92) 0.005 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 1.67 (1.08, 2.58) 0.01 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 1.65 (1.37, 1.99) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM 1.26 (0.77, 2.05) 0.6 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM 0.76 (0.46, 1.26) 0.5 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 2.02 (1.06, 3.84) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.22 (0.64, 2.33) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM 1.60 (0.72, 3.55) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.97 (1.71, 2.27) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.81 (0.57, 1.16) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 0.41 (0.29, 0.60) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.36 (1.03, 1.79) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.69 (0.52, 0.92) 0.005 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 1.67 (1.08, 2.58) 0.01 58.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.824472 0.2989723 Inf 0.4050521 1.678190 0.595 ns STOP/SCOPE (non-GDM) 1.191096 0.1075035 Inf 0.9979776 1.421585 0.053 ns STOP/SCOPE (GDM) 1.191096 0.1075035 Inf 0.9979776 1.421585 0.053 ns GDM/non-GDM (SCOPE) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/non-GDM (STOP) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA "],["homa-ir-35.html", "58.5 HOMA-IR", " 58.5 HOMA-IR GEE for repeated measures. 58.5.1 Model summary Var Effect P (Intercept) 2.23 (1.39, 3.58) 0.0009 Age_BMI_gp&lt;35 yrs, obese 1.67 (1.43, 1.95) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.37 (0.92, 2.05) 0.13 Age_BMI_gp&gt;=35 yrs, obese 2.10 (1.21, 3.64) 0.008 f39_gdm_newGDM 2.04 (1.52, 2.75) &lt;0.0001 StudySTOP 0.66 (0.56, 0.78) &lt;0.0001 GA_samp 1.02 (0.99, 1.05) 0.19 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.23 (1.02, 1.49) 0.03 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.59 (0.36, 0.97) 0.04 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.65 (0.36, 1.17) 0.15 f39_gdm_newGDM:StudySTOP 0.73 (0.53, 1.03) 0.07 58.5.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 2.92 0.16 Inf 2.62 3.26 &lt;35 yrs, obese SCOPE non-GDM 4.88 0.37 Inf 4.21 5.65 &gt;=35 yrs, non-obese SCOPE non-GDM 4.00 0.82 Inf 2.68 5.97 &gt;=35 yrs, obese SCOPE non-GDM 6.13 1.72 Inf 3.54 10.61 &lt;35 yrs, non-obese STOP non-GDM 1.93 0.08 Inf 1.78 2.10 &lt;35 yrs, obese STOP non-GDM 3.97 0.23 Inf 3.54 4.44 &gt;=35 yrs, non-obese STOP non-GDM 1.57 0.23 Inf 1.18 2.09 &gt;=35 yrs, obese STOP non-GDM 2.63 0.29 Inf 2.12 3.28 &lt;35 yrs, non-obese SCOPE GDM 5.97 0.93 Inf 4.40 8.09 &lt;35 yrs, obese SCOPE GDM 9.97 1.52 Inf 7.39 13.45 &gt;=35 yrs, non-obese SCOPE GDM 8.18 2.08 Inf 4.98 13.46 &gt;=35 yrs, obese SCOPE GDM 12.54 3.54 Inf 7.21 21.80 &lt;35 yrs, non-obese STOP GDM 2.90 0.25 Inf 2.46 3.43 &lt;35 yrs, obese STOP GDM 5.96 0.51 Inf 5.04 7.05 &gt;=35 yrs, non-obese STOP GDM 2.36 0.36 Inf 1.74 3.19 &gt;=35 yrs, obese STOP GDM 3.96 0.46 Inf 3.15 4.97 58.5.3 Post-hoc comparisons 58.5.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.67 (1.37, 2.04) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.37 (0.81, 2.33) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 0.82 (0.48, 1.41) 0.8 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 2.10 (1.02, 4.31) 0.04 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 1.26 (0.61, 2.59) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 1.53 (0.63, 3.70) 0.6 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 2.05 (1.77, 2.39) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 0.81 (0.56, 1.19) 0.5 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 0.40 (0.27, 0.58) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 1.36 (1.02, 1.82) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.66 (0.49, 0.90) 0.002 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 1.68 (1.07, 2.64) 0.02 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 1.67 (1.37, 2.04) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM 1.37 (0.81, 2.33) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM 0.82 (0.48, 1.41) 0.8 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 2.10 (1.02, 4.31) 0.04 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.26 (0.61, 2.59) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM 1.53 (0.63, 3.70) 0.6 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 2.05 (1.77, 2.39) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.81 (0.56, 1.19) 0.5 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 0.40 (0.27, 0.58) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.36 (1.02, 1.82) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.66 (0.49, 0.90) 0.002 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 1.68 (1.07, 2.64) 0.02 58.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.7488786 0.2962597 Inf 0.3448834 1.626113 0.465 ns STOP/SCOPE (non-GDM) 1.2300539 0.1197010 Inf 1.0164609 1.488530 0.033 * STOP/SCOPE (GDM) 1.2300539 0.1197010 Inf 1.0164609 1.488530 0.033 * GDM/non-GDM (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/non-GDM (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["glucose-35.html", "58.6 Glucose", " 58.6 Glucose GEE for repeated measures. 58.6.1 Model summary Var Effect P (Intercept) 5.54 (5.05, 6.07) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.99 (0.95, 1.02) 0.44 Age_BMI_gp&gt;=35 yrs, non-obese 1.01 (0.97, 1.06) 0.61 Age_BMI_gp&gt;=35 yrs, obese 1.06 (0.92, 1.23) 0.43 f39_gdm_newGDM 1.11 (1.00, 1.23) 0.06 StudySTOP 0.86 (0.83, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.67 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.04 (1.00, 1.09) 0.05 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.98 (0.93, 1.04) 0.55 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.93 (0.80, 1.09) 0.39 f39_gdm_newGDM:StudySTOP 0.93 (0.83, 1.04) 0.21 58.6.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 5.44 0.06 Inf 5.33 5.55 &lt;35 yrs, obese SCOPE non-GDM 5.36 0.09 Inf 5.19 5.54 &gt;=35 yrs, non-obese SCOPE non-GDM 5.50 0.12 Inf 5.28 5.74 &gt;=35 yrs, obese SCOPE non-GDM 5.78 0.44 Inf 4.98 6.71 &lt;35 yrs, non-obese STOP non-GDM 4.68 0.04 Inf 4.60 4.76 &lt;35 yrs, obese STOP non-GDM 4.82 0.06 Inf 4.71 4.93 &gt;=35 yrs, non-obese STOP non-GDM 4.66 0.07 Inf 4.52 4.79 &gt;=35 yrs, obese STOP non-GDM 4.65 0.08 Inf 4.49 4.80 &lt;35 yrs, non-obese SCOPE GDM 6.03 0.32 Inf 5.42 6.70 &lt;35 yrs, obese SCOPE GDM 5.94 0.29 Inf 5.39 6.54 &gt;=35 yrs, non-obese SCOPE GDM 6.10 0.34 Inf 5.46 6.80 &gt;=35 yrs, obese SCOPE GDM 6.40 0.49 Inf 5.51 7.45 &lt;35 yrs, non-obese STOP GDM 4.83 0.07 Inf 4.69 4.97 &lt;35 yrs, obese STOP GDM 4.97 0.08 Inf 4.83 5.12 &gt;=35 yrs, non-obese STOP GDM 4.80 0.08 Inf 4.65 4.97 &gt;=35 yrs, obese STOP GDM 4.80 0.09 Inf 4.62 4.97 58.6.3 Post-hoc comparisons 58.6.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.99 (0.94, 1.03) 0.9 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.01 (0.95, 1.07) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 1.03 (0.96, 1.09) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.06 (0.87, 1.29) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 1.08 (0.89, 1.31) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 1.05 (0.86, 1.28) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 1.03 (1.00, 1.07) 0.1 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 1.00 (0.96, 1.04) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 0.97 (0.92, 1.01) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.99 (0.95, 1.04) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.96 (0.92, 1.01) 0.2 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 1.00 (0.95, 1.05) 1.0 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.99 (0.94, 1.03) 0.9 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM 1.01 (0.95, 1.07) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM 1.03 (0.96, 1.09) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 1.06 (0.87, 1.29) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 1.08 (0.89, 1.31) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM 1.05 (0.86, 1.28) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.03 (1.00, 1.07) 0.1 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 1.00 (0.96, 1.04) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 0.97 (0.92, 1.01) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.99 (0.95, 1.04) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.96 (0.92, 1.01) 0.2 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 1.00 (0.95, 1.05) 1.0 58.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.032474 0.0850663 Inf 0.8785124 1.213417 0.698 ns STOP/SCOPE (non-GDM) 1.044655 0.0237775 Inf 0.9990758 1.092313 0.055 ns STOP/SCOPE (GDM) 1.044655 0.0237775 Inf 0.9990758 1.092313 0.055 ns GDM/non-GDM (SCOPE) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/non-GDM (STOP) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA "],["mets-17.html", "59 MetS", " 59 MetS Descriptives with univariate P-values. Within non-GDM Characteristic No MetS (n=1790) MetS (n=232) Total (n=2022) P-value PRL (ng/ml): Median (IQ range) 98.3 (58.8-161.4) 124.5 (70.2-202.6) 100.6 (59.5-168.4) 0.0003 hPL (μg/ml): Median (IQ range) 111.4 (55.7-180.8) 145.4 (69.9-187.6) 115.6 (56.2-181.3) 0.03 GH2 (ng/ml): Median (IQ range) 2.6 (1.2-4.3) 3.1 (1.9-4.7) 2.7 (1.3-4.3) 0.005 Within GDM Characteristic No MetS (n=172) MetS (n=68) Total (n=240) P-value PRL (ng/ml): Median (IQ range) 73.6 (47.5-122.7) 64.1 (41.6-110.2) 71.9 (44.4-114.1) 0.19 hPL (μg/ml): Median (IQ range) 64.3 (37.8-100.2) 55.7 (37.4-79.8) 60.2 (37.4-91.8) 0.22 GH2 (ng/ml): Median (IQ range) 1.4 (1.0-2.5) 1.5 (1.0-2.4) 1.4 (1.0-2.4) 0.97 Click here for table within SCOPE Within non-GDM Characteristic No MetS (n=892) MetS (n=165) Total (n=1057) P-value PRL (ng/ml): Median (IQ range) 138.3 (90.4-223.6) 157.2 (105.0-227.6) 140.9 (92.5-223.7) 0.12 hPL (μg/ml): Median (IQ range) 181.9 (152.1-218.4) 169.7 (138.1-204.2) 180.7 (149.1-217.1) 0.03 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.8) 3.9 (2.9-5.4) 4.2 (3.2-5.7) 0.07 Serum folate concentration (nM): Median (IQ range) 36.0 (28.3-42.8) 35.7 (25.7-42.5) 36.0 (28.2-42.7) 0.46 B12 concentration (pM): Median (IQ range) 248.0 (196.0-316.0) 228.0 (185.0-287.0) 244.0 (194.5-309.0) 0.001 Folate:B12 ratio: Median (IQ range) 141.7 (101.6-205.6) 153.2 (113.8-215.2) 143.0 (102.9-208.7) 0.27 Active B12 concentration (pM): Median (IQ range) 55.5 (42.0-72.0) 58.0 (45.0-78.0) 56.0 (43.0-73.0) 0.24 Folate:Active B12 ratio: Median (IQ range) 619.6 (452.5-929.5) 546.7 (392.3-771.2) 615.9 (438.8-904.2) 0.04 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.8) 4.4 (3.8-5.0) 0.06 Within GDM Characteristic No MetS (n=29) MetS (n=28) Total (n=57) P-value PRL (ng/ml): Median (IQ range) 119.0 (74.7-180.2) 73.7 (54.6-101.6) 92.0 (62.0-147.2) 0.09 hPL (μg/ml): Median (IQ range) 117.2 (105.8-161.5) 96.2 (77.6-113.5) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 3.0 (1.6-4.4) 2.0 (1.6-3.1) 2.7 (1.6-4.2) 0.49 Serum folate concentration (nM): Median (IQ range) 39.7 (31.7-44.0) 39.6 (31.9-42.3) 39.6 (31.9-43.8) 0.90 B12 concentration (pM): Median (IQ range) 274.0 (196.2-341.5) 240.0 (193.5-296.5) 254.0 (193.5-334.0) 0.39 Folate:B12 ratio: Median (IQ range) 152.8 (112.5-184.8) 167.7 (121.8-210.6) 155.4 (115.4-210.6) 0.59 Active B12 concentration (pM): Median (IQ range) 85.0 (58.0-99.5) 60.0 (53.0-79.0) 66.5 (54.5-89.2) 0.28 Folate:Active B12 ratio: Median (IQ range) 516.5 (418.5-688.3) 560.9 (424.7-636.8) 546.6 (419.7-674.3) 0.61 Homocysteine concentration (μM): Median (IQ range) 4.1 (3.8-4.7) 3.7 (3.5-4.1) 3.9 (3.6-4.6) 0.10 Click here for table within STOP Within non-GDM Characteristic No MetS (n=898) MetS (n=67) Total (n=965) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.6-114.5) 73.3 (52.9-116.0) 74.0 (48.6-114.6) 0.68 hPL (μg/ml): Median (IQ range) 60.2 (40.9-90.2) 46.5 (31.3-73.9) 59.4 (40.2-89.6) 0.01 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.4 (0.9-2.2) 1.4 (0.9-2.3) 0.67 Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.3) 39.8 (35.4-44.8) 40.5 (36.3-45.3) 0.35 B12 concentration (pM): Median (IQ range) 280.0 (219.8-363.0) 258.0 (200.5-330.5) 280.0 (218.0-357.0) 0.02 Folate:B12 ratio: Median (IQ range) 152.1 (114.8-220.5) 164.8 (128.2-206.1) 152.7 (115.2-220.2) 0.36 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-84.0) 63.0 (53.0-76.0) 63.0 (49.0-84.0) 0.94 Folate:Active B12 ratio: Median (IQ range) 664.2 (471.0-944.4) 550.7 (493.4-726.8) 646.8 (471.5-935.3) 0.10 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.3-5.9) 4.8 (4.3-5.6) 0.90 Within GDM Characteristic No MetS (n=143) MetS (n=40) Total (n=183) P-value PRL (ng/ml): Median (IQ range) 70.4 (43.4-111.5) 56.2 (38.6-110.4) 68.4 (42.3-111.0) 0.21 hPL (μg/ml): Median (IQ range) 59.4 (35.3-85.7) 50.0 (36.2-65.0) 55.6 (35.3-83.0) 0.06 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.1) 1.2 (0.8-2.0) 1.3 (0.9-2.1) 0.39 Serum folate concentration (nM): Median (IQ range) 40.7 (36.0-54.0) 37.2 (33.8-41.7) 40.0 (35.1-45.2) 0.02 B12 concentration (pM): Median (IQ range) 278.0 (217.0-359.2) 264.0 (207.0-306.0) 275.0 (216.0-353.0) 0.23 Folate:B12 ratio: Median (IQ range) 147.4 (109.7-228.7) 149.8 (114.6-211.8) 147.7 (111.7-223.1) 0.98 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-88.0) 73.0 (57.5-92.2) 75.0 (56.0-91.0) 0.99 Folate:Active B12 ratio: Median (IQ range) 531.9 (419.9-818.0) 551.8 (417.2-693.7) 534.2 (419.9-798.9) 0.77 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.4) 4.8 (4.1-5.2) 4.8 (4.0-5.3) 0.92 "],["prolactin-38.html", "59.1 Prolactin", " 59.1 Prolactin LME for duplicated or repeated measures. 59.1.1 Model summary Var Effect P (Intercept) 16.70 (11.50, 24.26) &lt;0.0001 metab.C1MetS 1.06 (0.94, 1.20) 0.36 f39_gdm_newGDM 1.14 (0.86, 1.49) 0.36 StudySTOP 0.95 (0.85, 1.07) 0.41 GA_samp 1.14 (1.12, 1.17) &lt;0.0001 metab.C1MetS:StudySTOP 0.97 (0.80, 1.19) 0.80 f39_gdm_newGDM:StudySTOP 0.96 (0.72, 1.28) 0.77 metab.C1MetS:f39_gdm_newGDM 0.63 (0.42, 0.93) 0.02 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.45 (0.89, 2.36) 0.13 59.1.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 98.42 7.47 91.31 84.65 114.44 MetS SCOPE non-GDM 104.23 9.58 192.47 86.95 124.94 No MetS STOP non-GDM 93.78 6.78 75.29 81.21 108.30 MetS STOP non-GDM 96.74 10.10 310.64 78.77 118.82 No MetS SCOPE GDM 111.86 17.10 976.01 82.86 151.00 MetS SCOPE GDM 74.12 11.93 909.00 54.03 101.66 No MetS STOP GDM 102.09 9.22 178.03 85.42 122.02 MetS STOP GDM 95.59 12.18 603.11 74.43 122.76 59.1.3 Post-hoc comparisons 59.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 1.06 (0.94, 1.20) 0.4 MetS / No MetS STOP non-GDM 1.03 (0.88, 1.21) 0.7 MetS / No MetS SCOPE GDM 0.66 (0.45, 0.97) 0.03 MetS / No MetS STOP GDM 0.94 (0.74, 1.18) 0.6 59.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.3766280 0.3404947 1852.486 0.8475066 2.236094 0.196 ns STOP/SCOPE (non-GDM) 0.9741793 0.1003823 2049.114 0.7959335 1.192343 0.800 ns STOP/SCOPE (GDM) 1.4131156 0.3182028 1765.650 0.9086031 2.197765 0.125 ns GDM/non-GDM (SCOPE) 0.6257010 0.1268518 1652.060 0.4204086 0.931241 0.021 * GDM/non-GDM (STOP) 0.9076233 0.1291481 2049.443 0.6866166 1.199767 0.496 ns "],["hpl-38.html", "59.2 HPL", " 59.2 HPL LME for duplicated or repeated measures. 59.2.1 Model summary Var Effect P (Intercept) 2.07 (1.71, 2.50) &lt;0.0001 metab.C1MetS 0.90 (0.85, 0.96) 0.002 f39_gdm_newGDM 0.98 (0.87, 1.12) 0.80 StudySTOP 1.09 (1.02, 1.15) 0.007 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.90 (0.81, 1.00) 0.05 f39_gdm_newGDM:StudySTOP 1.03 (0.90, 1.19) 0.67 metab.C1MetS:f39_gdm_newGDM 1.01 (0.84, 1.22) 0.90 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.07 (0.84, 1.37) 0.57 59.2.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 91.83 2.48 165.20 87.05 96.86 MetS SCOPE non-GDM 82.90 3.18 578.76 76.87 89.39 No MetS STOP non-GDM 99.69 2.47 118.50 94.92 104.71 MetS STOP non-GDM 80.91 3.84 1040.51 73.71 88.82 No MetS SCOPE GDM 90.34 6.07 1096.02 79.19 103.07 MetS SCOPE GDM 82.51 6.03 870.48 71.49 95.23 No MetS STOP GDM 101.09 3.85 505.08 93.79 108.95 MetS STOP GDM 89.03 5.46 1540.64 78.94 100.42 59.2.3 Post-hoc comparisons 59.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 0.90 (0.85, 0.96) 0.002 MetS / No MetS STOP non-GDM 0.81 (0.74, 0.88) &lt;0.0001 MetS / No MetS SCOPE GDM 0.91 (0.76, 1.09) 0.3 MetS / No MetS STOP GDM 0.88 (0.78, 1.00) 0.04 59.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8669583 0.1069444 1490.101 0.6806317 1.104293 0.247 ns STOP/SCOPE (non-GDM) 0.8990072 0.0491693 2041.170 0.8075712 1.000796 0.052 ns STOP/SCOPE (GDM) 0.9643509 0.1068321 1297.796 0.7759787 1.198451 0.743 ns GDM/non-GDM (SCOPE) 1.0116955 0.0983840 1022.998 0.8359404 1.224403 0.905 ns GDM/non-GDM (STOP) 1.0852299 0.0828458 2046.831 0.9343360 1.260493 0.284 ns "],["gh2-38.html", "59.3 GH2", " 59.3 GH2 LME for duplicated or repeated measures. 59.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 metab.C1MetS 0.91 (0.83, 0.99) 0.03 f39_gdm_newGDM 1.03 (0.85, 1.25) 0.78 StudySTOP 0.96 (0.88, 1.04) 0.30 GA_samp 1.29 (1.27, 1.32) &lt;0.0001 metab.C1MetS:StudySTOP 1.05 (0.91, 1.23) 0.50 f39_gdm_newGDM:StudySTOP 0.99 (0.80, 1.23) 0.95 metab.C1MetS:f39_gdm_newGDM 0.75 (0.56, 1.00) 0.05 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.39 (0.97, 2.00) 0.07 59.3.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 2.41 0.07 412.66 2.27 2.55 MetS SCOPE non-GDM 2.18 0.11 1421.94 1.98 2.40 No MetS STOP non-GDM 2.30 0.06 274.59 2.19 2.42 MetS STOP non-GDM 2.20 0.14 1890.36 1.94 2.48 No MetS SCOPE GDM 2.48 0.25 1813.51 2.03 3.01 MetS SCOPE GDM 1.67 0.18 1264.59 1.35 2.07 No MetS STOP GDM 2.35 0.11 932.40 2.14 2.58 MetS STOP GDM 2.34 0.19 1936.96 1.98 2.75 59.3.3 Post-hoc comparisons 59.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 0.91 (0.83, 0.99) 0.03 MetS / No MetS STOP non-GDM 0.95 (0.85, 1.08) 0.5 MetS / No MetS SCOPE GDM 0.68 (0.51, 0.89) 0.006 MetS / No MetS STOP GDM 0.99 (0.84, 1.18) 0.9 59.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.5485957 0.2856673 1874.331 1.0784912 2.223615 0.018 * STOP/SCOPE (non-GDM) 1.0541795 0.0819421 2099.366 0.9051320 1.227771 0.497 ns STOP/SCOPE (GDM) 1.4690057 0.2462316 1771.209 1.0574244 2.040787 0.022 * GDM/non-GDM (SCOPE) 0.7469699 0.1119974 1603.025 0.5566488 1.002363 0.052 ns GDM/non-GDM (STOP) 1.0409072 0.1123903 2104.508 0.8422713 1.286388 0.710 ns "],["insulin-36.html", "59.4 Insulin", " 59.4 Insulin GEE for repeated measures. 59.4.1 Model summary Var Effect P (Intercept) 9.31 (5.83, 14.86) &lt;0.0001 metab.C1MetS 2.47 (2.10, 2.92) &lt;0.0001 f39_gdm_newGDM 1.74 (1.15, 2.64) 0.009 StudySTOP 0.87 (0.75, 1.02) 0.08 GA_samp 1.02 (0.99, 1.05) 0.19 metab.C1MetS:StudySTOP 0.89 (0.67, 1.19) 0.44 f39_gdm_newGDM:StudySTOP 0.84 (0.54, 1.31) 0.44 metab.C1MetS:f39_gdm_newGDM 0.81 (0.47, 1.37) 0.42 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.23 (0.64, 2.38) 0.53 59.4.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 12.11 0.62 Inf 10.95 13.40 MetS SCOPE non-GDM 29.98 2.47 Inf 25.51 35.24 No MetS STOP non-GDM 10.55 0.42 Inf 9.76 11.40 MetS STOP non-GDM 23.34 2.71 Inf 18.58 29.30 No MetS SCOPE GDM 21.07 4.46 Inf 13.91 31.90 MetS SCOPE GDM 41.98 6.45 Inf 31.06 56.72 No MetS STOP GDM 15.39 1.26 Inf 13.11 18.07 MetS STOP GDM 33.79 4.93 Inf 25.38 44.98 59.4.3 Post-hoc comparisons 59.4.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 2.47 (2.10, 2.92) &lt;0.0001 MetS / No MetS STOP non-GDM 2.21 (1.76, 2.78) &lt;0.0001 MetS / No MetS SCOPE GDM 1.99 (1.20, 3.30) 0.007 MetS / No MetS STOP GDM 2.20 (1.60, 3.01) &lt;0.0001 59.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9847674 0.3312875 Inf 0.5093066 1.904092 0.964 ns STOP/SCOPE (non-GDM) 0.8937469 0.1289293 Inf 0.6736320 1.185786 0.436 ns STOP/SCOPE (GDM) 1.1018415 0.3349886 Inf 0.6071998 1.999432 0.750 ns GDM/non-GDM (SCOPE) 0.8050035 0.2178630 Inf 0.4736221 1.368244 0.423 ns GDM/non-GDM (STOP) 0.9924357 0.1984144 Inf 0.6706941 1.468521 0.970 ns "],["homa-ir-36.html", "59.5 HOMA-IR", " 59.5 HOMA-IR GEE for repeated measures. 59.5.1 Model summary Var Effect P (Intercept) 2.25 (1.38, 3.66) 0.001 metab.C1MetS 2.79 (2.33, 3.33) &lt;0.0001 f39_gdm_newGDM 1.92 (1.21, 3.06) 0.006 StudySTOP 0.76 (0.65, 0.90) 0.001 GA_samp 1.02 (0.99, 1.05) 0.25 metab.C1MetS:StudySTOP 0.91 (0.67, 1.23) 0.54 f39_gdm_newGDM:StudySTOP 0.77 (0.47, 1.27) 0.30 metab.C1MetS:f39_gdm_newGDM 0.74 (0.41, 1.34) 0.31 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.35 (0.65, 2.83) 0.42 59.5.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 2.87 0.15 Inf 2.58 3.19 MetS SCOPE non-GDM 7.99 0.72 Inf 6.70 9.52 No MetS STOP non-GDM 2.19 0.09 Inf 2.02 2.37 MetS STOP non-GDM 5.53 0.70 Inf 4.32 7.08 No MetS SCOPE GDM 5.51 1.30 Inf 3.47 8.74 MetS SCOPE GDM 11.29 1.99 Inf 8.00 15.95 No MetS STOP GDM 3.24 0.28 Inf 2.74 3.84 MetS STOP GDM 8.17 1.35 Inf 5.92 11.29 59.5.3 Post-hoc comparisons 59.5.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 2.79 (2.33, 3.33) &lt;0.0001 MetS / No MetS STOP non-GDM 2.53 (1.97, 3.24) &lt;0.0001 MetS / No MetS SCOPE GDM 2.05 (1.16, 3.63) 0.01 MetS / No MetS STOP GDM 2.52 (1.77, 3.59) &lt;0.0001 59.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.1157467 0.4198821 Inf 0.5336274 2.332884 0.771 ns STOP/SCOPE (non-GDM) 0.9077569 0.1421390 Inf 0.6678611 1.233823 0.537 ns STOP/SCOPE (GDM) 1.2291249 0.4207628 Inf 0.6283573 2.404282 0.547 ns GDM/non-GDM (SCOPE) 0.7362672 0.2243151 Inf 0.4052320 1.337726 0.315 ns GDM/non-GDM (STOP) 0.9969237 0.2203576 Inf 0.6464193 1.537480 0.989 ns "],["glucose-36.html", "59.6 Glucose", " 59.6 Glucose GEE for repeated measures. 59.6.1 Model summary Var Effect P (Intercept) 5.35 (4.88, 5.87) &lt;0.0001 metab.C1MetS 1.13 (1.10, 1.17) &lt;0.0001 f39_gdm_newGDM 1.07 (0.97, 1.19) 0.17 StudySTOP 0.88 (0.86, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.87 metab.C1MetS:StudySTOP 1.01 (0.96, 1.06) 0.60 f39_gdm_newGDM:StudySTOP 0.96 (0.86, 1.06) 0.42 metab.C1MetS:f39_gdm_newGDM 0.99 (0.81, 1.20) 0.90 metab.C1MetS:f39_gdm_newGDM:StudySTOP 0.99 (0.81, 1.23) 0.96 59.6.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 5.32 0.05 Inf 5.22 5.41 MetS SCOPE non-GDM 6.01 0.09 Inf 5.85 6.18 No MetS STOP non-GDM 4.68 0.04 Inf 4.61 4.75 MetS STOP non-GDM 5.36 0.11 Inf 5.15 5.58 No MetS SCOPE GDM 5.70 0.29 Inf 5.17 6.29 MetS SCOPE GDM 6.37 0.53 Inf 5.40 7.51 No MetS STOP GDM 4.81 0.07 Inf 4.67 4.94 MetS STOP GDM 5.41 0.16 Inf 5.11 5.73 59.6.3 Post-hoc comparisons 59.6.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 1.13 (1.10, 1.17) &lt;0.0001 MetS / No MetS STOP non-GDM 1.15 (1.10, 1.19) &lt;0.0001 MetS / No MetS SCOPE GDM 1.12 (0.92, 1.36) 0.3 MetS / No MetS STOP GDM 1.13 (1.06, 1.20) 0.0001 59.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0210418 0.1090279 Inf 0.8282306 1.258739 0.845 ns STOP/SCOPE (non-GDM) 1.0133090 0.0256246 Inf 0.9643101 1.064798 0.601 ns STOP/SCOPE (GDM) 1.0076312 0.1046693 Inf 0.8220186 1.235155 0.942 ns GDM/non-GDM (SCOPE) 0.9873294 0.0995287 Inf 0.8103187 1.203007 0.899 ns GDM/non-GDM (STOP) 0.9817971 0.0362711 Inf 0.9132198 1.055524 0.619 ns "],["birthweight-centile-5.html", "60 Birthweight centile", " 60 Birthweight centile Descriptives with univariate P-values. Within non-GDM Characteristic &lt;=90th centile (n=1885) &gt;90th centile (n=197) Total (n=2082) P-value PRL (ng/ml): Median (IQ range) 101.0 (59.8-165.9) 106.4 (62.4-192.0) 102.0 (60.0-168.9) 0.34 hPL (μg/ml): Median (IQ range) 120.9 (57.0-180.6) 102.8 (56.8-200.2) 119.2 (56.9-181.3) 0.40 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.3) 2.4 (1.2-4.4) 2.7 (1.3-4.3) 0.43 Within GDM Characteristic &lt;=90th centile (n=219) &gt;90th centile (n=30) Total (n=249) P-value PRL (ng/ml): Median (IQ range) 67.2 (43.9-113.0) 101.2 (82.0-181.8) 73.6 (45.6-121.8) 0.001 hPL (μg/ml): Median (IQ range) 61.3 (38.1-98.8) 67.2 (34.2-86.3) 61.4 (37.4-98.0) 0.93 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.3 (1.0-2.7) 1.5 (1.0-2.6) 0.97 Click here for table within SCOPE Within non-GDM Characteristic &lt;=90th centile (n=971) &gt;90th centile (n=95) Total (n=1066) P-value PRL (ng/ml): Median (IQ range) 139.3 (91.1-222.0) 178.4 (120.7-232.7) 141.2 (92.6-223.7) 0.02 hPL (μg/ml): Median (IQ range) 179.2 (149.1-214.8) 206.6 (155.4-239.5) 180.6 (149.6-216.9) 0.005 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.7) 4.6 (3.2-5.7) 4.2 (3.2-5.7) 0.61 Serum folate concentration (nM): Median (IQ range) 35.8 (28.1-42.6) 37.7 (30.3-42.6) 36.0 (28.2-42.6) 0.42 B12 concentration (pM): Median (IQ range) 243.0 (193.0-305.0) 250.0 (202.0-330.0) 244.0 (194.8-309.0) 0.16 Folate:B12 ratio: Median (IQ range) 142.7 (103.5-207.5) 153.8 (98.5-214.1) 143.0 (102.7-208.7) 0.96 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-72.2) 59.0 (44.8-79.2) 56.0 (43.0-73.0) 0.38 Folate:Active B12 ratio: Median (IQ range) 615.8 (431.1-909.8) 608.7 (467.2-871.9) 615.8 (438.3-903.7) 0.66 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.8) 4.4 (3.8-5.0) 0.18 Within GDM Characteristic &lt;=90th centile (n=50) &gt;90th centile (n=8) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 87.6 (59.0-138.5) 114.4 (93.1-148.1) 92.0 (62.0-147.2) 0.58 hPL (μg/ml): Median (IQ range) 105.8 (86.1-152.6) 107.3 (95.5-119.5) 106.2 (85.6-134.2) 1.00 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.0) 3.4 (2.3-4.3) 2.7 (1.6-4.2) 0.81 Serum folate concentration (nM): Median (IQ range) 39.6 (32.2-43.8) 41.4 (32.1-43.7) 40.1 (32.0-43.8) 0.93 B12 concentration (pM): Median (IQ range) 245.0 (192.0-332.0) 257.0 (245.0-324.5) 253.5 (194.2-333.0) 0.29 Folate:B12 ratio: Median (IQ range) 167.7 (118.7-211.5) 122.6 (114.2-155.7) 158.9 (116.5-210.2) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (53.0-81.5) 85.0 (77.0-104.0) 68.0 (55.0-86.0) 0.14 Folate:Active B12 ratio: Median (IQ range) 559.7 (436.8-674.3) 438.2 (424.7-516.5) 553.8 (424.7-660.3) 0.32 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 3.8 (3.7-4.2) 3.9 (3.6-4.6) 0.66 Click here for table within STOP Within non-GDM Characteristic &lt;=90th centile (n=914) &gt;90th centile (n=102) Total (n=1016) P-value PRL (ng/ml): Median (IQ range) 75.0 (49.5-118.8) 72.6 (47.8-113.4) 74.8 (49.2-118.7) 0.73 hPL (μg/ml): Median (IQ range) 60.5 (39.5-95.7) 60.9 (47.5-88.0) 60.6 (40.5-93.2) 0.31 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-2.2) 1.4 (0.9-2.4) 0.85 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-49.5) 40.7 (36.5-44.8) 40.5 (36.3-45.3) 0.87 B12 concentration (pM): Median (IQ range) 280.0 (217.2-356.0) 278.0 (231.0-381.0) 280.0 (218.0-357.0) 0.39 Folate:B12 ratio: Median (IQ range) 153.3 (115.6-222.3) 152.5 (114.3-207.6) 153.1 (115.3-219.3) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (48.8-84.2) 67.5 (49.8-80.2) 63.0 (49.0-84.2) 0.58 Folate:Active B12 ratio: Median (IQ range) 657.1 (472.5-946.1) 646.1 (455.3-856.4) 657.1 (472.0-940.5) 0.65 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.7 (4.3-5.4) 4.8 (4.3-5.6) 0.27 Within GDM Characteristic &lt;=90th centile (n=169) &gt;90th centile (n=22) Total (n=191) P-value PRL (ng/ml): Median (IQ range) 64.1 (42.3-111.0) 99.2 (82.6-186.0) 70.4 (43.2-114.3) 0.002 hPL (μg/ml): Median (IQ range) 57.0 (36.2-83.8) 56.7 (33.7-81.4) 57.0 (35.5-83.8) 0.85 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.3 (0.9-1.9) 1.3 (0.9-2.2) 0.80 Serum folate concentration (nM): Median (IQ range) 39.9 (35.1-44.7) 43.1 (38.3-63.6) 40.2 (35.5-45.2) 0.08 B12 concentration (pM): Median (IQ range) 275.5 (216.8-356.5) 269.5 (198.0-297.2) 273.5 (215.9-353.0) 0.34 Folate:B12 ratio: Median (IQ range) 145.9 (107.6-218.0) 162.5 (130.5-251.1) 148.0 (111.6-221.1) 0.12 Active B12 concentration (pM): Median (IQ range) 74.5 (56.0-88.0) 77.0 (68.8-96.2) 74.5 (56.0-88.8) 0.43 Folate:Active B12 ratio: Median (IQ range) 539.3 (419.9-784.7) 531.8 (431.4-817.4) 531.9 (419.8-790.5) 0.98 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.3) 4.5 (3.8-4.8) 4.7 (4.0-5.3) 0.06 "],["prolactin-39.html", "60.1 Prolactin", " 60.1 Prolactin LME for duplicated or repeated measures. 60.1.1 Model summary Var Effect P (Intercept) 14.54 (10.19, 20.75) &lt;0.0001 BW_gp&gt;90th centile 1.23 (1.05, 1.44) 0.01 f39_gdm_newGDM 0.94 (0.75, 1.17) 0.56 StudySTOP 1.00 (0.90, 1.11) 0.99 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.84 (0.68, 1.03) 0.09 f39_gdm_newGDM:StudySTOP 1.10 (0.87, 1.40) 0.42 BW_gp&gt;90th centile:f39_gdm_newGDM 1.11 (0.59, 2.10) 0.74 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 1.32 (0.65, 2.69) 0.44 60.1.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 95.80 7.17 87.32 82.56 111.16 &gt;90th centile SCOPE non-GDM 117.59 12.28 313.86 95.74 144.42 &lt;=90th centile STOP non-GDM 95.73 6.85 73.27 83.01 110.41 &gt;90th centile STOP non-GDM 98.20 9.20 209.33 81.65 118.11 &lt;=90th centile SCOPE GDM 89.88 11.41 581.42 70.05 115.34 &gt;90th centile SCOPE GDM 122.76 37.80 1384.90 67.09 224.59 &lt;=90th centile STOP GDM 98.98 8.66 159.30 83.27 117.65 &gt;90th centile STOP GDM 149.35 22.72 1007.87 110.81 201.29 60.1.3 Post-hoc comparisons 60.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.23 (1.05, 1.44) 0.01 &gt;90th centile / &lt;=90th centile STOP non-GDM 1.03 (0.90, 1.17) 0.7 &gt;90th centile / &lt;=90th centile SCOPE GDM 1.37 (0.74, 2.54) 0.3 &gt;90th centile / &lt;=90th centile STOP GDM 1.51 (1.14, 2.00) 0.004 60.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9232963 0.3342907 1570.827 0.4538533 1.878307 0.826 ns STOP/SCOPE (non-GDM) 0.8356854 0.0875801 2105.237 0.6804328 1.026361 0.087 ns STOP/SCOPE (GDM) 1.1048372 0.3830044 1506.293 0.5597348 2.180792 0.774 ns GDM/non-GDM (SCOPE) 1.1126039 0.3621971 1421.319 0.5874951 2.107060 0.743 ns GDM/non-GDM (STOP) 1.4709438 0.2318366 2109.398 1.0798427 2.003695 0.014 * "],["hpl-39.html", "60.2 HPL", " 60.2 HPL LME for duplicated or repeated measures. 60.2.1 Model summary Var Effect P (Intercept) 1.85 (1.54, 2.23) &lt;0.0001 BW_gp&gt;90th centile 1.09 (1.00, 1.19) 0.04 f39_gdm_newGDM 0.92 (0.83, 1.02) 0.12 StudySTOP 1.10 (1.04, 1.17) 0.001 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.07 (0.96, 1.19) 0.25 f39_gdm_newGDM:StudySTOP 1.09 (0.97, 1.22) 0.16 BW_gp&gt;90th centile:f39_gdm_newGDM 1.25 (0.92, 1.70) 0.15 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 0.71 (0.50, 1.01) 0.05 60.2.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 89.02 2.38 157.36 84.44 93.85 &gt;90th centile SCOPE non-GDM 97.13 4.61 1027.99 88.49 106.61 &lt;=90th centile STOP non-GDM 97.88 2.41 114.28 93.23 102.77 &gt;90th centile STOP non-GDM 114.10 4.75 741.82 105.14 123.83 &lt;=90th centile SCOPE GDM 82.04 4.55 859.00 73.57 91.48 &gt;90th centile SCOPE GDM 112.08 16.25 797.58 84.31 148.99 &lt;=90th centile STOP GDM 98.20 3.62 451.55 91.34 105.58 &gt;90th centile STOP GDM 101.37 7.99 1953.61 86.85 118.32 60.2.3 Post-hoc comparisons 60.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.09 (1.00, 1.19) 0.04 &gt;90th centile / &lt;=90th centile STOP non-GDM 1.17 (1.08, 1.25) &lt;0.0001 &gt;90th centile / &lt;=90th centile SCOPE GDM 1.37 (1.02, 1.84) 0.04 &gt;90th centile / &lt;=90th centile STOP GDM 1.03 (0.88, 1.21) 0.7 60.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8073864 0.1451141 1078.4479 0.5674406 1.148795 0.234 ns STOP/SCOPE (non-GDM) 1.0684496 0.0609857 2069.2155 0.9553008 1.195000 0.246 ns STOP/SCOPE (GDM) 0.7556616 0.1288844 984.2666 0.5407159 1.056053 0.101 ns GDM/non-GDM (SCOPE) 1.2521545 0.1966259 843.3842 0.9200291 1.704175 0.153 ns GDM/non-GDM (STOP) 0.8855870 0.0779027 2101.7654 0.7452641 1.052331 0.167 ns "],["gh2-39.html", "60.3 GH2", " 60.3 GH2 LME for duplicated or repeated measures. 60.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 BW_gp&gt;90th centile 1.03 (0.91, 1.16) 0.66 f39_gdm_newGDM 0.88 (0.75, 1.02) 0.10 StudySTOP 0.98 (0.90, 1.06) 0.53 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.00 (0.86, 1.17) 0.99 f39_gdm_newGDM:StudySTOP 1.18 (0.99, 1.41) 0.06 BW_gp&gt;90th centile:f39_gdm_newGDM 1.10 (0.69, 1.73) 0.70 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 0.80 (0.48, 1.34) 0.41 60.3.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 2.36 0.07 390.82 2.23 2.50 &gt;90th centile SCOPE non-GDM 2.43 0.15 1896.86 2.15 2.74 &lt;=90th centile STOP non-GDM 2.30 0.06 260.63 2.20 2.42 &gt;90th centile STOP non-GDM 2.37 0.12 1715.39 2.14 2.63 &lt;=90th centile SCOPE GDM 2.07 0.16 1507.63 1.77 2.42 &gt;90th centile SCOPE GDM 2.33 0.50 1007.05 1.53 3.54 &lt;=90th centile STOP GDM 2.39 0.11 842.95 2.19 2.60 &gt;90th centile STOP GDM 2.16 0.23 2146.63 1.76 2.66 60.3.3 Post-hoc comparisons 60.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.03 (0.91, 1.16) 0.7 &gt;90th centile / &lt;=90th centile STOP non-GDM 1.03 (0.93, 1.14) 0.6 &gt;90th centile / &lt;=90th centile SCOPE GDM 1.13 (0.72, 1.75) 0.6 &gt;90th centile / &lt;=90th centile STOP GDM 0.91 (0.73, 1.12) 0.4 60.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8060972 0.2113693 1353.853 0.4819383 1.348290 0.411 ns STOP/SCOPE (non-GDM) 1.0011281 0.0799389 2170.522 0.8560207 1.170833 0.989 ns STOP/SCOPE (GDM) 0.8051889 0.2011403 1260.248 0.4932406 1.314428 0.386 ns GDM/non-GDM (SCOPE) 1.0953986 0.2547571 1120.765 0.6940552 1.728822 0.695 ns GDM/non-GDM (STOP) 0.8810089 0.1060153 2170.863 0.6958164 1.115491 0.293 ns "],["insulin-37.html", "60.4 Insulin", " 60.4 Insulin GEE for repeated measures. 60.4.1 Model summary Var Effect P (Intercept) 10.87 (6.92, 17.08) &lt;0.0001 BW_gp&gt;90th centile 1.19 (0.92, 1.54) 0.20 f39_gdm_newGDM 2.36 (1.75, 3.17) &lt;0.0001 StudySTOP 0.80 (0.69, 0.93) 0.003 GA_samp 1.02 (0.99, 1.05) 0.22 BW_gp&gt;90th centile:StudySTOP 0.80 (0.58, 1.08) 0.15 f39_gdm_newGDM:StudySTOP 0.71 (0.51, 0.99) 0.04 BW_gp&gt;90th centile:f39_gdm_newGDM 0.45 (0.19, 1.07) 0.07 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 2.69 (0.99, 7.34) 0.05 60.4.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 13.80 0.69 Inf 12.52 15.22 &gt;90th centile SCOPE non-GDM 16.38 2.14 Inf 12.67 21.17 &lt;=90th centile STOP non-GDM 11.08 0.43 Inf 10.27 11.95 &gt;90th centile STOP non-GDM 10.45 0.89 Inf 8.85 12.35 &lt;=90th centile SCOPE GDM 32.52 4.93 Inf 24.17 43.76 &gt;90th centile SCOPE GDM 17.42 6.86 Inf 8.05 37.69 &lt;=90th centile STOP GDM 18.48 1.45 Inf 15.85 21.55 &gt;90th centile STOP GDM 21.18 5.04 Inf 13.28 33.77 60.4.3 Post-hoc comparisons 60.4.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.19 (0.92, 1.54) 0.2 &gt;90th centile / &lt;=90th centile STOP non-GDM 0.94 (0.80, 1.12) 0.5 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.54 (0.24, 1.22) 0.1 &gt;90th centile / &lt;=90th centile STOP GDM 1.15 (0.71, 1.86) 0.6 60.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.7012461 0.8714959 Inf 0.6233370 4.643136 0.300 ns STOP/SCOPE (non-GDM) 0.7952374 0.1251208 Inf 0.5842123 1.082487 0.145 ns STOP/SCOPE (GDM) 2.1392936 1.0428933 Inf 0.8228384 5.561939 0.119 ns GDM/non-GDM (SCOPE) 0.4513625 0.1987501 Inf 0.1904201 1.069888 0.071 ns GDM/non-GDM (STOP) 1.2142248 0.3178143 Inf 0.7269481 2.028125 0.458 ns "],["homa-ir-37.html", "60.5 HOMA-IR", " 60.5 HOMA-IR GEE for repeated measures. 60.5.1 Model summary Var Effect P (Intercept) 2.75 (1.71, 4.43) &lt;0.0001 BW_gp&gt;90th centile 1.20 (0.91, 1.58) 0.19 f39_gdm_newGDM 2.55 (1.81, 3.60) &lt;0.0001 StudySTOP 0.69 (0.59, 0.81) &lt;0.0001 GA_samp 1.01 (0.98, 1.05) 0.34 BW_gp&gt;90th centile:StudySTOP 0.80 (0.58, 1.10) 0.17 f39_gdm_newGDM:StudySTOP 0.68 (0.46, 1.00) 0.05 BW_gp&gt;90th centile:f39_gdm_newGDM 0.47 (0.20, 1.12) 0.09 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 2.44 (0.88, 6.79) 0.09 60.5.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 3.34 0.18 Inf 3.01 3.70 &gt;90th centile SCOPE non-GDM 4.00 0.55 Inf 3.06 5.24 &lt;=90th centile STOP non-GDM 2.30 0.09 Inf 2.13 2.50 &gt;90th centile STOP non-GDM 2.21 0.20 Inf 1.85 2.63 &lt;=90th centile SCOPE GDM 8.51 1.49 Inf 6.04 12.00 &gt;90th centile SCOPE GDM 4.78 1.85 Inf 2.23 10.22 &lt;=90th centile STOP GDM 4.01 0.34 Inf 3.40 4.74 &gt;90th centile STOP GDM 4.39 1.07 Inf 2.72 7.08 60.5.3 Post-hoc comparisons 60.5.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.20 (0.91, 1.58) 0.2 &gt;90th centile / &lt;=90th centile STOP non-GDM 0.96 (0.80, 1.14) 0.6 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.56 (0.24, 1.29) 0.2 &gt;90th centile / &lt;=90th centile STOP GDM 1.09 (0.66, 1.80) 0.7 60.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.5544488 0.8108305 Inf 0.5592079 4.320953 0.398 ns STOP/SCOPE (non-GDM) 0.7977406 0.1322008 Inf 0.5765027 1.103880 0.173 ns STOP/SCOPE (GDM) 1.9485643 0.9637642 Inf 0.7391092 5.137134 0.177 ns GDM/non-GDM (SCOPE) 0.4680306 0.2088955 Inf 0.1951455 1.122509 0.089 ns GDM/non-GDM (STOP) 1.1432135 0.3085962 Inf 0.6735287 1.940433 0.620 ns "],["glucose-37.html", "60.6 Glucose", " 60.6 Glucose GEE for repeated measures. 60.6.1 Model summary Var Effect P (Intercept) 5.53 (5.04, 6.07) &lt;0.0001 BW_gp&gt;90th centile 1.06 (1.00, 1.11) 0.04 f39_gdm_newGDM 1.12 (0.99, 1.25) 0.06 StudySTOP 0.87 (0.84, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.55 BW_gp&gt;90th centile:StudySTOP 1.00 (0.92, 1.08) 0.95 f39_gdm_newGDM:StudySTOP 0.94 (0.83, 1.06) 0.31 BW_gp&gt;90th centile:f39_gdm_newGDM 0.91 (0.79, 1.06) 0.23 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 0.99 (0.84, 1.17) 0.88 60.6.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 5.40 0.05 Inf 5.30 5.49 &gt;90th centile SCOPE non-GDM 5.71 0.15 Inf 5.42 6.01 &lt;=90th centile STOP non-GDM 4.68 0.03 Inf 4.62 4.75 &gt;90th centile STOP non-GDM 4.94 0.16 Inf 4.64 5.25 &lt;=90th centile SCOPE GDM 6.03 0.34 Inf 5.40 6.73 &gt;90th centile SCOPE GDM 5.82 0.24 Inf 5.37 6.31 &lt;=90th centile STOP GDM 4.92 0.07 Inf 4.78 5.05 &gt;90th centile STOP GDM 4.67 0.09 Inf 4.50 4.86 60.6.3 Post-hoc comparisons 60.6.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.06 (1.00, 1.11) 0.04 &gt;90th centile / &lt;=90th centile STOP non-GDM 1.05 (0.99, 1.12) 0.09 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.97 (0.84, 1.11) 0.6 &gt;90th centile / &lt;=90th centile STOP GDM 0.95 (0.91, 0.99) 0.02 60.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9818465 0.0842638 Inf 0.8298355 1.1617033 0.831 ns STOP/SCOPE (non-GDM) 0.9972751 0.0413351 Inf 0.9194631 1.0816720 0.948 ns STOP/SCOPE (GDM) 0.9845293 0.0736208 Inf 0.8503109 1.1399336 0.835 ns GDM/non-GDM (SCOPE) 0.9129940 0.0693179 Inf 0.7867587 1.0594837 0.231 ns GDM/non-GDM (STOP) 0.9013254 0.0348813 Inf 0.8354879 0.9723511 0.007 ** "],["hormone-models-5.html", "61 Hormone Models ", " 61 Hormone Models "],["scope-vs-stop-5.html", "61.1 SCOPE vs STOP", " 61.1 SCOPE vs STOP - Outcomes: Prolactin, hPL, GH2, Insulin, HOME-IR, glucose (all outcomes log-transformed) - Independent variables: Study, f39_gdm_new, BMI, Ethnicity (Caucasian/non-Caucasian), smoking (yes/no), GA at sampling - Model fitted: LME or GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       Random intercepts for Study ID and Plate #outc_ls &lt;- c(&quot;Prolactin&quot;,&quot;HPL&quot;,&quot;GH2&quot;) outc_ls &lt;- c(hormone_var,insulin_var) outc2 &lt;- preg_out # fit LME fit_ls &lt;- lapply(outc_ls,function(outc){ if(outc%in%hormone_var){ #LME for hormones fit_eq &lt;- as.formula(paste0(&quot;log(&quot;,outc,&quot;)~ Study + &quot;,outc2,&quot; + BMI + Ethnicity_cauc + f10c_any_cig_1st_vst + GA_samp + Study*&quot;,outc2,&quot; + (1|Study.ID) + (1|Assay.&quot;,outc,&quot;)&quot;)) fit &lt;- eval(bquote(lmer(.(fit_eq),data=dat_run)))} if(outc%in%insulin_var){ #GEE for insulin fit_eq &lt;- as.formula(paste0(&quot;log(&quot;,outc,&quot;)~ Study + &quot;,outc2,&quot;+BMI+Ethnicity_cauc+f10c_any_cig_1st_vst+GA_samp+Study*&quot;,outc2)) dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,&quot;BMI&quot;,&quot;Ethnicity_cauc&quot;,&quot;f10c_any_cig_1st_vst&quot;,outc,outc2)]) fit &lt;- eval(bquote(geeglm(.(fit_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(fit)}) names(fit_ls) &lt;- outc_ls # Type III SS anova_ls &lt;- lapply(fit_ls,function(fit){ if(!any(class(fit)%in%&quot;gee&quot;)){return(Anova(fit,type=&quot;III&quot;))} if(any(class(fit)%in%&quot;gee&quot;)){return(joint_tests(fit,cov.reduce=symmint(0)))}}) 61.1.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 250.7924480 1 &lt;0.0001 *** Study 3.2136720 1 0.07 ns f39_gdm_new 0.5754347 1 0.4 ns BMI 3.3368238 1 0.07 ns Ethnicity_cauc 105.4219556 1 &lt;0.0001 *** f10c_any_cig_1st_vst 49.1590682 1 &lt;0.0001 *** GA_samp 164.6323095 1 &lt;0.0001 *** Study:f39_gdm_new 1.8652579 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.8759535 1 &lt;0.0001 *** Study 7.3986291 1 0.007 ** f39_gdm_new 0.4357432 1 0.5 ns BMI 236.2094019 1 &lt;0.0001 *** Ethnicity_cauc 5.5165373 1 0.02 * f10c_any_cig_1st_vst 0.9176455 1 0.3 ns GA_samp 2601.9722143 1 &lt;0.0001 *** Study:f39_gdm_new 1.4845286 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 251.096669 1 &lt;0.0001 *** Study 1.107622 1 0.3 ns f39_gdm_new 1.386104 1 0.2 ns BMI 87.622496 1 &lt;0.0001 *** Ethnicity_cauc 3.246832 1 0.07 ns f10c_any_cig_1st_vst 1.039153 1 0.3 ns GA_samp 1032.266869 1 &lt;0.0001 *** Study:f39_gdm_new 3.376951 1 0.07 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.326 21.326 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 33.726 33.726 &lt;0.0001 *** 4 BMI 1 Inf 330.722 330.722 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 25.046 25.046 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 3.158 3.158 0.08 ns 7 GA_samp 1 Inf 2.506 2.506 0.1 ns 2 Study:f39_gdm_new 1 Inf 4.089 4.089 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 36.051 36.051 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 32.027 32.027 &lt;0.0001 *** 4 BMI 1 Inf 316.807 316.807 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 24.882 24.882 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 2.618 2.618 0.1 ns 7 GA_samp 1 Inf 1.602 1.602 0.2 ns 2 Study:f39_gdm_new 1 Inf 4.361 4.361 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 53.182 53.182 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 4.345 4.345 0.04 * 4 BMI 1 Inf 11.449 11.449 0.0007 *** 5 Ethnicity_cauc 1 Inf 0.718 0.718 0.4 ns 6 f10c_any_cig_1st_vst 1 Inf 0.028 0.028 0.9 ns 7 GA_samp 1 Inf 0.278 0.278 0.6 ns 2 Study:f39_gdm_new 1 Inf 1.558 1.558 0.2 ns 61.1.2 Model Summary Model summaries. ## Computing profile confidence intervals ... ## Computing profile confidence intervals ... ## Computing profile confidence intervals ... Prolactin Var Effect P (Intercept) 19.27 (13.37, 27.77) &lt;0.0001 StudySTOP 0.91 (0.82, 1.01) 0.07 f39_gdm_newGDM 0.93 (0.76, 1.13) 0.45 BMI 1.00 (0.99, 1.00) 0.07 Ethnicity_caucNo 1.54 (1.42, 1.68) &lt;0.0001 f10c_any_cig_1st_vstYes 0.79 (0.73, 0.84) &lt;0.0001 GA_samp 1.14 (1.12, 1.17) &lt;0.0001 StudySTOP:f39_gdm_newGDM 1.16 (0.94, 1.44) 0.17 HPL Var Effect P (Intercept) 3.24 (2.69, 3.91) &lt;0.0001 StudySTOP 1.08 (1.02, 1.14) 0.007 f39_gdm_newGDM 0.97 (0.88, 1.06) 0.51 BMI 0.98 (0.98, 0.98) &lt;0.0001 Ethnicity_caucNo 1.05 (1.01, 1.10) 0.02 f10c_any_cig_1st_vstYes 1.02 (0.98, 1.06) 0.34 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 StudySTOP:f39_gdm_newGDM 1.07 (0.96, 1.19) 0.22 GH2 Var Effect P (Intercept) 0.12 (0.09, 0.16) &lt;0.0001 StudySTOP 0.96 (0.89, 1.04) 0.29 f39_gdm_newGDM 0.92 (0.79, 1.06) 0.24 BMI 0.99 (0.98, 0.99) &lt;0.0001 Ethnicity_caucNo 1.06 (0.99, 1.13) 0.07 f10c_any_cig_1st_vstYes 1.03 (0.98, 1.08) 0.31 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 StudySTOP:f39_gdm_newGDM 1.16 (0.99, 1.36) 0.07 Insulin Var Effect P (Intercept) 2.65 (1.67, 4.18) &lt;0.0001 StudySTOP 0.76 (0.66, 0.88) 0.0002 f39_gdm_newGDM 1.71 (1.36, 2.16) &lt;0.0001 BMI 1.05 (1.05, 1.06) &lt;0.0001 Ethnicity_caucNo 1.37 (1.21, 1.56) &lt;0.0001 f10c_any_cig_1st_vstYes 0.92 (0.83, 1.01) 0.08 GA_samp 1.02 (0.99, 1.05) 0.11 StudySTOP:f39_gdm_newGDM 0.76 (0.58, 0.99) 0.04 HOMA.IR Var Effect P (Intercept) 0.63 (0.39, 1.02) 0.06 StudySTOP 0.65 (0.56, 0.76) &lt;0.0001 f39_gdm_newGDM 1.84 (1.40, 2.42) &lt;0.0001 BMI 1.05 (1.05, 1.06) &lt;0.0001 Ethnicity_caucNo 1.40 (1.22, 1.59) &lt;0.0001 f10c_any_cig_1st_vstYes 0.92 (0.83, 1.02) 0.11 GA_samp 1.02 (0.99, 1.05) 0.21 StudySTOP:f39_gdm_newGDM 0.72 (0.53, 0.98) 0.04 GLUC3_mmol.L Var Effect P (Intercept) 5.23 (4.75, 5.75) &lt;0.0001 StudySTOP 0.87 (0.84, 0.89) &lt;0.0001 f39_gdm_newGDM 1.10 (0.99, 1.22) 0.09 BMI 1.00 (1.00, 1.00) 0.0007 Ethnicity_caucNo 1.01 (0.99, 1.03) 0.40 f10c_any_cig_1st_vstYes 1.00 (0.98, 1.02) 0.87 GA_samp 1.00 (0.99, 1.00) 0.60 StudySTOP:f39_gdm_newGDM 0.93 (0.84, 1.04) 0.21 61.1.3 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 61.1.4 Results 61.1.4.1 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling, BMI, ethnicity and smoking. em_eq &lt;- as.formula(paste0(&quot;pairwise~Study*&quot;,outc2)) #fit_em &lt;- lapply(fit_ls,function(x){emmeans(x,em_eq,type=&quot;response&quot;)}) fit_em &lt;- foreach(ind2=1:length(fit_ls)) %dofuture% { emmeans(fit_ls[[ind2]],em_eq,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} names(fit_em) &lt;- names(fit_ls) fit_em_contrasts &lt;- lapply(fit_em,function(x){ contrast_dat &lt;- data.frame(x$emmeans) contrast_dat$Group &lt;- with(contrast_dat,paste(Study,get(outc2),sep=&quot;.&quot;)) contrast_mat &lt;- diag(nrow(contrast_dat)) rownames(contrast_mat) &lt;- colnames(contrast_mat) &lt;- contrast_dat$Group contrast_ls &lt;- list( &quot;STOP/SCOPE (non-cases)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1]),], &quot;STOP/SCOPE (Cases)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2]),], &quot;Cases/non-cases (SCOPE)&quot;=contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1]),], &quot;Cases/non-cases (STOP)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1]),]) names(contrast_ls) &lt;- c(&quot;STOP/SCOPE (non-cases)&quot;,paste0(&quot;STOP/SCOPE (&quot;,outc2,&quot;)&quot;), paste0(outc2,&quot;/non-cases (SCOPE)&quot;),paste0(outc2,&quot;/non-cases (STOP)&quot;)) contrast_out &lt;- contrast(x$emmeans,method=contrast_ls) return(contrast_out)}) Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 111.0154 8.681308 96.52335 95.05499 129.6557 STOP non-GDM 101.0402 7.521753 79.44826 87.12606 117.1765 SCOPE GDM 102.8206 12.570919 488.73126 80.86360 130.7395 STOP GDM 108.6664 9.407853 142.31669 91.57354 128.9498 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 92.79956 2.631487 208.5170 87.75417 98.13503 STOP non-GDM 100.16214 2.580611 143.9125 95.18905 105.39505 SCOPE GDM 89.90620 4.703155 855.7065 81.13321 99.62781 STOP GDM 103.60960 3.630797 403.1080 96.71224 110.99886 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.447434 0.0797623 643.5290 2.295715 2.609181 STOP non-GDM 2.348242 0.0646686 403.7659 2.224493 2.478876 SCOPE GDM 2.244898 0.1698300 1454.2571 1.935300 2.604024 STOP GDM 2.502546 0.1064317 815.6024 2.302116 2.720426 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 16.13732 0.9237574 Inf 14.42466 18.05332 STOP non-GDM 12.27648 0.5729224 Inf 11.20340 13.45235 SCOPE GDM 27.63445 3.3537549 Inf 21.78451 35.05531 STOP GDM 15.99781 1.1514391 Inf 13.89299 18.42153 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.941501 0.2407589 Inf 3.496775 4.442789 STOP non-GDM 2.576228 0.1260619 Inf 2.340629 2.835541 SCOPE GDM 7.264465 1.0212704 Inf 5.514904 9.569060 STOP GDM 3.432514 0.2659047 Inf 2.948986 3.995322 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.455388 0.0606409 Inf 5.337820 5.575546 STOP non-GDM 4.732806 0.0383650 Inf 4.658206 4.808600 SCOPE GDM 5.997698 0.3022740 Inf 5.433572 6.620392 STOP GDM 4.855922 0.0646889 Inf 4.730775 4.984380 61.1.4.2 Comparisons Prolactin contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases) 0.910 0.048 2134.356 0.821 1.009 0.073 ns STOP/SCOPE (f39_gdm_new) 1.057 0.121 1848.804 0.845 1.322 0.628 ns f39_gdm_new/non-cases (SCOPE) 0.926 0.094 1760.115 0.760 1.129 0.448 ns f39_gdm_new/non-cases (STOP) 1.075 0.057 2124.426 0.969 1.193 0.170 ns HPL contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases) 1.079 0.030 2146.493 1.022 1.140 0.007 ** STOP/SCOPE (f39_gdm_new) 1.152 0.065 1454.099 1.031 1.288 0.012 * f39_gdm_new/non-cases (SCOPE) 0.969 0.046 1008.430 0.882 1.064 0.509 ns f39_gdm_new/non-cases (STOP) 1.034 0.030 2143.118 0.978 1.094 0.238 ns GH2 contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases) 0.959 0.038 2093.891 0.888 1.036 0.293 ns STOP/SCOPE (f39_gdm_new) 1.115 0.095 1805.358 0.944 1.317 0.201 ns f39_gdm_new/non-cases (SCOPE) 0.917 0.067 1602.268 0.794 1.059 0.239 ns f39_gdm_new/non-cases (STOP) 1.066 0.042 2020.496 0.986 1.152 0.110 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (non-cases) 0.761 0.055 Inf 0.660 0.877 0.0002 *** STOP/SCOPE (f39_gdm_new) 0.579 0.081 Inf 0.440 0.762 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE) 1.712 0.202 Inf 1.358 2.159 &lt;0.0001 *** f39_gdm_new/non-cases (STOP) 1.303 0.089 Inf 1.139 1.491 0.0001 *** HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (non-cases) 0.654 0.050 Inf 0.562 0.760 &lt;0.0001 *** STOP/SCOPE (f39_gdm_new) 0.473 0.075 Inf 0.346 0.646 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE) 1.843 0.255 Inf 1.405 2.418 &lt;0.0001 *** f39_gdm_new/non-cases (STOP) 1.332 0.098 Inf 1.153 1.540 0.0001 *** GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (non-cases) 0.868 0.013 Inf 0.843 0.893 &lt;0.0001 *** STOP/SCOPE (f39_gdm_new) 0.810 0.040 Inf 0.734 0.893 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE) 1.099 0.061 Inf 0.987 1.225 0.086 ns f39_gdm_new/non-cases (STOP) 1.026 0.013 Inf 1.001 1.052 0.043 * 61.1.4.3 Barplots 61.1.5 Comparisons by Timepoint Prolactin contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases)|10wks 0.910 0.048 2134.356 0.821 1.009 0.073 ns STOP/SCOPE (f39_gdm_new)|10wks 1.057 0.121 1848.804 0.845 1.322 0.628 ns f39_gdm_new/non-cases (SCOPE)|10wks 0.926 0.094 1760.115 0.760 1.129 0.448 ns f39_gdm_new/non-cases (STOP)|10wks 1.075 0.057 2124.426 0.969 1.193 0.170 ns STOP/SCOPE (non-cases)|16wks 0.910 0.048 2134.356 0.821 1.009 0.073 ns STOP/SCOPE (f39_gdm_new)|16wks 1.057 0.121 1848.804 0.845 1.322 0.628 ns f39_gdm_new/non-cases (SCOPE)|16wks 0.926 0.094 1760.115 0.760 1.129 0.448 ns f39_gdm_new/non-cases (STOP)|16wks 1.075 0.057 2124.426 0.969 1.193 0.170 ns 16wks/10wks (non-cases)|SCOPE 2.234 0.140 2126.990 1.976 2.526 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|SCOPE 2.234 0.140 2126.990 1.976 2.526 &lt;0.0001 *** 16wks/10wks (non-cases)|STOP 2.234 0.140 2126.990 1.976 2.526 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|STOP 2.234 0.140 2126.990 1.976 2.526 &lt;0.0001 *** HPL contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases)|10wks 1.079 0.030 2146.493 1.022 1.140 0.007 ** STOP/SCOPE (f39_gdm_new)|10wks 1.152 0.065 1454.099 1.031 1.288 0.012 * f39_gdm_new/non-cases (SCOPE)|10wks 0.969 0.046 1008.430 0.882 1.064 0.509 ns f39_gdm_new/non-cases (STOP)|10wks 1.034 0.030 2143.118 0.978 1.094 0.238 ns STOP/SCOPE (non-cases)|16wks 1.079 0.030 2146.493 1.022 1.140 0.007 ** STOP/SCOPE (f39_gdm_new)|16wks 1.152 0.065 1454.099 1.031 1.288 0.012 * f39_gdm_new/non-cases (SCOPE)|16wks 0.969 0.046 1008.430 0.882 1.064 0.509 ns f39_gdm_new/non-cases (STOP)|16wks 1.034 0.030 2143.118 0.978 1.094 0.238 ns 16wks/10wks (non-cases)|SCOPE 5.598 0.189 2130.600 5.240 5.982 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|SCOPE 5.598 0.189 2130.600 5.240 5.982 &lt;0.0001 *** 16wks/10wks (non-cases)|STOP 5.598 0.189 2130.600 5.240 5.982 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|STOP 5.598 0.189 2130.600 5.240 5.982 &lt;0.0001 *** GH2 contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases)|10wks 0.959 0.038 2093.891 0.888 1.036 0.293 ns STOP/SCOPE (f39_gdm_new)|10wks 1.115 0.095 1805.358 0.944 1.317 0.201 ns f39_gdm_new/non-cases (SCOPE)|10wks 0.917 0.067 1602.268 0.794 1.059 0.239 ns f39_gdm_new/non-cases (STOP)|10wks 1.066 0.042 2020.496 0.986 1.152 0.110 ns STOP/SCOPE (non-cases)|16wks 0.959 0.038 2093.891 0.888 1.036 0.293 ns STOP/SCOPE (f39_gdm_new)|16wks 1.115 0.095 1805.358 0.944 1.317 0.201 ns f39_gdm_new/non-cases (SCOPE)|16wks 0.917 0.067 1602.268 0.794 1.059 0.239 ns f39_gdm_new/non-cases (STOP)|16wks 1.066 0.042 2020.496 0.986 1.152 0.110 ns 16wks/10wks (non-cases)|SCOPE 4.641 0.222 2163.793 4.226 5.097 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|SCOPE 4.641 0.222 2163.793 4.226 5.097 &lt;0.0001 *** 16wks/10wks (non-cases)|STOP 4.641 0.222 2163.793 4.226 5.097 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|STOP 4.641 0.222 2163.793 4.226 5.097 &lt;0.0001 *** Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (non-cases)|10wks 0.761 0.055 Inf 0.660 0.877 0.0002 *** STOP/SCOPE (f39_gdm_new)|10wks 0.579 0.081 Inf 0.440 0.762 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE)|10wks 1.712 0.202 Inf 1.358 2.159 &lt;0.0001 *** f39_gdm_new/non-cases (STOP)|10wks 1.303 0.089 Inf 1.139 1.491 0.0001 *** STOP/SCOPE (non-cases)|16wks 0.761 0.055 Inf 0.660 0.877 0.0002 *** STOP/SCOPE (f39_gdm_new)|16wks 0.579 0.081 Inf 0.440 0.762 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE)|16wks 1.712 0.202 Inf 1.358 2.159 &lt;0.0001 *** f39_gdm_new/non-cases (STOP)|16wks 1.303 0.089 Inf 1.139 1.491 0.0001 *** 16wks/10wks (non-cases)|SCOPE 1.144 0.097 Inf 0.968 1.352 0.113 ns 16wks/10wks (f39_gdm_new)|SCOPE 1.144 0.097 Inf 0.968 1.352 0.113 ns 16wks/10wks (non-cases)|STOP 1.144 0.097 Inf 0.968 1.352 0.113 ns 16wks/10wks (f39_gdm_new)|STOP 1.144 0.097 Inf 0.968 1.352 0.113 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (non-cases)|10wks 0.654 0.050 Inf 0.562 0.760 &lt;0.0001 *** STOP/SCOPE (f39_gdm_new)|10wks 0.473 0.075 Inf 0.346 0.646 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE)|10wks 1.843 0.255 Inf 1.405 2.418 &lt;0.0001 *** f39_gdm_new/non-cases (STOP)|10wks 1.332 0.098 Inf 1.153 1.540 0.0001 *** STOP/SCOPE (non-cases)|16wks 0.654 0.050 Inf 0.562 0.760 &lt;0.0001 *** STOP/SCOPE (f39_gdm_new)|16wks 0.473 0.075 Inf 0.346 0.646 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE)|16wks 1.843 0.255 Inf 1.405 2.418 &lt;0.0001 *** f39_gdm_new/non-cases (STOP)|16wks 1.332 0.098 Inf 1.153 1.540 0.0001 *** 16wks/10wks (non-cases)|SCOPE 1.121 0.101 Inf 0.939 1.337 0.206 ns 16wks/10wks (f39_gdm_new)|SCOPE 1.121 0.101 Inf 0.939 1.337 0.206 ns 16wks/10wks (non-cases)|STOP 1.121 0.101 Inf 0.939 1.337 0.206 ns 16wks/10wks (f39_gdm_new)|STOP 1.121 0.101 Inf 0.939 1.337 0.206 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value STOP/SCOPE (non-cases)|10wks 0.868 0.013 Inf 0.843 0.893 &lt;0.0001 *** STOP/SCOPE (f39_gdm_new)|10wks 0.810 0.040 Inf 0.734 0.893 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE)|10wks 1.099 0.061 Inf 0.987 1.225 0.086 ns f39_gdm_new/non-cases (STOP)|10wks 1.026 0.013 Inf 1.001 1.052 0.043 * STOP/SCOPE (non-cases)|16wks 0.868 0.013 Inf 0.843 0.893 &lt;0.0001 *** STOP/SCOPE (f39_gdm_new)|16wks 0.810 0.040 Inf 0.734 0.893 &lt;0.0001 *** f39_gdm_new/non-cases (SCOPE)|16wks 1.099 0.061 Inf 0.987 1.225 0.086 ns f39_gdm_new/non-cases (STOP)|16wks 1.026 0.013 Inf 1.001 1.052 0.043 * 16wks/10wks (non-cases)|SCOPE 0.990 0.019 Inf 0.954 1.027 0.598 ns 16wks/10wks (f39_gdm_new)|SCOPE 0.990 0.019 Inf 0.954 1.027 0.598 ns 16wks/10wks (non-cases)|STOP 0.990 0.019 Inf 0.954 1.027 0.598 ns 16wks/10wks (f39_gdm_new)|STOP 0.990 0.019 Inf 0.954 1.027 0.598 ns 61.1.5.1 Barplots by Timepoint 61.1.5.2 Plots for GA "],["folate-9.html", "61.2 Folate", " 61.2 Folate 61.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 250.7924480 1 &lt;0.0001 *** Study 3.2136720 1 0.07 ns f39_gdm_new 0.5754347 1 0.4 ns BMI 3.3368238 1 0.07 ns Ethnicity_cauc 105.4219556 1 &lt;0.0001 *** f10c_any_cig_1st_vst 49.1590682 1 &lt;0.0001 *** GA_samp 164.6323095 1 &lt;0.0001 *** Study:f39_gdm_new 1.8652579 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.8759535 1 &lt;0.0001 *** Study 7.3986291 1 0.007 ** f39_gdm_new 0.4357432 1 0.5 ns BMI 236.2094019 1 &lt;0.0001 *** Ethnicity_cauc 5.5165373 1 0.02 * f10c_any_cig_1st_vst 0.9176455 1 0.3 ns GA_samp 2601.9722143 1 &lt;0.0001 *** Study:f39_gdm_new 1.4845286 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 251.096669 1 &lt;0.0001 *** Study 1.107622 1 0.3 ns f39_gdm_new 1.386104 1 0.2 ns BMI 87.622496 1 &lt;0.0001 *** Ethnicity_cauc 3.246832 1 0.07 ns f10c_any_cig_1st_vst 1.039153 1 0.3 ns GA_samp 1032.266869 1 &lt;0.0001 *** Study:f39_gdm_new 3.376951 1 0.07 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.326 21.326 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 33.726 33.726 &lt;0.0001 *** 4 BMI 1 Inf 330.722 330.722 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 25.046 25.046 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 3.158 3.158 0.08 ns 7 GA_samp 1 Inf 2.506 2.506 0.1 ns 2 Study:f39_gdm_new 1 Inf 4.089 4.089 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 36.051 36.051 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 32.027 32.027 &lt;0.0001 *** 4 BMI 1 Inf 316.807 316.807 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 24.882 24.882 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 2.618 2.618 0.1 ns 7 GA_samp 1 Inf 1.602 1.602 0.2 ns 2 Study:f39_gdm_new 1 Inf 4.361 4.361 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 53.182 53.182 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 4.345 4.345 0.04 * 4 BMI 1 Inf 11.449 11.449 0.0007 *** 5 Ethnicity_cauc 1 Inf 0.718 0.718 0.4 ns 6 f10c_any_cig_1st_vst 1 Inf 0.028 0.028 0.9 ns 7 GA_samp 1 Inf 0.278 0.278 0.6 ns 2 Study:f39_gdm_new 1 Inf 1.558 1.558 0.2 ns 61.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.75 (2.39, 3.12) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.12 f39_gdm_newGDM -0.11 (-0.35, 0.13) 0.36 StudySTOP -0.08 (-0.21, 0.05) 0.23 GA_samp 0.14 (0.12, 0.16) &lt;0.0001 Folate:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.75 f39_gdm_newGDM:StudySTOP 0.16 (-0.07, 0.38) 0.17 Folate:StudySTOP 0.00 (-0.00, 0.00) 0.10 HPL Var Effect P (Intercept) 0.65 (0.46, 0.84) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.58 f39_gdm_newGDM -0.11 (-0.23, 0.01) 0.07 StudySTOP 0.10 (0.03, 0.17) 0.004 GA_samp 0.29 (0.28, 0.30) &lt;0.0001 Folate:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.28 f39_gdm_newGDM:StudySTOP 0.06 (-0.05, 0.17) 0.31 Folate:StudySTOP -0.00 (-0.00, 0.00) 0.89 GH2 Var Effect P (Intercept) -2.57 (-2.82, -2.32) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.37 f39_gdm_newGDM -0.17 (-0.34, 0.00) 0.05 StudySTOP -0.01 (-0.11, 0.08) 0.77 GA_samp 0.26 (0.25, 0.28) &lt;0.0001 Folate:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.65 f39_gdm_newGDM:StudySTOP 0.17 (0.00, 0.33) 0.05 Folate:StudySTOP -0.00 (-0.00, 0.00) 0.89 Insulin Var Effect P (Intercept) 2.45 (1.99, 2.91) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.56 f39_gdm_newGDM 0.94 (0.44, 1.44) 0.0002 StudySTOP -0.17 (-0.36, 0.02) 0.07 GA_samp 0.02 (-0.01, 0.05) 0.24 Folate:f39_gdm_newGDM -0.00 (-0.01, 0.00) 0.27 f39_gdm_newGDM:StudySTOP -0.42 (-0.98, 0.13) 0.14 Folate:StudySTOP -0.00 (-0.00, 0.00) 0.24 Folate:f39_gdm_newGDM:StudySTOP 0.00 (-0.00, 0.01) 0.38 HOMA.IR Var Effect P (Intercept) 1.09 (0.60, 1.58) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.54 f39_gdm_newGDM 1.08 (0.52, 1.65) 0.0002 StudySTOP -0.32 (-0.51, -0.12) 0.002 GA_samp 0.01 (-0.02, 0.04) 0.39 Folate:f39_gdm_newGDM -0.00 (-0.01, 0.00) 0.18 f39_gdm_newGDM:StudySTOP -0.51 (-1.13, 0.10) 0.10 Folate:StudySTOP -0.00 (-0.00, 0.00) 0.25 Folate:f39_gdm_newGDM:StudySTOP 0.00 (-0.00, 0.01) 0.33 GLUC3_mmol.L Var Effect P (Intercept) 1.73 (1.63, 1.82) &lt;0.0001 Folate -0.00 (-0.00, 0.00) 0.67 f39_gdm_newGDM 0.16 (0.03, 0.30) 0.02 StudySTOP -0.15 (-0.18, -0.11) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.44 Folate:f39_gdm_newGDM -0.00 (-0.00, -0.00) 0.03 f39_gdm_newGDM:StudySTOP -0.07 (-0.19, 0.04) 0.20 Folate:StudySTOP 0.00 (-0.00, 0.00) 0.61 61.2.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 97.77404 7.328399 86.89088 84.24089 113.4813 STOP non-GDM 95.21737 6.830184 73.12151 82.53345 109.8506 SCOPE GDM 88.89601 11.031476 534.09053 69.66477 113.4361 STOP GDM 101.42073 8.859190 156.34178 85.34803 120.5202 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 89.48653 2.397042 155.4415 84.87464 94.34902 STOP non-GDM 98.99553 2.442050 113.5757 94.27396 103.95357 SCOPE GDM 82.59212 4.500140 823.2588 74.21497 91.91486 STOP GDM 96.91737 3.552318 432.8746 90.18100 104.15695 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.358518 0.0675800 372.7572 2.229306 2.495219 STOP non-GDM 2.316497 0.0571383 254.7097 2.206662 2.431798 SCOPE GDM 2.022779 0.1546622 1400.9025 1.741041 2.350107 STOP GDM 2.343339 0.1019796 804.3136 2.151473 2.552315 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 14.21264 0.7009927 Inf 12.90303 15.65516 STOP non-GDM 11.34214 0.4379906 Inf 10.51538 12.23391 SCOPE GDM 32.57401 5.7010512 Inf 23.11508 45.90365 STOP GDM 18.90218 1.4998809 Inf 16.17966 22.08281 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.444485 0.1804177 Inf 3.108418 3.816885 STOP non-GDM 2.366071 0.0958502 Inf 2.185472 2.561593 SCOPE GDM 8.779249 1.7041093 Inf 6.001138 12.843433 STOP GDM 4.100215 0.3501282 Inf 3.468329 4.847223 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.431002 0.0507757 Inf 5.332390 5.531438 STOP non-GDM 4.701537 0.0367122 Inf 4.630130 4.774045 SCOPE GDM 6.129766 0.3417906 Inf 5.495177 6.837639 STOP GDM 4.927915 0.0698577 Inf 4.792881 5.066753 61.2.4 Comparisons 61.2.4.1 Within Groups Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin Folate40.2 / Folate39.2 SCOPE non-GDM 0.999 (0.998, 1.000) 0.1 Prolactin Folate40.2 / Folate39.2 STOP non-GDM 1.000 (0.999, 1.001) 0.5 Prolactin Folate40.2 / Folate39.2 SCOPE GDM 0.999 (0.997, 1.002) 0.6 Prolactin Folate40.2 / Folate39.2 STOP GDM 1.001 (0.998, 1.003) 0.5 HPL Folate40.2 / Folate39.2 SCOPE non-GDM 1.000 (0.999, 1.000) 0.6 HPL Folate40.2 / Folate39.2 STOP non-GDM 1.000 (0.999, 1.000) 0.4 HPL Folate40.2 / Folate39.2 SCOPE GDM 1.001 (0.999, 1.002) 0.5 HPL Folate40.2 / Folate39.2 STOP GDM 1.000 (0.999, 1.002) 0.5 GH2 Folate40.2 / Folate39.2 SCOPE non-GDM 1.000 (0.999, 1.001) 0.4 GH2 Folate40.2 / Folate39.2 STOP non-GDM 0.999 (0.999, 1.000) 0.2 GH2 Folate40.2 / Folate39.2 SCOPE GDM 1.000 (0.998, 1.002) 1.0 GH2 Folate40.2 / Folate39.2 STOP GDM 1.000 (0.998, 1.002) 0.9 Insulin Folate40.2 / Folate39.2 SCOPE non-GDM 0.999 (0.997, 1.001) 0.6 Insulin Folate40.2 / Folate39.2 STOP non-GDM 0.998 (0.997, 0.999) 0.002 Insulin Folate40.2 / Folate39.2 SCOPE GDM 0.997 (0.992, 1.001) 0.1 Insulin Folate40.2 / Folate39.2 STOP GDM 0.998 (0.995, 1.001) 0.2 HOMA.IR Folate40.2 / Folate39.2 SCOPE non-GDM 0.999 (0.997, 1.001) 0.5 HOMA.IR Folate40.2 / Folate39.2 STOP non-GDM 0.998 (0.997, 0.999) 0.002 HOMA.IR Folate40.2 / Folate39.2 SCOPE GDM 0.996 (0.991, 1.001) 0.09 HOMA.IR Folate40.2 / Folate39.2 STOP GDM 0.997 (0.994, 1.001) 0.1 GLUC3_mmol.L Folate40.2 / Folate39.2 SCOPE non-GDM 1.000 (1.000, 1.000) 0.7 GLUC3_mmol.L Folate40.2 / Folate39.2 STOP non-GDM 1.000 (1.000, 1.000) 0.7 GLUC3_mmol.L Folate40.2 / Folate39.2 SCOPE GDM 0.999 (0.998, 1.000) 0.05 GLUC3_mmol.L Folate40.2 / Folate39.2 STOP GDM 0.999 (0.998, 1.000) 0.01 61.2.4.2 Between Groups Below are comparisons of the differences in the change in Serum folate concentration (nM) between groups. I.e. whether the change in Serum folate concentration (nM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.002779 0.0017041 2094.601 0.9994426 1.006127 0.103 ns STOP/SCOPE (non-GDM) 1.001389 0.0008509 2094.601 0.9997213 1.003059 0.103 ns STOP/SCOPE (GDM) 1.001389 0.0008509 2094.601 0.9997213 1.003059 0.103 ns GDM/non-GDM (SCOPE) 1.000395 0.0012409 2037.473 0.9979647 1.002832 0.750 ns GDM/non-GDM (STOP) 1.000395 0.0012409 2037.473 0.9979647 1.002832 0.750 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9998737 0.0009085 1994.048 0.9980936 1.001657 0.889 ns STOP/SCOPE (non-GDM) 0.9999368 0.0004543 1994.048 0.9990463 1.000828 0.889 ns STOP/SCOPE (GDM) 0.9999368 0.0004543 1994.048 0.9990463 1.000828 0.889 ns GDM/non-GDM (SCOPE) 1.0007340 0.0006793 1984.351 0.9994026 1.002067 0.280 ns GDM/non-GDM (STOP) 1.0007340 0.0006793 1984.351 0.9994026 1.002067 0.280 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9998217 0.0012642 2132.661 0.9973455 1.002304 0.888 ns STOP/SCOPE (non-GDM) 0.9999109 0.0006322 2132.661 0.9986719 1.001151 0.888 ns STOP/SCOPE (GDM) 0.9999109 0.0006322 2132.661 0.9986719 1.001151 0.888 ns GDM/non-GDM (SCOPE) 1.0004210 0.0009372 2124.039 0.9985847 1.002261 0.653 ns GDM/non-GDM (STOP) 1.0004210 0.0009372 2124.039 0.9985847 1.002261 0.653 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9998688 0.0030312 Inf 0.9939453 1.005828 0.965 ns STOP/SCOPE (non-GDM) 0.9986023 0.0011978 Inf 0.9962573 1.000953 0.244 ns STOP/SCOPE (GDM) 1.0012683 0.0027886 Inf 0.9958176 1.006749 0.649 ns GDM/non-GDM (SCOPE) 0.9972847 0.0024473 Inf 0.9924996 1.002093 0.268 ns GDM/non-GDM (STOP) 0.9999472 0.0017836 Inf 0.9964576 1.003449 0.976 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0002609 0.0033478 Inf 0.9937207 1.006844 0.938 ns STOP/SCOPE (non-GDM) 0.9985119 0.0012831 Inf 0.9960002 1.001030 0.246 ns STOP/SCOPE (GDM) 1.0017516 0.0030963 Inf 0.9957013 1.007839 0.571 ns GDM/non-GDM (SCOPE) 0.9962530 0.0027774 Inf 0.9908243 1.001712 0.178 ns GDM/non-GDM (STOP) 0.9994854 0.0018533 Inf 0.9958597 1.003124 0.781 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0002587 0.0005109 Inf 0.9992579 1.0012605 0.613 ns STOP/SCOPE (non-GDM) 1.0001294 0.0002554 Inf 0.9996289 1.0006301 0.613 ns STOP/SCOPE (GDM) 1.0001294 0.0002554 Inf 0.9996289 1.0006301 0.613 ns GDM/non-GDM (SCOPE) 0.9989546 0.0004852 Inf 0.9980040 0.9999061 0.031 * GDM/non-GDM (STOP) 0.9989546 0.0004852 Inf 0.9980040 0.9999061 0.031 * 61.2.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 61.2.6 Plots "],["b12-9.html", "61.3 B12", " 61.3 B12 61.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 250.7924480 1 &lt;0.0001 *** Study 3.2136720 1 0.07 ns f39_gdm_new 0.5754347 1 0.4 ns BMI 3.3368238 1 0.07 ns Ethnicity_cauc 105.4219556 1 &lt;0.0001 *** f10c_any_cig_1st_vst 49.1590682 1 &lt;0.0001 *** GA_samp 164.6323095 1 &lt;0.0001 *** Study:f39_gdm_new 1.8652579 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.8759535 1 &lt;0.0001 *** Study 7.3986291 1 0.007 ** f39_gdm_new 0.4357432 1 0.5 ns BMI 236.2094019 1 &lt;0.0001 *** Ethnicity_cauc 5.5165373 1 0.02 * f10c_any_cig_1st_vst 0.9176455 1 0.3 ns GA_samp 2601.9722143 1 &lt;0.0001 *** Study:f39_gdm_new 1.4845286 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 251.096669 1 &lt;0.0001 *** Study 1.107622 1 0.3 ns f39_gdm_new 1.386104 1 0.2 ns BMI 87.622496 1 &lt;0.0001 *** Ethnicity_cauc 3.246832 1 0.07 ns f10c_any_cig_1st_vst 1.039153 1 0.3 ns GA_samp 1032.266869 1 &lt;0.0001 *** Study:f39_gdm_new 3.376951 1 0.07 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.326 21.326 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 33.726 33.726 &lt;0.0001 *** 4 BMI 1 Inf 330.722 330.722 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 25.046 25.046 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 3.158 3.158 0.08 ns 7 GA_samp 1 Inf 2.506 2.506 0.1 ns 2 Study:f39_gdm_new 1 Inf 4.089 4.089 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 36.051 36.051 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 32.027 32.027 &lt;0.0001 *** 4 BMI 1 Inf 316.807 316.807 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 24.882 24.882 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 2.618 2.618 0.1 ns 7 GA_samp 1 Inf 1.602 1.602 0.2 ns 2 Study:f39_gdm_new 1 Inf 4.361 4.361 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 53.182 53.182 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 4.345 4.345 0.04 * 4 BMI 1 Inf 11.449 11.449 0.0007 *** 5 Ethnicity_cauc 1 Inf 0.718 0.718 0.4 ns 6 f10c_any_cig_1st_vst 1 Inf 0.028 0.028 0.9 ns 7 GA_samp 1 Inf 0.278 0.278 0.6 ns 2 Study:f39_gdm_new 1 Inf 1.558 1.558 0.2 ns 61.3.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.58 (2.21, 2.96) &lt;0.0001 B12 0.00 (-0.00, 0.00) 0.05 f39_gdm_newGDM -0.14 (-0.42, 0.15) 0.35 StudySTOP -0.02 (-0.20, 0.16) 0.84 GA_samp 0.14 (0.12, 0.16) &lt;0.0001 B12:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.67 f39_gdm_newGDM:StudySTOP 0.16 (-0.06, 0.39) 0.16 B12:StudySTOP -0.00 (-0.00, 0.00) 0.87 HPL Var Effect P (Intercept) 0.57 (0.37, 0.76) &lt;0.0001 B12 0.00 (-0.00, 0.00) 0.08 f39_gdm_newGDM -0.01 (-0.16, 0.13) 0.86 StudySTOP 0.09 (-0.01, 0.19) 0.07 GA_samp 0.29 (0.28, 0.30) &lt;0.0001 B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.22 f39_gdm_newGDM:StudySTOP 0.08 (-0.04, 0.19) 0.18 B12:StudySTOP 0.00 (-0.00, 0.00) 0.96 GH2 Var Effect P (Intercept) -2.81 (-3.07, -2.54) &lt;0.0001 B12 0.00 (0.00, 0.00) &lt;0.0001 f39_gdm_newGDM -0.18 (-0.39, 0.02) 0.09 StudySTOP 0.10 (-0.04, 0.23) 0.16 GA_samp 0.26 (0.25, 0.28) &lt;0.0001 B12:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.82 f39_gdm_newGDM:StudySTOP 0.19 (0.02, 0.35) 0.03 B12:StudySTOP -0.00 (-0.00, -0.00) 0.02 Insulin Var Effect P (Intercept) 2.56 (2.07, 3.06) &lt;0.0001 B12 -0.00 (-0.00, 0.00) 0.13 f39_gdm_newGDM 1.24 (0.32, 2.17) 0.009 StudySTOP -0.30 (-0.56, -0.03) 0.03 GA_samp 0.02 (-0.01, 0.05) 0.24 B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.25 f39_gdm_newGDM:StudySTOP -0.61 (-1.61, 0.39) 0.23 B12:StudySTOP 0.00 (-0.00, 0.00) 0.60 B12:f39_gdm_newGDM:StudySTOP 0.00 (-0.00, 0.00) 0.42 HOMA.IR Var Effect P (Intercept) 1.19 (0.67, 1.71) &lt;0.0001 B12 -0.00 (-0.00, 0.00) 0.16 f39_gdm_newGDM 1.28 (0.24, 2.32) 0.02 StudySTOP -0.45 (-0.73, -0.16) 0.002 GA_samp 0.01 (-0.02, 0.04) 0.38 B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.36 f39_gdm_newGDM:StudySTOP -0.60 (-1.71, 0.51) 0.29 B12:StudySTOP 0.00 (-0.00, 0.00) 0.63 B12:f39_gdm_newGDM:StudySTOP 0.00 (-0.00, 0.00) 0.55 GLUC3_mmol.L Var Effect P (Intercept) 1.74 (1.65, 1.84) &lt;0.0001 B12 -0.00 (-0.00, 0.00) 0.16 f39_gdm_newGDM 0.11 (-0.04, 0.26) 0.15 StudySTOP -0.15 (-0.20, -0.11) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.46 B12:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.85 f39_gdm_newGDM:StudySTOP -0.08 (-0.20, 0.03) 0.16 B12:StudySTOP 0.00 (-0.00, 0.00) 0.55 61.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 99.48282 7.527503 90.84823 85.59952 115.6178 STOP non-GDM 96.25826 6.870852 72.18811 83.49184 110.9767 SCOPE GDM 91.16056 11.371799 545.10747 71.34899 116.4732 STOP GDM 103.59983 8.934423 149.87271 87.36834 122.8469 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 90.26660 2.468158 171.5369 85.52386 95.27234 STOP non-GDM 99.14269 2.415073 110.2077 94.47037 104.04610 SCOPE GDM 82.56036 4.512539 818.3553 74.16144 91.91047 STOP GDM 97.86903 3.519895 414.0479 91.18886 105.03858 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.436758 0.0725078 439.7072 2.298340 2.583512 STOP non-GDM 2.314613 0.0556715 242.8413 2.207509 2.426912 SCOPE GDM 2.072222 0.1583053 1395.6170 1.783829 2.407240 STOP GDM 2.371184 0.1004585 760.9642 2.181953 2.576826 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 13.77965 0.7143520 Inf 12.44832 15.25335 STOP non-GDM 10.98705 0.4168576 Inf 10.19966 11.83522 SCOPE GDM 27.81263 3.7909330 Inf 21.29222 36.32980 STOP GDM 18.16724 1.3699737 Inf 15.67114 21.06091 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.336606 0.1841394 Inf 2.994533 3.717755 STOP non-GDM 2.287398 0.0913192 Inf 2.115239 2.473569 SCOPE GDM 7.442549 1.1042775 Inf 5.564496 9.954455 STOP GDM 3.907561 0.3165887 Inf 3.333817 4.580044 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.402700 0.0546200 Inf 5.296700 5.510821 STOP non-GDM 4.703314 0.0358930 Inf 4.633488 4.774191 SCOPE GDM 6.070570 0.3237354 Inf 5.468094 6.739426 STOP GDM 4.866900 0.0625328 Inf 4.745869 4.991019 61.3.4 Comparisons 61.3.4.1 Within Groups Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin B12366 / B12266 SCOPE non-GDM 1.044 (0.999, 1.092) 0.05 Prolactin B12366 / B12266 STOP non-GDM 1.040 (1.007, 1.074) 0.02 Prolactin B12366 / B12266 SCOPE GDM 1.061 (0.978, 1.150) 0.2 Prolactin B12366 / B12266 STOP GDM 1.056 (0.989, 1.128) 0.1 HPL B12366 / B12266 SCOPE non-GDM 1.022 (0.998, 1.046) 0.08 HPL B12366 / B12266 STOP non-GDM 1.022 (1.005, 1.041) 0.01 HPL B12366 / B12266 SCOPE GDM 0.997 (0.955, 1.041) 0.9 HPL B12366 / B12266 STOP GDM 0.998 (0.963, 1.034) 0.9 GH2 B12366 / B12266 SCOPE non-GDM 1.073 (1.038, 1.109) &lt;0.0001 GH2 B12366 / B12266 STOP non-GDM 1.024 (1.000, 1.049) 0.05 GH2 B12366 / B12266 SCOPE GDM 1.080 (1.016, 1.147) 0.01 GH2 B12366 / B12266 STOP GDM 1.031 (0.981, 1.083) 0.2 Insulin B12366 / B12266 SCOPE non-GDM 0.948 (0.885, 1.016) 0.1 Insulin B12366 / B12266 STOP non-GDM 0.969 (0.925, 1.016) 0.2 Insulin B12366 / B12266 SCOPE GDM 0.799 (0.600, 1.064) 0.1 Insulin B12366 / B12266 STOP GDM 0.929 (0.841, 1.026) 0.1 HOMA.IR B12366 / B12266 SCOPE non-GDM 0.948 (0.880, 1.021) 0.2 HOMA.IR B12366 / B12266 STOP non-GDM 0.969 (0.922, 1.018) 0.2 HOMA.IR B12366 / B12266 SCOPE GDM 0.815 (0.594, 1.117) 0.2 HOMA.IR B12366 / B12266 STOP GDM 0.925 (0.831, 1.029) 0.1 GLUC3_mmol.L B12366 / B12266 SCOPE non-GDM 0.991 (0.979, 1.004) 0.2 GLUC3_mmol.L B12366 / B12266 STOP non-GDM 0.996 (0.988, 1.003) 0.3 GLUC3_mmol.L B12366 / B12266 SCOPE GDM 0.994 (0.964, 1.024) 0.7 GLUC3_mmol.L B12366 / B12266 STOP GDM 0.998 (0.977, 1.020) 0.9 61.3.4.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9913717 0.0545354 2067.758 0.8899886 1.104304 0.875 ns STOP/SCOPE (non-GDM) 0.9956765 0.0273861 2067.758 0.9433921 1.050859 0.875 ns STOP/SCOPE (GDM) 0.9956765 0.0273861 2067.758 0.9433921 1.050859 0.875 ns GDM/non-GDM (SCOPE) 1.0156870 0.0371835 2042.467 0.9453216 1.091290 0.671 ns GDM/non-GDM (STOP) 1.0156870 0.0371835 2042.467 0.9453216 1.091290 0.671 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0014580 0.0295309 1931.787 0.9451851 1.061081 0.961 ns STOP/SCOPE (non-GDM) 1.0007287 0.0147547 1931.787 0.9722063 1.030088 0.961 ns STOP/SCOPE (GDM) 1.0007287 0.0147547 1931.787 0.9722063 1.030088 0.961 ns GDM/non-GDM (SCOPE) 0.9763306 0.0192592 1973.738 0.9392813 1.014841 0.225 ns GDM/non-GDM (STOP) 0.9763306 0.0192592 1973.738 0.9392813 1.014841 0.225 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9111097 0.0372634 2095.061 0.8408864 0.9871974 0.023 * STOP/SCOPE (non-GDM) 0.9545206 0.0195194 2095.061 0.9169986 0.9935781 0.023 * STOP/SCOPE (GDM) 0.9545206 0.0195194 2095.061 0.9169986 0.9935781 0.023 * GDM/non-GDM (SCOPE) 1.0064190 0.0275758 2103.809 0.9537676 1.0619770 0.815 ns GDM/non-GDM (STOP) 1.0064190 0.0275758 2103.809 0.9537676 1.0619770 0.815 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.1891756 0.1906466 Inf 0.8685259 1.628205 0.280 ns STOP/SCOPE (non-GDM) 1.0222629 0.0433951 Inf 0.9406521 1.110954 0.604 ns STOP/SCOPE (GDM) 1.1632777 0.1798378 Inf 0.8591940 1.574982 0.328 ns GDM/non-GDM (SCOPE) 0.8423908 0.1265802 Inf 0.6274940 1.130883 0.254 ns GDM/non-GDM (STOP) 0.9585934 0.0535768 Inf 0.8591319 1.069570 0.449 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.1596192 0.2039332 Inf 0.8215258 1.636853 0.400 ns STOP/SCOPE (non-GDM) 1.0217772 0.0463690 Inf 0.9348201 1.116823 0.635 ns STOP/SCOPE (GDM) 1.1349042 0.1928267 Inf 0.8134581 1.583373 0.456 ns GDM/non-GDM (SCOPE) 0.8593715 0.1420847 Inf 0.6215084 1.188269 0.359 ns GDM/non-GDM (STOP) 0.9545175 0.0572632 Inf 0.8486308 1.073616 0.438 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.009181 0.0155431 Inf 0.9791723 1.040109 0.553 ns STOP/SCOPE (non-GDM) 1.004580 0.0077361 Inf 0.9895313 1.019858 0.553 ns STOP/SCOPE (GDM) 1.004580 0.0077361 Inf 0.9895313 1.019858 0.553 ns GDM/non-GDM (SCOPE) 1.002406 0.0127711 Inf 0.9776852 1.027752 0.850 ns GDM/non-GDM (STOP) 1.002406 0.0127711 Inf 0.9776852 1.027752 0.850 ns 61.3.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 98.40719 7.379890 87.68820 84.78112 114.2233 STOP non-GDM 95.32069 6.798638 71.96751 82.68715 109.8845 SCOPE GDM 89.82470 11.103764 530.19810 70.45843 114.5140 STOP GDM 102.19232 8.780994 147.75222 86.23305 121.1052 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 89.78496 2.407079 159.1047 85.15468 94.66702 STOP non-GDM 98.59574 2.398004 109.5640 93.95596 103.46463 SCOPE GDM 82.61309 4.461095 808.5369 74.30451 91.85071 STOP GDM 97.91371 3.500391 404.8910 91.26874 105.04249 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.394278 0.0688602 393.2630 2.262654 2.533559 STOP non-GDM 2.300881 0.0551683 240.6173 2.194733 2.412163 SCOPE GDM 2.032842 0.1535026 1385.4263 1.752961 2.357411 STOP GDM 2.353349 0.0987469 746.1677 2.167264 2.555412 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 13.96429 0.6920242 Inf 12.67174 15.38869 STOP non-GDM 11.07315 0.4138377 Inf 10.29104 11.91470 SCOPE GDM 29.42012 4.0226695 Inf 22.50391 38.46191 STOP GDM 18.50421 1.3916351 Inf 15.96816 21.44304 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.381458 0.1782188 Inf 3.049592 3.749440 STOP non-GDM 2.305694 0.0907315 Inf 2.134549 2.490562 SCOPE GDM 7.833855 1.1876586 Inf 5.820072 10.544420 STOP GDM 3.984922 0.3226905 Inf 3.400097 4.670338 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.414391 0.0518294 Inf 5.313754 5.516934 STOP non-GDM 4.708110 0.0358237 Inf 4.638418 4.778849 SCOPE GDM 6.080052 0.3296930 Inf 5.467019 6.761827 STOP GDM 4.868938 0.0624862 Inf 4.747994 4.992961 61.3.6 Comparisons (50 unit increase) 61.3.6.1 Within Groups Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin B12316 / B12266 SCOPE non-GDM 1.022 (1.000, 1.045) 0.05 Prolactin B12316 / B12266 STOP non-GDM 1.020 (1.003, 1.036) 0.02 Prolactin B12316 / B12266 SCOPE GDM 1.030 (0.989, 1.073) 0.2 Prolactin B12316 / B12266 STOP GDM 1.028 (0.994, 1.062) 0.1 HPL B12316 / B12266 SCOPE non-GDM 1.011 (0.999, 1.023) 0.08 HPL B12316 / B12266 STOP non-GDM 1.011 (1.002, 1.020) 0.01 HPL B12316 / B12266 SCOPE GDM 0.999 (0.977, 1.020) 0.9 HPL B12316 / B12266 STOP GDM 0.999 (0.981, 1.017) 0.9 GH2 B12316 / B12266 SCOPE non-GDM 1.036 (1.019, 1.053) &lt;0.0001 GH2 B12316 / B12266 STOP non-GDM 1.012 (1.000, 1.024) 0.05 GH2 B12316 / B12266 SCOPE GDM 1.039 (1.008, 1.071) 0.01 GH2 B12316 / B12266 STOP GDM 1.015 (0.990, 1.041) 0.2 Insulin B12316 / B12266 SCOPE non-GDM 0.974 (0.941, 1.008) 0.1 Insulin B12316 / B12266 STOP non-GDM 0.985 (0.962, 1.008) 0.2 Insulin B12316 / B12266 SCOPE GDM 0.894 (0.774, 1.031) 0.1 Insulin B12316 / B12266 STOP GDM 0.964 (0.917, 1.013) 0.1 HOMA.IR B12316 / B12266 SCOPE non-GDM 0.974 (0.938, 1.010) 0.2 HOMA.IR B12316 / B12266 STOP non-GDM 0.984 (0.960, 1.009) 0.2 HOMA.IR B12316 / B12266 SCOPE GDM 0.903 (0.771, 1.057) 0.2 HOMA.IR B12316 / B12266 STOP GDM 0.962 (0.912, 1.014) 0.1 GLUC3_mmol.L B12316 / B12266 SCOPE non-GDM 0.996 (0.990, 1.002) 0.2 GLUC3_mmol.L B12316 / B12266 STOP non-GDM 0.998 (0.994, 1.002) 0.3 GLUC3_mmol.L B12316 / B12266 SCOPE GDM 0.997 (0.982, 1.012) 0.7 GLUC3_mmol.L B12316 / B12266 STOP GDM 0.999 (0.988, 1.010) 0.9 61.3.6.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9956765 0.0273861 2067.758 0.9433921 1.050859 0.875 ns STOP/SCOPE (non-GDM) 0.9978359 0.0137227 2067.758 0.9712837 1.025114 0.875 ns STOP/SCOPE (GDM) 0.9978359 0.0137227 2067.758 0.9712837 1.025114 0.875 ns GDM/non-GDM (SCOPE) 1.0078130 0.0184476 2042.467 0.9722765 1.044648 0.671 ns GDM/non-GDM (STOP) 1.0078130 0.0184476 2042.467 0.9722765 1.044648 0.671 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0007287 0.0147547 1931.787 0.9722063 1.030088 0.961 ns STOP/SCOPE (non-GDM) 1.0003643 0.0073747 1931.787 0.9860052 1.014933 0.961 ns STOP/SCOPE (GDM) 1.0003643 0.0073747 1931.787 0.9860052 1.014933 0.961 ns GDM/non-GDM (SCOPE) 0.9880944 0.0097456 1973.738 0.9691653 1.007393 0.225 ns GDM/non-GDM (STOP) 0.9880944 0.0097456 1973.738 0.9691653 1.007393 0.225 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9545206 0.0195194 2095.061 0.9169986 0.9935781 0.023 * STOP/SCOPE (non-GDM) 0.9769957 0.0099895 2095.061 0.9576004 0.9967839 0.023 * STOP/SCOPE (GDM) 0.9769957 0.0099895 2095.061 0.9576004 0.9967839 0.023 * GDM/non-GDM (SCOPE) 1.0032044 0.0137439 2103.809 0.9766102 1.0305227 0.815 ns GDM/non-GDM (STOP) 1.0032044 0.0137439 2103.809 0.9766102 1.0305227 0.815 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0904933 0.0874130 Inf 0.9319474 1.276012 0.280 ns STOP/SCOPE (non-GDM) 1.0110702 0.0214600 Inf 0.9698722 1.054018 0.604 ns STOP/SCOPE (GDM) 1.0785535 0.0833699 Inf 0.9269272 1.254983 0.328 ns GDM/non-GDM (SCOPE) 0.9178185 0.0689571 Inf 0.7921452 1.063430 0.254 ns GDM/non-GDM (STOP) 0.9790778 0.0273609 Inf 0.9268937 1.034200 0.449 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0768562 0.0946892 Inf 0.9063806 1.279395 0.400 ns STOP/SCOPE (non-GDM) 1.0108300 0.0229361 Inf 0.9668610 1.056798 0.635 ns STOP/SCOPE (GDM) 1.0653188 0.0905019 Inf 0.9019191 1.258322 0.456 ns GDM/non-GDM (SCOPE) 0.9270229 0.0766349 Inf 0.7883581 1.090078 0.359 ns GDM/non-GDM (STOP) 0.9769941 0.0293058 Inf 0.9212116 1.036155 0.438 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.004580 0.0077361 Inf 0.9895313 1.019858 0.553 ns STOP/SCOPE (non-GDM) 1.002287 0.0038592 Inf 0.9947519 1.009880 0.553 ns STOP/SCOPE (GDM) 1.002287 0.0038592 Inf 0.9947519 1.009880 0.553 ns GDM/non-GDM (SCOPE) 1.001202 0.0063779 Inf 0.9887796 1.013781 0.850 ns GDM/non-GDM (STOP) 1.001202 0.0063779 Inf 0.9887796 1.013781 0.850 ns 61.3.7 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 61.3.8 Plots "],["folateb12-9.html", "61.4 Folate:B12", " 61.4 Folate:B12 61.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 250.7924480 1 &lt;0.0001 *** Study 3.2136720 1 0.07 ns f39_gdm_new 0.5754347 1 0.4 ns BMI 3.3368238 1 0.07 ns Ethnicity_cauc 105.4219556 1 &lt;0.0001 *** f10c_any_cig_1st_vst 49.1590682 1 &lt;0.0001 *** GA_samp 164.6323095 1 &lt;0.0001 *** Study:f39_gdm_new 1.8652579 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.8759535 1 &lt;0.0001 *** Study 7.3986291 1 0.007 ** f39_gdm_new 0.4357432 1 0.5 ns BMI 236.2094019 1 &lt;0.0001 *** Ethnicity_cauc 5.5165373 1 0.02 * f10c_any_cig_1st_vst 0.9176455 1 0.3 ns GA_samp 2601.9722143 1 &lt;0.0001 *** Study:f39_gdm_new 1.4845286 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 251.096669 1 &lt;0.0001 *** Study 1.107622 1 0.3 ns f39_gdm_new 1.386104 1 0.2 ns BMI 87.622496 1 &lt;0.0001 *** Ethnicity_cauc 3.246832 1 0.07 ns f10c_any_cig_1st_vst 1.039153 1 0.3 ns GA_samp 1032.266869 1 &lt;0.0001 *** Study:f39_gdm_new 3.376951 1 0.07 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.326 21.326 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 33.726 33.726 &lt;0.0001 *** 4 BMI 1 Inf 330.722 330.722 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 25.046 25.046 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 3.158 3.158 0.08 ns 7 GA_samp 1 Inf 2.506 2.506 0.1 ns 2 Study:f39_gdm_new 1 Inf 4.089 4.089 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 36.051 36.051 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 32.027 32.027 &lt;0.0001 *** 4 BMI 1 Inf 316.807 316.807 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 24.882 24.882 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 2.618 2.618 0.1 ns 7 GA_samp 1 Inf 1.602 1.602 0.2 ns 2 Study:f39_gdm_new 1 Inf 4.361 4.361 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 53.182 53.182 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 4.345 4.345 0.04 * 4 BMI 1 Inf 11.449 11.449 0.0007 *** 5 Ethnicity_cauc 1 Inf 0.718 0.718 0.4 ns 6 f10c_any_cig_1st_vst 1 Inf 0.028 0.028 0.9 ns 7 GA_samp 1 Inf 0.278 0.278 0.6 ns 2 Study:f39_gdm_new 1 Inf 1.558 1.558 0.2 ns 61.4.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.75 (2.39, 3.11) &lt;0.0001 folate_B12 -0.00 (-0.00, 0.00) 0.08 f39_gdm_newGDM -0.10 (-0.33, 0.13) 0.38 StudySTOP -0.07 (-0.20, 0.05) 0.25 GA_samp 0.14 (0.12, 0.16) &lt;0.0001 folate_B12:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.79 f39_gdm_newGDM:StudySTOP 0.16 (-0.07, 0.38) 0.17 folate_B12:StudySTOP 0.00 (-0.00, 0.00) 0.09 HPL Var Effect P (Intercept) 0.64 (0.46, 0.83) &lt;0.0001 folate_B12 -0.00 (-0.00, 0.00) 0.71 f39_gdm_newGDM -0.07 (-0.18, 0.04) 0.24 StudySTOP 0.11 (0.04, 0.18) 0.001 GA_samp 0.29 (0.28, 0.30) &lt;0.0001 folate_B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.84 f39_gdm_newGDM:StudySTOP 0.06 (-0.05, 0.18) 0.27 folate_B12:StudySTOP -0.00 (-0.00, 0.00) 0.53 GH2 Var Effect P (Intercept) -2.55 (-2.80, -2.30) &lt;0.0001 folate_B12 -0.00 (-0.00, -0.00) 0.01 f39_gdm_newGDM -0.16 (-0.32, 0.01) 0.06 StudySTOP -0.03 (-0.12, 0.06) 0.48 GA_samp 0.26 (0.25, 0.28) &lt;0.0001 folate_B12:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.77 f39_gdm_newGDM:StudySTOP 0.17 (0.00, 0.33) 0.05 folate_B12:StudySTOP 0.00 (-0.00, 0.00) 0.62 Insulin Var Effect P (Intercept) 2.39 (1.93, 2.85) &lt;0.0001 folate_B12 0.00 (-0.00, 0.00) 0.87 f39_gdm_newGDM 0.79 (0.34, 1.23) 0.0005 StudySTOP -0.19 (-0.36, -0.02) 0.03 GA_samp 0.02 (-0.01, 0.05) 0.20 folate_B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.98 f39_gdm_newGDM:StudySTOP -0.28 (-0.76, 0.21) 0.27 folate_B12:StudySTOP -0.00 (-0.00, 0.00) 0.25 folate_B12:f39_gdm_newGDM:StudySTOP 0.00 (-0.00, 0.00) 0.94 HOMA.IR Var Effect P (Intercept) 1.02 (0.53, 1.50) &lt;0.0001 folate_B12 0.00 (-0.00, 0.00) 0.89 f39_gdm_newGDM 0.91 (0.41, 1.40) 0.0003 StudySTOP -0.34 (-0.52, -0.16) 0.0003 GA_samp 0.02 (-0.01, 0.05) 0.32 folate_B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.81 f39_gdm_newGDM:StudySTOP -0.36 (-0.90, 0.19) 0.20 folate_B12:StudySTOP -0.00 (-0.00, 0.00) 0.25 folate_B12:f39_gdm_newGDM:StudySTOP 0.00 (-0.00, 0.00) 0.84 GLUC3_mmol.L Var Effect P (Intercept) 1.72 (1.62, 1.81) &lt;0.0001 folate_B12 0.00 (-0.00, 0.00) 0.94 f39_gdm_newGDM 0.14 (0.01, 0.27) 0.03 StudySTOP -0.15 (-0.18, -0.11) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.52 folate_B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.18 f39_gdm_newGDM:StudySTOP -0.08 (-0.19, 0.04) 0.18 folate_B12:StudySTOP 0.00 (-0.00, 0.00) 0.57 61.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 97.20412 7.281342 86.51760 83.75653 112.8108 STOP non-GDM 95.58684 6.831944 71.92643 82.89315 110.2243 SCOPE GDM 88.72606 10.976535 527.10852 69.58321 113.1352 STOP GDM 102.20950 8.817559 148.76685 86.18988 121.2066 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 89.39632 2.386189 154.4630 84.80467 94.23659 STOP non-GDM 98.68489 2.406359 109.2051 94.02907 103.57123 SCOPE GDM 83.02221 4.493204 800.7892 74.65469 92.32759 STOP GDM 97.59695 3.506629 407.6971 90.94143 104.73956 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.349434 0.0669864 371.0951 2.221338 2.484917 STOP non-GDM 2.302558 0.0555231 236.1645 2.195732 2.414582 SCOPE GDM 2.025946 0.1537443 1373.2989 1.745722 2.351151 STOP GDM 2.343037 0.0992274 751.0354 2.156119 2.546160 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 14.12243 0.6925753 Inf 12.82820 15.54723 STOP non-GDM 11.08270 0.4161006 Inf 10.29644 11.92900 SCOPE GDM 30.92614 4.9114459 Inf 22.65398 42.21889 STOP GDM 18.56835 1.4196529 Inf 15.98433 21.57011 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.418868 0.1780292 Inf 3.087152 3.786226 STOP non-GDM 2.307994 0.0911998 Inf 2.135992 2.493846 SCOPE GDM 8.231226 1.4380393 Inf 5.844603 11.592417 STOP GDM 4.003332 0.3292095 Inf 3.407407 4.703479 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.425348 0.0505319 Inf 5.327206 5.525298 STOP non-GDM 4.708502 0.0360794 Inf 4.638316 4.779750 SCOPE GDM 6.079494 0.3285876 Inf 5.468412 6.758863 STOP GDM 4.880484 0.0623350 Inf 4.759827 5.004201 61.4.4 Comparisons 61.4.4.1 Within Groups Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin folate_B12245.96 / folate_B12145.96 SCOPE non-GDM 0.979 (0.956, 1.003) 0.08 Prolactin folate_B12245.96 / folate_B12145.96 STOP non-GDM 1.008 (0.983, 1.033) 0.5 Prolactin folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.985 (0.937, 1.036) 0.6 Prolactin folate_B12245.96 / folate_B12145.96 STOP GDM 1.014 (0.973, 1.057) 0.5 HPL folate_B12245.96 / folate_B12145.96 SCOPE non-GDM 0.998 (0.985, 1.010) 0.7 HPL folate_B12245.96 / folate_B12145.96 STOP non-GDM 0.992 (0.978, 1.005) 0.2 HPL folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.995 (0.969, 1.022) 0.7 HPL folate_B12245.96 / folate_B12145.96 STOP GDM 0.989 (0.967, 1.012) 0.3 GH2 folate_B12245.96 / folate_B12145.96 SCOPE non-GDM 0.978 (0.961, 0.996) 0.01 GH2 folate_B12245.96 / folate_B12145.96 STOP non-GDM 0.984 (0.966, 1.003) 0.1 GH2 folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.983 (0.947, 1.021) 0.4 GH2 folate_B12245.96 / folate_B12145.96 STOP GDM 0.990 (0.959, 1.021) 0.5 Insulin folate_B12245.96 / folate_B12145.96 SCOPE non-GDM 1.003 (0.967, 1.040) 0.9 Insulin folate_B12245.96 / folate_B12145.96 STOP non-GDM 0.976 (0.949, 1.004) 0.09 Insulin folate_B12245.96 / folate_B12145.96 SCOPE GDM 1.002 (0.913, 1.099) 1.0 Insulin folate_B12245.96 / folate_B12145.96 STOP GDM 0.979 (0.927, 1.034) 0.4 HOMA.IR folate_B12245.96 / folate_B12145.96 SCOPE non-GDM 1.003 (0.965, 1.041) 0.9 HOMA.IR folate_B12245.96 / folate_B12145.96 STOP non-GDM 0.975 (0.946, 1.004) 0.09 HOMA.IR folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.987 (0.879, 1.109) 0.8 HOMA.IR folate_B12245.96 / folate_B12145.96 STOP GDM 0.973 (0.918, 1.033) 0.4 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 SCOPE non-GDM 1.000 (0.994, 1.006) 0.9 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 STOP non-GDM 1.004 (0.995, 1.012) 0.4 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 SCOPE GDM 0.986 (0.961, 1.010) 0.3 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 STOP GDM 0.989 (0.973, 1.006) 0.2 61.4.4.2 Between Groups Below are comparisons of the differences in the change in Folate:B12 ratio between groups. I.e. whether the change in Folate:B12 ratio are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.059647 0.0365028 2086.782 0.9904256 1.133706 0.093 ns STOP/SCOPE (non-GDM) 1.029392 0.0177303 2086.782 0.9952013 1.064756 0.093 ns STOP/SCOPE (GDM) 1.029392 0.0177303 2086.782 0.9952013 1.064756 0.093 ns GDM/non-GDM (SCOPE) 1.006263 0.0239070 1986.639 0.9604531 1.054258 0.793 ns GDM/non-GDM (STOP) 1.006263 0.0239070 1986.639 0.9604531 1.054258 0.793 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9885105 0.0182531 1977.580 0.9533537 1.024964 0.532 ns STOP/SCOPE (non-GDM) 0.9942387 0.0091794 1977.580 0.9763983 1.012405 0.532 ns STOP/SCOPE (GDM) 0.9942387 0.0091794 1977.580 0.9763983 1.012405 0.532 ns GDM/non-GDM (SCOPE) 0.9974014 0.0126798 1827.563 0.9728405 1.022582 0.838 ns GDM/non-GDM (STOP) 0.9974014 0.0126798 1827.563 0.9728405 1.022582 0.838 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.012904 0.0260314 2086.194 0.9631187 1.065262 0.618 ns STOP/SCOPE (non-GDM) 1.006431 0.0129325 2086.194 0.9813861 1.032115 0.618 ns STOP/SCOPE (GDM) 1.006431 0.0129325 2086.194 0.9813861 1.032115 0.618 ns GDM/non-GDM (SCOPE) 1.005274 0.0178169 1979.419 0.9709322 1.040830 0.767 ns GDM/non-GDM (STOP) 1.005274 0.0178169 1979.419 0.9709322 1.040830 0.767 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9513796 0.0568495 Inf 0.8462341 1.069590 0.404 ns STOP/SCOPE (non-GDM) 0.9732677 0.0228460 Inf 0.9295049 1.019091 0.248 ns STOP/SCOPE (GDM) 0.9775107 0.0537323 Inf 0.8776720 1.088706 0.679 ns GDM/non-GDM (SCOPE) 0.9985106 0.0508678 Inf 0.9036274 1.103357 0.977 ns GDM/non-GDM (STOP) 1.0028636 0.0313648 Inf 0.9432360 1.066261 0.927 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9584520 0.0681427 Inf 0.8337825 1.101762 0.551 ns STOP/SCOPE (non-GDM) 0.9722000 0.0240018 Inf 0.9262774 1.020399 0.253 ns STOP/SCOPE (GDM) 0.9858588 0.0657369 Inf 0.8650810 1.123499 0.831 ns GDM/non-GDM (SCOPE) 0.9848630 0.0615982 Inf 0.8712394 1.113305 0.807 ns GDM/non-GDM (STOP) 0.9986997 0.0337874 Inf 0.9346254 1.067167 0.969 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0067462 0.0119709 Inf 0.9835551 1.030484 0.572 ns STOP/SCOPE (non-GDM) 1.0033674 0.0059653 Inf 0.9917434 1.015128 0.572 ns STOP/SCOPE (GDM) 1.0033674 0.0059653 Inf 0.9917434 1.015128 0.572 ns GDM/non-GDM (SCOPE) 0.9853927 0.0108380 Inf 0.9643779 1.006865 0.181 ns GDM/non-GDM (STOP) 0.9853927 0.0108380 Inf 0.9643779 1.006865 0.181 ns 61.4.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 61.4.6 Plots "],["active-b12-9.html", "61.5 Active B12", " 61.5 Active B12 61.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 250.7924480 1 &lt;0.0001 *** Study 3.2136720 1 0.07 ns f39_gdm_new 0.5754347 1 0.4 ns BMI 3.3368238 1 0.07 ns Ethnicity_cauc 105.4219556 1 &lt;0.0001 *** f10c_any_cig_1st_vst 49.1590682 1 &lt;0.0001 *** GA_samp 164.6323095 1 &lt;0.0001 *** Study:f39_gdm_new 1.8652579 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.8759535 1 &lt;0.0001 *** Study 7.3986291 1 0.007 ** f39_gdm_new 0.4357432 1 0.5 ns BMI 236.2094019 1 &lt;0.0001 *** Ethnicity_cauc 5.5165373 1 0.02 * f10c_any_cig_1st_vst 0.9176455 1 0.3 ns GA_samp 2601.9722143 1 &lt;0.0001 *** Study:f39_gdm_new 1.4845286 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 251.096669 1 &lt;0.0001 *** Study 1.107622 1 0.3 ns f39_gdm_new 1.386104 1 0.2 ns BMI 87.622496 1 &lt;0.0001 *** Ethnicity_cauc 3.246832 1 0.07 ns f10c_any_cig_1st_vst 1.039153 1 0.3 ns GA_samp 1032.266869 1 &lt;0.0001 *** Study:f39_gdm_new 3.376951 1 0.07 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.326 21.326 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 33.726 33.726 &lt;0.0001 *** 4 BMI 1 Inf 330.722 330.722 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 25.046 25.046 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 3.158 3.158 0.08 ns 7 GA_samp 1 Inf 2.506 2.506 0.1 ns 2 Study:f39_gdm_new 1 Inf 4.089 4.089 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 36.051 36.051 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 32.027 32.027 &lt;0.0001 *** 4 BMI 1 Inf 316.807 316.807 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 24.882 24.882 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 2.618 2.618 0.1 ns 7 GA_samp 1 Inf 1.602 1.602 0.2 ns 2 Study:f39_gdm_new 1 Inf 4.361 4.361 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 53.182 53.182 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 4.345 4.345 0.04 * 4 BMI 1 Inf 11.449 11.449 0.0007 *** 5 Ethnicity_cauc 1 Inf 0.718 0.718 0.4 ns 6 f10c_any_cig_1st_vst 1 Inf 0.028 0.028 0.9 ns 7 GA_samp 1 Inf 0.278 0.278 0.6 ns 2 Study:f39_gdm_new 1 Inf 1.558 1.558 0.2 ns 61.5.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.77 (2.27, 3.26) &lt;0.0001 Active.B12 0.00 (-0.00, 0.00) 0.10 f39_gdm_newGDM -0.25 (-0.70, 0.20) 0.27 StudySTOP -0.02 (-0.26, 0.22) 0.88 GA_samp 0.13 (0.10, 0.16) &lt;0.0001 Active.B12:f39_gdm_newGDM 0.00 (-0.00, 0.01) 0.90 f39_gdm_newGDM:StudySTOP 0.22 (-0.09, 0.54) 0.15 Active.B12:StudySTOP -0.00 (-0.01, 0.00) 0.24 HPL Var Effect P (Intercept) 0.68 (0.42, 0.94) &lt;0.0001 Active.B12 -0.00 (-0.00, 0.00) 0.70 f39_gdm_newGDM -0.29 (-0.52, -0.06) 0.01 StudySTOP 0.09 (-0.04, 0.22) 0.19 GA_samp 0.29 (0.27, 0.30) &lt;0.0001 Active.B12:f39_gdm_newGDM 0.00 (0.00, 0.01) 0.05 f39_gdm_newGDM:StudySTOP 0.11 (-0.04, 0.27) 0.14 Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.72 GH2 Var Effect P (Intercept) -2.77 (-3.12, -2.42) &lt;0.0001 Active.B12 0.00 (-0.00, 0.00) 0.24 f39_gdm_newGDM -0.33 (-0.66, -0.01) 0.04 StudySTOP 0.12 (-0.06, 0.30) 0.19 GA_samp 0.27 (0.25, 0.29) &lt;0.0001 Active.B12:f39_gdm_newGDM 0.00 (-0.00, 0.01) 0.28 f39_gdm_newGDM:StudySTOP 0.20 (-0.01, 0.42) 0.07 Active.B12:StudySTOP -0.00 (-0.00, -0.00) 0.05 Insulin Var Effect P (Intercept) 2.48 (1.84, 3.11) &lt;0.0001 Active.B12 0.00 (-0.00, 0.01) 0.13 f39_gdm_newGDM 1.74 (0.69, 2.80) 0.001 StudySTOP -0.11 (-0.46, 0.23) 0.52 GA_samp 0.01 (-0.03, 0.04) 0.76 Active.B12:f39_gdm_newGDM -0.01 (-0.03, 0.00) 0.11 f39_gdm_newGDM:StudySTOP -1.03 (-2.28, 0.22) 0.11 Active.B12:StudySTOP -0.00 (-0.01, 0.00) 0.18 Active.B12:f39_gdm_newGDM:StudySTOP 0.01 (-0.01, 0.03) 0.26 HOMA.IR Var Effect P (Intercept) 1.14 (0.46, 1.82) 0.0010 Active.B12 0.00 (-0.00, 0.01) 0.09 f39_gdm_newGDM 1.95 (0.73, 3.17) 0.002 StudySTOP -0.23 (-0.60, 0.14) 0.23 GA_samp -0.00 (-0.04, 0.04) 0.91 Active.B12:f39_gdm_newGDM -0.01 (-0.03, 0.00) 0.09 f39_gdm_newGDM:StudySTOP -1.21 (-2.63, 0.20) 0.09 Active.B12:StudySTOP -0.00 (-0.01, 0.00) 0.11 Active.B12:f39_gdm_newGDM:StudySTOP 0.01 (-0.01, 0.03) 0.22 GLUC3_mmol.L Var Effect P (Intercept) 1.78 (1.66, 1.91) &lt;0.0001 Active.B12 0.00 (-0.00, 0.00) 0.69 f39_gdm_newGDM 0.28 (-0.02, 0.59) 0.06 StudySTOP -0.18 (-0.25, -0.11) &lt;0.0001 GA_samp -0.01 (-0.01, 0.00) 0.12 Active.B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.06 f39_gdm_newGDM:StudySTOP -0.13 (-0.30, 0.04) 0.14 Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.53 61.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 105.47360 8.797897 100.46567 89.38747 124.4546 STOP non-GDM 91.28296 7.311908 85.90561 77.84542 107.0401 SCOPE GDM 83.82405 13.286430 654.99319 61.40450 114.4293 STOP GDM 90.81424 9.510369 227.38215 73.88160 111.6276 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 93.33578 2.821670 211.1402 87.93602 99.06711 STOP non-GDM 103.94928 2.957134 170.7303 98.27290 109.95354 SCOPE GDM 82.17595 5.845062 532.8276 71.45985 94.49903 STOP GDM 102.60359 4.718066 563.5327 93.74263 112.30213 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.447513 0.0848546 355.6125 2.286195 2.620214 STOP non-GDM 2.358520 0.0749692 313.8559 2.215532 2.510736 SCOPE GDM 1.994865 0.1989180 729.4797 1.640193 2.426231 STOP GDM 2.359288 0.1347494 640.0163 2.108983 2.639302 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 15.43633 0.9590294 Inf 13.666600 17.43522 STOP non-GDM 11.05675 0.5725429 Inf 9.989654 12.23784 SCOPE GDM 40.65369 7.6148581 Inf 28.161842 58.68659 STOP GDM 19.40057 2.1825681 Inf 15.561599 24.18660 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.796055 0.2542084 Inf 3.329128 4.328470 STOP non-GDM 2.287413 0.1259047 Inf 2.053489 2.547984 SCOPE GDM 10.673449 2.3378803 Inf 6.948005 16.396435 STOP GDM 4.133515 0.4987094 Inf 3.263036 5.236211 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.504089 0.0649246 Inf 5.378299 5.632821 STOP non-GDM 4.721598 0.0523972 Inf 4.620010 4.825419 SCOPE GDM 6.412928 0.5706738 Inf 5.386536 7.634895 STOP GDM 4.828312 0.1019511 Inf 4.632570 5.032325 61.5.4 Comparisons 61.5.4.1 Within Groups Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin Active.B1271 / Active.B1261 SCOPE non-GDM 1.020 (0.996, 1.045) 0.10 Prolactin Active.B1271 / Active.B1261 STOP non-GDM 1.001 (0.979, 1.024) 0.9 Prolactin Active.B1271 / Active.B1261 SCOPE GDM 1.023 (0.973, 1.076) 0.4 Prolactin Active.B1271 / Active.B1261 STOP GDM 1.004 (0.960, 1.050) 0.9 HPL Active.B1271 / Active.B1261 SCOPE non-GDM 0.997 (0.985, 1.010) 0.7 HPL Active.B1271 / Active.B1261 STOP non-GDM 1.001 (0.989, 1.013) 0.9 HPL Active.B1271 / Active.B1261 SCOPE GDM 1.023 (0.996, 1.050) 0.09 HPL Active.B1271 / Active.B1261 STOP GDM 1.026 (1.002, 1.051) 0.03 GH2 Active.B1271 / Active.B1261 SCOPE non-GDM 1.011 (0.993, 1.028) 0.2 GH2 Active.B1271 / Active.B1261 STOP non-GDM 0.987 (0.971, 1.003) 0.1 GH2 Active.B1271 / Active.B1261 SCOPE GDM 1.031 (0.993, 1.070) 0.1 GH2 Active.B1271 / Active.B1261 STOP GDM 1.007 (0.974, 1.040) 0.7 Insulin Active.B1271 / Active.B1261 SCOPE non-GDM 1.028 (0.992, 1.066) 0.1 Insulin Active.B1271 / Active.B1261 STOP non-GDM 0.995 (0.963, 1.027) 0.7 Insulin Active.B1271 / Active.B1261 SCOPE GDM 0.914 (0.796, 1.049) 0.2 Insulin Active.B1271 / Active.B1261 STOP GDM 0.972 (0.900, 1.049) 0.5 HOMA.IR Active.B1271 / Active.B1261 SCOPE non-GDM 1.035 (0.995, 1.076) 0.09 HOMA.IR Active.B1271 / Active.B1261 STOP non-GDM 0.992 (0.960, 1.026) 0.6 HOMA.IR Active.B1271 / Active.B1261 SCOPE GDM 0.900 (0.770, 1.053) 0.2 HOMA.IR Active.B1271 / Active.B1261 STOP GDM 0.970 (0.892, 1.056) 0.5 GLUC3_mmol.L Active.B1271 / Active.B1261 SCOPE non-GDM 1.001 (0.995, 1.008) 0.7 GLUC3_mmol.L Active.B1271 / Active.B1261 STOP non-GDM 1.005 (0.997, 1.013) 0.2 GLUC3_mmol.L Active.B1271 / Active.B1261 SCOPE GDM 0.982 (0.959, 1.005) 0.1 GLUC3_mmol.L Active.B1271 / Active.B1261 STOP GDM 0.985 (0.968, 1.003) 0.10 61.5.4.2 Between Groups Below are comparisons of the differences in the change in Active B12 concentration (pM) between groups. I.e. whether the change in Active B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.962618 0.0313047 1074.736 0.9031115 1.026045 0.242 ns STOP/SCOPE (non-GDM) 0.981131 0.0159534 1074.736 0.9503218 1.012939 0.242 ns STOP/SCOPE (GDM) 0.981131 0.0159534 1074.736 0.9503218 1.012939 0.242 ns GDM/non-GDM (SCOPE) 1.002941 0.0244402 1057.071 0.9561131 1.052063 0.904 ns GDM/non-GDM (STOP) 1.002941 0.0244402 1057.071 0.9561131 1.052063 0.904 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.006290 0.0175121 1052.3229 0.9725073 1.041246 0.719 ns STOP/SCOPE (non-GDM) 1.003140 0.0087287 1052.3229 0.9861578 1.020415 0.719 ns STOP/SCOPE (GDM) 1.003140 0.0087287 1052.3229 0.9861578 1.020415 0.719 ns GDM/non-GDM (SCOPE) 1.025411 0.0131357 958.8608 0.9999541 1.051515 0.050 ns GDM/non-GDM (STOP) 1.025411 0.0131357 958.8608 0.9999541 1.051515 0.050 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9539858 0.0227571 1107.714 0.9103627 0.9996992 0.049 * STOP/SCOPE (non-GDM) 0.9767220 0.0116497 1107.714 0.9541293 0.9998496 0.049 * STOP/SCOPE (GDM) 0.9767220 0.0116497 1107.714 0.9541293 0.9998496 0.049 * GDM/non-GDM (SCOPE) 1.0197965 0.0183647 1081.377 0.9843912 1.0564752 0.277 ns GDM/non-GDM (STOP) 1.0197965 0.0183647 1081.377 0.9843912 1.0564752 0.277 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0284138 0.0865689 Inf 0.8719995 1.212885 0.739 ns STOP/SCOPE (non-GDM) 0.9673981 0.0237372 Inf 0.9219751 1.015059 0.177 ns STOP/SCOPE (GDM) 1.0630720 0.0857006 Inf 0.9076998 1.245040 0.448 ns GDM/non-GDM (SCOPE) 0.8892404 0.0647259 Inf 0.7710136 1.025596 0.107 ns GDM/non-GDM (STOP) 0.9771846 0.0414479 Inf 0.8992333 1.061893 0.586 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0334534 0.0973941 Inf 0.8591568 1.243109 0.727 ns STOP/SCOPE (non-GDM) 0.9588863 0.0250776 Inf 0.9109735 1.009319 0.108 ns STOP/SCOPE (GDM) 1.0777643 0.0976936 Inf 0.9023331 1.287303 0.409 ns GDM/non-GDM (SCOPE) 0.8701767 0.0714202 Inf 0.7408744 1.022046 0.090 ns GDM/non-GDM (STOP) 0.9780569 0.0454341 Inf 0.8929412 1.071286 0.633 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.007084 0.0112788 Inf 0.9852193 1.029435 0.528 ns STOP/SCOPE (non-GDM) 1.003536 0.0056195 Inf 0.9925821 1.014611 0.528 ns STOP/SCOPE (GDM) 1.003536 0.0056195 Inf 0.9925821 1.014611 0.528 ns GDM/non-GDM (SCOPE) 0.980328 0.0103639 Inf 0.9602242 1.000853 0.060 ns GDM/non-GDM (STOP) 0.980328 0.0103639 Inf 0.9602242 1.000853 0.060 ns 61.5.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 61.5.6 Plots "],["folateactive-b12-9.html", "61.6 Folate:Active B12", " 61.6 Folate:Active B12 61.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 250.7924480 1 &lt;0.0001 *** Study 3.2136720 1 0.07 ns f39_gdm_new 0.5754347 1 0.4 ns BMI 3.3368238 1 0.07 ns Ethnicity_cauc 105.4219556 1 &lt;0.0001 *** f10c_any_cig_1st_vst 49.1590682 1 &lt;0.0001 *** GA_samp 164.6323095 1 &lt;0.0001 *** Study:f39_gdm_new 1.8652579 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.8759535 1 &lt;0.0001 *** Study 7.3986291 1 0.007 ** f39_gdm_new 0.4357432 1 0.5 ns BMI 236.2094019 1 &lt;0.0001 *** Ethnicity_cauc 5.5165373 1 0.02 * f10c_any_cig_1st_vst 0.9176455 1 0.3 ns GA_samp 2601.9722143 1 &lt;0.0001 *** Study:f39_gdm_new 1.4845286 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 251.096669 1 &lt;0.0001 *** Study 1.107622 1 0.3 ns f39_gdm_new 1.386104 1 0.2 ns BMI 87.622496 1 &lt;0.0001 *** Ethnicity_cauc 3.246832 1 0.07 ns f10c_any_cig_1st_vst 1.039153 1 0.3 ns GA_samp 1032.266869 1 &lt;0.0001 *** Study:f39_gdm_new 3.376951 1 0.07 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.326 21.326 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 33.726 33.726 &lt;0.0001 *** 4 BMI 1 Inf 330.722 330.722 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 25.046 25.046 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 3.158 3.158 0.08 ns 7 GA_samp 1 Inf 2.506 2.506 0.1 ns 2 Study:f39_gdm_new 1 Inf 4.089 4.089 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 36.051 36.051 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 32.027 32.027 &lt;0.0001 *** 4 BMI 1 Inf 316.807 316.807 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 24.882 24.882 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 2.618 2.618 0.1 ns 7 GA_samp 1 Inf 1.602 1.602 0.2 ns 2 Study:f39_gdm_new 1 Inf 4.361 4.361 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 53.182 53.182 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 4.345 4.345 0.04 * 4 BMI 1 Inf 11.449 11.449 0.0007 *** 5 Ethnicity_cauc 1 Inf 0.718 0.718 0.4 ns 6 f10c_any_cig_1st_vst 1 Inf 0.028 0.028 0.9 ns 7 GA_samp 1 Inf 0.278 0.278 0.6 ns 2 Study:f39_gdm_new 1 Inf 1.558 1.558 0.2 ns 61.6.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.93 (2.45, 3.41) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.05 f39_gdm_newGDM -0.24 (-0.55, 0.07) 0.13 StudySTOP -0.23 (-0.40, -0.06) 0.008 GA_samp 0.13 (0.10, 0.16) &lt;0.0001 folate_Active.B12:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.60 f39_gdm_newGDM:StudySTOP 0.21 (-0.10, 0.52) 0.17 folate_Active.B12:StudySTOP 0.00 (0.00, 0.00) 0.03 HPL Var Effect P (Intercept) 0.67 (0.42, 0.93) &lt;0.0001 folate_Active.B12 0.00 (-0.00, 0.00) 0.65 f39_gdm_newGDM -0.13 (-0.28, 0.02) 0.09 StudySTOP 0.16 (0.07, 0.25) 0.0005 GA_samp 0.29 (0.27, 0.30) &lt;0.0001 folate_Active.B12:f39_gdm_newGDM 0.00 (-0.00, 0.00) 0.53 f39_gdm_newGDM:StudySTOP 0.11 (-0.04, 0.26) 0.15 folate_Active.B12:StudySTOP -0.00 (-0.00, -0.00) 0.02 GH2 Var Effect P (Intercept) -2.68 (-3.03, -2.34) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.13 f39_gdm_newGDM -0.17 (-0.38, 0.05) 0.13 StudySTOP -0.07 (-0.19, 0.06) 0.28 GA_samp 0.27 (0.25, 0.29) &lt;0.0001 folate_Active.B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.89 f39_gdm_newGDM:StudySTOP 0.18 (-0.04, 0.40) 0.11 folate_Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.29 Insulin Var Effect P (Intercept) 2.66 (2.05, 3.26) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.66 f39_gdm_newGDM 0.97 (0.43, 1.51) 0.0004 StudySTOP -0.31 (-0.54, -0.07) 0.01 GA_samp 0.01 (-0.03, 0.04) 0.74 folate_Active.B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.69 f39_gdm_newGDM:StudySTOP -0.35 (-0.96, 0.25) 0.25 folate_Active.B12:StudySTOP -0.00 (-0.00, 0.00) 0.89 folate_Active.B12:f39_gdm_newGDM:StudySTOP -0.00 (-0.00, 0.00) 0.68 HOMA.IR Var Effect P (Intercept) 1.36 (0.71, 2.00) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.65 f39_gdm_newGDM 1.04 (0.42, 1.66) 0.001 StudySTOP -0.47 (-0.73, -0.22) 0.0002 GA_samp -0.00 (-0.04, 0.04) 0.94 folate_Active.B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.65 f39_gdm_newGDM:StudySTOP -0.37 (-1.06, 0.32) 0.29 folate_Active.B12:StudySTOP -0.00 (-0.00, 0.00) 0.89 folate_Active.B12:f39_gdm_newGDM:StudySTOP -0.00 (-0.00, 0.00) 0.60 GLUC3_mmol.L Var Effect P (Intercept) 1.81 (1.68, 1.95) &lt;0.0001 folate_Active.B12 -0.00 (-0.00, 0.00) 0.16 f39_gdm_newGDM 0.17 (-0.01, 0.36) 0.07 StudySTOP -0.16 (-0.20, -0.11) &lt;0.0001 GA_samp -0.01 (-0.02, 0.00) 0.10 folate_Active.B12:f39_gdm_newGDM -0.00 (-0.00, 0.00) 0.08 f39_gdm_newGDM:StudySTOP -0.13 (-0.31, 0.05) 0.15 folate_Active.B12:StudySTOP 0.00 (-0.00, 0.00) 0.79 61.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 103.67295 8.607879 98.74735 87.92535 122.2410 STOP non-GDM 91.59491 7.337537 85.97214 78.11050 107.4072 SCOPE GDM 84.74948 13.335572 646.80044 62.22243 115.4322 STOP GDM 92.62091 9.551892 215.33962 75.58393 113.4981 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 93.68393 2.807221 204.3840 88.30943 99.38552 STOP non-GDM 103.51862 2.950107 171.1750 97.85610 109.50880 SCOPE GDM 84.16705 5.935862 553.3811 73.27903 96.67284 STOP GDM 104.09156 4.692758 537.1804 95.26956 113.73048 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.424603 0.0833960 340.9341 2.265994 2.594315 STOP non-GDM 2.353344 0.0753146 311.0320 2.209722 2.506299 SCOPE GDM 2.035655 0.2011072 715.8881 1.676755 2.471376 STOP GDM 2.364709 0.1320586 607.8943 2.119079 2.638812 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 15.14587 0.9305930 Inf 13.427488 17.08417 STOP non-GDM 11.03849 0.5683307 Inf 9.978941 12.21054 SCOPE GDM 38.40424 7.6683352 Inf 25.966668 56.79919 STOP GDM 18.65766 1.9151286 Inf 15.257560 22.81547 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.705064 0.2450049 Inf 3.254680 4.217773 STOP non-GDM 2.283943 0.1252114 Inf 2.051258 2.543022 SCOPE GDM 10.010554 2.3228700 Inf 6.352483 15.775121 STOP GDM 3.959116 0.4342997 Inf 3.193190 4.908759 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.505121 0.0619100 Inf 5.385107 5.627809 STOP non-GDM 4.722670 0.0538362 Inf 4.618323 4.829374 SCOPE GDM 6.276927 0.5367242 Inf 5.308391 7.422174 STOP GDM 4.726920 0.0774446 Inf 4.577542 4.881171 61.6.4 Comparisons 61.6.4.1 Within Groups Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE non-GDM 0.965 (0.931, 1.000) 0.05 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 STOP non-GDM 1.025 (0.983, 1.070) 0.2 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.986 (0.907, 1.073) 0.7 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 1.048 (0.975, 1.126) 0.2 HPL folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE non-GDM 1.004 (0.986, 1.023) 0.6 HPL folate_Active.B121123.57 / folate_Active.B12623.57 STOP non-GDM 0.970 (0.948, 0.993) 0.010 HPL folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 1.018 (0.974, 1.064) 0.4 HPL folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.983 (0.946, 1.022) 0.4 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE non-GDM 0.980 (0.956, 1.006) 0.1 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 STOP non-GDM 1.002 (0.970, 1.036) 0.9 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.976 (0.917, 1.039) 0.4 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.998 (0.946, 1.053) 0.9 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE non-GDM 0.986 (0.927, 1.049) 0.7 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 STOP non-GDM 0.981 (0.931, 1.033) 0.5 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.966 (0.889, 1.049) 0.4 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.931 (0.851, 1.019) 0.1 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE non-GDM 0.985 (0.921, 1.053) 0.7 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 STOP non-GDM 0.979 (0.926, 1.034) 0.4 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.958 (0.870, 1.055) 0.4 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.913 (0.833, 1.001) 0.05 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE non-GDM 0.996 (0.989, 1.002) 0.2 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 STOP non-GDM 0.997 (0.985, 1.010) 0.7 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE GDM 0.973 (0.947, 1.000) 0.05 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 STOP GDM 0.975 (0.955, 0.995) 0.01 61.6.4.2 Between Groups Below are comparisons of the differences in the change in Folate:Active B12 ratio between groups. I.e. whether the change in Folate:Active B12 ratio are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.129008 0.0624241 1070.3772 1.0129309 1.258387 0.028 * STOP/SCOPE (non-GDM) 1.062548 0.0293747 1070.3772 1.0064447 1.121778 0.028 * STOP/SCOPE (GDM) 1.062548 0.0293747 1070.3772 1.0064447 1.121778 0.028 * GDM/non-GDM (SCOPE) 1.021830 0.0416747 972.1293 0.9432344 1.106975 0.597 ns GDM/non-GDM (STOP) 1.021830 0.0416747 972.1293 0.9432344 1.106975 0.597 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9332675 0.0273714 1027.9503 0.8810737 0.9885533 0.019 * STOP/SCOPE (non-GDM) 0.9660577 0.0141665 1027.9503 0.9386552 0.9942602 0.019 * STOP/SCOPE (GDM) 0.9660577 0.0141665 1027.9503 0.9386552 0.9942602 0.019 * GDM/non-GDM (SCOPE) 1.0135354 0.0219233 891.5394 0.9714087 1.0574889 0.534 ns GDM/non-GDM (STOP) 1.0135354 0.0219233 891.5394 0.9714087 1.0574889 0.534 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0448347 0.0434404 1080.3324 0.9629818 1.133645 0.292 ns STOP/SCOPE (non-GDM) 1.0221715 0.0212491 1080.3324 0.9813163 1.064728 0.292 ns STOP/SCOPE (GDM) 1.0221715 0.0212491 1080.3324 0.9813163 1.064728 0.292 ns GDM/non-GDM (SCOPE) 0.9956797 0.0302511 977.0011 0.9380501 1.056850 0.887 ns GDM/non-GDM (STOP) 0.9956797 0.0302511 977.0011 0.9380501 1.056850 0.887 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9587955 0.0717422 Inf 0.8280079 1.110242 0.574 ns STOP/SCOPE (non-GDM) 0.9942499 0.0408609 Inf 0.9173046 1.077650 0.888 ns STOP/SCOPE (GDM) 0.9643405 0.0603443 Inf 0.8530331 1.090172 0.562 ns GDM/non-GDM (SCOPE) 0.9792031 0.0517149 Inf 0.8829132 1.085994 0.691 ns GDM/non-GDM (STOP) 0.9497463 0.0504299 Inf 0.8558748 1.053913 0.332 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9471149 0.0769590 Inf 0.8076762 1.110627 0.504 ns STOP/SCOPE (non-GDM) 0.9938934 0.0442180 Inf 0.9108989 1.084450 0.890 ns STOP/SCOPE (GDM) 0.9529341 0.0648199 Inf 0.8339941 1.088837 0.478 ns GDM/non-GDM (SCOPE) 0.9728165 0.0584730 Inf 0.8647047 1.094445 0.647 ns GDM/non-GDM (STOP) 0.9327258 0.0510453 Inf 0.8378577 1.038336 0.203 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0038962 0.0144286 Inf 0.9760112 1.032578 0.787 ns STOP/SCOPE (non-GDM) 1.0019462 0.0072003 Inf 0.9879328 1.016158 0.787 ns STOP/SCOPE (GDM) 1.0019462 0.0072003 Inf 0.9879328 1.016158 0.787 ns GDM/non-GDM (SCOPE) 0.9772807 0.0126769 Inf 0.9527476 1.002446 0.076 ns GDM/non-GDM (STOP) 0.9772807 0.0126769 Inf 0.9527476 1.002446 0.076 ns 61.6.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 61.6.6 Plots "],["homocysteine-9.html", "61.7 Homocysteine", " 61.7 Homocysteine 61.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 250.7924480 1 &lt;0.0001 *** Study 3.2136720 1 0.07 ns f39_gdm_new 0.5754347 1 0.4 ns BMI 3.3368238 1 0.07 ns Ethnicity_cauc 105.4219556 1 &lt;0.0001 *** f10c_any_cig_1st_vst 49.1590682 1 &lt;0.0001 *** GA_samp 164.6323095 1 &lt;0.0001 *** Study:f39_gdm_new 1.8652579 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.8759535 1 &lt;0.0001 *** Study 7.3986291 1 0.007 ** f39_gdm_new 0.4357432 1 0.5 ns BMI 236.2094019 1 &lt;0.0001 *** Ethnicity_cauc 5.5165373 1 0.02 * f10c_any_cig_1st_vst 0.9176455 1 0.3 ns GA_samp 2601.9722143 1 &lt;0.0001 *** Study:f39_gdm_new 1.4845286 1 0.2 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 251.096669 1 &lt;0.0001 *** Study 1.107622 1 0.3 ns f39_gdm_new 1.386104 1 0.2 ns BMI 87.622496 1 &lt;0.0001 *** Ethnicity_cauc 3.246832 1 0.07 ns f10c_any_cig_1st_vst 1.039153 1 0.3 ns GA_samp 1032.266869 1 &lt;0.0001 *** Study:f39_gdm_new 3.376951 1 0.07 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 21.326 21.326 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 33.726 33.726 &lt;0.0001 *** 4 BMI 1 Inf 330.722 330.722 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 25.046 25.046 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 3.158 3.158 0.08 ns 7 GA_samp 1 Inf 2.506 2.506 0.1 ns 2 Study:f39_gdm_new 1 Inf 4.089 4.089 0.04 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 36.051 36.051 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 32.027 32.027 &lt;0.0001 *** 4 BMI 1 Inf 316.807 316.807 &lt;0.0001 *** 5 Ethnicity_cauc 1 Inf 24.882 24.882 &lt;0.0001 *** 6 f10c_any_cig_1st_vst 1 Inf 2.618 2.618 0.1 ns 7 GA_samp 1 Inf 1.602 1.602 0.2 ns 2 Study:f39_gdm_new 1 Inf 4.361 4.361 0.04 * GLUC3_mmol.L model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 53.182 53.182 &lt;0.0001 *** 3 f39_gdm_new 1 Inf 4.345 4.345 0.04 * 4 BMI 1 Inf 11.449 11.449 0.0007 *** 5 Ethnicity_cauc 1 Inf 0.718 0.718 0.4 ns 6 f10c_any_cig_1st_vst 1 Inf 0.028 0.028 0.9 ns 7 GA_samp 1 Inf 0.278 0.278 0.6 ns 2 Study:f39_gdm_new 1 Inf 1.558 1.558 0.2 ns 61.7.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 3.11 (2.71, 3.51) &lt;0.0001 Homocysteine -0.06 (-0.10, -0.02) 0.002 f39_gdm_newGDM -0.12 (-0.55, 0.30) 0.57 StudySTOP 0.01 (-0.25, 0.26) 0.95 GA_samp 0.13 (0.11, 0.16) &lt;0.0001 Homocysteine:f39_gdm_newGDM 0.00 (-0.09, 0.09) 0.97 f39_gdm_newGDM:StudySTOP 0.17 (-0.06, 0.40) 0.15 Homocysteine:StudySTOP -0.01 (-0.06, 0.04) 0.79 HPL Var Effect P (Intercept) 0.68 (0.47, 0.89) &lt;0.0001 Homocysteine -0.00 (-0.02, 0.02) 0.80 f39_gdm_newGDM 0.20 (-0.02, 0.43) 0.08 StudySTOP 0.14 (0.00, 0.28) 0.05 GA_samp 0.29 (0.28, 0.30) &lt;0.0001 Homocysteine:f39_gdm_newGDM -0.07 (-0.12, -0.02) 0.006 f39_gdm_newGDM:StudySTOP 0.12 (-0.00, 0.24) 0.05 Homocysteine:StudySTOP -0.01 (-0.04, 0.02) 0.47 GH2 Var Effect P (Intercept) -2.55 (-2.83, -2.26) &lt;0.0001 Homocysteine -0.01 (-0.04, 0.01) 0.34 f39_gdm_newGDM 0.01 (-0.31, 0.33) 0.95 StudySTOP -0.11 (-0.30, 0.08) 0.25 GA_samp 0.26 (0.25, 0.28) &lt;0.0001 Homocysteine:f39_gdm_newGDM -0.04 (-0.11, 0.03) 0.23 f39_gdm_newGDM:StudySTOP 0.21 (0.04, 0.38) 0.02 Homocysteine:StudySTOP 0.02 (-0.02, 0.06) 0.31 Insulin Var Effect P (Intercept) 2.89 (2.35, 3.42) &lt;0.0001 Homocysteine -0.09 (-0.15, -0.03) 0.003 f39_gdm_newGDM 2.65 (1.49, 3.81) &lt;0.0001 StudySTOP -0.50 (-0.87, -0.12) 0.009 GA_samp 0.01 (-0.01, 0.04) 0.34 Homocysteine:f39_gdm_newGDM -0.46 (-0.73, -0.19) 0.0009 f39_gdm_newGDM:StudySTOP -1.67 (-3.07, -0.27) 0.02 Homocysteine:StudySTOP 0.05 (-0.02, 0.13) 0.16 Homocysteine:f39_gdm_newGDM:StudySTOP 0.36 (0.05, 0.68) 0.02 HOMA.IR Var Effect P (Intercept) 1.53 (0.97, 2.09) &lt;0.0001 Homocysteine -0.10 (-0.16, -0.03) 0.004 f39_gdm_newGDM 3.15 (1.87, 4.42) &lt;0.0001 StudySTOP -0.68 (-1.08, -0.29) 0.0008 GA_samp 0.01 (-0.02, 0.04) 0.48 Homocysteine:f39_gdm_newGDM -0.56 (-0.86, -0.26) 0.0003 f39_gdm_newGDM:StudySTOP -2.09 (-3.61, -0.57) 0.007 Homocysteine:StudySTOP 0.06 (-0.02, 0.14) 0.13 Homocysteine:f39_gdm_newGDM:StudySTOP 0.45 (0.11, 0.80) 0.01 GLUC3_mmol.L Var Effect P (Intercept) 1.78 (1.67, 1.88) &lt;0.0001 Homocysteine -0.01 (-0.02, -0.00) 0.04 f39_gdm_newGDM 0.28 (0.07, 0.49) 0.01 StudySTOP -0.21 (-0.29, -0.13) &lt;0.0001 GA_samp -0.00 (-0.01, 0.00) 0.44 Homocysteine:f39_gdm_newGDM -0.04 (-0.08, -0.01) 0.02 f39_gdm_newGDM:StudySTOP -0.04 (-0.14, 0.05) 0.38 Homocysteine:StudySTOP 0.01 (-0.00, 0.03) 0.11 61.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 96.93739 7.296174 88.95225 83.47194 112.5750 STOP non-GDM 94.42804 6.740419 72.19629 81.90403 108.8671 SCOPE GDM 86.29793 11.316786 644.05049 66.70630 111.6436 STOP GDM 99.58158 8.611586 151.48308 83.94141 118.1359 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 89.75740 2.434609 165.1749 85.07688 94.69541 STOP non-GDM 98.35183 2.403120 110.6971 93.70319 103.23109 SCOPE GDM 77.80345 4.626732 1028.3059 69.23423 87.43330 STOP GDM 95.78898 3.472769 422.3345 89.20045 102.86414 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.335576 0.0685072 407.4216 2.204714 2.474207 STOP non-GDM 2.305160 0.0560001 242.9305 2.197450 2.418150 SCOPE GDM 1.911626 0.1586259 1590.5707 1.624489 2.249516 STOP GDM 2.335396 0.1003974 778.5315 2.146401 2.541033 Insulin Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 13.76166 0.7009121 Inf 12.45424 15.20633 STOP non-GDM 10.99489 0.4119179 Inf 10.21647 11.83261 SCOPE GDM 19.43257 3.5314927 Inf 13.60946 27.74723 STOP GDM 17.87600 1.3720792 Inf 15.37928 20.77804 HOMA.IR Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 3.323180 0.1801687 Inf 2.988170 3.695749 STOP non-GDM 2.290423 0.0903586 Inf 2.119997 2.474549 SCOPE GDM 4.672579 0.9614765 Inf 3.121799 6.993722 STOP GDM 3.846700 0.3156904 Inf 3.275156 4.517983 GLUC3_mmol.L Study f39_gdm_new response SE df asymp.LCL asymp.UCL SCOPE non-GDM 5.404288 0.0507698 Inf 5.305692 5.504717 STOP non-GDM 4.704599 0.0347705 Inf 4.636941 4.773244 SCOPE GDM 5.784732 0.2594083 Inf 5.298004 6.316176 STOP GDM 4.818902 0.0617816 Inf 4.699321 4.941526 61.7.4 Comparisons 61.7.4.1 Within Groups Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.943 (0.908, 0.979) 0.002 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 0.936 (0.904, 0.969) 0.0002 Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.944 (0.858, 1.040) 0.2 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.938 (0.860, 1.022) 0.1 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.997 (0.977, 1.018) 0.8 HPL Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 0.987 (0.968, 1.006) 0.2 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.930 (0.883, 0.980) 0.007 HPL Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.921 (0.878, 0.965) 0.0006 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.987 (0.959, 1.015) 0.3 GH2 Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 1.006 (0.980, 1.033) 0.7 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.946 (0.880, 1.017) 0.1 GH2 Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.964 (0.904, 1.029) 0.3 Insulin Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.913 (0.860, 0.970) 0.003 Insulin Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 0.964 (0.922, 1.009) 0.1 Insulin Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.576 (0.441, 0.751) &lt;0.0001 Insulin Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.874 (0.750, 1.018) 0.08 HOMA.IR Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.909 (0.852, 0.969) 0.004 HOMA.IR Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 0.968 (0.922, 1.015) 0.2 HOMA.IR Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.519 (0.386, 0.697) &lt;0.0001 HOMA.IR Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.869 (0.739, 1.022) 0.09 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.989 (0.979, 0.999) 0.04 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 1.002 (0.991, 1.014) 0.7 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.949 (0.913, 0.986) 0.008 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.962 (0.932, 0.992) 0.01 61.7.4.2 Between Groups Below are comparisons of the differences in the change in Homocysteine concentration (μM) between groups. I.e. whether the change in Homocysteine concentration (μM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9861581 0.0511233 2091.497 0.8908283 1.091689 0.788 ns STOP/SCOPE (non-GDM) 0.9930549 0.0257404 2091.497 0.9438370 1.044839 0.788 ns STOP/SCOPE (GDM) 0.9930549 0.0257404 2091.497 0.9438370 1.044839 0.788 ns GDM/non-GDM (SCOPE) 1.0016420 0.0462236 2092.797 0.9149739 1.096520 0.972 ns GDM/non-GDM (STOP) 1.0016420 0.0462236 2092.797 0.9149739 1.096520 0.972 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9797390 0.0278321 2083.436 0.9266499 1.0358696 0.471 ns STOP/SCOPE (non-GDM) 0.9898177 0.0140592 2083.436 0.9626266 1.0177768 0.471 ns STOP/SCOPE (GDM) 0.9898177 0.0140592 2083.436 0.9626266 1.0177768 0.471 ns GDM/non-GDM (SCOPE) 0.9327881 0.0235558 2057.435 0.8877176 0.9801468 0.006 ** GDM/non-GDM (STOP) 0.9327881 0.0235558 2057.435 0.8877176 0.9801468 0.006 ** GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0397700 0.0403462 2148.401 0.9635837 1.121980 0.315 ns STOP/SCOPE (non-GDM) 1.0196911 0.0197836 2148.401 0.9816230 1.059235 0.315 ns STOP/SCOPE (GDM) 1.0196911 0.0197836 2148.401 0.9816230 1.059235 0.315 ns GDM/non-GDM (SCOPE) 0.9587366 0.0333350 2148.890 0.8955433 1.026389 0.226 ns GDM/non-GDM (STOP) 0.9587366 0.0333350 2148.890 0.8955433 1.026389 0.226 ns Insulin contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.6020617 0.2577237 Inf 1.1688167 2.1958974 0.003 ** STOP/SCOPE (non-GDM) 1.0560852 0.0405808 Inf 0.9794696 1.1386939 0.156 ns STOP/SCOPE (GDM) 1.5169814 0.2371161 Inf 1.1166852 2.0607710 0.008 ** GDM/non-GDM (SCOPE) 0.6306635 0.0877335 Inf 0.4801584 0.8283442 0.0009 *** GDM/non-GDM (STOP) 0.9058973 0.0734865 Inf 0.7727329 1.0620098 0.223 ns HOMA.IR contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.7829760 0.3143551 Inf 1.2620333 2.5189536 0.001 ** STOP/SCOPE (non-GDM) 1.0645212 0.0438052 Inf 0.9820356 1.1539351 0.129 ns STOP/SCOPE (GDM) 1.6749089 0.2871760 Inf 1.1968677 2.3438847 0.003 ** GDM/non-GDM (SCOPE) 0.5707085 0.0878613 Inf 0.4220566 0.7717168 0.0003 *** GDM/non-GDM (STOP) 0.8979480 0.0772057 Inf 0.7586907 1.0627661 0.211 ns GLUC3_mmol.L contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0274009 0.0171900 Inf 0.9942555 1.0616512 0.106 ns STOP/SCOPE (non-GDM) 1.0136079 0.0084796 Inf 0.9971236 1.0303646 0.106 ns STOP/SCOPE (GDM) 1.0136079 0.0084796 Inf 0.9971236 1.0303646 0.106 ns GDM/non-GDM (SCOPE) 0.9593689 0.0171755 Inf 0.9262892 0.9936299 0.021 * GDM/non-GDM (STOP) 0.9593689 0.0171755 Inf 0.9262892 0.9936299 0.021 * 61.7.5 Diagnostics Model diagnositcs. Diagnositcs for PRL (ng/ml) Diagnositcs for hPL (μg/ml) Diagnositcs for GH2 (ng/ml) Diagnositcs for Insulin (uU/ml) Diagnositcs for HOMA-IR Diagnositcs for Glucose (mmol/L) 61.7.6 Plots "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
